1 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELP4 |
2.18952097632563e-05 |
|
2 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAX6 |
2.18952097632563e-05 |
|
3 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000212551.1 |
2.18952097632563e-05 |
|
4 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WT1 |
2.18952097632563e-05 |
|
5 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF3M |
2.18952097632563e-05 |
|
6 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC73 |
2.18952097632563e-05 |
|
7 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRRG4 |
2.18952097632563e-05 |
|
8 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
QSER1 |
2.18952097632563e-05 |
|
9 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEPDC7 |
2.18952097632563e-05 |
|
10 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCP11L1 |
2.18952097632563e-05 |
|
11 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSTF3 |
2.18952097632563e-05 |
|
12 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIPK3 |
2.18952097632563e-05 |
|
13 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1549L |
2.18952097632563e-05 |
|
14 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf91 |
2.18952097632563e-05 |
|
15 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD59 |
2.18952097632563e-05 |
|
16 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO3 |
2.18952097632563e-05 |
|
17 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMO2 |
2.18952097632563e-05 |
|
18 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPRIN1 |
2.18952097632563e-05 |
|
19 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAT10 |
2.18952097632563e-05 |
|
20 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABTB2 |
2.18952097632563e-05 |
|
21 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAT |
2.18952097632563e-05 |
|
22 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELF5 |
2.18952097632563e-05 |
|
23 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EHF |
2.18952097632563e-05 |
|
24 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APIP |
2.18952097632563e-05 |
|
25 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDHX |
2.18952097632563e-05 |
|
26 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1343 |
2.18952097632563e-05 |
|
27 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD44 |
2.19293667117482e-05 |
|
28 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC1A2 |
2.19293667117482e-05 |
|
29 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAMR1 |
2.19293667117482e-05 |
|
30 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FJX1 |
2.19293667117482e-05 |
|
31 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM44 |
2.19293667117482e-05 |
|
32 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LDLRAD3 |
2.19293667117482e-05 |
|
33 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3973 |
2.19293667117482e-05 |
|
34 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COMMD9 |
2.19293667117482e-05 |
|
35 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00610 |
2.19293667117482e-05 |
|
36 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR5L |
2.19293667117482e-05 |
|
37 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAF6 |
2.19293667117482e-05 |
|
38 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAG1 |
2.19293667117482e-05 |
|
39 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAG2 |
2.19293667117482e-05 |
|
40 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf74 |
2.19293667117482e-05 |
|
41 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000251838.1 |
2.19293667117482e-05 |
|
42 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LUZP2 |
0.000231234698565896 |
|
43 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL5P |
0.000684600376997246 |
|
44 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00583 |
0.000684600376997246 |
|
45 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFIB |
0.000684600376997246 |
|
46 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDHHC21 |
0.000684600376997246 |
|
47 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CER1 |
0.000684600376997246 |
|
48 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FREM1 |
0.000684600376997246 |
|
49 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC39B |
0.000684600376997246 |
|
50 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL157P |
0.000684600376997246 |
|
51 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNAPC3 |
0.000684600376997246 |
|
52 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSIP1 |
0.000684600376997246 |
|
53 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL98P |
0.000684600376997246 |
|
54 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC171 |
0.000684600376997246 |
|
55 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf92 |
0.000684600376997246 |
|
56 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BNC2 |
0.000684600376997246 |
|
57 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL720P |
0.000684600376997246 |
|
58 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNTLN |
0.000684600376997246 |
|
59 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3GL2 |
0.000684600376997246 |
|
60 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAMTSL1 |
0.000684600376997246 |
|
61 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3152 |
0.000684600376997246 |
|
62 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP258 |
0.000684600376997246 |
|
63 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM154A |
0.000684600376997246 |
|
64 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRAGA |
0.000684600376997246 |
|
65 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAUS6 |
0.000684600376997246 |
|
66 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA8 |
0.000684600376997246 |
|
67 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL158P |
0.000684600376997246 |
|
68 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLIN2 |
0.000684600376997246 |
|
69 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DENND4C |
0.000684600376997246 |
|
70 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238348.1 |
0.000684600376997246 |
|
71 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS6 |
0.000684600376997246 |
|
72 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACER2 |
0.000684600376997246 |
|
73 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC24A2 |
0.000684600376997246 |
|
74 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLLT3 |
0.000684600376997246 |
|
75 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4473 |
0.000684600376997246 |
|
76 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4474 |
0.000684600376997246 |
|
77 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOCAD |
0.000684600376997246 |
|
78 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPLAD2 |
0.000684600376997246 |
|
79 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNB1 |
0.000684600376997246 |
|
80 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNW1 |
0.000684600376997246 |
|
81 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNA21 |
0.000684600376997246 |
|
82 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNA4 |
0.000684600376997246 |
|
83 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNA10 |
0.000684600376997246 |
|
84 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNA16 |
0.000684600376997246 |
|
85 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNA7 |
0.000684600376997246 |
|
86 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNA17 |
0.000684600376997246 |
|
87 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNA14 |
0.000684600376997246 |
|
88 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNA5 |
0.000684600376997246 |
|
89 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL9 |
0.000684600376997246 |
|
90 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNA6 |
0.000684600376997246 |
|
91 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNA13 |
0.000684600376997246 |
|
92 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNA2 |
0.000684600376997246 |
|
93 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNA8 |
0.000684600376997246 |
|
94 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNA1 |
0.000684600376997246 |
|
95 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR31HG |
0.000684600376997246 |
|
96 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNE |
0.000684600376997246 |
|
97 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR31 |
0.000684600376997246 |
|
98 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD39|ENSG00000264379.1 |
0.000684600376997246 |
|
99 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL151P |
0.000684600376997246 |
|
100 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPRD |
0.000689242473090435 |
|
101 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP14 |
0.000777102643616301 |
|
102 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCPEP1 |
0.000777102643616301 |
|
103 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF126P1 |
0.000777102643616301 |
|
104 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSI2 |
0.000777102643616301 |
|
105 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL437P |
0.000777102643616301 |
|
106 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL449P |
0.000777102643616301 |
|
107 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC24 |
0.000889004513371705 |
|
108 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IMMP1L |
0.000889004513371705 |
|
109 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTAP |
0.000906863223243404 |
|
110 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC4C |
0.00103948297973333 |
|
111 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MASTL |
0.00180046083559793 |
|
112 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACBD5 |
0.00180046083559793 |
|
113 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC37A6P |
0.00180046083559793 |
|
114 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARMC4P1 |
0.00180046083559793 |
|
115 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTCHD3 |
0.00180046083559793 |
|
116 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB18 |
0.00180046083559793 |
|
117 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MKX |
0.00180046083559793 |
|
118 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARMC4 |
0.00180046083559793 |
|
119 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP132 |
0.00180046083559793 |
|
120 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPP7 |
0.00180046083559793 |
|
121 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000222666.1 |
0.00180046083559793 |
|
122 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP39 |
0.00180046083559793 |
|
123 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WAC |
0.00180046083559793 |
|
124 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU4ATAC6P |
0.00180046083559793 |
|
125 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAMBI |
0.00180046083559793 |
|
126 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00837 |
0.00180046083559793 |
|
127 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf126 |
0.00180046083559793 |
|
128 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP308 |
0.00180046083559793 |
|
129 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYZL1 |
0.00180046083559793 |
|
130 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTCHD3P1 |
0.00180046083559793 |
|
131 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SVIL |
0.00180046083559793 |
|
132 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR604 |
0.00180046083559793 |
|
133 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD115|ENSG00000212411.1 |
0.00180046083559793 |
|
134 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR938 |
0.00180046083559793 |
|
135 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1462 |
0.00180046083559793 |
|
136 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTPAP |
0.00180046083559793 |
|
137 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL241P |
0.00180046083559793 |
|
138 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP3K8 |
0.00180046083559793 |
|
139 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL63P |
0.00180046083559793 |
|
140 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYZL2 |
0.00180046083559793 |
|
141 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SVILP1 |
0.00180046083559793 |
|
142 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RCN1 |
0.00219371991862716 |
|
143 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKAP1 |
0.00231809039787279 |
|
144 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR158 |
0.00441763660798833 |
|
145 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP306 |
0.00441763660798833 |
|
146 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYO3A |
0.00441763660798833 |
|
147 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAD2 |
0.00441763660798833 |
|
148 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APBB1IP |
0.00441763660798833 |
|
149 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP307 |
0.00441763660798833 |
|
150 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00264 |
0.00441763660798833 |
|
151 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDSS1 |
0.00441763660798833 |
|
152 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABI1 |
0.00441763660798833 |
|
153 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA57|ENSG00000223027.1 |
0.00441763660798833 |
|
154 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238414.1 |
0.00441763660798833 |
|
155 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00614 |
0.00441763660798833 |
|
156 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD26 |
0.00441763660798833 |
|
157 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YME1L1 |
0.00441763660798833 |
|
158 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00708 |
0.00477588625624048 |
|
159 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP299 |
0.00477588625624048 |
|
160 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00709 |
0.00477588625624048 |
|
161 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFTA1P |
0.00477588625624048 |
|
162 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00710 |
0.00477588625624048 |
|
163 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CELF2 |
0.00477588625624048 |
|
164 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP6NL |
0.00477588625624048 |
|
165 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ECHDC3 |
0.00477588625624048 |
|
166 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PROSER2 |
0.00477588625624048 |
|
167 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UPF2 |
0.00477588625624048 |
|
168 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHTKD1 |
0.00477588625624048 |
|
169 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548AK |
0.00477588625624048 |
|
170 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC61A2 |
0.00477588625624048 |
|
171 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U6|ENSG00000272507.1 |
0.00477588625624048 |
|
172 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238900.1 |
0.00477588625624048 |
|
173 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDT5 |
0.00477588625624048 |
|
174 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC123 |
0.00477588625624048 |
|
175 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL232P |
0.00477588625624048 |
|
176 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL198P |
0.00477588625624048 |
|
177 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAMK1D |
0.00477588625624048 |
|
178 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD45|ENSG00000252438.1 |
0.00477588625624048 |
|
179 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC39P |
0.00477588625624048 |
|
180 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4480 |
0.00477588625624048 |
|
181 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548Q |
0.00477588625624048 |
|
182 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC3 |
0.00477588625624048 |
|
183 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP300 |
0.00477588625624048 |
|
184 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OPTN |
0.00477588625624048 |
|
185 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCM10 |
0.00477588625624048 |
|
186 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UCMA |
0.00477588625624048 |
|
187 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHYH |
0.00477588625624048 |
|
188 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEPHS1 |
0.00477588625624048 |
|
189 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BEND7 |
0.00477588625624048 |
|
190 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRPF18 |
0.00477588625624048 |
|
191 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRMD4A |
0.00477588625624048 |
|
192 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP301 |
0.00477588625624048 |
|
193 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4293 |
0.00477588625624048 |
|
194 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1265 |
0.00477588625624048 |
|
195 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM107B |
0.00477588625624048 |
|
196 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP302 |
0.00477588625624048 |
|
197 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDNF |
0.00477588625624048 |
|
198 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPA14 |
0.00477588625624048 |
|
199 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUV39H2 |
0.00477588625624048 |
|
200 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCLRE1C |
0.00477588625624048 |
|
201 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEIG1 |
0.00477588625624048 |
|
202 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OLAH |
0.00477588625624048 |
|
203 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACBD7 |
0.00477588625624048 |
|
204 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf111 |
0.00477588625624048 |
|
205 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NMT2 |
0.00477588625624048 |
|
206 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPP38 |
0.00477588625624048 |
|
207 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM171A1 |
0.00477588625624048 |
|
208 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGA8 |
0.00477588625624048 |
|
209 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM188A |
0.00477588625624048 |
|
210 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239130.1 |
0.00477588625624048 |
|
211 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000252537.1 |
0.00477588625624048 |
|
212 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238552.1 |
0.00477588625624048 |
|
213 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTER |
0.00477588625624048 |
|
214 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1QL3 |
0.00477588625624048 |
|
215 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RSU1 |
0.00477588625624048 |
|
216 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CUBN |
0.00477588625624048 |
|
217 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRDMT1 |
0.00477588625624048 |
|
218 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VIM |
0.00477588625624048 |
|
219 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST8SIA6 |
0.00477588625624048 |
|
220 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPLA |
0.00477588625624048 |
|
221 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAM |
0.00477588625624048 |
|
222 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoR442|ENSG00000251959.1 |
0.00477588625624048 |
|
223 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRC1L1 |
0.00477588625624048 |
|
224 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRC1 |
0.00477588625624048 |
|
225 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC39A12 |
0.00477588625624048 |
|
226 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM236|ENSG00000148483.7 |
0.00477588625624048 |
|
227 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM236|ENSG00000184040.7 |
0.00477588625624048 |
|
228 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNB2 |
0.00477588625624048 |
|
229 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NSUN6 |
0.00477588625624048 |
|
230 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL5B |
0.00477588625624048 |
|
231 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf112 |
0.00477588625624048 |
|
232 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000200545.1 |
0.00477588625624048 |
|
233 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP303 |
0.00477588625624048 |
|
234 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLXDC2 |
0.00477588625624048 |
|
235 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4675 |
0.00477588625624048 |
|
236 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEBL |
0.00477588625624048 |
|
237 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf113 |
0.00477588625624048 |
|
238 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000251749.1 |
0.00477588625624048 |
|
239 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASC10 |
0.00477588625624048 |
|
240 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1915 |
0.00477588625624048 |
|
241 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SKIDA1 |
0.00477588625624048 |
|
242 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLLT10 |
0.00477588625624048 |
|
243 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP219 |
0.00477588625624048 |
|
244 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP37 |
0.00477588625624048 |
|
245 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EBLN1 |
0.00477588625624048 |
|
246 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BMI1 |
0.00477588625624048 |
|
247 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COMMD3 |
0.00477588625624048 |
|
248 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPAG6 |
0.00477588625624048 |
|
249 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIP4K2A |
0.00477588625624048 |
|
250 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARMC3 |
0.00477588625624048 |
|
251 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP304 |
0.00477588625624048 |
|
252 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSRB2 |
0.00477588625624048 |
|
253 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA40|ENSG00000252049.1 |
0.00477588625624048 |
|
254 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTF1A |
0.00477588625624048 |
|
255 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf115 |
0.00477588625624048 |
|
256 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf67 |
0.00477588625624048 |
|
257 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238515.1 |
0.00477588625624048 |
|
258 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OTUD1 |
0.00477588625624048 |
|
259 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1217 |
0.00477588625624048 |
|
260 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR603 |
0.00477588625624048 |
|
261 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP21 |
0.00477588625624048 |
|
262 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP305 |
0.00477588625624048 |
|
263 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRTFDC1 |
0.00477588625624048 |
|
264 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP241 |
0.00477588625624048 |
|
265 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENKUR |
0.00477588625624048 |
|
266 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THNSL1 |
0.00477588625624048 |
|
267 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP220 |
0.00477588625624048 |
|
268 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HS6ST3 |
0.00731964254193851 |
|
269 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL240P |
0.0095193263984914 |
|
270 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNA4 |
0.0095193263984914 |
|
271 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FSHB |
0.0095193263984914 |
|
272 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL14EP |
0.0095193263984914 |
|
273 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPPED2 |
0.0095193263984914 |
|
274 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCDC1 |
0.0095193263984914 |
|
275 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PFAS |
0.0113892661087175 |
|
276 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A35 |
0.0113892661087175 |
|
277 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RANGRF |
0.0113892661087175 |
|
278 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF15 |
0.0113892661087175 |
|
279 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA69|ENSG00000212206.1 |
0.0113892661087175 |
|
280 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ODF4 |
0.0113892661087175 |
|
281 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRBA2 |
0.0113892661087175 |
|
282 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL26 |
0.0113892661087175 |
|
283 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF222 |
0.0113892661087175 |
|
284 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDEL1 |
0.0113892661087175 |
|
285 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYH10 |
0.0113892661087175 |
|
286 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL129P |
0.0113892661087175 |
|
287 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC42 |
0.0113892661087175 |
|
288 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPDYE4 |
0.0113892661087175 |
|
289 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFSD6L |
0.0113892661087175 |
|
290 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIK3R6 |
0.0113892661087175 |
|
291 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIK3R5 |
0.0113892661087175 |
|
292 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NTN1 |
0.0113892661087175 |
|
293 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STX8 |
0.0113892661087175 |
|
294 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POU3F4 |
0.0124302582387182 |
|
295 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYLC1 |
0.0124302582387182 |
|
296 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS6KA6 |
0.0124302582387182 |
|
297 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548I4 |
0.0124302582387182 |
|
298 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HDX |
0.0124302582387182 |
|
299 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOOL |
0.0124302582387182 |
|
300 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POF1B |
0.0124302582387182 |
|
301 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SATL1 |
0.0124302582387182 |
|
302 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2DNL |
0.0124302582387182 |
|
303 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF711 |
0.0124302582387182 |
|
304 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHM |
0.0124302582387182 |
|
305 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR361 |
0.0124302582387182 |
|
306 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DACH2 |
0.0124302582387182 |
|
307 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD45|ENSG00000200422.1 |
0.0124302582387182 |
|
308 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL4 |
0.0124302582387182 |
|
309 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACA64|ENSG00000252016.1 |
0.0124302582387182 |
|
310 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPXCR1 |
0.0124302582387182 |
|
311 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM133A |
0.0124302582387182 |
|
312 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAP1L3 |
0.0124302582387182 |
|
313 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548M |
0.0124302582387182 |
|
314 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL379P |
0.0124302582387182 |
|
315 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP510 |
0.0124302582387182 |
|
316 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP194 |
0.0124302582387182 |
|
317 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA25|ENSG00000252296.1 |
0.0124302582387182 |
|
318 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDH19 |
0.0124302582387182 |
|
319 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNMD |
0.0124302582387182 |
|
320 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPAN6 |
0.0124302582387182 |
|
321 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRPX2 |
0.0124302582387182 |
|
322 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYTL4 |
0.0124302582387182 |
|
323 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSTF2 |
0.0124302582387182 |
|
324 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA9|ENSG00000202231.1 |
0.0124302582387182 |
|
325 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOX1 |
0.0124302582387182 |
|
326 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL13A |
0.0124302582387182 |
|
327 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM35 |
0.0124302582387182 |
|
328 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRMT2B |
0.0124302582387182 |
|
329 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XKRX |
0.0124302582387182 |
|
330 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CENPI |
0.0124302582387182 |
|
331 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DRP2 |
0.0124302582387182 |
|
332 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAF7L |
0.0124302582387182 |
|
333 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTK |
0.0124302582387182 |
|
334 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIMM8A |
0.0124302582387182 |
|
335 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL36A |
0.0124302582387182 |
|
336 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLA |
0.0124302582387182 |
|
337 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPH2 |
0.0124302582387182 |
|
338 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARMCX4 |
0.0124302582387182 |
|
339 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARMCX1 |
0.0124302582387182 |
|
340 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARMCX6 |
0.0124302582387182 |
|
341 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARMCX3 |
0.0124302582387182 |
|
342 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARMCX2 |
0.0124302582387182 |
|
343 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NXF5 |
0.0124302582387182 |
|
344 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZMAT1 |
0.0124302582387182 |
|
345 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCEAL2 |
0.0124302582387182 |
|
346 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCEAL6 |
0.0124302582387182 |
|
347 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BEX5 |
0.0124302582387182 |
|
348 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCP11X3P |
0.0124302582387182 |
|
349 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NXF2 |
0.0124302582387182 |
|
350 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCP11X1 |
0.0124302582387182 |
|
351 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NXF2B |
0.0124302582387182 |
|
352 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCP11X2 |
0.0124302582387182 |
|
353 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMSB15A |
0.0124302582387182 |
|
354 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NXF4 |
0.0124302582387182 |
|
355 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARMCX5 |
0.0124302582387182 |
|
356 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPRASP1 |
0.0124302582387182 |
|
357 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPRASP2 |
0.0124302582387182 |
|
358 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BHLHB9 |
0.0124302582387182 |
|
359 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP511 |
0.0124302582387182 |
|
360 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMSB15B |
0.0124302582387182 |
|
361 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
H2BFM |
0.0124302582387182 |
|
362 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
H2BFWT |
0.0124302582387182 |
|
363 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A53 |
0.0124302582387182 |
|
364 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZCCHC18 |
0.0124302582387182 |
|
365 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM199X |
0.0124302582387182 |
|
366 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ESX1 |
0.0124302582387182 |
|
367 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL1RAPL2 |
0.0124302582387182 |
|
368 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MST4 |
0.0124302582387182 |
|
369 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRMD7 |
0.0124302582387182 |
|
370 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAP2C |
0.0124302582387182 |
|
371 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBNL3 |
0.0124302582387182 |
|
372 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HS6ST2 |
0.0124302582387182 |
|
373 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP26 |
0.0124302582387182 |
|
374 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA8|ENSG00000207100.1 |
0.0124302582387182 |
|
375 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFDP3 |
0.0124302582387182 |
|
376 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPC4 |
0.0124302582387182 |
|
377 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPC3 |
0.0124302582387182 |
|
378 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR106A |
0.0124302582387182 |
|
379 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR18B |
0.0124302582387182 |
|
380 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR19B2 |
0.0124302582387182 |
|
381 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR20B |
0.0124302582387182 |
|
382 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR363 |
0.0124302582387182 |
|
383 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR92A2 |
0.0124302582387182 |
|
384 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC160 |
0.0124302582387182 |
|
385 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHF6 |
0.0124302582387182 |
|
386 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HPRT1 |
0.0124302582387182 |
|
387 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR450A1 |
0.0124302582387182 |
|
388 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR450A2 |
0.0124302582387182 |
|
389 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR450B |
0.0124302582387182 |
|
390 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR503HG |
0.0124302582387182 |
|
391 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR542 |
0.0124302582387182 |
|
392 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR503 |
0.0124302582387182 |
|
393 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00629 |
0.0124302582387182 |
|
394 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLAC1 |
0.0124302582387182 |
|
395 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM122B |
0.0124302582387182 |
|
396 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM122C |
0.0124302582387182 |
|
397 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOSPD1 |
0.0124302582387182 |
|
398 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMIM10 |
0.0124302582387182 |
|
399 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM127C |
0.0124302582387182 |
|
400 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM127A |
0.0124302582387182 |
|
401 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM127B |
0.0124302582387182 |
|
402 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00087 |
0.0124302582387182 |
|
403 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00633 |
0.0124302582387182 |
|
404 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CT45A1 |
0.0124302582387182 |
|
405 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CT45A2 |
0.0124302582387182 |
|
406 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CT45A3 |
0.0124302582387182 |
|
407 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CT45A4 |
0.0124302582387182 |
|
408 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CT45A5 |
0.0124302582387182 |
|
409 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CT45A6 |
0.0124302582387182 |
|
410 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXorf48 |
0.0124302582387182 |
|
411 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX26B |
0.0124302582387182 |
|
412 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00086 |
0.0124302582387182 |
|
413 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP515 |
0.0124302582387182 |
|
414 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAGE1 |
0.0124302582387182 |
|
415 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF449 |
0.0124302582387182 |
|
416 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF75D |
0.0124302582387182 |
|
417 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMGT1 |
0.0124302582387182 |
|
418 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC9A6 |
0.0124302582387182 |
|
419 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239080.1 |
0.0124302582387182 |
|
420 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FHL1 |
0.0124302582387182 |
|
421 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP7D3 |
0.0124302582387182 |
|
422 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR112 |
0.0124302582387182 |
|
423 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRS3 |
0.0124302582387182 |
|
424 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTATSF1 |
0.0124302582387182 |
|
425 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VGLL1 |
0.0124302582387182 |
|
426 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR934 |
0.0124302582387182 |
|
427 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00892 |
0.0124302582387182 |
|
428 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD40LG |
0.0124302582387182 |
|
429 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF6 |
0.0124302582387182 |
|
430 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBMX |
0.0124302582387182 |
|
431 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD61|ENSG00000206979.1 |
0.0124302582387182 |
|
432 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR101 |
0.0124302582387182 |
|
433 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZIC3 |
0.0124302582387182 |
|
434 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL325P |
0.0124302582387182 |
|
435 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP31 |
0.0124302582387182 |
|
436 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGF13 |
0.0124302582387182 |
|
437 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR504 |
0.0124302582387182 |
|
438 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
F9 |
0.0124302582387182 |
|
439 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCF2 |
0.0124302582387182 |
|
440 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP11C |
0.0124302582387182 |
|
441 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXorf66 |
0.0124302582387182 |
|
442 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR505 |
0.0124302582387182 |
|
443 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL727P |
0.0124302582387182 |
|
444 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC23P |
0.0124302582387182 |
|
445 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA18|ENSG00000252719.1 |
0.0124302582387182 |
|
446 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238485.1 |
0.0124302582387182 |
|
447 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOX3 |
0.0124302582387182 |
|
448 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00632 |
0.0124302582387182 |
|
449 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDR1 |
0.0124302582387182 |
|
450 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR320D2 |
0.0124302582387182 |
|
451 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPANXB1 |
0.0124302582387182 |
|
452 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPANXB2 |
0.0124302582387182 |
|
453 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP94 |
0.0132358577882201 |
|
454 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL15 |
0.0134961753084003 |
|
455 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP158 |
0.0134961753084003 |
|
456 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP3B1 |
0.0149392419381001 |
|
457 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCAMP1 |
0.0149392419381001 |
|
458 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LHFPL2 |
0.0149392419381001 |
|
459 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARSB |
0.0149392419381001 |
|
460 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DMGDH |
0.0151375632794106 |
|
461 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BHMT2 |
0.0151375632794106 |
|
462 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BHMT |
0.0151375632794106 |
|
463 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY3P1 |
0.0151375632794106 |
|
464 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA18|ENSG00000206592.1 |
0.0151375632794106 |
|
465 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JMY |
0.0151375632794106 |
|
466 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOMER1 |
0.0151375632794106 |
|
467 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAPD4 |
0.0151375632794106 |
|
468 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CMYA5 |
0.0151375632794106 |
|
469 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTX3 |
0.0151375632794106 |
|
470 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THBS4 |
0.0151375632794106 |
|
471 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERINC5 |
0.0151375632794106 |
|
472 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239159.1 |
0.0151375632794106 |
|
473 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000251828.1 |
0.0151375632794106 |
|
474 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPZ1 |
0.0151375632794106 |
|
475 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFYVE16 |
0.0151375632794106 |
|
476 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM151B |
0.0151375632794106 |
|
477 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD34B |
0.0151375632794106 |
|
478 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHFR |
0.0151375632794106 |
|
479 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTRNR2L2 |
0.0151375632794106 |
|
480 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSH3 |
0.0151375632794106 |
|
481 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASGRF2 |
0.0151375632794106 |
|
482 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CKMT2 |
0.0151375632794106 |
|
483 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZCCHC9 |
0.0151375632794106 |
|
484 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACOT12 |
0.0151375632794106 |
|
485 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSBP2 |
0.0151375632794106 |
|
486 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATG10 |
0.0151375632794106 |
|
487 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL378P |
0.0151375632794106 |
|
488 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS23 |
0.0151375632794106 |
|
489 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6AP1L |
0.0151375632794106 |
|
490 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00630 |
0.0151555819559157 |
|
491 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB40AL |
0.0151555819559157 |
|
492 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BEX1 |
0.0151555819559157 |
|
493 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NXF3 |
0.0151555819559157 |
|
494 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BEX4 |
0.0151555819559157 |
|
495 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCEAL8 |
0.0151555819559157 |
|
496 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCEAL5 |
0.0151555819559157 |
|
497 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BEX2 |
0.0151555819559157 |
|
498 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCEAL7 |
0.0151555819559157 |
|
499 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WBP5 |
0.0151555819559157 |
|
500 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NGFRAP1 |
0.0151555819559157 |
|
501 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB40A |
0.0151555819559157 |
|
502 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCEAL4 |
0.0151555819559157 |
|
503 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCEAL3 |
0.0151555819559157 |
|
504 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCEAL1 |
0.0151555819559157 |
|
505 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MORF4L2 |
0.0151555819559157 |
|
506 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLRA4 |
0.0151555819559157 |
|
507 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM31 |
0.0151555819559157 |
|
508 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLP1 |
0.0151555819559157 |
|
509 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB9B |
0.0151555819559157 |
|
510 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR16 |
0.0152657616730298 |
|
511 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP43 |
0.0152657616730298 |
|
512 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHRS7C |
0.0152657616730298 |
|
513 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLP2R |
0.0152657616730298 |
|
514 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RCVRN |
0.0152657616730298 |
|
515 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAS7 |
0.0152657616730298 |
|
516 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYH13 |
0.0152657616730298 |
|
517 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYH8 |
0.0152657616730298 |
|
518 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYH4 |
0.0152657616730298 |
|
519 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYH1 |
0.0152657616730298 |
|
520 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYH2 |
0.0152657616730298 |
|
521 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYH3 |
0.0152657616730298 |
|
522 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCO1 |
0.0152657616730298 |
|
523 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADPRM |
0.0152657616730298 |
|
524 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM220 |
0.0152657616730298 |
|
525 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGOH2 |
0.0152657616730298 |
|
526 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00675 |
0.0152657616730298 |
|
527 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIRT |
0.0152657616730298 |
|
528 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL601P |
0.0152657616730298 |
|
529 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHISA6 |
0.0152657616730298 |
|
530 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAH9 |
0.0152657616730298 |
|
531 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF18 |
0.0152657616730298 |
|
532 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL21P122 |
0.0152657616730298 |
|
533 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP2K4 |
0.0152657616730298 |
|
534 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR744 |
0.0152657616730298 |
|
535 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00670 |
0.0152657616730298 |
|
536 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYOCD |
0.0152657616730298 |
|
537 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP44 |
0.0152657616730298 |
|
538 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1269B |
0.0152657616730298 |
|
539 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL550P |
0.0152657616730298 |
|
540 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELAC2 |
0.0152657616730298 |
|
541 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HS3ST3A1 |
0.0152657616730298 |
|
542 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548H3 |
0.0152657616730298 |
|
543 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX10 |
0.0152657616730298 |
|
544 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA74|ENSG00000252305.1 |
0.0152657616730298 |
|
545 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WSCD1 |
0.0154317348036435 |
|
546 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AIPL1 |
0.0154317348036435 |
|
547 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM64A |
0.0154317348036435 |
|
548 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACKR6 |
0.0154317348036435 |
|
549 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0753 |
0.0154317348036435 |
|
550 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP435 |
0.0154317348036435 |
|
551 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED31 |
0.0154317348036435 |
|
552 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TXNDC17 |
0.0154317348036435 |
|
553 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf100 |
0.0154317348036435 |
|
554 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4520B |
0.0154317348036435 |
|
555 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC13A5 |
0.0154317348036435 |
|
556 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XAF1 |
0.0154317348036435 |
|
557 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO39 |
0.0154317348036435 |
|
558 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEKT1 |
0.0154317348036435 |
|
559 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALOX12P2 |
0.0154317348036435 |
|
560 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALOX12 |
0.0154317348036435 |
|
561 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf49 |
0.0154317348036435 |
|
562 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR497HG |
0.0154317348036435 |
|
563 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNASEK |
0.0154317348036435 |
|
564 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCL6B |
0.0154317348036435 |
|
565 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC16A11 |
0.0154317348036435 |
|
566 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC16A13 |
0.0154317348036435 |
|
567 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC10A |
0.0154317348036435 |
|
568 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASGR2 |
0.0154317348036435 |
|
569 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASGR1 |
0.0154317348036435 |
|
570 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLG4 |
0.0154317348036435 |
|
571 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACADVL |
0.0154317348036435 |
|
572 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DVL2 |
0.0154317348036435 |
|
573 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR324 |
0.0154317348036435 |
|
574 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHF23 |
0.0154317348036435 |
|
575 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABARAP |
0.0154317348036435 |
|
576 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTDNEP1 |
0.0154317348036435 |
|
577 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELP5 |
0.0154317348036435 |
|
578 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLDN7 |
0.0154317348036435 |
|
579 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC2A4 |
0.0154317348036435 |
|
580 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YBX2 |
0.0154317348036435 |
|
581 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF5A |
0.0154317348036435 |
|
582 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPS2 |
0.0154317348036435 |
|
583 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEURL4 |
0.0154317348036435 |
|
584 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACAP1 |
0.0154317348036435 |
|
585 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCTD11 |
0.0154317348036435 |
|
586 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM95 |
0.0154317348036435 |
|
587 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNK1 |
0.0154317348036435 |
|
588 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLSCR3 |
0.0154317348036435 |
|
589 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NLGN2 |
0.0154317348036435 |
|
590 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM256 |
0.0154317348036435 |
|
591 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPEM1 |
0.0154317348036435 |
|
592 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf74 |
0.0154317348036435 |
|
593 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGF11 |
0.0154317348036435 |
|
594 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM102 |
0.0154317348036435 |
|
595 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRNB1 |
0.0154317348036435 |
|
596 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB4 |
0.0154317348036435 |
|
597 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35G6 |
0.0154317348036435 |
|
598 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR2A |
0.0154317348036435 |
|
599 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFSF12 |
0.0154317348036435 |
|
600 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SENP3 |
0.0154317348036435 |
|
601 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFSF13 |
0.0154317348036435 |
|
602 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF4A1 |
0.0154317348036435 |
|
603 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA48|ENSG00000209582.1 |
0.0154317348036435 |
|
604 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA67|ENSG00000264772.2 |
0.0154317348036435 |
|
605 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD10 |
0.0154317348036435 |
|
606 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD68 |
0.0154317348036435 |
|
607 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FXR2 |
0.0154317348036435 |
|
608 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPDU1 |
0.0154317348036435 |
|
609 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOX15 |
0.0154317348036435 |
|
610 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHBG |
0.0154317348036435 |
|
611 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000251860.1 |
0.0154317348036435 |
|
612 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAT2 |
0.0154317348036435 |
|
613 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP1B2 |
0.0154317348036435 |
|
614 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TP53 |
0.0154317348036435 |
|
615 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WRAP53 |
0.0154317348036435 |
|
616 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFNB3 |
0.0154317348036435 |
|
617 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAH2 |
0.0154317348036435 |
|
618 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL29P2 |
0.0154317348036435 |
|
619 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KDM6B |
0.0154317348036435 |
|
620 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYB5D1 |
0.0154317348036435 |
|
621 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LSMD1 |
0.0154317348036435 |
|
622 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM88 |
0.0154317348036435 |
|
623 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHD3 |
0.0154317348036435 |
|
624 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA21|ENSG00000252835.1 |
0.0154317348036435 |
|
625 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNAB3 |
0.0154317348036435 |
|
626 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNTROB |
0.0154317348036435 |
|
627 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAPPC1 |
0.0154317348036435 |
|
628 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GUCY2D |
0.0154317348036435 |
|
629 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238676.1 |
0.0154317348036435 |
|
630 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALOX15B |
0.0154317348036435 |
|
631 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALOX12B |
0.0154317348036435 |
|
632 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4314 |
0.0154317348036435 |
|
633 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALOXE3 |
0.0154317348036435 |
|
634 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HES7 |
0.0154317348036435 |
|
635 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PER1 |
0.0154317348036435 |
|
636 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VAMP2 |
0.0154317348036435 |
|
637 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD118 |
0.0154317348036435 |
|
638 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM107 |
0.0154317348036435 |
|
639 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf59 |
0.0154317348036435 |
|
640 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3676 |
0.0154317348036435 |
|
641 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AURKB |
0.0154317348036435 |
|
642 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00324 |
0.0154317348036435 |
|
643 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTC1 |
0.0154317348036435 |
|
644 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE4D |
0.0158536011779635 |
|
645 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR582 |
0.0158536011779635 |
|
646 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000251863.1 |
0.0163898909648805 |
|
647 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP154 |
0.0165201177446537 |
|
648 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUC5AC |
0.0169250489335524 |
|
649 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUC5B |
0.0169250489335524 |
|
650 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOLLIP |
0.0169250489335524 |
|
651 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRSK2 |
0.0169250489335524 |
|
652 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOB2 |
0.0169250489335524 |
|
653 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUSP8 |
0.0169250489335524 |
|
654 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTSD |
0.0169250489335524 |
|
655 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM99A |
0.0169250489335524 |
|
656 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM99B |
0.0169250489335524 |
|
657 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFITM10 |
0.0169250489335524 |
|
658 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LSP1|ENSG00000130592.9 |
0.0169250489335524 |
|
659 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4298 |
0.0169250489335524 |
|
660 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYT8 |
0.0169250489335524 |
|
661 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNNI2 |
0.0169250489335524 |
|
662 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf89 |
0.0169250489335524 |
|
663 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNNT3 |
0.0169250489335524 |
|
664 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL23 |
0.0169250489335524 |
|
665 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
H19 |
0.0169250489335524 |
|
666 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGF2 |
0.0169250489335524 |
|
667 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR483 |
0.0169250489335524 |
|
668 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INS |
0.0169250489335524 |
|
669 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4686 |
0.0169250489335524 |
|
670 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TH |
0.0169250489335524 |
|
671 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASCL2 |
0.0169250489335524 |
|
672 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf21 |
0.0169250489335524 |
|
673 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPAN32 |
0.0169250489335524 |
|
674 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL26P30 |
0.0169250489335524 |
|
675 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD81 |
0.0169250489335524 |
|
676 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPM5 |
0.0169250489335524 |
|
677 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSSC4 |
0.0169250489335524 |
|
678 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNQ1 |
0.0169250489335524 |
|
679 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNQ1OT1 |
0.0169250489335524 |
|
680 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNQ1DN |
0.0169250489335524 |
|
681 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDKN1C |
0.0169250489335524 |
|
682 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC22A18AS |
0.0169250489335524 |
|
683 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC22A18 |
0.0169250489335524 |
|
684 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHLDA2 |
0.0169250489335524 |
|
685 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAP1L4 |
0.0169250489335524 |
|
686 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA54 |
0.0169250489335524 |
|
687 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CARS |
0.0169250489335524 |
|
688 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSBPL5 |
0.0169250489335524 |
|
689 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRGPRE |
0.0169250489335524 |
|
690 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRGPRG |
0.0169250489335524 |
|
691 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF195 |
0.0169250489335524 |
|
692 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSSC2 |
0.0169250489335524 |
|
693 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPC2 |
0.0169250489335524 |
|
694 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ART1 |
0.0169250489335524 |
|
695 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ART5 |
0.0169250489335524 |
|
696 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRNA10 |
0.0169250489335524 |
|
697 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUP98 |
0.0169250489335524 |
|
698 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238686.1 |
0.0169250489335524 |
|
699 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGAP2 |
0.0169250489335524 |
|
700 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHOG |
0.0169250489335524 |
|
701 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4687 |
0.0169250489335524 |
|
702 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STIM1 |
0.0169250489335524 |
|
703 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA7|ENSG00000206976.1 |
0.0169250489335524 |
|
704 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRM1 |
0.0169250489335524 |
|
705 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR52B4 |
0.0169250489335524 |
|
706 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM21 |
0.0169250489335524 |
|
707 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR52K2 |
0.0169250489335524 |
|
708 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR52K1 |
0.0169250489335524 |
|
709 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR52M1 |
0.0169250489335524 |
|
710 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf40 |
0.0169250489335524 |
|
711 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR52I2 |
0.0169250489335524 |
|
712 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR52I1 |
0.0169250489335524 |
|
713 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM68 |
0.0169250489335524 |
|
714 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR51D1 |
0.0169250489335524 |
|
715 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR51E1 |
0.0169250489335524 |
|
716 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR51E2 |
0.0169250489335524 |
|
717 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR51C1P |
0.0169250489335524 |
|
718 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMP26 |
0.0169250489335524 |
|
719 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA62|ENSG00000201980.1 |
0.0169250489335524 |
|
720 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR51F1 |
0.0169250489335524 |
|
721 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR52R1 |
0.0169250489335524 |
|
722 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR51F2 |
0.0169250489335524 |
|
723 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR51S1 |
0.0169250489335524 |
|
724 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR51H1P |
0.0169250489335524 |
|
725 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR51T1 |
0.0169250489335524 |
|
726 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR51A7 |
0.0169250489335524 |
|
727 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR51G2 |
0.0169250489335524 |
|
728 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR51G1 |
0.0169250489335524 |
|
729 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR51A2 |
0.0169250489335524 |
|
730 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR51A4 |
0.0169250489335524 |
|
731 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR51L1 |
0.0169250489335524 |
|
732 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR52J3 |
0.0169250489335524 |
|
733 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR52E2 |
0.0169250489335524 |
|
734 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR52A4 |
0.0169250489335524 |
|
735 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR52A5 |
0.0169250489335524 |
|
736 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR52A1 |
0.0169250489335524 |
|
737 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR51V1 |
0.0169250489335524 |
|
738 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HBB |
0.0169250489335524 |
|
739 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HBD |
0.0169250489335524 |
|
740 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HBBP1 |
0.0169250489335524 |
|
741 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HBG1 |
0.0169250489335524 |
|
742 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HBG2 |
0.0169250489335524 |
|
743 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HBE1 |
0.0169250489335524 |
|
744 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR51B4 |
0.0169250489335524 |
|
745 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR51B2 |
0.0169250489335524 |
|
746 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR51B5 |
0.0169250489335524 |
|
747 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR51B6 |
0.0169250489335524 |
|
748 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR51M1 |
0.0169250489335524 |
|
749 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR51J1 |
0.0169250489335524 |
|
750 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR51Q1 |
0.0169250489335524 |
|
751 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR51I1 |
0.0169250489335524 |
|
752 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR51I2 |
0.0169250489335524 |
|
753 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR52D1 |
0.0169250489335524 |
|
754 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBQLN3 |
0.0169250489335524 |
|
755 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBQLNL |
0.0169250489335524 |
|
756 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR52H1 |
0.0169250489335524 |
|
757 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR52B6 |
0.0169250489335524 |
|
758 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM6 |
0.0169250489335524 |
|
759 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM34 |
0.0169250489335524 |
|
760 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM5 |
0.0169250489335524 |
|
761 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM22 |
0.0169250489335524 |
|
762 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR56B1 |
0.0169250489335524 |
|
763 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR52N4 |
0.0169250489335524 |
|
764 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR52N1 |
0.0169250489335524 |
|
765 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR52N5 |
0.0169250489335524 |
|
766 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR52N2 |
0.0169250489335524 |
|
767 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR52E6 |
0.0169250489335524 |
|
768 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR52E4 |
0.0169250489335524 |
|
769 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR52E8 |
0.0169250489335524 |
|
770 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR56A3 |
0.0169250489335524 |
|
771 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR52L1 |
0.0169250489335524 |
|
772 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR56A1 |
0.0169250489335524 |
|
773 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR56A4 |
0.0169250489335524 |
|
774 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR56B4 |
0.0169250489335524 |
|
775 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP329 |
0.0169250489335524 |
|
776 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR52B2 |
0.0169250489335524 |
|
777 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR52W1 |
0.0169250489335524 |
|
778 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf42 |
0.0169250489335524 |
|
779 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM160A2 |
0.0169250489335524 |
|
780 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNGA4 |
0.0169250489335524 |
|
781 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCKBR |
0.0169250489335524 |
|
782 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKCDBP |
0.0169250489335524 |
|
783 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APBB1 |
0.0169250489335524 |
|
784 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMPD1 |
0.0169250489335524 |
|
785 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HPX |
0.0169250489335524 |
|
786 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM3 |
0.0169250489335524 |
|
787 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARFIP2 |
0.0169250489335524 |
|
788 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIMM10B |
0.0169250489335524 |
|
789 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNHD1 |
0.0169250489335524 |
|
790 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRP8 |
0.0169250489335524 |
|
791 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ILK |
0.0169250489335524 |
|
792 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAF10 |
0.0169250489335524 |
|
793 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPP1 |
0.0169250489335524 |
|
794 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCHS1 |
0.0169250489335524 |
|
795 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL17 |
0.0169250489335524 |
|
796 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GVINP1 |
0.0169250489335524 |
|
797 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2AG2 |
0.0169250489335524 |
|
798 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2AG1 |
0.0169250489335524 |
|
799 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6A2 |
0.0169250489335524 |
|
800 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10A5 |
0.0169250489335524 |
|
801 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10A2 |
0.0169250489335524 |
|
802 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10A4 |
0.0169250489335524 |
|
803 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2D2 |
0.0169250489335524 |
|
804 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2D3 |
0.0169250489335524 |
|
805 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF215 |
0.0169250489335524 |
|
806 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF214 |
0.0169250489335524 |
|
807 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NLRP14 |
0.0169250489335524 |
|
808 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBMXL2 |
0.0169250489335524 |
|
809 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR302E |
0.0169250489335524 |
|
810 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYT9 |
0.0169250489335524 |
|
811 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OLFML1 |
0.0169250489335524 |
|
812 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPFIBP2 |
0.0169250489335524 |
|
813 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYB5R2 |
0.0169250489335524 |
|
814 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OVCH2 |
0.0169250489335524 |
|
815 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10AB1P |
0.0169250489335524 |
|
816 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5P2 |
0.0169250489335524 |
|
817 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5P3 |
0.0169250489335524 |
|
818 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10A6 |
0.0169250489335524 |
|
819 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10A3 |
0.0169250489335524 |
|
820 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NLRP10 |
0.0169250489335524 |
|
821 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF3F |
0.0169250489335524 |
|
822 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUB |
0.0169250489335524 |
|
823 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIC3 |
0.0169250489335524 |
|
824 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMO1 |
0.0169250489335524 |
|
825 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STK33 |
0.0169250489335524 |
|
826 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA20|ENSG00000252778.1 |
0.0169250489335524 |
|
827 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM66 |
0.0169250489335524 |
|
828 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL27A |
0.0169250489335524 |
|
829 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA3|ENSG00000200983.1 |
0.0169250489335524 |
|
830 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA45 |
0.0169250489335524 |
|
831 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST5 |
0.0169250489335524 |
|
832 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP330 |
0.0169250489335524 |
|
833 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKIP1 |
0.0169250489335524 |
|
834 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf16 |
0.0169250489335524 |
|
835 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASCL3 |
0.0169250489335524 |
|
836 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM9B |
0.0169250489335524 |
|
837 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRIP3 |
0.0169250489335524 |
|
838 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCUBE2 |
0.0169250489335524 |
|
839 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5691 |
0.0169250489335524 |
|
840 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DENND5A |
0.0176115840636017 |
|
841 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM41B |
0.0176115840636017 |
|
842 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IPO7 |
0.0176115840636017 |
|
843 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA23 |
0.0176115840636017 |
|
844 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF143 |
0.0176115840636017 |
|
845 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL56P |
0.0176115840636017 |
|
846 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WEE1 |
0.0176115840636017 |
|
847 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238387.1 |
0.0176115840636017 |
|
848 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SWAP70 |
0.0176115840636017 |
|
849 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP50 |
0.0176115840636017 |
|
850 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADM |
0.0176115840636017 |
|
851 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMPD3 |
0.0176115840636017 |
|
852 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC33P |
0.0176115840636017 |
|
853 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTRNR2L8 |
0.0176115840636017 |
|
854 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF141 |
0.0176115840636017 |
|
855 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYVE1 |
0.0176115840636017 |
|
856 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRVI1 |
0.0176115840636017 |
|
857 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTR9 |
0.0176115840636017 |
|
858 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF4G2 |
0.0176115840636017 |
|
859 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD97 |
0.0176115840636017 |
|
860 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBED5 |
0.0176115840636017 |
|
861 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00958 |
0.0176115840636017 |
|
862 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUCB2 |
0.0176115840636017 |
|
863 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCR3LG1 |
0.0176115840636017 |
|
864 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNJ11 |
0.0176115840636017 |
|
865 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCC8 |
0.0176115840636017 |
|
866 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USH1C |
0.0176115840636017 |
|
867 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OTOG |
0.0176115840636017 |
|
868 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYOD1 |
0.0176115840636017 |
|
869 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNC1 |
0.0176115840636017 |
|
870 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERGEF |
0.0176115840636017 |
|
871 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPH1 |
0.0176115840636017 |
|
872 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAAL1 |
0.0176115840636017 |
|
873 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAA3P |
0.0176115840636017 |
|
874 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRGPRX3 |
0.0176115840636017 |
|
875 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRGPRX4 |
0.0176115840636017 |
|
876 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAA4 |
0.0176115840636017 |
|
877 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAA2 |
0.0176115840636017 |
|
878 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP333 |
0.0176115840636017 |
|
879 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP334 |
0.0176115840636017 |
|
880 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAA1 |
0.0176115840636017 |
|
881 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HPS5 |
0.0176115840636017 |
|
882 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF2H1 |
0.0176115840636017 |
|
883 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3159 |
0.0176115840636017 |
|
884 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LDHA |
0.0176115840636017 |
|
885 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LDHC |
0.0176115840636017 |
|
886 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LDHAL6A |
0.0176115840636017 |
|
887 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSG101 |
0.0176115840636017 |
|
888 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UEVLD |
0.0176115840636017 |
|
889 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPTY2D1 |
0.0176115840636017 |
|
890 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM86A |
0.0176115840636017 |
|
891 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGSF22 |
0.0176115840636017 |
|
892 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPN5 |
0.0176115840636017 |
|
893 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRGPRX1 |
0.0176115840636017 |
|
894 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRGPRX2 |
0.0176115840636017 |
|
895 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDHHC13 |
0.0176115840636017 |
|
896 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSRP3 |
0.0176115840636017 |
|
897 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
E2F8 |
0.0176115840636017 |
|
898 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAV2 |
0.0176115840636017 |
|
899 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP335 |
0.0176115840636017 |
|
900 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4486 |
0.0176115840636017 |
|
901 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA1|ENSG00000207407.1 |
0.0176115840636017 |
|
902 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4694 |
0.0176115840636017 |
|
903 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DBX1 |
0.0176115840636017 |
|
904 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTATIP2 |
0.0176115840636017 |
|
905 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRMT3 |
0.0176115840636017 |
|
906 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC6A5 |
0.0176115840636017 |
|
907 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NELL1 |
0.0176115840636017 |
|
908 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP336 |
0.0176115840636017 |
|
909 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP337 |
0.0176115840636017 |
|
910 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANO5 |
0.0176115840636017 |
|
911 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC17A6 |
0.0176115840636017 |
|
912 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FANCF |
0.0176115840636017 |
|
913 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAS2 |
0.0176115840636017 |
|
914 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP338 |
0.0176115840636017 |
|
915 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SVIP |
0.0176115840636017 |
|
916 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC179 |
0.0176115840636017 |
|
917 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANO3 |
0.0176115840636017 |
|
918 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUC15 |
0.0176115840636017 |
|
919 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC5A12 |
0.0176115840636017 |
|
920 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FIBIN |
0.0176115840636017 |
|
921 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BBOX1 |
0.0176115840636017 |
|
922 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC34 |
0.0176115840636017 |
|
923 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGR4 |
0.0176115840636017 |
|
924 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIN7C |
0.0176115840636017 |
|
925 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP339 |
0.0176115840636017 |
|
926 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00678 |
0.0176115840636017 |
|
927 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BDNF |
0.0176115840636017 |
|
928 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF18A |
0.0176115840636017 |
|
929 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR610 |
0.0176115840636017 |
|
930 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHKA1 |
0.0176527086995506 |
|
931 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000202482.1 |
0.0176527086995506 |
|
932 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DMRTC1B |
0.0176527086995506 |
|
933 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM226A |
0.0176527086995506 |
|
934 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DMRTC1 |
0.0176527086995506 |
|
935 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00684 |
0.0176527086995506 |
|
936 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PABPC1L2B |
0.0176527086995506 |
|
937 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PABPC1L2A |
0.0176527086995506 |
|
938 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAP1L6 |
0.0176527086995506 |
|
939 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAP1L2 |
0.0176527086995506 |
|
940 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDX4 |
0.0176527086995506 |
|
941 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP2K4P1 |
0.0176527086995506 |
|
942 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHIC1 |
0.0176527086995506 |
|
943 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSIX |
0.0176527086995506 |
|
944 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XIST |
0.0176527086995506 |
|
945 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JPX |
0.0176527086995506 |
|
946 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FTX |
0.0176527086995506 |
|
947 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR374B |
0.0176527086995506 |
|
948 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR421 |
0.0176527086995506 |
|
949 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL648P |
0.0176527086995506 |
|
950 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR374A |
0.0176527086995506 |
|
951 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR545 |
0.0176527086995506 |
|
952 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZCCHC13 |
0.0176527086995506 |
|
953 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL790P |
0.0176527086995506 |
|
954 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC16A2 |
0.0176527086995506 |
|
955 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL641P |
0.0176527086995506 |
|
956 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RLIM |
0.0176527086995506 |
|
957 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA2022 |
0.0176527086995506 |
|
958 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCB7 |
0.0176527086995506 |
|
959 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEE2 |
0.0176527086995506 |
|
960 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UPRT |
0.0176527086995506 |
|
961 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDHHC15 |
0.0176527086995506 |
|
962 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PBDC1 |
0.0176527086995506 |
|
963 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEE1 |
0.0176527086995506 |
|
964 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP508 |
0.0176527086995506 |
|
965 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR325 |
0.0176527086995506 |
|
966 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP509 |
0.0176527086995506 |
|
967 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGF16 |
0.0176527086995506 |
|
968 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATRX |
0.0176527086995506 |
|
969 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGT1 |
0.0176527086995506 |
|
970 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL460P |
0.0176527086995506 |
|
971 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP7A |
0.0176527086995506 |
|
972 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX7B |
0.0176527086995506 |
|
973 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGAM4 |
0.0176527086995506 |
|
974 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGK1 |
0.0176527086995506 |
|
975 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAF9B |
0.0176527086995506 |
|
976 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYSLTR1 |
0.0176527086995506 |
|
977 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZCCHC5 |
0.0176527086995506 |
|
978 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPAR4 |
0.0176527086995506 |
|
979 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
P2RY10 |
0.0176527086995506 |
|
980 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR174 |
0.0176527086995506 |
|
981 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITM2A |
0.0176527086995506 |
|
982 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBX22 |
0.0176527086995506 |
|
983 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM46D |
0.0176527086995506 |
|
984 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRWD3 |
0.0176527086995506 |
|
985 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACA64|ENSG00000239008.1 |
0.0176527086995506 |
|
986 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMGN5 |
0.0176527086995506 |
|
987 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3BGRL |
0.0176527086995506 |
|
988 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA4|ENSG00000202183.1 |
0.0176527086995506 |
|
989 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLD2 |
0.019063223761059 |
|
990 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMB6 |
0.019063223761059 |
|
991 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MINK1 |
0.019063223761059 |
|
992 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL171P |
0.019063223761059 |
|
993 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL784P |
0.019063223761059 |
|
994 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRNE |
0.019063223761059 |
|
995 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf107 |
0.019063223761059 |
|
996 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GP1BA |
0.019063223761059 |
|
997 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A11 |
0.019063223761059 |
|
998 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF167 |
0.019063223761059 |
|
999 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENO3 |
0.019063223761059 |
|
1000 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PFN1 |
0.019063223761059 |
|
1001 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPAG7 |
0.019063223761059 |
|
1002 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAMTA2 |
0.019063223761059 |
|
1003 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INCA1 |
0.019063223761059 |
|
1004 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF1C |
0.019063223761059 |
|
1005 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC52A1 |
0.019063223761059 |
|
1006 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFP3 |
0.019063223761059 |
|
1007 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP6 |
0.019063223761059 |
|
1008 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF232 |
0.019063223761059 |
|
1009 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF594 |
0.019063223761059 |
|
1010 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCIMP |
0.019063223761059 |
|
1011 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RABEP1 |
0.019063223761059 |
|
1012 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUP88 |
0.019063223761059 |
|
1013 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPAIN |
0.019063223761059 |
|
1014 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1QBP |
0.019063223761059 |
|
1015 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHX33 |
0.019063223761059 |
|
1016 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DERL2 |
0.019063223761059 |
|
1017 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIS12 |
0.019063223761059 |
|
1018 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NLRP1 |
0.019063223761059 |
|
1019 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP297 |
0.0192737435228149 |
|
1020 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP298 |
0.0192737435228149 |
|
1021 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBB8 |
0.0192737435228149 |
|
1022 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZMYND11 |
0.0192737435228149 |
|
1023 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL754P |
0.0192737435228149 |
|
1024 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5699 |
0.0192737435228149 |
|
1025 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPA4 |
0.0194181525242421 |
|
1026 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALG10B |
0.0199021279371052 |
|
1027 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALG10 |
0.0199021279371052 |
|
1028 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPNE8 |
0.0199021279371052 |
|
1029 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP358 |
0.0199021279371052 |
|
1030 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP359 |
0.0199021279371052 |
|
1031 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYT10 |
0.0199021279371052 |
|
1032 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NF1 |
0.0218958972910546 |
|
1033 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOB1 |
0.0218958972910546 |
|
1034 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPAG9 |
0.0218958972910546 |
|
1035 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238815.1 |
0.0218958972910546 |
|
1036 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NME1 |
0.0218958972910546 |
|
1037 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NME2 |
0.0218958972910546 |
|
1038 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBTD1 |
0.0218958972910546 |
|
1039 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UTP18 |
0.0218958972910546 |
|
1040 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL699P |
0.0218958972910546 |
|
1041 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP93 |
0.0224029482299088 |
|
1042 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MGAT5 |
0.0224029482299088 |
|
1043 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3679 |
0.0224029482299088 |
|
1044 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP104 |
0.0224029482299088 |
|
1045 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM163 |
0.0224029482299088 |
|
1046 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACMSD |
0.0224029482299088 |
|
1047 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5590 |
0.0224029482299088 |
|
1048 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNT2 |
0.0224029482299088 |
|
1049 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP3K19 |
0.0224029482299088 |
|
1050 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB3GAP1 |
0.0224029482299088 |
|
1051 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238337.1 |
0.0224029482299088 |
|
1052 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA40|ENSG00000208308.1 |
0.0224029482299088 |
|
1053 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZRANB3 |
0.0224029482299088 |
|
1054 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
R3HDM1 |
0.0224029482299088 |
|
1055 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBXN4 |
0.0224029482299088 |
|
1056 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCT |
0.0224029482299088 |
|
1057 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCM6 |
0.0224029482299088 |
|
1058 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DARS |
0.0224029482299088 |
|
1059 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXCR4 |
0.0224029482299088 |
|
1060 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP141 |
0.0224029482299088 |
|
1061 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL74P |
0.0229714728753295 |
|
1062 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CA10 |
0.0241819906213486 |
|
1063 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoZ178 |
0.0241819906213486 |
|
1064 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf112 |
0.0241819906213486 |
|
1065 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFX3 |
0.0252072885488128 |
|
1066 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLIS3 |
0.0252072885488128 |
|
1067 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC1A1 |
0.0252072885488128 |
|
1068 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA6L |
0.0252072885488128 |
|
1069 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPAPDC2 |
0.0252072885488128 |
|
1070 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC37L1 |
0.0252072885488128 |
|
1071 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AK3 |
0.0252072885488128 |
|
1072 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RCL1 |
0.0252072885488128 |
|
1073 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JAK2 |
0.0252072885488128 |
|
1074 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INSL4 |
0.0252072885488128 |
|
1075 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INSL6 |
0.0252072885488128 |
|
1076 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RLN2 |
0.0252072885488128 |
|
1077 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RLN1 |
0.0252072885488128 |
|
1078 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLGRKT |
0.0252072885488128 |
|
1079 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD274 |
0.0252072885488128 |
|
1080 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDCD1LG2 |
0.0252072885488128 |
|
1081 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1432 |
0.0252072885488128 |
|
1082 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERMP1 |
0.0252072885488128 |
|
1083 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA2026 |
0.0252072885488128 |
|
1084 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLANA |
0.0252072885488128 |
|
1085 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238654.1 |
0.0252072885488128 |
|
1086 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4665 |
0.0252072885488128 |
|
1087 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RANBP6 |
0.0252072885488128 |
|
1088 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL33 |
0.0252072885488128 |
|
1089 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf38 |
0.0252072885488128 |
|
1090 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLDC |
0.0252072885488128 |
|
1091 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KDM4C |
0.0252072885488128 |
|
1092 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL123P |
0.0252072885488128 |
|
1093 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL25P |
0.0252072885488128 |
|
1094 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPD52L3 |
0.0252072885488128 |
|
1095 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UHRF2 |
0.0252072885488128 |
|
1096 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000252110.1 |
0.0252072885488128 |
|
1097 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf123 |
0.0252072885488128 |
|
1098 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD27|ENSG00000251699.1 |
0.0252072885488128 |
|
1099 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL849P |
0.0252072885488128 |
|
1100 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LURAP1L |
0.0252072885488128 |
|
1101 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPDZ |
0.0252072885488128 |
|
1102 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR491 |
0.0252072885488128 |
|
1103 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA30|ENSG00000202189.1 |
0.0252072885488128 |
|
1104 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DMRTA1 |
0.0252072885488128 |
|
1105 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELAVL2 |
0.0252072885488128 |
|
1106 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IZUMO3 |
0.0252072885488128 |
|
1107 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RMRPP5 |
0.0252072885488128 |
|
1108 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP120 |
0.0252072885488128 |
|
1109 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUSC1 |
0.0252072885488128 |
|
1110 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000252580.1 |
0.0252072885488128 |
|
1111 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAAP1 |
0.0252072885488128 |
|
1112 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL100P |
0.0252072885488128 |
|
1113 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLAA |
0.0252072885488128 |
|
1114 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFT74 |
0.0252072885488128 |
|
1115 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC19 |
0.0252072885488128 |
|
1116 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEK |
0.0252072885488128 |
|
1117 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP280 |
0.0252072885488128 |
|
1118 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00032 |
0.0252072885488128 |
|
1119 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EQTN |
0.0252072885488128 |
|
1120 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOB3B |
0.0252072885488128 |
|
1121 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNK |
0.0252072885488128 |
|
1122 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf72 |
0.0252072885488128 |
|
1123 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR873 |
0.0252072885488128 |
|
1124 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR876 |
0.0252072885488128 |
|
1125 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239155.1 |
0.0252072885488128 |
|
1126 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP281 |
0.0252072885488128 |
|
1127 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACO1 |
0.0252072885488128 |
|
1128 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX58 |
0.0252072885488128 |
|
1129 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOPORS |
0.0252072885488128 |
|
1130 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFB6 |
0.0252072885488128 |
|
1131 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GVQW1 |
0.0252072885488128 |
|
1132 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAF1L |
0.0252072885488128 |
|
1133 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM215 |
0.0252072885488128 |
|
1134 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APTX |
0.0252072885488128 |
|
1135 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJA1 |
0.0252072885488128 |
|
1136 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMU1 |
0.0252072885488128 |
|
1137 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B4GALT1 |
0.0252072885488128 |
|
1138 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU4ATAC15P |
0.0252072885488128 |
|
1139 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DIAPH2 |
0.0253226828299177 |
|
1140 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM4B |
0.0254151660458908 |
|
1141 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPTBN2 |
0.0254151660458908 |
|
1142 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL12P |
0.0254151660458908 |
|
1143 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf80 |
0.0254151660458908 |
|
1144 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PC |
0.0254151660458908 |
|
1145 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RCE1 |
0.0254151660458908 |
|
1146 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRFN4 |
0.0254151660458908 |
|
1147 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3163 |
0.0254151660458908 |
|
1148 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf86 |
0.0254151660458908 |
|
1149 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCT6P3 |
0.0263689288068469 |
|
1150 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INTS4L1 |
0.0263689288068469 |
|
1151 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INTS4L2 |
0.0263689288068469 |
|
1152 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA15|ENSG00000207062.1 |
0.0263689288068469 |
|
1153 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA22|ENSG00000207344.1 |
0.0263689288068469 |
|
1154 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA63|ENSG00000200130.1 |
0.0263689288068469 |
|
1155 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA63|ENSG00000252102.1 |
0.0263689288068469 |
|
1156 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF92 |
0.0263689288068469 |
|
1157 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCT6P1 |
0.0263689288068469 |
|
1158 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA15|ENSG00000206785.1 |
0.0263689288068469 |
|
1159 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA22|ENSG00000206634.1 |
0.0263689288068469 |
|
1160 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VKORC1L1 |
0.0263689288068469 |
|
1161 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GUSB |
0.0263689288068469 |
|
1162 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASL |
0.0263689288068469 |
|
1163 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRCP |
0.0263689288068469 |
|
1164 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPST1 |
0.0263689288068469 |
|
1165 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00174 |
0.0263689288068469 |
|
1166 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000252265.1 |
0.0263689288068469 |
|
1167 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP35 |
0.0263992975852394 |
|
1168 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBAC2 |
0.0272493193688116 |
|
1169 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR18 |
0.0272493193688116 |
|
1170 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR183 |
0.0272493193688116 |
|
1171 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR623 |
0.0272493193688116 |
|
1172 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00449 |
0.0272493193688116 |
|
1173 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TM9SF2 |
0.0272493193688116 |
|
1174 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY3P6 |
0.0272493193688116 |
|
1175 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEAF1 |
0.0272927397707755 |
|
1176 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPS8L2 |
0.0272927397707755 |
|
1177 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM80 |
0.0272927397707755 |
|
1178 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TALDO1 |
0.0272927397707755 |
|
1179 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDDC1 |
0.0272927397707755 |
|
1180 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEND1 |
0.0272927397707755 |
|
1181 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A22 |
0.0272927397707755 |
|
1182 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIDD |
0.0272927397707755 |
|
1183 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPLP2 |
0.0272927397707755 |
|
1184 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA52 |
0.0272927397707755 |
|
1185 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNPLA2 |
0.0272927397707755 |
|
1186 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD151 |
0.0272927397707755 |
|
1187 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFCAB4A |
0.0272927397707755 |
|
1188 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR2L |
0.0272927397707755 |
|
1189 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPAN4 |
0.0272927397707755 |
|
1190 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHID1 |
0.0272927397707755 |
|
1191 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP2A2 |
0.0272927397707755 |
|
1192 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUC6 |
0.0272927397707755 |
|
1193 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUC2 |
0.0272927397707755 |
|
1194 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINGO2 |
0.0275384561514692 |
|
1195 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANO9 |
0.0276493856980518 |
|
1196 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATHL1 |
0.0276493856980518 |
|
1197 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B4GALNT4 |
0.0276493856980518 |
|
1198 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BET1L |
0.0276493856980518 |
|
1199 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFITM1 |
0.0276493856980518 |
|
1200 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFITM2 |
0.0276493856980518 |
|
1201 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFITM3 |
0.0276493856980518 |
|
1202 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFITM5 |
0.0276493856980518 |
|
1203 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NLRP6 |
0.0276493856980518 |
|
1204 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ODF3 |
0.0276493856980518 |
|
1205 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKP3 |
0.0276493856980518 |
|
1206 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMD13 |
0.0276493856980518 |
|
1207 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTDSS2 |
0.0276493856980518 |
|
1208 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIC8A |
0.0276493856980518 |
|
1209 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL838P |
0.0276493856980518 |
|
1210 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCGB1C1 |
0.0276493856980518 |
|
1211 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIGIRR |
0.0276493856980518 |
|
1212 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIRT3 |
0.0276493856980518 |
|
1213 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNH1 |
0.0276493856980518 |
|
1214 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HRAS |
0.0276493856980518 |
|
1215 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC56 |
0.0276493856980518 |
|
1216 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf35 |
0.0276493856980518 |
|
1217 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASSF7 |
0.0276493856980518 |
|
1218 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR210HG |
0.0276493856980518 |
|
1219 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR210 |
0.0276493856980518 |
|
1220 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHRF1 |
0.0276493856980518 |
|
1221 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDHR5 |
0.0276493856980518 |
|
1222 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRF7 |
0.0276493856980518 |
|
1223 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCT |
0.0276493856980518 |
|
1224 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DRD4 |
0.0276493856980518 |
|
1225 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABR |
0.0279937116816171 |
|
1226 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf97 |
0.0279937116816171 |
|
1227 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DBIL5P |
0.0279937116816171 |
|
1228 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOC2B |
0.0279937116816171 |
|
1229 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM101B |
0.0279937116816171 |
|
1230 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM57A |
0.0279937116816171 |
|
1231 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GEMIN4 |
0.0279937116816171 |
|
1232 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLOD4 |
0.0279937116816171 |
|
1233 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3183 |
0.0279937116816171 |
|
1234 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NXN |
0.0279937116816171 |
|
1235 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNMTL1 |
0.0279937116816171 |
|
1236 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPH3AL |
0.0279937116816171 |
|
1237 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIMM22 |
0.0279937116816171 |
|
1238 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS53 |
0.0279937116816171 |
|
1239 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BHLHA9 |
0.0279937116816171 |
|
1240 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUSC5 |
0.0279937116816171 |
|
1241 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YWHAE |
0.0279937116816171 |
|
1242 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRK |
0.0279937116816171 |
|
1243 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYO1C |
0.0279937116816171 |
|
1244 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INPP5K |
0.0279937116816171 |
|
1245 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PITPNA |
0.0279937116816171 |
|
1246 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC43A2 |
0.0279937116816171 |
|
1247 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL105P |
0.0279937116816171 |
|
1248 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238946.1 |
0.0279937116816171 |
|
1249 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARF1 |
0.0279937116816171 |
|
1250 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RILP |
0.0279937116816171 |
|
1251 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRPF8 |
0.0279937116816171 |
|
1252 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR22HG |
0.0279937116816171 |
|
1253 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLCD2 |
0.0279937116816171 |
|
1254 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR81 |
0.0279937116816171 |
|
1255 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINF2 |
0.0279937116816171 |
|
1256 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINF1 |
0.0279937116816171 |
|
1257 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMYD4 |
0.0279937116816171 |
|
1258 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPA1 |
0.0279937116816171 |
|
1259 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RTN4RL1 |
0.0279937116816171 |
|
1260 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPH1 |
0.0279937116816171 |
|
1261 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OVCA2 |
0.0279937116816171 |
|
1262 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIC1 |
0.0279937116816171 |
|
1263 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR132 |
0.0279937116816171 |
|
1264 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR212 |
0.0279937116816171 |
|
1265 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMG6 |
0.0279937116816171 |
|
1266 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL624P |
0.0279937116816171 |
|
1267 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRR |
0.0279937116816171 |
|
1268 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD91A |
0.0279937116816171 |
|
1269 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD91B |
0.0279937116816171 |
|
1270 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSR1 |
0.0279937116816171 |
|
1271 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGSM2 |
0.0279937116816171 |
|
1272 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MNT |
0.0279937116816171 |
|
1273 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL16 |
0.0279937116816171 |
|
1274 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL33P |
0.0279937116816171 |
|
1275 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAFAH1B1 |
0.0279937116816171 |
|
1276 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239024.1 |
0.0279937116816171 |
|
1277 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL608P |
0.0279937116816171 |
|
1278 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLUH |
0.0279937116816171 |
|
1279 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1253 |
0.0279937116816171 |
|
1280 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL605P |
0.0279937116816171 |
|
1281 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAP1GAP2 |
0.0279937116816171 |
|
1282 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1D2 |
0.0279937116816171 |
|
1283 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1D5 |
0.0279937116816171 |
|
1284 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1G1 |
0.0279937116816171 |
|
1285 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1A2 |
0.0279937116816171 |
|
1286 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1A1 |
0.0279937116816171 |
|
1287 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1D4 |
0.0279937116816171 |
|
1288 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR3A2 |
0.0279937116816171 |
|
1289 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR3A1 |
0.0279937116816171 |
|
1290 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR3A4P |
0.0279937116816171 |
|
1291 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1E1 |
0.0279937116816171 |
|
1292 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR3A3 |
0.0279937116816171 |
|
1293 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1E2 |
0.0279937116816171 |
|
1294 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA22 |
0.0279937116816171 |
|
1295 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASPA |
0.0279937116816171 |
|
1296 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPV3 |
0.0279937116816171 |
|
1297 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHPK |
0.0279937116816171 |
|
1298 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPV1 |
0.0279937116816171 |
|
1299 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTNS |
0.0279937116816171 |
|
1300 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMC6 |
0.0279937116816171 |
|
1301 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
P2RX5 |
0.0279937116816171 |
|
1302 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAX1BP3 |
0.0279937116816171 |
|
1303 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGAE |
0.0279937116816171 |
|
1304 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSG2 |
0.0279937116816171 |
|
1305 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf85 |
0.0279937116816171 |
|
1306 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAMKK1 |
0.0279937116816171 |
|
1307 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
P2RX1 |
0.0279937116816171 |
|
1308 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP2A3 |
0.0279937116816171 |
|
1309 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZZEF1 |
0.0279937116816171 |
|
1310 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP434 |
0.0279937116816171 |
|
1311 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238807.1 |
0.0279937116816171 |
|
1312 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL774P |
0.0279937116816171 |
|
1313 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPNS3 |
0.0279937116816171 |
|
1314 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPNS2 |
0.0279937116816171 |
|
1315 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYBBP1A |
0.0279937116816171 |
|
1316 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GGT6 |
0.0279937116816171 |
|
1317 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMTNL2 |
0.0279937116816171 |
|
1318 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALOX15 |
0.0279937116816171 |
|
1319 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARRB2 |
0.0279937116816171 |
|
1320 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED11 |
0.0279937116816171 |
|
1321 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXCL16 |
0.0279937116816171 |
|
1322 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZMYND15 |
0.0279937116816171 |
|
1323 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLTPD2 |
0.0279937116816171 |
|
1324 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TM4SF5 |
0.0279937116816171 |
|
1325 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VMO1 |
0.0279937116816171 |
|
1326 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM4 |
0.0281812627617773 |
|
1327 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000252709.1 |
0.0281812627617773 |
|
1328 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYT12 |
0.0281812627617773 |
|
1329 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHOD |
0.0281812627617773 |
|
1330 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDRT15 |
0.0282064489444598 |
|
1331 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDRT1 |
0.0282064489444598 |
|
1332 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDRT4 |
0.0282064489444598 |
|
1333 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDRT7 |
0.0282064489444598 |
|
1334 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDRT8 |
0.0282064489444598 |
|
1335 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HS3ST3B1 |
0.0282064489444598 |
|
1336 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4731 |
0.0282064489444598 |
|
1337 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PMP22 |
0.0282064489444598 |
|
1338 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL792P |
0.0282064489444598 |
|
1339 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA74|ENSG00000252129.1 |
0.0282064489444598 |
|
1340 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEKT3 |
0.0282064489444598 |
|
1341 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM16 |
0.0282064489444598 |
|
1342 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TVP23C |
0.0282064489444598 |
|
1343 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238806.1 |
0.0282064489444598 |
|
1344 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D26 |
0.0282064489444598 |
|
1345 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF286A |
0.0282064489444598 |
|
1346 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP436 |
0.0282064489444598 |
|
1347 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADORA2B |
0.0282064489444598 |
|
1348 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSWIM7 |
0.0282064489444598 |
|
1349 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC19 |
0.0282064489444598 |
|
1350 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCOR1 |
0.0282064489444598 |
|
1351 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL442P |
0.0282064489444598 |
|
1352 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIGL |
0.0282064489444598 |
|
1353 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1288 |
0.0282064489444598 |
|
1354 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CENPV |
0.0282064489444598 |
|
1355 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBB |
0.0282064489444598 |
|
1356 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPV2 |
0.0282064489444598 |
|
1357 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM211A |
0.0282064489444598 |
|
1358 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF287 |
0.0282064489444598 |
|
1359 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF624 |
0.0282064489444598 |
|
1360 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC144A |
0.0282064489444598 |
|
1361 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL620P |
0.0282064489444598 |
|
1362 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT16P2 |
0.0282064489444598 |
|
1363 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT17P1 |
0.0282064489444598 |
|
1364 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP32P1 |
0.0282064489444598 |
|
1365 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D27 |
0.0282064489444598 |
|
1366 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFRSF13B |
0.0282064489444598 |
|
1367 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPRIP |
0.0282064489444598 |
|
1368 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL775P |
0.0282064489444598 |
|
1369 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLD6 |
0.0282064489444598 |
|
1370 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLCN |
0.0282064489444598 |
|
1371 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COPS3 |
0.0282064489444598 |
|
1372 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NT5M |
0.0282064489444598 |
|
1373 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED9 |
0.0282064489444598 |
|
1374 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASD1 |
0.0282064489444598 |
|
1375 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEMT |
0.0282064489444598 |
|
1376 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMCR2 |
0.0282064489444598 |
|
1377 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAI1 |
0.0282064489444598 |
|
1378 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMCR5 |
0.0282064489444598 |
|
1379 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALNT18 |
0.0284346994795838 |
|
1380 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSNK2A3 |
0.0284346994795838 |
|
1381 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4299 |
0.0284346994795838 |
|
1382 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP47 |
0.0284346994795838 |
|
1383 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DKK3 |
0.0284346994795838 |
|
1384 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MICAL2 |
0.0284346994795838 |
|
1385 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MICALCL |
0.0284346994795838 |
|
1386 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARVA |
0.0284346994795838 |
|
1387 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARNTL |
0.0284346994795838 |
|
1388 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP151 |
0.0284346994795838 |
|
1389 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTBD10 |
0.0284346994795838 |
|
1390 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTH |
0.0284346994795838 |
|
1391 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAR1 |
0.0284346994795838 |
|
1392 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP331 |
0.0284346994795838 |
|
1393 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPON1 |
0.0284346994795838 |
|
1394 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP332 |
0.0284346994795838 |
|
1395 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRAS2 |
0.0284346994795838 |
|
1396 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COPB1 |
0.0284346994795838 |
|
1397 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMA1 |
0.0284346994795838 |
|
1398 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE3B |
0.0284346994795838 |
|
1399 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP2R1 |
0.0284346994795838 |
|
1400 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CALCB |
0.0284346994795838 |
|
1401 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CALCA |
0.0284346994795838 |
|
1402 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INSC |
0.0284346994795838 |
|
1403 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOX6 |
0.0284346994795838 |
|
1404 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL188P |
0.0284346994795838 |
|
1405 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf58 |
0.0284346994795838 |
|
1406 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHA7 |
0.0284346994795838 |
|
1407 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP90 |
0.0284346994795838 |
|
1408 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR7E14P |
0.0284346994795838 |
|
1409 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS13 |
0.0284346994795838 |
|
1410 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD14A |
0.0284346994795838 |
|
1411 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD14B |
0.0284346994795838 |
|
1412 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIK3C2A |
0.0284346994795838 |
|
1413 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXOC3L2 |
0.0286300015571732 |
|
1414 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATXN7L1 |
0.0294337250449294 |
|
1415 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCT |
0.0296818833385903 |
|
1416 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TGDS |
0.0296818833385903 |
|
1417 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR180 |
0.0296818833385903 |
|
1418 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP36 |
0.0296818833385903 |
|
1419 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL585P |
0.0296818833385903 |
|
1420 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00391 |
0.0296818833385903 |
|
1421 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOX21 |
0.0296818833385903 |
|
1422 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00557 |
0.0296818833385903 |
|
1423 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238463.1 |
0.0296818833385903 |
|
1424 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY3P8 |
0.0296818833385903 |
|
1425 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P27 |
0.0296818833385903 |
|
1426 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLDN10 |
0.0296818833385903 |
|
1427 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DZIP1 |
0.0296818833385903 |
|
1428 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC3 |
0.0296818833385903 |
|
1429 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snR65|ENSG00000251901.1 |
0.0296818833385903 |
|
1430 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGGT2 |
0.0296818833385903 |
|
1431 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL164P |
0.0296818833385903 |
|
1432 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00359 |
0.0296818833385903 |
|
1433 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP7 |
0.0296818833385903 |
|
1434 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252154.1 |
0.0296818833385903 |
|
1435 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OXGR1 |
0.0296818833385903 |
|
1436 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238522.1 |
0.0296818833385903 |
|
1437 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBNL2 |
0.0296818833385903 |
|
1438 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP37 |
0.0296818833385903 |
|
1439 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAP2A |
0.0296818833385903 |
|
1440 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238407.1 |
0.0296818833385903 |
|
1441 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IPO5 |
0.0296818833385903 |
|
1442 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FARP1 |
0.0296818833385903 |
|
1443 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF113B |
0.0296818833385903 |
|
1444 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP8 |
0.0296818833385903 |
|
1445 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3170 |
0.0296818833385903 |
|
1446 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STK24 |
0.0296818833385903 |
|
1447 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL60P |
0.0296818833385903 |
|
1448 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC15A1 |
0.0296818833385903 |
|
1449 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOCK9 |
0.0296818833385903 |
|
1450 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP9 |
0.0296818833385903 |
|
1451 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLYBL |
0.0296818833385903 |
|
1452 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4306 |
0.0296818833385903 |
|
1453 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA25|ENSG00000201245.1 |
0.0296818833385903 |
|
1454 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238305.1 |
0.0296818833385903 |
|
1455 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZIC5 |
0.0296818833385903 |
|
1456 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZIC2 |
0.0296818833385903 |
|
1457 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00554 |
0.0296818833385903 |
|
1458 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GGACT |
0.0296818833385903 |
|
1459 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMTC4 |
0.0296818833385903 |
|
1460 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00411 |
0.0296818833385903 |
|
1461 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NALCN |
0.0296818833385903 |
|
1462 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGBL1 |
0.0296818833385903 |
|
1463 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGF14 |
0.0296818833385903 |
|
1464 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR2681 |
0.0296818833385903 |
|
1465 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY1P2 |
0.0296818833385903 |
|
1466 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4705 |
0.0296818833385903 |
|
1467 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00555 |
0.0296818833385903 |
|
1468 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPP2 |
0.0296818833385903 |
|
1469 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL21C |
0.0296818833385903 |
|
1470 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238869.1 |
0.0296818833385903 |
|
1471 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC168 |
0.0296818833385903 |
|
1472 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00283 |
0.0296818833385903 |
|
1473 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX30 |
0.0296818833385903 |
|
1474 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KDELC1 |
0.0296818833385903 |
|
1475 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BIVM |
0.0296818833385903 |
|
1476 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY5P8 |
0.0296818833385903 |
|
1477 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERCC5 |
0.0296818833385903 |
|
1478 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL21EP |
0.0296818833385903 |
|
1479 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC10A2 |
0.0296818833385903 |
|
1480 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IMMP2L |
0.0302984228789878 |
|
1481 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FKBP6 |
0.0303963902126426 |
|
1482 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FZD9 |
0.0303963902126426 |
|
1483 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAZ1B |
0.0303963902126426 |
|
1484 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCL7B |
0.0303963902126426 |
|
1485 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBL2 |
0.0303963902126426 |
|
1486 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLXIPL |
0.0303963902126426 |
|
1487 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS37D |
0.0303963902126426 |
|
1488 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC30 |
0.0303963902126426 |
|
1489 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WBSCR22 |
0.0303963902126426 |
|
1490 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STX1A |
0.0303963902126426 |
|
1491 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4284 |
0.0303963902126426 |
|
1492 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABHD11 |
0.0303963902126426 |
|
1493 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00035 |
0.0303963902126426 |
|
1494 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL265P |
0.0303963902126426 |
|
1495 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLDN3 |
0.0303963902126426 |
|
1496 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLDN4 |
0.0303963902126426 |
|
1497 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WBSCR27 |
0.0303963902126426 |
|
1498 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WBSCR28 |
0.0303963902126426 |
|
1499 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELN |
0.0303963902126426 |
|
1500 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIMK1 |
0.0303963902126426 |
|
1501 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF4H |
0.0303963902126426 |
|
1502 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR590 |
0.0303963902126426 |
|
1503 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAT2 |
0.0303963902126426 |
|
1504 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFC2 |
0.0303963902126426 |
|
1505 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLIP2 |
0.0303963902126426 |
|
1506 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF2IRD1 |
0.0303963902126426 |
|
1507 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP233 |
0.0303963902126426 |
|
1508 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF2I |
0.0303963902126426 |
|
1509 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAG3L2 |
0.0303963902126426 |
|
1510 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF2IRD2 |
0.0303963902126426 |
|
1511 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCF1 |
0.0303963902126426 |
|
1512 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GATSL1 |
0.0303963902126426 |
|
1513 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WBSCR16 |
0.0303963902126426 |
|
1514 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF2IRD2B |
0.0303963902126426 |
|
1515 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GATSL2 |
0.0303963902126426 |
|
1516 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAG3L1 |
0.0303963902126426 |
|
1517 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM73 |
0.0303963902126426 |
|
1518 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NSUN5P1 |
0.0303963902126426 |
|
1519 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POM121C |
0.0303963902126426 |
|
1520 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PMS2P3 |
0.0303963902126426 |
|
1521 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIP1 |
0.0303963902126426 |
|
1522 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL642P |
0.0303963902126426 |
|
1523 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL26 |
0.0303963902126426 |
|
1524 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL24 |
0.0303963902126426 |
|
1525 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHBDD2 |
0.0303963902126426 |
|
1526 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POR |
0.0303963902126426 |
|
1527 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4651 |
0.0303963902126426 |
|
1528 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA14A |
0.0303963902126426 |
|
1529 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM120A |
0.0303963902126426 |
|
1530 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STYXL1 |
0.0303963902126426 |
|
1531 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MDH2 |
0.0303963902126426 |
|
1532 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238935.1 |
0.0303963902126426 |
|
1533 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRRM3 |
0.0303963902126426 |
|
1534 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL212P |
0.0303963902126426 |
|
1535 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPB1 |
0.0303963902126426 |
|
1536 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YWHAG |
0.0303963902126426 |
|
1537 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRCRB4D |
0.0303963902126426 |
|
1538 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZP3 |
0.0303963902126426 |
|
1539 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC146 |
0.0303963902126426 |
|
1540 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DTX2 |
0.0303963902126426 |
|
1541 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POMZP3 |
0.0303963902126426 |
|
1542 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UPK3B |
0.0303963902126426 |
|
1543 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGL2 |
0.0303963902126426 |
|
1544 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSAP |
0.0303963902126426 |
|
1545 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238453.1 |
0.0303963902126426 |
|
1546 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPN12 |
0.0303963902126426 |
|
1547 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RSBN1L |
0.0303963902126426 |
|
1548 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM60 |
0.0303963902126426 |
|
1549 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ORC5 |
0.0303963902126426 |
|
1550 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LHFPL3 |
0.0303963902126426 |
|
1551 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL8P |
0.0303963902126426 |
|
1552 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000251911.1 |
0.0303963902126426 |
|
1553 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KMT2E |
0.0303963902126426 |
|
1554 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRPK2 |
0.0303963902126426 |
|
1555 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PUS7 |
0.0303963902126426 |
|
1556 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RINT1 |
0.0303963902126426 |
|
1557 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFCAB10 |
0.0303963902126426 |
|
1558 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDHR3 |
0.0303963902126426 |
|
1559 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYPL1 |
0.0303963902126426 |
|
1560 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAMPT |
0.0303963902126426 |
|
1561 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC71L |
0.0303963902126426 |
|
1562 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP236 |
0.0303963902126426 |
|
1563 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIK3CG |
0.0303963902126426 |
|
1564 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKAR2B |
0.0303963902126426 |
|
1565 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HBP1 |
0.0303963902126426 |
|
1566 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COG5 |
0.0303963902126426 |
|
1567 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR22 |
0.0303963902126426 |
|
1568 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUS4L |
0.0303963902126426 |
|
1569 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCAP29 |
0.0303963902126426 |
|
1570 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU109|ENSG00000238832.1 |
0.0303963902126426 |
|
1571 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC26A4 |
0.0303963902126426 |
|
1572 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBLL1 |
0.0303963902126426 |
|
1573 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC26A3 |
0.0303963902126426 |
|
1574 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLD |
0.0303963902126426 |
|
1575 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAMB1 |
0.0303963902126426 |
|
1576 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000238297.1 |
0.0303963902126426 |
|
1577 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAMB4 |
0.0303963902126426 |
|
1578 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRCAM |
0.0303963902126426 |
|
1579 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNPLA8 |
0.0303963902126426 |
|
1580 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THAP5 |
0.0303963902126426 |
|
1581 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJB9 |
0.0303963902126426 |
|
1582 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C7orf66 |
0.0303963902126426 |
|
1583 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLJ00325 |
0.0303963902126426 |
|
1584 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRN3 |
0.0303963902126426 |
|
1585 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238922.1 |
0.0303963902126426 |
|
1586 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOCK4 |
0.0303963902126426 |
|
1587 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP237 |
0.0303963902126426 |
|
1588 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF277 |
0.0303963902126426 |
|
1589 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP187 |
0.0303963902126426 |
|
1590 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFRD1 |
0.0303963902126426 |
|
1591 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LSMEM1 |
0.0303963902126426 |
|
1592 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM168 |
0.0303963902126426 |
|
1593 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C7orf60 |
0.0303963902126426 |
|
1594 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR85 |
0.0303963902126426 |
|
1595 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSRM |
0.0303963902126426 |
|
1596 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R3A |
0.0303963902126426 |
|
1597 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXP2 |
0.0303963902126426 |
|
1598 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP238 |
0.0303963902126426 |
|
1599 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3666 |
0.0303963902126426 |
|
1600 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MDFIC |
0.0303963902126426 |
|
1601 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA25|ENSG00000202377.1 |
0.0303963902126426 |
|
1602 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFEC |
0.0303963902126426 |
|
1603 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TES |
0.0303963902126426 |
|
1604 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAV2 |
0.0303963902126426 |
|
1605 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoZ185 |
0.0303963902126426 |
|
1606 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAV1 |
0.0303963902126426 |
|
1607 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MET |
0.0303963902126426 |
|
1608 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPZA2 |
0.0303963902126426 |
|
1609 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP239 |
0.0303963902126426 |
|
1610 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST7 |
0.0303963902126426 |
|
1611 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WNT2 |
0.0303963902126426 |
|
1612 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASZ1 |
0.0303963902126426 |
|
1613 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CFTR |
0.0303963902126426 |
|
1614 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTTNBP2 |
0.0303963902126426 |
|
1615 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAA38 |
0.0303963902126426 |
|
1616 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD7 |
0.0303963902126426 |
|
1617 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSN |
0.0305028644524867 |
|
1618 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR223 |
0.0305028644524867 |
|
1619 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VSIG4 |
0.0305028644524867 |
|
1620 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HEPH |
0.0305028644524867 |
|
1621 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EDA2R |
0.0305028644524867 |
|
1622 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AR |
0.0305028644524867 |
|
1623 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OPHN1 |
0.0305028644524867 |
|
1624 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YIPF6 |
0.0305028644524867 |
|
1625 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL855P |
0.0308273377479946 |
|
1626 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF733P |
0.0308273377479946 |
|
1627 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF727 |
0.0308273377479946 |
|
1628 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF679 |
0.0308273377479946 |
|
1629 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF736 |
0.0308273377479946 |
|
1630 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF680 |
0.0308273377479946 |
|
1631 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF107 |
0.0308273377479946 |
|
1632 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF138 |
0.0308273377479946 |
|
1633 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF273 |
0.0308273377479946 |
|
1634 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF117 |
0.0308273377479946 |
|
1635 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPEF1 |
0.0327386073140891 |
|
1636 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR64 |
0.0327386073140891 |
|
1637 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHKA2 |
0.0327386073140891 |
|
1638 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL48P |
0.0327386073140891 |
|
1639 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDHA1 |
0.0327386073140891 |
|
1640 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP3K15 |
0.0327386073140891 |
|
1641 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS23 |
0.0331210159329096 |
|
1642 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CUEDC1 |
0.0331210159329096 |
|
1643 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VEZF1 |
0.0331210159329096 |
|
1644 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRSF1 |
0.0331210159329096 |
|
1645 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DYNLL2 |
0.0331210159329096 |
|
1646 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4D1 |
0.0331210159329096 |
|
1647 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4D2 |
0.0331210159329096 |
|
1648 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPX |
0.0331210159329096 |
|
1649 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MKS1 |
0.0331210159329096 |
|
1650 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBD1 |
0.0331210159329096 |
|
1651 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS6KB1 |
0.0331210159329096 |
|
1652 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNFT1 |
0.0331210159329096 |
|
1653 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HEATR6 |
0.0331210159329096 |
|
1654 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4737 |
0.0331210159329096 |
|
1655 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CA4 |
0.0331210159329096 |
|
1656 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP32 |
0.0331210159329096 |
|
1657 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA20|ENSG00000252577.1 |
0.0331210159329096 |
|
1658 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf64 |
0.0331210159329096 |
|
1659 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL12P38 |
0.0331210159329096 |
|
1660 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APPBP2 |
0.0331210159329096 |
|
1661 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPM1D |
0.0331210159329096 |
|
1662 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCAS3 |
0.0331210159329096 |
|
1663 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL606P |
0.0331210159329096 |
|
1664 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL448P |
0.0331210159329096 |
|
1665 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238799.1 |
0.0331210159329096 |
|
1666 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBX2 |
0.0331210159329096 |
|
1667 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf82 |
0.0331210159329096 |
|
1668 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBX4 |
0.0331210159329096 |
|
1669 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NACA2 |
0.0331210159329096 |
|
1670 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRIP1 |
0.0331210159329096 |
|
1671 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INTS2 |
0.0331210159329096 |
|
1672 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED13 |
0.0331210159329096 |
|
1673 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL800P |
0.0331210159329096 |
|
1674 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D3P2 |
0.0331210159329096 |
|
1675 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFCAB3 |
0.0331210159329096 |
|
1676 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL2A |
0.0331210159329096 |
|
1677 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TYRP1 |
0.0339108908702351 |
|
1678 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PELP1 |
0.0339801478536237 |
|
1679 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS6KA5 |
0.0340278064072234 |
|
1680 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C14orf159 |
0.0340278064072234 |
|
1681 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA11B |
0.0340278064072234 |
|
1682 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL506P |
0.0340278064072234 |
|
1683 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SBF2 |
0.0340511069902837 |
|
1684 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C14orf28 |
0.0342347240285485 |
|
1685 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL28 |
0.0342347240285485 |
|
1686 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM179B |
0.0342347240285485 |
|
1687 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCTD7 |
0.0346194702343946 |
|
1688 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RABGEF1 |
0.0346194702343946 |
|
1689 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238841.1 |
0.0346194702343946 |
|
1690 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF2IRD1P1 |
0.0346194702343946 |
|
1691 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM248 |
0.0346194702343946 |
|
1692 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL43P |
0.0346194702343946 |
|
1693 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SBDS |
0.0346194702343946 |
|
1694 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TYW1 |
0.0346194702343946 |
|
1695 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PMS2P4 |
0.0346194702343946 |
|
1696 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAG3L4 |
0.0346194702343946 |
|
1697 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPIN3 |
0.0346235468843725 |
|
1698 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPIN2A |
0.0346235468843725 |
|
1699 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPIN2B |
0.0346235468843725 |
|
1700 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAAH2 |
0.0346235468843725 |
|
1701 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZXDB |
0.0346235468843725 |
|
1702 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZXDA |
0.0346235468843725 |
|
1703 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THSD7B |
0.0347647276467806 |
|
1704 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AUTS2 |
0.0348032731907559 |
|
1705 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF21A |
0.0356224338133573 |
|
1706 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCD2 |
0.0356224338133573 |
|
1707 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX13A |
0.0360448830836628 |
|
1708 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRK |
0.0360448830836628 |
|
1709 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINA7 |
0.0360448830836628 |
|
1710 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUM1L1 |
0.0360448830836628 |
|
1711 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXorf57 |
0.0360448830836628 |
|
1712 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548AN |
0.0360448830836628 |
|
1713 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF128 |
0.0360448830836628 |
|
1714 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D8B |
0.0360448830836628 |
|
1715 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MORC4 |
0.0360448830836628 |
|
1716 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLDN2 |
0.0360448830836628 |
|
1717 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIPPLY1 |
0.0360448830836628 |
|
1718 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUP62CL |
0.0360448830836628 |
|
1719 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIH1D3 |
0.0360448830836628 |
|
1720 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM41 |
0.0360448830836628 |
|
1721 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRMPD3 |
0.0360448830836628 |
|
1722 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRPS1 |
0.0360448830836628 |
|
1723 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSC22D3 |
0.0360448830836628 |
|
1724 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCBP2L |
0.0360448830836628 |
|
1725 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MID2 |
0.0360448830836628 |
|
1726 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX13B |
0.0360448830836628 |
|
1727 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VSIG1 |
0.0360448830836628 |
|
1728 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMD10 |
0.0360448830836628 |
|
1729 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATG4A |
0.0360448830836628 |
|
1730 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL4A6 |
0.0360448830836628 |
|
1731 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL4A5 |
0.0360448830836628 |
|
1732 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NXT2 |
0.0360448830836628 |
|
1733 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNE1L |
0.0360448830836628 |
|
1734 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACSL4 |
0.0360448830836628 |
|
1735 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM164 |
0.0360448830836628 |
|
1736 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR652 |
0.0360448830836628 |
|
1737 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3978 |
0.0360448830836628 |
|
1738 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMMECR1 |
0.0360448830836628 |
|
1739 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD96B |
0.0360448830836628 |
|
1740 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNG5P2 |
0.0360448830836628 |
|
1741 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGAG1 |
0.0360448830836628 |
|
1742 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TDGF1P3 |
0.0360448830836628 |
|
1743 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRDL1 |
0.0360448830836628 |
|
1744 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAK3 |
0.0360448830836628 |
|
1745 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPN6 |
0.0360448830836628 |
|
1746 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCX |
0.0360448830836628 |
|
1747 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00890 |
0.0360448830836628 |
|
1748 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL661P |
0.0360448830836628 |
|
1749 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALG13 |
0.0360448830836628 |
|
1750 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP512 |
0.0360448830836628 |
|
1751 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPC5 |
0.0360448830836628 |
|
1752 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPC5OS |
0.0360448830836628 |
|
1753 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZCCHC16 |
0.0360448830836628 |
|
1754 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LHFPL1 |
0.0360448830836628 |
|
1755 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMOT |
0.0360448830836628 |
|
1756 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4329 |
0.0360448830836628 |
|
1757 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL266P |
0.0360448830836628 |
|
1758 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238811.1 |
0.0360448830836628 |
|
1759 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000201674.1 |
0.0360448830836628 |
|
1760 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL93P |
0.0360448830836628 |
|
1761 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD30 |
0.0360448830836628 |
|
1762 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTR2C |
0.0360448830836628 |
|
1763 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA35|ENSG00000208839.1 |
0.0360448830836628 |
|
1764 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR764 |
0.0360448830836628 |
|
1765 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1912 |
0.0360448830836628 |
|
1766 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1298 |
0.0360448830836628 |
|
1767 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1911 |
0.0360448830836628 |
|
1768 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR448 |
0.0360448830836628 |
|
1769 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL13RA2 |
0.0360448830836628 |
|
1770 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRCH2 |
0.0360448830836628 |
|
1771 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LUZP4 |
0.0360448830836628 |
|
1772 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBMXL3 |
0.0360448830836628 |
|
1773 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA35|ENSG00000271907.1 |
0.0360448830836628 |
|
1774 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA64|ENSG00000252441.1 |
0.0360448830836628 |
|
1775 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLS3 |
0.0360448830836628 |
|
1776 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL712P |
0.0360448830836628 |
|
1777 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGTR2 |
0.0360448830836628 |
|
1778 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC6A14 |
0.0360448830836628 |
|
1779 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXorf61 |
0.0360448830836628 |
|
1780 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL13 |
0.0360448830836628 |
|
1781 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR44 |
0.0360448830836628 |
|
1782 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1277 |
0.0360448830836628 |
|
1783 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOCK11 |
0.0360448830836628 |
|
1784 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL13RA1 |
0.0360448830836628 |
|
1785 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA35|ENSG00000239182.1 |
0.0360448830836628 |
|
1786 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZCCHC12 |
0.0360448830836628 |
|
1787 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LONRF3 |
0.0360448830836628 |
|
1788 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1210 |
0.0360448830836628 |
|
1789 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGRMC1 |
0.0360448830836628 |
|
1790 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL118P |
0.0360448830836628 |
|
1791 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A43 |
0.0360448830836628 |
|
1792 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A5 |
0.0360448830836628 |
|
1793 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXorf56 |
0.0360448830836628 |
|
1794 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2A |
0.0360448830836628 |
|
1795 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NKRF |
0.0360448830836628 |
|
1796 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEPT6 |
0.0360448830836628 |
|
1797 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR766 |
0.0360448830836628 |
|
1798 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOWAHD |
0.0360448830836628 |
|
1799 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL39 |
0.0360448830836628 |
|
1800 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA69|ENSG00000206622.1 |
0.0360448830836628 |
|
1801 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UPF3B |
0.0360448830836628 |
|
1802 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFA1 |
0.0360448830836628 |
|
1803 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF113A |
0.0360448830836628 |
|
1804 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKAP14 |
0.0360448830836628 |
|
1805 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NKAP |
0.0360448830836628 |
|
1806 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHOXF2B |
0.0360448830836628 |
|
1807 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHOXF1 |
0.0360448830836628 |
|
1808 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NKAPP1 |
0.0360448830836628 |
|
1809 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHOXF2 |
0.0360448830836628 |
|
1810 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB33 |
0.0360448830836628 |
|
1811 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM255A |
0.0360448830836628 |
|
1812 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP1B4 |
0.0360448830836628 |
|
1813 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAMP2 |
0.0360448830836628 |
|
1814 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CUL4B |
0.0360448830836628 |
|
1815 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000272179.1 |
0.0360448830836628 |
|
1816 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCTS1 |
0.0360448830836628 |
|
1817 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1GALT1C1 |
0.0360448830836628 |
|
1818 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CT47A10 |
0.0360448830836628 |
|
1819 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CT47A11 |
0.0360448830836628 |
|
1820 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CT47A12 |
0.0360448830836628 |
|
1821 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CT47A1 |
0.0360448830836628 |
|
1822 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CT47A2 |
0.0360448830836628 |
|
1823 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CT47A3 |
0.0360448830836628 |
|
1824 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CT47A4 |
0.0360448830836628 |
|
1825 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CT47A5 |
0.0360448830836628 |
|
1826 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CT47A6 |
0.0360448830836628 |
|
1827 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CT47A7 |
0.0360448830836628 |
|
1828 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CT47A8 |
0.0360448830836628 |
|
1829 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CT47A9 |
0.0360448830836628 |
|
1830 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CT47B1 |
0.0360448830836628 |
|
1831 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLUD2 |
0.0360448830836628 |
|
1832 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3672 |
0.0360448830836628 |
|
1833 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000212321.1 |
0.0360448830836628 |
|
1834 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRIA3 |
0.0360448830836628 |
|
1835 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THOC2 |
0.0360448830836628 |
|
1836 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL29P |
0.0360448830836628 |
|
1837 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XIAP |
0.0360448830836628 |
|
1838 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAG2 |
0.0360448830836628 |
|
1839 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239058.1 |
0.0360448830836628 |
|
1840 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA40|ENSG00000252693.1 |
0.0360448830836628 |
|
1841 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH2D1A |
0.0360448830836628 |
|
1842 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TENM1 |
0.0360448830836628 |
|
1843 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238626.1 |
0.0360448830836628 |
|
1844 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCAF12L2 |
0.0360448830836628 |
|
1845 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCAF12L1 |
0.0360448830836628 |
|
1846 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXorf64 |
0.0360448830836628 |
|
1847 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTRT1 |
0.0360448830836628 |
|
1848 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP513 |
0.0360448830836628 |
|
1849 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMARCA1 |
0.0360448830836628 |
|
1850 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OCRL |
0.0360448830836628 |
|
1851 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APLN |
0.0360448830836628 |
|
1852 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XPNPEP2 |
0.0360448830836628 |
|
1853 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SASH3 |
0.0360448830836628 |
|
1854 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDHHC9 |
0.0360448830836628 |
|
1855 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UTP14A |
0.0360448830836628 |
|
1856 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCORL1 |
0.0360448830836628 |
|
1857 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELF4 |
0.0360448830836628 |
|
1858 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AIFM1 |
0.0360448830836628 |
|
1859 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB33A |
0.0360448830836628 |
|
1860 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF280C |
0.0360448830836628 |
|
1861 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A14 |
0.0360448830836628 |
|
1862 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR119 |
0.0360448830836628 |
|
1863 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBMX2 |
0.0360448830836628 |
|
1864 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM45B |
0.0360448830836628 |
|
1865 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENOX2 |
0.0360448830836628 |
|
1866 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP36 |
0.0360448830836628 |
|
1867 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL191P |
0.0360448830836628 |
|
1868 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGSF1 |
0.0360448830836628 |
|
1869 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR13H1 |
0.0360448830836628 |
|
1870 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP514 |
0.0360448830836628 |
|
1871 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPO |
0.0367370697762541 |
|
1872 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPO |
0.0367370697762541 |
|
1873 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BZRAP1 |
0.0367370697762541 |
|
1874 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR142 |
0.0367370697762541 |
|
1875 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4736 |
0.0367370697762541 |
|
1876 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUPT4H1 |
0.0367370697762541 |
|
1877 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF43 |
0.0367370697762541 |
|
1878 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSF5 |
0.0367370697762541 |
|
1879 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTMR4 |
0.0367370697762541 |
|
1880 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEPT4 |
0.0367370697762541 |
|
1881 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf47 |
0.0367370697762541 |
|
1882 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX14 |
0.0367370697762541 |
|
1883 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000212195.1 |
0.0367370697762541 |
|
1884 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAD51C |
0.0367370697762541 |
|
1885 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPM1E |
0.0367370697762541 |
|
1886 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL716P |
0.0367370697762541 |
|
1887 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM37 |
0.0367370697762541 |
|
1888 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SKA2 |
0.0367370697762541 |
|
1889 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR454 |
0.0367370697762541 |
|
1890 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR301A |
0.0367370697762541 |
|
1891 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR11 |
0.0367370697762541 |
|
1892 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMG8 |
0.0367370697762541 |
|
1893 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GDPD1 |
0.0367370697762541 |
|
1894 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YPEL2 |
0.0367370697762541 |
|
1895 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4729 |
0.0367370697762541 |
|
1896 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHX40 |
0.0367370697762541 |
|
1897 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLTC |
0.0367370697762541 |
|
1898 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTRH2 |
0.0367370697762541 |
|
1899 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR21 |
0.0367370697762541 |
|
1900 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXorf28 |
0.0378039042243885 |
|
1901 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MXRA5 |
0.0378039042243885 |
|
1902 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA48|ENSG00000212214.1 |
0.0378039042243885 |
|
1903 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKX |
0.0378039042243885 |
|
1904 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA20|ENSG00000201660.1 |
0.0378039042243885 |
|
1905 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NLGN4X |
0.0378039042243885 |
|
1906 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000252291.1 |
0.0378039042243885 |
|
1907 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4770 |
0.0378039042243885 |
|
1908 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GUCY2F |
0.0380982977972918 |
|
1909 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP231 |
0.0382283100365822 |
|
1910 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL371P |
0.0382283100365822 |
|
1911 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WBSCR17 |
0.0382283100365822 |
|
1912 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP75 |
0.0382283100365822 |
|
1913 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CALN1 |
0.0382283100365822 |
|
1914 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP232 |
0.0382283100365822 |
|
1915 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL377P |
0.0382283100365822 |
|
1916 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL625P |
0.0382283100365822 |
|
1917 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TYW1B |
0.0382283100365822 |
|
1918 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POM121 |
0.0382283100365822 |
|
1919 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF2IRD2P1 |
0.0382283100365822 |
|
1920 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCF1B |
0.0382283100365822 |
|
1921 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NSUN5P2 |
0.0382283100365822 |
|
1922 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NSUN5 |
0.0382283100365822 |
|
1923 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAG3L3 |
0.0382283100365822 |
|
1924 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM50 |
0.0382283100365822 |
|
1925 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM74 |
0.0382283100365822 |
|
1926 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHTF2 |
0.0382283100365822 |
|
1927 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VMP1 |
0.0386171517979413 |
|
1928 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TGIF2LX |
0.0389907260317885 |
|
1929 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PABPC5 |
0.0389907260317885 |
|
1930 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDH11X |
0.0389907260317885 |
|
1931 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLITRK2 |
0.039555767534355 |
|
1932 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM257 |
0.039555767534355 |
|
1933 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR888 |
0.039555767534355 |
|
1934 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR890 |
0.039555767534355 |
|
1935 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR892A |
0.039555767534355 |
|
1936 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR892B |
0.039555767534355 |
|
1937 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR891B |
0.039555767534355 |
|
1938 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR891A |
0.039555767534355 |
|
1939 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP517 |
0.039555767534355 |
|
1940 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXorf51A |
0.039555767534355 |
|
1941 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXorf51B |
0.039555767534355 |
|
1942 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR513C |
0.039555767534355 |
|
1943 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR513B |
0.039555767534355 |
|
1944 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR513A1 |
0.039555767534355 |
|
1945 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR513A2 |
0.039555767534355 |
|
1946 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR506 |
0.039555767534355 |
|
1947 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR507 |
0.039555767534355 |
|
1948 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR508 |
0.039555767534355 |
|
1949 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR514B |
0.039555767534355 |
|
1950 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR510 |
0.039555767534355 |
|
1951 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR514A1 |
0.039555767534355 |
|
1952 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR514A2 |
0.039555767534355 |
|
1953 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR514A3 |
0.039555767534355 |
|
1954 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FMR1 |
0.039555767534355 |
|
1955 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FMR1NB |
0.039555767534355 |
|
1956 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AFF2 |
0.039555767534355 |
|
1957 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP267 |
0.039555767534355 |
|
1958 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IDS |
0.039555767534355 |
|
1959 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00893 |
0.039555767534355 |
|
1960 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXorf40A |
0.039555767534355 |
|
1961 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXorf40B |
0.039555767534355 |
|
1962 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSFX1 |
0.039555767534355 |
|
1963 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSFX2 |
0.039555767534355 |
|
1964 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00894 |
0.039555767534355 |
|
1965 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEA11 |
0.039555767534355 |
|
1966 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEA8 |
0.039555767534355 |
|
1967 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEA9B |
0.039555767534355 |
|
1968 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEA9 |
0.039555767534355 |
|
1969 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM185A |
0.039555767534355 |
|
1970 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR2114 |
0.039555767534355 |
|
1971 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAMLD1 |
0.039555767534355 |
|
1972 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTM1 |
0.039555767534355 |
|
1973 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTMR1 |
0.039555767534355 |
|
1974 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD99L2 |
0.039555767534355 |
|
1975 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000253009.1 |
0.039555767534355 |
|
1976 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMGB3 |
0.039555767534355 |
|
1977 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4330 |
0.039555767534355 |
|
1978 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR50 |
0.039555767534355 |
|
1979 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VMA21 |
0.039555767534355 |
|
1980 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PASD1 |
0.039555767534355 |
|
1981 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRRG3 |
0.039555767534355 |
|
1982 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FATE1 |
0.039555767534355 |
|
1983 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNGA2 |
0.039555767534355 |
|
1984 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEA4 |
0.039555767534355 |
|
1985 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABRE |
0.039555767534355 |
|
1986 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR224 |
0.039555767534355 |
|
1987 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR452 |
0.039555767534355 |
|
1988 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEA10 |
0.039555767534355 |
|
1989 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABRA3 |
0.039555767534355 |
|
1990 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR767 |
0.039555767534355 |
|
1991 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABRQ |
0.039555767534355 |
|
1992 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CETN2 |
0.039555767534355 |
|
1993 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSAG1 |
0.039555767534355 |
|
1994 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSAG2 |
0.039555767534355 |
|
1995 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSAG3 |
0.039555767534355 |
|
1996 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSAG4 |
0.039555767534355 |
|
1997 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEA12 |
0.039555767534355 |
|
1998 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEA1 |
0.039555767534355 |
|
1999 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEA2B |
0.039555767534355 |
|
2000 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEA2 |
0.039555767534355 |
|
2001 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEA3 |
0.039555767534355 |
|
2002 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEA6 |
0.039555767534355 |
|
2003 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NSDHL |
0.039555767534355 |
|
2004 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNMA3 |
0.039555767534355 |
|
2005 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNMA5 |
0.039555767534355 |
|
2006 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNMA6A |
0.039555767534355 |
|
2007 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNMA6B |
0.039555767534355 |
|
2008 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNMA6C |
0.039555767534355 |
|
2009 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNMA6D |
0.039555767534355 |
|
2010 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL190P |
0.039555767534355 |
|
2011 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL667P |
0.039555767534355 |
|
2012 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFP92 |
0.039555767534355 |
|
2013 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF185 |
0.039555767534355 |
|
2014 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF275 |
0.039555767534355 |
|
2015 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239037.1 |
0.039555767534355 |
|
2016 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAUS7 |
0.039555767534355 |
|
2017 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TREX2 |
0.039555767534355 |
|
2018 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BGN |
0.039555767534355 |
|
2019 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP2B3 |
0.039555767534355 |
|
2020 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM58A |
0.039555767534355 |
|
2021 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUSP9 |
0.039555767534355 |
|
2022 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL687P |
0.039555767534355 |
|
2023 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNCK |
0.039555767534355 |
|
2024 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC6A8 |
0.039555767534355 |
|
2025 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCAP31 |
0.039555767534355 |
|
2026 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCD1 |
0.039555767534355 |
|
2027 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLXNB3 |
0.039555767534355 |
|
2028 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IDH3G |
0.039555767534355 |
|
2029 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRPK3 |
0.039555767534355 |
|
2030 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSR4 |
0.039555767534355 |
|
2031 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDZD4 |
0.039555767534355 |
|
2032 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AVPR2 |
0.039555767534355 |
|
2033 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP4 |
0.039555767534355 |
|
2034 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAA10 |
0.039555767534355 |
|
2035 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCFC1 |
0.039555767534355 |
|
2036 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RENBP |
0.039555767534355 |
|
2037 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM187 |
0.039555767534355 |
|
2038 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRAK1 |
0.039555767534355 |
|
2039 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MECP2 |
0.039555767534355 |
|
2040 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR718 |
0.039555767534355 |
|
2041 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OPN1LW |
0.039555767534355 |
|
2042 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OPN1MW2 |
0.039555767534355 |
|
2043 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OPN1MW |
0.039555767534355 |
|
2044 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX28P1 |
0.039555767534355 |
|
2045 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX28P2 |
0.039555767534355 |
|
2046 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX28 |
0.039555767534355 |
|
2047 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TKTL1 |
0.039555767534355 |
|
2048 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMD |
0.039555767534355 |
|
2049 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLNA |
0.039555767534355 |
|
2050 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL10 |
0.039555767534355 |
|
2051 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000207165.1 |
0.039555767534355 |
|
2052 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNASE1L1 |
0.039555767534355 |
|
2053 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAZ |
0.039555767534355 |
|
2054 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6AP1 |
0.039555767534355 |
|
2055 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM50A |
0.039555767534355 |
|
2056 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GDI1 |
0.039555767534355 |
|
2057 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLXNA3 |
0.039555767534355 |
|
2058 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAGE3 |
0.039555767534355 |
|
2059 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBL4A |
0.039555767534355 |
|
2060 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC10A3 |
0.039555767534355 |
|
2061 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL697P |
0.039555767534355 |
|
2062 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL742P |
0.039555767534355 |
|
2063 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM3A |
0.039555767534355 |
|
2064 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
G6PD |
0.039555767534355 |
|
2065 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IKBKG |
0.039555767534355 |
|
2066 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRCC3 |
0.039555767534355 |
|
2067 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLIC2 |
0.039555767534355 |
|
2068 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CMC4 |
0.039555767534355 |
|
2069 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTAG1A |
0.039555767534355 |
|
2070 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTAG1B |
0.039555767534355 |
|
2071 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTAG2 |
0.039555767534355 |
|
2072 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DKC1 |
0.039555767534355 |
|
2073 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
F8A1 |
0.039555767534355 |
|
2074 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
F8A2 |
0.039555767534355 |
|
2075 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
F8A3 |
0.039555767534355 |
|
2076 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
F8 |
0.039555767534355 |
|
2077 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FUNDC2 |
0.039555767534355 |
|
2078 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAB3 |
0.039555767534355 |
|
2079 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
H2AFB1 |
0.039555767534355 |
|
2080 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
H2AFB2 |
0.039555767534355 |
|
2081 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
H2AFB3 |
0.039555767534355 |
|
2082 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPP1 |
0.039555767534355 |
|
2083 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTCP1 |
0.039555767534355 |
|
2084 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB39B |
0.039555767534355 |
|
2085 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMIM9 |
0.039555767534355 |
|
2086 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA36A |
0.039555767534355 |
|
2087 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA56 |
0.039555767534355 |
|
2088 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMLHE |
0.039555767534355 |
|
2089 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VBP1 |
0.039555767534355 |
|
2090 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL9R|ENSG00000124334.12 |
0.039555767534355 |
|
2091 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPRY3|ENSG00000168939.6 |
0.039555767534355 |
|
2092 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VAMP7|ENSG00000124333.10 |
0.039555767534355 |
|
2093 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WASH6P|ENSG00000182484.10 |
0.039555767534355 |
|
2094 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WASIR1|ENSG00000185203.7
|
0.039555767534355
|
|
2095 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf228 |
0.0396653744673379 |
|
2096 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXorf21 |
0.0405439245889383 |
|
2097 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GK |
0.0405439245889383 |
|
2098 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAB3 |
0.0405439245889383 |
|
2099 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DMD |
0.0405439245889383 |
|
2100 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FTHL17 |
0.0405439245889383 |
|
2101 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP501 |
0.0405439245889383 |
|
2102 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3915 |
0.0405439245889383 |
|
2103 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548F5 |
0.0405439245889383 |
|
2104 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238969.1 |
0.0405439245889383 |
|
2105 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM47A |
0.0405439245889383 |
|
2106 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM47 |
0.0405439245889383 |
|
2107 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM47B |
0.0405439245889383 |
|
2108 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEB16 |
0.0405439245889383 |
|
2109 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXorf22 |
0.0405439245889383 |
|
2110 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHDC2 |
0.0405439245889383 |
|
2111 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXorf30 |
0.0405439245889383 |
|
2112 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM47C |
0.0405439245889383 |
|
2113 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRRG1 |
0.0405439245889383 |
|
2114 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TM4SF2 |
0.0405439245889383 |
|
2115 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LANCL3 |
0.0405439245889383 |
|
2116 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XK |
0.0405439245889383 |
|
2117 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYBB |
0.0405439245889383 |
|
2118 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DYNLT3 |
0.0405439245889383 |
|
2119 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXorf27 |
0.0405439245889383 |
|
2120 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548AJ2 |
0.0405439245889383 |
|
2121 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRPX |
0.0405439245889383 |
|
2122 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYTL5 |
0.0405439245889383 |
|
2123 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPGR |
0.0405439245889383 |
|
2124 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000252050.1 |
0.0405439245889383 |
|
2125 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OTC |
0.0405439245889383 |
|
2126 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPAN7 |
0.0405439245889383 |
|
2127 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MID1IP1 |
0.0405439245889383 |
|
2128 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3937 |
0.0405439245889383 |
|
2129 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL732P |
0.0405439245889383 |
|
2130 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1587 |
0.0405439245889383 |
|
2131 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCOR |
0.0405439245889383 |
|
2132 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238920.1 |
0.0405439245889383 |
|
2133 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6AP2 |
0.0405439245889383 |
|
2134 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXorf38 |
0.0405439245889383 |
|
2135 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED14 |
0.0405439245889383 |
|
2136 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NYX |
0.0405439245889383 |
|
2137 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASK |
0.0405439245889383 |
|
2138 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL406P |
0.0405439245889383 |
|
2139 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL144P |
0.0405439245889383 |
|
2140 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR34 |
0.0405439245889383 |
|
2141 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR82 |
0.0405439245889383 |
|
2142 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAOA |
0.0405439245889383 |
|
2143 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAOB |
0.0405439245889383 |
|
2144 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDP |
0.0405439245889383 |
|
2145 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFHC2 |
0.0405439245889383 |
|
2146 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FUNDC1 |
0.0405439245889383 |
|
2147 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL291P |
0.0405439245889383 |
|
2148 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUSP21 |
0.0405439245889383 |
|
2149 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KDM6A |
0.0405439245889383 |
|
2150 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXorf36 |
0.0405439245889383 |
|
2151 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR221 |
0.0405439245889383 |
|
2152 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR222 |
0.0405439245889383 |
|
2153 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD77|ENSG00000212347.2 |
0.0405439245889383 |
|
2154 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRBOX4 |
0.0405439245889383 |
|
2155 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF674 |
0.0405439245889383 |
|
2156 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHST7 |
0.0405439245889383 |
|
2157 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC9A7 |
0.0405439245889383 |
|
2158 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RP2 |
0.0405439245889383 |
|
2159 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXorf31 |
0.0405439245889383 |
|
2160 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHF16 |
0.0405439245889383 |
|
2161 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGN |
0.0405439245889383 |
|
2162 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFB11 |
0.0405439245889383 |
|
2163 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM10 |
0.0405439245889383 |
|
2164 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBA1 |
0.0405439245889383 |
|
2165 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INE1 |
0.0405439245889383 |
|
2166 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK16 |
0.0405439245889383 |
|
2167 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP11 |
0.0405439245889383 |
|
2168 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL785P |
0.0405439245889383 |
|
2169 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238729.1 |
0.0405439245889383 |
|
2170 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF157 |
0.0405439245889383 |
|
2171 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA11C |
0.0405439245889383 |
|
2172 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF41 |
0.0405439245889383 |
|
2173 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXorf24 |
0.0405439245889383 |
|
2174 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARAF |
0.0405439245889383 |
|
2175 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYN1 |
0.0405439245889383 |
|
2176 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIMP1 |
0.0405439245889383 |
|
2177 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4769 |
0.0405439245889383 |
|
2178 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CFP |
0.0405439245889383 |
|
2179 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELK1 |
0.0405439245889383 |
|
2180 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UXT |
0.0405439245889383 |
|
2181 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXXC1P1 |
0.0405439245889383 |
|
2182 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF81 |
0.0405439245889383 |
|
2183 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPACA5B |
0.0405439245889383 |
|
2184 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPACA5 |
0.0405439245889383 |
|
2185 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSX6 |
0.0405439245889383 |
|
2186 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF182 |
0.0405439245889383 |
|
2187 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF630 |
0.0405439245889383 |
|
2188 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238473.1 |
0.0405439245889383 |
|
2189 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSX5 |
0.0405439245889383 |
|
2190 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP503 |
0.0405439245889383 |
|
2191 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSX1 |
0.0405439245889383 |
|
2192 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSX3 |
0.0405439245889383 |
|
2193 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSX4B |
0.0405439245889383 |
|
2194 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSX4 |
0.0405439245889383 |
|
2195 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSX9 |
0.0405439245889383 |
|
2196 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC38A5 |
0.0405439245889383 |
|
2197 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FTSJ1 |
0.0405439245889383 |
|
2198 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PORCN |
0.0405439245889383 |
|
2199 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EBP |
0.0405439245889383 |
|
2200 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D25 |
0.0405439245889383 |
|
2201 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239017.1 |
0.0405439245889383 |
|
2202 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM3 |
0.0405439245889383 |
|
2203 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR13 |
0.0405439245889383 |
|
2204 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WAS |
0.0405439245889383 |
|
2205 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUV39H1 |
0.0405439245889383 |
|
2206 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLOD5 |
0.0405439245889383 |
|
2207 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GATA1 |
0.0405439245889383 |
|
2208 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HDAC6 |
0.0405439245889383 |
|
2209 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERAS |
0.0405439245889383 |
|
2210 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCSK1N |
0.0405439245889383 |
|
2211 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIMM17B |
0.0405439245889383 |
|
2212 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PQBP1 |
0.0405439245889383 |
|
2213 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIM2 |
0.0405439245889383 |
|
2214 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35A2 |
0.0405439245889383 |
|
2215 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OTUD5 |
0.0405439245889383 |
|
2216 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCND1 |
0.0405439245889383 |
|
2217 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRIPAP1 |
0.0405439245889383 |
|
2218 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL139P |
0.0405439245889383 |
|
2219 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFE3 |
0.0405439245889383 |
|
2220 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC120 |
0.0405439245889383 |
|
2221 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAF2 |
0.0405439245889383 |
|
2222 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR45 |
0.0405439245889383 |
|
2223 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPKOW |
0.0405439245889383 |
|
2224 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL262P |
0.0405439245889383 |
|
2225 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGIX |
0.0405439245889383 |
|
2226 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLP2 |
0.0405439245889383 |
|
2227 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRICKLE3 |
0.0405439245889383 |
|
2228 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYP |
0.0405439245889383 |
|
2229 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNA1F |
0.0405439245889383 |
|
2230 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC22 |
0.0405439245889383 |
|
2231 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXP3 |
0.0405439245889383 |
|
2232 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R3F |
0.0405439245889383 |
|
2233 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAGE10 |
0.0405439245889383 |
|
2234 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAGE12B |
0.0405439245889383 |
|
2235 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAGE12C |
0.0405439245889383 |
|
2236 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAGE12D |
0.0405439245889383 |
|
2237 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAGE12E |
0.0405439245889383 |
|
2238 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAGE12F |
0.0405439245889383 |
|
2239 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAGE12G |
0.0405439245889383 |
|
2240 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAGE12H |
0.0405439245889383 |
|
2241 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAGE12I |
0.0405439245889383 |
|
2242 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAGE12J |
0.0405439245889383 |
|
2243 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAGE13 |
0.0405439245889383 |
|
2244 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAGE2A |
0.0405439245889383 |
|
2245 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAGE2B |
0.0405439245889383 |
|
2246 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAGE2C |
0.0405439245889383 |
|
2247 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAGE2D |
0.0405439245889383 |
|
2248 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAGE2E |
0.0405439245889383 |
|
2249 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAGE1 |
0.0405439245889383 |
|
2250 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAGE1 |
0.0405439245889383 |
|
2251 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAGE4 |
0.0405439245889383 |
|
2252 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP27X |
0.0405439245889383 |
|
2253 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLCN5 |
0.0405439245889383 |
|
2254 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR532 |
0.0405439245889383 |
|
2255 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR188 |
0.0405439245889383 |
|
2256 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR362 |
0.0405439245889383 |
|
2257 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR500A |
0.0405439245889383 |
|
2258 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR500B |
0.0405439245889383 |
|
2259 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR501 |
0.0405439245889383 |
|
2260 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR660 |
0.0405439245889383 |
|
2261 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR502 |
0.0405439245889383 |
|
2262 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKAP4 |
0.0405439245889383 |
|
2263 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNB3 |
0.0405439245889383 |
|
2264 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DGKK |
0.0405439245889383 |
|
2265 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHROOM4 |
0.0405439245889383 |
|
2266 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BMP15 |
0.0405439245889383 |
|
2267 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDT10 |
0.0405439245889383 |
|
2268 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXorf67 |
0.0405439245889383 |
|
2269 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDT11 |
0.0405439245889383 |
|
2270 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CENPVP1 |
0.0405439245889383 |
|
2271 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSPT2 |
0.0405439245889383 |
|
2272 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGED1 |
0.0405439245889383 |
|
2273 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGED4B |
0.0405439245889383 |
|
2274 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGED4 |
0.0405439245889383 |
|
2275 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA11D |
0.0405439245889383 |
|
2276 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA11E |
0.0405439245889383 |
|
2277 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NELL2 |
0.0413402257923966 |
|
2278 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DBX2 |
0.0413402257923966 |
|
2279 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP361 |
0.0413402257923966 |
|
2280 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHA8P1 |
0.0413402257923966 |
|
2281 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANO6 |
0.0413402257923966 |
|
2282 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARID2 |
0.0413402257923966 |
|
2283 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL246P |
0.0413402257923966 |
|
2284 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCAF11 |
0.0413402257923966 |
|
2285 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC38A1 |
0.0413402257923966 |
|
2286 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf40 |
0.0419198638365958 |
|
2287 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC2A13 |
0.0419198638365958 |
|
2288 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRK2 |
0.0419198638365958 |
|
2289 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACP1 |
0.0435268107372855 |
|
2290 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM110C |
0.0435268107372855 |
|
2291 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM150B |
0.0435268107372855 |
|
2292 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3YL1 |
0.0435268107372855 |
|
2293 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM18 |
0.0435268107372855 |
|
2294 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYT1L |
0.0435268107372855 |
|
2295 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PXDN |
0.0435268107372855 |
|
2296 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNTG2 |
0.0435268107372855 |
|
2297 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPO |
0.0435268107372855 |
|
2298 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238722.1 |
0.0435268107372855 |
|
2299 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSSC1 |
0.0435268107372855 |
|
2300 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAPPC12 |
0.0435268107372855 |
|
2301 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADI1 |
0.0435268107372855 |
|
2302 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNASEH1 |
0.0435268107372855 |
|
2303 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS7 |
0.0435268107372855 |
|
2304 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA73|ENSG00000252531.1 |
0.0435268107372855 |
|
2305 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COLEC11 |
0.0435268107372855 |
|
2306 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALLC |
0.0435268107372855 |
|
2307 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCDC2C |
0.0435268107372855 |
|
2308 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL531P |
0.0435268107372855 |
|
2309 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000252238.1 |
0.0435268107372855 |
|
2310 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOX11 |
0.0435268107372855 |
|
2311 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLJ30594 |
0.0435268107372855 |
|
2312 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00487 |
0.0435268107372855 |
|
2313 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CMPK2 |
0.0435268107372855 |
|
2314 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RSAD2 |
0.0435268107372855 |
|
2315 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF144A |
0.0435268107372855 |
|
2316 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP112 |
0.0435268107372855 |
|
2317 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC37P |
0.0435268107372855 |
|
2318 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00299 |
0.0435268107372855 |
|
2319 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ID2 |
0.0435268107372855 |
|
2320 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIDINS220 |
0.0435268107372855 |
|
2321 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBOAT2 |
0.0435268107372855 |
|
2322 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238888.1 |
0.0435268107372855 |
|
2323 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASAP2 |
0.0435268107372855 |
|
2324 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGB1BP1 |
0.0435268107372855 |
|
2325 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPSF3 |
0.0435268107372855 |
|
2326 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IAH1 |
0.0435268107372855 |
|
2327 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM17 |
0.0435268107372855 |
|
2328 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPY19L2P1 |
0.0437565684841839 |
|
2329 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBX20 |
0.0437565684841839 |
|
2330 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HERPUD2 |
0.0437565684841839 |
|
2331 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEPT7 |
0.0437565684841839 |
|
2332 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PP13004 |
0.0437565684841839 |
|
2333 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EEPD1 |
0.0437565684841839 |
|
2334 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0895 |
0.0437565684841839 |
|
2335 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANLN |
0.0437565684841839 |
|
2336 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AOAH |
0.0437565684841839 |
|
2337 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELMO1 |
0.0437565684841839 |
|
2338 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1200 |
0.0437565684841839 |
|
2339 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238772.1 |
0.0437565684841839 |
|
2340 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA51|ENSG00000200113.1 |
0.0437565684841839 |
|
2341 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPDR1 |
0.0437565684841839 |
|
2342 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR141 |
0.0437565684841839 |
|
2343 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NME8 |
0.0437565684841839 |
|
2344 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFRP4 |
0.0437565684841839 |
|
2345 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STARD3NL |
0.0437565684841839 |
|
2346 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRGC1 |
0.0437565684841839 |
|
2347 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRGC2 |
0.0437565684841839 |
|
2348 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRGJ1 |
0.0437565684841839 |
|
2349 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRGJ2 |
0.0437565684841839 |
|
2350 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRGJP1 |
0.0437565684841839 |
|
2351 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRGJP2 |
0.0437565684841839 |
|
2352 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRGJP |
0.0437565684841839 |
|
2353 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRGV10 |
0.0437565684841839 |
|
2354 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRGV11 |
0.0437565684841839 |
|
2355 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRGV1 |
0.0437565684841839 |
|
2356 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRGV2 |
0.0437565684841839 |
|
2357 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRGV3 |
0.0437565684841839 |
|
2358 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRGV4 |
0.0437565684841839 |
|
2359 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRGV5 |
0.0437565684841839 |
|
2360 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRGV8 |
0.0437565684841839 |
|
2361 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRGV9 |
0.0437565684841839 |
|
2362 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMPH |
0.0437565684841839 |
|
2363 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL83P |
0.0437565684841839 |
|
2364 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM183B |
0.0437565684841839 |
|
2365 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS41 |
0.0437565684841839 |
|
2366 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POU6F2 |
0.0437565684841839 |
|
2367 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA20|ENSG00000206947.1 |
0.0437565684841839 |
|
2368 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YAE1D1 |
0.0437565684841839 |
|
2369 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RALA |
0.0437565684841839 |
|
2370 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00265 |
0.0437565684841839 |
|
2371 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL496P |
0.0437565684841839 |
|
2372 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK13 |
0.0437565684841839 |
|
2373 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPLKIP |
0.0437565684841839 |
|
2374 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INHBA |
0.0437565684841839 |
|
2375 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLI3 |
0.0437565684841839 |
|
2376 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C7orf25 |
0.0437565684841839 |
|
2377 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HECW1 |
0.0437565684841839 |
|
2378 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3943 |
0.0437565684841839 |
|
2379 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL32 |
0.0437565684841839 |
|
2380 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMA2 |
0.0437565684841839 |
|
2381 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STK17A |
0.0437565684841839 |
|
2382 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COA1 |
0.0437565684841839 |
|
2383 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BLVRA |
0.0437565684841839 |
|
2384 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS24 |
0.0437565684841839 |
|
2385 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
URGCP |
0.0437565684841839 |
|
2386 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2D4 |
0.0437565684841839 |
|
2387 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR2J4 |
0.0437565684841839 |
|
2388 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPDYE1 |
0.0437565684841839 |
|
2389 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASA4CP |
0.0437565684841839 |
|
2390 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00957 |
0.0437565684841839 |
|
2391 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DBNL |
0.0437565684841839 |
|
2392 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGAM2 |
0.0437565684841839 |
|
2393 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLM |
0.0437565684841839 |
|
2394 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AEBP1 |
0.0437565684841839 |
|
2395 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4649 |
0.0437565684841839 |
|
2396 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLD2 |
0.0437565684841839 |
|
2397 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP230 |
0.0437565684841839 |
|
2398 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYL7 |
0.0437565684841839 |
|
2399 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCK |
0.0437565684841839 |
|
2400 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YKT6 |
0.0437565684841839 |
|
2401 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAMK2B |
0.0437565684841839 |
|
2402 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDCD3 |
0.0437565684841839 |
|
2403 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPC1L1 |
0.0437565684841839 |
|
2404 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX56 |
0.0437565684841839 |
|
2405 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMED4 |
0.0437565684841839 |
|
2406 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OGDH |
0.0437565684841839 |
|
2407 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZMIZ2 |
0.0437565684841839 |
|
2408 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPIA |
0.0437565684841839 |
|
2409 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
H2AFV |
0.0437565684841839 |
|
2410 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PURB |
0.0437565684841839 |
|
2411 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4657 |
0.0437565684841839 |
|
2412 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYO1G |
0.0437565684841839 |
|
2413 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNHG15 |
0.0437565684841839 |
|
2414 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCM2 |
0.0437565684841839 |
|
2415 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NACAD |
0.0437565684841839 |
|
2416 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBRG4 |
0.0437565684841839 |
|
2417 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA5A |
0.0437565684841839 |
|
2418 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA5B |
0.0437565684841839 |
|
2419 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA5C |
0.0437565684841839 |
|
2420 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAMP3 |
0.0437565684841839 |
|
2421 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADCY1 |
0.0437565684841839 |
|
2422 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEPT7P2 |
0.0437565684841839 |
|
2423 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGFBP1 |
0.0437565684841839 |
|
2424 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGFBP3 |
0.0437565684841839 |
|
2425 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPS15P1 |
0.0437565684841839 |
|
2426 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNS3 |
0.0437565684841839 |
|
2427 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C7orf65 |
0.0437565684841839 |
|
2428 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HUS1 |
0.0437565684841839 |
|
2429 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00525 |
0.0437565684841839 |
|
2430 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKD1L1 |
0.0437565684841839 |
|
2431 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C7orf69 |
0.0437565684841839 |
|
2432 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUN3 |
0.0437565684841839 |
|
2433 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C7orf57 |
0.0437565684841839 |
|
2434 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UPP1 |
0.0437565684841839 |
|
2435 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCA13 |
0.0437565684841839 |
|
2436 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VWC2 |
0.0437565684841839 |
|
2437 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZPBP |
0.0437565684841839 |
|
2438 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C7orf72 |
0.0437565684841839 |
|
2439 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IKZF1 |
0.0437565684841839 |
|
2440 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FIGNL1 |
0.0437565684841839 |
|
2441 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDC |
0.0437565684841839 |
|
2442 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRB10 |
0.0437565684841839 |
|
2443 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA4|ENSG00000201133.1 |
0.0437565684841839 |
|
2444 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COBL |
0.0437565684841839 |
|
2445 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL292P |
0.0437565684841839 |
|
2446 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000253028.1 |
0.0437565684841839 |
|
2447 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238506.1 |
0.0437565684841839 |
|
2448 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POM121L12 |
0.0437565684841839 |
|
2449 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP218 |
0.0437565684841839 |
|
2450 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238354.1 |
0.0437565684841839 |
|
2451 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LDOC1 |
0.044514884442496 |
|
2452 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEC1 |
0.044514884442496 |
|
2453 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEC3 |
0.044514884442496 |
|
2454 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPANXA1 |
0.044514884442496 |
|
2455 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPANXA2 |
0.044514884442496 |
|
2456 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPANXC |
0.044514884442496 |
|
2457 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPANXD |
0.044514884442496 |
|
2458 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEC2 |
0.044514884442496 |
|
2459 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP516 |
0.044514884442496 |
|
2460 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239188.1 |
0.044514884442496 |
|
2461 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPANXN4 |
0.044514884442496 |
|
2462 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP81 |
0.044514884442496 |
|
2463 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP149 |
0.044514884442496 |
|
2464 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPANXN3 |
0.044514884442496 |
|
2465 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLITRK4 |
0.044514884442496 |
|
2466 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPANXN2 |
0.044514884442496 |
|
2467 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2NL |
0.044514884442496 |
|
2468 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP189 |
0.044514884442496 |
|
2469 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPANXN1 |
0.044514884442496 |
|
2470 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBQLN2 |
0.0446325759326075 |
|
2471 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C7orf10 |
0.0458155712700766 |
|
2472 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACP6 |
0.0460229619436333 |
|
2473 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD20A12P |
0.0460229619436333 |
|
2474 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD34A |
0.0460229619436333 |
|
2475 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD35 |
0.0460229619436333 |
|
2476 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCL9 |
0.0460229619436333 |
|
2477 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BOLA1 |
0.0460229619436333 |
|
2478 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD160 |
0.0460229619436333 |
|
2479 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHD1L |
0.0460229619436333 |
|
2480 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM72B |
0.0460229619436333 |
|
2481 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM72C |
0.0460229619436333 |
|
2482 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM72D |
0.0460229619436333 |
|
2483 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCGR1A |
0.0460229619436333 |
|
2484 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCGR1B |
0.0460229619436333 |
|
2485 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCGR1C |
0.0460229619436333 |
|
2486 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FMO5 |
0.0460229619436333 |
|
2487 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GJA5 |
0.0460229619436333 |
|
2488 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GJA8 |
0.0460229619436333 |
|
2489 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNRHR2 |
0.0460229619436333 |
|
2490 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR89A |
0.0460229619436333 |
|
2491 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR89B |
0.0460229619436333 |
|
2492 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR89C |
0.0460229619436333 |
|
2493 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HFE2 |
0.0460229619436333 |
|
2494 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST2H2AA3 |
0.0460229619436333 |
|
2495 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST2H2AA4 |
0.0460229619436333 |
|
2496 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST2H2AB |
0.0460229619436333 |
|
2497 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST2H2AC |
0.0460229619436333 |
|
2498 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST2H2BA |
0.0460229619436333 |
|
2499 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST2H2BE |
0.0460229619436333 |
|
2500 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST2H2BF |
0.0460229619436333 |
|
2501 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST2H3A |
0.0460229619436333 |
|
2502 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST2H3C |
0.0460229619436333 |
|
2503 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST2H3D |
0.0460229619436333 |
|
2504 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST2H4A |
0.0460229619436333 |
|
2505 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST2H4B |
0.0460229619436333 |
|
2506 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HYDIN2 |
0.0460229619436333 |
|
2507 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGA10 |
0.0460229619436333 |
|
2508 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00623 |
0.0460229619436333 |
|
2509 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00624 |
0.0460229619436333 |
|
2510 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIX1L |
0.0460229619436333 |
|
2511 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBPF10 |
0.0460229619436333 |
|
2512 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBPF11 |
0.0460229619436333 |
|
2513 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBPF12 |
0.0460229619436333 |
|
2514 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBPF14 |
0.0460229619436333 |
|
2515 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBPF15 |
0.0460229619436333 |
|
2516 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBPF16 |
0.0460229619436333 |
|
2517 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBPF20 |
0.0460229619436333 |
|
2518 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBPF24 |
0.0460229619436333 |
|
2519 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBPF8 |
0.0460229619436333 |
|
2520 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBPF9 |
0.0460229619436333 |
|
2521 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOTCH2NL |
0.0460229619436333 |
|
2522 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDT17 |
0.0460229619436333 |
|
2523 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE4DIP |
0.0460229619436333 |
|
2524 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDZK1P1 |
0.0460229619436333 |
|
2525 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDZK1 |
0.0460229619436333 |
|
2526 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEX11B |
0.0460229619436333 |
|
2527 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIAS3 |
0.0460229619436333 |
|
2528 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR3C |
0.0460229619436333 |
|
2529 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR3GL |
0.0460229619436333 |
|
2530 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPIAL4A |
0.0460229619436333 |
|
2531 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPIAL4B |
0.0460229619436333 |
|
2532 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPIAL4C |
0.0460229619436333 |
|
2533 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPIAL4D |
0.0460229619436333 |
|
2534 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPIAL4G |
0.0460229619436333 |
|
2535 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKAB2 |
0.0460229619436333 |
|
2536 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM8A |
0.0460229619436333 |
|
2537 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP88 |
0.0460229619436333 |
|
2538 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL261P |
0.0460229619436333 |
|
2539 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP57 |
0.0460229619436333 |
|
2540 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP58 |
0.0460229619436333 |
|
2541 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP59 |
0.0460229619436333 |
|
2542 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF115 |
0.0460229619436333 |
|
2543 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC22B |
0.0460229619436333 |
|
2544 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRGAP2B |
0.0460229619436333 |
|
2545 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TXNIP |
0.0460229619436333 |
|
2546 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK14 |
0.0465883324307976 |
|
2547 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HDHD1 |
0.047113463864233 |
|
2548 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4767 |
0.047113463864233 |
|
2549 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR651 |
0.047113463864233 |
|
2550 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNPLA4 |
0.047113463864233 |
|
2551 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STS |
0.047113463864233 |
|
2552 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VCX2 |
0.047113463864233 |
|
2553 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VCX3A |
0.047113463864233 |
|
2554 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VCX |
0.047113463864233 |
|
2555 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KAL1 |
0.047113463864233 |
|
2556 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VCX3B |
0.047113463864233 |
|
2557 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM9A |
0.047113463864233 |
|
2558 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM9B |
0.047113463864233 |
|
2559 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP499 |
0.047113463864233 |
|
2560 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBL1X |
0.047113463864233 |
|
2561 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP6 |
0.047113463864233 |
|
2562 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCCS |
0.047113463864233 |
|
2563 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMELX |
0.047113463864233 |
|
2564 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548AX |
0.047113463864233 |
|
2565 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSL3 |
0.047113463864233 |
|
2566 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRMPD4 |
0.047113463864233 |
|
2567 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
7SK|ENSG00000271814.1 |
0.047113463864233 |
|
2568 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRPS2 |
0.047113463864233 |
|
2569 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLR7 |
0.047113463864233 |
|
2570 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLR8 |
0.047113463864233 |
|
2571 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMSB4X |
0.047113463864233 |
|
2572 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM9C |
0.047113463864233 |
|
2573 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATXN3L |
0.047113463864233 |
|
2574 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EGFL6 |
0.047113463864233 |
|
2575 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP20 |
0.047113463864233 |
|
2576 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCEANC |
0.047113463864233 |
|
2577 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB9A |
0.047113463864233 |
|
2578 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAPPC2 |
0.047113463864233 |
|
2579 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OFD1 |
0.047113463864233 |
|
2580 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPM6B |
0.047113463864233 |
|
2581 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GEMIN8 |
0.047113463864233 |
|
2582 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLRA2 |
0.047113463864233 |
|
2583 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FANCB |
0.047113463864233 |
|
2584 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOSPD2 |
0.047113463864233 |
|
2585 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACE2 |
0.047113463864233 |
|
2586 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASB11 |
0.047113463864233 |
|
2587 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASB9 |
0.047113463864233 |
|
2588 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BMX |
0.047113463864233 |
|
2589 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FIGF |
0.047113463864233 |
|
2590 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIGA |
0.047113463864233 |
|
2591 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIR |
0.047113463864233 |
|
2592 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM27 |
0.047113463864233 |
|
2593 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CA5BP1 |
0.047113463864233 |
|
2594 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CA5B |
0.047113463864233 |
|
2595 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA7|ENSG00000200620.1 |
0.047113463864233 |
|
2596 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZRSR2 |
0.047113463864233 |
|
2597 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP1S2 |
0.047113463864233 |
|
2598 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRPR |
0.047113463864233 |
|
2599 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEB17 |
0.047113463864233 |
|
2600 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL658P |
0.047113463864233 |
|
2601 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTPS2 |
0.047113463864233 |
|
2602 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548AM |
0.047113463864233 |
|
2603 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S100G |
0.047113463864233 |
|
2604 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYAP1 |
0.047113463864233 |
|
2605 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TXLNG |
0.047113463864233 |
|
2606 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBBP7 |
0.047113463864233 |
|
2607 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REPS2 |
0.047113463864233 |
|
2608 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA16|ENSG00000201467.1 |
0.047113463864233 |
|
2609 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4768 |
0.047113463864233 |
|
2610 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NHS |
0.047113463864233 |
|
2611 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238764.1 |
0.047113463864233 |
|
2612 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCML1 |
0.047113463864233 |
|
2613 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAI2 |
0.047113463864233 |
|
2614 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BEND2 |
0.047113463864233 |
|
2615 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCML2 |
0.047113463864233 |
|
2616 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDKL5 |
0.047113463864233 |
|
2617 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RS1 |
0.047113463864233 |
|
2618 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3KBP1 |
0.047113463864233 |
|
2619 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXorf23 |
0.047113463864233 |
|
2620 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP7D2 |
0.047113463864233 |
|
2621 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR23C |
0.047113463864233 |
|
2622 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF1AX |
0.047113463864233 |
|
2623 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS6KA3 |
0.047113463864233 |
|
2624 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP183 |
0.047113463864233 |
|
2625 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNKSR2 |
0.047113463864233 |
|
2626 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL34 |
0.047113463864233 |
|
2627 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMPX |
0.047113463864233 |
|
2628 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBTPS2 |
0.047113463864233 |
|
2629 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YY2 |
0.047113463864233 |
|
2630 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMS |
0.047113463864233 |
|
2631 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHEX |
0.047113463864233 |
|
2632 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL436P |
0.047113463864233 |
|
2633 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF645 |
0.047113463864233 |
|
2634 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX53 |
0.047113463864233 |
|
2635 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTCHD1 |
0.047113463864233 |
|
2636 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238327.1 |
0.047113463864233 |
|
2637 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRDX4 |
0.047113463864233 |
|
2638 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACOT9 |
0.047113463864233 |
|
2639 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAT1 |
0.047113463864233 |
|
2640 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOO |
0.047113463864233 |
|
2641 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXorf58 |
0.047113463864233 |
|
2642 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL15 |
0.047113463864233 |
|
2643 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF2S3 |
0.047113463864233 |
|
2644 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA68|ENSG00000201407.1 |
0.047113463864233 |
|
2645 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFX |
0.047113463864233 |
|
2646 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDK3 |
0.047113463864233 |
|
2647 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCYT1B |
0.047113463864233 |
|
2648 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLA1 |
0.047113463864233 |
|
2649 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA23 |
0.047113463864233 |
|
2650 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLAC1L |
0.0504687344417454 |
|
2651 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MS4A3 |
0.0504687344417454 |
|
2652 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MS4A2 |
0.0504687344417454 |
|
2653 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MS4A6A |
0.0504687344417454 |
|
2654 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MS4A4E |
0.0504687344417454 |
|
2655 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MS4A4A |
0.0504687344417454 |
|
2656 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MS4A6E |
0.0504687344417454 |
|
2657 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MS4A14 |
0.0504687344417454 |
|
2658 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MS4A7 |
0.0504687344417454 |
|
2659 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MS4A5 |
0.0504687344417454 |
|
2660 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MS4A1 |
0.0504687344417454 |
|
2661 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MS4A12 |
0.0504687344417454 |
|
2662 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MS4A13 |
0.0504687344417454 |
|
2663 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00301 |
0.0504687344417454 |
|
2664 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MS4A8 |
0.0504687344417454 |
|
2665 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MS4A18 |
0.0504687344417454 |
|
2666 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MS4A15 |
0.0504687344417454 |
|
2667 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MS4A10 |
0.0504687344417454 |
|
2668 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC86 |
0.0504687344417454 |
|
2669 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTGDR2 |
0.0504687344417454 |
|
2670 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZP1 |
0.0504687344417454 |
|
2671 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRPF19 |
0.0504687344417454 |
|
2672 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM109 |
0.0504687344417454 |
|
2673 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM132A |
0.0504687344417454 |
|
2674 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC15A3 |
0.0504687344417454 |
|
2675 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD6 |
0.0504687344417454 |
|
2676 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD5 |
0.0504687344417454 |
|
2677 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS37C |
0.0504687344417454 |
|
2678 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGA3 |
0.0504687344417454 |
|
2679 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGA4 |
0.0504687344417454 |
|
2680 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGA5 |
0.0504687344417454 |
|
2681 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VWCE |
0.0504687344417454 |
|
2682 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDB1 |
0.0504687344417454 |
|
2683 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DAK |
0.0504687344417454 |
|
2684 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYB561A3 |
0.0504687344417454 |
|
2685 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM138 |
0.0504687344417454 |
|
2686 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUC19 |
0.0526812288729898 |
|
2687 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNTN1 |
0.0526812288729898 |
|
2688 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDZRN4 |
0.0526812288729898 |
|
2689 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP360 |
0.0526812288729898 |
|
2690 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GXYLT1 |
0.0526812288729898 |
|
2691 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YAF2 |
0.0526812288729898 |
|
2692 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPHLN1 |
0.0526812288729898 |
|
2693 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL10P |
0.0526812288729898 |
|
2694 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZCRB1 |
0.0526812288729898 |
|
2695 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA74|ENSG00000252917.1 |
0.0526812288729898 |
|
2696 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRICKLE1 |
0.0526812288729898 |
|
2697 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAMTS20 |
0.0526812288729898 |
|
2698 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PUS7L |
0.0526812288729898 |
|
2699 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRAK4 |
0.0526812288729898 |
|
2700 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TWF1 |
0.0526812288729898 |
|
2701 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM117 |
0.0526812288729898 |
|
2702 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARX |
0.0530199352298554 |
|
2703 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL91P |
0.0530199352298554 |
|
2704 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEB18 |
0.0530199352298554 |
|
2705 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEB6 |
0.0530199352298554 |
|
2706 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEB5 |
0.0530199352298554 |
|
2707 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VENTXP1 |
0.0530199352298554 |
|
2708 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCAF8L2 |
0.0530199352298554 |
|
2709 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEB10 |
0.0530199352298554 |
|
2710 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCAF8L1 |
0.0530199352298554 |
|
2711 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD74|ENSG00000201666.1 |
0.0530199352298554 |
|
2712 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP500 |
0.0530199352298554 |
|
2713 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEB2 |
0.0530199352298554 |
|
2714 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEB3 |
0.0530199352298554 |
|
2715 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEB4 |
0.0530199352298554 |
|
2716 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEB1 |
0.0530199352298554 |
|
2717 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NR0B1 |
0.0530199352298554 |
|
2718 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP9X |
0.0530199352298554 |
|
2719 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP502 |
0.0530199352298554 |
|
2720 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX3X |
0.0530199352298554 |
|
2721 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL15P |
0.0530199352298554 |
|
2722 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPHN2 |
0.0536527602464346 |
|
2723 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTPBP10 |
0.0544272797968585 |
|
2724 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLDN12 |
0.0544272797968585 |
|
2725 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238739.1 |
0.0544272797968585 |
|
2726 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FZD1 |
0.0544272797968585 |
|
2727 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFPI2 |
0.0544272797968585 |
|
2728 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNG11 |
0.0544272797968585 |
|
2729 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BET1 |
0.0544272797968585 |
|
2730 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL1A2 |
0.0544272797968585 |
|
2731 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASD1 |
0.0544272797968585 |
|
2732 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGCE |
0.0544272797968585 |
|
2733 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEG10 |
0.0544272797968585 |
|
2734 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP129 |
0.0544272797968585 |
|
2735 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R9A |
0.0544272797968585 |
|
2736 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238384.1 |
0.0544272797968585 |
|
2737 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PON1 |
0.0544272797968585 |
|
2738 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PON3 |
0.0544272797968585 |
|
2739 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PON2 |
0.0544272797968585 |
|
2740 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASB4 |
0.0544272797968585 |
|
2741 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDK4 |
0.0544272797968585 |
|
2742 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DYNC1I1 |
0.0544272797968585 |
|
2743 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A13 |
0.0544272797968585 |
|
2744 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR591 |
0.0544272797968585 |
|
2745 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C7orf76 |
0.0544272797968585 |
|
2746 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHFM1 |
0.0544272797968585 |
|
2747 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL252P |
0.0544272797968585 |
|
2748 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLX6 |
0.0544272797968585 |
|
2749 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLX5 |
0.0544272797968585 |
|
2750 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACN9 |
0.0544272797968585 |
|
2751 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP104 |
0.0544272797968585 |
|
2752 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAC1 |
0.0544272797968585 |
|
2753 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASNS |
0.0544272797968585 |
|
2754 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5692A1 |
0.0544272797968585 |
|
2755 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5692C2 |
0.0544272797968585 |
|
2756 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OCM2 |
0.0544272797968585 |
|
2757 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL478P |
0.0544272797968585 |
|
2758 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL13P |
0.0544272797968585 |
|
2759 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMTK2 |
0.0544272797968585 |
|
2760 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BHLHA15 |
0.0544272797968585 |
|
2761 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TECPR1 |
0.0544272797968585 |
|
2762 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRI3 |
0.0544272797968585 |
|
2763 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAIAP2L1 |
0.0544272797968585 |
|
2764 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPTX2 |
0.0544272797968585 |
|
2765 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3609 |
0.0544272797968585 |
|
2766 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMURF1 |
0.0544272797968585 |
|
2767 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM130 |
0.0544272797968585 |
|
2768 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRRAP |
0.0544272797968585 |
|
2769 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238459.1 |
0.0544272797968585 |
|
2770 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KPNA7 |
0.0544272797968585 |
|
2771 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYH16 |
0.0544272797968585 |
|
2772 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARPC1A |
0.0544272797968585 |
|
2773 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARPC1B |
0.0544272797968585 |
|
2774 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDAP1 |
0.0544272797968585 |
|
2775 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BUD31 |
0.0544272797968585 |
|
2776 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239133.1 |
0.0544272797968585 |
|
2777 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTCD1 |
0.0544272797968585 |
|
2778 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPSF4 |
0.0544272797968585 |
|
2779 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP5J2 |
0.0544272797968585 |
|
2780 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF789 |
0.0544272797968585 |
|
2781 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF394 |
0.0544272797968585 |
|
2782 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZKSCAN5 |
0.0544272797968585 |
|
2783 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM200A |
0.0544272797968585 |
|
2784 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF655 |
0.0544272797968585 |
|
2785 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSCAN25 |
0.0544272797968585 |
|
2786 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP3A5 |
0.0544272797968585 |
|
2787 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP3A7 |
0.0544272797968585 |
|
2788 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP3A4 |
0.0544272797968585 |
|
2789 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP3A43 |
0.0544272797968585 |
|
2790 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2AE1 |
0.0544272797968585 |
|
2791 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM4 |
0.0544272797968585 |
|
2792 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GJC3 |
0.0544272797968585 |
|
2793 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA40|ENSG00000222966.1 |
0.0544272797968585 |
|
2794 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AZGP1 |
0.0544272797968585 |
|
2795 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AZGP1P1 |
0.0544272797968585 |
|
2796 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZKSCAN1 |
0.0544272797968585 |
|
2797 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSCAN21 |
0.0544272797968585 |
|
2798 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF3 |
0.0544272797968585 |
|
2799 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COPS6 |
0.0544272797968585 |
|
2800 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCM7 |
0.0544272797968585 |
|
2801 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR106B |
0.0544272797968585 |
|
2802 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR25 |
0.0544272797968585 |
|
2803 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR93 |
0.0544272797968585 |
|
2804 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP4M1 |
0.0544272797968585 |
|
2805 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAF6 |
0.0544272797968585 |
|
2806 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNPY4 |
0.0544272797968585 |
|
2807 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBLAC1 |
0.0544272797968585 |
|
2808 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAMTOR4 |
0.0544272797968585 |
|
2809 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C7orf43 |
0.0544272797968585 |
|
2810 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAL3ST4 |
0.0544272797968585 |
|
2811 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4658 |
0.0544272797968585 |
|
2812 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPC2 |
0.0544272797968585 |
|
2813 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAG3 |
0.0544272797968585 |
|
2814 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GATS |
0.0544272797968585 |
|
2815 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PVRIG |
0.0544272797968585 |
|
2816 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPDYE3 |
0.0544272797968585 |
|
2817 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PILRB |
0.0544272797968585 |
|
2818 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAG3L5P |
0.0544272797968585 |
|
2819 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PILRA |
0.0544272797968585 |
|
2820 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZCWPW1 |
0.0544272797968585 |
|
2821 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEPCE |
0.0544272797968585 |
|
2822 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R35 |
0.0544272797968585 |
|
2823 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C7orf61 |
0.0544272797968585 |
|
2824 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL161P |
0.0544272797968585 |
|
2825 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSC22D4 |
0.0544272797968585 |
|
2826 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NYAP1 |
0.0544272797968585 |
|
2827 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL416P |
0.0544272797968585 |
|
2828 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGFG2 |
0.0544272797968585 |
|
2829 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRCH4 |
0.0544272797968585 |
|
2830 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAP25 |
0.0544272797968585 |
|
2831 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO24 |
0.0544272797968585 |
|
2832 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOSPD3 |
0.0544272797968585 |
|
2833 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCOLCE |
0.0544272797968585 |
|
2834 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFR2 |
0.0544272797968585 |
|
2835 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTL6B |
0.0544272797968585 |
|
2836 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GIGYF1 |
0.0544272797968585 |
|
2837 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNB2 |
0.0544272797968585 |
|
2838 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POP7 |
0.0544272797968585 |
|
2839 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPO |
0.0544272797968585 |
|
2840 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZAN |
0.0544272797968585 |
|
2841 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPHB4 |
0.0544272797968585 |
|
2842 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL750P |
0.0544272797968585 |
|
2843 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC12A9 |
0.0544272797968585 |
|
2844 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIP6 |
0.0544272797968585 |
|
2845 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRRT |
0.0544272797968585 |
|
2846 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACHE |
0.0544272797968585 |
|
2847 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UFSP1 |
0.0544272797968585 |
|
2848 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL549P |
0.0544272797968585 |
|
2849 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUC3A |
0.0544272797968585 |
|
2850 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUC12 |
0.0544272797968585 |
|
2851 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUC17 |
0.0544272797968585 |
|
2852 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP54 |
0.0544272797968585 |
|
2853 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM56 |
0.0544272797968585 |
|
2854 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINE1 |
0.0544272797968585 |
|
2855 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP1S1 |
0.0544272797968585 |
|
2856 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4653 |
0.0544272797968585 |
|
2857 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VGF |
0.0544272797968585 |
|
2858 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAT16 |
0.0544272797968585 |
|
2859 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOGAT3 |
0.0544272797968585 |
|
2860 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLOD3 |
0.0544272797968585 |
|
2861 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNHIT1 |
0.0544272797968585 |
|
2862 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLDN15 |
0.0544272797968585 |
|
2863 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FIS1 |
0.0544272797968585 |
|
2864 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL26A1 |
0.0544272797968585 |
|
2865 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RABL5 |
0.0544272797968585 |
|
2866 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYL10 |
0.0544272797968585 |
|
2867 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CUX1 |
0.0544272797968585 |
|
2868 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA48|ENSG00000252824.1 |
0.0544272797968585 |
|
2869 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4285 |
0.0544272797968585 |
|
2870 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH2B2 |
0.0544272797968585 |
|
2871 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKRIP1 |
0.0544272797968585 |
|
2872 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548O |
0.0544272797968585 |
|
2873 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ORAI2 |
0.0544272797968585 |
|
2874 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALKBH4 |
0.0544272797968585 |
|
2875 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM185A |
0.0544272797968585 |
|
2876 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRWD1 |
0.0544272797968585 |
|
2877 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4467 |
0.0544272797968585 |
|
2878 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5090 |
0.0544272797968585 |
|
2879 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR2J2 |
0.0544272797968585 |
|
2880 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR2J3 |
0.0544272797968585 |
|
2881 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR2J |
0.0544272797968585 |
|
2882 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASA4B |
0.0544272797968585 |
|
2883 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASA4 |
0.0544272797968585 |
|
2884 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPDYE2B |
0.0544272797968585 |
|
2885 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPDYE2 |
0.0544272797968585 |
|
2886 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UPK3BL |
0.0544272797968585 |
|
2887 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXL13 |
0.0544272797968585 |
|
2888 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP198 |
0.0544272797968585 |
|
2889 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC17 |
0.0544272797968585 |
|
2890 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARMC10 |
0.0544272797968585 |
|
2891 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAPEPLD |
0.0544272797968585 |
|
2892 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPY19L2P2 |
0.0544272797968585 |
|
2893 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PMPCB |
0.0544272797968585 |
|
2894 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC2 |
0.0544272797968585 |
|
2895 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMC2 |
0.0544272797968585 |
|
2896 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC26A5 |
0.0544272797968585 |
|
2897 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RELN |
0.0544272797968585 |
|
2898 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP86 |
0.0544272797968585 |
|
2899 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM216 |
0.0554814024005553 |
|
2900 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPSF7 |
0.0554814024005553 |
|
2901 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDHAF2 |
0.0554814024005553 |
|
2902 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL23P |
0.0554814024005553 |
|
2903 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R32 |
0.0554814024005553 |
|
2904 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC10B |
0.0554814024005553 |
|
2905 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4488 |
0.0554814024005553 |
|
2906 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYT7 |
0.0554814024005553 |
|
2907 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPLP0P2 |
0.0554814024005553 |
|
2908 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DAGLA |
0.0554814024005553 |
|
2909 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYRF |
0.0554814024005553 |
|
2910 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM258 |
0.0554814024005553 |
|
2911 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FADS2 |
0.0554814024005553 |
|
2912 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FEN1 |
0.0554814024005553 |
|
2913 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR611 |
0.0554814024005553 |
|
2914 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FADS1 |
0.0554814024005553 |
|
2915 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1908 |
0.0554814024005553 |
|
2916 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FADS3 |
0.0554814024005553 |
|
2917 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB3IL1 |
0.0554814024005553 |
|
2918 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BEST1 |
0.0554814024005553 |
|
2919 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FTH1 |
0.0554814024005553 |
|
2920 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INCENP |
0.0554814024005553 |
|
2921 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCGB1D1 |
0.0554814024005553 |
|
2922 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCGB2A1 |
0.0554814024005553 |
|
2923 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCGB1D2 |
0.0554814024005553 |
|
2924 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCGB2A2 |
0.0554814024005553 |
|
2925 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCGB1D4 |
0.0554814024005553 |
|
2926 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASRGL1 |
0.0554814024005553 |
|
2927 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCGB1A1 |
0.0554814024005553 |
|
2928 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AHNAK |
0.0554814024005553 |
|
2929 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EEF1G |
0.0554814024005553 |
|
2930 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3654 |
0.0554814024005553 |
|
2931 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUT1 |
0.0554814024005553 |
|
2932 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTA2 |
0.0554814024005553 |
|
2933 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EML3 |
0.0554814024005553 |
|
2934 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ROM1 |
0.0554814024005553 |
|
2935 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B3GAT3 |
0.0554814024005553 |
|
2936 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GANAB |
0.0554814024005553 |
|
2937 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INTS5 |
0.0554814024005553 |
|
2938 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf48 |
0.0554814024005553 |
|
2939 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf83 |
0.0554814024005553 |
|
2940 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL12 |
0.0554814024005553 |
|
2941 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA57|ENSG00000206597.1 |
0.0554814024005553 |
|
2942 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBXN1 |
0.0554814024005553 |
|
2943 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRN4CL |
0.0554814024005553 |
|
2944 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BSCL2 |
0.0554814024005553 |
|
2945 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNG3 |
0.0554814024005553 |
|
2946 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPUL2 |
0.0554814024005553 |
|
2947 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC9C |
0.0554814024005553 |
|
2948 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR2G |
0.0554814024005553 |
|
2949 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB3 |
0.0554814024005553 |
|
2950 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAF6L |
0.0554814024005553 |
|
2951 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM223 |
0.0554814024005553 |
|
2952 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM179B |
0.0554814024005553 |
|
2953 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NXF1 |
0.0554814024005553 |
|
2954 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STX5 |
0.0554814024005553 |
|
2955 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL119P |
0.0554814024005553 |
|
2956 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR74 |
0.0554814024005553 |
|
2957 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNHG1 |
0.0554814024005553 |
|
2958 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC3A2 |
0.0554814024005553 |
|
2959 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRM1 |
0.0554814024005553 |
|
2960 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL259P |
0.0554814024005553 |
|
2961 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC22A6 |
0.0554814024005553 |
|
2962 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC22A8 |
0.0554814024005553 |
|
2963 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC22A24 |
0.0554814024005553 |
|
2964 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XAGE2B |
0.0578148239895803 |
|
2965 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XAGE1A |
0.0578148239895803 |
|
2966 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XAGE1B |
0.0578148239895803 |
|
2967 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XAGE2 |
0.0578148239895803 |
|
2968 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XAGE1C |
0.0578148239895803 |
|
2969 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XAGE1D |
0.0578148239895803 |
|
2970 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XAGE1E |
0.0578148239895803 |
|
2971 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSX7 |
0.0578148239895803 |
|
2972 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP504 |
0.0578148239895803 |
|
2973 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSX2 |
0.0578148239895803 |
|
2974 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSX2B |
0.0578148239895803 |
|
2975 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPANXN5 |
0.0578148239895803 |
|
2976 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XAGE5 |
0.0578148239895803 |
|
2977 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM156A |
0.0578148239895803 |
|
2978 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM156B |
0.0578148239895803 |
|
2979 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XAGE3 |
0.0578148239895803 |
|
2980 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR173 |
0.0578148239895803 |
|
2981 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPYL2 |
0.0578148239895803 |
|
2982 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KDM5C |
0.0578148239895803 |
|
2983 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IQSEC2 |
0.0578148239895803 |
|
2984 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMC1A |
0.0578148239895803 |
|
2985 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIBC1 |
0.0578148239895803 |
|
2986 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSD17B10 |
0.0578148239895803 |
|
2987 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HUWE1 |
0.0578148239895803 |
|
2988 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR98 |
0.0578148239895803 |
|
2989 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIRLET7F2 |
0.0578148239895803 |
|
2990 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHF8 |
0.0578148239895803 |
|
2991 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP505 |
0.0578148239895803 |
|
2992 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000252175.1 |
0.0578148239895803 |
|
2993 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM120C |
0.0578148239895803 |
|
2994 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WNK3 |
0.0578148239895803 |
|
2995 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGD1 |
0.0578148239895803 |
|
2996 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSR2 |
0.0578148239895803 |
|
2997 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNL3L |
0.0578148239895803 |
|
2998 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITIH6 |
0.0578148239895803 |
|
2999 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGED2 |
0.0578148239895803 |
|
3000 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA11|ENSG00000221716.1 |
0.0578148239895803 |
|
3001 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRO |
0.0578148239895803 |
|
3002 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA11|ENSG00000221750.1 |
0.0578148239895803 |
|
3003 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PFKFB1 |
0.0578148239895803 |
|
3004 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALAS2 |
0.0578148239895803 |
|
3005 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APEX2 |
0.0578148239895803 |
|
3006 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAGE2B |
0.0578148239895803 |
|
3007 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAGE2 |
0.0578148239895803 |
|
3008 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM104B |
0.0578148239895803 |
|
3009 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTRNR2L10 |
0.0578148239895803 |
|
3010 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAGE5 |
0.0578148239895803 |
|
3011 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAGE3 |
0.0578148239895803 |
|
3012 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEH1 |
0.0578148239895803 |
|
3013 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP51 |
0.0578148239895803 |
|
3014 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXR2 |
0.0578148239895803 |
|
3015 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRAGB |
0.0578148239895803 |
|
3016 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252961.1 |
0.0578148239895803 |
|
3017 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLF8 |
0.0578148239895803 |
|
3018 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCKAP5 |
0.0587217914679685 |
|
3019 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBAP1 |
0.0587430752511936 |
|
3020 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP282 |
0.0587430752511936 |
|
3021 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF24 |
0.0587430752511936 |
|
3022 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDT2 |
0.0587430752511936 |
|
3023 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1161 |
0.0587430752511936 |
|
3024 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf24 |
0.0587430752511936 |
|
3025 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM219A |
0.0587430752511936 |
|
3026 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAI1 |
0.0587430752511936 |
|
3027 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP24 |
0.0587430752511936 |
|
3028 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENHO |
0.0587430752511936 |
|
3029 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNTFR |
0.0587430752511936 |
|
3030 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPP25L |
0.0587430752511936 |
|
3031 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCTN3 |
0.0587430752511936 |
|
3032 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARID3C |
0.0587430752511936 |
|
3033 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALT |
0.0587430752511936 |
|
3034 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIGMAR1 |
0.0587430752511936 |
|
3035 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL11RA |
0.0587430752511936 |
|
3036 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL27 |
0.0587430752511936 |
|
3037 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL19 |
0.0587430752511936 |
|
3038 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL21 |
0.0587430752511936 |
|
3039 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM205A |
0.0587430752511936 |
|
3040 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM205B |
0.0587430752511936 |
|
3041 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM205CP |
0.0587430752511936 |
|
3042 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1045 |
0.0587430752511936 |
|
3043 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJB5 |
0.0587430752511936 |
|
3044 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf131 |
0.0587430752511936 |
|
3045 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLJ00273 |
0.0587430752511936 |
|
3046 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL338P |
0.0587430752511936 |
|
3047 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VCP |
0.0587430752511936 |
|
3048 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FANCG |
0.0587430752511936 |
|
3049 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIGO |
0.0587430752511936 |
|
3050 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STOML2 |
0.0587430752511936 |
|
3051 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM214B |
0.0587430752511936 |
|
3052 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UNC13B |
0.0587430752511936 |
|
3053 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP8B5P |
0.0587430752511936 |
|
3054 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RUSC2 |
0.0587430752511936 |
|
3055 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM166B |
0.0587430752511936 |
|
3056 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD72 |
0.0587430752511936 |
|
3057 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4667 |
0.0587430752511936 |
|
3058 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TESK1 |
0.0587430752511936 |
|
3059 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIT1 |
0.0587430752511936 |
|
3060 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF39 |
0.0587430752511936 |
|
3061 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC107 |
0.0587430752511936 |
|
3062 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RMRP |
0.0587430752511936 |
|
3063 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CA9 |
0.0587430752511936 |
|
3064 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL22P |
0.0587430752511936 |
|
3065 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPM2 |
0.0587430752511936 |
|
3066 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLN1 |
0.0587430752511936 |
|
3067 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CREB3 |
0.0587430752511936 |
|
3068 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GBA2 |
0.0587430752511936 |
|
3069 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGP1 |
0.0587430752511936 |
|
3070 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSMP |
0.0587430752511936 |
|
3071 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPR2 |
0.0587430752511936 |
|
3072 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPAG8 |
0.0587430752511936 |
|
3073 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM221B |
0.0587430752511936 |
|
3074 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HINT2 |
0.0587430752511936 |
|
3075 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM8B |
0.0587430752511936 |
|
3076 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR13J1 |
0.0587430752511936 |
|
3077 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HRCT1 |
0.0587430752511936 |
|
3078 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00961 |
0.0587430752511936 |
|
3079 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2S2 |
0.0587430752511936 |
|
3080 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RECK |
0.0587430752511936 |
|
3081 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLIPR2 |
0.0587430752511936 |
|
3082 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCIN |
0.0587430752511936 |
|
3083 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLTA |
0.0587430752511936 |
|
3084 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNE |
0.0587430752511936 |
|
3085 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF38 |
0.0587430752511936 |
|
3086 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MELK |
0.0587430752511936 |
|
3087 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4475 |
0.0587430752511936 |
|
3088 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAX5 |
0.0587430752511936 |
|
3089 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4540 |
0.0587430752511936 |
|
3090 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4476 |
0.0587430752511936 |
|
3091 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZCCHC7 |
0.0587430752511936 |
|
3092 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRHPR |
0.0587430752511936 |
|
3093 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB5 |
0.0587430752511936 |
|
3094 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL463P |
0.0587430752511936 |
|
3095 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR1E |
0.0587430752511936 |
|
3096 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO10 |
0.0587430752511936 |
|
3097 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOMM5 |
0.0587430752511936 |
|
3098 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRMPD1 |
0.0587430752511936 |
|
3099 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP171 |
0.0587430752511936 |
|
3100 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRMT10B |
0.0587430752511936 |
|
3101 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXOSC3 |
0.0587430752511936 |
|
3102 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCAF10 |
0.0587430752511936 |
|
3103 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A51 |
0.0587430752511936 |
|
3104 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHB |
0.0587430752511936 |
|
3105 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000200026.1 |
0.0587430752511936 |
|
3106 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238313.1 |
0.0587430752511936 |
|
3107 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALDH1B1 |
0.0587430752511936 |
|
3108 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGFBPL1 |
0.0587430752511936 |
|
3109 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX18P3 |
0.0587430752511936 |
|
3110 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC22A25 |
0.0604313797323737 |
|
3111 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMER1 |
0.0615991756060944 |
|
3112 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL799P |
0.0615991756060944 |
|
3113 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASB12 |
0.0615991756060944 |
|
3114 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTMR8 |
0.0615991756060944 |
|
3115 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZC4H2 |
0.0615991756060944 |
|
3116 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZC3H12B |
0.0615991756060944 |
|
3117 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAS1L |
0.0615991756060944 |
|
3118 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGI2 |
0.0622798300988815 |
|
3119 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL13AP17 |
0.0622798300988815 |
|
3120 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP157 |
0.0638348925918464 |
|
3121 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF2A |
0.0638348925918464 |
|
3122 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DIMT1 |
0.0638348925918464 |
|
3123 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IPO11 |
0.0638348925918464 |
|
3124 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CKS1B|ENSG00000268942.1 |
0.0638348925918464 |
|
3125 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC70 |
0.0638348925918464 |
|
3126 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTR1A |
0.0638348925918464 |
|
3127 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF180 |
0.0638348925918464 |
|
3128 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGS7BP |
0.0638348925918464 |
|
3129 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL169P |
0.0638348925918464 |
|
3130 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM159B |
0.0638348925918464 |
|
3131 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SREK1IP1 |
0.0638348925918464 |
|
3132 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CWC27 |
0.0638348925918464 |
|
3133 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAMTS6 |
0.0638348925918464 |
|
3134 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CENPK |
0.0638348925918464 |
|
3135 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPWD1 |
0.0638348925918464 |
|
3136 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM23 |
0.0638348925918464 |
|
3137 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAPPC13 |
0.0638348925918464 |
|
3138 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGTB |
0.0638348925918464 |
|
3139 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NLN |
0.0638348925918464 |
|
3140 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERBB2IP |
0.0638348925918464 |
|
3141 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA76|ENSG00000252904.1 |
0.0638348925918464 |
|
3142 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SREK1 |
0.0638348925918464 |
|
3143 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238400.1 |
0.0638348925918464 |
|
3144 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD180 |
0.0638348925918464 |
|
3145 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STARD8 |
0.064403318764411 |
|
3146 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFNB1 |
0.064403318764411 |
|
3147 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PJA1 |
0.064403318764411 |
|
3148 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00269 |
0.064403318764411 |
|
3149 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM155B |
0.064403318764411 |
|
3150 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EDA |
0.064403318764411 |
|
3151 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000212434.1 |
0.064403318764411 |
|
3152 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AWAT2 |
0.064403318764411 |
|
3153 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DGAT2L6 |
0.064403318764411 |
|
3154 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGBP1 |
0.064403318764411 |
|
3155 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR676 |
0.064403318764411 |
|
3156 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OTUD6A |
0.064403318764411 |
|
3157 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL581P |
0.064403318764411 |
|
3158 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AWAT1 |
0.064403318764411 |
|
3159 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP507 |
0.064403318764411 |
|
3160 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
P2RY4 |
0.064403318764411 |
|
3161 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARR3 |
0.064403318764411 |
|
3162 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDZD11 |
0.064403318764411 |
|
3163 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB41 |
0.064403318764411 |
|
3164 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF4A |
0.064403318764411 |
|
3165 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P23 |
0.064403318764411 |
|
3166 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GDPD2 |
0.064403318764411 |
|
3167 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLG3 |
0.064403318764411 |
|
3168 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX11 |
0.064403318764411 |
|
3169 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000199769.1 |
0.064403318764411 |
|
3170 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC7A3 |
0.064403318764411 |
|
3171 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX12 |
0.064403318764411 |
|
3172 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL746P |
0.064403318764411 |
|
3173 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXorf65 |
0.064403318764411 |
|
3174 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXO4 |
0.064403318764411 |
|
3175 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL2RG |
0.064403318764411 |
|
3176 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED12 |
0.064403318764411 |
|
3177 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NLGN3 |
0.064403318764411 |
|
3178 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GJB1 |
0.064403318764411 |
|
3179 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZMYM3 |
0.064403318764411 |
|
3180 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NONO |
0.064403318764411 |
|
3181 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGB1BP2 |
0.064403318764411 |
|
3182 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAF1 |
0.064403318764411 |
|
3183 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000252525.1 |
0.064403318764411 |
|
3184 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INGX |
0.064403318764411 |
|
3185 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OGT |
0.064403318764411 |
|
3186 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACRC |
0.064403318764411 |
|
3187 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXCR3 |
0.064403318764411 |
|
3188 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXorf49 |
0.064403318764411 |
|
3189 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXorf49B |
0.064403318764411 |
|
3190 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NHSL2 |
0.064403318764411 |
|
3191 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGAG4 |
0.064403318764411 |
|
3192 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIN4 |
0.064403318764411 |
|
3193 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL388P |
0.064403318764411 |
|
3194 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERCC6L |
0.064403318764411 |
|
3195 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL264P |
0.064403318764411 |
|
3196 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS4X |
0.064403318764411 |
|
3197 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CITED1 |
0.064403318764411 |
|
3198 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HDAC8 |
0.064403318764411 |
|
3199 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIK3R1 |
0.0644573335075898 |
|
3200 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000212249.2 |
0.0644573335075898 |
|
3201 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
7SK|ENSG00000249352.3 |
0.0644573335075898 |
|
3202 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC30A5 |
0.0644573335075898 |
|
3203 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL103P |
0.0644573335075898 |
|
3204 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA50|ENSG00000220986.1 |
0.0644573335075898 |
|
3205 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNB1 |
0.0644573335075898 |
|
3206 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238334.1 |
0.0644573335075898 |
|
3207 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CENPH |
0.0644573335075898 |
|
3208 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS36 |
0.0644573335075898 |
|
3209 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK7 |
0.0644573335075898 |
|
3210 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC125 |
0.0644573335075898 |
|
3211 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAF9 |
0.0644573335075898 |
|
3212 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAD17 |
0.0644573335075898 |
|
3213 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MARVELD2 |
0.0644573335075898 |
|
3214 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF2H2B |
0.0644573335075898 |
|
3215 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF2H2C |
0.0644573335075898 |
|
3216 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF2H2 |
0.0644573335075898 |
|
3217 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GUSBP3 |
0.0644573335075898 |
|
3218 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAIP |
0.0644573335075898 |
|
3219 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OCLN |
0.0644573335075898 |
|
3220 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL476P |
0.0644573335075898 |
|
3221 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL616P |
0.0644573335075898 |
|
3222 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL9P |
0.0644573335075898 |
|
3223 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERF1A |
0.0644573335075898 |
|
3224 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERF1B |
0.0644573335075898 |
|
3225 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMN1 |
0.0644573335075898 |
|
3226 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMN2 |
0.0644573335075898 |
|
3227 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238451.1 |
0.0644573335075898 |
|
3228 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238740.1 |
0.0644573335075898 |
|
3229 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PMCHL2 |
0.0644573335075898 |
|
3230 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BDP1 |
0.0644573335075898 |
|
3231 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCCC2 |
0.0644573335075898 |
|
3232 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CARTPT |
0.0644573335075898 |
|
3233 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP1B |
0.0644573335075898 |
|
3234 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4803 |
0.0644573335075898 |
|
3235 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS27 |
0.0644573335075898 |
|
3236 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL153P |
0.0644573335075898 |
|
3237 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTCD2 |
0.0644573335075898 |
|
3238 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF366 |
0.0644573335075898 |
|
3239 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNPO1 |
0.0644573335075898 |
|
3240 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4804 |
0.0644573335075898 |
|
3241 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCHO2 |
0.0644573335075898 |
|
3242 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM171 |
0.0644573335075898 |
|
3243 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM174 |
0.0644573335075898 |
|
3244 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXD1 |
0.0644573335075898 |
|
3245 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTF3 |
0.0644573335075898 |
|
3246 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRA2 |
0.0644573335075898 |
|
3247 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UTP15 |
0.0644573335075898 |
|
3248 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF28 |
0.0644573335075898 |
|
3249 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL814P |
0.0644573335075898 |
|
3250 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENC1 |
0.0644573335075898 |
|
3251 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HEXB |
0.0644573335075898 |
|
3252 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GFM2 |
0.0644573335075898 |
|
3253 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NSA2 |
0.0644573335075898 |
|
3254 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM169A |
0.0644573335075898 |
|
3255 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA40|ENSG00000212363.1 |
0.0644573335075898 |
|
3256 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCNT4 |
0.0644573335075898 |
|
3257 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD31 |
0.0644573335075898 |
|
3258 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL4A3BP |
0.0644573335075898 |
|
3259 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMGCR |
0.0644573335075898 |
|
3260 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLK |
0.0644573335075898 |
|
3261 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKDD1B |
0.0644573335075898 |
|
3262 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POC5 |
0.0644573335075898 |
|
3263 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SV2C |
0.0644573335075898 |
|
3264 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP186 |
0.0644573335075898 |
|
3265 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IQGAP2 |
0.0644573335075898 |
|
3266 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
F2RL2 |
0.0644573335075898 |
|
3267 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
F2R |
0.0644573335075898 |
|
3268 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
F2RL1 |
0.0644573335075898 |
|
3269 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL208P |
0.0644573335075898 |
|
3270 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238688.1 |
0.0644573335075898 |
|
3271 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S100Z |
0.0644573335075898 |
|
3272 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC36P |
0.0644573335075898 |
|
3273 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRHBP |
0.0644573335075898 |
|
3274 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGGF1 |
0.0644573335075898 |
|
3275 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBED3 |
0.0644573335075898 |
|
3276 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA47 |
0.0644573335075898 |
|
3277 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE8B |
0.0644573335075898 |
|
3278 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR41 |
0.0644573335075898 |
|
3279 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OTP |
0.0644573335075898 |
|
3280 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBCA |
0.0644573335075898 |
|
3281 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL1RAPL1 |
0.0646205791552279 |
|
3282 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRS4 |
0.0655589271972163 |
|
3283 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPINK4 |
0.0657394668505132 |
|
3284 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAG1 |
0.0657394668505132 |
|
3285 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHMP5 |
0.0657394668505132 |
|
3286 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFX1 |
0.0657394668505132 |
|
3287 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AQP7 |
0.0657394668505132 |
|
3288 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AQP3 |
0.0657394668505132 |
|
3289 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOL6 |
0.0657394668505132 |
|
3290 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD18B |
0.0657394668505132 |
|
3291 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTENP1 |
0.0657394668505132 |
|
3292 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS3 |
0.0657394668505132 |
|
3293 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD121A |
0.0657394668505132 |
|
3294 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP114 |
0.0657394668505132 |
|
3295 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCAF12 |
0.0657394668505132 |
|
3296 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SV2A |
0.0658833499174191 |
|
3297 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD30BL |
0.0704205022996944 |
|
3298 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR39 |
0.0704205022996944 |
|
3299 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR663B |
0.0704205022996944 |
|
3300 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP103 |
0.0704205022996944 |
|
3301 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYPD1 |
0.0704205022996944 |
|
3302 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP234 |
0.0713227955515128 |
|
3303 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNAI1 |
0.0713227955515128 |
|
3304 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL869P |
0.0713227955515128 |
|
3305 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL35P |
0.0713227955515128 |
|
3306 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD36 |
0.0713227955515128 |
|
3307 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNAT3 |
0.0713227955515128 |
|
3308 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEMA3C |
0.0713227955515128 |
|
3309 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HGF |
0.0713227955515128 |
|
3310 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNA2D1 |
0.0713227955515128 |
|
3311 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1255B1 |
0.0713227955515128 |
|
3312 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCLO |
0.0713227955515128 |
|
3313 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP235 |
0.0713227955515128 |
|
3314 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEMA3E |
0.0713227955515128 |
|
3315 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEMA3A |
0.0713227955515128 |
|
3316 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEMA3D |
0.0713227955515128 |
|
3317 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00972 |
0.0713227955515128 |
|
3318 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRM3 |
0.0713227955515128 |
|
3319 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1324L |
0.0713227955515128 |
|
3320 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DMTF1 |
0.0713227955515128 |
|
3321 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM243 |
0.0713227955515128 |
|
3322 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TP53TG1 |
0.0713227955515128 |
|
3323 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CROT |
0.0713227955515128 |
|
3324 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCB4 |
0.0713227955515128 |
|
3325 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCB1 |
0.0713227955515128 |
|
3326 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238587.1 |
0.0713227955515128 |
|
3327 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RUNDC3B |
0.0713227955515128 |
|
3328 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A40 |
0.0713227955515128 |
|
3329 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DBF4 |
0.0713227955515128 |
|
3330 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM22 |
0.0713227955515128 |
|
3331 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRI |
0.0713227955515128 |
|
3332 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STEAP4 |
0.0713227955515128 |
|
3333 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA67|ENSG00000207094.1 |
0.0713227955515128 |
|
3334 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C7orf62 |
0.0713227955515128 |
|
3335 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C7orf63 |
0.0713227955515128 |
|
3336 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPY19L2P4 |
0.0713227955515128 |
|
3337 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STEAP1 |
0.0713227955515128 |
|
3338 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STEAP2 |
0.0713227955515128 |
|
3339 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF804B |
0.0713227955515128 |
|
3340 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD18A |
0.0717604354189271 |
|
3341 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM201A |
0.0717604354189271 |
|
3342 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VSTM2A |
0.0727581435724094 |
|
3343 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC61G |
0.0727581435724094 |
|
3344 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA73|ENSG00000252054.1 |
0.0727581435724094 |
|
3345 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EGFR |
0.0727581435724094 |
|
3346 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LANCL2 |
0.0727581435724094 |
|
3347 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VOPP1 |
0.0727581435724094 |
|
3348 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FKBP9L |
0.0727581435724094 |
|
3349 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEPT14 |
0.0727581435724094 |
|
3350 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS17 |
0.0727581435724094 |
|
3351 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF713 |
0.0727581435724094 |
|
3352 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL64P |
0.0727581435724094 |
|
3353 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GBAS |
0.0727581435724094 |
|
3354 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSPH |
0.0727581435724094 |
|
3355 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCT6A |
0.0727581435724094 |
|
3356 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA15|ENSG00000207168.1 |
0.0727581435724094 |
|
3357 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA22|ENSG00000206603.1 |
0.0727581435724094 |
|
3358 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUMF2 |
0.0727581435724094 |
|
3359 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHKG1 |
0.0727581435724094 |
|
3360 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHCHD2 |
0.0727581435724094 |
|
3361 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238673.1 |
0.0727581435724094 |
|
3362 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUPR1L |
0.0727581435724094 |
|
3363 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL816P |
0.0727581435724094 |
|
3364 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF479 |
0.0727581435724094 |
|
3365 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3147 |
0.0727581435724094 |
|
3366 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF716 |
0.0727581435724094 |
|
3367 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A12 |
0.0739464992116856 |
|
3368 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAT1 |
0.0739464992116856 |
|
3369 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METAP1D |
0.0739464992116856 |
|
3370 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLX1 |
0.0739464992116856 |
|
3371 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLX2 |
0.0739464992116856 |
|
3372 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238572.1 |
0.0739464992116856 |
|
3373 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGA6 |
0.0739464992116856 |
|
3374 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDK1 |
0.0739464992116856 |
|
3375 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239041.1 |
0.0739464992116856 |
|
3376 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAPGEF4 |
0.0739464992116856 |
|
3377 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLTK |
0.0739464992116856 |
|
3378 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDCA7 |
0.0739464992116856 |
|
3379 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SP3 |
0.0739464992116856 |
|
3380 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OLA1 |
0.0739464992116856 |
|
3381 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL65P |
0.0739464992116856 |
|
3382 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SP9 |
0.0739464992116856 |
|
3383 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CIR1 |
0.0739464992116856 |
|
3384 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCRN3 |
0.0739464992116856 |
|
3385 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR155 |
0.0739464992116856 |
|
3386 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WIPF1 |
0.0739464992116856 |
|
3387 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRNA1 |
0.0739464992116856 |
|
3388 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHN1 |
0.0739464992116856 |
|
3389 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATF2 |
0.0739464992116856 |
|
3390 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR933 |
0.0739464992116856 |
|
3391 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP5G3 |
0.0739464992116856 |
|
3392 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1715 |
0.0739464992116856 |
|
3393 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EVX2 |
0.0739464992116856 |
|
3394 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXD13 |
0.0739464992116856 |
|
3395 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXD12 |
0.0739464992116856 |
|
3396 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXD10 |
0.0739464992116856 |
|
3397 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXD11 |
0.0739464992116856 |
|
3398 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXD9 |
0.0739464992116856 |
|
3399 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXD8 |
0.0739464992116856 |
|
3400 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXD3 |
0.0739464992116856 |
|
3401 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXD4 |
0.0739464992116856 |
|
3402 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR10B |
0.0739464992116856 |
|
3403 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXD1 |
0.0739464992116856 |
|
3404 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTX2 |
0.0739464992116856 |
|
3405 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF767 |
0.0747566352888025 |
|
3406 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIAM1 |
0.0767429165370306 |
|
3407 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYB5D2 |
0.0769572026599777 |
|
3408 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKFY1 |
0.0769572026599777 |
|
3409 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2G1 |
0.0769572026599777 |
|
3410 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSHR |
0.0773805964916404 |
|
3411 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF2A1 |
0.0773805964916404 |
|
3412 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA79|ENSG00000221303.1 |
0.0773805964916404 |
|
3413 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRDM11 |
0.0793459252443012 |
|
3414 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYT13 |
0.0793459252443012 |
|
3415 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHST1 |
0.0793459252443012 |
|
3416 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35C1 |
0.0793459252443012 |
|
3417 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRY2 |
0.0793459252443012 |
|
3418 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPK8IP1 |
0.0793459252443012 |
|
3419 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf94 |
0.0793459252443012 |
|
3420 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEX16 |
0.0793459252443012 |
|
3421 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GYLTL1B |
0.0793459252443012 |
|
3422 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHF21A |
0.0793459252443012 |
|
3423 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CREB3L1 |
0.0793459252443012 |
|
3424 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DGKZ |
0.0793459252443012 |
|
3425 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRM4 |
0.0793459252443012 |
|
3426 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MDK |
0.0793459252443012 |
|
3427 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4688 |
0.0793459252443012 |
|
3428 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMBRA1 |
0.0793459252443012 |
|
3429 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HARBI1 |
0.0793459252443012 |
|
3430 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATG13 |
0.0793459252443012 |
|
3431 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP1 |
0.0793459252443012 |
|
3432 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF408 |
0.0793459252443012 |
|
3433 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
F2 |
0.0793459252443012 |
|
3434 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CKAP5 |
0.0793459252443012 |
|
3435 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5582 |
0.0793459252443012 |
|
3436 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD67|ENSG00000252427.1 |
0.0793459252443012 |
|
3437 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD67|ENSG00000212135.1 |
0.0793459252443012 |
|
3438 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRP4 |
0.0793459252443012 |
|
3439 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf49 |
0.0793459252443012 |
|
3440 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARFGAP2 |
0.0793459252443012 |
|
3441 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PACSIN3 |
0.0793459252443012 |
|
3442 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL772P |
0.0793459252443012 |
|
3443 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDB2 |
0.0793459252443012 |
|
3444 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACP2 |
0.0793459252443012 |
|
3445 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NR1H3 |
0.0793459252443012 |
|
3446 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MADD |
0.0793459252443012 |
|
3447 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYBPC3 |
0.0793459252443012 |
|
3448 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPI1 |
0.0793459252443012 |
|
3449 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4487 |
0.0793459252443012 |
|
3450 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC39A13 |
0.0793459252443012 |
|
3451 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMC3 |
0.0793459252443012 |
|
3452 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAPSN |
0.0793459252443012 |
|
3453 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CELF1 |
0.0793459252443012 |
|
3454 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL652P |
0.0793459252443012 |
|
3455 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFS3 |
0.0793459252443012 |
|
3456 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPMT1 |
0.0793459252443012 |
|
3457 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KBTBD4 |
0.0793459252443012 |
|
3458 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1QTNF4 |
0.0793459252443012 |
|
3459 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM180B |
0.0793459252443012 |
|
3460 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTCH2 |
0.0793459252443012 |
|
3461 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGBL2 |
0.0793459252443012 |
|
3462 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FNBP4 |
0.0793459252443012 |
|
3463 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000252447.1 |
0.0793459252443012 |
|
3464 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUP160 |
0.0793459252443012 |
|
3465 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP340 |
0.0793459252443012 |
|
3466 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNYL2 |
0.0798951816660307 |
|
3467 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DAOA |
0.0802386378912026 |
|
3468 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00343 |
0.0802386378912026 |
|
3469 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00344 |
0.0802386378912026 |
|
3470 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA25|ENSG00000252550.1 |
0.0802386378912026 |
|
3471 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP38 |
0.0802386378912026 |
|
3472 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00460 |
0.0802386378912026 |
|
3473 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFNB2 |
0.0802386378912026 |
|
3474 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARGLU1 |
0.0802386378912026 |
|
3475 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00551 |
0.0802386378912026 |
|
3476 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00443 |
0.0802386378912026 |
|
3477 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM155A |
0.0802386378912026 |
|
3478 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD31 |
0.0802386378912026 |
|
3479 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1267 |
0.0802386378912026 |
|
3480 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIG4 |
0.0802386378912026 |
|
3481 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP39 |
0.0802386378912026 |
|
3482 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYO16 |
0.0802386378912026 |
|
3483 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00676 |
0.0802386378912026 |
|
3484 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRS2 |
0.0802386378912026 |
|
3485 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP10 |
0.0802386378912026 |
|
3486 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL783P |
0.0802386378912026 |
|
3487 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL4A1 |
0.0802386378912026 |
|
3488 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL4A2 |
0.0802386378912026 |
|
3489 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238629.1 |
0.0802386378912026 |
|
3490 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB20 |
0.0802386378912026 |
|
3491 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CARKD |
0.0802386378912026 |
|
3492 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CARS2 |
0.0802386378912026 |
|
3493 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ING1 |
0.0802386378912026 |
|
3494 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC38A2 |
0.0814967440323787 |
|
3495 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC14P |
0.0816910942417043 |
|
3496 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCC4 |
0.0820376931837397 |
|
3497 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INTS8 |
0.083655338264663 |
|
3498 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNE2 |
0.083655338264663 |
|
3499 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2R2 |
0.0851296903302838 |
|
3500 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU4ATAC11P |
0.0851296903302838 |
|
3501 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBAP2 |
0.0851296903302838 |
|
3502 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD121B |
0.0851296903302838 |
|
3503 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf96 |
0.0858126185625482 |
|
3504 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR8K3 |
0.0872526530432139 |
|
3505 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR8K1 |
0.0872526530432139 |
|
3506 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR8J1 |
0.0872526530432139 |
|
3507 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR8U1 |
0.0872526530432139 |
|
3508 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5R1 |
0.0872526530432139 |
|
3509 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5M9 |
0.0872526530432139 |
|
3510 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5M3 |
0.0872526530432139 |
|
3511 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5M8 |
0.0872526530432139 |
|
3512 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5M11 |
0.0872526530432139 |
|
3513 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5M10 |
0.0872526530432139 |
|
3514 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5M1 |
0.0872526530432139 |
|
3515 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5AP2 |
0.0872526530432139 |
|
3516 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5AR1 |
0.0872526530432139 |
|
3517 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR9G1 |
0.0872526530432139 |
|
3518 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR9G4 |
0.0872526530432139 |
|
3519 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5G5P |
0.0872526530432139 |
|
3520 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5AK2 |
0.0872526530432139 |
|
3521 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC55 |
0.0872526530432139 |
|
3522 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APLNR |
0.0872526530432139 |
|
3523 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNKS1BP1 |
0.0872526530432139 |
|
3524 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSRP1 |
0.0872526530432139 |
|
3525 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238692.1 |
0.0872526530432139 |
|
3526 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
P2RX3 |
0.0872526530432139 |
|
3527 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRG3 |
0.0872526530432139 |
|
3528 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRG2 |
0.0872526530432139 |
|
3529 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC43A3 |
0.0872526530432139 |
|
3530 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP341 |
0.0872526530432139 |
|
3531 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP259 |
0.0872526530432139 |
|
3532 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RTN4RL2 |
0.0872526530432139 |
|
3533 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC43A1 |
0.0872526530432139 |
|
3534 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIMM10 |
0.0872526530432139 |
|
3535 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMTNL1 |
0.0872526530432139 |
|
3536 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2L6 |
0.0872526530432139 |
|
3537 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPING1 |
0.0872526530432139 |
|
3538 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR130A |
0.0872526530432139 |
|
3539 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YPEL4 |
0.0872526530432139 |
|
3540 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLP1 |
0.0872526530432139 |
|
3541 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDHHC5 |
0.0872526530432139 |
|
3542 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED19 |
0.0872526530432139 |
|
3543 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMX2 |
0.0872526530432139 |
|
3544 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTBD18 |
0.0872526530432139 |
|
3545 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf31 |
0.0872526530432139 |
|
3546 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTNND1 |
0.0872526530432139 |
|
3547 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR9Q1 |
0.0872526530432139 |
|
3548 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6Q1 |
0.0872526530432139 |
|
3549 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR9I1 |
0.0872526530432139 |
|
3550 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR9Q2 |
0.0872526530432139 |
|
3551 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1S2 |
0.0872526530432139 |
|
3552 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1S1 |
0.0872526530432139 |
|
3553 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10Q1 |
0.0872526530432139 |
|
3554 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10W1 |
0.0872526530432139 |
|
3555 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5B17 |
0.0872526530432139 |
|
3556 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5B3 |
0.0872526530432139 |
|
3557 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5B2 |
0.0872526530432139 |
|
3558 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5B12 |
0.0872526530432139 |
|
3559 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5B21 |
0.0872526530432139 |
|
3560 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPXN |
0.0872526530432139 |
|
3561 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFP91 |
0.0872526530432139 |
|
3562 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNTF |
0.0872526530432139 |
|
3563 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLYAT |
0.0872526530432139 |
|
3564 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLYATL2 |
0.0872526530432139 |
|
3565 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLYATL1P2 |
0.0872526530432139 |
|
3566 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLYATL1 |
0.0872526530432139 |
|
3567 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM111B |
0.0872526530432139 |
|
3568 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM111A |
0.0872526530432139 |
|
3569 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DTX4 |
0.0872526530432139 |
|
3570 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPEG1 |
0.0872526530432139 |
|
3571 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL42P |
0.0872526530432139 |
|
3572 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL435P |
0.0872526530432139 |
|
3573 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5AN1 |
0.0872526530432139 |
|
3574 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5A2 |
0.0872526530432139 |
|
3575 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5A1 |
0.0872526530432139 |
|
3576 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4D6 |
0.0872526530432139 |
|
3577 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4D10 |
0.0872526530432139 |
|
3578 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4D11 |
0.0872526530432139 |
|
3579 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4D9 |
0.0872526530432139 |
|
3580 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSBP |
0.0872526530432139 |
|
3581 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3162 |
0.0872526530432139 |
|
3582 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL16 |
0.0872526530432139 |
|
3583 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GIF |
0.0872526530432139 |
|
3584 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCN1 |
0.0872526530432139 |
|
3585 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OOSP1 |
0.0872526530432139 |
|
3586 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOTCH2 |
0.0880942995999926 |
|
3587 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00567 |
0.0882553047794161 |
|
3588 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00346 |
0.0882553047794161 |
|
3589 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD10 |
0.0882553047794161 |
|
3590 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF7 |
0.0882553047794161 |
|
3591 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX29 |
0.0882553047794161 |
|
3592 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00354 |
0.0882553047794161 |
|
3593 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD44 |
0.0882553047794161 |
|
3594 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOX1 |
0.0882553047794161 |
|
3595 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00403 |
0.0882553047794161 |
|
3596 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00404 |
0.0882553047794161 |
|
3597 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPACA7 |
0.0882553047794161 |
|
3598 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBGCP3 |
0.0882553047794161 |
|
3599 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C13orf35 |
0.0882553047794161 |
|
3600 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP11A |
0.0882553047794161 |
|
3601 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCF2L |
0.0882553047794161 |
|
3602 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
F7 |
0.0882553047794161 |
|
3603 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
F10 |
0.0882553047794161 |
|
3604 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PROZ |
0.0882553047794161 |
|
3605 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCID2 |
0.0882553047794161 |
|
3606 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CUL4A |
0.0882553047794161 |
|
3607 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAMP1 |
0.0882553047794161 |
|
3608 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRTP1 |
0.0882553047794161 |
|
3609 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADPRHL1 |
0.0882553047794161 |
|
3610 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCUN1D2 |
0.0882553047794161 |
|
3611 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMCO3 |
0.0882553047794161 |
|
3612 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFDP1 |
0.0882553047794161 |
|
3613 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP4B |
0.0882553047794161 |
|
3614 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAS6 |
0.0882553047794161 |
|
3615 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRK1 |
0.0882553047794161 |
|
3616 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00454 |
0.0882553047794161 |
|
3617 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM255B |
0.0882553047794161 |
|
3618 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00453 |
0.0882553047794161 |
|
3619 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00452 |
0.0882553047794161 |
|
3620 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00565 |
0.0882553047794161 |
|
3621 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASA3 |
0.0882553047794161 |
|
3622 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC16 |
0.0882553047794161 |
|
3623 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHAMP1 |
0.0882553047794161 |
|
3624 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4502 |
0.0882553047794161 |
|
3625 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548AR |
0.0882553047794161 |
|
3626 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UPF3A |
0.0882553047794161 |
|
3627 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDKN2B |
0.091612313750441 |
|
3628 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3923 |
0.0923406377550308 |
|
3629 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GBE1 |
0.0923406377550308 |
|
3630 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC22A10 |
0.093008803529412 |
|
3631 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SND1 |
0.09411189324592 |
|
3632 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC4 |
0.09411189324592 |
|
3633 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR593 |
0.09411189324592 |
|
3634 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KMT2C |
0.09411189324592 |
|
3635 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCCB |
0.0953977004474635 |
|
3636 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PATL1 |
0.0966089983749466 |
|
3637 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP192 |
0.0966089983749466 |
|
3638 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10V1 |
0.0966089983749466 |
|
3639 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STX3 |
0.0966089983749466 |
|
3640 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR33B |
0.0995679647901333 |
|
3641 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SREBF1 |
0.0995679647901333 |
|
3642 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOM1L2 |
0.0995679647901333 |
|
3643 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC48 |
0.0995679647901333 |
|
3644 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATPAF2 |
0.0995679647901333 |
|
3645 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GID4 |
0.0995679647901333 |
|
3646 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DRG2 |
0.0995679647901333 |
|
3647 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYO15A |
0.0995679647901333 |
|
3648 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238691.1 |
0.0995679647901333 |
|
3649 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALKBH5 |
0.0995679647901333 |
|
3650 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LLGL1 |
0.0995679647901333 |
|
3651 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLII |
0.0995679647901333 |
|
3652 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMCR7 |
0.0995679647901333 |
|
3653 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOP3A |
0.0995679647901333 |
|
3654 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMCR8 |
0.0995679647901333 |
|
3655 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHMT1 |
0.0995679647901333 |
|
3656 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EVPLL |
0.0995679647901333 |
|
3657 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC144B |
0.0995679647901333 |
|
3658 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM106A |
0.0995679647901333 |
|
3659 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT16P1 |
0.0995679647901333 |
|
3660 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT17P2 |
0.0995679647901333 |
|
3661 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGALS9C |
0.0995679647901333 |
|
3662 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL639P |
0.0995679647901333 |
|
3663 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D28 |
0.0995679647901333 |
|
3664 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP32P2 |
0.0995679647901333 |
|
3665 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF286B |
0.0995679647901333 |
|
3666 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM16L |
0.0995679647901333 |
|
3667 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXW10 |
0.0995679647901333 |
|
3668 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TVP23B |
0.0995679647901333 |
|
3669 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRPSAP2 |
0.0995679647901333 |
|
3670 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL627P |
0.0995679647901333 |
|
3671 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC5A10 |
0.0995679647901333 |
|
3672 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPN2 |
0.0995679647901333 |
|
3673 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM83G |
0.0995679647901333 |
|
3674 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRAPL |
0.0995679647901333 |
|
3675 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRAP |
0.0995679647901333 |
|
3676 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD3A |
0.0995679647901333 |
|
3677 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD3C |
0.0995679647901333 |
|
3678 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD3D |
0.0995679647901333 |
|
3679 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B9D1 |
0.0995679647901333 |
|
3680 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1180 |
0.0995679647901333 |
|
3681 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPK7 |
0.0995679647901333 |
|
3682 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFAP4 |
0.0995679647901333 |
|
3683 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF112 |
0.0995679647901333 |
|
3684 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC47A1 |
0.0995679647901333 |
|
3685 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA59B |
0.0995679647901333 |
|
3686 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALDH3A2 |
0.0995679647901333 |
|
3687 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000252349.1 |
0.0995679647901333 |
|
3688 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC47A2 |
0.0995679647901333 |
|
3689 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALDH3A1 |
0.0995679647901333 |
|
3690 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ULK2 |
0.0995679647901333 |
|
3691 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKAP10 |
0.0995679647901333 |
|
3692 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPECC1 |
0.0995679647901333 |
|
3693 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC144CP |
0.0995679647901333 |
|
3694 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL17P |
0.0995679647901333 |
|
3695 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U6|ENSG00000266839.2 |
0.0995679647901333 |
|
3696 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UPF3AP2 |
0.0995679647901333 |
|
3697 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP32P3 |
0.0995679647901333 |
|
3698 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT16P3 |
0.0995679647901333 |
|
3699 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGALS9B |
0.0995679647901333 |
|
3700 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOS2P3 |
0.0995679647901333 |
|
3701 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDRT15L2 |
0.0995679647901333 |
|
3702 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC144NL |
0.0995679647901333 |
|
3703 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP22 |
0.0995679647901333 |
|
3704 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHRS7B |
0.0995679647901333 |
|
3705 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM11 |
0.0995679647901333 |
|
3706 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL426P |
0.0995679647901333 |
|
3707 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf103 |
0.0995679647901333 |
|
3708 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP2K3 |
0.0995679647901333 |
|
3709 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNJ12 |
0.0995679647901333 |
|
3710 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf51 |
0.0995679647901333 |
|
3711 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM27L |
0.0995679647901333 |
|
3712 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTND1P15 |
0.0995679647901333 |
|
3713 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTRNR2L1 |
0.0995679647901333 |
|
3714 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBBP4 |
0.0995679647901333 |
|
3715 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPIN4 |
0.100395066444933 |
|
3716 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF9 |
0.100395066444933 |
|
3717 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1468 |
0.100395066444933 |
|
3718 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00839 |
0.102879624012378 |
|
3719 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF37BP |
0.102879624012378 |
|
3720 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF33B |
0.102879624012378 |
|
3721 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BMS1 |
0.102879624012378 |
|
3722 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238732.1 |
0.102879624012378 |
|
3723 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5100 |
0.102879624012378 |
|
3724 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RET |
0.102879624012378 |
|
3725 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSGALNACT2 |
0.102879624012378 |
|
3726 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASGEF1A |
0.102879624012378 |
|
3727 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC11P |
0.102879624012378 |
|
3728 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FXYD4 |
0.102879624012378 |
|
3729 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPF |
0.102879624012378 |
|
3730 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000221400.1 |
0.102879624012378 |
|
3731 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF487 |
0.102879624012378 |
|
3732 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF239 |
0.102879624012378 |
|
3733 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF485 |
0.102879624012378 |
|
3734 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF32 |
0.102879624012378 |
|
3735 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAST4 |
0.102974659793799 |
|
3736 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF2B |
0.10412664342113 |
|
3737 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOM1L1 |
0.10412664342113 |
|
3738 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX11 |
0.10412664342113 |
|
3739 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STXBP4 |
0.10412664342113 |
|
3740 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HLF |
0.10412664342113 |
|
3741 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMD |
0.10412664342113 |
|
3742 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM100 |
0.10412664342113 |
|
3743 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCTP |
0.10412664342113 |
|
3744 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKFN1 |
0.10412664342113 |
|
3745 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOG |
0.10412664342113 |
|
3746 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf67 |
0.10412664342113 |
|
3747 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DGKE |
0.10412664342113 |
|
3748 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM25 |
0.10412664342113 |
|
3749 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3614 |
0.10412664342113 |
|
3750 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COIL |
0.10412664342113 |
|
3751 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF438 |
0.107058247696156 |
|
3752 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP309 |
0.107058247696156 |
|
3753 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZEB1 |
0.107058247696156 |
|
3754 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP12 |
0.107058247696156 |
|
3755 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL825P |
0.107058247696156 |
|
3756 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF5B |
0.107058247696156 |
|
3757 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPC1 |
0.107058247696156 |
|
3758 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC7 |
0.107058247696156 |
|
3759 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf68 |
0.107058247696156 |
|
3760 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGB1 |
0.107058247696156 |
|
3761 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL847P |
0.107058247696156 |
|
3762 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRP1 |
0.107058247696156 |
|
3763 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL398P |
0.107058247696156 |
|
3764 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00838 |
0.107058247696156 |
|
3765 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CUL2 |
0.107058247696156 |
|
3766 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3611 |
0.107058247696156 |
|
3767 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CREM |
0.107058247696156 |
|
3768 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNY |
0.107058247696156 |
|
3769 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GJD4 |
0.107058247696156 |
|
3770 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FZD8 |
0.107058247696156 |
|
3771 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4683 |
0.107058247696156 |
|
3772 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA40|ENSG00000237002.2 |
0.107058247696156 |
|
3773 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAMPTL |
0.107058247696156 |
|
3774 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD30A |
0.107058247696156 |
|
3775 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL314P |
0.107058247696156 |
|
3776 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTRNR2L7 |
0.107058247696156 |
|
3777 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF248 |
0.107058247696156 |
|
3778 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF25 |
0.107058247696156 |
|
3779 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF33A |
0.107058247696156 |
|
3780 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF37A |
0.107058247696156 |
|
3781 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSD17B7P2 |
0.107058247696156 |
|
3782 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEPT7P9 |
0.107058247696156 |
|
3783 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00619 |
0.107058247696156 |
|
3784 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00840 |
0.107058247696156 |
|
3785 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00841 |
0.107058247696156 |
|
3786 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXCL12 |
0.107058247696156 |
|
3787 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM72 |
0.107058247696156 |
|
3788 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASSF4 |
0.107058247696156 |
|
3789 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf10 |
0.107058247696156 |
|
3790 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf25 |
0.107058247696156 |
|
3791 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP164P1 |
0.107058247696156 |
|
3792 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF22 |
0.107058247696156 |
|
3793 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RSU1P2 |
0.107058247696156 |
|
3794 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MARCH8 |
0.107058247696156 |
|
3795 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00943 |
0.107058247696156 |
|
3796 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00944 |
0.107058247696156 |
|
3797 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00507 |
0.107058247696156 |
|
3798 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00508 |
0.107058247696156 |
|
3799 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4419B |
0.107058247696156 |
|
3800 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3612 |
0.107058247696156 |
|
3801 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM132C |
0.107058247696156 |
|
3802 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238895.1 |
0.107058247696156 |
|
3803 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC15A4 |
0.107058247696156 |
|
3804 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLT1D1 |
0.107058247696156 |
|
3805 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM132D |
0.107058247696156 |
|
3806 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FZD10 |
0.107058247696156 |
|
3807 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIWIL1 |
0.107058247696156 |
|
3808 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIMBP2 |
0.107058247696156 |
|
3809 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL534P |
0.107058247696156 |
|
3810 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STX2 |
0.107058247696156 |
|
3811 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238822.1 |
0.107058247696156 |
|
3812 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAN |
0.107058247696156 |
|
3813 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR133 |
0.107058247696156 |
|
3814 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP376 |
0.107058247696156 |
|
3815 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP377 |
0.107058247696156 |
|
3816 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFSWAP |
0.107058247696156 |
|
3817 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP378 |
0.107058247696156 |
|
3818 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMP17 |
0.107058247696156 |
|
3819 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ULK1 |
0.107058247696156 |
|
3820 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PUS1 |
0.107058247696156 |
|
3821 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EP400 |
0.107058247696156 |
|
3822 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA49 |
0.107058247696156 |
|
3823 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EP400NL |
0.107058247696156 |
|
3824 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX51 |
0.107058247696156 |
|
3825 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALNT9 |
0.107058247696156 |
|
3826 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOC4L |
0.107058247696156 |
|
3827 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUC8 |
0.107058247696156 |
|
3828 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBRSL1 |
0.107058247696156 |
|
3829 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANHX |
0.107058247696156 |
|
3830 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKLE2 |
0.107058247696156 |
|
3831 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHFR |
0.107058247696156 |
|
3832 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA3 |
0.107058247696156 |
|
3833 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRCOL1 |
0.107058247696156 |
|
3834 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
P2RX2 |
0.107058247696156 |
|
3835 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGAM5 |
0.107058247696156 |
|
3836 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLE |
0.107058247696156 |
|
3837 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PXMP2 |
0.107058247696156 |
|
3838 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP379 |
0.107058247696156 |
|
3839 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU4ATAC12P |
0.107058247696156 |
|
3840 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF10 |
0.107058247696156 |
|
3841 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF140 |
0.107058247696156 |
|
3842 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF268 |
0.107058247696156 |
|
3843 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF26 |
0.107058247696156 |
|
3844 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF605 |
0.107058247696156 |
|
3845 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF84 |
0.107058247696156 |
|
3846 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF891 |
0.107058247696156 |
|
3847 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLF12 |
0.114665906835472 |
|
3848 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00402 |
0.114665906835472 |
|
3849 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY1P5 |
0.114665906835472 |
|
3850 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00381 |
0.114665906835472 |
|
3851 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00347 |
0.114665906835472 |
|
3852 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D4 |
0.114665906835472 |
|
3853 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COMMD6 |
0.114665906835472 |
|
3854 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UCHL3 |
0.114665906835472 |
|
3855 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMO7 |
0.114665906835472 |
|
3856 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C13orf45 |
0.114665906835472 |
|
3857 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00561 |
0.114665906835472 |
|
3858 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL571P |
0.114665906835472 |
|
3859 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCTD12 |
0.114665906835472 |
|
3860 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRG1 |
0.114665906835472 |
|
3861 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLN5 |
0.114665906835472 |
|
3862 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXL3 |
0.114665906835472 |
|
3863 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYCBP2 |
0.114665906835472 |
|
3864 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCEL |
0.114665906835472 |
|
3865 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY3P7 |
0.114665906835472 |
|
3866 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3665 |
0.114665906835472 |
|
3867 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLAIN1 |
0.114665906835472 |
|
3868 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EDNRB |
0.114665906835472 |
|
3869 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL810P |
0.114665906835472 |
|
3870 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00446 |
0.114665906835472 |
|
3871 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY3P3 |
0.114665906835472 |
|
3872 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POU4F1 |
0.114665906835472 |
|
3873 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF219 |
0.114665906835472 |
|
3874 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00331 |
0.114665906835472 |
|
3875 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM26 |
0.114665906835472 |
|
3876 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP33 |
0.114665906835472 |
|
3877 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDFIP2 |
0.114665906835472 |
|
3878 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPRY2 |
0.114665906835472 |
|
3879 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00564 |
0.114665906835472 |
|
3880 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTMAP5 |
0.114665906835472 |
|
3881 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLITRK1 |
0.114665906835472 |
|
3882 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00333 |
0.114665906835472 |
|
3883 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00351 |
0.114665906835472 |
|
3884 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLITRK6 |
0.114665906835472 |
|
3885 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4500HG |
0.114665906835472 |
|
3886 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4500 |
0.114665906835472 |
|
3887 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLITRK5 |
0.114665906835472 |
|
3888 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00433 |
0.114665906835472 |
|
3889 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00560 |
0.114665906835472 |
|
3890 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00440 |
0.114665906835472 |
|
3891 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00353 |
0.114665906835472 |
|
3892 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD38|ENSG00000200733.1 |
0.114665906835472 |
|
3893 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXOC4 |
0.116139136985684 |
|
3894 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00348 |
0.117146100868043 |
|
3895 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00559 |
0.117146100868043 |
|
3896 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP34 |
0.117146100868043 |
|
3897 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR622 |
0.117146100868043 |
|
3898 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00410 |
0.117146100868043 |
|
3899 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00379 |
0.117146100868043 |
|
3900 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR17HG |
0.117146100868043 |
|
3901 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPC5 |
0.117146100868043 |
|
3902 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU4ATAC3P |
0.117146100868043 |
|
3903 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548AS |
0.117146100868043 |
|
3904 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD22 |
0.117146100868043 |
|
3905 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SF3B4 |
0.117861639709938 |
|
3906 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTMR11 |
0.117861639709938 |
|
3907 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD20A8P |
0.118212525801881 |
|
3908 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEKT4 |
0.118212525801881 |
|
3909 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL575P |
0.118212525801881 |
|
3910 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAL |
0.118212525801881 |
|
3911 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS5 |
0.118212525801881 |
|
3912 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF514 |
0.118212525801881 |
|
3913 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF2 |
0.118212525801881 |
|
3914 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PROM2 |
0.118212525801881 |
|
3915 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNIP3 |
0.118212525801881 |
|
3916 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAHD2A |
0.118212525801881 |
|
3917 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLJ14082 |
0.118212525801881 |
|
3918 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00342 |
0.118212525801881 |
|
3919 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM43 |
0.118212525801881 |
|
3920 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD36C |
0.118212525801881 |
|
3921 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAHD2CP |
0.118212525801881 |
|
3922 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL210P |
0.118212525801881 |
|
3923 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPAT2 |
0.118212525801881 |
|
3924 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADRA2B |
0.118212525801881 |
|
3925 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASTL |
0.118212525801881 |
|
3926 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUSP2 |
0.118212525801881 |
|
3927 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STARD7 |
0.118212525801881 |
|
3928 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM127 |
0.118212525801881 |
|
3929 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CIAO1 |
0.118212525801881 |
|
3930 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNRNP200 |
0.118212525801881 |
|
3931 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITPRIPL1 |
0.118212525801881 |
|
3932 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCAPH |
0.118212525801881 |
|
3933 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEURL3 |
0.118212525801881 |
|
3934 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARID5A |
0.118212525801881 |
|
3935 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KANSL3 |
0.118212525801881 |
|
3936 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FER1L5 |
0.118212525801881 |
|
3937 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMAN2L |
0.118212525801881 |
|
3938 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNNM4 |
0.118212525801881 |
|
3939 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3127 |
0.118212525801881 |
|
3940 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP101 |
0.118212525801881 |
|
3941 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238760.1 |
0.118212525801881 |
|
3942 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTR1B |
0.118212525801881 |
|
3943 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD36B |
0.118212525801881 |
|
3944 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD36 |
0.118212525801881 |
|
3945 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX5B |
0.118212525801881 |
|
3946 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAHD2B |
0.118212525801881 |
|
3947 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL313P |
0.118212525801881 |
|
3948 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZAP70 |
0.118212525801881 |
|
3949 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM131 |
0.118212525801881 |
|
3950 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VWA3B |
0.118212525801881 |
|
3951 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNGA3 |
0.118212525801881 |
|
3952 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INPP4A |
0.118212525801881 |
|
3953 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COA5 |
0.118212525801881 |
|
3954 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UNC50 |
0.118212525801881 |
|
3955 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MGAT4A |
0.118212525801881 |
|
3956 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1211L |
0.118212525801881 |
|
3957 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSGA10 |
0.118212525801881 |
|
3958 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf15 |
0.118212525801881 |
|
3959 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIPT1 |
0.118212525801881 |
|
3960 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL30 |
0.118212525801881 |
|
3961 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MITD1 |
0.118212525801881 |
|
3962 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYG1 |
0.118212525801881 |
|
3963 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYG2 |
0.118212525801881 |
|
3964 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TXNDC9 |
0.118212525801881 |
|
3965 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF5B |
0.118212525801881 |
|
3966 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REV1 |
0.118212525801881 |
|
3967 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AFF3 |
0.118212525801881 |
|
3968 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LONRF2 |
0.118212525801881 |
|
3969 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHST10 |
0.118212525801881 |
|
3970 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NMS |
0.118212525801881 |
|
3971 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL611P |
0.118212525801881 |
|
3972 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDCL3 |
0.118212525801881 |
|
3973 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238328.1 |
0.118212525801881 |
|
3974 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL360P |
0.118212525801881 |
|
3975 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPAS2 |
0.118212525801881 |
|
3976 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL31 |
0.118212525801881 |
|
3977 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D8 |
0.118212525801881 |
|
3978 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL548P |
0.118212525801881 |
|
3979 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNOT11 |
0.118212525801881 |
|
3980 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF149 |
0.118212525801881 |
|
3981 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD89 |
0.118212525801881 |
|
3982 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5696 |
0.118212525801881 |
|
3983 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CREG2 |
0.118212525801881 |
|
3984 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFX8 |
0.118212525801881 |
|
3985 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP4K4 |
0.118212525801881 |
|
3986 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLJ20373 |
0.118212525801881 |
|
3987 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL1R2 |
0.118212525801881 |
|
3988 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL1R1 |
0.118212525801881 |
|
3989 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL1RL2 |
0.118212525801881 |
|
3990 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL18R1 |
0.118212525801881 |
|
3991 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL1RL1 |
0.118212525801881 |
|
3992 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL18RAP |
0.118212525801881 |
|
3993 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4772 |
0.118212525801881 |
|
3994 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC9A4 |
0.118212525801881 |
|
3995 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC9A2 |
0.118212525801881 |
|
3996 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFSD9 |
0.118212525801881 |
|
3997 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM182 |
0.118212525801881 |
|
3998 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000199727.1 |
0.118212525801881 |
|
3999 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA72|ENSG00000207249.1 |
0.118212525801881 |
|
4000 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POU3F3 |
0.118212525801881 |
|
4001 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS9 |
0.118212525801881 |
|
4002 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR45 |
0.118212525801881 |
|
4003 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TGFBRAP1 |
0.118212525801881 |
|
4004 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf49 |
0.118212525801881 |
|
4005 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FHL2 |
0.118212525801881 |
|
4006 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCK2 |
0.118212525801881 |
|
4007 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf40 |
0.118212525801881 |
|
4008 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UXS1 |
0.118212525801881 |
|
4009 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLGLA |
0.118212525801881 |
|
4010 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGPD3 |
0.118212525801881 |
|
4011 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD8BP |
0.118212525801881 |
|
4012 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST6GAL2 |
0.118212525801881 |
|
4013 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GACAT1 |
0.118212525801881 |
|
4014 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGPD4 |
0.118212525801881 |
|
4015 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC5A7 |
0.118212525801881 |
|
4016 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SULT1C3 |
0.118212525801881 |
|
4017 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SULT1C2 |
0.118212525801881 |
|
4018 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SULT1C2P1 |
0.118212525801881 |
|
4019 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SULT1C4 |
0.118212525801881 |
|
4020 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCC2 |
0.118212525801881 |
|
4021 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIMS1 |
0.118212525801881 |
|
4022 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RANBP2 |
0.118212525801881 |
|
4023 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC138 |
0.118212525801881 |
|
4024 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EDAR |
0.118212525801881 |
|
4025 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3RF3 |
0.118212525801881 |
|
4026 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4265 |
0.118212525801881 |
|
4027 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4266 |
0.118212525801881 |
|
4028 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEPT10 |
0.118212525801881 |
|
4029 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOWAHC |
0.118212525801881 |
|
4030 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BUB1 |
0.118212525801881 |
|
4031 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIMS3L |
0.118212525801881 |
|
4032 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIMS3|ENSG00000256977.6 |
0.118212525801881 |
|
4033 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIMS3|ENSG00000257207.4 |
0.118212525801881 |
|
4034 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00116 |
0.118212525801881 |
|
4035 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MALL |
0.118212525801881 |
|
4036 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4267 |
0.118212525801881 |
|
4037 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4436B1 |
0.118212525801881 |
|
4038 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4436B2 |
0.118212525801881 |
|
4039 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPHP1 |
0.118212525801881 |
|
4040 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGPD5 |
0.118212525801881 |
|
4041 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGPD6 |
0.118212525801881 |
|
4042 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACOXL |
0.118212525801881 |
|
4043 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCL2L11 |
0.118212525801881 |
|
4044 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANAPC1 |
0.118212525801881 |
|
4045 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MERTK |
0.118212525801881 |
|
4046 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL297P |
0.118212525801881 |
|
4047 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM87B |
0.118212525801881 |
|
4048 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBLN7 |
0.118212525801881 |
|
4049 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZC3H8 |
0.118212525801881 |
|
4050 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238951.1 |
0.118212525801881 |
|
4051 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZC3H6 |
0.118212525801881 |
|
4052 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGPD8 |
0.118212525801881 |
|
4053 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTL |
0.118212525801881 |
|
4054 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR1B |
0.118212525801881 |
|
4055 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHCHD5 |
0.118212525801881 |
|
4056 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC20A1 |
0.118212525801881 |
|
4057 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NT5DC4 |
0.118212525801881 |
|
4058 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CKAP2L |
0.118212525801881 |
|
4059 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL1A |
0.118212525801881 |
|
4060 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL1B |
0.118212525801881 |
|
4061 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL37 |
0.118212525801881 |
|
4062 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL36G |
0.118212525801881 |
|
4063 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL36A |
0.118212525801881 |
|
4064 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL36B |
0.118212525801881 |
|
4065 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL36RN |
0.118212525801881 |
|
4066 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL1F10 |
0.118212525801881 |
|
4067 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL1RN |
0.118212525801881 |
|
4068 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSD4 |
0.118212525801881 |
|
4069 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAX8 |
0.118212525801881 |
|
4070 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBWD2 |
0.118212525801881 |
|
4071 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXD4L1 |
0.118212525801881 |
|
4072 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM138B |
0.118212525801881 |
|
4073 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RABL2A |
0.118212525801881 |
|
4074 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL23AP7 |
0.118212525801881 |
|
4075 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WASH2P |
0.118212525801881 |
|
4076 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35F5 |
0.118212525801881 |
|
4077 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4782 |
0.118212525801881 |
|
4078 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239077.1 |
0.118212525801881 |
|
4079 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTR3 |
0.118212525801881 |
|
4080 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000212182.1 |
0.118212525801881 |
|
4081 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238520.1 |
0.118212525801881 |
|
4082 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPP10 |
0.118212525801881 |
|
4083 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX18 |
0.118212525801881 |
|
4084 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTR5BP |
0.118212525801881 |
|
4085 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC93 |
0.118212525801881 |
|
4086 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL111P |
0.118212525801881 |
|
4087 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INSIG2 |
0.118212525801881 |
|
4088 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EN1 |
0.118212525801881 |
|
4089 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MARCO |
0.118212525801881 |
|
4090 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1QL2 |
0.118212525801881 |
|
4091 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL468P |
0.118212525801881 |
|
4092 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STEAP3 |
0.118212525801881 |
|
4093 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf76 |
0.118212525801881 |
|
4094 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DBI |
0.118212525801881 |
|
4095 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM37 |
0.118212525801881 |
|
4096 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCTR |
0.118212525801881 |
|
4097 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDP1 |
0.118212525801881 |
|
4098 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM177 |
0.118212525801881 |
|
4099 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPN4 |
0.118212525801881 |
|
4100 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238368.1 |
0.118212525801881 |
|
4101 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPB41L5 |
0.118212525801881 |
|
4102 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM185B |
0.118212525801881 |
|
4103 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RALB |
0.118212525801881 |
|
4104 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INHBB |
0.118212525801881 |
|
4105 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLJ14816 |
0.118212525801881 |
|
4106 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLI2 |
0.118212525801881 |
|
4107 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFCP2L1 |
0.118212525801881 |
|
4108 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLASP1 |
0.118212525801881 |
|
4109 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU4ATAC |
0.118212525801881 |
|
4110 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238341.1 |
0.118212525801881 |
|
4111 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MKI67IP |
0.118212525801881 |
|
4112 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSN |
0.118212525801881 |
|
4113 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPPL3 |
0.119319700674196 |
|
4114 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNF1A |
0.119319700674196 |
|
4115 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf43 |
0.119319700674196 |
|
4116 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OASL |
0.119319700674196 |
|
4117 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000201945.1 |
0.119319700674196 |
|
4118 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
P2RX7 |
0.119319700674196 |
|
4119 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
P2RX4 |
0.119319700674196 |
|
4120 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAMKK2 |
0.119319700674196 |
|
4121 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANAPC5 |
0.119319700674196 |
|
4122 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF34 |
0.119319700674196 |
|
4123 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KDM2B |
0.119319700674196 |
|
4124 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ORAI1 |
0.119319700674196 |
|
4125 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MORN3 |
0.119319700674196 |
|
4126 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM120B |
0.119319700674196 |
|
4127 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHOF |
0.119319700674196 |
|
4128 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SETD1B |
0.119319700674196 |
|
4129 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HPD |
0.119319700674196 |
|
4130 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMD9 |
0.119319700674196 |
|
4131 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR66 |
0.119319700674196 |
|
4132 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCL7A |
0.119319700674196 |
|
4133 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLXIP |
0.119319700674196 |
|
4134 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC43 |
0.119319700674196 |
|
4135 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL31 |
0.119319700674196 |
|
4136 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B3GNT4 |
0.119319700674196 |
|
4137 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DIABLO |
0.119319700674196 |
|
4138 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS33A |
0.119319700674196 |
|
4139 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLIP1 |
0.119319700674196 |
|
4140 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZCCHC8 |
0.119319700674196 |
|
4141 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA9|ENSG00000252192.1 |
0.119319700674196 |
|
4142 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RSRC2 |
0.119319700674196 |
|
4143 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KNTC1 |
0.119319700674196 |
|
4144 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCAR1 |
0.119319700674196 |
|
4145 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCAR2 |
0.119319700674196 |
|
4146 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCAR3 |
0.119319700674196 |
|
4147 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DENR |
0.119319700674196 |
|
4148 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC62 |
0.119319700674196 |
|
4149 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIP1R |
0.119319700674196 |
|
4150 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS37B |
0.119319700674196 |
|
4151 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf65 |
0.119319700674196 |
|
4152 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK2AP1 |
0.119319700674196 |
|
4153 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP375 |
0.119319700674196 |
|
4154 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SBNO1 |
0.119319700674196 |
|
4155 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SETD8 |
0.119319700674196 |
|
4156 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RILPL2 |
0.119319700674196 |
|
4157 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNRNP35 |
0.119319700674196 |
|
4158 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RILPL1 |
0.119319700674196 |
|
4159 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3908 |
0.119319700674196 |
|
4160 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMED2 |
0.119319700674196 |
|
4161 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX55 |
0.119319700674196 |
|
4162 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA9|ENSG00000206897.1 |
0.119319700674196 |
|
4163 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF2B1 |
0.119319700674196 |
|
4164 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6V0A2 |
0.119319700674196 |
|
4165 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF2H3 |
0.119319700674196 |
|
4166 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCTN2 |
0.119319700674196 |
|
4167 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAH10 |
0.119319700674196 |
|
4168 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC92 |
0.119319700674196 |
|
4169 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAH10OS |
0.119319700674196 |
|
4170 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF664 |
0.119319700674196 |
|
4171 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM101A |
0.119319700674196 |
|
4172 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCOR2 |
0.119319700674196 |
|
4173 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARB1 |
0.119319700674196 |
|
4174 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBC |
0.119319700674196 |
|
4175 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5188 |
0.119319700674196 |
|
4176 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL22P19 |
0.119319700674196 |
|
4177 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHX37 |
0.119319700674196 |
|
4178 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRI3BP |
0.119319700674196 |
|
4179 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AACS |
0.119319700674196 |
|
4180 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM132B |
0.119319700674196 |
|
4181 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00939 |
0.119319700674196 |
|
4182 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR13A1 |
0.119909066630919 |
|
4183 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALOX5 |
0.119909066630919 |
|
4184 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS2R16 |
0.120237759343967 |
|
4185 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC13A1 |
0.120237759343967 |
|
4186 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IQUB |
0.120237759343967 |
|
4187 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFA5 |
0.120237759343967 |
|
4188 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASB15 |
0.120237759343967 |
|
4189 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMOD2 |
0.120237759343967 |
|
4190 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WASL |
0.120237759343967 |
|
4191 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HYAL4 |
0.120237759343967 |
|
4192 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPAM1 |
0.120237759343967 |
|
4193 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM229A |
0.120237759343967 |
|
4194 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR37 |
0.120237759343967 |
|
4195 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POT1 |
0.120237759343967 |
|
4196 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRM8 |
0.120237759343967 |
|
4197 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR592 |
0.120237759343967 |
|
4198 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF800 |
0.120237759343967 |
|
4199 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCC1 |
0.120237759343967 |
|
4200 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARF5 |
0.120237759343967 |
|
4201 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FSCN3 |
0.120237759343967 |
|
4202 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAX4 |
0.120237759343967 |
|
4203 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LEP |
0.120237759343967 |
|
4204 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM28 |
0.120237759343967 |
|
4205 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRRT4 |
0.120237759343967 |
|
4206 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IMPDH1 |
0.120237759343967 |
|
4207 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM71F1 |
0.120237759343967 |
|
4208 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM71F2 |
0.120237759343967 |
|
4209 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HILPDA |
0.120237759343967 |
|
4210 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL2B |
0.120237759343967 |
|
4211 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP242 |
0.120237759343967 |
|
4212 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP243 |
0.120237759343967 |
|
4213 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CALU |
0.120237759343967 |
|
4214 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL81P |
0.120237759343967 |
|
4215 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OPN1SW |
0.120237759343967 |
|
4216 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC136 |
0.120237759343967 |
|
4217 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLNC |
0.120237759343967 |
|
4218 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCP |
0.120237759343967 |
|
4219 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6V1F |
0.120237759343967 |
|
4220 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRF5 |
0.120237759343967 |
|
4221 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNPO3 |
0.120237759343967 |
|
4222 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL306P |
0.120237759343967 |
|
4223 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238733.1 |
0.120237759343967 |
|
4224 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPAN33 |
0.120237759343967 |
|
4225 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMO |
0.120237759343967 |
|
4226 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AHCYL2 |
0.120237759343967 |
|
4227 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STRIP2 |
0.120237759343967 |
|
4228 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMKR1 |
0.120237759343967 |
|
4229 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRF1 |
0.120237759343967 |
|
4230 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP244 |
0.120237759343967 |
|
4231 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR182 |
0.120237759343967 |
|
4232 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR183 |
0.120237759343967 |
|
4233 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR96 |
0.120237759343967 |
|
4234 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2H |
0.120237759343967 |
|
4235 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZC3HC1 |
0.120237759343967 |
|
4236 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP245 |
0.120237759343967 |
|
4237 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHDC10 |
0.120237759343967 |
|
4238 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM209 |
0.120237759343967 |
|
4239 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSMEM1 |
0.120237759343967 |
|
4240 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPA2 |
0.120237759343967 |
|
4241 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPA4 |
0.120237759343967 |
|
4242 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238336.1 |
0.120237759343967 |
|
4243 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239044.1 |
0.120237759343967 |
|
4244 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPA5 |
0.120237759343967 |
|
4245 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPA1 |
0.120237759343967 |
|
4246 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP41 |
0.120237759343967 |
|
4247 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEST |
0.120237759343967 |
|
4248 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR335 |
0.120237759343967 |
|
4249 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COPG2 |
0.120237759343967 |
|
4250 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP246 |
0.120237759343967 |
|
4251 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSGA13 |
0.120237759343967 |
|
4252 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLF14 |
0.120237759343967 |
|
4253 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR29A |
0.120237759343967 |
|
4254 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR29B1 |
0.120237759343967 |
|
4255 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MKLN1 |
0.120237759343967 |
|
4256 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PODXL |
0.120237759343967 |
|
4257 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLXNA4 |
0.120237759343967 |
|
4258 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD46|ENSG00000201009.1 |
0.120237759343967 |
|
4259 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHCHD3 |
0.120237759343967 |
|
4260 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U6|ENSG00000272393.1 |
0.120237759343967 |
|
4261 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238488.1 |
0.120237759343967 |
|
4262 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRM2 |
0.120237759343967 |
|
4263 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR490 |
0.120237759343967 |
|
4264 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTN |
0.120237759343967 |
|
4265 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD81|ENSG00000202023.1 |
0.120237759343967 |
|
4266 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DGKI |
0.120237759343967 |
|
4267 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CREB3L2 |
0.120237759343967 |
|
4268 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKR1D1 |
0.120237759343967 |
|
4269 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP223 |
0.120237759343967 |
|
4270 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239145.1 |
0.120237759343967 |
|
4271 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4468 |
0.120237759343967 |
|
4272 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA51|ENSG00000201465.1 |
0.120237759343967 |
|
4273 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238984.1 |
0.120237759343967 |
|
4274 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM24 |
0.120237759343967 |
|
4275 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239123.1 |
0.120237759343967 |
|
4276 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SVOPL |
0.120237759343967 |
|
4277 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA40|ENSG00000252188.1 |
0.120237759343967 |
|
4278 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6V0A4 |
0.120237759343967 |
|
4279 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM213 |
0.120237759343967 |
|
4280 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1549 |
0.120237759343967 |
|
4281 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZC3HAV1L |
0.120237759343967 |
|
4282 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZC3HAV1 |
0.120237759343967 |
|
4283 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC26 |
0.120237759343967 |
|
4284 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBN2 |
0.120237759343967 |
|
4285 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C7orf55 |
0.120237759343967 |
|
4286 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LUC7L2 |
0.120237759343967 |
|
4287 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLRG2 |
0.120237759343967 |
|
4288 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC2L |
0.120237759343967 |
|
4289 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIPK2 |
0.120237759343967 |
|
4290 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBXAS1 |
0.120237759343967 |
|
4291 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARP12 |
0.120237759343967 |
|
4292 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JHDM1D |
0.120237759343967 |
|
4293 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC37A3 |
0.120237759343967 |
|
4294 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB19 |
0.120237759343967 |
|
4295 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP247 |
0.120237759343967 |
|
4296 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP248 |
0.120237759343967 |
|
4297 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238868.1 |
0.120237759343967 |
|
4298 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MKRN1 |
0.120237759343967 |
|
4299 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DENND2A |
0.120237759343967 |
|
4300 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL771P |
0.120237759343967 |
|
4301 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADCK2 |
0.120237759343967 |
|
4302 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFB2 |
0.120237759343967 |
|
4303 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRAF |
0.120237759343967 |
|
4304 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U6|ENSG00000271932.1 |
0.120237759343967 |
|
4305 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS33 |
0.120237759343967 |
|
4306 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM178B |
0.120237759343967 |
|
4307 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGK |
0.120237759343967 |
|
4308 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1147 |
0.120237759343967 |
|
4309 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WEE2 |
0.120237759343967 |
|
4310 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSBP1 |
0.120237759343967 |
|
4311 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS2R3 |
0.120237759343967 |
|
4312 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS2R4 |
0.120237759343967 |
|
4313 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS2R5 |
0.120237759343967 |
|
4314 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS37 |
0.120237759343967 |
|
4315 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR9A3P |
0.120237759343967 |
|
4316 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR9A1P |
0.120237759343967 |
|
4317 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MGAM |
0.120237759343967 |
|
4318 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR9A4 |
0.120237759343967 |
|
4319 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC5A |
0.120237759343967 |
|
4320 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS2R38 |
0.120237759343967 |
|
4321 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOXD2P |
0.120237759343967 |
|
4322 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS58 |
0.120237759343967 |
|
4323 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTRNR2L6 |
0.120237759343967 |
|
4324 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS1 |
0.120237759343967 |
|
4325 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS3P2 |
0.120237759343967 |
|
4326 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS3P3 |
0.120237759343967 |
|
4327 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRBC2 |
0.120237759343967 |
|
4328 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRBV19 |
0.120237759343967 |
|
4329 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRBV27 |
0.120237759343967 |
|
4330 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRBV28 |
0.120237759343967 |
|
4331 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRBV2 |
0.120237759343967 |
|
4332 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRBV9 |
0.120237759343967 |
|
4333 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRBV30 |
0.120237759343967 |
|
4334 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPHB6 |
0.120237759343967 |
|
4335 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPV6 |
0.120237759343967 |
|
4336 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPV5 |
0.120237759343967 |
|
4337 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C7orf34 |
0.120237759343967 |
|
4338 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KEL |
0.120237759343967 |
|
4339 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR9A2 |
0.120237759343967 |
|
4340 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6V1 |
0.120237759343967 |
|
4341 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6W1P |
0.120237759343967 |
|
4342 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIP |
0.120237759343967 |
|
4343 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS2R39 |
0.120237759343967 |
|
4344 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS2R40 |
0.120237759343967 |
|
4345 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSTK1 |
0.120237759343967 |
|
4346 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM139 |
0.120237759343967 |
|
4347 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASP2 |
0.120237759343967 |
|
4348 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL535P |
0.120237759343967 |
|
4349 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL481P |
0.120237759343967 |
|
4350 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLCN1 |
0.120237759343967 |
|
4351 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM131B |
0.120237759343967 |
|
4352 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZYX |
0.120237759343967 |
|
4353 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPHA1 |
0.120237759343967 |
|
4354 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS2R60 |
0.120237759343967 |
|
4355 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS2R41 |
0.120237759343967 |
|
4356 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTAGE15 |
0.120237759343967 |
|
4357 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTAGE6 |
0.120237759343967 |
|
4358 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM115A |
0.120237759343967 |
|
4359 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM115C |
0.120237759343967 |
|
4360 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2F2 |
0.120237759343967 |
|
4361 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2F1 |
0.120237759343967 |
|
4362 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6B1 |
0.120237759343967 |
|
4363 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2A5 |
0.120237759343967 |
|
4364 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2A25 |
0.120237759343967 |
|
4365 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2A12 |
0.120237759343967 |
|
4366 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2A2 |
0.120237759343967 |
|
4367 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2A14 |
0.120237759343967 |
|
4368 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF35 |
0.120237759343967 |
|
4369 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF5 |
0.120237759343967 |
|
4370 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTAGE4 |
0.120237759343967 |
|
4371 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTAGE8 |
0.120237759343967 |
|
4372 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOBOX |
0.120237759343967 |
|
4373 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2A1 |
0.120237759343967 |
|
4374 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2A20P |
0.120237759343967 |
|
4375 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2A42 |
0.120237759343967 |
|
4376 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2A7 |
0.120237759343967 |
|
4377 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2A9P |
0.120237759343967 |
|
4378 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC40P |
0.120237759343967 |
|
4379 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPK1 |
0.120237759343967 |
|
4380 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP174 |
0.120237759343967 |
|
4381 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL207P |
0.120237759343967 |
|
4382 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNTNAP2 |
0.120237759343967 |
|
4383 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548F4 |
0.120237759343967 |
|
4384 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP249 |
0.120237759343967 |
|
4385 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL456P |
0.120237759343967 |
|
4386 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000199370.1 |
0.120237759343967 |
|
4387 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL72P |
0.120237759343967 |
|
4388 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C7orf33 |
0.120237759343967 |
|
4389 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CUL1 |
0.120237759343967 |
|
4390 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EZH2 |
0.120237759343967 |
|
4391 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL569P |
0.120237759343967 |
|
4392 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY5 |
0.120237759343967 |
|
4393 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY1 |
0.120237759343967 |
|
4394 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY3 |
0.120237759343967 |
|
4395 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4 |
0.120237759343967 |
|
4396 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDIA4 |
0.120237759343967 |
|
4397 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF425 |
0.120237759343967 |
|
4398 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF786 |
0.120237759343967 |
|
4399 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL521P |
0.120237759343967 |
|
4400 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF398 |
0.120237759343967 |
|
4401 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF282 |
0.120237759343967 |
|
4402 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF212 |
0.120237759343967 |
|
4403 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF783 |
0.120237759343967 |
|
4404 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252557.1 |
0.120237759343967 |
|
4405 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF777 |
0.120237759343967 |
|
4406 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF746 |
0.120237759343967 |
|
4407 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRBA1 |
0.120237759343967 |
|
4408 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF467 |
0.120237759343967 |
|
4409 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSPO |
0.120237759343967 |
|
4410 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6V0E2 |
0.120237759343967 |
|
4411 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF862 |
0.120237759343967 |
|
4412 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTR3C |
0.120237759343967 |
|
4413 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC61 |
0.120237759343967 |
|
4414 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBED6CL |
0.120237759343967 |
|
4415 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RARRES2 |
0.120237759343967 |
|
4416 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REPIN1 |
0.120237759343967 |
|
4417 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF775 |
0.120237759343967 |
|
4418 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GIMAP8 |
0.120237759343967 |
|
4419 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GIMAP7 |
0.120237759343967 |
|
4420 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GIMAP4 |
0.120237759343967 |
|
4421 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GIMAP6 |
0.120237759343967 |
|
4422 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GIMAP2 |
0.120237759343967 |
|
4423 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GIMAP1 |
0.120237759343967 |
|
4424 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GIMAP5 |
0.120237759343967 |
|
4425 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM176B |
0.120237759343967 |
|
4426 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM176A |
0.120237759343967 |
|
4427 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AOC1 |
0.120237759343967 |
|
4428 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNH2 |
0.120237759343967 |
|
4429 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOS3 |
0.120237759343967 |
|
4430 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATG9B |
0.120237759343967 |
|
4431 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCB8 |
0.120237759343967 |
|
4432 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASIC3 |
0.120237759343967 |
|
4433 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK5 |
0.120237759343967 |
|
4434 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC4A2 |
0.120237759343967 |
|
4435 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FASTK |
0.120237759343967 |
|
4436 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMUB1 |
0.120237759343967 |
|
4437 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGAP3 |
0.120237759343967 |
|
4438 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GBX1 |
0.120237759343967 |
|
4439 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASB10 |
0.120237759343967 |
|
4440 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IQCA1P1 |
0.120237759343967 |
|
4441 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCF2 |
0.120237759343967 |
|
4442 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHPF2 |
0.120237759343967 |
|
4443 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR671 |
0.120237759343967 |
|
4444 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMARCD3 |
0.120237759343967 |
|
4445 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUB1 |
0.120237759343967 |
|
4446 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR86 |
0.120237759343967 |
|
4447 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRYGN |
0.120237759343967 |
|
4448 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3907 |
0.120237759343967 |
|
4449 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHEB |
0.120237759343967 |
|
4450 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL76P |
0.120237759343967 |
|
4451 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKAG2 |
0.120237759343967 |
|
4452 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALNTL5 |
0.120237759343967 |
|
4453 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALNT11 |
0.120237759343967 |
|
4454 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239045.1 |
0.120237759343967 |
|
4455 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FABP5P3 |
0.120237759343967 |
|
4456 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP250 |
0.120237759343967 |
|
4457 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238557.1 |
0.120237759343967 |
|
4458 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA26|ENSG00000212590.1 |
0.120237759343967 |
|
4459 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XRCC2 |
0.120237759343967 |
|
4460 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL811P |
0.120237759343967 |
|
4461 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL845P |
0.120237759343967 |
|
4462 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTR3B |
0.120237759343967 |
|
4463 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPP6 |
0.120237759343967 |
|
4464 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAXIP1 |
0.120237759343967 |
|
4465 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTR5A |
0.120237759343967 |
|
4466 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP280 |
0.120237759343967 |
|
4467 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INSIG1 |
0.120237759343967 |
|
4468 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BLACE |
0.120237759343967 |
|
4469 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EN2 |
0.120237759343967 |
|
4470 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNPY1 |
0.120237759343967 |
|
4471 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM33 |
0.120237759343967 |
|
4472 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHH |
0.120237759343967 |
|
4473 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C7orf13 |
0.120237759343967 |
|
4474 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF32 |
0.120237759343967 |
|
4475 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMBR1 |
0.120237759343967 |
|
4476 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOM1 |
0.120237759343967 |
|
4477 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MNX1 |
0.120237759343967 |
|
4478 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE3C |
0.120237759343967 |
|
4479 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL142P |
0.120237759343967 |
|
4480 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJB6 |
0.120237759343967 |
|
4481 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPRN2 |
0.120237759343967 |
|
4482 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR595 |
0.120237759343967 |
|
4483 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5707 |
0.120237759343967 |
|
4484 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ESYT2 |
0.120237759343967 |
|
4485 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00689 |
0.120237759343967 |
|
4486 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCAPG2 |
0.120237759343967 |
|
4487 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VIPR2 |
0.120237759343967 |
|
4488 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR60 |
0.120237759343967 |
|
4489 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00516 |
0.124950581359623 |
|
4490 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED15P1 |
0.124950581359623 |
|
4491 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED15P6 |
0.124950581359623 |
|
4492 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR11H12 |
0.124950581359623 |
|
4493 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4K13 |
0.124950581359623 |
|
4494 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4K14 |
0.124950581359623 |
|
4495 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4K15 |
0.124950581359623 |
|
4496 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4K1 |
0.124950581359623 |
|
4497 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4K2 |
0.124950581359623 |
|
4498 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4K5 |
0.124950581359623 |
|
4499 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4M1 |
0.124950581359623 |
|
4500 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4N2 |
0.124950581359623 |
|
4501 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4Q2 |
0.124950581359623 |
|
4502 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4Q3 |
0.124950581359623 |
|
4503 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POTEG |
0.124950581359623 |
|
4504 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POTEM |
0.124950581359623 |
|
4505 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238492.1 |
0.124950581359623 |
|
4506 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4L1 |
0.124950581359623 |
|
4507 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP380 |
0.124950581359623 |
|
4508 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4K17 |
0.124950581359623 |
|
4509 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4N5 |
0.124950581359623 |
|
4510 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP381 |
0.124950581359623 |
|
4511 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR11G2 |
0.124950581359623 |
|
4512 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR11H6 |
0.124950581359623 |
|
4513 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR11H7 |
0.124950581359623 |
|
4514 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR11H4 |
0.124950581359623 |
|
4515 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC5 |
0.124950581359623 |
|
4516 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNB1IP1 |
0.124950581359623 |
|
4517 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA79|ENSG00000222489.1 |
0.124950581359623 |
|
4518 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD126 |
0.124950581359623 |
|
4519 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPPH1 |
0.124950581359623 |
|
4520 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARP2 |
0.124950581359623 |
|
4521 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEP1 |
0.124950581359623 |
|
4522 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP382 |
0.124950581359623 |
|
4523 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL33 |
0.124950581359623 |
|
4524 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSGEP |
0.124950581359623 |
|
4525 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APEX1 |
0.124950581359623 |
|
4526 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM55B |
0.124950581359623 |
|
4527 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNP |
0.124950581359623 |
|
4528 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNASE10 |
0.124950581359623 |
|
4529 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNASE9 |
0.124950581359623 |
|
4530 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNASE11 |
0.124950581359623 |
|
4531 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNASE12 |
0.124950581359623 |
|
4532 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6S1 |
0.124950581359623 |
|
4533 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANG |
0.124950581359623 |
|
4534 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNASE4 |
0.124950581359623 |
|
4535 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EDDM3A |
0.124950581359623 |
|
4536 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EDDM3B |
0.124950581359623 |
|
4537 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNASE6 |
0.124950581359623 |
|
4538 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNASE1 |
0.124950581359623 |
|
4539 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL189P |
0.124950581359623 |
|
4540 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNASE2 |
0.124950581359623 |
|
4541 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNASE3 |
0.124950581359623 |
|
4542 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL17 |
0.124950581359623 |
|
4543 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC39A2 |
0.124950581359623 |
|
4544 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDRG2 |
0.124950581359623 |
|
4545 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPPP2 |
0.124950581359623 |
|
4546 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNASE13 |
0.124950581359623 |
|
4547 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNASE7 |
0.124950581359623 |
|
4548 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNASE8 |
0.124950581359623 |
|
4549 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF40 |
0.124950581359623 |
|
4550 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF219 |
0.124950581359623 |
|
4551 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM253 |
0.124950581359623 |
|
4552 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5AU1 |
0.124950581359623 |
|
4553 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00641 |
0.124950581359623 |
|
4554 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPC |
0.124950581359623 |
|
4555 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPGRIP1 |
0.124950581359623 |
|
4556 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUPT16H |
0.124950581359623 |
|
4557 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHD8 |
0.124950581359623 |
|
4558 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD9 |
0.124950581359623 |
|
4559 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD8 |
0.124950581359623 |
|
4560 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL650P |
0.124950581359623 |
|
4561 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB2B |
0.124950581359623 |
|
4562 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOX4 |
0.124950581359623 |
|
4563 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL3 |
0.124950581359623 |
|
4564 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SALL2 |
0.124950581359623 |
|
4565 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10G3 |
0.124950581359623 |
|
4566 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10G2 |
0.124950581359623 |
|
4567 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABHD4 |
0.124950581359623 |
|
4568 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DAD1 |
0.124950581359623 |
|
4569 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4E2 |
0.124950581359623 |
|
4570 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6J1 |
0.124950581359623 |
|
4571 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAC |
0.124950581359623 |
|
4572 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ10 |
0.124950581359623 |
|
4573 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ11 |
0.124950581359623 |
|
4574 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ12 |
0.124950581359623 |
|
4575 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ13 |
0.124950581359623 |
|
4576 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ14 |
0.124950581359623 |
|
4577 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ16 |
0.124950581359623 |
|
4578 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ17 |
0.124950581359623 |
|
4579 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ18 |
0.124950581359623 |
|
4580 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ19 |
0.124950581359623 |
|
4581 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ1 |
0.124950581359623 |
|
4582 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ20 |
0.124950581359623 |
|
4583 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ21 |
0.124950581359623 |
|
4584 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ22 |
0.124950581359623 |
|
4585 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ23 |
0.124950581359623 |
|
4586 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ24 |
0.124950581359623 |
|
4587 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ25 |
0.124950581359623 |
|
4588 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ26 |
0.124950581359623 |
|
4589 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ27 |
0.124950581359623 |
|
4590 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ28 |
0.124950581359623 |
|
4591 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ29 |
0.124950581359623 |
|
4592 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ2 |
0.124950581359623 |
|
4593 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ30 |
0.124950581359623 |
|
4594 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ31 |
0.124950581359623 |
|
4595 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ32 |
0.124950581359623 |
|
4596 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ33 |
0.124950581359623 |
|
4597 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ34 |
0.124950581359623 |
|
4598 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ35 |
0.124950581359623 |
|
4599 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ36 |
0.124950581359623 |
|
4600 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ37 |
0.124950581359623 |
|
4601 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ38 |
0.124950581359623 |
|
4602 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ39 |
0.124950581359623 |
|
4603 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ3 |
0.124950581359623 |
|
4604 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ40 |
0.124950581359623 |
|
4605 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ41 |
0.124950581359623 |
|
4606 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ42 |
0.124950581359623 |
|
4607 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ43 |
0.124950581359623 |
|
4608 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ44 |
0.124950581359623 |
|
4609 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ45 |
0.124950581359623 |
|
4610 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ46 |
0.124950581359623 |
|
4611 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ47 |
0.124950581359623 |
|
4612 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ48 |
0.124950581359623 |
|
4613 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ49 |
0.124950581359623 |
|
4614 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ4 |
0.124950581359623 |
|
4615 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ50 |
0.124950581359623 |
|
4616 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ52 |
0.124950581359623 |
|
4617 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ53 |
0.124950581359623 |
|
4618 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ54 |
0.124950581359623 |
|
4619 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ56 |
0.124950581359623 |
|
4620 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ57 |
0.124950581359623 |
|
4621 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ58 |
0.124950581359623 |
|
4622 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ59 |
0.124950581359623 |
|
4623 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ5 |
0.124950581359623 |
|
4624 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ61 |
0.124950581359623 |
|
4625 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ6 |
0.124950581359623 |
|
4626 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ7 |
0.124950581359623 |
|
4627 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ8 |
0.124950581359623 |
|
4628 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAJ9 |
0.124950581359623 |
|
4629 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV10 |
0.124950581359623 |
|
4630 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV14DV4 |
0.124950581359623 |
|
4631 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV16 |
0.124950581359623 |
|
4632 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV17 |
0.124950581359623 |
|
4633 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV18 |
0.124950581359623 |
|
4634 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV19 |
0.124950581359623 |
|
4635 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV20 |
0.124950581359623 |
|
4636 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV21 |
0.124950581359623 |
|
4637 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV22 |
0.124950581359623 |
|
4638 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV23DV6 |
0.124950581359623 |
|
4639 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV24 |
0.124950581359623 |
|
4640 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV25 |
0.124950581359623 |
|
4641 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV27 |
0.124950581359623 |
|
4642 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV29DV5 |
0.124950581359623 |
|
4643 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV2 |
0.124950581359623 |
|
4644 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV30 |
0.124950581359623 |
|
4645 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV34 |
0.124950581359623 |
|
4646 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV35 |
0.124950581359623 |
|
4647 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV36DV7 |
0.124950581359623 |
|
4648 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV39 |
0.124950581359623 |
|
4649 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV3 |
0.124950581359623 |
|
4650 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV40 |
0.124950581359623 |
|
4651 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV41 |
0.124950581359623 |
|
4652 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV4 |
0.124950581359623 |
|
4653 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV5 |
0.124950581359623 |
|
4654 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV6 |
0.124950581359623 |
|
4655 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAV7 |
0.124950581359623 |
|
4656 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRDC |
0.124950581359623 |
|
4657 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRDD1 |
0.124950581359623 |
|
4658 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRDD2 |
0.124950581359623 |
|
4659 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRDD3 |
0.124950581359623 |
|
4660 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRDJ1 |
0.124950581359623 |
|
4661 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRDJ2 |
0.124950581359623 |
|
4662 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRDJ3 |
0.124950581359623 |
|
4663 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRDJ4 |
0.124950581359623 |
|
4664 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRDV1 |
0.124950581359623 |
|
4665 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRDV2 |
0.124950581359623 |
|
4666 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRDV3 |
0.124950581359623 |
|
4667 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OXA1L |
0.124950581359623 |
|
4668 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC7A7 |
0.124950581359623 |
|
4669 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD41|ENSG00000212302.1 |
0.124950581359623 |
|
4670 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL52 |
0.124950581359623 |
|
4671 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMP14 |
0.124950581359623 |
|
4672 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRP10 |
0.124950581359623 |
|
4673 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REM2 |
0.124950581359623 |
|
4674 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM23 |
0.124950581359623 |
|
4675 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRMT5 |
0.124950581359623 |
|
4676 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAUS4 |
0.124950581359623 |
|
4677 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4707 |
0.124950581359623 |
|
4678 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AJUBA |
0.124950581359623 |
|
4679 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C14orf93 |
0.124950581359623 |
|
4680 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMB5 |
0.124950581359623 |
|
4681 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA73|ENSG00000252114.1 |
0.124950581359623 |
|
4682 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMB11 |
0.124950581359623 |
|
4683 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDH24 |
0.124950581359623 |
|
4684 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACIN1 |
0.124950581359623 |
|
4685 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C14orf119 |
0.124950581359623 |
|
4686 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEBPE |
0.124950581359623 |
|
4687 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC7A8 |
0.124950581359623 |
|
4688 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C14orf164 |
0.124950581359623 |
|
4689 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOMEZ |
0.124950581359623 |
|
4690 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R3E |
0.124950581359623 |
|
4691 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCL2L2 |
0.124950581359623 |
|
4692 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PABPN1 |
0.124950581359623 |
|
4693 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC22A17 |
0.124950581359623 |
|
4694 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFS |
0.124950581359623 |
|
4695 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL25 |
0.124950581359623 |
|
4696 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CMTM5 |
0.124950581359623 |
|
4697 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYH6 |
0.124950581359623 |
|
4698 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR208A |
0.124950581359623 |
|
4699 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYH7 |
0.124950581359623 |
|
4700 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR208B |
0.124950581359623 |
|
4701 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NGDN |
0.124950581359623 |
|
4702 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFHX2 |
0.124950581359623 |
|
4703 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THTPA |
0.124950581359623 |
|
4704 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP1G2 |
0.124950581359623 |
|
4705 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JPH4 |
0.124950581359623 |
|
4706 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHRS2 |
0.124950581359623 |
|
4707 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP205 |
0.124950581359623 |
|
4708 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00596 |
0.124950581359623 |
|
4709 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHRS4 |
0.124950581359623 |
|
4710 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHRS4L2 |
0.124950581359623 |
|
4711 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHRS4L1 |
0.124950581359623 |
|
4712 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC16B |
0.124950581359623 |
|
4713 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPNE6 |
0.124950581359623 |
|
4714 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRL |
0.124950581359623 |
|
4715 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCK2 |
0.124950581359623 |
|
4716 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCAF11 |
0.124950581359623 |
|
4717 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FITM1 |
0.124950581359623 |
|
4718 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMC9 |
0.124950581359623 |
|
4719 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSME1 |
0.124950581359623 |
|
4720 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSME2 |
0.124950581359623 |
|
4721 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF31 |
0.124950581359623 |
|
4722 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRF9 |
0.124950581359623 |
|
4723 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP383 |
0.124950581359623 |
|
4724 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REC8 |
0.124950581359623 |
|
4725 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IPO4 |
0.124950581359623 |
|
4726 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TM9SF1 |
0.124950581359623 |
|
4727 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHMP4A |
0.124950581359623 |
|
4728 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSSK4 |
0.124950581359623 |
|
4729 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MDP1 |
0.124950581359623 |
|
4730 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEDD8 |
0.124950581359623 |
|
4731 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GMPR2 |
0.124950581359623 |
|
4732 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TINF2 |
0.124950581359623 |
|
4733 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TGM1 |
0.124950581359623 |
|
4734 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RABGGTA |
0.124950581359623 |
|
4735 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHRS1 |
0.124950581359623 |
|
4736 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOP9 |
0.124950581359623 |
|
4737 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CIDEB |
0.124950581359623 |
|
4738 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LTB4R2 |
0.124950581359623 |
|
4739 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LTB4R |
0.124950581359623 |
|
4740 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADCY4 |
0.124950581359623 |
|
4741 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIPK3 |
0.124950581359623 |
|
4742 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFATC4 |
0.124950581359623 |
|
4743 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NYNRIN |
0.124950581359623 |
|
4744 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBLN3 |
0.124950581359623 |
|
4745 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KHNYN |
0.124950581359623 |
|
4746 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDR39U1 |
0.124950581359623 |
|
4747 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CMA1 |
0.124950581359623 |
|
4748 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTSG |
0.124950581359623 |
|
4749 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GZMH |
0.124950581359623 |
|
4750 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GZMB |
0.124950581359623 |
|
4751 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD37|ENSG00000212270.1 |
0.124950581359623 |
|
4752 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOVA1 |
0.124950581359623 |
|
4753 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4307 |
0.124950581359623 |
|
4754 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00645 |
0.124950581359623 |
|
4755 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BNIP3P1 |
0.124950581359623 |
|
4756 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C14orf23 |
0.124950581359623 |
|
4757 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXG1 |
0.124950581359623 |
|
4758 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKD1 |
0.124950581359623 |
|
4759 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
G2E3 |
0.124950581359623 |
|
4760 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCFD1 |
0.124950581359623 |
|
4761 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COCH |
0.124950581359623 |
|
4762 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STRN3 |
0.124950581359623 |
|
4763 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR624 |
0.124950581359623 |
|
4764 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP4S1 |
0.124950581359623 |
|
4765 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HECTD1 |
0.124950581359623 |
|
4766 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HEATR5A |
0.124950581359623 |
|
4767 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DTD2 |
0.124950581359623 |
|
4768 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR33 |
0.124950581359623 |
|
4769 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUBPL |
0.124950581359623 |
|
4770 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP5 |
0.124950581359623 |
|
4771 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKAP6 |
0.124950581359623 |
|
4772 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL660P |
0.124950581359623 |
|
4773 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPAS3 |
0.124950581359623 |
|
4774 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EGLN3 |
0.124950581359623 |
|
4775 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPTSSA |
0.124950581359623 |
|
4776 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EAPP |
0.124950581359623 |
|
4777 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX6 |
0.124950581359623 |
|
4778 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CFL2 |
0.124950581359623 |
|
4779 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAZ1A |
0.124950581359623 |
|
4780 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRP54 |
0.124950581359623 |
|
4781 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM177A1 |
0.124950581359623 |
|
4782 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP2R3C |
0.124950581359623 |
|
4783 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0391 |
0.124950581359623 |
|
4784 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMA6 |
0.124950581359623 |
|
4785 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFKBIA |
0.124950581359623 |
|
4786 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INSM2 |
0.124950581359623 |
|
4787 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RALGAPA1 |
0.124950581359623 |
|
4788 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000253059.1 |
0.124950581359623 |
|
4789 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238718.1 |
0.124950581359623 |
|
4790 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRMS1L |
0.124950581359623 |
|
4791 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00609 |
0.124950581359623 |
|
4792 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTCSC3 |
0.124950581359623 |
|
4793 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP21 |
0.124950581359623 |
|
4794 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBIP |
0.124950581359623 |
|
4795 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPPA3P2 |
0.124950581359623 |
|
4796 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFTA3 |
0.124950581359623 |
|
4797 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP257 |
0.124950581359623 |
|
4798 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAX9 |
0.124950581359623 |
|
4799 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A21 |
0.124950581359623 |
|
4800 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4503 |
0.124950581359623 |
|
4801 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIPOL1 |
0.124950581359623 |
|
4802 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXA1 |
0.124950581359623 |
|
4803 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC6 |
0.124950581359623 |
|
4804 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA42|ENSG00000200385.1 |
0.124950581359623 |
|
4805 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00517 |
0.124950581359623 |
|
4806 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSTR1 |
0.124950581359623 |
|
4807 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC14A |
0.124950581359623 |
|
4808 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00639 |
0.124950581359623 |
|
4809 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC23A |
0.124950581359623 |
|
4810 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GEMIN2 |
0.124950581359623 |
|
4811 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAPPC6B |
0.124950581359623 |
|
4812 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNN |
0.124950581359623 |
|
4813 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIA2 |
0.124950581359623 |
|
4814 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTAGE5 |
0.124950581359623 |
|
4815 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO33 |
0.124950581359623 |
|
4816 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000251858.1 |
0.124950581359623 |
|
4817 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRFN5 |
0.124950581359623 |
|
4818 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FSCB |
0.124950581359623 |
|
4819 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238501.1 |
0.124950581359623 |
|
4820 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRPF39 |
0.124950581359623 |
|
4821 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD58 |
0.124950581359623 |
|
4822 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD127 |
0.124950581359623 |
|
4823 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FKBP3 |
0.124950581359623 |
|
4824 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FANCM |
0.124950581359623 |
|
4825 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIS18BP1 |
0.124950581359623 |
|
4826 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKP2 |
0.125341439856408 |
|
4827 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GZMA |
0.126115632786642 |
|
4828 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC20B |
0.126115632786642 |
|
4829 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPX8 |
0.126115632786642 |
|
4830 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR449A |
0.126115632786642 |
|
4831 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR449B |
0.126115632786642 |
|
4832 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR449C |
0.126115632786642 |
|
4833 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCIDAS |
0.126115632786642 |
|
4834 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNO |
0.126115632786642 |
|
4835 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHX29 |
0.126115632786642 |
|
4836 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SKIV2L2 |
0.126115632786642 |
|
4837 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPAP2A |
0.126115632786642 |
|
4838 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5687 |
0.126115632786642 |
|
4839 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC38A9 |
0.126115632786642 |
|
4840 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX4 |
0.126115632786642 |
|
4841 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP183 |
0.126115632786642 |
|
4842 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL31RA |
0.126115632786642 |
|
4843 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL6ST |
0.126115632786642 |
|
4844 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238326.1 |
0.126115632786642 |
|
4845 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD55 |
0.126115632786642 |
|
4846 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP184 |
0.126115632786642 |
|
4847 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP185 |
0.126115632786642 |
|
4848 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC2P |
0.126115632786642 |
|
4849 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP3K1 |
0.126115632786642 |
|
4850 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238717.1 |
0.126115632786642 |
|
4851 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SETD9 |
0.126115632786642 |
|
4852 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIER3 |
0.126115632786642 |
|
4853 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPBP1 |
0.126115632786642 |
|
4854 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTBL2 |
0.126115632786642 |
|
4855 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238899.1 |
0.126115632786642 |
|
4856 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLK2 |
0.126115632786642 |
|
4857 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAPT |
0.126115632786642 |
|
4858 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548AE2 |
0.126115632786642 |
|
4859 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB3C |
0.126115632786642 |
|
4860 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FKSG52 |
0.126115632786642 |
|
4861 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PART1 |
0.126115632786642 |
|
4862 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEPDC1B |
0.126115632786642 |
|
4863 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELOVL7 |
0.126115632786642 |
|
4864 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERCC8 |
0.126115632786642 |
|
4865 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFAF2 |
0.126115632786642 |
|
4866 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMIM15 |
0.126115632786642 |
|
4867 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSWIM6 |
0.126115632786642 |
|
4868 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf64 |
0.126115632786642 |
|
4869 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STXBP6 |
0.12973305164742 |
|
4870 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPC6 |
0.129938845603903 |
|
4871 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FSIP2 |
0.130092215517023 |
|
4872 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000212581.1 |
0.130092215517023 |
|
4873 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPRO |
0.130448011427179 |
|
4874 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPS8 |
0.130448011427179 |
|
4875 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STRAP |
0.130448011427179 |
|
4876 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DERA |
0.130448011427179 |
|
4877 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC15A5 |
0.130448011427179 |
|
4878 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MGST1 |
0.130448011427179 |
|
4879 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMO3 |
0.130448011427179 |
|
4880 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RERGL |
0.130448011427179 |
|
4881 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIK3C2G |
0.130448011427179 |
|
4882 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLCZ1 |
0.130448011427179 |
|
4883 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPZA3 |
0.130448011427179 |
|
4884 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHA5 |
0.130448011427179 |
|
4885 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL459P |
0.130448011427179 |
|
4886 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL67P |
0.130448011427179 |
|
4887 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AEBP2 |
0.130448011427179 |
|
4888 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE3A |
0.130448011427179 |
|
4889 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLCO1C1 |
0.130448011427179 |
|
4890 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLCO1B3 |
0.130448011427179 |
|
4891 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LST3 |
0.130448011427179 |
|
4892 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLCO1B7 |
0.130448011427179 |
|
4893 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLCO1B1 |
0.130448011427179 |
|
4894 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLCO1A2 |
0.130448011427179 |
|
4895 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IAPP |
0.130448011427179 |
|
4896 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PYROXD1 |
0.130448011427179 |
|
4897 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RECQL |
0.130448011427179 |
|
4898 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLT1B |
0.130448011427179 |
|
4899 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf39 |
0.130448011427179 |
|
4900 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GYS2 |
0.130448011427179 |
|
4901 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LDHB |
0.130448011427179 |
|
4902 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNJ8 |
0.130448011427179 |
|
4903 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCC9 |
0.130448011427179 |
|
4904 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CMAS |
0.130448011427179 |
|
4905 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST8SIA1 |
0.130448011427179 |
|
4906 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2CD5 |
0.130448011427179 |
|
4907 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ETNK1 |
0.130448011427179 |
|
4908 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOX5 |
0.130448011427179 |
|
4909 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR920 |
0.130448011427179 |
|
4910 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00477 |
0.130448011427179 |
|
4911 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL38P |
0.130448011427179 |
|
4912 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCAT1 |
0.130448011427179 |
|
4913 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf77 |
0.130448011427179 |
|
4914 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRMP |
0.130448011427179 |
|
4915 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASC1 |
0.130448011427179 |
|
4916 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYRM5 |
0.130448011427179 |
|
4917 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRAS |
0.130448011427179 |
|
4918 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFLTD1 |
0.130448011427179 |
|
4919 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP262 |
0.130448011427179 |
|
4920 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASSF8 |
0.130448011427179 |
|
4921 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BHLHE41 |
0.130448011427179 |
|
4922 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSPN |
0.130448011427179 |
|
4923 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITPR2 |
0.130448011427179 |
|
4924 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP354 |
0.130448011427179 |
|
4925 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASUN |
0.130448011427179 |
|
4926 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGFR1OP2 |
0.130448011427179 |
|
4927 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TM7SF3 |
0.130448011427179 |
|
4928 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED21 |
0.130448011427179 |
|
4929 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf71 |
0.130448011427179 |
|
4930 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STK38L |
0.130448011427179 |
|
4931 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARNTL2 |
0.130448011427179 |
|
4932 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMCO2 |
0.130448011427179 |
|
4933 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPFIBP1 |
0.130448011427179 |
|
4934 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REP15 |
0.130448011427179 |
|
4935 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS35 |
0.130448011427179 |
|
4936 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MANSC4 |
0.130448011427179 |
|
4937 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL42 |
0.130448011427179 |
|
4938 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP15 |
0.130448011427179 |
|
4939 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTHLH |
0.130448011427179 |
|
4940 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC91 |
0.130448011427179 |
|
4941 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP355 |
0.130448011427179 |
|
4942 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STON2 |
0.130900395822237 |
|
4943 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEL1L |
0.130900395822237 |
|
4944 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238978.1 |
0.130900395822237 |
|
4945 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC28P |
0.130900395822237 |
|
4946 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU3P3 |
0.130900395822237 |
|
4947 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00911 |
0.130900395822237 |
|
4948 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLRT2 |
0.130900395822237 |
|
4949 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALC |
0.130900395822237 |
|
4950 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR65 |
0.130900395822237 |
|
4951 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNK10 |
0.130900395822237 |
|
4952 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA7 |
0.130900395822237 |
|
4953 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPN21 |
0.130900395822237 |
|
4954 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZC3H14 |
0.130900395822237 |
|
4955 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EML5 |
0.130900395822237 |
|
4956 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC8 |
0.130900395822237 |
|
4957 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXN3 |
0.130900395822237 |
|
4958 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP107 |
0.130900395822237 |
|
4959 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP255 |
0.130900395822237 |
|
4960 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFCAB11 |
0.130900395822237 |
|
4961 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TDP1 |
0.130900395822237 |
|
4962 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNK13 |
0.130900395822237 |
|
4963 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMC1 |
0.130900395822237 |
|
4964 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRDE2 |
0.130900395822237 |
|
4965 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CALM1 |
0.130900395822237 |
|
4966 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00642 |
0.130900395822237 |
|
4967 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC7B |
0.130900395822237 |
|
4968 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR68 |
0.130900395822237 |
|
4969 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC88C |
0.130900395822237 |
|
4970 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMEK1 |
0.130900395822237 |
|
4971 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CATSPERB |
0.130900395822237 |
|
4972 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000200042.1 |
0.130900395822237 |
|
4973 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TC2N |
0.130900395822237 |
|
4974 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBLN5 |
0.130900395822237 |
|
4975 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIP11 |
0.130900395822237 |
|
4976 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATXN3 |
0.130900395822237 |
|
4977 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFB1 |
0.130900395822237 |
|
4978 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPSF2 |
0.130900395822237 |
|
4979 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC24A4 |
0.130900395822237 |
|
4980 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIN3 |
0.130900395822237 |
|
4981 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGMN |
0.130900395822237 |
|
4982 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA5 |
0.130900395822237 |
|
4983 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOAP1 |
0.130900395822237 |
|
4984 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM251 |
0.130900395822237 |
|
4985 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C14orf142 |
0.130900395822237 |
|
4986 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBR7 |
0.130900395822237 |
|
4987 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTBD7 |
0.130900395822237 |
|
4988 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UNC79 |
0.130900395822237 |
|
4989 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX8C |
0.130900395822237 |
|
4990 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRIMA1 |
0.130900395822237 |
|
4991 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARD3 |
0.132307177020498 |
|
4992 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR609 |
0.136743046653737 |
|
4993 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSTO1 |
0.136743046653737 |
|
4994 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSTO2 |
0.136743046653737 |
|
4995 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITPRIP |
0.136743046653737 |
|
4996 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC147 |
0.136743046653737 |
|
4997 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238620.1 |
0.136743046653737 |
|
4998 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SORCS3 |
0.136743046653737 |
|
4999 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SORCS1 |
0.136743046653737 |
|
5000 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP325 |
0.136743046653737 |
|
5001 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP326 |
0.136743046653737 |
|
5002 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ESM1 |
0.1380551208117 |
|
5003 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GZMK |
0.1380551208117 |
|
5004 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAR2 |
0.138910109075681 |
|
5005 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERGIC2 |
0.138910109075681 |
|
5006 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OVCH1 |
0.138910109075681 |
|
5007 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMTC1 |
0.138910109075681 |
|
5008 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000253052.1 |
0.138910109075681 |
|
5009 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP356 |
0.138910109075681 |
|
5010 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IPO8 |
0.138910109075681 |
|
5011 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPRIN2 |
0.138910109075681 |
|
5012 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00941 |
0.138910109075681 |
|
5013 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPAN11 |
0.138910109075681 |
|
5014 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA75|ENSG00000212533.1 |
0.138910109075681 |
|
5015 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGD4 |
0.138910109075681 |
|
5016 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNM1L |
0.138910109075681 |
|
5017 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YARS2 |
0.138910109075681 |
|
5018 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXOC6B |
0.141794504504345 |
|
5019 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZC3H15 |
0.144708755434746 |
|
5020 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGAV |
0.144708755434746 |
|
5021 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM171B |
0.144708755434746 |
|
5022 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSWIM2 |
0.144708755434746 |
|
5023 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP42 |
0.144708755434746 |
|
5024 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CALCRL |
0.144708755434746 |
|
5025 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFPI |
0.144708755434746 |
|
5026 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP114 |
0.144708755434746 |
|
5027 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GULP1 |
0.144708755434746 |
|
5028 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR561 |
0.144708755434746 |
|
5029 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DIRC1 |
0.144708755434746 |
|
5030 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL3A1 |
0.144708755434746 |
|
5031 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1245A |
0.144708755434746 |
|
5032 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL5A2 |
0.144708755434746 |
|
5033 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3129 |
0.144708755434746 |
|
5034 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR75 |
0.144708755434746 |
|
5035 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC40A1 |
0.144708755434746 |
|
5036 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASNSD1 |
0.144708755434746 |
|
5037 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKAR |
0.144708755434746 |
|
5038 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSGEPL1 |
0.144708755434746 |
|
5039 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ORMDL1 |
0.144708755434746 |
|
5040 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PMS1 |
0.144708755434746 |
|
5041 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf88 |
0.144708755434746 |
|
5042 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSTN |
0.144708755434746 |
|
5043 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIBCH |
0.144708755434746 |
|
5044 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INPP1 |
0.144708755434746 |
|
5045 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFSD6 |
0.144708755434746 |
|
5046 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM194B |
0.144708755434746 |
|
5047 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP179 |
0.144708755434746 |
|
5048 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAB1 |
0.144708755434746 |
|
5049 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLS |
0.144708755434746 |
|
5050 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAT1 |
0.144708755434746 |
|
5051 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAT4 |
0.144708755434746 |
|
5052 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYO1B |
0.144708755434746 |
|
5053 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NABP1 |
0.144708755434746 |
|
5054 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDPR |
0.144708755434746 |
|
5055 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEFF2 |
0.144708755434746 |
|
5056 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCGEM1 |
0.144708755434746 |
|
5057 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD59|ENSG00000252517.1 |
0.144708755434746 |
|
5058 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC39A10 |
0.144708755434746 |
|
5059 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAH7 |
0.144708755434746 |
|
5060 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STK17B |
0.144708755434746 |
|
5061 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HECW2 |
0.144708755434746 |
|
5062 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239161.1 |
0.144708755434746 |
|
5063 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL820P |
0.144708755434746 |
|
5064 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC150 |
0.144708755434746 |
|
5065 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA16|ENSG00000252923.1 |
0.144708755434746 |
|
5066 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF3C3 |
0.144708755434746 |
|
5067 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf66 |
0.144708755434746 |
|
5068 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGAP1 |
0.144708755434746 |
|
5069 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD44 |
0.144708755434746 |
|
5070 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SF3B1 |
0.144708755434746 |
|
5071 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA4|ENSG00000202434.1 |
0.144708755434746 |
|
5072 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COQ10B |
0.144708755434746 |
|
5073 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPD1 |
0.144708755434746 |
|
5074 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPE1 |
0.144708755434746 |
|
5075 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOB4 |
0.144708755434746 |
|
5076 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFTN2 |
0.144708755434746 |
|
5077 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRGUK |
0.1447529529261 |
|
5078 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35B4 |
0.1447529529261 |
|
5079 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKR1B1 |
0.1447529529261 |
|
5080 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKR1B10 |
0.1447529529261 |
|
5081 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKR1B15 |
0.1447529529261 |
|
5082 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BPGM |
0.1447529529261 |
|
5083 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CALD1 |
0.1447529529261 |
|
5084 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGBL3 |
0.1447529529261 |
|
5085 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C7orf49 |
0.1447529529261 |
|
5086 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM140 |
0.1447529529261 |
|
5087 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR91 |
0.1447529529261 |
|
5088 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STRA8 |
0.1447529529261 |
|
5089 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNOT4 |
0.1447529529261 |
|
5090 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUP205 |
0.1447529529261 |
|
5091 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C7orf73 |
0.1447529529261 |
|
5092 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC13A4 |
0.1447529529261 |
|
5093 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM180A |
0.1447529529261 |
|
5094 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LUZP6 |
0.1447529529261 |
|
5095 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTPN |
0.1447529529261 |
|
5096 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD69 |
0.145137787963921 |
|
5097 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLRF1 |
0.145137787963921 |
|
5098 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC2B |
0.145137787963921 |
|
5099 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLRF2 |
0.145137787963921 |
|
5100 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC2A |
0.145137787963921 |
|
5101 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC12A |
0.145137787963921 |
|
5102 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC1B |
0.145137787963921 |
|
5103 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC12B |
0.145137787963921 |
|
5104 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC9A |
0.145137787963921 |
|
5105 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC1A |
0.145137787963921 |
|
5106 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP161 |
0.145137787963921 |
|
5107 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC7A |
0.145137787963921 |
|
5108 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OLR1 |
0.145137787963921 |
|
5109 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM52B |
0.145137787963921 |
|
5110 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABARAPL1 |
0.145137787963921 |
|
5111 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLRD1 |
0.145137787963921 |
|
5112 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLRK1 |
0.145137787963921 |
|
5113 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLRC4 |
0.145137787963921 |
|
5114 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLRC1 |
0.145137787963921 |
|
5115 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLRC2 |
0.145137787963921 |
|
5116 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLRC3 |
0.145137787963921 |
|
5117 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF2S3L |
0.145137787963921 |
|
5118 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLRAP1 |
0.145137787963921 |
|
5119 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGOHB |
0.145137787963921 |
|
5120 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STYK1 |
0.145137787963921 |
|
5121 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YBX3 |
0.145137787963921 |
|
5122 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS2R7 |
0.145137787963921 |
|
5123 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS2R8 |
0.145137787963921 |
|
5124 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS2R9 |
0.145137787963921 |
|
5125 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR4 |
0.145137787963921 |
|
5126 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS2R10 |
0.145137787963921 |
|
5127 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRH1 |
0.145137787963921 |
|
5128 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS2R13 |
0.145137787963921 |
|
5129 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRH2 |
0.145137787963921 |
|
5130 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS2R14 |
0.145137787963921 |
|
5131 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS2R50 |
0.145137787963921 |
|
5132 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS2R20 |
0.145137787963921 |
|
5133 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS2R19 |
0.145137787963921 |
|
5134 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS2R30 |
0.145137787963921 |
|
5135 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS2R31 |
0.145137787963921 |
|
5136 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS2R42 |
0.145137787963921 |
|
5137 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS2R43 |
0.145137787963921 |
|
5138 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS2R46 |
0.145137787963921 |
|
5139 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS2R64P |
0.145137787963921 |
|
5140 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRB3 |
0.145137787963921 |
|
5141 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRB4 |
0.145137787963921 |
|
5142 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRB1 |
0.145137787963921 |
|
5143 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRB2 |
0.145137787963921 |
|
5144 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ETV6 |
0.145137787963921 |
|
5145 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCL2L14 |
0.145137787963921 |
|
5146 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRP6 |
0.145137787963921 |
|
5147 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MANSC1 |
0.145137787963921 |
|
5148 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LOH12CR2 |
0.145137787963921 |
|
5149 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LOH12CR1 |
0.145137787963921 |
|
5150 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUSP16 |
0.145137787963921 |
|
5151 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CREBL2 |
0.145137787963921 |
|
5152 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR19 |
0.145137787963921 |
|
5153 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDKN1B |
0.145137787963921 |
|
5154 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOLD1 |
0.145137787963921 |
|
5155 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR613 |
0.145137787963921 |
|
5156 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX47 |
0.145137787963921 |
|
5157 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPRC5A |
0.145137787963921 |
|
5158 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPRC5D |
0.145137787963921 |
|
5159 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSG1 |
0.145137787963921 |
|
5160 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HEBP1 |
0.145137787963921 |
|
5161 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTR7P1 |
0.145137787963921 |
|
5162 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1467 |
0.145137787963921 |
|
5163 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR614 |
0.145137787963921 |
|
5164 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD88 |
0.145137787963921 |
|
5165 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMP1 |
0.145137787963921 |
|
5166 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf36 |
0.145137787963921 |
|
5167 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP353 |
0.145137787963921 |
|
5168 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRIN2B |
0.145137787963921 |
|
5169 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP162 |
0.145137787963921 |
|
5170 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL46P |
0.145137787963921 |
|
5171 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL676P |
0.145137787963921 |
|
5172 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL30P11 |
0.145137787963921 |
|
5173 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATF7IP |
0.145137787963921 |
|
5174 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLBD1 |
0.145137787963921 |
|
5175 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP134 |
0.145137787963921 |
|
5176 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GUCY2C |
0.145137787963921 |
|
5177 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
H2AFJ |
0.145137787963921 |
|
5178 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST4H4 |
0.145137787963921 |
|
5179 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WBP11 |
0.145137787963921 |
|
5180 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf60 |
0.145137787963921 |
|
5181 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMCO3 |
0.145137787963921 |
|
5182 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ART4 |
0.145137787963921 |
|
5183 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MGP |
0.145137787963921 |
|
5184 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERP27 |
0.145137787963921 |
|
5185 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGDIB |
0.145137787963921 |
|
5186 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE6H |
0.145137787963921 |
|
5187 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RERG |
0.145137787963921 |
|
5188 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OTUD7B |
0.146529602900438 |
|
5189 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS45 |
0.146529602900438 |
|
5190 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHO1 |
0.146529602900438 |
|
5191 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL480P |
0.146529602900438 |
|
5192 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANP32E |
0.146529602900438 |
|
5193 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CA14 |
0.146529602900438 |
|
5194 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238526.1 |
0.146529602900438 |
|
5195 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APH1A |
0.146529602900438 |
|
5196 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf54 |
0.146529602900438 |
|
5197 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf51 |
0.146529602900438 |
|
5198 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS21 |
0.146529602900438 |
|
5199 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRPF3 |
0.146529602900438 |
|
5200 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPRD2 |
0.146529602900438 |
|
5201 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TARS2 |
0.146529602900438 |
|
5202 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ECM1 |
0.146529602900438 |
|
5203 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00568 |
0.146529602900438 |
|
5204 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAMTSL4 |
0.146529602900438 |
|
5205 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4257 |
0.146529602900438 |
|
5206 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf138 |
0.146529602900438 |
|
5207 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL473P |
0.146529602900438 |
|
5208 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL600P |
0.146529602900438 |
|
5209 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCL1 |
0.146529602900438 |
|
5210 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENSA |
0.146529602900438 |
|
5211 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA40|ENSG00000253047.1 |
0.146529602900438 |
|
5212 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLPH3L |
0.146529602900438 |
|
5213 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HORMAD1 |
0.146529602900438 |
|
5214 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTSS |
0.146529602900438 |
|
5215 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTSK |
0.146529602900438 |
|
5216 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARNT |
0.146529602900438 |
|
5217 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SETDB1 |
0.146529602900438 |
|
5218 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CERS2 |
0.146529602900438 |
|
5219 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANXA9 |
0.146529602900438 |
|
5220 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM63A |
0.146529602900438 |
|
5221 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRUNE |
0.146529602900438 |
|
5222 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BNIPL |
0.146529602900438 |
|
5223 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf56 |
0.146529602900438 |
|
5224 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC42SE1 |
0.146529602900438 |
|
5225 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLLT11 |
0.146529602900438 |
|
5226 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABPB2 |
0.146529602900438 |
|
5227 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEMA6C |
0.146529602900438 |
|
5228 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYSMD1 |
0.146529602900438 |
|
5229 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCNM1 |
0.146529602900438 |
|
5230 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFAIP8L2 |
0.146529602900438 |
|
5231 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMOD4 |
0.146529602900438 |
|
5232 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS72 |
0.146529602900438 |
|
5233 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIP5K1A |
0.146529602900438 |
|
5234 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMD4 |
0.146529602900438 |
|
5235 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF687 |
0.146529602900438 |
|
5236 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PI4KB |
0.146529602900438 |
|
5237 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL444P |
0.146529602900438 |
|
5238 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFX5 |
0.146529602900438 |
|
5239 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POGZ |
0.146529602900438 |
|
5240 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMB4 |
0.146529602900438 |
|
5241 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SELENBP1 |
0.146529602900438 |
|
5242 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P25 |
0.146529602900438 |
|
5243 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CGN |
0.146529602900438 |
|
5244 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA44 |
0.146529602900438 |
|
5245 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUFT1 |
0.146529602900438 |
|
5246 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR554 |
0.146529602900438 |
|
5247 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX27 |
0.146529602900438 |
|
5248 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CELF3 |
0.146529602900438 |
|
5249 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIIAD1 |
0.146529602900438 |
|
5250 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL9 |
0.146529602900438 |
|
5251 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OAZ3 |
0.146529602900438 |
|
5252 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TDRKH |
0.146529602900438 |
|
5253 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINGO4 |
0.146529602900438 |
|
5254 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RORC |
0.146529602900438 |
|
5255 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2CD4D |
0.146529602900438 |
|
5256 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THEM5 |
0.146529602900438 |
|
5257 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THEM4 |
0.146529602900438 |
|
5258 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S100A10 |
0.146529602900438 |
|
5259 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBPF18P |
0.146529602900438 |
|
5260 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S100A11 |
0.146529602900438 |
|
5261 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCHHL1 |
0.146529602900438 |
|
5262 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCHH |
0.146529602900438 |
|
5263 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPTN |
0.146529602900438 |
|
5264 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HRNR |
0.146529602900438 |
|
5265 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLG |
0.146529602900438 |
|
5266 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLG2 |
0.146529602900438 |
|
5267 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRNN |
0.146529602900438 |
|
5268 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCE5A |
0.146529602900438 |
|
5269 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRCT1 |
0.146529602900438 |
|
5270 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCE3B |
0.146529602900438 |
|
5271 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCE3C |
0.146529602900438 |
|
5272 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCE3D |
0.146529602900438 |
|
5273 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCE3E |
0.146529602900438 |
|
5274 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCE3A |
0.146529602900438 |
|
5275 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCE2D |
0.146529602900438 |
|
5276 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00302 |
0.146529602900438 |
|
5277 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCE2B |
0.146529602900438 |
|
5278 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCE2C |
0.146529602900438 |
|
5279 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCE2A |
0.146529602900438 |
|
5280 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCE4A |
0.146529602900438 |
|
5281 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf68 |
0.146529602900438 |
|
5282 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KPRP |
0.146529602900438 |
|
5283 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCE1F |
0.146529602900438 |
|
5284 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCE1C |
0.146529602900438 |
|
5285 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCE1D |
0.146529602900438 |
|
5286 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCE1E |
0.146529602900438 |
|
5287 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCE1B |
0.146529602900438 |
|
5288 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCE1A |
0.146529602900438 |
|
5289 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCE6A |
0.146529602900438 |
|
5290 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMCP |
0.146529602900438 |
|
5291 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IVL |
0.146529602900438 |
|
5292 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPRR4 |
0.146529602900438 |
|
5293 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPRR1A |
0.146529602900438 |
|
5294 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPRR3 |
0.146529602900438 |
|
5295 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000252920.1 |
0.146529602900438 |
|
5296 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPRR1B |
0.146529602900438 |
|
5297 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPRR2D |
0.146529602900438 |
|
5298 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPRR2A |
0.146529602900438 |
|
5299 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPRR2B |
0.146529602900438 |
|
5300 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPRR2E |
0.146529602900438 |
|
5301 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPRR2F |
0.146529602900438 |
|
5302 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPRR2G |
0.146529602900438 |
|
5303 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LELP1 |
0.146529602900438 |
|
5304 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR9 |
0.146529602900438 |
|
5305 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LOR |
0.146529602900438 |
|
5306 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGLYRP3 |
0.146529602900438 |
|
5307 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGLYRP4 |
0.146529602900438 |
|
5308 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S100A12 |
0.146529602900438 |
|
5309 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S100A8 |
0.146529602900438 |
|
5310 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S100A9 |
0.146529602900438 |
|
5311 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S100A7A |
0.146529602900438 |
|
5312 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S100A7L2 |
0.146529602900438 |
|
5313 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S100A7 |
0.146529602900438 |
|
5314 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL44P |
0.146529602900438 |
|
5315 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S100A3 |
0.146529602900438 |
|
5316 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S100A4 |
0.146529602900438 |
|
5317 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S100A5 |
0.146529602900438 |
|
5318 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S100A6 |
0.146529602900438 |
|
5319 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S100A2 |
0.146529602900438 |
|
5320 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S100A16 |
0.146529602900438 |
|
5321 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S100A14 |
0.146529602900438 |
|
5322 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S100A13 |
0.146529602900438 |
|
5323 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S100A1 |
0.146529602900438 |
|
5324 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHTOP |
0.146529602900438 |
|
5325 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNAPIN |
0.146529602900438 |
|
5326 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ILF2 |
0.146529602900438 |
|
5327 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPR1 |
0.146529602900438 |
|
5328 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INTS3 |
0.146529602900438 |
|
5329 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL372P |
0.146529602900438 |
|
5330 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238511.1 |
0.146529602900438 |
|
5331 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC27A3 |
0.146529602900438 |
|
5332 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GATAD2B |
0.146529602900438 |
|
5333 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DENND4B |
0.146529602900438 |
|
5334 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRTC2 |
0.146529602900438 |
|
5335 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC39A1 |
0.146529602900438 |
|
5336 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CREB3L4 |
0.146529602900438 |
|
5337 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JTB |
0.146529602900438 |
|
5338 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB13 |
0.146529602900438 |
|
5339 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUP210L |
0.146529602900438 |
|
5340 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS27 |
0.146529602900438 |
|
5341 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000252669.1 |
0.146529602900438 |
|
5342 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5698 |
0.146529602900438 |
|
5343 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPM3 |
0.146529602900438 |
|
5344 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL431P |
0.146529602900438 |
|
5345 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR190B |
0.146529602900438 |
|
5346 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf189 |
0.146529602900438 |
|
5347 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf43 |
0.146529602900438 |
|
5348 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBAP2L |
0.146529602900438 |
|
5349 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA58|ENSG00000201129.1 |
0.146529602900438 |
|
5350 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAX1 |
0.146529602900438 |
|
5351 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD59|ENSG00000252682.1 |
0.146529602900438 |
|
5352 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AQP10 |
0.146529602900438 |
|
5353 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP8B2 |
0.146529602900438 |
|
5354 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL6R |
0.146529602900438 |
|
5355 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHE |
0.146529602900438 |
|
5356 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TDRD10 |
0.146529602900438 |
|
5357 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2Q1 |
0.146529602900438 |
|
5358 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRNB2 |
0.146529602900438 |
|
5359 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAR |
0.146529602900438 |
|
5360 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNN3 |
0.146529602900438 |
|
5361 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PMVK |
0.146529602900438 |
|
5362 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCN3 |
0.146529602900438 |
|
5363 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKLR |
0.146529602900438 |
|
5364 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FDPS |
0.146529602900438 |
|
5365 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RUSC1 |
0.146529602900438 |
|
5366 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASH1L |
0.146529602900438 |
|
5367 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR555 |
0.146529602900438 |
|
5368 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238805.1 |
0.146529602900438 |
|
5369 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSTO1 |
0.146529602900438 |
|
5370 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YY1AP1 |
0.146529602900438 |
|
5371 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DAP3 |
0.146529602900438 |
|
5372 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GON4L |
0.146529602900438 |
|
5373 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYT11 |
0.146529602900438 |
|
5374 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIT1 |
0.146529602900438 |
|
5375 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0907 |
0.146529602900438 |
|
5376 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA42|ENSG00000207475.1 |
0.146529602900438 |
|
5377 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA4|ENSG00000252808.1 |
0.146529602900438 |
|
5378 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RXFP4 |
0.146529602900438 |
|
5379 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF2 |
0.146529602900438 |
|
5380 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSR2 |
0.146529602900438 |
|
5381 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBQLN4 |
0.146529602900438 |
|
5382 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAMTOR2 |
0.146529602900438 |
|
5383 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB25 |
0.146529602900438 |
|
5384 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEX3A |
0.146529602900438 |
|
5385 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMNA |
0.146529602900438 |
|
5386 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEMA4A |
0.146529602900438 |
|
5387 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA26|ENSG00000252236.1 |
0.146529602900438 |
|
5388 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A44 |
0.146529602900438 |
|
5389 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PMF1 |
0.146529602900438 |
|
5390 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BGLAP |
0.146529602900438 |
|
5391 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAQR6 |
0.146529602900438 |
|
5392 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMG5 |
0.146529602900438 |
|
5393 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf85 |
0.146529602900438 |
|
5394 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM79 |
0.146529602900438 |
|
5395 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VHLL |
0.146529602900438 |
|
5396 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCT3 |
0.146529602900438 |
|
5397 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSACC |
0.146529602900438 |
|
5398 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHBG |
0.146529602900438 |
|
5399 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf61 |
0.146529602900438 |
|
5400 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEF2D |
0.146529602900438 |
|
5401 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IQGAP3 |
0.146529602900438 |
|
5402 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238843.1 |
0.146529602900438 |
|
5403 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC24 |
0.146529602900438 |
|
5404 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOA1BP |
0.146529602900438 |
|
5405 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPATCH4 |
0.146529602900438 |
|
5406 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAPLN2 |
0.146529602900438 |
|
5407 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCAN |
0.146529602900438 |
|
5408 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NES |
0.146529602900438 |
|
5409 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRABP2 |
0.146529602900438 |
|
5410 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ISG20L2 |
0.146529602900438 |
|
5411 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRNAD1 |
0.146529602900438 |
|
5412 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL24 |
0.146529602900438 |
|
5413 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HDGF |
0.146529602900438 |
|
5414 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRCC |
0.146529602900438 |
|
5415 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH2D2A |
0.146529602900438 |
|
5416 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NTRK1 |
0.146529602900438 |
|
5417 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INSRR |
0.146529602900438 |
|
5418 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEAR1 |
0.146529602900438 |
|
5419 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC71 |
0.146529602900438 |
|
5420 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF11 |
0.146529602900438 |
|
5421 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR765 |
0.146529602900438 |
|
5422 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL612P |
0.146529602900438 |
|
5423 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ETV3L |
0.146529602900438 |
|
5424 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ETV3 |
0.146529602900438 |
|
5425 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCRL5 |
0.146529602900438 |
|
5426 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCRL4 |
0.146529602900438 |
|
5427 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCRL3 |
0.146529602900438 |
|
5428 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCRL2 |
0.146529602900438 |
|
5429 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCRL1 |
0.146529602900438 |
|
5430 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD5L |
0.146529602900438 |
|
5431 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIRREL |
0.146529602900438 |
|
5432 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD1D |
0.146529602900438 |
|
5433 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD1A |
0.146529602900438 |
|
5434 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD1C |
0.146529602900438 |
|
5435 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD1B |
0.146529602900438 |
|
5436 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD1E |
0.146529602900438 |
|
5437 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10T2 |
0.146529602900438 |
|
5438 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10K2 |
0.146529602900438 |
|
5439 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10K1 |
0.146529602900438 |
|
5440 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10R2 |
0.146529602900438 |
|
5441 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10X1 |
0.146529602900438 |
|
5442 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6P1 |
0.146529602900438 |
|
5443 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6Y1 |
0.146529602900438 |
|
5444 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10Z1 |
0.146529602900438 |
|
5445 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPTA1 |
0.146529602900438 |
|
5446 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6K2 |
0.146529602900438 |
|
5447 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6K3 |
0.146529602900438 |
|
5448 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6K6 |
0.146529602900438 |
|
5449 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6N1 |
0.146529602900438 |
|
5450 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6N2 |
0.146529602900438 |
|
5451 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MNDA |
0.146529602900438 |
|
5452 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PYHIN1 |
0.146529602900438 |
|
5453 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFI16 |
0.146529602900438 |
|
5454 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AIM2 |
0.146529602900438 |
|
5455 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CADM3 |
0.146529602900438 |
|
5456 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP60 |
0.146529602900438 |
|
5457 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DARC |
0.146529602900438 |
|
5458 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCER1A |
0.146529602900438 |
|
5459 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10J3 |
0.146529602900438 |
|
5460 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10J4 |
0.146529602900438 |
|
5461 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10J1 |
0.146529602900438 |
|
5462 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10J5 |
0.146529602900438 |
|
5463 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APCS |
0.146529602900438 |
|
5464 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRP |
0.146529602900438 |
|
5465 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUSP23 |
0.146529602900438 |
|
5466 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCRL6 |
0.146529602900438 |
|
5467 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLAMF8 |
0.146529602900438 |
|
5468 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf204 |
0.146529602900438 |
|
5469 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD64|ENSG00000212161.1 |
0.146529602900438 |
|
5470 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VSIG8 |
0.146529602900438 |
|
5471 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC19 |
0.146529602900438 |
|
5472 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAGLN2 |
0.146529602900438 |
|
5473 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGSF9 |
0.146529602900438 |
|
5474 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLAMF9 |
0.146529602900438 |
|
5475 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIGM |
0.146529602900438 |
|
5476 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNJ10 |
0.146529602900438 |
|
5477 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNJ9 |
0.146529602900438 |
|
5478 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGSF8 |
0.146529602900438 |
|
5479 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP1A2 |
0.146529602900438 |
|
5480 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP1A4 |
0.146529602900438 |
|
5481 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASQ1 |
0.146529602900438 |
|
5482 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEA15 |
0.146529602900438 |
|
5483 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCAF8 |
0.146529602900438 |
|
5484 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEX19 |
0.146529602900438 |
|
5485 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COPA |
0.146529602900438 |
|
5486 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCSTN |
0.146529602900438 |
|
5487 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NHLH1 |
0.146529602900438 |
|
5488 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VANGL2 |
0.146529602900438 |
|
5489 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLAMF6 |
0.146529602900438 |
|
5490 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD84 |
0.146529602900438 |
|
5491 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLAMF1 |
0.146529602900438 |
|
5492 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD48 |
0.146529602900438 |
|
5493 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLAMF7 |
0.146529602900438 |
|
5494 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LY9 |
0.146529602900438 |
|
5495 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD244 |
0.146529602900438 |
|
5496 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITLN1 |
0.146529602900438 |
|
5497 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITLN2 |
0.146529602900438 |
|
5498 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
F11R |
0.146529602900438 |
|
5499 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSTD1 |
0.146529602900438 |
|
5500 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USF1 |
0.146529602900438 |
|
5501 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP30 |
0.146529602900438 |
|
5502 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PVRL4 |
0.146529602900438 |
|
5503 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHDC9 |
0.146529602900438 |
|
5504 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PFDN2 |
0.146529602900438 |
|
5505 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NIT1 |
0.146529602900438 |
|
5506 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEDD |
0.146529602900438 |
|
5507 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACA64|ENSG00000238934.1 |
0.146529602900438 |
|
5508 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UFC1 |
0.146529602900438 |
|
5509 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP21 |
0.146529602900438 |
|
5510 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B4GALT3 |
0.146529602900438 |
|
5511 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPOX |
0.146529602900438 |
|
5512 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAMTS4 |
0.146529602900438 |
|
5513 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFS2 |
0.146529602900438 |
|
5514 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCER1G |
0.146529602900438 |
|
5515 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOA2 |
0.146529602900438 |
|
5516 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5187 |
0.146529602900438 |
|
5517 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NR1I3 |
0.146529602900438 |
|
5518 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOMM40L |
0.146529602900438 |
|
5519 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCP4L1 |
0.146529602900438 |
|
5520 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPZ |
0.146529602900438 |
|
5521 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDHC |
0.146529602900438 |
|
5522 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf192 |
0.146529602900438 |
|
5523 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCGR2A |
0.146529602900438 |
|
5524 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCGR2B |
0.146529602900438 |
|
5525 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCGR2C |
0.146529602900438 |
|
5526 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCGR3A |
0.146529602900438 |
|
5527 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCGR3B |
0.146529602900438 |
|
5528 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPA6 |
0.146529602900438 |
|
5529 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL31P11 |
0.146529602900438 |
|
5530 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCRLA |
0.146529602900438 |
|
5531 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCRLB |
0.146529602900438 |
|
5532 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL466P |
0.146529602900438 |
|
5533 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUSP12 |
0.146529602900438 |
|
5534 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATF6 |
0.146529602900438 |
|
5535 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OLFML2B |
0.146529602900438 |
|
5536 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOS1AP |
0.146529602900438 |
|
5537 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4654 |
0.146529602900438 |
|
5538 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP61 |
0.146529602900438 |
|
5539 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR556 |
0.146529602900438 |
|
5540 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf226 |
0.146529602900438 |
|
5541 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf111 |
0.146529602900438 |
|
5542 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH2D1B |
0.146529602900438 |
|
5543 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UHMK1 |
0.146529602900438 |
|
5544 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UAP1 |
0.146529602900438 |
|
5545 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDR2 |
0.146529602900438 |
|
5546 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL861P |
0.146529602900438 |
|
5547 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSD17B7 |
0.146529602900438 |
|
5548 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf110 |
0.146529602900438 |
|
5549 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGS4 |
0.146529602900438 |
|
5550 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGS5 |
0.146529602900438 |
|
5551 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUF2 |
0.146529602900438 |
|
5552 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252740.1 |
0.146529602900438 |
|
5553 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP62 |
0.146529602900438 |
|
5554 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP63 |
0.146529602900438 |
|
5555 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000212538.1 |
0.146529602900438 |
|
5556 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000251817.1 |
0.146529602900438 |
|
5557 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTGDR |
0.148748509353261 |
|
5558 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTGER2 |
0.148748509353261 |
|
5559 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR137C |
0.148748509353261 |
|
5560 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERO1L |
0.148748509353261 |
|
5561 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMC6 |
0.148748509353261 |
|
5562 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STYX |
0.148748509353261 |
|
5563 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNPNAT1 |
0.148748509353261 |
|
5564 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL588P |
0.148748509353261 |
|
5565 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FERMT2 |
0.148748509353261 |
|
5566 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDHD1 |
0.148748509353261 |
|
5567 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5580 |
0.148748509353261 |
|
5568 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BMP4 |
0.148748509353261 |
|
5569 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDKN3 |
0.148748509353261 |
|
5570 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNIH |
0.148748509353261 |
|
5571 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GMFB |
0.148748509353261 |
|
5572 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CGRRF1 |
0.148748509353261 |
|
5573 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAMD4A |
0.148748509353261 |
|
5574 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCH1 |
0.148748509353261 |
|
5575 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC9P |
0.148748509353261 |
|
5576 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4308 |
0.148748509353261 |
|
5577 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDHD1 |
0.148748509353261 |
|
5578 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOCS4 |
0.148748509353261 |
|
5579 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPK1IP1L |
0.148748509353261 |
|
5580 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGALS3 |
0.148748509353261 |
|
5581 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLGAP5 |
0.148748509353261 |
|
5582 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO34 |
0.148748509353261 |
|
5583 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATG14 |
0.148748509353261 |
|
5584 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBPL2 |
0.148748509353261 |
|
5585 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KTN1 |
0.148748509353261 |
|
5586 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00520 |
0.148748509353261 |
|
5587 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL13AP3 |
0.148748509353261 |
|
5588 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MXI1 |
0.151556678620764 |
|
5589 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMNDC1 |
0.151556678620764 |
|
5590 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239125.1 |
0.151556678620764 |
|
5591 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL686P |
0.151556678620764 |
|
5592 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM20 |
0.151556678620764 |
|
5593 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP288 |
0.151556678620764 |
|
5594 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP327 |
0.151556678620764 |
|
5595 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDCD4 |
0.151556678620764 |
|
5596 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BBIP1 |
0.151556678620764 |
|
5597 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4680 |
0.151556678620764 |
|
5598 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHOC2 |
0.151556678620764 |
|
5599 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548E |
0.151556678620764 |
|
5600 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADRA2A |
0.151556678620764 |
|
5601 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPAM |
0.151556678620764 |
|
5602 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TECTB |
0.151556678620764 |
|
5603 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GUCY2GP |
0.151556678620764 |
|
5604 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACSL5 |
0.151556678620764 |
|
5605 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDHHC6 |
0.151556678620764 |
|
5606 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VTI1A |
0.151556678620764 |
|
5607 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4295 |
0.151556678620764 |
|
5608 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCF7L2 |
0.151556678620764 |
|
5609 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HABP2 |
0.151556678620764 |
|
5610 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRAP |
0.151556678620764 |
|
5611 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASP7 |
0.151556678620764 |
|
5612 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHS1 |
0.151556678620764 |
|
5613 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA17|ENSG00000212589.1 |
0.151556678620764 |
|
5614 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCLRE1A |
0.151556678620764 |
|
5615 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NHLRC2 |
0.151556678620764 |
|
5616 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADRB1 |
0.151556678620764 |
|
5617 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf118 |
0.151556678620764 |
|
5618 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR2110 |
0.151556678620764 |
|
5619 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TDRD1 |
0.151556678620764 |
|
5620 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VWA2 |
0.151556678620764 |
|
5621 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AFAP1L2 |
0.151556678620764 |
|
5622 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL384P |
0.151556678620764 |
|
5623 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABLIM1 |
0.151556678620764 |
|
5624 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238577.1 |
0.151556678620764 |
|
5625 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM160B1 |
0.151556678620764 |
|
5626 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRUB1 |
0.151556678620764 |
|
5627 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATRNL1 |
0.151556678620764 |
|
5628 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GFRA1 |
0.151556678620764 |
|
5629 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC172 |
0.151556678620764 |
|
5630 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNLIPRP3 |
0.151556678620764 |
|
5631 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNLIP |
0.151556678620764 |
|
5632 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNLIPRP1 |
0.151556678620764 |
|
5633 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNLIPRP2 |
0.151556678620764 |
|
5634 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf82 |
0.151556678620764 |
|
5635 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPA12A |
0.151556678620764 |
|
5636 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENO4 |
0.151556678620764 |
|
5637 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1598 |
0.151556678620764 |
|
5638 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VAX1 |
0.151556678620764 |
|
5639 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3663 |
0.151556678620764 |
|
5640 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNK18 |
0.151556678620764 |
|
5641 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC18A2 |
0.151556678620764 |
|
5642 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDZD8 |
0.151556678620764 |
|
5643 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMX2OS |
0.151556678620764 |
|
5644 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMX2 |
0.151556678620764 |
|
5645 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB11FIP2 |
0.151556678620764 |
|
5646 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASC2 |
0.151556678620764 |
|
5647 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM204A |
0.151556678620764 |
|
5648 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00867 |
0.151556678620764 |
|
5649 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRLHR |
0.151556678620764 |
|
5650 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACUL1 |
0.151556678620764 |
|
5651 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000251836.1 |
0.151556678620764 |
|
5652 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF3A |
0.151556678620764 |
|
5653 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NANOS1 |
0.151556678620764 |
|
5654 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA19|ENSG00000207468.1 |
0.151556678620764 |
|
5655 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA19|ENSG00000222588.1 |
0.151556678620764 |
|
5656 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM45A |
0.151556678620764 |
|
5657 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFXN4 |
0.151556678620764 |
|
5658 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRDX3 |
0.151556678620764 |
|
5659 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRK5 |
0.151556678620764 |
|
5660 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL749P |
0.151556678620764 |
|
5661 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4681 |
0.151556678620764 |
|
5662 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGS10 |
0.151556678620764 |
|
5663 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIAL1 |
0.151556678620764 |
|
5664 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAG3 |
0.151556678620764 |
|
5665 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INPP5F |
0.151556678620764 |
|
5666 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL846P |
0.151556678620764 |
|
5667 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCMBP |
0.151556678620764 |
|
5668 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC23IP |
0.151556678620764 |
|
5669 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4682 |
0.151556678620764 |
|
5670 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPAPDC1A |
0.151556678620764 |
|
5671 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf85 |
0.151556678620764 |
|
5672 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR11 |
0.151556678620764 |
|
5673 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP167 |
0.151556678620764 |
|
5674 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGFR2 |
0.151556678620764 |
|
5675 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATE1 |
0.151556678620764 |
|
5676 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NSMCE4A |
0.151556678620764 |
|
5677 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TACC2 |
0.151556678620764 |
|
5678 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTBD16 |
0.151556678620764 |
|
5679 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHA1 |
0.151556678620764 |
|
5680 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3941 |
0.151556678620764 |
|
5681 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARMS2 |
0.151556678620764 |
|
5682 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTRA1 |
0.151556678620764 |
|
5683 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DMBT1 |
0.151556678620764 |
|
5684 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf120 |
0.151556678620764 |
|
5685 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CUZD1 |
0.151556678620764 |
|
5686 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM24B |
0.151556678620764 |
|
5687 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM24A |
0.151556678620764 |
|
5688 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf88 |
0.151556678620764 |
|
5689 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSTK |
0.151556678620764 |
|
5690 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IKZF5 |
0.151556678620764 |
|
5691 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACADSB |
0.151556678620764 |
|
5692 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMX2 |
0.151556678620764 |
|
5693 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMX3 |
0.151556678620764 |
|
5694 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BUB3 |
0.151556678620764 |
|
5695 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR26 |
0.151556678620764 |
|
5696 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPXM2 |
0.151556678620764 |
|
5697 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHST15 |
0.151556678620764 |
|
5698 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OAT |
0.151556678620764 |
|
5699 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LHPP |
0.151556678620764 |
|
5700 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM53B |
0.151556678620764 |
|
5701 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL10 |
0.151556678620764 |
|
5702 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM175B |
0.151556678620764 |
|
5703 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZRANB1 |
0.151556678620764 |
|
5704 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTBP2 |
0.151556678620764 |
|
5705 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4296 |
0.151556678620764 |
|
5706 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX36 |
0.151556678620764 |
|
5707 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf137 |
0.151556678620764 |
|
5708 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMP21 |
0.151556678620764 |
|
5709 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UROS |
0.151556678620764 |
|
5710 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4484 |
0.151556678620764 |
|
5711 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCCIP |
0.151556678620764 |
|
5712 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHX32 |
0.151556678620764 |
|
5713 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FANK1 |
0.151556678620764 |
|
5714 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM12 |
0.151556678620764 |
|
5715 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP328 |
0.151556678620764 |
|
5716 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00601 |
0.151556678620764 |
|
5717 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf90 |
0.151556678620764 |
|
5718 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD60|ENSG00000199321.1 |
0.151556678620764 |
|
5719 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOCK1 |
0.151556678620764 |
|
5720 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM196A |
0.151556678620764 |
|
5721 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPS |
0.151556678620764 |
|
5722 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXI2 |
0.151556678620764 |
|
5723 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLRN3 |
0.151556678620764 |
|
5724 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MKI67 |
0.151556678620764 |
|
5725 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP105 |
0.152664493830576 |
|
5726 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NXPH2 |
0.152664493830576 |
|
5727 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP286 |
0.152664493830576 |
|
5728 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA72|ENSG00000206901.1 |
0.152664493830576 |
|
5729 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL283P |
0.152664493830576 |
|
5730 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHGA |
0.152769501184308 |
|
5731 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITPK1 |
0.152769501184308 |
|
5732 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPS1 |
0.153292815473938 |
|
5733 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERBB4 |
0.153292815473938 |
|
5734 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP119 |
0.153292815473938 |
|
5735 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548F2 |
0.153292815473938 |
|
5736 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPAG16 |
0.153292815473938 |
|
5737 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4438 |
0.153292815473938 |
|
5738 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VWC2L |
0.153292815473938 |
|
5739 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000207274.1 |
0.153292815473938 |
|
5740 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCA12 |
0.153292815473938 |
|
5741 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238663.1 |
0.153292815473938 |
|
5742 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATIC |
0.153292815473938 |
|
5743 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FN1 |
0.153292815473938 |
|
5744 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00607 |
0.153292815473938 |
|
5745 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MREG |
0.153292815473938 |
|
5746 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PECR |
0.153292815473938 |
|
5747 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM169 |
0.153292815473938 |
|
5748 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XRCC5 |
0.153292815473938 |
|
5749 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MARCH4 |
0.153292815473938 |
|
5750 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMARCAL1 |
0.153292815473938 |
|
5751 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL37A |
0.153292815473938 |
|
5752 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGFBP2 |
0.153292815473938 |
|
5753 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGFBP5 |
0.153292815473938 |
|
5754 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP120 |
0.153292815473938 |
|
5755 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNP1 |
0.153292815473938 |
|
5756 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP43 |
0.153292815473938 |
|
5757 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DIRC3 |
0.153292815473938 |
|
5758 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNS1 |
0.153292815473938 |
|
5759 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RUFY4 |
0.153292815473938 |
|
5760 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXCR2P1 |
0.153292815473938 |
|
5761 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXCR2 |
0.153292815473938 |
|
5762 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXCR1 |
0.153292815473938 |
|
5763 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238428.1 |
0.153292815473938 |
|
5764 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARPC2 |
0.153292815473938 |
|
5765 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AAMP |
0.153292815473938 |
|
5766 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPBAR1 |
0.153292815473938 |
|
5767 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNKD |
0.153292815473938 |
|
5768 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMBIM1 |
0.153292815473938 |
|
5769 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238736.1 |
0.153292815473938 |
|
5770 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf62 |
0.153292815473938 |
|
5771 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC11A1 |
0.153292815473938 |
|
5772 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTDSP1 |
0.153292815473938 |
|
5773 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR26B |
0.153292815473938 |
|
5774 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VIL1 |
0.153292815473938 |
|
5775 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP37 |
0.153292815473938 |
|
5776 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP38 |
0.153292815473938 |
|
5777 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RQCD1 |
0.153292815473938 |
|
5778 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLCD4 |
0.153292815473938 |
|
5779 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000252805.1 |
0.153292815473938 |
|
5780 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP27A1 |
0.153292815473938 |
|
5781 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKAG3 |
0.153292815473938 |
|
5782 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WNT6 |
0.153292815473938 |
|
5783 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WNT10A |
0.153292815473938 |
|
5784 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK5R2 |
0.153292815473938 |
|
5785 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00608 |
0.153292815473938 |
|
5786 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRYBA2 |
0.153292815473938 |
|
5787 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FEV |
0.153292815473938 |
|
5788 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC108 |
0.153292815473938 |
|
5789 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR375 |
0.153292815473938 |
|
5790 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IHH |
0.153292815473938 |
|
5791 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3131 |
0.153292815473938 |
|
5792 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NHEJ1 |
0.153292815473938 |
|
5793 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC23A3 |
0.153292815473938 |
|
5794 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL764P |
0.153292815473938 |
|
5795 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNPPD1 |
0.153292815473938 |
|
5796 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM134A |
0.153292815473938 |
|
5797 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFAND2B |
0.153292815473938 |
|
5798 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCB6 |
0.153292815473938 |
|
5799 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATG9A |
0.153292815473938 |
|
5800 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKZF1 |
0.153292815473938 |
|
5801 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLB1L |
0.153292815473938 |
|
5802 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STK16 |
0.153292815473938 |
|
5803 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBA4A |
0.153292815473938 |
|
5804 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBA4B |
0.153292815473938 |
|
5805 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJB2 |
0.153292815473938 |
|
5806 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPRN |
0.153292815473938 |
|
5807 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RESP18 |
0.153292815473938 |
|
5808 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNPEP |
0.153292815473938 |
|
5809 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DES |
0.153292815473938 |
|
5810 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPEG |
0.153292815473938 |
|
5811 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GMPPA |
0.153292815473938 |
|
5812 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASIC4 |
0.153292815473938 |
|
5813 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHPF |
0.153292815473938 |
|
5814 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM198 |
0.153292815473938 |
|
5815 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3132 |
0.153292815473938 |
|
5816 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OBSL1 |
0.153292815473938 |
|
5817 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INHA |
0.153292815473938 |
|
5818 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP213 |
0.153292815473938 |
|
5819 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LTBP4 |
0.15340823476332 |
|
5820 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL758P |
0.15340823476332 |
|
5821 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHKBP1 |
0.15340823476332 |
|
5822 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUMBL |
0.15340823476332 |
|
5823 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADCK4 |
0.15340823476332 |
|
5824 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITPKC |
0.15340823476332 |
|
5825 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf54 |
0.15340823476332 |
|
5826 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNRPA |
0.15340823476332 |
|
5827 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIA |
0.15340823476332 |
|
5828 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB4B |
0.15340823476332 |
|
5829 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EGLN2 |
0.15340823476332 |
|
5830 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP2A6 |
0.15340823476332 |
|
5831 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP2A7 |
0.15340823476332 |
|
5832 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP2G1P |
0.15340823476332 |
|
5833 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP2B7P1 |
0.15340823476332 |
|
5834 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP2B6 |
0.15340823476332 |
|
5835 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP2A13 |
0.15340823476332 |
|
5836 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP2F1 |
0.15340823476332 |
|
5837 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP2S1 |
0.15340823476332 |
|
5838 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL718P |
0.15340823476332 |
|
5839 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AXL |
0.15340823476332 |
|
5840 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPUL1 |
0.15340823476332 |
|
5841 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL34P |
0.15340823476332 |
|
5842 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TGFB1 |
0.15340823476332 |
|
5843 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC97 |
0.15340823476332 |
|
5844 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B9D2 |
0.15340823476332 |
|
5845 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCKDHA |
0.15340823476332 |
|
5846 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM91 |
0.15340823476332 |
|
5847 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXOSC5 |
0.15340823476332 |
|
5848 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B3GNT8 |
0.15340823476332 |
|
5849 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP5SL |
0.15340823476332 |
|
5850 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf69 |
0.15340823476332 |
|
5851 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEACAM21 |
0.15340823476332 |
|
5852 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEACAMP3 |
0.15340823476332 |
|
5853 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000253004.1 |
0.153736121950221 |
|
5854 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP2R3A |
0.153736121950221 |
|
5855 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSL2 |
0.153736121950221 |
|
5856 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAG1 |
0.153736121950221 |
|
5857 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P4 |
0.153736121950221 |
|
5858 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35G2 |
0.153736121950221 |
|
5859 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCK1 |
0.153736121950221 |
|
5860 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL20RB |
0.153736121950221 |
|
5861 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP142 |
0.153736121950221 |
|
5862 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOX14 |
0.153736121950221 |
|
5863 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLDN18 |
0.153736121950221 |
|
5864 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
A4GNT |
0.153736121950221 |
|
5865 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DZIP1L |
0.153736121950221 |
|
5866 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DBR1 |
0.153736121950221 |
|
5867 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARMC8 |
0.153736121950221 |
|
5868 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NME9 |
0.153736121950221 |
|
5869 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRAS |
0.153736121950221 |
|
5870 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ESYT3 |
0.153736121950221 |
|
5871 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP70 |
0.153736121950221 |
|
5872 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAIM |
0.153736121950221 |
|
5873 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIK3CB |
0.153736121950221 |
|
5874 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf72 |
0.153736121950221 |
|
5875 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXL2 |
0.153736121950221 |
|
5876 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS22 |
0.153736121950221 |
|
5877 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR23A |
0.153736121950221 |
|
5878 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR23B |
0.153736121950221 |
|
5879 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR23C |
0.153736121950221 |
|
5880 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BPESC1 |
0.153736121950221 |
|
5881 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COPB2 |
0.153736121950221 |
|
5882 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBP2 |
0.153736121950221 |
|
5883 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBP1 |
0.153736121950221 |
|
5884 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NMNAT3 |
0.153736121950221 |
|
5885 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP124 |
0.153736121950221 |
|
5886 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL724P |
0.153736121950221 |
|
5887 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLSTN2 |
0.153736121950221 |
|
5888 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM42 |
0.153736121950221 |
|
5889 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A36 |
0.153736121950221 |
|
5890 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPSB4 |
0.153736121950221 |
|
5891 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACPL2 |
0.153736121950221 |
|
5892 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB38 |
0.153736121950221 |
|
5893 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASA2 |
0.153736121950221 |
|
5894 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF7 |
0.153736121950221 |
|
5895 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRK7 |
0.153736121950221 |
|
5896 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP1B3 |
0.153736121950221 |
|
5897 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFDP2 |
0.153736121950221 |
|
5898 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GK5 |
0.153736121950221 |
|
5899 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XRN1 |
0.153736121950221 |
|
5900 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATR |
0.153736121950221 |
|
5901 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP143 |
0.153736121950221 |
|
5902 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLS1 |
0.153736121950221 |
|
5903 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP25 |
0.153736121950221 |
|
5904 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPC1 |
0.153736121950221 |
|
5905 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCOLCE2 |
0.153736121950221 |
|
5906 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAQR9 |
0.153736121950221 |
|
5907 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U2SURP |
0.153736121950221 |
|
5908 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHST2 |
0.153736121950221 |
|
5909 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PBX2P1 |
0.153736121950221 |
|
5910 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC9A9 |
0.153736121950221 |
|
5911 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf58 |
0.153736121950221 |
|
5912 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP144 |
0.153736121950221 |
|
5913 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLOD2 |
0.153736121950221 |
|
5914 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLSCR4 |
0.153736121950221 |
|
5915 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLSCR2 |
0.153736121950221 |
|
5916 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLSCR1 |
0.153736121950221 |
|
5917 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLSCR5 |
0.153736121950221 |
|
5918 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000251800.1 |
0.153736121950221 |
|
5919 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZIC4 |
0.153736121950221 |
|
5920 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZIC1 |
0.153736121950221 |
|
5921 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGTR1 |
0.153736121950221 |
|
5922 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPB1 |
0.153736121950221 |
|
5923 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPA3 |
0.153736121950221 |
|
5924 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GYG1 |
0.153736121950221 |
|
5925 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HLTF |
0.153736121950221 |
|
5926 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HPS3 |
0.153736121950221 |
|
5927 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CP |
0.153736121950221 |
|
5928 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPHL1P |
0.153736121950221 |
|
5929 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TM4SF18 |
0.153736121950221 |
|
5930 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TM4SF1 |
0.153736121950221 |
|
5931 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TM4SF4 |
0.153736121950221 |
|
5932 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WWTR1 |
0.153736121950221 |
|
5933 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COMMD2 |
0.153736121950221 |
|
5934 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKUB1 |
0.153736121950221 |
|
5935 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF13 |
0.153736121950221 |
|
5936 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PFN2 |
0.153736121950221 |
|
5937 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000243321.2 |
0.153736121950221 |
|
5938 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSC22D2 |
0.153736121950221 |
|
5939 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERP1 |
0.153736121950221 |
|
5940 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF2A |
0.153736121950221 |
|
5941 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SELT |
0.153736121950221 |
|
5942 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM194A |
0.153736121950221 |
|
5943 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIAH2 |
0.153736121950221 |
|
5944 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM188B2 |
0.153736121950221 |
|
5945 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLRN1 |
0.153736121950221 |
|
5946 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED12L |
0.153736121950221 |
|
5947 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP145 |
0.153736121950221 |
|
5948 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR171 |
0.153736121950221 |
|
5949 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
P2RY14 |
0.153736121950221 |
|
5950 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR87 |
0.153736121950221 |
|
5951 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
P2RY13 |
0.153736121950221 |
|
5952 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
P2RY12 |
0.153736121950221 |
|
5953 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGSF10 |
0.153736121950221 |
|
5954 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5186 |
0.153736121950221 |
|
5955 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AADACL2 |
0.153736121950221 |
|
5956 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AADAC |
0.153736121950221 |
|
5957 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUCNR1 |
0.153736121950221 |
|
5958 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBNL1 |
0.153736121950221 |
|
5959 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM14E |
0.153736121950221 |
|
5960 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
P2RY1 |
0.153736121950221 |
|
5961 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAP2B |
0.153736121950221 |
|
5962 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL300P |
0.153736121950221 |
|
5963 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf79 |
0.153736121950221 |
|
5964 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000201398.1 |
0.153736121950221 |
|
5965 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF26 |
0.153736121950221 |
|
5966 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHX36 |
0.153736121950221 |
|
5967 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000271922.1 |
0.153736121950221 |
|
5968 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR149 |
0.153736121950221 |
|
5969 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MME |
0.153736121950221 |
|
5970 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLCH1 |
0.153736121950221 |
|
5971 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf33 |
0.153736121950221 |
|
5972 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC33A1 |
0.153736121950221 |
|
5973 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GMPS |
0.153736121950221 |
|
5974 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNAB1 |
0.153736121950221 |
|
5975 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSR3 |
0.153736121950221 |
|
5976 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIPARP |
0.153736121950221 |
|
5977 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00886 |
0.153736121950221 |
|
5978 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LEKR1 |
0.153736121950221 |
|
5979 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP177 |
0.153736121950221 |
|
5980 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00880 |
0.153736121950221 |
|
5981 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00881 |
0.153736121950221 |
|
5982 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNL1 |
0.153736121950221 |
|
5983 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP146 |
0.153736121950221 |
|
5984 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VEPH1 |
0.153736121950221 |
|
5985 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTX3 |
0.153736121950221 |
|
5986 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf55 |
0.153736121950221 |
|
5987 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP46 |
0.153736121950221 |
|
5988 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHOX2 |
0.153736121950221 |
|
5989 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RSRC1 |
0.153736121950221 |
|
5990 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLF1 |
0.153736121950221 |
|
5991 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GFM1 |
0.153736121950221 |
|
5992 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LXN |
0.153736121950221 |
|
5993 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RARRES1 |
0.153736121950221 |
|
5994 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFSD1 |
0.153736121950221 |
|
5995 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IQCJ |
0.153736121950221 |
|
5996 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3919 |
0.153736121950221 |
|
5997 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCHIP1 |
0.153736121950221 |
|
5998 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL12A |
0.153736121950221 |
|
5999 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf80 |
0.153736121950221 |
|
6000 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFT80 |
0.153736121950221 |
|
6001 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMC4 |
0.153736121950221 |
|
6002 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR15B |
0.153736121950221 |
|
6003 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM59 |
0.153736121950221 |
|
6004 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KPNA4 |
0.153736121950221 |
|
6005 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA7 |
0.153736121950221 |
|
6006 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT8P12 |
0.153736121950221 |
|
6007 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL14 |
0.153736121950221 |
|
6008 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA72|ENSG00000207084.1 |
0.153736121950221 |
|
6009 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPM1L |
0.153736121950221 |
|
6010 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B3GALNT1 |
0.153736121950221 |
|
6011 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NMD3 |
0.153736121950221 |
|
6012 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPTSSB |
0.153736121950221 |
|
6013 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OTOL1 |
0.153736121950221 |
|
6014 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CT64 |
0.153736121950221 |
|
6015 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238398.1 |
0.153736121950221 |
|
6016 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1263 |
0.153736121950221 |
|
6017 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR720 |
0.153736121950221 |
|
6018 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SI |
0.153736121950221 |
|
6019 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLITRK3 |
0.153736121950221 |
|
6020 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCHE |
0.153736121950221 |
|
6021 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP298 |
0.153736121950221 |
|
6022 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBBX |
0.153736121950221 |
|
6023 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINI2 |
0.153736121950221 |
|
6024 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR49 |
0.153736121950221 |
|
6025 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDCD10 |
0.153736121950221 |
|
6026 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINI1 |
0.153736121950221 |
|
6027 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLIM4 |
0.153736121950221 |
|
6028 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EGFEM1P |
0.153736121950221 |
|
6029 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR551B |
0.153736121950221 |
|
6030 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MECOM |
0.153736121950221 |
|
6031 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTRT3 |
0.153736121950221 |
|
6032 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TERC |
0.153736121950221 |
|
6033 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYNN |
0.153736121950221 |
|
6034 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC34 |
0.153736121950221 |
|
6035 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRIQ4 |
0.153736121950221 |
|
6036 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC31 |
0.153736121950221 |
|
6037 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAMD7 |
0.153736121950221 |
|
6038 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC62 |
0.153736121950221 |
|
6039 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR160 |
0.153736121950221 |
|
6040 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHC3 |
0.153736121950221 |
|
6041 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKCI |
0.153736121950221 |
|
6042 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SKIL |
0.153736121950221 |
|
6043 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLDN11 |
0.153736121950221 |
|
6044 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC7A14 |
0.153736121950221 |
|
6045 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY5P3 |
0.153736121950221 |
|
6046 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL22L1 |
0.153736121950221 |
|
6047 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF5A2 |
0.153736121950221 |
|
6048 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC2A2 |
0.153736121950221 |
|
6049 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNIK |
0.153736121950221 |
|
6050 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR569 |
0.153736121950221 |
|
6051 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLD1 |
0.153736121950221 |
|
6052 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PP13439 |
0.153736121950221 |
|
6053 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM212 |
0.153736121950221 |
|
6054 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238359.1 |
0.153736121950221 |
|
6055 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FNDC3B |
0.153736121950221 |
|
6056 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL141P |
0.153736121950221 |
|
6057 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GHSR |
0.153736121950221 |
|
6058 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFSF10 |
0.153736121950221 |
|
6059 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCEH1 |
0.153736121950221 |
|
6060 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ECT2 |
0.153736121950221 |
|
6061 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA72|ENSG00000200355.1 |
0.153736121950221 |
|
6062 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA16 |
0.153736121950221 |
|
6063 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239141.1 |
0.153736121950221 |
|
6064 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NLGN1 |
0.153736121950221 |
|
6065 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP234 |
0.153736121950221 |
|
6066 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAALADL2 |
0.153736121950221 |
|
6067 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4789 |
0.153736121950221 |
|
6068 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000271842.1 |
0.153736121950221 |
|
6069 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP147 |
0.153736121950221 |
|
6070 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBL1XR1 |
0.153736121950221 |
|
6071 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00501 |
0.153736121950221 |
|
6072 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00578 |
0.153736121950221 |
|
6073 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP52 |
0.153736121950221 |
|
6074 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA18|ENSG00000200288.1 |
0.153736121950221 |
|
6075 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNMB2 |
0.153736121950221 |
|
6076 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP148 |
0.153736121950221 |
|
6077 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZMAT3 |
0.153736121950221 |
|
6078 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIK3CA |
0.153736121950221 |
|
6079 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA25|ENSG00000201957.1 |
0.153736121950221 |
|
6080 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNMB3 |
0.153736121950221 |
|
6081 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF639 |
0.153736121950221 |
|
6082 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFN1 |
0.153736121950221 |
|
6083 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNB4 |
0.153736121950221 |
|
6084 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTL6A |
0.153736121950221 |
|
6085 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL47 |
0.153736121950221 |
|
6086 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFB5 |
0.153736121950221 |
|
6087 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239096.1 |
0.153736121950221 |
|
6088 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP13 |
0.153736121950221 |
|
6089 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEX5L |
0.153736121950221 |
|
6090 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP149 |
0.153736121950221 |
|
6091 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000201810.1 |
0.153736121950221 |
|
6092 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC14 |
0.153736121950221 |
|
6093 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC39 |
0.153736121950221 |
|
6094 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL229P |
0.153736121950221 |
|
6095 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FXR1 |
0.153736121950221 |
|
6096 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC19 |
0.153736121950221 |
|
6097 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOX2 |
0.153736121950221 |
|
6098 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL703P |
0.153736121950221 |
|
6099 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP150 |
0.153736121950221 |
|
6100 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP265 |
0.153736121950221 |
|
6101 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP11B |
0.153736121950221 |
|
6102 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCUN1D1 |
0.153736121950221 |
|
6103 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCCC1 |
0.153736121950221 |
|
6104 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAMP3 |
0.153736121950221 |
|
6105 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCF2L2 |
0.153736121950221 |
|
6106 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B3GNT5 |
0.153736121950221 |
|
6107 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP151 |
0.153736121950221 |
|
6108 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCC5 |
0.153736121950221 |
|
6109 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP2M1 |
0.153736121950221 |
|
6110 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP2AB1P |
0.153736121950221 |
|
6111 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DVL3 |
0.153736121950221 |
|
6112 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF2B5 |
0.153736121950221 |
|
6113 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTR3C |
0.153736121950221 |
|
6114 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTR3D |
0.153736121950221 |
|
6115 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTR3E |
0.153736121950221 |
|
6116 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL24 |
0.153736121950221 |
|
6117 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL6 |
0.153736121950221 |
|
6118 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00888 |
0.153736121950221 |
|
6119 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP6D1 |
0.153736121950221 |
|
6120 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4448 |
0.153736121950221 |
|
6121 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARL |
0.153736121950221 |
|
6122 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA4|ENSG00000251730.1 |
0.153736121950221 |
|
6123 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA63|ENSG00000199363.1 |
0.153736121950221 |
|
6124 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA63|ENSG00000201229.1 |
0.153736121950221 |
|
6125 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA81|ENSG00000253092.1 |
0.153736121950221 |
|
6126 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YEATS2 |
0.153736121950221 |
|
6127 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCF3 |
0.153736121950221 |
|
6128 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VWA5B2 |
0.153736121950221 |
|
6129 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALG3 |
0.153736121950221 |
|
6130 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ECE2 |
0.153736121950221 |
|
6131 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1224 |
0.153736121950221 |
|
6132 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAMK2N2 |
0.153736121950221 |
|
6133 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMD2 |
0.153736121950221 |
|
6134 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF4G1 |
0.153736121950221 |
|
6135 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD66|ENSG00000212158.1 |
0.153736121950221 |
|
6136 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM131A |
0.153736121950221 |
|
6137 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLCN2 |
0.153736121950221 |
|
6138 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR2H |
0.153736121950221 |
|
6139 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THPO |
0.153736121950221 |
|
6140 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRD |
0.153736121950221 |
|
6141 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPHB3 |
0.153736121950221 |
|
6142 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEF1 |
0.153736121950221 |
|
6143 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS8 |
0.153736121950221 |
|
6144 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf70 |
0.153736121950221 |
|
6145 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EHHADH |
0.153736121950221 |
|
6146 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP3K13 |
0.153736121950221 |
|
6147 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239146.1 |
0.153736121950221 |
|
6148 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM41A |
0.153736121950221 |
|
6149 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIPH |
0.153736121950221 |
|
6150 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SENP2 |
0.153736121950221 |
|
6151 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGF2BP2 |
0.153736121950221 |
|
6152 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf65 |
0.153736121950221 |
|
6153 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548AQ |
0.153736121950221 |
|
6154 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRA2B |
0.153736121950221 |
|
6155 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL637P |
0.153736121950221 |
|
6156 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ETV5 |
0.153736121950221 |
|
6157 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DGKG |
0.153736121950221 |
|
6158 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRYGS |
0.153736121950221 |
|
6159 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBCCD1 |
0.153736121950221 |
|
6160 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJB11 |
0.153736121950221 |
|
6161 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AHSG |
0.153736121950221 |
|
6162 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FETUB |
0.153736121950221 |
|
6163 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HRG |
0.153736121950221 |
|
6164 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KNG1 |
0.153736121950221 |
|
6165 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF4A2 |
0.153736121950221 |
|
6166 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD2|ENSG00000238942.1 |
0.153736121950221 |
|
6167 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFC4 |
0.153736121950221 |
|
6168 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA4|ENSG00000263776.1 |
0.153736121950221 |
|
6169 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA63|ENSG00000200320.1 |
0.153736121950221 |
|
6170 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA63|ENSG00000200418.1 |
0.153736121950221 |
|
6171 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA81|ENSG00000221420.2 |
0.153736121950221 |
|
6172 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADIPOQ |
0.153736121950221 |
|
6173 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST6GAL1 |
0.153736121950221 |
|
6174 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL39L |
0.153736121950221 |
|
6175 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RTP1 |
0.153736121950221 |
|
6176 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MASP1 |
0.153736121950221 |
|
6177 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RTP4 |
0.153736121950221 |
|
6178 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239093.1 |
0.153736121950221 |
|
6179 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SST |
0.153736121950221 |
|
6180 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RTP2 |
0.153736121950221 |
|
6181 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCL6 |
0.153736121950221 |
|
6182 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPP |
0.153736121950221 |
|
6183 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR28 |
0.153736121950221 |
|
6184 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPRG1 |
0.153736121950221 |
|
6185 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TP63 |
0.153736121950221 |
|
6186 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR944 |
0.153736121950221 |
|
6187 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LEPREL1 |
0.153736121950221 |
|
6188 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL486P |
0.153736121950221 |
|
6189 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLDN1 |
0.153736121950221 |
|
6190 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLDN16 |
0.153736121950221 |
|
6191 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM207 |
0.153736121950221 |
|
6192 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL1RAP |
0.153736121950221 |
|
6193 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP296 |
0.153736121950221 |
|
6194 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GMNC |
0.153736121950221 |
|
6195 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSTN |
0.153736121950221 |
|
6196 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UTS2B |
0.153736121950221 |
|
6197 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC50 |
0.153736121950221 |
|
6198 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PYDC2 |
0.153736121950221 |
|
6199 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP222 |
0.153736121950221 |
|
6200 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGF12 |
0.153736121950221 |
|
6201 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238902.1 |
0.153736121950221 |
|
6202 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MB21D2 |
0.153736121950221 |
|
6203 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HRASLS |
0.153736121950221 |
|
6204 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP13A5 |
0.153736121950221 |
|
6205 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP13A4 |
0.153736121950221 |
|
6206 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OPA1 |
0.153736121950221 |
|
6207 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL447P |
0.153736121950221 |
|
6208 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HES1 |
0.153736121950221 |
|
6209 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL215P |
0.153736121950221 |
|
6210 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00887 |
0.153736121950221 |
|
6211 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPN2 |
0.153736121950221 |
|
6212 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC15 |
0.153736121950221 |
|
6213 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GP5 |
0.153736121950221 |
|
6214 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP13A3 |
0.153736121950221 |
|
6215 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM44 |
0.153736121950221 |
|
6216 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LSG1 |
0.153736121950221 |
|
6217 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM43A |
0.153736121950221 |
|
6218 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XXYLT1 |
0.153736121950221 |
|
6219 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3137 |
0.153736121950221 |
|
6220 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL36P |
0.153736121950221 |
|
6221 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACAP2 |
0.153736121950221 |
|
6222 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOD |
0.153736121950221 |
|
6223 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00969 |
0.153736121950221 |
|
6224 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR570 |
0.153736121950221 |
|
6225 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUC20 |
0.153736121950221 |
|
6226 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUC4 |
0.153736121950221 |
|
6227 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R2 |
0.153736121950221 |
|
6228 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL773P |
0.153736121950221 |
|
6229 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC24P |
0.153736121950221 |
|
6230 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDHAP1 |
0.153736121950221 |
|
6231 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNK2 |
0.153736121950221 |
|
6232 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFRC |
0.153736121950221 |
|
6233 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00885 |
0.153736121950221 |
|
6234 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDHHC19 |
0.153736121950221 |
|
6235 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC51A |
0.153736121950221 |
|
6236 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCYT1A |
0.153736121950221 |
|
6237 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCTEX1D2 |
0.153736121950221 |
|
6238 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TM4SF19 |
0.153736121950221 |
|
6239 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBXN7 |
0.153736121950221 |
|
6240 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL434P |
0.153736121950221 |
|
6241 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL738P |
0.153736121950221 |
|
6242 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF168 |
0.153736121950221 |
|
6243 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMCO1 |
0.153736121950221 |
|
6244 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR53 |
0.153736121950221 |
|
6245 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO45 |
0.153736121950221 |
|
6246 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRROS |
0.153736121950221 |
|
6247 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIGX |
0.153736121950221 |
|
6248 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP19 |
0.153736121950221 |
|
6249 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLG1 |
0.153736121950221 |
|
6250 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFI2 |
0.153736121950221 |
|
6251 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCBP2 |
0.153736121950221 |
|
6252 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAK2 |
0.153736121950221 |
|
6253 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIGZ |
0.153736121950221 |
|
6254 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SENP5 |
0.153736121950221 |
|
6255 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U4|ENSG00000272359.1 |
0.153736121950221 |
|
6256 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4797 |
0.153736121950221 |
|
6257 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238491.1 |
0.153736121950221 |
|
6258 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BDH1 |
0.153736121950221 |
|
6259 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10AG1 |
0.153804704168257 |
|
6260 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4A15 |
0.153804704168257 |
|
6261 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4A16 |
0.153804704168257 |
|
6262 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4A5 |
0.153804704168257 |
|
6263 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4C11 |
0.153804704168257 |
|
6264 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4C15 |
0.153804704168257 |
|
6265 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4C16 |
0.153804704168257 |
|
6266 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4C46 |
0.153804704168257 |
|
6267 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4C6 |
0.153804704168257 |
|
6268 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4P4 |
0.153804704168257 |
|
6269 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4S2 |
0.153804704168257 |
|
6270 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5AS1 |
0.153804704168257 |
|
6271 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5D13 |
0.153804704168257 |
|
6272 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5D14 |
0.153804704168257 |
|
6273 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5D16 |
0.153804704168257 |
|
6274 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5D18 |
0.153804704168257 |
|
6275 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5F1 |
0.153804704168257 |
|
6276 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5I1 |
0.153804704168257 |
|
6277 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5J2 |
0.153804704168257 |
|
6278 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5L1 |
0.153804704168257 |
|
6279 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5L2 |
0.153804704168257 |
|
6280 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5T2 |
0.153804704168257 |
|
6281 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5W2 |
0.153804704168257 |
|
6282 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR8H2 |
0.153804704168257 |
|
6283 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR8H3 |
0.153804704168257 |
|
6284 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR8I2 |
0.153804704168257 |
|
6285 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR8J3 |
0.153804704168257 |
|
6286 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR8K5 |
0.153804704168257 |
|
6287 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM48 |
0.153804704168257 |
|
6288 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM51HP |
0.153804704168257 |
|
6289 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM51 |
0.153804704168257 |
|
6290 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5T3 |
0.153804704168257 |
|
6291 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5T1 |
0.153804704168257 |
|
6292 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR8H1 |
0.153804704168257 |
|
6293 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PMS2CL |
0.154037231648207 |
|
6294 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RSPH10B2 |
0.154037231648207 |
|
6295 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCZ1B |
0.154037231648207 |
|
6296 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3683 |
0.154037231648207 |
|
6297 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1GALT1 |
0.154037231648207 |
|
6298 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL28A1 |
0.154037231648207 |
|
6299 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIOS |
0.154037231648207 |
|
6300 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPA3 |
0.154037231648207 |
|
6301 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLCCI1 |
0.154037231648207 |
|
6302 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPKP3 |
0.156212960953217 |
|
6303 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
API5 |
0.156212960953217 |
|
6304 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC17 |
0.156212960953217 |
|
6305 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP287 |
0.156212960953217 |
|
6306 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSD17B12 |
0.156212960953217 |
|
6307 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR670 |
0.156212960953217 |
|
6308 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALKBH3 |
0.156212960953217 |
|
6309 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACCSL |
0.156212960953217 |
|
6310 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACCS |
0.156212960953217 |
|
6311 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXT2 |
0.156212960953217 |
|
6312 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALX4 |
0.156212960953217 |
|
6313 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD82 |
0.156212960953217 |
|
6314 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPAN18 |
0.156212960953217 |
|
6315 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TP53I11 |
0.156212960953217 |
|
6316 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3161 |
0.156212960953217 |
|
6317 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4B1 |
0.156212960953217 |
|
6318 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4X2 |
0.156212960953217 |
|
6319 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4X1 |
0.156212960953217 |
|
6320 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4S1 |
0.156212960953217 |
|
6321 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4C3 |
0.156212960953217 |
|
6322 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSMD1 |
0.156418894904726 |
|
6323 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP251 |
0.156418894904726 |
|
6324 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IKZF2 |
0.157115028249465 |
|
6325 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX11 |
0.157491475794636 |
|
6326 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM60A |
0.157491475794636 |
|
6327 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238661.1 |
0.157491475794636 |
|
6328 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DENND5B |
0.157491475794636 |
|
6329 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239033.1 |
0.157491475794636 |
|
6330 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL20 |
0.157491475794636 |
|
6331 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMN1 |
0.157491475794636 |
|
6332 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STMN1P1 |
0.157491475794636 |
|
6333 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
H3F3C |
0.157491475794636 |
|
6334 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA25|ENSG00000252204.1 |
0.157491475794636 |
|
6335 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1551 |
0.157491475794636 |
|
6336 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BICD1 |
0.157491475794636 |
|
6337 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RDH13 |
0.159136939538603 |
|
6338 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPS8L1 |
0.159136939538603 |
|
6339 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R12C |
0.159136939538603 |
|
6340 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNNT1 |
0.159136939538603 |
|
6341 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAAF3 |
0.159136939538603 |
|
6342 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNNI3 |
0.159136939538603 |
|
6343 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239137.1 |
0.159136939538603 |
|
6344 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYT5 |
0.159136939538603 |
|
6345 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPRH |
0.159136939538603 |
|
6346 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM86B |
0.159136939538603 |
|
6347 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP6R1 |
0.159136939538603 |
|
6348 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPBP1 |
0.159136939538603 |
|
6349 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRSK1 |
0.159136939538603 |
|
6350 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM150B |
0.159136939538603 |
|
6351 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX6B2 |
0.159136939538603 |
|
6352 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUV420H2 |
0.159136939538603 |
|
6353 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM71E2 |
0.159136939538603 |
|
6354 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL11 |
0.159136939538603 |
|
6355 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM190 |
0.159136939538603 |
|
6356 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM238 |
0.159136939538603 |
|
6357 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL28 |
0.159136939538603 |
|
6358 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2S |
0.159136939538603 |
|
6359 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHISA7 |
0.159136939538603 |
|
6360 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ISOC2 |
0.159136939538603 |
|
6361 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF628 |
0.159136939538603 |
|
6362 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAT14 |
0.159136939538603 |
|
6363 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSC5D |
0.159136939538603 |
|
6364 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SBK2 |
0.159136939538603 |
|
6365 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGK110 |
0.159136939538603 |
|
6366 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF579 |
0.159136939538603 |
|
6367 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FIZ1 |
0.159136939538603 |
|
6368 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF524 |
0.159136939538603 |
|
6369 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF865 |
0.159136939538603 |
|
6370 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF784 |
0.159136939538603 |
|
6371 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF580 |
0.159136939538603 |
|
6372 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF581 |
0.159136939538603 |
|
6373 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC106 |
0.159136939538603 |
|
6374 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U2AF2 |
0.159136939538603 |
|
6375 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPN1 |
0.159136939538603 |
|
6376 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NLRP9 |
0.159136939538603 |
|
6377 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP109 |
0.159136939538603 |
|
6378 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFPL4AL1 |
0.159136939538603 |
|
6379 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFPL4A |
0.159136939538603 |
|
6380 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NLRP11 |
0.159136939538603 |
|
6381 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NLRP4 |
0.159136939538603 |
|
6382 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NLRP13 |
0.159136939538603 |
|
6383 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NLRP5 |
0.159136939538603 |
|
6384 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NLRP8 |
0.159136939538603 |
|
6385 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF787 |
0.159136939538603 |
|
6386 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF444 |
0.159136939538603 |
|
6387 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALP |
0.159136939538603 |
|
6388 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSCAN5B |
0.159136939538603 |
|
6389 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSCAN5A |
0.159136939538603 |
|
6390 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSCAN5C |
0.159136939538603 |
|
6391 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSCAN5D |
0.159136939538603 |
|
6392 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF542 |
0.159136939538603 |
|
6393 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF582 |
0.159136939538603 |
|
6394 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF583 |
0.159136939538603 |
|
6395 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF667 |
0.159136939538603 |
|
6396 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF471 |
0.159136939538603 |
|
6397 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFP28 |
0.159136939538603 |
|
6398 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF470 |
0.159136939538603 |
|
6399 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF71 |
0.159136939538603 |
|
6400 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMIM17 |
0.159136939538603 |
|
6401 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF835 |
0.159136939538603 |
|
6402 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZIM2 |
0.159136939538603 |
|
6403 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEG3 |
0.159136939538603 |
|
6404 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIMT1 |
0.159136939538603 |
|
6405 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP29 |
0.159136939538603 |
|
6406 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUXA |
0.159136939538603 |
|
6407 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000252683.1 |
0.159136939538603 |
|
6408 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZIM3 |
0.159136939538603 |
|
6409 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF264 |
0.159136939538603 |
|
6410 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AURKC |
0.159136939538603 |
|
6411 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF805 |
0.159136939538603 |
|
6412 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF460 |
0.159136939538603 |
|
6413 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF543 |
0.159136939538603 |
|
6414 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF304 |
0.159136939538603 |
|
6415 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAPPC2P1 |
0.159136939538603 |
|
6416 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF547 |
0.159136939538603 |
|
6417 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF548 |
0.159136939538603 |
|
6418 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF17 |
0.159136939538603 |
|
6419 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF749 |
0.159136939538603 |
|
6420 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VN1R1 |
0.159136939538603 |
|
6421 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF419 |
0.159136939538603 |
|
6422 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF772 |
0.159136939538603 |
|
6423 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF773 |
0.159136939538603 |
|
6424 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF549 |
0.159136939538603 |
|
6425 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF550 |
0.159136939538603 |
|
6426 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF416 |
0.159136939538603 |
|
6427 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZIK1 |
0.159136939538603 |
|
6428 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF530 |
0.159136939538603 |
|
6429 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF134 |
0.159136939538603 |
|
6430 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF211 |
0.159136939538603 |
|
6431 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSCAN4 |
0.159136939538603 |
|
6432 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF551 |
0.159136939538603 |
|
6433 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF154 |
0.159136939538603 |
|
6434 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF671 |
0.159136939538603 |
|
6435 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF776 |
0.159136939538603 |
|
6436 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF586 |
0.159136939538603 |
|
6437 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF552 |
0.159136939538603 |
|
6438 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF587B |
0.159136939538603 |
|
6439 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF814 |
0.159136939538603 |
|
6440 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF587 |
0.159136939538603 |
|
6441 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF417 |
0.159136939538603 |
|
6442 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF418 |
0.159136939538603 |
|
6443 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF256 |
0.159136939538603 |
|
6444 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf18 |
0.159136939538603 |
|
6445 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF606 |
0.159136939538603 |
|
6446 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSCAN1 |
0.159136939538603 |
|
6447 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF135 |
0.159136939538603 |
|
6448 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL526P |
0.159136939538603 |
|
6449 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSCAN18 |
0.159136939538603 |
|
6450 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF329 |
0.159136939538603 |
|
6451 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF274 |
0.159136939538603 |
|
6452 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF544 |
0.159136939538603 |
|
6453 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF8 |
0.159136939538603 |
|
6454 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSCAN22 |
0.159136939538603 |
|
6455 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
A1BG |
0.159136939538603 |
|
6456 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF497 |
0.159136939538603 |
|
6457 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP473 |
0.159136939538603 |
|
6458 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHMP2A |
0.159136939538603 |
|
6459 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4754 |
0.159136939538603 |
|
6460 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MZF1 |
0.159136939538603 |
|
6461 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL525P |
0.159136939538603 |
|
6462 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL693P |
0.159136939538603 |
|
6463 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL23AP79 |
0.159136939538603 |
|
6464 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS5 |
0.159136939538603 |
|
6465 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC27A5 |
0.159136939538603 |
|
6466 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM28 |
0.159136939538603 |
|
6467 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2M |
0.159136939538603 |
|
6468 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB45 |
0.159136939538603 |
|
6469 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF132 |
0.159136939538603 |
|
6470 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF324B |
0.159136939538603 |
|
6471 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF324 |
0.159136939538603 |
|
6472 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF446 |
0.159136939538603 |
|
6473 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF584 |
0.159136939538603 |
|
6474 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF837 |
0.159136939538603 |
|
6475 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP102 |
0.161243337144483 |
|
6476 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNTNAP5 |
0.161243337144483 |
|
6477 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP102 |
0.161243337144483 |
|
6478 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GYPC |
0.161243337144483 |
|
6479 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BIN1 |
0.161243337144483 |
|
6480 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP3K2 |
0.161243337144483 |
|
6481 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4783 |
0.161243337144483 |
|
6482 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PROC |
0.161243337144483 |
|
6483 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IWS1 |
0.161243337144483 |
|
6484 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYO7B |
0.161243337144483 |
|
6485 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIMS2 |
0.161243337144483 |
|
6486 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR17 |
0.161243337144483 |
|
6487 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFT2D3 |
0.161243337144483 |
|
6488 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR33 |
0.161243337144483 |
|
6489 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P7 |
0.161243337144483 |
|
6490 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR2D |
0.161243337144483 |
|
6491 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMMECR1L |
0.161243337144483 |
|
6492 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAP130 |
0.161243337144483 |
|
6493 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGGT1 |
0.161243337144483 |
|
6494 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL206P |
0.161243337144483 |
|
6495 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HS6ST1 |
0.161243337144483 |
|
6496 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP103 |
0.161243337144483 |
|
6497 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238546.1 |
0.161243337144483 |
|
6498 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB6C |
0.161243337144483 |
|
6499 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC115 |
0.161243337144483 |
|
6500 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC74B |
0.161243337144483 |
|
6501 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP4F43P |
0.161243337144483 |
|
6502 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IMP4 |
0.161243337144483 |
|
6503 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MZT2B |
0.161243337144483 |
|
6504 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POTEF |
0.161243337144483 |
|
6505 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPN18 |
0.161243337144483 |
|
6506 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMPD4 |
0.161243337144483 |
|
6507 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBA3E |
0.161243337144483 |
|
6508 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CFC1B |
0.161243337144483 |
|
6509 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CFC1 |
0.161243337144483 |
|
6510 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP4F30P |
0.161243337144483 |
|
6511 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POTEI |
0.161243337144483 |
|
6512 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POTEJ |
0.161243337144483 |
|
6513 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR148 |
0.161243337144483 |
|
6514 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMER3 |
0.161243337144483 |
|
6515 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF4 |
0.161243337144483 |
|
6516 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA4|ENSG00000252829.2 |
0.161243337144483 |
|
6517 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM168B |
0.161243337144483 |
|
6518 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHB2 |
0.161243337144483 |
|
6519 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP4F31P |
0.161243337144483 |
|
6520 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4784 |
0.161243337144483 |
|
6521 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MZT2A |
0.161243337144483 |
|
6522 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POTEE |
0.161243337144483 |
|
6523 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBA3D |
0.161243337144483 |
|
6524 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC74A |
0.161243337144483 |
|
6525 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf27A |
0.161243337144483 |
|
6526 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf27B |
0.161243337144483 |
|
6527 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL701P |
0.161243337144483 |
|
6528 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JAZF1 |
0.161498360827609 |
|
6529 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4522 |
0.163445185809154 |
|
6530 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WSB1 |
0.163445185809154 |
|
6531 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D3P5 |
0.163445185809154 |
|
6532 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KSR1 |
0.163445185809154 |
|
6533 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGALS9 |
0.163445185809154 |
|
6534 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL576P |
0.163445185809154 |
|
6535 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOS2 |
0.163445185809154 |
|
6536 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYRM9 |
0.163445185809154 |
|
6537 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA20|ENSG00000251818.1 |
0.163445185809154 |
|
6538 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000202389.1 |
0.163445185809154 |
|
6539 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NLK |
0.163445185809154 |
|
6540 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
Vault|ENSG00000252283.1 |
0.163445185809154 |
|
6541 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PYY2 |
0.163445185809154 |
|
6542 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPY2 |
0.163445185809154 |
|
6543 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT18P55 |
0.163445185809154 |
|
6544 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM97 |
0.163445185809154 |
|
6545 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFT20 |
0.163445185809154 |
|
6546 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFAIP1 |
0.163445185809154 |
|
6547 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLDIP2 |
0.163445185809154 |
|
6548 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM199 |
0.163445185809154 |
|
6549 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4723 |
0.163445185809154 |
|
6550 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SARM1 |
0.163445185809154 |
|
6551 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEBOX |
0.163445185809154 |
|
6552 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VTN |
0.163445185809154 |
|
6553 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC46A1 |
0.163445185809154 |
|
6554 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC13A2 |
0.163445185809154 |
|
6555 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXN1 |
0.163445185809154 |
|
6556 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UNC119 |
0.163445185809154 |
|
6557 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIGS |
0.163445185809154 |
|
6558 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALDOC |
0.163445185809154 |
|
6559 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPAG5 |
0.163445185809154 |
|
6560 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0100 |
0.163445185809154 |
|
6561 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGK494 |
0.163445185809154 |
|
6562 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDF2 |
0.163445185809154 |
|
6563 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUPT6H |
0.163445185809154 |
|
6564 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PROCA1 |
0.163445185809154 |
|
6565 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB34 |
0.163445185809154 |
|
6566 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL23A |
0.163445185809154 |
|
6567 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD42B |
0.163445185809154 |
|
6568 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD42A |
0.163445185809154 |
|
6569 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD4A |
0.163445185809154 |
|
6570 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD4B |
0.163445185809154 |
|
6571 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLCD1 |
0.163445185809154 |
|
6572 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEK8 |
0.163445185809154 |
|
6573 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAF4 |
0.163445185809154 |
|
6574 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM222B |
0.163445185809154 |
|
6575 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERAL1 |
0.163445185809154 |
|
6576 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4732 |
0.163445185809154 |
|
6577 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLOT2 |
0.163445185809154 |
|
6578 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHRS13 |
0.163445185809154 |
|
6579 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHF12 |
0.163445185809154 |
|
6580 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIPOX |
0.163445185809154 |
|
6581 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEZ6 |
0.163445185809154 |
|
6582 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYO18A |
0.163445185809154 |
|
6583 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIAF1 |
0.163445185809154 |
|
6584 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRYBA1 |
0.163445185809154 |
|
6585 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUFIP2 |
0.163445185809154 |
|
6586 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4523 |
0.163445185809154 |
|
6587 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAOK1 |
0.163445185809154 |
|
6588 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABHD15 |
0.163445185809154 |
|
6589 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GIT1 |
0.163445185809154 |
|
6590 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TP53I13 |
0.163445185809154 |
|
6591 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD13B |
0.163445185809154 |
|
6592 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CORO6 |
0.163445185809154 |
|
6593 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSH2 |
0.163445185809154 |
|
6594 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000252657.1 |
0.163445185809154 |
|
6595 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239129.1 |
0.163445185809154 |
|
6596 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFCAB5 |
0.163445185809154 |
|
6597 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P13 |
0.163445185809154 |
|
6598 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3184 |
0.163445185809154 |
|
6599 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR423 |
0.163445185809154 |
|
6600 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NSRP1 |
0.163445185809154 |
|
6601 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC6A4 |
0.163445185809154 |
|
6602 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BLMH |
0.163445185809154 |
|
6603 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD63|ENSG00000252112.1 |
0.163445185809154 |
|
6604 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMIGD1 |
0.163445185809154 |
|
6605 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPD |
0.163445185809154 |
|
6606 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOSR1 |
0.163445185809154 |
|
6607 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D29 |
0.163445185809154 |
|
6608 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMURF2P1 |
0.163445185809154 |
|
6609 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATAD5 |
0.163445185809154 |
|
6610 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRLF3 |
0.163445185809154 |
|
6611 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC37BP1 |
0.163445185809154 |
|
6612 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL316P |
0.163445185809154 |
|
6613 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUZ12P |
0.163445185809154 |
|
6614 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEFM |
0.163445185809154 |
|
6615 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAP2 |
0.163445185809154 |
|
6616 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL138P |
0.163445185809154 |
|
6617 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF135 |
0.163445185809154 |
|
6618 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4733 |
0.163445185809154 |
|
6619 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OMG |
0.163445185809154 |
|
6620 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EVI2B |
0.163445185809154 |
|
6621 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EVI2A |
0.163445185809154 |
|
6622 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB11FIP4 |
0.163445185809154 |
|
6623 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL79P |
0.163445185809154 |
|
6624 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL45P |
0.163445185809154 |
|
6625 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4724 |
0.163445185809154 |
|
6626 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COPRS |
0.163445185809154 |
|
6627 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UTP6 |
0.163445185809154 |
|
6628 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUZ12 |
0.163445185809154 |
|
6629 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP437 |
0.163445185809154 |
|
6630 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC37B |
0.163445185809154 |
|
6631 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3GL1P1 |
0.163445185809154 |
|
6632 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHOT1 |
0.163445185809154 |
|
6633 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHBDL3 |
0.163445185809154 |
|
6634 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf75 |
0.163445185809154 |
|
6635 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR632 |
0.163445185809154 |
|
6636 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF207 |
0.163445185809154 |
|
6637 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMD11 |
0.163445185809154 |
|
6638 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK5R1 |
0.163445185809154 |
|
6639 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM98 |
0.163445185809154 |
|
6640 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPACA3 |
0.163445185809154 |
|
6641 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASIC2 |
0.163445185809154 |
|
6642 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf102 |
0.163445185809154 |
|
6643 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL11 |
0.163445185809154 |
|
6644 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL13 |
0.163445185809154 |
|
6645 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL1 |
0.163445185809154 |
|
6646 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL2 |
0.163445185809154 |
|
6647 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL7 |
0.163445185809154 |
|
6648 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL8 |
0.163445185809154 |
|
6649 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP438 |
0.163445185809154 |
|
6650 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM132E |
0.163445185809154 |
|
6651 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCT6B |
0.163445185809154 |
|
6652 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF830 |
0.163445185809154 |
|
6653 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIG3 |
0.163445185809154 |
|
6654 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFFL |
0.163445185809154 |
|
6655 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238858.1 |
0.163445185809154 |
|
6656 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAD51D |
0.163445185809154 |
|
6657 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
Vault|ENSG00000252328.1 |
0.163445185809154 |
|
6658 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FNDC8 |
0.163445185809154 |
|
6659 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NLE1 |
0.163445185809154 |
|
6660 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UNC45B |
0.163445185809154 |
|
6661 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35G3 |
0.163445185809154 |
|
6662 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLFN5 |
0.163445185809154 |
|
6663 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLFN11 |
0.163445185809154 |
|
6664 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLFN12 |
0.163445185809154 |
|
6665 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLFN13 |
0.163445185809154 |
|
6666 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLFN12L |
0.163445185809154 |
|
6667 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLFN14 |
0.163445185809154 |
|
6668 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP2B1 |
0.163445185809154 |
|
6669 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEX12 |
0.163445185809154 |
|
6670 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD7 |
0.163445185809154 |
|
6671 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASL10B |
0.163445185809154 |
|
6672 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAS2L2 |
0.163445185809154 |
|
6673 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMP28 |
0.163445185809154 |
|
6674 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf50 |
0.163445185809154 |
|
6675 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAF15 |
0.163445185809154 |
|
6676 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf66 |
0.163445185809154 |
|
6677 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL5 |
0.163445185809154 |
|
6678 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP274 |
0.163445185809154 |
|
6679 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RDM1 |
0.163445185809154 |
|
6680 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYZL6 |
0.163445185809154 |
|
6681 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL16 |
0.163445185809154 |
|
6682 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL14 |
0.163445185809154 |
|
6683 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL15 |
0.163445185809154 |
|
6684 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL23 |
0.163445185809154 |
|
6685 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL18 |
0.163445185809154 |
|
6686 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL3L1 |
0.163445185809154 |
|
6687 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL3L3 |
0.163445185809154 |
|
6688 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL3 |
0.163445185809154 |
|
6689 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL4L1 |
0.163445185809154 |
|
6690 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL4L2 |
0.163445185809154 |
|
6691 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL4 |
0.163445185809154 |
|
6692 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GGNBP2 |
0.163445185809154 |
|
6693 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYO19 |
0.163445185809154 |
|
6694 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIGW |
0.163445185809154 |
|
6695 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL301P |
0.163445185809154 |
|
6696 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP439 |
0.163445185809154 |
|
6697 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D3B |
0.163445185809154 |
|
6698 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D3C |
0.163445185809154 |
|
6699 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D3G |
0.163445185809154 |
|
6700 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D3H |
0.163445185809154 |
|
6701 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNHIT3 |
0.163445185809154 |
|
6702 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHRS11 |
0.163445185809154 |
|
6703 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRM1 |
0.163445185809154 |
|
6704 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LHX1 |
0.163445185809154 |
|
6705 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AATF |
0.163445185809154 |
|
6706 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR2909 |
0.163445185809154 |
|
6707 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACACA |
0.163445185809154 |
|
6708 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMGB1P24 |
0.163445185809154 |
|
6709 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf78 |
0.163445185809154 |
|
6710 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TADA2A |
0.163445185809154 |
|
6711 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUSP14 |
0.163445185809154 |
|
6712 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYNRG |
0.163445185809154 |
|
6713 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX52 |
0.163445185809154 |
|
6714 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNF1B |
0.163445185809154 |
|
6715 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D3F |
0.163445185809154 |
|
6716 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D3 |
0.163445185809154 |
|
6717 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL45 |
0.163445185809154 |
|
6718 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR179 |
0.163445185809154 |
|
6719 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOCS7 |
0.163445185809154 |
|
6720 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL458P |
0.163445185809154 |
|
6721 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP23 |
0.163445185809154 |
|
6722 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRCIN1 |
0.163445185809154 |
|
6723 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL102P |
0.163445185809154 |
|
6724 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf96 |
0.163445185809154 |
|
6725 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4734 |
0.163445185809154 |
|
6726 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLLT6 |
0.163445185809154 |
|
6727 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CISD3 |
0.163445185809154 |
|
6728 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4726 |
0.163445185809154 |
|
6729 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP440 |
0.163445185809154 |
|
6730 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCGF2 |
0.163445185809154 |
|
6731 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMB3 |
0.163445185809154 |
|
6732 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIP4K2B |
0.163445185809154 |
|
6733 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CWC25 |
0.163445185809154 |
|
6734 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4727 |
0.163445185809154 |
|
6735 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf98 |
0.163445185809154 |
|
6736 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL23 |
0.163445185809154 |
|
6737 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA21|ENSG00000199293.1 |
0.163445185809154 |
|
6738 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA21|ENSG00000252699.1 |
0.163445185809154 |
|
6739 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LASP1 |
0.163445185809154 |
|
6740 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00672 |
0.163445185809154 |
|
6741 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO47 |
0.163445185809154 |
|
6742 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC37A11P |
0.163445185809154 |
|
6743 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLXDC1 |
0.163445185809154 |
|
6744 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL5C |
0.163445185809154 |
|
6745 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNB1 |
0.163445185809154 |
|
6746 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL19 |
0.163445185809154 |
|
6747 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAC2 |
0.163445185809154 |
|
6748 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXL20 |
0.163445185809154 |
|
6749 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED1 |
0.163445185809154 |
|
6750 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK12 |
0.163445185809154 |
|
6751 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEUROD2 |
0.163445185809154 |
|
6752 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R1B |
0.163445185809154 |
|
6753 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STARD3 |
0.163445185809154 |
|
6754 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCAP |
0.163445185809154 |
|
6755 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNMT |
0.163445185809154 |
|
6756 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGAP3 |
0.163445185809154 |
|
6757 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERBB2 |
0.163445185809154 |
|
6758 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4728 |
0.163445185809154 |
|
6759 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIEN1 |
0.163445185809154 |
|
6760 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRB7 |
0.163445185809154 |
|
6761 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IKZF3 |
0.163445185809154 |
|
6762 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZPBP2 |
0.163445185809154 |
|
6763 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSDMB |
0.163445185809154 |
|
6764 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ORMDL3 |
0.163445185809154 |
|
6765 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC3C |
0.163445185809154 |
|
6766 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSDMA |
0.163445185809154 |
|
6767 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMD3 |
0.163445185809154 |
|
6768 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSF3 |
0.163445185809154 |
|
6769 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED24 |
0.163445185809154 |
|
6770 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD124 |
0.163445185809154 |
|
6771 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THRA |
0.163445185809154 |
|
6772 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NR1D1 |
0.163445185809154 |
|
6773 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSL1 |
0.163445185809154 |
|
6774 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASC3 |
0.163445185809154 |
|
6775 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAPGEFL1 |
0.163445185809154 |
|
6776 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WIPF2 |
0.163445185809154 |
|
6777 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P8 |
0.163445185809154 |
|
6778 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC6 |
0.163445185809154 |
|
6779 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RARA |
0.163445185809154 |
|
6780 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GJD3 |
0.163445185809154 |
|
6781 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP441 |
0.163445185809154 |
|
6782 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOP2A |
0.163445185809154 |
|
6783 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGFBP4 |
0.163445185809154 |
|
6784 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNS4 |
0.163445185809154 |
|
6785 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCR7 |
0.163445185809154 |
|
6786 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT222 |
0.163445185809154 |
|
6787 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMARCE1 |
0.163445185809154 |
|
6788 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT24 |
0.163445185809154 |
|
6789 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT223P |
0.163445185809154 |
|
6790 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT25 |
0.163445185809154 |
|
6791 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT26 |
0.163445185809154 |
|
6792 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT27 |
0.163445185809154 |
|
6793 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT28 |
0.163445185809154 |
|
6794 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT10 |
0.163445185809154 |
|
6795 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM99 |
0.163445185809154 |
|
6796 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT12 |
0.163445185809154 |
|
6797 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT20 |
0.163445185809154 |
|
6798 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT23 |
0.163445185809154 |
|
6799 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT39 |
0.163445185809154 |
|
6800 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT40 |
0.163445185809154 |
|
6801 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT33A |
0.163445185809154 |
|
6802 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT33B |
0.163445185809154 |
|
6803 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT31 |
0.163445185809154 |
|
6804 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT34 |
0.163445185809154 |
|
6805 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT37 |
0.163445185809154 |
|
6806 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT38 |
0.163445185809154 |
|
6807 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT32 |
0.163445185809154 |
|
6808 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT35 |
0.163445185809154 |
|
6809 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT36 |
0.163445185809154 |
|
6810 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT13 |
0.163445185809154 |
|
6811 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT15 |
0.163445185809154 |
|
6812 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT19 |
0.163445185809154 |
|
6813 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00974 |
0.163445185809154 |
|
6814 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT9 |
0.163445185809154 |
|
6815 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT14 |
0.163445185809154 |
|
6816 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT16 |
0.163445185809154 |
|
6817 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JUP |
0.163445185809154 |
|
6818 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT17 |
0.163445185809154 |
|
6819 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT42P |
0.163445185809154 |
|
6820 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF1 |
0.163445185809154 |
|
6821 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAST |
0.163445185809154 |
|
6822 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAP1 |
0.163445185809154 |
|
6823 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP442 |
0.163445185809154 |
|
6824 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL399P |
0.163445185809154 |
|
6825 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LEPREL4 |
0.163445185809154 |
|
6826 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FKBP10 |
0.163445185809154 |
|
6827 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NT5C3B |
0.163445185809154 |
|
6828 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL10 |
0.163445185809154 |
|
6829 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL871P |
0.163445185809154 |
|
6830 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL11 |
0.163445185809154 |
|
6831 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACLY |
0.163445185809154 |
|
6832 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC25 |
0.163445185809154 |
|
6833 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNP |
0.163445185809154 |
|
6834 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC7 |
0.163445185809154 |
|
6835 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NKIRAS2 |
0.163445185809154 |
|
6836 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF385C |
0.163445185809154 |
|
6837 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHX58 |
0.163445185809154 |
|
6838 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KAT2A |
0.163445185809154 |
|
6839 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPB9 |
0.163445185809154 |
|
6840 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB5C |
0.163445185809154 |
|
6841 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNH4 |
0.163445185809154 |
|
6842 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCRT |
0.163445185809154 |
|
6843 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GHDC |
0.163445185809154 |
|
6844 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAT5B |
0.163445185809154 |
|
6845 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAT5A |
0.163445185809154 |
|
6846 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAT3 |
0.163445185809154 |
|
6847 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTRF |
0.163445185809154 |
|
6848 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6V0A1 |
0.163445185809154 |
|
6849 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548AT |
0.163445185809154 |
|
6850 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5010 |
0.163445185809154 |
|
6851 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAGLU |
0.163445185809154 |
|
6852 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSD17B1 |
0.163445185809154 |
|
6853 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COASY |
0.163445185809154 |
|
6854 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLX |
0.163445185809154 |
|
6855 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMC3IP |
0.163445185809154 |
|
6856 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM134C |
0.163445185809154 |
|
6857 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBG1 |
0.163445185809154 |
|
6858 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBG2 |
0.163445185809154 |
|
6859 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCR10 |
0.163445185809154 |
|
6860 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNTNAP1 |
0.163445185809154 |
|
6861 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHH3 |
0.163445185809154 |
|
6862 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EZH1 |
0.163445185809154 |
|
6863 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAMP2 |
0.163445185809154 |
|
6864 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS25 |
0.163445185809154 |
|
6865 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WNK4 |
0.163445185809154 |
|
6866 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNTD1 |
0.163445185809154 |
|
6867 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COA3 |
0.163445185809154 |
|
6868 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BECN1 |
0.163445185809154 |
|
6869 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSME3 |
0.163445185809154 |
|
6870 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AOC2 |
0.163445185809154 |
|
6871 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AOC3 |
0.163445185809154 |
|
6872 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AOC4P |
0.163445185809154 |
|
6873 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00671 |
0.163445185809154 |
|
6874 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
G6PC |
0.163445185809154 |
|
6875 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P2 |
0.163445185809154 |
|
6876 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA40|ENSG00000212149.1 |
0.163445185809154 |
|
6877 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AARSD1 |
0.163445185809154 |
|
6878 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTGES3L |
0.163445185809154 |
|
6879 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RUNDC1 |
0.163445185809154 |
|
6880 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL27 |
0.163445185809154 |
|
6881 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFI35 |
0.163445185809154 |
|
6882 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VAT1 |
0.163445185809154 |
|
6883 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RND2 |
0.163445185809154 |
|
6884 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRCA1 |
0.163445185809154 |
|
6885 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBR2 |
0.163445185809154 |
|
6886 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBR1 |
0.163445185809154 |
|
6887 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL4D |
0.163445185809154 |
|
6888 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00854 |
0.163445185809154 |
|
6889 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00910 |
0.163445185809154 |
|
6890 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM106A |
0.163445185809154 |
|
6891 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEOX1 |
0.163445185809154 |
|
6892 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOST |
0.163445185809154 |
|
6893 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUSP3 |
0.163445185809154 |
|
6894 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf105 |
0.163445185809154 |
|
6895 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPP3 |
0.163445185809154 |
|
6896 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD300LG |
0.163445185809154 |
|
6897 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPP2 |
0.163445185809154 |
|
6898 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM215A |
0.163445185809154 |
|
6899 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPY |
0.163445185809154 |
|
6900 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PYY |
0.163445185809154 |
|
6901 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAGS |
0.163445185809154 |
|
6902 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM101 |
0.163445185809154 |
|
6903 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000221044.1 |
0.163445185809154 |
|
6904 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LSM12 |
0.163445185809154 |
|
6905 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
G6PC3 |
0.163445185809154 |
|
6906 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HDAC5 |
0.163445185809154 |
|
6907 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf53 |
0.163445185809154 |
|
6908 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASB16 |
0.163445185809154 |
|
6909 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMUB2 |
0.163445185809154 |
|
6910 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATXN7L3 |
0.163445185809154 |
|
6911 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBTF |
0.163445185809154 |
|
6912 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC4A1 |
0.163445185809154 |
|
6913 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL507P |
0.163445185809154 |
|
6914 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RUNDC3A |
0.163445185809154 |
|
6915 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000221496.1 |
0.163445185809154 |
|
6916 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A39 |
0.163445185809154 |
|
6917 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRN |
0.163445185809154 |
|
6918 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM171A2 |
0.163445185809154 |
|
6919 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGA2B |
0.163445185809154 |
|
6920 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPATCH8 |
0.163445185809154 |
|
6921 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL258P |
0.163445185809154 |
|
6922 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FZD2 |
0.163445185809154 |
|
6923 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf104 |
0.163445185809154 |
|
6924 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC43 |
0.163445185809154 |
|
6925 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DBF4B |
0.163445185809154 |
|
6926 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL819P |
0.163445185809154 |
|
6927 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM11 |
0.163445185809154 |
|
6928 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GJC1 |
0.163445185809154 |
|
6929 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIGD1B |
0.163445185809154 |
|
6930 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFTUD2 |
0.163445185809154 |
|
6931 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL405P |
0.163445185809154 |
|
6932 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC103 |
0.163445185809154 |
|
6933 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM187A |
0.163445185809154 |
|
6934 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GFAP |
0.163445185809154 |
|
6935 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF18B |
0.163445185809154 |
|
6936 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1QL1 |
0.163445185809154 |
|
6937 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCAKD |
0.163445185809154 |
|
6938 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NMT1 |
0.163445185809154 |
|
6939 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLCD3 |
0.163445185809154 |
|
6940 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACBD4 |
0.163445185809154 |
|
6941 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HEXIM1 |
0.163445185809154 |
|
6942 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HEXIM2 |
0.163445185809154 |
|
6943 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FMNL1 |
0.163445185809154 |
|
6944 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA32 |
0.163445185809154 |
|
6945 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP3K14 |
0.163445185809154 |
|
6946 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP443 |
0.163445185809154 |
|
6947 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP27 |
0.163445185809154 |
|
6948 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL17A |
0.163445185809154 |
|
6949 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL17B |
0.163445185809154 |
|
6950 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRHR1 |
0.163445185809154 |
|
6951 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM215B |
0.163445185809154 |
|
6952 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KANSL1 |
0.163445185809154 |
|
6953 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC37A2 |
0.163445185809154 |
|
6954 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC37A4P |
0.163445185809154 |
|
6955 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC37A |
0.163445185809154 |
|
6956 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPT |
0.163445185809154 |
|
6957 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NSF |
0.163445185809154 |
|
6958 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHM1 |
0.163445185809154 |
|
6959 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL199P |
0.163445185809154 |
|
6960 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL656P |
0.163445185809154 |
|
6961 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL730P |
0.163445185809154 |
|
6962 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL739P |
0.163445185809154 |
|
6963 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPPL2C |
0.163445185809154 |
|
6964 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STH |
0.163445185809154 |
|
6965 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WNT3 |
0.163445185809154 |
|
6966 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WNT9B |
0.163445185809154 |
|
6967 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC3P |
0.163445185809154 |
|
6968 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOSR2 |
0.163445185809154 |
|
6969 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5089 |
0.163445185809154 |
|
6970 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC37A17P |
0.163445185809154 |
|
6971 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPRML |
0.163445185809154 |
|
6972 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL270P |
0.163445185809154 |
|
6973 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC27 |
0.163445185809154 |
|
6974 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYL4 |
0.163445185809154 |
|
6975 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000252088.1 |
0.163445185809154 |
|
6976 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGB3 |
0.163445185809154 |
|
6977 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFCAB13 |
0.163445185809154 |
|
6978 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL45P2 |
0.163445185809154 |
|
6979 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPEPPS |
0.163445185809154 |
|
6980 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KPNB1 |
0.163445185809154 |
|
6981 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBKBP1 |
0.163445185809154 |
|
6982 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBX21 |
0.163445185809154 |
|
6983 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSBPL7 |
0.163445185809154 |
|
6984 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL10 |
0.163445185809154 |
|
6985 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC46 |
0.163445185809154 |
|
6986 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCRN2 |
0.163445185809154 |
|
6987 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SP6 |
0.163445185809154 |
|
6988 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SP2 |
0.163445185809154 |
|
6989 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNPO |
0.163445185809154 |
|
6990 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR15L |
0.163445185809154 |
|
6991 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK5RAP3 |
0.163445185809154 |
|
6992 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COPZ2 |
0.163445185809154 |
|
6993 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR152 |
0.163445185809154 |
|
6994 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFE2L1 |
0.163445185809154 |
|
6995 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBX1 |
0.163445185809154 |
|
6996 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX11 |
0.163445185809154 |
|
6997 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SKAP1 |
0.163445185809154 |
|
6998 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1203 |
0.163445185809154 |
|
6999 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000200538.1 |
0.163445185809154 |
|
7000 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXB1 |
0.163445185809154 |
|
7001 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXB2 |
0.163445185809154 |
|
7002 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXB3 |
0.163445185809154 |
|
7003 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXB4 |
0.163445185809154 |
|
7004 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR10A |
0.163445185809154 |
|
7005 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXB5 |
0.163445185809154 |
|
7006 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXB6 |
0.163445185809154 |
|
7007 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXB7 |
0.163445185809154 |
|
7008 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXB8 |
0.163445185809154 |
|
7009 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXB9 |
0.163445185809154 |
|
7010 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR196A1 |
0.163445185809154 |
|
7011 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXB13 |
0.163445185809154 |
|
7012 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3185 |
0.163445185809154 |
|
7013 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAC |
0.163445185809154 |
|
7014 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTLL6 |
0.163445185809154 |
|
7015 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL125P |
0.163445185809154 |
|
7016 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CALCOCO2 |
0.163445185809154 |
|
7017 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA68|ENSG00000212565.1 |
0.163445185809154 |
|
7018 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP5G1 |
0.163445185809154 |
|
7019 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2Z |
0.163445185809154 |
|
7020 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNF8 |
0.163445185809154 |
|
7021 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238804.1 |
0.163445185809154 |
|
7022 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GIP |
0.163445185809154 |
|
7023 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGF2BP1 |
0.163445185809154 |
|
7024 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B4GALNT2 |
0.163445185809154 |
|
7025 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNGT2 |
0.163445185809154 |
|
7026 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABI3 |
0.163445185809154 |
|
7027 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHOSPHO1 |
0.163445185809154 |
|
7028 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF652 |
0.163445185809154 |
|
7029 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHB |
0.163445185809154 |
|
7030 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NGFR |
0.163445185809154 |
|
7031 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NXPH3 |
0.163445185809154 |
|
7032 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPOP |
0.163445185809154 |
|
7033 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35B1 |
0.163445185809154 |
|
7034 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM117A |
0.163445185809154 |
|
7035 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KAT7 |
0.163445185809154 |
|
7036 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAC4 |
0.163445185809154 |
|
7037 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLX4 |
0.163445185809154 |
|
7038 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLX3 |
0.163445185809154 |
|
7039 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGA3 |
0.163445185809154 |
|
7040 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDK2 |
0.163445185809154 |
|
7041 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAMD14 |
0.163445185809154 |
|
7042 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R9B |
0.163445185809154 |
|
7043 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGCA |
0.163445185809154 |
|
7044 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HILS1 |
0.163445185809154 |
|
7045 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL1A1 |
0.163445185809154 |
|
7046 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239135.1 |
0.163445185809154 |
|
7047 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM92 |
0.163445185809154 |
|
7048 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XYLT2 |
0.163445185809154 |
|
7049 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL27 |
0.163445185809154 |
|
7050 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EME1 |
0.163445185809154 |
|
7051 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC59 |
0.163445185809154 |
|
7052 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACSF2 |
0.163445185809154 |
|
7053 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHAD |
0.163445185809154 |
|
7054 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RSAD1 |
0.163445185809154 |
|
7055 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYCBPAP |
0.163445185809154 |
|
7056 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPN3 |
0.163445185809154 |
|
7057 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA20 |
0.163445185809154 |
|
7058 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNA1G |
0.163445185809154 |
|
7059 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCC3 |
0.163445185809154 |
|
7060 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD40 |
0.163445185809154 |
|
7061 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LUC7L3 |
0.163445185809154 |
|
7062 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00483 |
0.163445185809154 |
|
7063 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WFIKKN2 |
0.163445185809154 |
|
7064 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRP1B |
0.163893403507099 |
|
7065 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDHAF1 |
0.164526496021885 |
|
7066 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYNE4 |
0.164526496021885 |
|
7067 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALKBH6 |
0.164526496021885 |
|
7068 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLIP3 |
0.164526496021885 |
|
7069 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THAP8 |
0.164526496021885 |
|
7070 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR62 |
0.164526496021885 |
|
7071 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRRM5 |
0.164526496021885 |
|
7072 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF428 |
0.164526496021885 |
|
7073 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CADM4 |
0.164526496021885 |
|
7074 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLAUR |
0.164526496021885 |
|
7075 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL368P |
0.164526496021885 |
|
7076 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRGC |
0.164526496021885 |
|
7077 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMG9 |
0.164526496021885 |
|
7078 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNN4 |
0.164526496021885 |
|
7079 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYPD5 |
0.164526496021885 |
|
7080 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF283 |
0.164526496021885 |
|
7081 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF404 |
0.164526496021885 |
|
7082 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF45 |
0.164526496021885 |
|
7083 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF221 |
0.164526496021885 |
|
7084 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF155 |
0.164526496021885 |
|
7085 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF230 |
0.164526496021885 |
|
7086 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF222 |
0.164526496021885 |
|
7087 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF223 |
0.164526496021885 |
|
7088 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF284 |
0.164526496021885 |
|
7089 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL53P |
0.164526496021885 |
|
7090 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF224 |
0.164526496021885 |
|
7091 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF225 |
0.164526496021885 |
|
7092 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF234 |
0.164526496021885 |
|
7093 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF226 |
0.164526496021885 |
|
7094 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF227 |
0.164526496021885 |
|
7095 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF235 |
0.164526496021885 |
|
7096 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF233 |
0.164526496021885 |
|
7097 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF112 |
0.164526496021885 |
|
7098 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF285 |
0.164526496021885 |
|
7099 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF229 |
0.164526496021885 |
|
7100 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF180 |
0.164526496021885 |
|
7101 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEACAM20 |
0.164526496021885 |
|
7102 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEACAM22P |
0.164526496021885 |
|
7103 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGSF23 |
0.164526496021885 |
|
7104 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PVR |
0.164526496021885 |
|
7105 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEACAM19 |
0.164526496021885 |
|
7106 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEACAM16 |
0.164526496021885 |
|
7107 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoZ6|ENSG00000252200.1 |
0.164526496021885 |
|
7108 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCL3 |
0.164526496021885 |
|
7109 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000253027.1 |
0.164526496021885 |
|
7110 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBLC |
0.164526496021885 |
|
7111 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCAM |
0.164526496021885 |
|
7112 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PVRL2 |
0.164526496021885 |
|
7113 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNMT |
0.164600749454033 |
|
7114 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPOPL |
0.164600749454033 |
|
7115 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PELI2 |
0.164658699705095 |
|
7116 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM260 |
0.164658699705095 |
|
7117 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OTX2 |
0.164658699705095 |
|
7118 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL461P |
0.164658699705095 |
|
7119 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXOC5 |
0.164658699705095 |
|
7120 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP5M1 |
0.164658699705095 |
|
7121 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAA30 |
0.164658699705095 |
|
7122 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C14orf105 |
0.164658699705095 |
|
7123 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35F4 |
0.164658699705095 |
|
7124 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP99 |
0.164658699705095 |
|
7125 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C14orf37 |
0.164658699705095 |
|
7126 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL598P |
0.164658699705095 |
|
7127 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTR10 |
0.164658699705095 |
|
7128 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMA3 |
0.164658699705095 |
|
7129 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARID4A |
0.164658699705095 |
|
7130 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOMM20L |
0.164658699705095 |
|
7131 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIMM9 |
0.164658699705095 |
|
7132 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0586 |
0.164658699705095 |
|
7133 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DACT1 |
0.164658699705095 |
|
7134 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR135 |
0.164658699705095 |
|
7135 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
L3HYPDH |
0.164658699705095 |
|
7136 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JKAMP |
0.164658699705095 |
|
7137 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC175 |
0.164658699705095 |
|
7138 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RTN1 |
0.164658699705095 |
|
7139 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5586 |
0.164658699705095 |
|
7140 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC9 |
0.164658699705095 |
|
7141 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCNXL4 |
0.164658699705095 |
|
7142 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHRS7 |
0.164658699705095 |
|
7143 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPM1A |
0.164658699705095 |
|
7144 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C14orf39 |
0.164658699705095 |
|
7145 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIX6 |
0.164658699705095 |
|
7146 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000253014.1 |
0.164658699705095 |
|
7147 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIX1 |
0.164658699705095 |
|
7148 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIX4 |
0.164658699705095 |
|
7149 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MNAT1 |
0.164658699705095 |
|
7150 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRMT5 |
0.164658699705095 |
|
7151 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC38A6 |
0.164658699705095 |
|
7152 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKCH |
0.164658699705095 |
|
7153 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252380.1 |
0.164658699705095 |
|
7154 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM30B |
0.164658699705095 |
|
7155 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIF1A |
0.164658699705095 |
|
7156 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNAPC1 |
0.164658699705095 |
|
7157 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYT16 |
0.164658699705095 |
|
7158 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00643 |
0.164658699705095 |
|
7159 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00644 |
0.164658699705095 |
|
7160 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OVOL3 |
0.166117619240261 |
|
7161 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR2I |
0.166117619240261 |
|
7162 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBCB |
0.166117619240261 |
|
7163 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPNS1 |
0.166117619240261 |
|
7164 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX7A1 |
0.166117619240261 |
|
7165 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL287P |
0.166117619240261 |
|
7166 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF146 |
0.166117619240261 |
|
7167 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEACAM4 |
0.166117619240261 |
|
7168 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEACAM7 |
0.166117619240261 |
|
7169 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEACAM5 |
0.166117619240261 |
|
7170 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEA |
0.166117619240261 |
|
7171 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEACAM3 |
0.166117619240261 |
|
7172 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEACAM6 |
0.166117619240261 |
|
7173 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYPD4 |
0.166117619240261 |
|
7174 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DMRTC2 |
0.166117619240261 |
|
7175 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS19 |
0.166117619240261 |
|
7176 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD79A |
0.166117619240261 |
|
7177 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF1 |
0.166117619240261 |
|
7178 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RABAC1 |
0.166117619240261 |
|
7179 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP1A3 |
0.166117619240261 |
|
7180 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRIK5 |
0.166117619240261 |
|
7181 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF574 |
0.166117619240261 |
|
7182 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POU2F2 |
0.166117619240261 |
|
7183 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4323 |
0.166117619240261 |
|
7184 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252356.1 |
0.166117619240261 |
|
7185 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEDD2 |
0.166117619240261 |
|
7186 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF526 |
0.166117619240261 |
|
7187 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSK3A |
0.166117619240261 |
|
7188 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERF |
0.166117619240261 |
|
7189 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CIC |
0.166117619240261 |
|
7190 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAFAH1B3 |
0.166117619240261 |
|
7191 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR19 |
0.166117619240261 |
|
7192 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM145 |
0.166117619240261 |
|
7193 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEGF8 |
0.166117619240261 |
|
7194 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNFN |
0.166117619240261 |
|
7195 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIPE |
0.166117619240261 |
|
7196 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXCL17 |
0.166117619240261 |
|
7197 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEACAM1 |
0.166117619240261 |
|
7198 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEACAM8 |
0.166117619240261 |
|
7199 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD177 |
0.166117619240261 |
|
7200 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEACAMP10 |
0.166117619240261 |
|
7201 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSG10P |
0.166117619240261 |
|
7202 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSG11 |
0.166117619240261 |
|
7203 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSG1 |
0.166117619240261 |
|
7204 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSG2 |
0.166117619240261 |
|
7205 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSG3 |
0.166117619240261 |
|
7206 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSG4 |
0.166117619240261 |
|
7207 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSG5 |
0.166117619240261 |
|
7208 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSG6 |
0.166117619240261 |
|
7209 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSG7 |
0.166117619240261 |
|
7210 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSG8 |
0.166117619240261 |
|
7211 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSG9 |
0.166117619240261 |
|
7212 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX101 |
0.166117619240261 |
|
7213 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYPD3 |
0.166117619240261 |
|
7214 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHLDB3 |
0.166117619240261 |
|
7215 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ETHE1 |
0.166117619240261 |
|
7216 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF575 |
0.166117619240261 |
|
7217 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XRCC1 |
0.166117619240261 |
|
7218 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PINLYP |
0.166117619240261 |
|
7219 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRGQ |
0.166117619240261 |
|
7220 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF576 |
0.166117619240261 |
|
7221 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PBXIP1 |
0.166687407330179 |
|
7222 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PYGO2 |
0.166687407330179 |
|
7223 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHC1 |
0.166687407330179 |
|
7224 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CKS1B|ENSG00000173207.8 |
0.166687407330179 |
|
7225 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4258 |
0.166687407330179 |
|
7226 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLAD1 |
0.166687407330179 |
|
7227 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LENEP |
0.166687407330179 |
|
7228 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB7B |
0.166687407330179 |
|
7229 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCST2 |
0.166687407330179 |
|
7230 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCST1 |
0.166687407330179 |
|
7231 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM15 |
0.166687407330179 |
|
7232 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFNA3 |
0.166687407330179 |
|
7233 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFNA4 |
0.166687407330179 |
|
7234 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFNA1 |
0.166687407330179 |
|
7235 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPM3 |
0.166687407330179 |
|
7236 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC50A1 |
0.166687407330179 |
|
7237 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRTCAP2 |
0.166687407330179 |
|
7238 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM46 |
0.166687407330179 |
|
7239 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR92B |
0.166687407330179 |
|
7240 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUC1 |
0.166687407330179 |
|
7241 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THBS3 |
0.166687407330179 |
|
7242 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTX1 |
0.166687407330179 |
|
7243 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GBAP1 |
0.166687407330179 |
|
7244 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GBA |
0.166687407330179 |
|
7245 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM189B |
0.166687407330179 |
|
7246 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCAMP3 |
0.166687407330179 |
|
7247 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLK2 |
0.166687407330179 |
|
7248 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM20C |
0.166927492867243 |
|
7249 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDGFA |
0.166927492867243 |
|
7250 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKAR1B |
0.166927492867243 |
|
7251 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HEATR2 |
0.166927492867243 |
|
7252 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUN1 |
0.166927492867243 |
|
7253 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GET4 |
0.166927492867243 |
|
7254 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAP1 |
0.166927492867243 |
|
7255 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C7orf50 |
0.166927492867243 |
|
7256 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX19 |
0.166927492867243 |
|
7257 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP2W1 |
0.166927492867243 |
|
7258 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPER |
0.166927492867243 |
|
7259 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR146 |
0.166927492867243 |
|
7260 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR339 |
0.166927492867243 |
|
7261 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFAND2A |
0.166927492867243 |
|
7262 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UNCX |
0.166927492867243 |
|
7263 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MICALL2 |
0.166927492867243 |
|
7264 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INTS1 |
0.166927492867243 |
|
7265 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAFK |
0.166927492867243 |
|
7266 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM184A |
0.166927492867243 |
|
7267 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMG3 |
0.166927492867243 |
|
7268 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELFN1 |
0.166927492867243 |
|
7269 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAD1L1 |
0.166927492867243 |
|
7270 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4655 |
0.166927492867243 |
|
7271 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FTSJ2 |
0.166927492867243 |
|
7272 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDT1 |
0.166927492867243 |
|
7273 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX8 |
0.166927492867243 |
|
7274 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHST12 |
0.166927492867243 |
|
7275 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF3B |
0.166927492867243 |
|
7276 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRIFIN |
0.166927492867243 |
|
7277 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LFNG |
0.166927492867243 |
|
7278 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4648 |
0.166927492867243 |
|
7279 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRAT1 |
0.166927492867243 |
|
7280 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238857.1 |
0.166927492867243 |
|
7281 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IQCE |
0.166927492867243 |
|
7282 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTYH3 |
0.166927492867243 |
|
7283 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMZ1 |
0.166927492867243 |
|
7284 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNA12 |
0.166927492867243 |
|
7285 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CARD11 |
0.166927492867243 |
|
7286 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP130 |
0.166927492867243 |
|
7287 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDK1 |
0.166927492867243 |
|
7288 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXK1 |
0.166927492867243 |
|
7289 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238781.1 |
0.166927492867243 |
|
7290 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP5Z1 |
0.166927492867243 |
|
7291 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4656 |
0.166927492867243 |
|
7292 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RADIL |
0.166927492867243 |
|
7293 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAPOLB |
0.166927492867243 |
|
7294 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMD2 |
0.166927492867243 |
|
7295 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBAK |
0.166927492867243 |
|
7296 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF216P1 |
0.166927492867243 |
|
7297 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF890P |
0.166927492867243 |
|
7298 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WIPI2 |
0.166927492867243 |
|
7299 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC29A4 |
0.166927492867243 |
|
7300 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNRC18 |
0.166927492867243 |
|
7301 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXL18 |
0.166927492867243 |
|
7302 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238394.1 |
0.166927492867243 |
|
7303 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR589 |
0.166927492867243 |
|
7304 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTB |
0.166927492867243 |
|
7305 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FSCN1 |
0.166927492867243 |
|
7306 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF216 |
0.166927492867243 |
|
7307 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCZ1 |
0.166927492867243 |
|
7308 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OCM |
0.166927492867243 |
|
7309 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PMS2 |
0.166927492867243 |
|
7310 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL556P |
0.166927492867243 |
|
7311 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RSPH10B |
0.166927492867243 |
|
7312 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF815P |
0.166927492867243 |
|
7313 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AIMP2 |
0.166927492867243 |
|
7314 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA42|ENSG00000207217.1 |
0.166927492867243 |
|
7315 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF2AK1 |
0.166927492867243 |
|
7316 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD61 |
0.166927492867243 |
|
7317 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL851P |
0.166927492867243 |
|
7318 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP42 |
0.166927492867243 |
|
7319 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYTH3 |
0.166927492867243 |
|
7320 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM220A |
0.166927492867243 |
|
7321 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAC1 |
0.166927492867243 |
|
7322 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DAGLB |
0.166927492867243 |
|
7323 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KDELR2 |
0.166927492867243 |
|
7324 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLJ20306 |
0.166927492867243 |
|
7325 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRID2IP |
0.166927492867243 |
|
7326 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDHHC4 |
0.166927492867243 |
|
7327 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C7orf26 |
0.166927492867243 |
|
7328 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF853 |
0.166927492867243 |
|
7329 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF12 |
0.166927492867243 |
|
7330 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ICA1 |
0.166927492867243 |
|
7331 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NXPH1 |
0.166927492867243 |
|
7332 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000212422.1 |
0.166927492867243 |
|
7333 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFA4 |
0.166927492867243 |
|
7334 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHF14 |
0.166927492867243 |
|
7335 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THSD7A |
0.166927492867243 |
|
7336 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM106B |
0.166927492867243 |
|
7337 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VWDE |
0.166927492867243 |
|
7338 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCIN |
0.166927492867243 |
|
7339 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL4A |
0.166927492867243 |
|
7340 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA64|ENSG00000199470.1 |
0.166927492867243 |
|
7341 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP228 |
0.166927492867243 |
|
7342 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ETV1 |
0.166927492867243 |
|
7343 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DGKB |
0.166927492867243 |
|
7344 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGMO |
0.166927492867243 |
|
7345 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEOX2 |
0.166927492867243 |
|
7346 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ISPD |
0.166927492867243 |
|
7347 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOSTDC1 |
0.166927492867243 |
|
7348 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC72 |
0.166927492867243 |
|
7349 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKMY2 |
0.166927492867243 |
|
7350 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BZW2 |
0.166927492867243 |
|
7351 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPAN13 |
0.166927492867243 |
|
7352 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGR2 |
0.166927492867243 |
|
7353 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGR3 |
0.166927492867243 |
|
7354 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AHR |
0.166927492867243 |
|
7355 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA63|ENSG00000199473.1 |
0.166927492867243 |
|
7356 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX13 |
0.166927492867243 |
|
7357 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRPS1L1 |
0.166927492867243 |
|
7358 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HDAC9 |
0.166927492867243 |
|
7359 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP266 |
0.166927492867243 |
|
7360 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FERD3L |
0.166927492867243 |
|
7361 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3146 |
0.166927492867243 |
|
7362 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM196 |
0.166927492867243 |
|
7363 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TWIST1 |
0.166927492867243 |
|
7364 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TWISTNB |
0.166927492867243 |
|
7365 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MACC1 |
0.166927492867243 |
|
7366 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGB8 |
0.166927492867243 |
|
7367 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD56|ENSG00000200753.1 |
0.166927492867243 |
|
7368 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCB5 |
0.166927492867243 |
|
7369 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SP8 |
0.166927492867243 |
|
7370 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL542P |
0.166927492867243 |
|
7371 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SP4 |
0.166927492867243 |
|
7372 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1183 |
0.166927492867243 |
|
7373 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAH11 |
0.166927492867243 |
|
7374 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDCA7L |
0.166927492867243 |
|
7375 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAPGEF5 |
0.166927492867243 |
|
7376 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP227 |
0.166927492867243 |
|
7377 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STEAP1B |
0.166927492867243 |
|
7378 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL6 |
0.166927492867243 |
|
7379 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOMM7 |
0.166927492867243 |
|
7380 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD93 |
0.166927492867243 |
|
7381 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM126A |
0.166927492867243 |
|
7382 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL7 |
0.166927492867243 |
|
7383 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUPL2 |
0.166927492867243 |
|
7384 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPNMB |
0.166927492867243 |
|
7385 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MALSU1 |
0.166927492867243 |
|
7386 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGF2BP3 |
0.166927492867243 |
|
7387 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD65|ENSG00000212264.1 |
0.166927492867243 |
|
7388 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRA2A |
0.166927492867243 |
|
7389 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC126 |
0.166927492867243 |
|
7390 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM221A |
0.166927492867243 |
|
7391 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STK31 |
0.166927492867243 |
|
7392 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238849.1 |
0.166927492867243 |
|
7393 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP228 |
0.166927492867243 |
|
7394 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239098.1 |
0.166927492867243 |
|
7395 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPY |
0.166927492867243 |
|
7396 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPP6 |
0.166927492867243 |
|
7397 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DFNA5 |
0.166927492867243 |
|
7398 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSBPL3 |
0.166927492867243 |
|
7399 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYCS |
0.166927492867243 |
|
7400 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C7orf31 |
0.166927492867243 |
|
7401 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPVF |
0.166927492867243 |
|
7402 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000202233.1 |
0.166927492867243 |
|
7403 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR148A |
0.166927492867243 |
|
7404 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFE2L3 |
0.166927492867243 |
|
7405 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPA2B1 |
0.166927492867243 |
|
7406 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBX3 |
0.166927492867243 |
|
7407 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX10 |
0.166927492867243 |
|
7408 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0087 |
0.166927492867243 |
|
7409 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C7orf71 |
0.166927492867243 |
|
7410 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SKAP2 |
0.166927492867243 |
|
7411 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXA1 |
0.166927492867243 |
|
7412 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOTAIRM1 |
0.166927492867243 |
|
7413 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXA2 |
0.166927492867243 |
|
7414 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXA3 |
0.166927492867243 |
|
7415 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXA4 |
0.166927492867243 |
|
7416 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXA5 |
0.166927492867243 |
|
7417 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXA6 |
0.166927492867243 |
|
7418 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXA7 |
0.166927492867243 |
|
7419 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXA9 |
0.166927492867243 |
|
7420 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXA10 |
0.166927492867243 |
|
7421 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR196B |
0.166927492867243 |
|
7422 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXA11 |
0.166927492867243 |
|
7423 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXA13 |
0.166927492867243 |
|
7424 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOTTIP |
0.166927492867243 |
|
7425 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EVX1 |
0.166927492867243 |
|
7426 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIBADH |
0.166927492867243 |
|
7427 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAX1BP1 |
0.166927492867243 |
|
7428 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL365P |
0.166927492867243 |
|
7429 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CREB5 |
0.166927492867243 |
|
7430 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIL |
0.166927492867243 |
|
7431 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPVL |
0.166927492867243 |
|
7432 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHN2 |
0.166927492867243 |
|
7433 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR15 |
0.166927492867243 |
|
7434 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR550A3 |
0.166927492867243 |
|
7435 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WIPF3 |
0.166927492867243 |
|
7436 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238906.1 |
0.166927492867243 |
|
7437 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCRN1 |
0.166927492867243 |
|
7438 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FKBP14 |
0.166927492867243 |
|
7439 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHA8 |
0.166927492867243 |
|
7440 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C7orf41 |
0.166927492867243 |
|
7441 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR550A1 |
0.166927492867243 |
|
7442 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNRF2 |
0.166927492867243 |
|
7443 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOD1 |
0.166927492867243 |
|
7444 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GGCT |
0.166927492867243 |
|
7445 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GARS |
0.166927492867243 |
|
7446 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRHR2 |
0.166927492867243 |
|
7447 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INMT |
0.166927492867243 |
|
7448 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM188B |
0.166927492867243 |
|
7449 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AQP1 |
0.166927492867243 |
|
7450 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GHRHR |
0.166927492867243 |
|
7451 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADCYAP1R1 |
0.166927492867243 |
|
7452 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEUROD6 |
0.166927492867243 |
|
7453 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC129 |
0.166927492867243 |
|
7454 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R17 |
0.166927492867243 |
|
7455 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE1C |
0.166927492867243 |
|
7456 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LSM5 |
0.166927492867243 |
|
7457 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AVL9 |
0.166927492867243 |
|
7458 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR550A2 |
0.166927492867243 |
|
7459 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000251999.1 |
0.166927492867243 |
|
7460 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KBTBD2 |
0.166927492867243 |
|
7461 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RP9P |
0.166927492867243 |
|
7462 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FKBP9 |
0.166927492867243 |
|
7463 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NT5C3A |
0.166927492867243 |
|
7464 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL505P |
0.166927492867243 |
|
7465 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BBS9 |
0.166927492867243 |
|
7466 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RP9 |
0.166927492867243 |
|
7467 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000252706.1 |
0.166927492867243 |
|
7468 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP229 |
0.166927492867243 |
|
7469 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BMPER |
0.166927492867243 |
|
7470 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPSR1 |
0.166927492867243 |
|
7471 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL132P |
0.166927492867243 |
|
7472 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000251802.1 |
0.166927492867243 |
|
7473 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPY19L1 |
0.166927492867243 |
|
7474 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548N |
0.166927492867243 |
|
7475 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP40 |
0.167791024907304 |
|
7476 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPA3 |
0.16899494867544 |
|
7477 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFE2L2 |
0.16899494867544 |
|
7478 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3128 |
0.16899494867544 |
|
7479 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf174 |
0.171433410894931 |
|
7480 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AJAP1 |
0.171433410894931 |
|
7481 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4417 |
0.171433410894931 |
|
7482 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4689 |
0.171433410894931 |
|
7483 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPHP4 |
0.171433410894931 |
|
7484 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNAB2 |
0.171433410894931 |
|
7485 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHD5 |
0.171433410894931 |
|
7486 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL22 |
0.171433410894931 |
|
7487 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF207 |
0.171433410894931 |
|
7488 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ICMT |
0.171433410894931 |
|
7489 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00337 |
0.171433410894931 |
|
7490 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR153 |
0.171433410894931 |
|
7491 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HES3 |
0.171433410894931 |
|
7492 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACOT7 |
0.171433410894931 |
|
7493 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HES2 |
0.171433410894931 |
|
7494 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ESPN |
0.171433410894931 |
|
7495 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4252 |
0.171433410894931 |
|
7496 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHG5 |
0.171433410894931 |
|
7497 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFRSF25 |
0.171433410894931 |
|
7498 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOL9 |
0.171433410894931 |
|
7499 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS1R1 |
0.171433410894931 |
|
7500 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB48 |
0.171433410894931 |
|
7501 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL21 |
0.171433410894931 |
|
7502 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHF13 |
0.171433410894931 |
|
7503 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THAP3 |
0.171433410894931 |
|
7504 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC11 |
0.171433410894931 |
|
7505 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239166.1 |
0.171433410894931 |
|
7506 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAMTA1 |
0.171433410894931 |
|
7507 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VAMP3 |
0.171433410894931 |
|
7508 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PER3 |
0.171433410894931 |
|
7509 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UTS2 |
0.171433410894931 |
|
7510 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFRSF9 |
0.171433410894931 |
|
7511 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARK7 |
0.171433410894931 |
|
7512 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERRFI1 |
0.171433410894931 |
|
7513 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL729P |
0.171433410894931 |
|
7514 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC45A1 |
0.171433410894931 |
|
7515 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENO1 |
0.171433410894931 |
|
7516 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CA6 |
0.171433410894931 |
|
7517 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL451P |
0.171433410894931 |
|
7518 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC2A7 |
0.171433410894931 |
|
7519 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC2A5 |
0.171433410894931 |
|
7520 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA16|ENSG00000252404.1 |
0.171433410894931 |
|
7521 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR157 |
0.171433410894931 |
|
7522 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR34A |
0.171433410894931 |
|
7523 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
H6PD |
0.171433410894931 |
|
7524 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPSB1 |
0.171433410894931 |
|
7525 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP40 |
0.171433410894931 |
|
7526 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A33 |
0.171433410894931 |
|
7527 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM201 |
0.171433410894931 |
|
7528 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf200 |
0.171433410894931 |
|
7529 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIK3CD |
0.171433410894931 |
|
7530 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLSTN1 |
0.171433410894931 |
|
7531 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTNNBIP1 |
0.171433410894931 |
|
7532 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LZIC |
0.171433410894931 |
|
7533 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NMNAT1 |
0.171433410894931 |
|
7534 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP269 |
0.171433410894931 |
|
7535 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5697 |
0.171433410894931 |
|
7536 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBP7 |
0.171433410894931 |
|
7537 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE4B |
0.171433410894931 |
|
7538 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF1B |
0.171433410894931 |
|
7539 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1273D |
0.171433410894931 |
|
7540 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL731P |
0.171433410894931 |
|
7541 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL721P |
0.171433410894931 |
|
7542 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGD |
0.171433410894931 |
|
7543 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APITD1 |
0.171433410894931 |
|
7544 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CORT |
0.171433410894931 |
|
7545 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DFFA |
0.171433410894931 |
|
7546 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEX14 |
0.171433410894931 |
|
7547 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL614P |
0.171433410894931 |
|
7548 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASZ1 |
0.171433410894931 |
|
7549 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf127 |
0.171433410894931 |
|
7550 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TARDBP |
0.171433410894931 |
|
7551 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MASP2 |
0.171433410894931 |
|
7552 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRM |
0.171433410894931 |
|
7553 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXOSC10 |
0.171433410894931 |
|
7554 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTOR |
0.171433410894931 |
|
7555 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000271794.1 |
0.171433410894931 |
|
7556 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANGPTL7 |
0.171433410894931 |
|
7557 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBIAD1 |
0.171433410894931 |
|
7558 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTCHD2 |
0.171433410894931 |
|
7559 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO2 |
0.171433410894931 |
|
7560 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO44 |
0.171433410894931 |
|
7561 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO6 |
0.171433410894931 |
|
7562 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAD2L2 |
0.171433410894931 |
|
7563 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DRAXIN |
0.171433410894931 |
|
7564 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGTRAP |
0.171433410894931 |
|
7565 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf167 |
0.171433410894931 |
|
7566 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTHFR |
0.171433410894931 |
|
7567 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLCN6 |
0.171433410894931 |
|
7568 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPPA |
0.171433410894931 |
|
7569 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPPB |
0.171433410894931 |
|
7570 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA2013 |
0.171433410894931 |
|
7571 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLOD1 |
0.171433410894931 |
|
7572 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFN2 |
0.171433410894931 |
|
7573 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIIP |
0.171433410894931 |
|
7574 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL649P |
0.171433410894931 |
|
7575 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFRSF8 |
0.171433410894931 |
|
7576 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFRSF1B |
0.171433410894931 |
|
7577 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4632 |
0.171433410894931 |
|
7578 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000252969.1 |
0.171433410894931 |
|
7579 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS13D |
0.171433410894931 |
|
7580 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA59A |
0.171433410894931 |
|
7581 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHRS3 |
0.171433410894931 |
|
7582 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC18P |
0.171433410894931 |
|
7583 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AADACL4 |
0.171433410894931 |
|
7584 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AADACL3 |
0.171433410894931 |
|
7585 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238771.1 |
0.171433410894931 |
|
7586 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf158 |
0.171433410894931 |
|
7587 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPCL1 |
0.171433410894931 |
|
7588 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAMEF10 |
0.171433410894931 |
|
7589 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAMEF11 |
0.171433410894931 |
|
7590 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAMEF12 |
0.171433410894931 |
|
7591 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAMEF13 |
0.171433410894931 |
|
7592 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAMEF14 |
0.171433410894931 |
|
7593 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAMEF15 |
0.171433410894931 |
|
7594 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAMEF16 |
0.171433410894931 |
|
7595 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAMEF17 |
0.171433410894931 |
|
7596 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAMEF18 |
0.171433410894931 |
|
7597 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAMEF19 |
0.171433410894931 |
|
7598 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAMEF1 |
0.171433410894931 |
|
7599 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAMEF21 |
0.171433410894931 |
|
7600 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAMEF22 |
0.171433410894931 |
|
7601 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAMEF2 |
0.171433410894931 |
|
7602 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAMEF3 |
0.171433410894931 |
|
7603 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAMEF4 |
0.171433410894931 |
|
7604 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAMEF5 |
0.171433410894931 |
|
7605 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAMEF6 |
0.171433410894931 |
|
7606 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAMEF7 |
0.171433410894931 |
|
7607 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAMEF8 |
0.171433410894931 |
|
7608 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAMEF9 |
0.171433410894931 |
|
7609 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAMEF20 |
0.171433410894931 |
|
7610 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC38 |
0.171433410894931 |
|
7611 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDPN |
0.171433410894931 |
|
7612 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP41 |
0.171433410894931 |
|
7613 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA11|ENSG00000253085.1 |
0.171433410894931 |
|
7614 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRDM2 |
0.171433410894931 |
|
7615 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KAZN |
0.171433410894931 |
|
7616 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM51 |
0.171433410894931 |
|
7617 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf195 |
0.171433410894931 |
|
7618 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FHAD1 |
0.171433410894931 |
|
7619 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFHD2 |
0.171433410894931 |
|
7620 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTRC |
0.171433410894931 |
|
7621 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CELA2A |
0.171433410894931 |
|
7622 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CELA2B |
0.171433410894931 |
|
7623 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASP9 |
0.171433410894931 |
|
7624 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC16 |
0.171433410894931 |
|
7625 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA21|ENSG00000251866.1 |
0.171433410894931 |
|
7626 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGMAT |
0.171433410894931 |
|
7627 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDI2 |
0.171433410894931 |
|
7628 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RSC1A1 |
0.171433410894931 |
|
7629 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHM2 |
0.171433410894931 |
|
7630 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBLIM1 |
0.171433410894931 |
|
7631 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A34 |
0.171433410894931 |
|
7632 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM82 |
0.171433410894931 |
|
7633 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPEN |
0.171433410894931 |
|
7634 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238818.1 |
0.171433410894931 |
|
7635 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB17 |
0.171433410894931 |
|
7636 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf64 |
0.171433410894931 |
|
7637 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPB7 |
0.171433410894931 |
|
7638 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLCNKA |
0.171433410894931 |
|
7639 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLCNKB |
0.171433410894931 |
|
7640 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM131C |
0.171433410894931 |
|
7641 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPHA2 |
0.171433410894931 |
|
7642 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF19 |
0.171433410894931 |
|
7643 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANO7P1 |
0.171433410894931 |
|
7644 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf134 |
0.171433410894931 |
|
7645 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RSG1 |
0.171433410894931 |
|
7646 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO42 |
0.171433410894931 |
|
7647 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SZRD1 |
0.171433410894931 |
|
7648 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA21 |
0.171433410894931 |
|
7649 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NECAP2 |
0.171433410894931 |
|
7650 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CROCCP3 |
0.171433410894931 |
|
7651 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP13A2 |
0.171433410894931 |
|
7652 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CROCCP2 |
0.171433410894931 |
|
7653 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CROCC |
0.171433410894931 |
|
7654 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ESPNP |
0.171433410894931 |
|
7655 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFAP2 |
0.171433410894931 |
|
7656 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3675 |
0.171433410894931 |
|
7657 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MST1L |
0.171433410894931 |
|
7658 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBPF1 |
0.171433410894931 |
|
7659 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U1|ENSG00000228549.2 |
0.171433410894931 |
|
7660 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U1|ENSG00000233421.3 |
0.171433410894931 |
|
7661 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDHB |
0.171433410894931 |
|
7662 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PADI2 |
0.171433410894931 |
|
7663 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PADI1 |
0.171433410894931 |
|
7664 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PADI3 |
0.171433410894931 |
|
7665 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3972 |
0.171433410894931 |
|
7666 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PADI4 |
0.171433410894931 |
|
7667 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PADI6 |
0.171433410894931 |
|
7668 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RCC2 |
0.171433410894931 |
|
7669 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239020.1 |
0.171433410894931 |
|
7670 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF10L |
0.171433410894931 |
|
7671 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTL8 |
0.171433410894931 |
|
7672 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGSF21 |
0.171433410894931 |
|
7673 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHDC7A |
0.171433410894931 |
|
7674 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAX7 |
0.171433410894931 |
|
7675 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS1R2 |
0.171433410894931 |
|
7676 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALDH4A1 |
0.171433410894931 |
|
7677 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4695 |
0.171433410894931 |
|
7678 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1290 |
0.171433410894931 |
|
7679 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFFO2 |
0.171433410894931 |
|
7680 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBR4 |
0.171433410894931 |
|
7681 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMC1 |
0.171433410894931 |
|
7682 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRTO4 |
0.171433410894931 |
|
7683 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKR7A3 |
0.171433410894931 |
|
7684 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKR7L |
0.171433410894931 |
|
7685 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKR7A2 |
0.171433410894931 |
|
7686 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PQLC2 |
0.171433410894931 |
|
7687 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL85P |
0.171433410894931 |
|
7688 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPZB |
0.171433410894931 |
|
7689 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL277P |
0.171433410894931 |
|
7690 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239027.1 |
0.171433410894931 |
|
7691 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MINOS1 |
0.171433410894931 |
|
7692 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBL1 |
0.171433410894931 |
|
7693 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTR6 |
0.171433410894931 |
|
7694 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMCO4 |
0.171433410894931 |
|
7695 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF186 |
0.171433410894931 |
|
7696 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OTUD3 |
0.171433410894931 |
|
7697 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLA2G2E |
0.171433410894931 |
|
7698 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLA2G2A |
0.171433410894931 |
|
7699 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL304P |
0.171433410894931 |
|
7700 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1256 |
0.171433410894931 |
|
7701 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ECE1 |
0.171433410894931 |
|
7702 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBPF3 |
0.171433410894931 |
|
7703 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALPL |
0.171433410894931 |
|
7704 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAP1GAP |
0.171433410894931 |
|
7705 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL136P |
0.171433410894931 |
|
7706 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZMYM4 |
0.171433410894931 |
|
7707 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL503P |
0.171433410894931 |
|
7708 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA62|ENSG00000201542.1 |
0.171433410894931 |
|
7709 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY5P1 |
0.171433410894931 |
|
7710 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0319L |
0.171433410894931 |
|
7711 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCDN |
0.171433410894931 |
|
7712 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFAP2E |
0.171433410894931 |
|
7713 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMB2 |
0.171433410894931 |
|
7714 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL281P |
0.171433410894931 |
|
7715 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf216 |
0.171433410894931 |
|
7716 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLSPN |
0.171433410894931 |
|
7717 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGO4 |
0.171433410894931 |
|
7718 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGO1 |
0.171433410894931 |
|
7719 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGO3 |
0.171433410894931 |
|
7720 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEKT2 |
0.171433410894931 |
|
7721 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADPRHL2 |
0.171433410894931 |
|
7722 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL8A2 |
0.171433410894931 |
|
7723 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAPPC3 |
0.171433410894931 |
|
7724 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP7D1 |
0.171433410894931 |
|
7725 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL131P |
0.171433410894931 |
|
7726 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THRAP3 |
0.171433410894931 |
|
7727 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3D21 |
0.171433410894931 |
|
7728 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EVA1B |
0.171433410894931 |
|
7729 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STK40 |
0.171433410894931 |
|
7730 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LSM10 |
0.171433410894931 |
|
7731 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSCP1 |
0.171433410894931 |
|
7732 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA63|ENSG00000201448.1 |
0.171433410894931 |
|
7733 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS15 |
0.171433410894931 |
|
7734 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSF3R |
0.171433410894931 |
|
7735 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRIK3 |
0.171433410894931 |
|
7736 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4255 |
0.171433410894931 |
|
7737 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP43 |
0.171433410894931 |
|
7738 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZC3H12A |
0.171433410894931 |
|
7739 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEAF6 |
0.171433410894931 |
|
7740 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5581 |
0.171433410894931 |
|
7741 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNIP1 |
0.171433410894931 |
|
7742 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNALI1 |
0.171433410894931 |
|
7743 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNL2 |
0.171433410894931 |
|
7744 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RSPO1 |
0.171433410894931 |
|
7745 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf109 |
0.171433410894931 |
|
7746 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDCA8 |
0.171433410894931 |
|
7747 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPHA10 |
0.171433410894931 |
|
7748 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238871.1 |
0.171433410894931 |
|
7749 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MANEAL |
0.171433410894931 |
|
7750 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YRDC |
0.171433410894931 |
|
7751 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf122 |
0.171433410894931 |
|
7752 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTF1 |
0.171433410894931 |
|
7753 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INPP5B |
0.171433410894931 |
|
7754 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA63|ENSG00000252448.1 |
0.171433410894931 |
|
7755 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SF3A3 |
0.171433410894931 |
|
7756 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FHL3 |
0.171433410894931 |
|
7757 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UTP11L |
0.171433410894931 |
|
7758 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POU3F1 |
0.171433410894931 |
|
7759 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3659 |
0.171433410894931 |
|
7760 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRAGC |
0.171433410894931 |
|
7761 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYCBP |
0.171433410894931 |
|
7762 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GJA9 |
0.171433410894931 |
|
7763 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHBDL2 |
0.171433410894931 |
|
7764 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKIRIN1 |
0.171433410894931 |
|
7765 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFS5 |
0.171433410894931 |
|
7766 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP44 |
0.171433410894931 |
|
7767 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0754 |
0.171433410894931 |
|
7768 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PABPC4 |
0.171433410894931 |
|
7769 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA55 |
0.171433410894931 |
|
7770 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HEYL |
0.171433410894931 |
|
7771 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HPCAL4 |
0.171433410894931 |
|
7772 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NT5C1A |
0.171433410894931 |
|
7773 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPIE |
0.171433410894931 |
|
7774 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BMP8B |
0.171433410894931 |
|
7775 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OXCT2 |
0.171433410894931 |
|
7776 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIT1 |
0.171433410894931 |
|
7777 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYCL |
0.171433410894931 |
|
7778 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFSD2A |
0.171433410894931 |
|
7779 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAP1 |
0.171433410894931 |
|
7780 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPT1 |
0.171433410894931 |
|
7781 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RLF |
0.171433410894931 |
|
7782 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMCO2 |
0.171433410894931 |
|
7783 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZMPSTE24 |
0.171433410894931 |
|
7784 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL9A2 |
0.171433410894931 |
|
7785 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMAP2 |
0.171433410894931 |
|
7786 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFP69B |
0.171433410894931 |
|
7787 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFP69 |
0.171433410894931 |
|
7788 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXO5 |
0.171433410894931 |
|
7789 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF684 |
0.171433410894931 |
|
7790 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIMS3 |
0.171433410894931 |
|
7791 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFYC |
0.171433410894931 |
|
7792 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR30E |
0.171433410894931 |
|
7793 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR30C1 |
0.171433410894931 |
|
7794 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNQ4 |
0.171433410894931 |
|
7795 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL326P |
0.171433410894931 |
|
7796 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CITED4 |
0.171433410894931 |
|
7797 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTPS1 |
0.171433410894931 |
|
7798 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLFNL1 |
0.171433410894931 |
|
7799 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCMH1 |
0.171433410894931 |
|
7800 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXO6 |
0.171433410894931 |
|
7801 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP45 |
0.171433410894931 |
|
7802 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EDN2 |
0.171433410894931 |
|
7803 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GUCA2B |
0.171433410894931 |
|
7804 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GUCA2A |
0.171433410894931 |
|
7805 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXJ3 |
0.171433410894931 |
|
7806 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIMKLA |
0.171433410894931 |
|
7807 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZMYND12 |
0.171433410894931 |
|
7808 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPCS |
0.171433410894931 |
|
7809 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC30 |
0.171433410894931 |
|
7810 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPIH |
0.171433410894931 |
|
7811 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YBX1 |
0.171433410894931 |
|
7812 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLDN19 |
0.171433410894931 |
|
7813 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LEPRE1 |
0.171433410894931 |
|
7814 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf50 |
0.171433410894931 |
|
7815 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC23 |
0.171433410894931 |
|
7816 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERMAP |
0.171433410894931 |
|
7817 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF691 |
0.171433410894931 |
|
7818 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC2A1 |
0.171433410894931 |
|
7819 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM183A |
0.171433410894931 |
|
7820 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EBNA1BP2 |
0.171433410894931 |
|
7821 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR65 |
0.171433410894931 |
|
7822 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP46 |
0.171433410894931 |
|
7823 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM125 |
0.171433410894931 |
|
7824 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf210 |
0.171433410894931 |
|
7825 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIE1 |
0.171433410894931 |
|
7826 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPL |
0.171433410894931 |
|
7827 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC20 |
0.171433410894931 |
|
7828 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELOVL1 |
0.171433410894931 |
|
7829 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED8 |
0.171433410894931 |
|
7830 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SZT2 |
0.171433410894931 |
|
7831 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HYI |
0.171433410894931 |
|
7832 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPRF |
0.171433410894931 |
|
7833 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KDM4A |
0.171433410894931 |
|
7834 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST3GAL3 |
0.171433410894931 |
|
7835 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARTN |
0.171433410894931 |
|
7836 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IPO13 |
0.171433410894931 |
|
7837 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPH2 |
0.171433410894931 |
|
7838 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6V0B |
0.171433410894931 |
|
7839 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B4GALT2 |
0.171433410894931 |
|
7840 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC24 |
0.171433410894931 |
|
7841 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC6A9 |
0.171433410894931 |
|
7842 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLF17 |
0.171433410894931 |
|
7843 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL479P |
0.171433410894931 |
|
7844 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DMAP1 |
0.171433410894931 |
|
7845 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERI3 |
0.171433410894931 |
|
7846 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF220 |
0.171433410894931 |
|
7847 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5584 |
0.171433410894931 |
|
7848 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM53 |
0.171433410894931 |
|
7849 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF2C |
0.171433410894931 |
|
7850 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BEST4 |
0.171433410894931 |
|
7851 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTBD19 |
0.171433410894931 |
|
7852 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLK3 |
0.171433410894931 |
|
7853 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS8 |
0.171433410894931 |
|
7854 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD38A |
0.171433410894931 |
|
7855 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD38B |
0.171433410894931 |
|
7856 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD46|ENSG00000200913.1 |
0.171433410894931 |
|
7857 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD55 |
0.171433410894931 |
|
7858 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCTEX1D4 |
0.171433410894931 |
|
7859 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTCH2 |
0.171433410894931 |
|
7860 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF2B3 |
0.171433410894931 |
|
7861 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP47 |
0.171433410894931 |
|
7862 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HECTD3 |
0.171433410894931 |
|
7863 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UROD |
0.171433410894931 |
|
7864 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSWIM5 |
0.171433410894931 |
|
7865 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HPDL |
0.171433410894931 |
|
7866 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUTYH |
0.171433410894931 |
|
7867 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TESK2 |
0.171433410894931 |
|
7868 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOE1 |
0.171433410894931 |
|
7869 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238945.1 |
0.171433410894931 |
|
7870 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC163P |
0.171433410894931 |
|
7871 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMACHC |
0.171433410894931 |
|
7872 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRDX1 |
0.171433410894931 |
|
7873 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKR1A1 |
0.171433410894931 |
|
7874 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NASP |
0.171433410894931 |
|
7875 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC17 |
0.171433410894931 |
|
7876 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPBP1L1 |
0.171433410894931 |
|
7877 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM69 |
0.171433410894931 |
|
7878 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IPP |
0.171433410894931 |
|
7879 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAST2 |
0.171433410894931 |
|
7880 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIK3R3 |
0.171433410894931 |
|
7881 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPAN1 |
0.171433410894931 |
|
7882 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POMGNT1 |
0.171433410894931 |
|
7883 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LURAP1 |
0.171433410894931 |
|
7884 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAD54L |
0.171433410894931 |
|
7885 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC41 |
0.171433410894931 |
|
7886 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UQCRH |
0.171433410894931 |
|
7887 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NSUN4 |
0.171433410894931 |
|
7888 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAAH |
0.171433410894931 |
|
7889 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00505 |
0.171433410894931 |
|
7890 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DMBX1 |
0.171433410894931 |
|
7891 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KNCN |
0.171433410894931 |
|
7892 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MKNK1 |
0.171433410894931 |
|
7893 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOB3C |
0.171433410894931 |
|
7894 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATPAF1 |
0.171433410894931 |
|
7895 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFCAB14 |
0.171433410894931 |
|
7896 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX38 |
0.171433410894931 |
|
7897 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP4B1 |
0.171433410894931 |
|
7898 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP4Z2P |
0.171433410894931 |
|
7899 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP4A11 |
0.171433410894931 |
|
7900 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP4X1 |
0.171433410894931 |
|
7901 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP4Z1 |
0.171433410894931 |
|
7902 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP4A22 |
0.171433410894931 |
|
7903 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00853 |
0.171433410894931 |
|
7904 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDZK1IP1 |
0.171433410894931 |
|
7905 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAL1 |
0.171433410894931 |
|
7906 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STIL |
0.171433410894931 |
|
7907 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CMPK1 |
0.171433410894931 |
|
7908 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXE3 |
0.171433410894931 |
|
7909 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXD2 |
0.171433410894931 |
|
7910 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRABD2B |
0.171433410894931 |
|
7911 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SKINTL |
0.171433410894931 |
|
7912 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC5A9 |
0.171433410894931 |
|
7913 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA6 |
0.171433410894931 |
|
7914 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGBL4 |
0.171433410894931 |
|
7915 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BEND5 |
0.171433410894931 |
|
7916 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RERE |
0.171496355731612 |
|
7917 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA77|ENSG00000221083.1 |
0.171496355731612 |
|
7918 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00152 |
0.171859934863551 |
|
7919 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLGLB1 |
0.171859934863551 |
|
7920 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLGLB2 |
0.171859934863551 |
|
7921 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGPD1 |
0.171859934863551 |
|
7922 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGPD2 |
0.171859934863551 |
|
7923 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238979.1 |
0.171859934863551 |
|
7924 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRCC1 |
0.171859934863551 |
|
7925 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMYD1 |
0.171859934863551 |
|
7926 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4780 |
0.171859934863551 |
|
7927 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FABP1 |
0.171859934863551 |
|
7928 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THNSL2 |
0.171859934863551 |
|
7929 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P15 |
0.171859934863551 |
|
7930 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239049.1 |
0.171859934863551 |
|
7931 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXI3 |
0.171859934863551 |
|
7932 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGKC |
0.171859934863551 |
|
7933 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGKJ1 |
0.171859934863551 |
|
7934 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGKJ2 |
0.171859934863551 |
|
7935 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGKJ3 |
0.171859934863551 |
|
7936 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGKJ4 |
0.171859934863551 |
|
7937 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGKJ5 |
0.171859934863551 |
|
7938 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP100 |
0.171859934863551 |
|
7939 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC9B1P2 |
0.171859934863551 |
|
7940 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf53 |
0.174149201443949 |
|
7941 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDKN2A |
0.174149201443949 |
|
7942 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCCA |
0.174732597947204 |
|
7943 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VGLL3 |
0.176823058537725 |
|
7944 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHMP2B |
0.176823058537725 |
|
7945 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4795 |
0.176823058537725 |
|
7946 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POU1F1 |
0.176823058537725 |
|
7947 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPRJ |
0.178966103543508 |
|
7948 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BARD1 |
0.179286642610911 |
|
7949 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPATCH2 |
0.179618924458822 |
|
7950 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA17 |
0.179618924458822 |
|
7951 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCB9 |
0.181673491371939 |
|
7952 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL6IP4 |
0.181673491371939 |
|
7953 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OGFOD2 |
0.181673491371939 |
|
7954 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PITPNM2 |
0.181673491371939 |
|
7955 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4304 |
0.181673491371939 |
|
7956 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL133P |
0.181673491371939 |
|
7957 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPHOSPH9 |
0.181673491371939 |
|
7958 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP278 |
0.183004812984172 |
|
7959 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XPNPEP1 |
0.183004812984172 |
|
7960 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U4|ENSG00000272160.1 |
0.183004812984172 |
|
7961 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4A47 |
0.186240097312717 |
|
7962 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4C5 |
0.186240097312717 |
|
7963 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM49B |
0.186240097312717 |
|
7964 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM64C |
0.186240097312717 |
|
7965 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOLH1 |
0.186240097312717 |
|
7966 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4C13 |
0.186240097312717 |
|
7967 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4C12 |
0.186240097312717 |
|
7968 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MACF1 |
0.186879281353705 |
|
7969 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BMP8A |
0.186879281353705 |
|
7970 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHCR7 |
0.187905430356413 |
|
7971 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NADSYN1 |
0.187905430356413 |
|
7972 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UNC93B6 |
0.187905430356413 |
|
7973 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENPP7P8 |
0.187905430356413 |
|
7974 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM86C1 |
0.187905430356413 |
|
7975 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF705E |
0.187905430356413 |
|
7976 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB108B |
0.187905430356413 |
|
7977 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP342 |
0.187905430356413 |
|
7978 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF121 |
0.187905430356413 |
|
7979 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL18BP |
0.187905430356413 |
|
7980 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUMA1 |
0.187905430356413 |
|
7981 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3165 |
0.187905430356413 |
|
7982 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRTOMT |
0.187905430356413 |
|
7983 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAMTOR1 |
0.187905430356413 |
|
7984 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238768.1 |
0.187905430356413 |
|
7985 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANAPC15 |
0.187905430356413 |
|
7986 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOLR3 |
0.187905430356413 |
|
7987 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOLR1 |
0.187905430356413 |
|
7988 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOLR2 |
0.187905430356413 |
|
7989 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INPPL1 |
0.187905430356413 |
|
7990 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHOX2A |
0.187905430356413 |
|
7991 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLPB |
0.187905430356413 |
|
7992 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE2A |
0.187905430356413 |
|
7993 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR139 |
0.187905430356413 |
|
7994 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARAP1 |
0.187905430356413 |
|
7995 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STARD10 |
0.187905430356413 |
|
7996 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4692 |
0.187905430356413 |
|
7997 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATG16L2 |
0.187905430356413 |
|
7998 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCHSD2 |
0.187905430356413 |
|
7999 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
P2RY2 |
0.187905430356413 |
|
8000 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF17 |
0.187905430356413 |
|
8001 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RELT |
0.187905430356413 |
|
8002 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM168A |
0.187905430356413 |
|
8003 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHB1 |
0.187905430356413 |
|
8004 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB6A |
0.187905430356413 |
|
8005 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL48 |
0.187905430356413 |
|
8006 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP243 |
0.187905430356413 |
|
8007 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COA4 |
0.187905430356413 |
|
8008 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAAF1 |
0.187905430356413 |
|
8009 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJB13 |
0.187905430356413 |
|
8010 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UCP2 |
0.187905430356413 |
|
8011 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UCP3 |
0.187905430356413 |
|
8012 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2CD3 |
0.187905430356413 |
|
8013 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPME1 |
0.187905430356413 |
|
8014 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP343 |
0.187905430356413 |
|
8015 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
P4HA3 |
0.187905430356413 |
|
8016 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA7|ENSG00000206913.1 |
0.187905430356413 |
|
8017 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGM2L1 |
0.187905430356413 |
|
8018 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548AL |
0.187905430356413 |
|
8019 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNE3 |
0.187905430356413 |
|
8020 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIPT2 |
0.187905430356413 |
|
8021 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLD3 |
0.187905430356413 |
|
8022 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP297 |
0.187905430356413 |
|
8023 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRDL2 |
0.187905430356413 |
|
8024 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD43|ENSG00000212277.1 |
0.187905430356413 |
|
8025 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4696 |
0.187905430356413 |
|
8026 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF169 |
0.187905430356413 |
|
8027 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XRRA1 |
0.187905430356413 |
|
8028 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL239P |
0.187905430356413 |
|
8029 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPCS2 |
0.187905430356413 |
|
8030 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEU3 |
0.187905430356413 |
|
8031 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2AT4 |
0.187905430356413 |
|
8032 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLCO2B1 |
0.187905430356413 |
|
8033 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPBGL |
0.187905430356413 |
|
8034 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARRB1 |
0.187905430356413 |
|
8035 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR326 |
0.187905430356413 |
|
8036 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS3 |
0.187905430356413 |
|
8037 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD15A |
0.187905430356413 |
|
8038 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD15B |
0.187905430356413 |
|
8039 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL35 |
0.187905430356413 |
|
8040 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GDPD5 |
0.187905430356413 |
|
8041 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINH1 |
0.187905430356413 |
|
8042 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP6 |
0.187905430356413 |
|
8043 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOGAT2 |
0.187905430356413 |
|
8044 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL786P |
0.187905430356413 |
|
8045 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DGAT2 |
0.187905430356413 |
|
8046 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UVRAG |
0.187905430356413 |
|
8047 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP344 |
0.187905430356413 |
|
8048 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WNT11 |
0.187905430356413 |
|
8049 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP112 |
0.189701805140012 |
|
8050 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238295.1 |
0.189701805140012 |
|
8051 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGPS |
0.189701805140012 |
|
8052 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC30A |
0.189701805140012 |
|
8053 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE11A |
0.189701805140012 |
|
8054 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM45 |
0.189701805140012 |
|
8055 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSBPL6 |
0.189701805140012 |
|
8056 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKRA |
0.189701805140012 |
|
8057 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DFNB59 |
0.189701805140012 |
|
8058 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FKBP7 |
0.189701805140012 |
|
8059 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHA3 |
0.189701805140012 |
|
8060 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTN |
0.189701805140012 |
|
8061 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC141 |
0.189701805140012 |
|
8062 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACA59|ENSG00000252000.1 |
0.189701805140012 |
|
8063 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SESTD1 |
0.189701805140012 |
|
8064 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238339.1 |
0.189701805140012 |
|
8065 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF385B |
0.189701805140012 |
|
8066 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1258 |
0.189701805140012 |
|
8067 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA43|ENSG00000202216.1 |
0.189701805140012 |
|
8068 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CWC22 |
0.189701805140012 |
|
8069 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTERF |
0.193419358130812 |
|
8070 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKAP9 |
0.193419358130812 |
|
8071 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP51A1 |
0.193419358130812 |
|
8072 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRD1 |
0.193419358130812 |
|
8073 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRIT1 |
0.193419358130812 |
|
8074 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKIB1 |
0.193419358130812 |
|
8075 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GATAD1 |
0.193419358130812 |
|
8076 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEX1 |
0.193419358130812 |
|
8077 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM48 |
0.193419358130812 |
|
8078 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM133B |
0.193419358130812 |
|
8079 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK6 |
0.193419358130812 |
|
8080 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL7P |
0.193419358130812 |
|
8081 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAMD9 |
0.193419358130812 |
|
8082 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAMD9L |
0.193419358130812 |
|
8083 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HEPACAM2 |
0.193419358130812 |
|
8084 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC132 |
0.193419358130812 |
|
8085 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CALCR |
0.193419358130812 |
|
8086 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR489 |
0.193419358130812 |
|
8087 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR653 |
0.193419358130812 |
|
8088 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNGT1 |
0.193419358130812 |
|
8089 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4652 |
0.193419358130812 |
|
8090 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL872P |
0.193799401506654 |
|
8091 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD20A19P |
0.194507514783299 |
|
8092 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1QTNF9B |
0.194507514783299 |
|
8093 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIPEP |
0.194507514783299 |
|
8094 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA13 |
0.194507514783299 |
|
8095 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFRSF19 |
0.194507514783299 |
|
8096 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR2276 |
0.194507514783299 |
|
8097 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1QTNF9 |
0.194507514783299 |
|
8098 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00566 |
0.194507514783299 |
|
8099 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARP4 |
0.194507514783299 |
|
8100 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPTE2P6 |
0.194507514783299 |
|
8101 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP12A |
0.194507514783299 |
|
8102 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY1P7 |
0.194507514783299 |
|
8103 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF17 |
0.194507514783299 |
|
8104 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CENPJ |
0.194507514783299 |
|
8105 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPTE2P1 |
0.194507514783299 |
|
8106 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LSP1|ENSG00000269099.1 |
0.194507514783299 |
|
8107 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PABPC3 |
0.194507514783299 |
|
8108 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMER2 |
0.194507514783299 |
|
8109 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTMR6 |
0.194507514783299 |
|
8110 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUPL1 |
0.194507514783299 |
|
8111 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP8A2 |
0.194507514783299 |
|
8112 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL289P |
0.194507514783299 |
|
8113 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL741P |
0.194507514783299 |
|
8114 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY1P3 |
0.194507514783299 |
|
8115 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHISA2 |
0.194507514783299 |
|
8116 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00415 |
0.194507514783299 |
|
8117 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF6 |
0.194507514783299 |
|
8118 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK8 |
0.194507514783299 |
|
8119 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WASF3 |
0.194507514783299 |
|
8120 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR12 |
0.194507514783299 |
|
8121 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP12 |
0.194507514783299 |
|
8122 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL21 |
0.194507514783299 |
|
8123 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD102 |
0.194507514783299 |
|
8124 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA27|ENSG00000207051.1 |
0.194507514783299 |
|
8125 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASL11A |
0.194507514783299 |
|
8126 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY1P1 |
0.194507514783299 |
|
8127 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF3A |
0.194507514783299 |
|
8128 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTIF3 |
0.194507514783299 |
|
8129 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LNX2 |
0.194507514783299 |
|
8130 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR1D |
0.194507514783299 |
|
8131 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSX1 |
0.194507514783299 |
|
8132 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP5EP2 |
0.194507514783299 |
|
8133 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDX2 |
0.194507514783299 |
|
8134 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00543 |
0.194507514783299 |
|
8135 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDX1 |
0.194507514783299 |
|
8136 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
URAD |
0.194507514783299 |
|
8137 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL272P |
0.194507514783299 |
|
8138 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLT3 |
0.194507514783299 |
|
8139 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAN3 |
0.194507514783299 |
|
8140 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLT1 |
0.194507514783299 |
|
8141 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POMP |
0.194507514783299 |
|
8142 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC46A3 |
0.194507514783299 |
|
8143 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTUS2 |
0.194507514783299 |
|
8144 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC7A1 |
0.194507514783299 |
|
8145 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBL3 |
0.194507514783299 |
|
8146 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00297 |
0.194507514783299 |
|
8147 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00572 |
0.194507514783299 |
|
8148 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00544 |
0.194507514783299 |
|
8149 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00365 |
0.194507514783299 |
|
8150 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KATNAL1 |
0.194507514783299 |
|
8151 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00427 |
0.194507514783299 |
|
8152 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00426 |
0.194507514783299 |
|
8153 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMGB1 |
0.194507514783299 |
|
8154 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USPL1 |
0.194507514783299 |
|
8155 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALOX5AP |
0.194507514783299 |
|
8156 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00398 |
0.194507514783299 |
|
8157 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00545 |
0.194507514783299 |
|
8158 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEDAG |
0.194507514783299 |
|
8159 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX26 |
0.194507514783299 |
|
8160 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPH1 |
0.194507514783299 |
|
8161 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B3GALTL |
0.194507514783299 |
|
8162 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC1 |
0.194930327012547 |
|
8163 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC30B |
0.196747785634088 |
|
8164 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2E3 |
0.196747785634088 |
|
8165 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4437 |
0.196747785634088 |
|
8166 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGA4 |
0.196747785634088 |
|
8167 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CERKL |
0.196747785634088 |
|
8168 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEUROD1 |
0.196747785634088 |
|
8169 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC19P |
0.196747785634088 |
|
8170 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSFA2 |
0.196747785634088 |
|
8171 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R1C |
0.196747785634088 |
|
8172 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP113 |
0.196747785634088 |
|
8173 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE1A |
0.196747785634088 |
|
8174 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL267P |
0.196747785634088 |
|
8175 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC10 |
0.196747785634088 |
|
8176 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRZB |
0.196747785634088 |
|
8177 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCKAP1 |
0.196747785634088 |
|
8178 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA77|ENSG00000221498.1 |
0.196747785634088 |
|
8179 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUSP19 |
0.196747785634088 |
|
8180 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUP35 |
0.196747785634088 |
|
8181 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238306.1 |
0.196747785634088 |
|
8182 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548AE1 |
0.196747785634088 |
|
8183 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF804A |
0.196747785634088 |
|
8184 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000212598.1 |
0.198826290811707 |
|
8185 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP284 |
0.199751068197149 |
|
8186 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC6P |
0.199751068197149 |
|
8187 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTR1F |
0.199751068197149 |
|
8188 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CGGBP1 |
0.199751068197149 |
|
8189 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF654 |
0.199751068197149 |
|
8190 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf38 |
0.199751068197149 |
|
8191 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPHA3 |
0.199751068197149 |
|
8192 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
P2RY6 |
0.200145336131724 |
|
8193 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPNE4 |
0.201650094992749 |
|
8194 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5704 |
0.201650094992749 |
|
8195 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238701.1 |
0.201650094992749 |
|
8196 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACPP |
0.201650094992749 |
|
8197 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC13 |
0.201650094992749 |
|
8198 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACAD11 |
0.201650094992749 |
|
8199 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPHP3 |
0.201650094992749 |
|
8200 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACKR4 |
0.201650094992749 |
|
8201 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBA5 |
0.201650094992749 |
|
8202 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM108 |
0.201650094992749 |
|
8203 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BFSP2 |
0.201650094992749 |
|
8204 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA33|ENSG00000201827.1 |
0.201650094992749 |
|
8205 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDV3 |
0.201650094992749 |
|
8206 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOPBP1 |
0.201650094992749 |
|
8207 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFP1 |
0.201650094992749 |
|
8208 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP140 |
0.201650094992749 |
|
8209 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TF |
0.201650094992749 |
|
8210 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRPRB |
0.201650094992749 |
|
8211 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB6B |
0.201650094992749 |
|
8212 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf36 |
0.201650094992749 |
|
8213 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLCO2A1 |
0.201650094992749 |
|
8214 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RYK |
0.201650094992749 |
|
8215 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL39P5 |
0.201650094992749 |
|
8216 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMOTL2 |
0.201650094992749 |
|
8217 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4788 |
0.201650094992749 |
|
8218 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANAPC13 |
0.201650094992749 |
|
8219 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP63 |
0.201650094992749 |
|
8220 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPHB1 |
0.201650094992749 |
|
8221 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KY |
0.201650094992749 |
|
8222 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP141 |
0.201650094992749 |
|
8223 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4421 |
0.202230458940847 |
|
8224 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf185 |
0.202230458940847 |
|
8225 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238618.1 |
0.202230458940847 |
|
8226 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF11 |
0.202230458940847 |
|
8227 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC39A |
0.202230458940847 |
|
8228 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPS15 |
0.202230458940847 |
|
8229 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSBPL9 |
0.202230458940847 |
|
8230 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA26|ENSG00000212624.1 |
0.202230458940847 |
|
8231 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRD1 |
0.202230458940847 |
|
8232 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR761 |
0.202230458940847 |
|
8233 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB3B |
0.202230458940847 |
|
8234 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP48 |
0.202230458940847 |
|
8235 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL290P |
0.202230458940847 |
|
8236 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TXNDC12 |
0.202230458940847 |
|
8237 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KTI12 |
0.202230458940847 |
|
8238 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTF3L4 |
0.202230458940847 |
|
8239 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGM1 |
0.202230458940847 |
|
8240 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL130P |
0.202230458940847 |
|
8241 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL538P |
0.202230458940847 |
|
8242 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIN1P1 |
0.202230458940847 |
|
8243 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC40 |
0.202230458940847 |
|
8244 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL242P |
0.202230458940847 |
|
8245 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRSF11 |
0.202230458940847 |
|
8246 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD13C |
0.202230458940847 |
|
8247 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HHLA3 |
0.202230458940847 |
|
8248 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTH |
0.202230458940847 |
|
8249 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTGER3 |
0.202230458940847 |
|
8250 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZRANB2 |
0.202230458940847 |
|
8251 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR186 |
0.202230458940847 |
|
8252 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEGR1 |
0.202230458940847 |
|
8253 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP19 |
0.202230458940847 |
|
8254 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP50 |
0.202230458940847 |
|
8255 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU4ATAC8P |
0.202230458940847 |
|
8256 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRIQ3 |
0.202230458940847 |
|
8257 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FPGT |
0.202230458940847 |
|
8258 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNNI3K |
0.202230458940847 |
|
8259 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC53 |
0.202230458940847 |
|
8260 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf173 |
0.202230458940847 |
|
8261 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRYZ |
0.202230458940847 |
|
8262 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TYW3 |
0.202230458940847 |
|
8263 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP48 |
0.204569452206933 |
|
8264 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LDLRAD2 |
0.204569452206933 |
|
8265 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPG2 |
0.204569452206933 |
|
8266 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC42 |
0.204569452206933 |
|
8267 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CELA3A |
0.204569452206933 |
|
8268 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CELA3B |
0.204569452206933 |
|
8269 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00339 |
0.204569452206933 |
|
8270 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL186P |
0.204569452206933 |
|
8271 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL386P |
0.204569452206933 |
|
8272 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL421P |
0.204569452206933 |
|
8273 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL768P |
0.204569452206933 |
|
8274 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WNT4 |
0.204569452206933 |
|
8275 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4418 |
0.204569452206933 |
|
8276 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB40 |
0.204569452206933 |
|
8277 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPHA8 |
0.204569452206933 |
|
8278 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1QA |
0.204569452206933 |
|
8279 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1QC |
0.204569452206933 |
|
8280 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1QB |
0.204569452206933 |
|
8281 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPHB2 |
0.204569452206933 |
|
8282 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4684 |
0.204569452206933 |
|
8283 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4253 |
0.204569452206933 |
|
8284 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LACTBL1 |
0.204569452206933 |
|
8285 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf234 |
0.204569452206933 |
|
8286 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KDM1A |
0.204569452206933 |
|
8287 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3115 |
0.204569452206933 |
|
8288 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4419A |
0.204569452206933 |
|
8289 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LUZP1 |
0.204569452206933 |
|
8290 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTR1D |
0.204569452206933 |
|
8291 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPR |
0.204569452206933 |
|
8292 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF436 |
0.204569452206933 |
|
8293 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf213 |
0.204569452206933 |
|
8294 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCEA3 |
0.204569452206933 |
|
8295 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASAP3 |
0.204569452206933 |
|
8296 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
E2F2 |
0.204569452206933 |
|
8297 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ID3 |
0.204569452206933 |
|
8298 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MDS2 |
0.204569452206933 |
|
8299 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL11 |
0.204569452206933 |
|
8300 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL532P |
0.204569452206933 |
|
8301 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCEB3 |
0.204569452206933 |
|
8302 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PITHD1 |
0.204569452206933 |
|
8303 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALE |
0.204569452206933 |
|
8304 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMGCL |
0.204569452206933 |
|
8305 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYPLA2 |
0.204569452206933 |
|
8306 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FUCA1 |
0.204569452206933 |
|
8307 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNR2 |
0.204569452206933 |
|
8308 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL24P |
0.204569452206933 |
|
8309 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238538.1 |
0.204569452206933 |
|
8310 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR378F |
0.204569452206933 |
|
8311 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNRC2 |
0.204569452206933 |
|
8312 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRSF10 |
0.204569452206933 |
|
8313 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYOM3 |
0.204569452206933 |
|
8314 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL22RA1 |
0.204569452206933 |
|
8315 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNLR1 |
0.204569452206933 |
|
8316 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRHL3 |
0.204569452206933 |
|
8317 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STPG1 |
0.204569452206933 |
|
8318 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NIPAL3 |
0.204569452206933 |
|
8319 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RCAN3 |
0.204569452206933 |
|
8320 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL857P |
0.204569452206933 |
|
8321 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCMAP |
0.204569452206933 |
|
8322 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRRM1 |
0.204569452206933 |
|
8323 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238986.1 |
0.204569452206933 |
|
8324 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLIC4 |
0.204569452206933 |
|
8325 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RUNX3 |
0.204569452206933 |
|
8326 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4425 |
0.204569452206933 |
|
8327 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf63 |
0.204569452206933 |
|
8328 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHCE |
0.204569452206933 |
|
8329 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHD |
0.204569452206933 |
|
8330 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYF2 |
0.204569452206933 |
|
8331 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM50A |
0.204569452206933 |
|
8332 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238889.1 |
0.204569452206933 |
|
8333 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM57 |
0.204569452206933 |
|
8334 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LDLRAP1 |
0.204569452206933 |
|
8335 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAN1C1 |
0.204569452206933 |
|
8336 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEPN1 |
0.204569452206933 |
|
8337 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTFR1L |
0.204569452206933 |
|
8338 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AUNIP |
0.204569452206933 |
|
8339 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAQR7 |
0.204569452206933 |
|
8340 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STMN1 |
0.204569452206933 |
|
8341 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3917 |
0.204569452206933 |
|
8342 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAFAH2 |
0.204569452206933 |
|
8343 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA17|ENSG00000252190.1 |
0.204569452206933 |
|
8344 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA18|ENSG00000252691.1 |
0.204569452206933 |
|
8345 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXTL1 |
0.204569452206933 |
|
8346 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC30A2 |
0.204569452206933 |
|
8347 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM63 |
0.204569452206933 |
|
8348 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDIK1L |
0.204569452206933 |
|
8349 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM110D |
0.204569452206933 |
|
8350 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF593 |
0.204569452206933 |
|
8351 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNKSR1 |
0.204569452206933 |
|
8352 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CATSPER4 |
0.204569452206933 |
|
8353 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP85 |
0.204569452206933 |
|
8354 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3BGRL3 |
0.204569452206933 |
|
8355 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBXN11 |
0.204569452206933 |
|
8356 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AIM1L |
0.204569452206933 |
|
8357 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD52 |
0.204569452206933 |
|
8358 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL490P |
0.204569452206933 |
|
8359 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF683 |
0.204569452206933 |
|
8360 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIN28A |
0.204569452206933 |
|
8361 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHDDS |
0.204569452206933 |
|
8362 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMGN2 |
0.204569452206933 |
|
8363 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS6KA1 |
0.204569452206933 |
|
8364 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1976 |
0.204569452206933 |
|
8365 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL679P |
0.204569452206933 |
|
8366 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238316.1 |
0.204569452206933 |
|
8367 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARID1A |
0.204569452206933 |
|
8368 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL501P |
0.204569452206933 |
|
8369 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIGV |
0.204569452206933 |
|
8370 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL165P |
0.204569452206933 |
|
8371 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDHHC18 |
0.204569452206933 |
|
8372 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFN |
0.204569452206933 |
|
8373 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPN2 |
0.204569452206933 |
|
8374 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPATCH3 |
0.204569452206933 |
|
8375 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDC |
0.204569452206933 |
|
8376 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NR0B2 |
0.204569452206933 |
|
8377 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf172 |
0.204569452206933 |
|
8378 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRNP1 |
0.204569452206933 |
|
8379 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM46B |
0.204569452206933 |
|
8380 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC9A1 |
0.204569452206933 |
|
8381 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDTC1 |
0.204569452206933 |
|
8382 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM222 |
0.204569452206933 |
|
8383 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYTL1 |
0.204569452206933 |
|
8384 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP3K6 |
0.204569452206933 |
|
8385 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCN3 |
0.204569452206933 |
|
8386 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD164L2 |
0.204569452206933 |
|
8387 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR3 |
0.204569452206933 |
|
8388 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WASF2 |
0.204569452206933 |
|
8389 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AHDC1 |
0.204569452206933 |
|
8390 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGR |
0.204569452206933 |
|
8391 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFI6 |
0.204569452206933 |
|
8392 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM76A |
0.204569452206933 |
|
8393 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STX12 |
0.204569452206933 |
|
8394 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R8 |
0.204569452206933 |
|
8395 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA1 |
0.204569452206933 |
|
8396 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THEMIS2 |
0.204569452206933 |
|
8397 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPA2 |
0.204569452206933 |
|
8398 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMPDL3B |
0.204569452206933 |
|
8399 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XKR8 |
0.204569452206933 |
|
8400 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EYA3 |
0.204569452206933 |
|
8401 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL559P |
0.204569452206933 |
|
8402 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTAFR |
0.204569452206933 |
|
8403 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC8 |
0.204569452206933 |
|
8404 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATPIF1 |
0.204569452206933 |
|
8405 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SESN2 |
0.204569452206933 |
|
8406 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED18 |
0.204569452206933 |
|
8407 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHACTR4 |
0.204569452206933 |
|
8408 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC27P |
0.204569452206933 |
|
8409 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RCC1 |
0.204569452206933 |
|
8410 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNHG3 |
0.204569452206933 |
|
8411 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA73B |
0.204569452206933 |
|
8412 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238821.1 |
0.204569452206933 |
|
8413 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRNAU1AP |
0.204569452206933 |
|
8414 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNHG12 |
0.204569452206933 |
|
8415 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD99 |
0.204569452206933 |
|
8416 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAF12 |
0.204569452206933 |
|
8417 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB42 |
0.204569452206933 |
|
8418 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU11 |
0.204569452206933 |
|
8419 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GMEB1 |
0.204569452206933 |
|
8420 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA24|ENSG00000252777.1 |
0.204569452206933 |
|
8421 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YTHDF2 |
0.204569452206933 |
|
8422 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OPRD1 |
0.204569452206933 |
|
8423 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPB41 |
0.204569452206933 |
|
8424 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM200B |
0.204569452206933 |
|
8425 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRSF4 |
0.204569452206933 |
|
8426 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MECR |
0.204569452206933 |
|
8427 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPRU |
0.204569452206933 |
|
8428 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAPTM5 |
0.204569452206933 |
|
8429 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MATN1 |
0.204569452206933 |
|
8430 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4420 |
0.204569452206933 |
|
8431 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP91 |
0.204569452206933 |
|
8432 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDC3 |
0.204569452206933 |
|
8433 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PUM1 |
0.204569452206933 |
|
8434 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD103A |
0.204569452206933 |
|
8435 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD103B |
0.204569452206933 |
|
8436 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD85 |
0.204569452206933 |
|
8437 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NKAIN1 |
0.204569452206933 |
|
8438 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNRNP40 |
0.204569452206933 |
|
8439 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZCCHC17 |
0.204569452206933 |
|
8440 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FABP3 |
0.204569452206933 |
|
8441 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERINC2 |
0.204569452206933 |
|
8442 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TINAGL1 |
0.204569452206933 |
|
8443 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCRTR1 |
0.204569452206933 |
|
8444 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEF1 |
0.204569452206933 |
|
8445 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL16A1 |
0.204569452206933 |
|
8446 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAI2 |
0.204569452206933 |
|
8447 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4254 |
0.204569452206933 |
|
8448 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPOCD1 |
0.204569452206933 |
|
8449 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTP4A2 |
0.204569452206933 |
|
8450 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KHDRBS1 |
0.204569452206933 |
|
8451 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM39B |
0.204569452206933 |
|
8452 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5585 |
0.204569452206933 |
|
8453 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KPNA6 |
0.204569452206933 |
|
8454 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TXLNA |
0.204569452206933 |
|
8455 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC28B |
0.204569452206933 |
|
8456 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IQCC |
0.204569452206933 |
|
8457 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCDC2B |
0.204569452206933 |
|
8458 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM234 |
0.204569452206933 |
|
8459 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF3I |
0.204569452206933 |
|
8460 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTMR9LP |
0.204569452206933 |
|
8461 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM167B |
0.204569452206933 |
|
8462 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCK |
0.204569452206933 |
|
8463 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HDAC1 |
0.204569452206933 |
|
8464 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MARCKSL1 |
0.204569452206933 |
|
8465 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSSK3 |
0.204569452206933 |
|
8466 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BSDC1 |
0.204569452206933 |
|
8467 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM229A |
0.204569452206933 |
|
8468 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL122P |
0.204569452206933 |
|
8469 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB8B |
0.204569452206933 |
|
8470 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB8A |
0.204569452206933 |
|
8471 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB8OS |
0.204569452206933 |
|
8472 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBBP4 |
0.204569452206933 |
|
8473 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYNC |
0.204569452206933 |
|
8474 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1522 |
0.204569452206933 |
|
8475 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YARS |
0.204569452206933 |
|
8476 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S100PBP |
0.204569452206933 |
|
8477 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FNDC5 |
0.204569452206933 |
|
8478 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HPCA |
0.204569452206933 |
|
8479 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM54 |
0.204569452206933 |
|
8480 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF19B |
0.204569452206933 |
|
8481 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FKSG48 |
0.204569452206933 |
|
8482 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AK2 |
0.204569452206933 |
|
8483 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADC |
0.204569452206933 |
|
8484 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM62 |
0.204569452206933 |
|
8485 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF362 |
0.204569452206933 |
|
8486 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
A3GALT2 |
0.204569452206933 |
|
8487 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHC2 |
0.204569452206933 |
|
8488 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3605 |
0.204569452206933 |
|
8489 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP16 |
0.204569452206933 |
|
8490 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSCAN20 |
0.204569452206933 |
|
8491 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSMD2 |
0.204569452206933 |
|
8492 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMGB4 |
0.204569452206933 |
|
8493 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP42 |
0.204569452206933 |
|
8494 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf94 |
0.204569452206933 |
|
8495 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR552 |
0.204569452206933 |
|
8496 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMIM12 |
0.204569452206933 |
|
8497 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GJB5 |
0.204569452206933 |
|
8498 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GJB4 |
0.204569452206933 |
|
8499 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GJB3 |
0.204569452206933 |
|
8500 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GJA4 |
0.204569452206933 |
|
8501 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLGAP3 |
0.204569452206933 |
|
8502 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252728.1 |
0.204569452206933 |
|
8503 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZMYM6NB |
0.204569452206933 |
|
8504 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZMYM6 |
0.204569452206933 |
|
8505 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZMYM1 |
0.204569452206933 |
|
8506 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFPQ |
0.204569452206933 |
|
8507 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239144.1 |
0.204569452206933 |
|
8508 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELAVL4 |
0.204569452206933 |
|
8509 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFYVE9 |
0.204569452206933 |
|
8510 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL788P |
0.204569452206933 |
|
8511 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CC2D1B |
0.204569452206933 |
|
8512 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ORC1 |
0.204569452206933 |
|
8513 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRPF38A |
0.204569452206933 |
|
8514 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZCCHC11 |
0.204569452206933 |
|
8515 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239063.1 |
0.204569452206933 |
|
8516 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPX7 |
0.204569452206933 |
|
8517 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM159A |
0.204569452206933 |
|
8518 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SELRC1 |
0.204569452206933 |
|
8519 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL62P |
0.204569452206933 |
|
8520 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZYG11B |
0.204569452206933 |
|
8521 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZYG11A |
0.204569452206933 |
|
8522 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ECHDC2 |
0.204569452206933 |
|
8523 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCP2 |
0.204569452206933 |
|
8524 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1273F |
0.204569452206933 |
|
8525 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5095 |
0.204569452206933 |
|
8526 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1273G |
0.204569452206933 |
|
8527 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PODN |
0.204569452206933 |
|
8528 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC1A7 |
0.204569452206933 |
|
8529 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPT2 |
0.204569452206933 |
|
8530 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf123 |
0.204569452206933 |
|
8531 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGOH |
0.204569452206933 |
|
8532 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRP8 |
0.204569452206933 |
|
8533 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A3P1 |
0.204569452206933 |
|
8534 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DMRTB1 |
0.204569452206933 |
|
8535 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLIS1 |
0.204569452206933 |
|
8536 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDC1 |
0.204569452206933 |
|
8537 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA58|ENSG00000201003.1 |
0.204569452206933 |
|
8538 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YIPF1 |
0.204569452206933 |
|
8539 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DIO1 |
0.204569452206933 |
|
8540 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPB11 |
0.204569452206933 |
|
8541 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC42 |
0.204569452206933 |
|
8542 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LDLRAD1 |
0.204569452206933 |
|
8543 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM59 |
0.204569452206933 |
|
8544 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4781 |
0.204569452206933 |
|
8545 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCEANC2 |
0.204569452206933 |
|
8546 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDCP2 |
0.204569452206933 |
|
8547 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYB5RL |
0.204569452206933 |
|
8548 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL37 |
0.204569452206933 |
|
8549 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSBP3 |
0.204569452206933 |
|
8550 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf191 |
0.204569452206933 |
|
8551 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252646.1 |
0.204569452206933 |
|
8552 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACOT11 |
0.204569452206933 |
|
8553 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM151A |
0.204569452206933 |
|
8554 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MROH7 |
0.204569452206933 |
|
8555 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC4 |
0.204569452206933 |
|
8556 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf177 |
0.204569452206933 |
|
8557 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARS2 |
0.204569452206933 |
|
8558 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC22 |
0.204569452206933 |
|
8559 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHCR24 |
0.204569452206933 |
|
8560 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM61 |
0.204569452206933 |
|
8561 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BSND |
0.204569452206933 |
|
8562 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCSK9 |
0.204569452206933 |
|
8563 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP24 |
0.204569452206933 |
|
8564 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4422 |
0.204569452206933 |
|
8565 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP291 |
0.204569452206933 |
|
8566 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPAP2B |
0.204569452206933 |
|
8567 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKAA2 |
0.204569452206933 |
|
8568 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf168 |
0.204569452206933 |
|
8569 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C8A |
0.204569452206933 |
|
8570 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C8B |
0.204569452206933 |
|
8571 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DAB1 |
0.204569452206933 |
|
8572 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OMA1 |
0.204569452206933 |
|
8573 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL713P |
0.204569452206933 |
|
8574 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TACSTD2 |
0.204569452206933 |
|
8575 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYSM1 |
0.204569452206933 |
|
8576 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JUN |
0.204569452206933 |
|
8577 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGGY |
0.204569452206933 |
|
8578 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4711 |
0.204569452206933 |
|
8579 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOOK1 |
0.204569452206933 |
|
8580 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP2J2 |
0.204569452206933 |
|
8581 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL475P |
0.204569452206933 |
|
8582 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf87 |
0.204569452206933 |
|
8583 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFIA |
0.204569452206933 |
|
8584 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TM2D1 |
0.204569452206933 |
|
8585 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INADL |
0.204569452206933 |
|
8586 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL180P |
0.204569452206933 |
|
8587 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
L1TD1 |
0.204569452206933 |
|
8588 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KANK4 |
0.204569452206933 |
|
8589 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP1 |
0.204569452206933 |
|
8590 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOCK7 |
0.204569452206933 |
|
8591 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANGPTL3 |
0.204569452206933 |
|
8592 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATG4C |
0.204569452206933 |
|
8593 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00466 |
0.204569452206933 |
|
8594 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP49 |
0.204569452206933 |
|
8595 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXD3 |
0.204569452206933 |
|
8596 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALG6 |
0.204569452206933 |
|
8597 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGB3BP |
0.204569452206933 |
|
8598 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFCAB7 |
0.204569452206933 |
|
8599 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL488P |
0.204569452206933 |
|
8600 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLEU2L |
0.204569452206933 |
|
8601 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ROR1 |
0.204569452206933 |
|
8602 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2U |
0.204569452206933 |
|
8603 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACHD1 |
0.204569452206933 |
|
8604 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4794 |
0.204569452206933 |
|
8605 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAVER2 |
0.204569452206933 |
|
8606 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JAK1 |
0.204569452206933 |
|
8607 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3671 |
0.204569452206933 |
|
8608 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AK4 |
0.204569452206933 |
|
8609 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC6 |
0.204569452206933 |
|
8610 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LEPROT |
0.204569452206933 |
|
8611 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LEPR |
0.204569452206933 |
|
8612 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238931.1 |
0.204569452206933 |
|
8613 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL854P |
0.204569452206933 |
|
8614 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE4B |
0.204569452206933 |
|
8615 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGIP1 |
0.204569452206933 |
|
8616 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3117 |
0.204569452206933 |
|
8617 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCTEX1D1 |
0.204569452206933 |
|
8618 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INSL5 |
0.204569452206933 |
|
8619 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR78 |
0.204569452206933 |
|
8620 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIER1 |
0.204569452206933 |
|
8621 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35D1 |
0.204569452206933 |
|
8622 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf141 |
0.204569452206933 |
|
8623 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000252433.1 |
0.204569452206933 |
|
8624 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL23R |
0.204569452206933 |
|
8625 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU4ATAC4P |
0.204569452206933 |
|
8626 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL12RB2 |
0.204569452206933 |
|
8627 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERBP1 |
0.204569452206933 |
|
8628 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL392P |
0.204569452206933 |
|
8629 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GADD45A |
0.204569452206933 |
|
8630 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNG12 |
0.204569452206933 |
|
8631 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DIRAS3 |
0.204569452206933 |
|
8632 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WLS |
0.204569452206933 |
|
8633 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1262 |
0.204569452206933 |
|
8634 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPE65 |
0.204569452206933 |
|
8635 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEPDC1 |
0.204569452206933 |
|
8636 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC7 |
0.204569452206933 |
|
8637 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLA2G5 |
0.204904540587298 |
|
8638 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLA2G2D |
0.204904540587298 |
|
8639 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLA2G2F |
0.204904540587298 |
|
8640 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLA2G2C |
0.204904540587298 |
|
8641 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBXN10 |
0.204904540587298 |
|
8642 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VWA5B1 |
0.204904540587298 |
|
8643 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAMK2N1 |
0.204904540587298 |
|
8644 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUL1 |
0.204904540587298 |
|
8645 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM43B |
0.204904540587298 |
|
8646 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDA |
0.204904540587298 |
|
8647 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PINK1 |
0.204904540587298 |
|
8648 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDOST |
0.204904540587298 |
|
8649 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF17 |
0.204904540587298 |
|
8650 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH2D5 |
0.204904540587298 |
|
8651 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HP1BP3 |
0.204904540587298 |
|
8652 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF4G3 |
0.204904540587298 |
|
8653 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIVEP3 |
0.204904540587298 |
|
8654 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPRG |
0.205041935034136 |
|
8655 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR193A |
0.205154247814498 |
|
8656 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC7P |
0.205154247814498 |
|
8657 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR365B |
0.205154247814498 |
|
8658 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4725 |
0.205154247814498 |
|
8659 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACAP3 |
0.206318812866621 |
|
8660 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTRT2 |
0.206318812866621 |
|
8661 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGRN |
0.206318812866621 |
|
8662 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD65 |
0.206318812866621 |
|
8663 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATAD3A |
0.206318812866621 |
|
8664 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATAD3B |
0.206318812866621 |
|
8665 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATAD3C |
0.206318812866621 |
|
8666 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AURKAIP1 |
0.206318812866621 |
|
8667 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B3GALT6 |
0.206318812866621 |
|
8668 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf159 |
0.206318812866621 |
|
8669 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf170 |
0.206318812866621 |
|
8670 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf222 |
0.206318812866621 |
|
8671 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf233 |
0.206318812866621 |
|
8672 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf86 |
0.206318812866621 |
|
8673 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CALML6 |
0.206318812866621 |
|
8674 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNL2 |
0.206318812866621 |
|
8675 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK11A |
0.206318812866621 |
|
8676 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK11B |
0.206318812866621 |
|
8677 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPSF3L |
0.206318812866621 |
|
8678 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX11L1 |
0.206318812866621 |
|
8679 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DVL1 |
0.206318812866621 |
|
8680 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM132A |
0.206318812866621 |
|
8681 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM138A |
0.206318812866621 |
|
8682 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM213B |
0.206318812866621 |
|
8683 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM41C |
0.206318812866621 |
|
8684 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM87B |
0.206318812866621 |
|
8685 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABRD |
0.206318812866621 |
|
8686 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLTPD1 |
0.206318812866621 |
|
8687 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNB1 |
0.206318812866621 |
|
8688 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HES4 |
0.206318812866621 |
|
8689 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HES5 |
0.206318812866621 |
|
8690 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ISG15 |
0.206318812866621 |
|
8691 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL17 |
0.206318812866621 |
|
8692 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00115 |
0.206318812866621 |
|
8693 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00982 |
0.206318812866621 |
|
8694 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIB2 |
0.206318812866621 |
|
8695 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR200A |
0.206318812866621 |
|
8696 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR200B |
0.206318812866621 |
|
8697 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR429 |
0.206318812866621 |
|
8698 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMEL1 |
0.206318812866621 |
|
8699 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMP23B |
0.206318812866621 |
|
8700 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MORN1 |
0.206318812866621 |
|
8701 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL20 |
0.206318812866621 |
|
8702 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MXRA8 |
0.206318812866621 |
|
8703 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NADK |
0.206318812866621 |
|
8704 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOC2L |
0.206318812866621 |
|
8705 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4F16 |
0.206318812866621 |
|
8706 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4F29 |
0.206318812866621 |
|
8707 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4F5 |
0.206318812866621 |
|
8708 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PANK4 |
0.206318812866621 |
|
8709 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEX10 |
0.206318812866621 |
|
8710 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLCH2 |
0.206318812866621 |
|
8711 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHN1 |
0.206318812866621 |
|
8712 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRDM16 |
0.206318812866621 |
|
8713 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKCZ |
0.206318812866621 |
|
8714 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PUSL1 |
0.206318812866621 |
|
8715 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RER1 |
0.206318812866621 |
|
8716 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL657P |
0.206318812866621 |
|
8717 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF223 |
0.206318812866621 |
|
8718 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAMD11 |
0.206318812866621 |
|
8719 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCNN1D |
0.206318812866621 |
|
8720 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDF4 |
0.206318812866621 |
|
8721 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SKI |
0.206318812866621 |
|
8722 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35E2B |
0.206318812866621 |
|
8723 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35E2 |
0.206318812866621 |
|
8724 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSU72 |
0.206318812866621 |
|
8725 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS1R3 |
0.206318812866621 |
|
8726 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM240 |
0.206318812866621 |
|
8727 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM52 |
0.206318812866621 |
|
8728 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM88B |
0.206318812866621 |
|
8729 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFRSF14 |
0.206318812866621 |
|
8730 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFRSF18 |
0.206318812866621 |
|
8731 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFRSF4 |
0.206318812866621 |
|
8732 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC34 |
0.206318812866621 |
|
8733 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTLL10 |
0.206318812866621 |
|
8734 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2J2 |
0.206318812866621 |
|
8735 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VWA1 |
0.206318812866621 |
|
8736 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF16 |
0.206318812866621 |
|
8737 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEGF6 |
0.206318812866621 |
|
8738 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR551A |
0.206318812866621 |
|
8739 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPRG1L |
0.206318812866621 |
|
8740 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WRAP73 |
0.206318812866621 |
|
8741 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TP73 |
0.206318812866621 |
|
8742 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC27 |
0.206318812866621 |
|
8743 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMIM1 |
0.206318812866621 |
|
8744 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC47 |
0.206318812866621 |
|
8745 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL574P |
0.206318812866621 |
|
8746 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP104 |
0.206318812866621 |
|
8747 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DFFB |
0.206318812866621 |
|
8748 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC39C |
0.206887544254552 |
|
8749 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CABYR |
0.206887544254552 |
|
8750 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSBPL1A |
0.206887544254552 |
|
8751 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP452 |
0.206887544254552 |
|
8752 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL247P |
0.206887544254552 |
|
8753 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR320C2 |
0.206887544254552 |
|
8754 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IMPACT |
0.206887544254552 |
|
8755 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HRH4 |
0.206887544254552 |
|
8756 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAF4B |
0.206887544254552 |
|
8757 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000252921.1 |
0.206887544254552 |
|
8758 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCTD1 |
0.206887544254552 |
|
8759 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000265369.2 |
0.206887544254552 |
|
8760 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AQP4 |
0.206887544254552 |
|
8761 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHST9 |
0.206887544254552 |
|
8762 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDH2 |
0.206887544254552 |
|
8763 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MARS2 |
0.209718606831689 |
|
8764 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BOLL |
0.209718606831689 |
|
8765 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLCL1 |
0.209718606831689 |
|
8766 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SATB2 |
0.209718606831689 |
|
8767 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FTCDNL1 |
0.209718606831689 |
|
8768 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL717P |
0.209718606831689 |
|
8769 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf69 |
0.209718606831689 |
|
8770 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TYW5 |
0.209718606831689 |
|
8771 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf47 |
0.209718606831689 |
|
8772 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATS2L |
0.209718606831689 |
|
8773 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCTD18 |
0.209718606831689 |
|
8774 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGOL2 |
0.209718606831689 |
|
8775 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AOX1 |
0.209718606831689 |
|
8776 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AOX2P |
0.209718606831689 |
|
8777 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BZW1 |
0.209718606831689 |
|
8778 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP115 |
0.209718606831689 |
|
8779 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLK1 |
0.209718606831689 |
|
8780 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPIL3 |
0.209718606831689 |
|
8781 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NIF3L1 |
0.209718606831689 |
|
8782 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ORC2 |
0.209718606831689 |
|
8783 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL694P |
0.209718606831689 |
|
8784 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM126B |
0.209718606831689 |
|
8785 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFB3 |
0.209718606831689 |
|
8786 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CFLAR |
0.209718606831689 |
|
8787 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASP10 |
0.209718606831689 |
|
8788 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASP8 |
0.209718606831689 |
|
8789 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALS2CR12 |
0.209718606831689 |
|
8790 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAK2 |
0.209718606831689 |
|
8791 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STRADB |
0.209718606831689 |
|
8792 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RXFP2 |
0.212253932364932 |
|
8793 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EEF1DP3 |
0.212253932364932 |
|
8794 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRY |
0.212253932364932 |
|
8795 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZAR1L |
0.212253932364932 |
|
8796 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRCA2 |
0.212253932364932 |
|
8797 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
N4BP2L1 |
0.212253932364932 |
|
8798 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA16|ENSG00000212293.1 |
0.212253932364932 |
|
8799 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
N4BP2L2 |
0.212253932364932 |
|
8800 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDS5B |
0.212253932364932 |
|
8801 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY1P4 |
0.212253932364932 |
|
8802 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00423 |
0.212253932364932 |
|
8803 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KL |
0.212253932364932 |
|
8804 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STARD13 |
0.212253932364932 |
|
8805 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00884 |
0.213863498119888 |
|
8806 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0226 |
0.213863498119888 |
|
8807 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR922 |
0.213863498119888 |
|
8808 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FYTTD1 |
0.213863498119888 |
|
8809 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRCH3 |
0.213863498119888 |
|
8810 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD18DP |
0.213863498119888 |
|
8811 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM157A |
0.213863498119888 |
|
8812 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IQCG |
0.213863498119888 |
|
8813 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMLN |
0.213863498119888 |
|
8814 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL35A |
0.213863498119888 |
|
8815 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPAP3 |
0.214441667878861 |
|
8816 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENDOU |
0.214441667878861 |
|
8817 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAPGEF3 |
0.214441667878861 |
|
8818 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC48A1 |
0.214441667878861 |
|
8819 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HDAC7 |
0.214441667878861 |
|
8820 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VDR |
0.214441667878861 |
|
8821 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM106C |
0.214441667878861 |
|
8822 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL2A1 |
0.214441667878861 |
|
8823 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SENP1 |
0.214441667878861 |
|
8824 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PFKM |
0.214441667878861 |
|
8825 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASB8 |
0.214441667878861 |
|
8826 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf68 |
0.214441667878861 |
|
8827 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DKFZP779L1853 |
0.214441667878861 |
|
8828 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10AD1 |
0.214441667878861 |
|
8829 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC38A4 |
0.215467867941261 |
|
8830 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMIGO2 |
0.215467867941261 |
|
8831 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCED1B |
0.215467867941261 |
|
8832 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4698 |
0.215467867941261 |
|
8833 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA64|ENSG00000199566.1 |
0.215467867941261 |
|
8834 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4494 |
0.215467867941261 |
|
8835 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM129A |
0.215522995527483 |
|
8836 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238462.1 |
0.215676900459991 |
|
8837 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YWHAQ |
0.215676900459991 |
|
8838 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAF1B |
0.215676900459991 |
|
8839 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRHL1 |
0.215676900459991 |
|
8840 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLF11 |
0.215676900459991 |
|
8841 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYS1 |
0.215676900459991 |
|
8842 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA26|ENSG00000212558.1 |
0.215676900459991 |
|
8843 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRM2 |
0.215676900459991 |
|
8844 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf48 |
0.215676900459991 |
|
8845 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA2|ENSG00000206647.1 |
0.215676900459991 |
|
8846 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4261 |
0.215676900459991 |
|
8847 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL66P |
0.215676900459991 |
|
8848 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA51|ENSG00000206898.1 |
0.215676900459991 |
|
8849 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HPCAL1 |
0.215676900459991 |
|
8850 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ODC1 |
0.215676900459991 |
|
8851 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA80B |
0.215676900459991 |
|
8852 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOL10 |
0.215676900459991 |
|
8853 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL832P |
0.215676900459991 |
|
8854 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6V1C2 |
0.215676900459991 |
|
8855 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDIA6 |
0.215676900459991 |
|
8856 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNF1 |
0.215676900459991 |
|
8857 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf50 |
0.215676900459991 |
|
8858 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PQLC3 |
0.215676900459991 |
|
8859 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ROCK2 |
0.215676900459991 |
|
8860 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00570 |
0.215676900459991 |
|
8861 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
E2F6 |
0.215676900459991 |
|
8862 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP84 |
0.215676900459991 |
|
8863 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GREB1 |
0.215676900459991 |
|
8864 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4429 |
0.215676900459991 |
|
8865 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP85 |
0.215676900459991 |
|
8866 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL674P |
0.215676900459991 |
|
8867 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NTSR2 |
0.215676900459991 |
|
8868 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPIN1 |
0.215676900459991 |
|
8869 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548S |
0.215676900459991 |
|
8870 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4262 |
0.215676900459991 |
|
8871 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD18|ENSG00000238503.1 |
0.215676900459991 |
|
8872 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3681 |
0.215676900459991 |
|
8873 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIB2 |
0.215676900459991 |
|
8874 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3125 |
0.215676900459991 |
|
8875 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00276 |
0.215676900459991 |
|
8876 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM84A |
0.215676900459991 |
|
8877 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBAS |
0.215676900459991 |
|
8878 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX1 |
0.215676900459991 |
|
8879 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238371.1 |
0.215676900459991 |
|
8880 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYCNOS |
0.215676900459991 |
|
8881 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYCN |
0.215676900459991 |
|
8882 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL104P |
0.215676900459991 |
|
8883 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA40|ENSG00000251704.1 |
0.215676900459991 |
|
8884 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM49A |
0.215676900459991 |
|
8885 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP168 |
0.215676900459991 |
|
8886 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAD51AP2 |
0.215676900459991 |
|
8887 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VSNL1 |
0.215676900459991 |
|
8888 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMC6 |
0.215676900459991 |
|
8889 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GEN1 |
0.215676900459991 |
|
8890 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSGN1 |
0.215676900459991 |
|
8891 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNS3 |
0.215676900459991 |
|
8892 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA40|ENSG00000212455.1 |
0.215676900459991 |
|
8893 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NT5C1B |
0.215676900459991 |
|
8894 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RDH14 |
0.215676900459991 |
|
8895 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4757 |
0.215676900459991 |
|
8896 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSR1 |
0.215676900459991 |
|
8897 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00954 |
0.215676900459991 |
|
8898 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC32 |
0.215676900459991 |
|
8899 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR35 |
0.215676900459991 |
|
8900 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MATN3 |
0.215676900459991 |
|
8901 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAPTM4A |
0.215676900459991 |
|
8902 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL140P |
0.215676900459991 |
|
8903 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDC1 |
0.215676900459991 |
|
8904 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PUM2 |
0.215676900459991 |
|
8905 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP86 |
0.215676900459991 |
|
8906 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHOB |
0.215676900459991 |
|
8907 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HS1BP3 |
0.215676900459991 |
|
8908 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GDF7 |
0.215676900459991 |
|
8909 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf43 |
0.215676900459991 |
|
8910 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOB |
0.215676900459991 |
|
8911 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TDRD15 |
0.215676900459991 |
|
8912 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL117P |
0.215676900459991 |
|
8913 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP87 |
0.215676900459991 |
|
8914 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP27 |
0.215676900459991 |
|
8915 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL29 |
0.215676900459991 |
|
8916 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATAD2B |
0.215676900459991 |
|
8917 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBXN2A |
0.215676900459991 |
|
8918 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL610P |
0.215676900459991 |
|
8919 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFSD2B |
0.215676900459991 |
|
8920 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf44 |
0.215676900459991 |
|
8921 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FKBP1B |
0.215676900459991 |
|
8922 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SF3B14 |
0.215676900459991 |
|
8923 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM228B |
0.215676900459991 |
|
8924 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TP53I3 |
0.215676900459991 |
|
8925 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PFN4 |
0.215676900459991 |
|
8926 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM228A |
0.215676900459991 |
|
8927 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITSN2 |
0.215676900459991 |
|
8928 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA21|ENSG00000251805.1 |
0.215676900459991 |
|
8929 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCOA1 |
0.215676900459991 |
|
8930 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP88 |
0.215676900459991 |
|
8931 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTRHD1 |
0.215676900459991 |
|
8932 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CENPO |
0.215676900459991 |
|
8933 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADCY3 |
0.215676900459991 |
|
8934 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC27 |
0.215676900459991 |
|
8935 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD14 |
0.215676900459991 |
|
8936 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFR3B |
0.215676900459991 |
|
8937 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL856P |
0.215676900459991 |
|
8938 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POMC |
0.215676900459991 |
|
8939 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNMT3A |
0.215676900459991 |
|
8940 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1301 |
0.215676900459991 |
|
8941 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DTNB |
0.215676900459991 |
|
8942 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASXL2 |
0.215676900459991 |
|
8943 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF3C |
0.215676900459991 |
|
8944 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB10 |
0.215676900459991 |
|
8945 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAREML |
0.215676900459991 |
|
8946 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HADHA |
0.215676900459991 |
|
8947 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HADHB |
0.215676900459991 |
|
8948 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPT1 |
0.215676900459991 |
|
8949 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR113 |
0.215676900459991 |
|
8950 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DRC1 |
0.215676900459991 |
|
8951 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OTOF |
0.215676900459991 |
|
8952 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf70 |
0.215676900459991 |
|
8953 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CIB4 |
0.215676900459991 |
|
8954 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNK3 |
0.215676900459991 |
|
8955 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CENPA |
0.215676900459991 |
|
8956 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35F6 |
0.215676900459991 |
|
8957 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPYSL5 |
0.215676900459991 |
|
8958 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPRE3 |
0.215676900459991 |
|
8959 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM214 |
0.215676900459991 |
|
8960 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGBL5 |
0.215676900459991 |
|
8961 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OST4 |
0.215676900459991 |
|
8962 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMILIN1 |
0.215676900459991 |
|
8963 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KHK |
0.215676900459991 |
|
8964 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CGREF1 |
0.215676900459991 |
|
8965 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABHD1 |
0.215676900459991 |
|
8966 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PREB |
0.215676900459991 |
|
8967 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf53 |
0.215676900459991 |
|
8968 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCF23 |
0.215676900459991 |
|
8969 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC5A6 |
0.215676900459991 |
|
8970 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATRAID |
0.215676900459991 |
|
8971 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAD |
0.215676900459991 |
|
8972 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC30A3 |
0.215676900459991 |
|
8973 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC5G |
0.215676900459991 |
|
8974 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM54 |
0.215676900459991 |
|
8975 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPV17 |
0.215676900459991 |
|
8976 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UCN |
0.215676900459991 |
|
8977 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF3C2 |
0.215676900459991 |
|
8978 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF2B4 |
0.215676900459991 |
|
8979 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX17 |
0.215676900459991 |
|
8980 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF513 |
0.215676900459991 |
|
8981 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPM1G |
0.215676900459991 |
|
8982 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRBP1 |
0.215676900459991 |
|
8983 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFT172 |
0.215676900459991 |
|
8984 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRTCAP3 |
0.215676900459991 |
|
8985 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FNDC4 |
0.215676900459991 |
|
8986 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCKR |
0.215676900459991 |
|
8987 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf16 |
0.215676900459991 |
|
8988 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF512 |
0.215676900459991 |
|
8989 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC121 |
0.215676900459991 |
|
8990 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPN1 |
0.215676900459991 |
|
8991 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA36|ENSG00000206731.1 |
0.215676900459991 |
|
8992 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUPT7L |
0.215676900459991 |
|
8993 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC4A1AP |
0.215676900459991 |
|
8994 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL33 |
0.215676900459991 |
|
8995 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBKS |
0.215676900459991 |
|
8996 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRE |
0.215676900459991 |
|
8997 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4263 |
0.215676900459991 |
|
8998 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOSL2 |
0.215676900459991 |
|
8999 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLB1 |
0.215676900459991 |
|
9000 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP89 |
0.215676900459991 |
|
9001 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL361P |
0.215676900459991 |
|
9002 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAPOLG |
0.215676900459991 |
|
9003 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL632P |
0.215676900459991 |
|
9004 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REL |
0.215676900459991 |
|
9005 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70B |
0.215676900459991 |
|
9006 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XPO1 |
0.215676900459991 |
|
9007 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM161A |
0.215676900459991 |
|
9008 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCT4 |
0.215676900459991 |
|
9009 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COMMD1 |
0.215676900459991 |
|
9010 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B3GNT2 |
0.215676900459991 |
|
9011 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5192 |
0.215676900459991 |
|
9012 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL51P |
0.215676900459991 |
|
9013 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238809.1 |
0.215676900459991 |
|
9014 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL18P |
0.215676900459991 |
|
9015 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM17 |
0.215676900459991 |
|
9016 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EHBP1 |
0.215676900459991 |
|
9017 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OTX1 |
0.215676900459991 |
|
9018 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DBIL5P2 |
0.215676900459991 |
|
9019 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDPCP |
0.215676900459991 |
|
9020 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MDH1 |
0.215676900459991 |
|
9021 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS4XP5 |
0.215676900459991 |
|
9022 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGP2 |
0.215676900459991 |
|
9023 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACA59|ENSG00000251775.1 |
0.215676900459991 |
|
9024 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS54 |
0.215676900459991 |
|
9025 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PELI1 |
0.215676900459991 |
|
9026 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00309 |
0.215676900459991 |
|
9027 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4433 |
0.215676900459991 |
|
9028 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGALSL |
0.215676900459991 |
|
9029 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AFTPH |
0.215676900459991 |
|
9030 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERTAD2 |
0.215676900459991 |
|
9031 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL341P |
0.215676900459991 |
|
9032 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL211P |
0.215676900459991 |
|
9033 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238696.1 |
0.215676900459991 |
|
9034 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC1A4 |
0.215676900459991 |
|
9035 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP68 |
0.215676900459991 |
|
9036 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB1A |
0.215676900459991 |
|
9037 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA74|ENSG00000272025.1 |
0.215676900459991 |
|
9038 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTR2 |
0.215676900459991 |
|
9039 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPRED2 |
0.215676900459991 |
|
9040 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL635P |
0.215676900459991 |
|
9041 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
Vault|ENSG00000251900.1 |
0.215676900459991 |
|
9042 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4778 |
0.215676900459991 |
|
9043 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEIS1 |
0.215676900459991 |
|
9044 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ETAA1 |
0.215676900459991 |
|
9045 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1D |
0.215676900459991 |
|
9046 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR92 |
0.215676900459991 |
|
9047 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP3R1 |
0.215676900459991 |
|
9048 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNO1 |
0.215676900459991 |
|
9049 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNRIP1 |
0.215676900459991 |
|
9050 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEK |
0.215676900459991 |
|
9051 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APLF |
0.215676900459991 |
|
9052 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP25 |
0.215676900459991 |
|
9053 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO48 |
0.215676900459991 |
|
9054 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PROKR1 |
0.215676900459991 |
|
9055 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BMP10 |
0.215676900459991 |
|
9056 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GKN2 |
0.215676900459991 |
|
9057 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GKN1 |
0.215676900459991 |
|
9058 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANTXR1 |
0.215676900459991 |
|
9059 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3126 |
0.215676900459991 |
|
9060 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP96 |
0.215676900459991 |
|
9061 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GFPT1 |
0.215676900459991 |
|
9062 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFU1 |
0.215676900459991 |
|
9063 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AAK1 |
0.215676900459991 |
|
9064 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL604P |
0.215676900459991 |
|
9065 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA36C |
0.215676900459991 |
|
9066 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANXA4 |
0.215676900459991 |
|
9067 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238708.1 |
0.215676900459991 |
|
9068 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GMCL1 |
0.215676900459991 |
|
9069 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNRNP27 |
0.215676900459991 |
|
9070 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MXD1 |
0.215676900459991 |
|
9071 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238465.1 |
0.215676900459991 |
|
9072 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239072.1 |
0.215676900459991 |
|
9073 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASPRV1 |
0.215676900459991 |
|
9074 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL470P |
0.215676900459991 |
|
9075 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCBP1 |
0.215676900459991 |
|
9076 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf42 |
0.215676900459991 |
|
9077 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIA1 |
0.215676900459991 |
|
9078 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCYOX1 |
0.215676900459991 |
|
9079 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNRPG |
0.215676900459991 |
|
9080 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM136A |
0.215676900459991 |
|
9081 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TGFA |
0.215676900459991 |
|
9082 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADD2 |
0.215676900459991 |
|
9083 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FIGLA |
0.215676900459991 |
|
9084 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC4F |
0.215676900459991 |
|
9085 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD207 |
0.215676900459991 |
|
9086 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VAX2 |
0.215676900459991 |
|
9087 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6V1B1 |
0.215676900459991 |
|
9088 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239064.1 |
0.215676900459991 |
|
9089 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL160P |
0.215676900459991 |
|
9090 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD53 |
0.215676900459991 |
|
9091 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX261 |
0.215676900459991 |
|
9092 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAGK |
0.215676900459991 |
|
9093 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCEE |
0.215676900459991 |
|
9094 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPHOSPH10 |
0.215676900459991 |
|
9095 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAIP2B |
0.215676900459991 |
|
9096 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF638 |
0.215676900459991 |
|
9097 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DYSF |
0.215676900459991 |
|
9098 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP26B1 |
0.215676900459991 |
|
9099 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD78|ENSG00000212378.1 |
0.215676900459991 |
|
9100 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPR |
0.215676900459991 |
|
9101 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMX1 |
0.215676900459991 |
|
9102 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFXN5 |
0.215676900459991 |
|
9103 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB11FIP5 |
0.215676900459991 |
|
9104 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOTO |
0.215676900459991 |
|
9105 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMYD5 |
0.215676900459991 |
|
9106 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCT7 |
0.215676900459991 |
|
9107 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRADC1 |
0.215676900459991 |
|
9108 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO41 |
0.215676900459991 |
|
9109 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EGR4 |
0.215676900459991 |
|
9110 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALMS1 |
0.215676900459991 |
|
9111 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALMS1P |
0.215676900459991 |
|
9112 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAT8 |
0.215676900459991 |
|
9113 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPRKB |
0.215676900459991 |
|
9114 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUSP11 |
0.215676900459991 |
|
9115 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf78 |
0.215676900459991 |
|
9116 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAMBP |
0.215676900459991 |
|
9117 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTG2 |
0.215676900459991 |
|
9118 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DGUOK |
0.215676900459991 |
|
9119 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP97 |
0.215676900459991 |
|
9120 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TET3 |
0.215676900459991 |
|
9121 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BOLA3 |
0.215676900459991 |
|
9122 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MGC10955 |
0.215676900459991 |
|
9123 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOB1A |
0.215676900459991 |
|
9124 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTHFD2 |
0.215676900459991 |
|
9125 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC4A5 |
0.215676900459991 |
|
9126 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCTN1 |
0.215676900459991 |
|
9127 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf81 |
0.215676900459991 |
|
9128 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR54 |
0.215676900459991 |
|
9129 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RTKN |
0.215676900459991 |
|
9130 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INO80B |
0.215676900459991 |
|
9131 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WBP1 |
0.215676900459991 |
|
9132 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOGS |
0.215676900459991 |
|
9133 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC142 |
0.215676900459991 |
|
9134 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL53 |
0.215676900459991 |
|
9135 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC31 |
0.215676900459991 |
|
9136 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LBX2 |
0.215676900459991 |
|
9137 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCGF1 |
0.215676900459991 |
|
9138 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLX2 |
0.215676900459991 |
|
9139 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DQX1 |
0.215676900459991 |
|
9140 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AUP1 |
0.215676900459991 |
|
9141 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTRA2 |
0.215676900459991 |
|
9142 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LOXL3 |
0.215676900459991 |
|
9143 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOK1 |
0.215676900459991 |
|
9144 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
M1AP |
0.215676900459991 |
|
9145 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEMA4F |
0.215676900459991 |
|
9146 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HK2 |
0.215676900459991 |
|
9147 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLE4 |
0.215676900459991 |
|
9148 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TACR1 |
0.215676900459991 |
|
9149 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5000 |
0.215676900459991 |
|
9150 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238521.1 |
0.215676900459991 |
|
9151 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EVA1A |
0.215676900459991 |
|
9152 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU109|ENSG00000238410.1 |
0.215676900459991 |
|
9153 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCFC2 |
0.215676900459991 |
|
9154 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL19 |
0.215676900459991 |
|
9155 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000221638.1 |
0.215676900459991 |
|
9156 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239018.1 |
0.215676900459991 |
|
9157 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP203 |
0.215676900459991 |
|
9158 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP164 |
0.215676900459991 |
|
9159 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRTM4 |
0.215676900459991 |
|
9160 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP98 |
0.215676900459991 |
|
9161 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REG1A |
0.215676900459991 |
|
9162 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REG1B |
0.215676900459991 |
|
9163 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REG1P |
0.215676900459991 |
|
9164 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REG3A |
0.215676900459991 |
|
9165 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REG3G |
0.215676900459991 |
|
9166 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL18 |
0.216529476215293 |
|
9167 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPN23 |
0.216529476215293 |
|
9168 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCAP |
0.216529476215293 |
|
9169 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238350.1 |
0.216529476215293 |
|
9170 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELP6 |
0.216529476215293 |
|
9171 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL870P |
0.216529476215293 |
|
9172 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSPG5 |
0.216529476215293 |
|
9173 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMARCC1 |
0.216529476215293 |
|
9174 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIH1 |
0.217054157606602 |
|
9175 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U1|ENSG00000271739.1 |
0.218732022884623 |
|
9176 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCND2 |
0.218732022884623 |
|
9177 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPAN12 |
0.218732022884623 |
|
9178 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ING3 |
0.218732022884623 |
|
9179 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP240 |
0.218732022884623 |
|
9180 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPED1 |
0.218732022884623 |
|
9181 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP241 |
0.218732022884623 |
|
9182 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WNT16 |
0.218732022884623 |
|
9183 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM3C |
0.218732022884623 |
|
9184 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP277 |
0.218732022884623 |
|
9185 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPRZ1 |
0.218732022884623 |
|
9186 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AASS |
0.218732022884623 |
|
9187 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FEZF1 |
0.218732022884623 |
|
9188 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAF1 |
0.221215030515776 |
|
9189 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDKN2C |
0.221215030515776 |
|
9190 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPRE |
0.222704220540728 |
|
9191 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MGMT |
0.222704220540728 |
|
9192 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EBF3 |
0.222704220540728 |
|
9193 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4297 |
0.222704220540728 |
|
9194 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00959 |
0.222704220540728 |
|
9195 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLRX3 |
0.222704220540728 |
|
9196 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR378C |
0.222704220540728 |
|
9197 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCERG1L |
0.222704220540728 |
|
9198 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP2R2D |
0.222704220540728 |
|
9199 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BNIP3 |
0.222704220540728 |
|
9200 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JAKMIP3 |
0.222704220540728 |
|
9201 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPYSL4 |
0.222704220540728 |
|
9202 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STK32C |
0.222704220540728 |
|
9203 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC27 |
0.222704220540728 |
|
9204 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PWWP2B |
0.222704220540728 |
|
9205 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf91 |
0.222704220540728 |
|
9206 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INPP5A |
0.222704220540728 |
|
9207 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC40 |
0.222704220540728 |
|
9208 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLCB3 |
0.2238317565999 |
|
9209 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R14B |
0.2238317565999 |
|
9210 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL11 |
0.2238317565999 |
|
9211 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PELI3 |
0.2238317565999 |
|
9212 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR205HG |
0.224183456662984 |
|
9213 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAMK1G |
0.224183456662984 |
|
9214 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAMB3 |
0.224183456662984 |
|
9215 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4260 |
0.224183456662984 |
|
9216 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
G0S2 |
0.224183456662984 |
|
9217 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSD11B1 |
0.224183456662984 |
|
9218 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAF3IP3 |
0.224183456662984 |
|
9219 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf74 |
0.224183456662984 |
|
9220 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRF6 |
0.224183456662984 |
|
9221 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DIEXF |
0.224183456662984 |
|
9222 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYT14 |
0.224183456662984 |
|
9223 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERTAD4 |
0.224183456662984 |
|
9224 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNH1 |
0.224183456662984 |
|
9225 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RCOR3 |
0.224183456662984 |
|
9226 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAF5 |
0.224183456662984 |
|
9227 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00467 |
0.224183456662984 |
|
9228 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RD3 |
0.224183456662984 |
|
9229 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC30A1 |
0.224183456662984 |
|
9230 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEK2 |
0.224183456662984 |
|
9231 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPGAT1 |
0.224183456662984 |
|
9232 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL344P |
0.224183456662984 |
|
9233 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INTS7 |
0.224183456662984 |
|
9234 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA26|ENSG00000212187.1 |
0.224183456662984 |
|
9235 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DTL |
0.224183456662984 |
|
9236 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3122 |
0.224183456662984 |
|
9237 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP98 |
0.224183456662984 |
|
9238 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP2R5A |
0.224183456662984 |
|
9239 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA16B |
0.224183456662984 |
|
9240 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM206 |
0.224183456662984 |
|
9241 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NENF |
0.224183456662984 |
|
9242 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATF3 |
0.224183456662984 |
|
9243 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL512P |
0.224183456662984 |
|
9244 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM71A |
0.224183456662984 |
|
9245 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BATF3 |
0.224183456662984 |
|
9246 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NSL1 |
0.224183456662984 |
|
9247 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TATDN3 |
0.224183456662984 |
|
9248 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf227 |
0.224183456662984 |
|
9249 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLVCR1 |
0.224183456662984 |
|
9250 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VASH2 |
0.224183456662984 |
|
9251 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANGEL2 |
0.224183456662984 |
|
9252 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS6KC1 |
0.224183456662984 |
|
9253 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PROX1 |
0.224183456662984 |
|
9254 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMYD2 |
0.224183456662984 |
|
9255 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPN14 |
0.224183456662984 |
|
9256 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CENPF |
0.224183456662984 |
|
9257 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNK2 |
0.224183456662984 |
|
9258 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCTD3 |
0.224183456662984 |
|
9259 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USH2A |
0.224183456662984 |
|
9260 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD116|ENSG00000202498.1 |
0.224183456662984 |
|
9261 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ESRRG |
0.224183456662984 |
|
9262 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00210 |
0.224183456662984 |
|
9263 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRP15 |
0.224183456662984 |
|
9264 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TGFB2 |
0.224183456662984 |
|
9265 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf143 |
0.224183456662984 |
|
9266 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000212610.1 |
0.224183456662984 |
|
9267 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYPLAL1 |
0.224183456662984 |
|
9268 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC30A10 |
0.224183456662984 |
|
9269 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP76 |
0.224183456662984 |
|
9270 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000221673.1 |
0.224183456662984 |
|
9271 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPRS |
0.224183456662984 |
|
9272 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238798.1 |
0.224183456662984 |
|
9273 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BPNT1 |
0.224183456662984 |
|
9274 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IARS2 |
0.224183456662984 |
|
9275 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR215 |
0.224183456662984 |
|
9276 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238576.1 |
0.224183456662984 |
|
9277 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB3GAP2 |
0.224183456662984 |
|
9278 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA36B |
0.224183456662984 |
|
9279 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MARK1 |
0.224183456662984 |
|
9280 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL464P |
0.224183456662984 |
|
9281 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HDAC1P2 |
0.224183456662984 |
|
9282 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf115 |
0.224183456662984 |
|
9283 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MARC2 |
0.224183456662984 |
|
9284 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MARC1 |
0.224183456662984 |
|
9285 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC35P |
0.224183456662984 |
|
9286 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HLX |
0.224183456662984 |
|
9287 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUSP10 |
0.224183456662984 |
|
9288 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HHIPL2 |
0.224183456662984 |
|
9289 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAF1A |
0.224183456662984 |
|
9290 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIA3 |
0.224183456662984 |
|
9291 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AIDA |
0.224183456662984 |
|
9292 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BROX |
0.224183456662984 |
|
9293 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL276P |
0.224183456662984 |
|
9294 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM177B |
0.224183456662984 |
|
9295 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DISP1 |
0.224183456662984 |
|
9296 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239054.1 |
0.224183456662984 |
|
9297 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLR5 |
0.224183456662984 |
|
9298 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUSD4 |
0.224183456662984 |
|
9299 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf65 |
0.224183456662984 |
|
9300 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPN8 |
0.224183456662984 |
|
9301 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPN2 |
0.224183456662984 |
|
9302 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TP53BP2 |
0.224183456662984 |
|
9303 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP49 |
0.224183456662984 |
|
9304 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO28 |
0.224183456662984 |
|
9305 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEGS1 |
0.224183456662984 |
|
9306 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA72|ENSG00000201898.1 |
0.224183456662984 |
|
9307 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NVL |
0.224183456662984 |
|
9308 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR320B2 |
0.224183456662984 |
|
9309 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238856.1 |
0.224183456662984 |
|
9310 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNIH4 |
0.224183456662984 |
|
9311 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR26 |
0.224183456662984 |
|
9312 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4742 |
0.224183456662984 |
|
9313 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNIH3 |
0.224183456662984 |
|
9314 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAH14 |
0.224183456662984 |
|
9315 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LBR |
0.224183456662984 |
|
9316 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENAH |
0.224183456662984 |
|
9317 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRP9 |
0.224183456662984 |
|
9318 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPHX1 |
0.224183456662984 |
|
9319 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM63A |
0.224183456662984 |
|
9320 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LEFTY1 |
0.224183456662984 |
|
9321 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PYCR2 |
0.224183456662984 |
|
9322 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LEFTY2 |
0.224183456662984 |
|
9323 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDE2 |
0.224183456662984 |
|
9324 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
H3F3A |
0.224183456662984 |
|
9325 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACBD3 |
0.224183456662984 |
|
9326 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIXL1 |
0.224183456662984 |
|
9327 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIN9 |
0.224183456662984 |
|
9328 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238545.1 |
0.224183456662984 |
|
9329 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239094.1 |
0.224183456662984 |
|
9330 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARP1 |
0.224183456662984 |
|
9331 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP165 |
0.224183456662984 |
|
9332 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf95 |
0.224183456662984 |
|
9333 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITPKB |
0.224183456662984 |
|
9334 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSEN2 |
0.224183456662984 |
|
9335 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADCK3 |
0.224183456662984 |
|
9336 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC42BPA |
0.224183456662984 |
|
9337 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP77 |
0.224183456662984 |
|
9338 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF678 |
0.224183456662984 |
|
9339 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JMJD4 |
0.224183456662984 |
|
9340 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNAP47 |
0.224183456662984 |
|
9341 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS38 |
0.224183456662984 |
|
9342 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WNT9A |
0.224183456662984 |
|
9343 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5008 |
0.224183456662984 |
|
9344 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WNT3A |
0.224183456662984 |
|
9345 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARF1 |
0.224183456662984 |
|
9346 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3620 |
0.224183456662984 |
|
9347 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf35 |
0.224183456662984 |
|
9348 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL55 |
0.224183456662984 |
|
9349 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GJC2 |
0.224183456662984 |
|
9350 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GUK1 |
0.224183456662984 |
|
9351 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf148 |
0.224183456662984 |
|
9352 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IBA57 |
0.224183456662984 |
|
9353 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf145 |
0.224183456662984 |
|
9354 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OBSCN |
0.224183456662984 |
|
9355 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTNL10 |
0.224183456662984 |
|
9356 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST3H2A |
0.224183456662984 |
|
9357 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST3H2BB |
0.224183456662984 |
|
9358 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST3H3 |
0.224183456662984 |
|
9359 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4666A |
0.224183456662984 |
|
9360 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5S10 |
0.224183456662984 |
|
9361 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5S11 |
0.224183456662984 |
|
9362 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5S12 |
0.224183456662984 |
|
9363 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5S13 |
0.224183456662984 |
|
9364 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5S14 |
0.224183456662984 |
|
9365 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5S15 |
0.224183456662984 |
|
9366 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5S16 |
0.224183456662984 |
|
9367 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5S17 |
0.224183456662984 |
|
9368 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5S1 |
0.224183456662984 |
|
9369 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5S2 |
0.224183456662984 |
|
9370 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5S3 |
0.224183456662984 |
|
9371 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5S4 |
0.224183456662984 |
|
9372 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5S5 |
0.224183456662984 |
|
9373 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5S6 |
0.224183456662984 |
|
9374 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5S7 |
0.224183456662984 |
|
9375 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5S8 |
0.224183456662984 |
|
9376 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5S9 |
0.224183456662984 |
|
9377 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP18 |
0.224183456662984 |
|
9378 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP19 |
0.224183456662984 |
|
9379 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF187 |
0.224183456662984 |
|
9380 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA51|ENSG00000206878.1 |
0.224183456662984 |
|
9381 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM11 |
0.224183456662984 |
|
9382 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM17 |
0.224183456662984 |
|
9383 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHOU |
0.224183456662984 |
|
9384 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM78 |
0.224183456662984 |
|
9385 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB4A |
0.224183456662984 |
|
9386 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPHAR |
0.224183456662984 |
|
9387 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCSAP |
0.224183456662984 |
|
9388 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP276 |
0.224183456662984 |
|
9389 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTA1 |
0.224183456662984 |
|
9390 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUP133 |
0.224183456662984 |
|
9391 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCB10 |
0.224183456662984 |
|
9392 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP78 |
0.224183456662984 |
|
9393 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAF5L |
0.224183456662984 |
|
9394 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
URB2 |
0.224183456662984 |
|
9395 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALNT2 |
0.224183456662984 |
|
9396 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGBD5 |
0.224183456662984 |
|
9397 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COG2 |
0.224183456662984 |
|
9398 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGT |
0.224183456662984 |
|
9399 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL467P |
0.224183456662984 |
|
9400 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPN9 |
0.224183456662984 |
|
9401 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP79 |
0.224183456662984 |
|
9402 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf198 |
0.224183456662984 |
|
9403 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL837P |
0.224183456662984 |
|
9404 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238985.1 |
0.224183456662984 |
|
9405 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC13 |
0.224183456662984 |
|
9406 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARV1 |
0.224183456662984 |
|
9407 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM89A |
0.224183456662984 |
|
9408 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1182 |
0.224183456662984 |
|
9409 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM67 |
0.224183456662984 |
|
9410 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf131 |
0.224183456662984 |
|
9411 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNPAT |
0.224183456662984 |
|
9412 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP80 |
0.224183456662984 |
|
9413 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXOC8 |
0.224183456662984 |
|
9414 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPRTN |
0.224183456662984 |
|
9415 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EGLN1 |
0.224183456662984 |
|
9416 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAX |
0.224183456662984 |
|
9417 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSNAX |
0.224183456662984 |
|
9418 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DISC1 |
0.224183456662984 |
|
9419 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00582 |
0.224183456662984 |
|
9420 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL299P |
0.224183456662984 |
|
9421 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIPA1L2 |
0.224183456662984 |
|
9422 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP10 |
0.224183456662984 |
|
9423 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NTPCR |
0.224183456662984 |
|
9424 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCNXL2 |
0.224183456662984 |
|
9425 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLK4 |
0.224183456662984 |
|
9426 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNK1 |
0.224183456662984 |
|
9427 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4427 |
0.224183456662984 |
|
9428 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35F3 |
0.224183456662984 |
|
9429 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4671 |
0.224183456662984 |
|
9430 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COA6 |
0.224183456662984 |
|
9431 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TARBP1 |
0.224183456662984 |
|
9432 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000212144.1 |
0.224183456662984 |
|
9433 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRF2BP2 |
0.224183456662984 |
|
9434 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00184 |
0.224183456662984 |
|
9435 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P16 |
0.224183456662984 |
|
9436 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL668P |
0.224183456662984 |
|
9437 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOMM20 |
0.224183456662984 |
|
9438 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARID4B |
0.224183456662984 |
|
9439 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM34 |
0.224183456662984 |
|
9440 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA14B |
0.224183456662984 |
|
9441 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4753 |
0.224183456662984 |
|
9442 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GGPS1 |
0.224183456662984 |
|
9443 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBCE |
0.224183456662984 |
|
9444 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B3GALNT2 |
0.224183456662984 |
|
9445 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNG4 |
0.224183456662984 |
|
9446 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYST |
0.224183456662984 |
|
9447 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1537 |
0.224183456662984 |
|
9448 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NID1 |
0.224183456662984 |
|
9449 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR137B |
0.224183456662984 |
|
9450 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERO1LB |
0.224183456662984 |
|
9451 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000252638.1 |
0.224183456662984 |
|
9452 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EDARADD |
0.224183456662984 |
|
9453 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGALS8 |
0.224183456662984 |
|
9454 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HEATR1 |
0.224183456662984 |
|
9455 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTN2 |
0.224183456662984 |
|
9456 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTR |
0.224183456662984 |
|
9457 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MT1HL1 |
0.224183456662984 |
|
9458 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RYR2 |
0.224183456662984 |
|
9459 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP195 |
0.224183456662984 |
|
9460 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4428 |
0.224183456662984 |
|
9461 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA25|ENSG00000252290.1 |
0.224183456662984 |
|
9462 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZP4 |
0.224183456662984 |
|
9463 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTRNR2L11 |
0.224183456662984 |
|
9464 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRM3 |
0.224183456662984 |
|
9465 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FMN2 |
0.224183456662984 |
|
9466 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GREM2 |
0.224183456662984 |
|
9467 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGS7 |
0.224183456662984 |
|
9468 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3123 |
0.224183456662984 |
|
9469 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DMRTA2 |
0.224196668314592 |
|
9470 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD36|ENSG00000251846.1 |
0.224480690419228 |
|
9471 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
L1CAM |
0.224480690419228 |
|
9472 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCA10 |
0.224480690419228 |
|
9473 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STK11IP |
0.228502874432337 |
|
9474 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC4A3 |
0.228502874432337 |
|
9475 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4268 |
0.228502874432337 |
|
9476 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PBX1 |
0.228720142437982 |
|
9477 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERICH1 |
0.231175100915131 |
|
9478 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO25 |
0.231175100915131 |
|
9479 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4F21 |
0.231175100915131 |
|
9480 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL23AP53 |
0.231175100915131 |
|
9481 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TDRP |
0.231175100915131 |
|
9482 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF596 |
0.231175100915131 |
|
9483 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLGAP2 |
0.231175100915131 |
|
9484 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLN8 |
0.231175100915131 |
|
9485 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR596 |
0.231175100915131 |
|
9486 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF10 |
0.231175100915131 |
|
9487 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KBTBD11 |
0.231175100915131 |
|
9488 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYOM2 |
0.231175100915131 |
|
9489 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000206661.1 |
0.231175100915131 |
|
9490 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL318P |
0.231175100915131 |
|
9491 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP159 |
0.231175100915131 |
|
9492 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCPH1 |
0.231175100915131 |
|
9493 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANGPT2 |
0.231175100915131 |
|
9494 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGPAT5 |
0.231175100915131 |
|
9495 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4659A |
0.231175100915131 |
|
9496 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XKR5 |
0.231175100915131 |
|
9497 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB1 |
0.231175100915131 |
|
9498 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFA6 |
0.231175100915131 |
|
9499 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFA4 |
0.231175100915131 |
|
9500 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALG1L13P |
0.231175100915131 |
|
9501 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFA1B |
0.231175100915131 |
|
9502 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFA1 |
0.231175100915131 |
|
9503 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFA3 |
0.231175100915131 |
|
9504 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFA5 |
0.231175100915131 |
|
9505 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB103A |
0.231175100915131 |
|
9506 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB103B |
0.231175100915131 |
|
9507 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB104A |
0.231175100915131 |
|
9508 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB104B |
0.231175100915131 |
|
9509 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB105A |
0.231175100915131 |
|
9510 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB105B |
0.231175100915131 |
|
9511 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB106A |
0.231175100915131 |
|
9512 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB106B |
0.231175100915131 |
|
9513 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB107A |
0.231175100915131 |
|
9514 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB107B |
0.231175100915131 |
|
9515 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB4A |
0.231175100915131 |
|
9516 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB4B |
0.231175100915131 |
|
9517 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM66B |
0.231175100915131 |
|
9518 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM66E |
0.231175100915131 |
|
9519 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM85B |
0.231175100915131 |
|
9520 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM86B3P |
0.231175100915131 |
|
9521 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM90A24P |
0.231175100915131 |
|
9522 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRLE1 |
0.231175100915131 |
|
9523 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548I3 |
0.231175100915131 |
|
9524 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGK223 |
0.231175100915131 |
|
9525 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPAG11A |
0.231175100915131 |
|
9526 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPAG11B |
0.231175100915131 |
|
9527 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF705B |
0.231175100915131 |
|
9528 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF705G |
0.231175100915131 |
|
9529 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL178P |
0.231175100915131 |
|
9530 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLDN23 |
0.231175100915131 |
|
9531 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFHAS1 |
0.231175100915131 |
|
9532 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000207244.1 |
0.231175100915131 |
|
9533 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERI1 |
0.231175100915131 |
|
9534 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4660 |
0.231175100915131 |
|
9535 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R3B |
0.231175100915131 |
|
9536 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000252543.1 |
0.231175100915131 |
|
9537 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNKS |
0.231175100915131 |
|
9538 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR597 |
0.231175100915131 |
|
9539 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239065.1 |
0.231175100915131 |
|
9540 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00599 |
0.231175100915131 |
|
9541 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238496.1 |
0.231175100915131 |
|
9542 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSRA |
0.231175100915131 |
|
9543 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS51 |
0.231175100915131 |
|
9544 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS55 |
0.231175100915131 |
|
9545 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RP1L1 |
0.231175100915131 |
|
9546 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4286 |
0.231175100915131 |
|
9547 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C8orf74 |
0.231175100915131 |
|
9548 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP252 |
0.231175100915131 |
|
9549 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOX7 |
0.231175100915131 |
|
9550 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PINX1 |
0.231175100915131 |
|
9551 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252565.1 |
0.231175100915131 |
|
9552 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XKR6 |
0.231175100915131 |
|
9553 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR598 |
0.231175100915131 |
|
9554 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00529 |
0.231175100915131 |
|
9555 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTMR9 |
0.231175100915131 |
|
9556 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35G5 |
0.231175100915131 |
|
9557 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TDH |
0.231175100915131 |
|
9558 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C8orf12 |
0.231175100915131 |
|
9559 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL293P |
0.231175100915131 |
|
9560 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM167A |
0.231175100915131 |
|
9561 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BLK |
0.231175100915131 |
|
9562 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00208 |
0.231175100915131 |
|
9563 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GATA4 |
0.231175100915131 |
|
9564 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C8orf49 |
0.231175100915131 |
|
9565 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEIL2 |
0.231175100915131 |
|
9566 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTSB |
0.231175100915131 |
|
9567 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB130|ENSG00000232948.1 |
0.231175100915131 |
|
9568 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB130|ENSG00000233050.1 |
0.231175100915131 |
|
9569 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB134 |
0.231175100915131 |
|
9570 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB135 |
0.231175100915131 |
|
9571 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB136 |
0.231175100915131 |
|
9572 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM66A |
0.231175100915131 |
|
9573 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM66D |
0.231175100915131 |
|
9574 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM86B1 |
0.231175100915131 |
|
9575 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM86B2 |
0.231175100915131 |
|
9576 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FDFT1 |
0.231175100915131 |
|
9577 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP253 |
0.231175100915131 |
|
9578 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP254 |
0.231175100915131 |
|
9579 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP17L2 |
0.231175100915131 |
|
9580 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF705D |
0.231175100915131 |
|
9581 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5692A2 |
0.231175100915131 |
|
9582 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LONRF1 |
0.231175100915131 |
|
9583 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00681 |
0.231175100915131 |
|
9584 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1456 |
0.231175100915131 |
|
9585 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLC1 |
0.231175100915131 |
|
9586 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP255 |
0.231175100915131 |
|
9587 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C8orf48 |
0.231175100915131 |
|
9588 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGCZ |
0.231175100915131 |
|
9589 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR383 |
0.231175100915131 |
|
9590 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUSC3 |
0.231175100915131 |
|
9591 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSR1 |
0.231175100915131 |
|
9592 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL474P |
0.231175100915131 |
|
9593 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGF20 |
0.231175100915131 |
|
9594 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MICU3 |
0.231175100915131 |
|
9595 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDHHC2 |
0.231175100915131 |
|
9596 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNOT7 |
0.231175100915131 |
|
9597 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS37A |
0.231175100915131 |
|
9598 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTMR7 |
0.231175100915131 |
|
9599 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC7A2 |
0.231175100915131 |
|
9600 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDGFRL |
0.231175100915131 |
|
9601 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTUS1 |
0.231175100915131 |
|
9602 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548V |
0.231175100915131 |
|
9603 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP256 |
0.231175100915131 |
|
9604 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGL1 |
0.231175100915131 |
|
9605 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCM1 |
0.231175100915131 |
|
9606 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASAH1 |
0.231175100915131 |
|
9607 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAT1 |
0.231175100915131 |
|
9608 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAT2 |
0.231175100915131 |
|
9609 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSD3 |
0.231175100915131 |
|
9610 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA62|ENSG00000201157.1 |
0.231175100915131 |
|
9611 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH2D4A |
0.231175100915131 |
|
9612 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSGALNACT1 |
0.231175100915131 |
|
9613 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INTS10 |
0.231175100915131 |
|
9614 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPL |
0.231175100915131 |
|
9615 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC18A1 |
0.231175100915131 |
|
9616 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6V1B2 |
0.231175100915131 |
|
9617 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LZTS1 |
0.231175100915131 |
|
9618 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000251944.1 |
0.231175100915131 |
|
9619 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GFRA2 |
0.231175100915131 |
|
9620 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOK2 |
0.231175100915131 |
|
9621 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XPO7 |
0.231175100915131 |
|
9622 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPM2 |
0.231175100915131 |
|
9623 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238466.1 |
0.231175100915131 |
|
9624 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGF17 |
0.231175100915131 |
|
9625 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DMTN |
0.231175100915131 |
|
9626 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM160B2 |
0.231175100915131 |
|
9627 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDT18 |
0.231175100915131 |
|
9628 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HR |
0.231175100915131 |
|
9629 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REEP4 |
0.231175100915131 |
|
9630 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGI3 |
0.231175100915131 |
|
9631 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFTPC |
0.231175100915131 |
|
9632 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BMP1 |
0.231175100915131 |
|
9633 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHYHIP |
0.231175100915131 |
|
9634 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR320A |
0.231175100915131 |
|
9635 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR3D |
0.231175100915131 |
|
9636 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIWIL2 |
0.231175100915131 |
|
9637 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP3CC |
0.231175100915131 |
|
9638 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC39A14 |
0.231175100915131 |
|
9639 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SORBS3 |
0.231175100915131 |
|
9640 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDLIM2 |
0.231175100915131 |
|
9641 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C8orf58 |
0.231175100915131 |
|
9642 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1967 |
0.231175100915131 |
|
9643 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BIN3 |
0.231175100915131 |
|
9644 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EGR3 |
0.231175100915131 |
|
9645 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEBP4 |
0.231175100915131 |
|
9646 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL303P |
0.231175100915131 |
|
9647 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHOBTB2 |
0.231175100915131 |
|
9648 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFRSF10B |
0.231175100915131 |
|
9649 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFRSF10C |
0.231175100915131 |
|
9650 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFRSF10D |
0.231175100915131 |
|
9651 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFRSF10A |
0.231175100915131 |
|
9652 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHMP7 |
0.231175100915131 |
|
9653 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
R3HCC1 |
0.231175100915131 |
|
9654 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LOXL2 |
0.231175100915131 |
|
9655 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENTPD4 |
0.231175100915131 |
|
9656 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A37 |
0.231175100915131 |
|
9657 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FP15737 |
0.231175100915131 |
|
9658 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA67|ENSG00000207027.1 |
0.231175100915131 |
|
9659 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STC1 |
0.231175100915131 |
|
9660 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM28 |
0.231175100915131 |
|
9661 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAMDEC1 |
0.231175100915131 |
|
9662 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM7 |
0.231175100915131 |
|
9663 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEFM |
0.231175100915131 |
|
9664 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEFL |
0.231175100915131 |
|
9665 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL651P |
0.231175100915131 |
|
9666 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOCK5 |
0.231175100915131 |
|
9667 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNRH1 |
0.231175100915131 |
|
9668 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCTD9 |
0.231175100915131 |
|
9669 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDCA2 |
0.231175100915131 |
|
9670 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRP5 |
0.232988466188877 |
|
9671 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP6R3 |
0.232988466188877 |
|
9672 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD26P1 |
0.233299839166087 |
|
9673 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP23P1 |
0.233299839166087 |
|
9674 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HERC2P4 |
0.233299839166087 |
|
9675 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HERC2P5 |
0.233299839166087 |
|
9676 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HERC2P8 |
0.233299839166087 |
|
9677 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00273 |
0.233299839166087 |
|
9678 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP406 |
0.233299839166087 |
|
9679 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP407 |
0.233299839166087 |
|
9680 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP408 |
0.233299839166087 |
|
9681 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP409 |
0.233299839166087 |
|
9682 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP410 |
0.233299839166087 |
|
9683 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP413 |
0.233299839166087 |
|
9684 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP415 |
0.233299839166087 |
|
9685 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP416 |
0.233299839166087 |
|
9686 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP417 |
0.233299839166087 |
|
9687 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP418 |
0.233299839166087 |
|
9688 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP419 |
0.233299839166087 |
|
9689 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP420 |
0.233299839166087 |
|
9690 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP421 |
0.233299839166087 |
|
9691 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP422 |
0.233299839166087 |
|
9692 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP423 |
0.233299839166087 |
|
9693 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC6A10P |
0.233299839166087 |
|
9694 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TP53TG3B |
0.233299839166087 |
|
9695 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TP53TG3C |
0.233299839166087 |
|
9696 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TP53TG3D |
0.233299839166087 |
|
9697 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TP53TG3 |
0.233299839166087 |
|
9698 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF267 |
0.233299839166087 |
|
9699 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CADPS2 |
0.234154218621315 |
|
9700 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF133 |
0.234154218621315 |
|
9701 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF148 |
0.234154218621315 |
|
9702 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MACROD1 |
0.234671713901994 |
|
9703 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLRT1 |
0.234671713901994 |
|
9704 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STIP1 |
0.234671713901994 |
|
9705 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FERMT3 |
0.234671713901994 |
|
9706 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPT1 |
0.234671713901994 |
|
9707 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDT22 |
0.234671713901994 |
|
9708 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC4 |
0.234671713901994 |
|
9709 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VEGFB |
0.234671713901994 |
|
9710 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FKBP2 |
0.234671713901994 |
|
9711 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPAS4 |
0.234671713901994 |
|
9712 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA43|ENSG00000201733.1 |
0.234671713901994 |
|
9713 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPP3 |
0.234671713901994 |
|
9714 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BBS1 |
0.234671713901994 |
|
9715 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDHHC24 |
0.234671713901994 |
|
9716 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTN3 |
0.234671713901994 |
|
9717 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTSF |
0.234671713901994 |
|
9718 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC87 |
0.234671713901994 |
|
9719 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCS |
0.234671713901994 |
|
9720 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM14 |
0.234671713901994 |
|
9721 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHKA |
0.23608585891636 |
|
9722 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUV420H1 |
0.23608585891636 |
|
9723 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf24 |
0.23608585891636 |
|
9724 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAL |
0.23608585891636 |
|
9725 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTL5 |
0.23608585891636 |
|
9726 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPT1A |
0.23608585891636 |
|
9727 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL21 |
0.23608585891636 |
|
9728 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGHMBP2 |
0.23608585891636 |
|
9729 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRGPRD |
0.23608585891636 |
|
9730 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRGPRF |
0.23608585891636 |
|
9731 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPCN2 |
0.23608585891636 |
|
9732 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3164 |
0.23608585891636 |
|
9733 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITPR1 |
0.238051774477269 |
|
9734 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4666B |
0.242318591912466 |
|
9735 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf66 |
0.24349530239376 |
|
9736 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS11P6 |
0.24349530239376 |
|
9737 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf56 |
0.24349530239376 |
|
9738 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238440.1 |
0.24349530239376 |
|
9739 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XPOT |
0.24349530239376 |
|
9740 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBK1 |
0.24349530239376 |
|
9741 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD83 |
0.24349530239376 |
|
9742 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASSF3 |
0.24349530239376 |
|
9743 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548C |
0.24349530239376 |
|
9744 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNS |
0.24349530239376 |
|
9745 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238592.1 |
0.24349530239376 |
|
9746 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D30 |
0.24349530239376 |
|
9747 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC42P |
0.24349530239376 |
|
9748 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WIF1 |
0.24349530239376 |
|
9749 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LEMD3 |
0.24349530239376 |
|
9750 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSRB3 |
0.24349530239376 |
|
9751 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPSAP52 |
0.24349530239376 |
|
9752 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMGA2 |
0.24349530239376 |
|
9753 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP362 |
0.24349530239376 |
|
9754 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LLPH |
0.24349530239376 |
|
9755 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMBIM4 |
0.24349530239376 |
|
9756 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRAK3 |
0.24349530239376 |
|
9757 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP166 |
0.24349530239376 |
|
9758 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HELB |
0.24349530239376 |
|
9759 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238528.1 |
0.24349530239376 |
|
9760 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRIP1 |
0.24349530239376 |
|
9761 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAND1 |
0.24349530239376 |
|
9762 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DYRK2 |
0.24349530239376 |
|
9763 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNG |
0.24349530239376 |
|
9764 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL26 |
0.24349530239376 |
|
9765 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL22 |
0.24349530239376 |
|
9766 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MDM1 |
0.24349530239376 |
|
9767 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAP1B |
0.24349530239376 |
|
9768 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70G |
0.24349530239376 |
|
9769 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUP107 |
0.24349530239376 |
|
9770 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35E3 |
0.24349530239376 |
|
9771 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MDM2 |
0.24349530239376 |
|
9772 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPM |
0.24349530239376 |
|
9773 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPSF6 |
0.24349530239376 |
|
9774 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYZ |
0.24349530239376 |
|
9775 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YEATS4 |
0.24349530239376 |
|
9776 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL804P |
0.24349530239376 |
|
9777 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRS2 |
0.24349530239376 |
|
9778 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCT2 |
0.24349530239376 |
|
9779 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC10 |
0.24349530239376 |
|
9780 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BEST3 |
0.24349530239376 |
|
9781 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB3IP |
0.24349530239376 |
|
9782 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYRFL |
0.24349530239376 |
|
9783 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNOT2 |
0.24349530239376 |
|
9784 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNMB4 |
0.24349530239376 |
|
9785 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPRB |
0.24349530239376 |
|
9786 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPRR |
0.24349530239376 |
|
9787 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPAN8 |
0.24349530239376 |
|
9788 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGR5 |
0.24349530239376 |
|
9789 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFC3H1 |
0.24349530239376 |
|
9790 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA17|ENSG00000212461.1 |
0.24349530239376 |
|
9791 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THAP2 |
0.24349530239376 |
|
9792 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM19 |
0.24349530239376 |
|
9793 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB21 |
0.24349530239376 |
|
9794 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D15 |
0.24349530239376 |
|
9795 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPH2 |
0.24349530239376 |
|
9796 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRHDE |
0.24349530239376 |
|
9797 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000201809.1 |
0.24349530239376 |
|
9798 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATXN7L3B |
0.24349530239376 |
|
9799 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNC2 |
0.24349530239376 |
|
9800 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPS2 |
0.24349530239376 |
|
9801 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLIPR1L1 |
0.24349530239376 |
|
9802 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLIPR1L2 |
0.24349530239376 |
|
9803 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLIPR1 |
0.24349530239376 |
|
9804 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRR1 |
0.24349530239376 |
|
9805 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000251893.2 |
0.24349530239376 |
|
9806 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL734P |
0.24349530239376 |
|
9807 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHLDA1 |
0.24349530239376 |
|
9808 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAP1L1 |
0.24349530239376 |
|
9809 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP172 |
0.24349530239376 |
|
9810 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BBS10 |
0.24349530239376 |
|
9811 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSBPL8 |
0.24349530239376 |
|
9812 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDHHC17 |
0.24349530239376 |
|
9813 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSRP2 |
0.24349530239376 |
|
9814 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
E2F7 |
0.24349530239376 |
|
9815 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238769.1 |
0.24349530239376 |
|
9816 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAV3 |
0.24349530239376 |
|
9817 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYT1 |
0.24349530239376 |
|
9818 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1252 |
0.24349530239376 |
|
9819 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL696P |
0.24349530239376 |
|
9820 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAWR |
0.24349530239376 |
|
9821 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R12A |
0.24349530239376 |
|
9822 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP363 |
0.24349530239376 |
|
9823 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OTOGL |
0.24349530239376 |
|
9824 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP261 |
0.24349530239376 |
|
9825 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPRQ |
0.24349530239376 |
|
9826 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYF6 |
0.24349530239376 |
|
9827 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYF5 |
0.24349530239376 |
|
9828 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIN7A |
0.24349530239376 |
|
9829 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR617 |
0.24349530239376 |
|
9830 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACSS3 |
0.24349530239376 |
|
9831 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR618 |
0.24349530239376 |
|
9832 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4699 |
0.24349530239376 |
|
9833 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPFIA2 |
0.24349530239376 |
|
9834 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC59 |
0.24349530239376 |
|
9835 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL25 |
0.24349530239376 |
|
9836 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMTC2 |
0.24349530239376 |
|
9837 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA3|ENSG00000221148.1 |
0.24349530239376 |
|
9838 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC6A15 |
0.24349530239376 |
|
9839 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPAN19 |
0.24349530239376 |
|
9840 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRIQ1 |
0.24349530239376 |
|
9841 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALX1 |
0.24349530239376 |
|
9842 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASSF9 |
0.24349530239376 |
|
9843 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NTS |
0.24349530239376 |
|
9844 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MGAT4C |
0.24349530239376 |
|
9845 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MKRN9P |
0.24349530239376 |
|
9846 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf50 |
0.24349530239376 |
|
9847 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf29 |
0.24349530239376 |
|
9848 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP290 |
0.24349530239376 |
|
9849 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP364 |
0.24349530239376 |
|
9850 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMTC3 |
0.24349530239376 |
|
9851 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KITLG |
0.24349530239376 |
|
9852 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUSP6 |
0.24349530239376 |
|
9853 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POC1B |
0.24349530239376 |
|
9854 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALNT4 |
0.24349530239376 |
|
9855 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP2B1 |
0.24349530239376 |
|
9856 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00936 |
0.24349530239376 |
|
9857 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP365 |
0.24349530239376 |
|
9858 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LHX8 |
0.243629049344884 |
|
9859 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC44A5 |
0.243629049344884 |
|
9860 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACADM |
0.243629049344884 |
|
9861 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RABGGTB |
0.243629049344884 |
|
9862 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD45C |
0.243629049344884 |
|
9863 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD45A |
0.243629049344884 |
|
9864 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD45B |
0.243629049344884 |
|
9865 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSH4 |
0.243629049344884 |
|
9866 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASB17 |
0.243629049344884 |
|
9867 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST6GALNAC3 |
0.243629049344884 |
|
9868 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST6GALNAC5 |
0.243629049344884 |
|
9869 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIGK |
0.243629049344884 |
|
9870 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AK5 |
0.243629049344884 |
|
9871 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZZZ3 |
0.243629049344884 |
|
9872 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP20 |
0.243629049344884 |
|
9873 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL370P |
0.243629049344884 |
|
9874 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP33 |
0.243629049344884 |
|
9875 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM73A |
0.243629049344884 |
|
9876 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP21 |
0.243629049344884 |
|
9877 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEXN |
0.243629049344884 |
|
9878 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FUBP1 |
0.243629049344884 |
|
9879 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJB4 |
0.243629049344884 |
|
9880 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GIPC2 |
0.243629049344884 |
|
9881 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP22 |
0.243629049344884 |
|
9882 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTGFR |
0.243629049344884 |
|
9883 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP23 |
0.243629049344884 |
|
9884 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFI44L |
0.243629049344884 |
|
9885 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFI44 |
0.243629049344884 |
|
9886 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELTD1 |
0.243629049344884 |
|
9887 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP247 |
0.243629049344884 |
|
9888 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTLL7 |
0.243629049344884 |
|
9889 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKACB |
0.243629049344884 |
|
9890 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA2|ENSG00000199959.1 |
0.243629049344884 |
|
9891 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAMD13 |
0.243629049344884 |
|
9892 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UOX |
0.243629049344884 |
|
9893 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNASE2B |
0.243629049344884 |
|
9894 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPF1 |
0.243629049344884 |
|
9895 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNG5 |
0.243629049344884 |
|
9896 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA1 |
0.243629049344884 |
|
9897 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTBS |
0.243629049344884 |
|
9898 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf180 |
0.243629049344884 |
|
9899 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSX2IP |
0.243629049344884 |
|
9900 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPAR3 |
0.243629049344884 |
|
9901 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCOLN2 |
0.243629049344884 |
|
9902 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR63 |
0.243629049344884 |
|
9903 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCOLN3 |
0.243629049344884 |
|
9904 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4423 |
0.243629049344884 |
|
9905 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYDE2 |
0.243629049344884 |
|
9906 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf52 |
0.243629049344884 |
|
9907 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCL10 |
0.243629049344884 |
|
9908 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDAH1 |
0.243629049344884 |
|
9909 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYR61 |
0.243629049344884 |
|
9910 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD81|ENSG00000199934.1 |
0.243629049344884 |
|
9911 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNHIT6 |
0.243629049344884 |
|
9912 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL24A1 |
0.243629049344884 |
|
9913 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP51 |
0.243629049344884 |
|
9914 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ODF2L |
0.243629049344884 |
|
9915 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLCA2 |
0.243629049344884 |
|
9916 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLCA1 |
0.243629049344884 |
|
9917 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLCA4 |
0.243629049344884 |
|
9918 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLCA3P |
0.243629049344884 |
|
9919 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3GLB1 |
0.243629049344884 |
|
9920 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HS2ST1 |
0.243629049344884 |
|
9921 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMO4 |
0.243629049344884 |
|
9922 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP52 |
0.243629049344884 |
|
9923 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL583P |
0.243629049344884 |
|
9924 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKN2 |
0.243629049344884 |
|
9925 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF2B |
0.243629049344884 |
|
9926 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCBL2 |
0.243629049344884 |
|
9927 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBMXL1 |
0.243629049344884 |
|
9928 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GBP3 |
0.243629049344884 |
|
9929 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GBP1 |
0.243629049344884 |
|
9930 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GBP2 |
0.243629049344884 |
|
9931 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GBP7 |
0.243629049344884 |
|
9932 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GBP4 |
0.243629049344884 |
|
9933 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GBP5 |
0.243629049344884 |
|
9934 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GBP6 |
0.243629049344884 |
|
9935 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GBP1P1 |
0.243629049344884 |
|
9936 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC8B |
0.243629049344884 |
|
9937 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC8C |
0.243629049344884 |
|
9938 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239176.1 |
0.243629049344884 |
|
9939 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC8D |
0.243629049344884 |
|
9940 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP272 |
0.243629049344884 |
|
9941 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF326 |
0.243629049344884 |
|
9942 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000199666.1 |
0.243629049344884 |
|
9943 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BARHL2 |
0.243629049344884 |
|
9944 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF644 |
0.243629049344884 |
|
9945 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HFM1 |
0.243629049344884 |
|
9946 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC7 |
0.243629049344884 |
|
9947 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TGFBR3 |
0.243629049344884 |
|
9948 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL653P |
0.243629049344884 |
|
9949 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL235P |
0.243629049344884 |
|
9950 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRDT |
0.243629049344884 |
|
9951 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPHX4 |
0.243629049344884 |
|
9952 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTBD8 |
0.243629049344884 |
|
9953 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1107 |
0.243629049344884 |
|
9954 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf146 |
0.243629049344884 |
|
9955 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTBP12 |
0.243629049344884 |
|
9956 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLMN |
0.243629049344884 |
|
9957 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPAP2 |
0.243629049344884 |
|
9958 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL824P |
0.243629049344884 |
|
9959 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GFI1 |
0.243629049344884 |
|
9960 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EVI5 |
0.243629049344884 |
|
9961 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL5 |
0.243629049344884 |
|
9962 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD21 |
0.243629049344884 |
|
9963 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA66|ENSG00000251795.1 |
0.243629049344884 |
|
9964 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA66|ENSG00000207523.1 |
0.243629049344884 |
|
9965 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM69A |
0.243629049344884 |
|
9966 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA51|ENSG00000207022.1 |
0.243629049344884 |
|
9967 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL692P |
0.243629049344884 |
|
9968 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP123 |
0.243629049344884 |
|
9969 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTF2 |
0.243629049344884 |
|
9970 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMED5 |
0.243629049344884 |
|
9971 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC18 |
0.243629049344884 |
|
9972 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DR1 |
0.243629049344884 |
|
9973 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FNBP1L |
0.243629049344884 |
|
9974 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP53 |
0.243629049344884 |
|
9975 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCAR3 |
0.243629049344884 |
|
9976 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR760 |
0.243629049344884 |
|
9977 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNTTIP2 |
0.243629049344884 |
|
9978 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCLM |
0.243629049344884 |
|
9979 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCA4 |
0.243629049344884 |
|
9980 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP29 |
0.243629049344884 |
|
9981 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL440P |
0.243629049344884 |
|
9982 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238389.1 |
0.243629049344884 |
|
9983 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCD3 |
0.243629049344884 |
|
9984 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
F3 |
0.243629049344884 |
|
9985 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR378G |
0.243629049344884 |
|
9986 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC44A3 |
0.243629049344884 |
|
9987 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNN3 |
0.243629049344884 |
|
9988 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALG14 |
0.243629049344884 |
|
9989 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM56 |
0.243629049344884 |
|
9990 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RWDD3 |
0.243629049344884 |
|
9991 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL831P |
0.243629049344884 |
|
9992 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP270 |
0.243629049344884 |
|
9993 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTBP2 |
0.243629049344884 |
|
9994 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPYD |
0.243629049344884 |
|
9995 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR137HG |
0.243629049344884 |
|
9996 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX7 |
0.243629049344884 |
|
9997 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPPR5 |
0.243629049344884 |
|
9998 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPPR4 |
0.243629049344884 |
|
9999 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PALMD |
0.243629049344884 |
|
10000 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRRS1 |
0.243629049344884 |
|
10001 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGL |
0.243629049344884 |
|
10002 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35A3 |
0.243629049344884 |
|
10003 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIAT1 |
0.243629049344884 |
|
10004 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SASS6 |
0.243629049344884 |
|
10005 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRMT13 |
0.243629049344884 |
|
10006 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC39 |
0.243629049344884 |
|
10007 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DBT |
0.243629049344884 |
|
10008 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RTCA |
0.243629049344884 |
|
10009 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR553 |
0.243629049344884 |
|
10010 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC14A |
0.243629049344884 |
|
10011 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR88 |
0.243629049344884 |
|
10012 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VCAM1 |
0.243629049344884 |
|
10013 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXTL2 |
0.243629049344884 |
|
10014 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC30A7 |
0.243629049344884 |
|
10015 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPH5 |
0.243629049344884 |
|
10016 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA16|ENSG00000252765.1 |
0.243629049344884 |
|
10017 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238296.1 |
0.243629049344884 |
|
10018 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S1PR1 |
0.243629049344884 |
|
10019 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OLFM3 |
0.243629049344884 |
|
10020 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL11A1 |
0.243629049344884 |
|
10021 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP285 |
0.243629049344884 |
|
10022 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMY1A |
0.243629049344884 |
|
10023 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMY1B |
0.243629049344884 |
|
10024 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMY1C |
0.243629049344884 |
|
10025 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMY2A |
0.243629049344884 |
|
10026 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMY2B |
0.243629049344884 |
|
10027 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNPC3 |
0.243629049344884 |
|
10028 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRMT6 |
0.243629049344884 |
|
10029 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NTNG1 |
0.243629049344884 |
|
10030 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VAV3 |
0.243629049344884 |
|
10031 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A24 |
0.243629049344884 |
|
10032 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBPF4 |
0.243629049344884 |
|
10033 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A24P1 |
0.243629049344884 |
|
10034 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBPF5P |
0.243629049344884 |
|
10035 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBPF6 |
0.243629049344884 |
|
10036 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM102B |
0.243629049344884 |
|
10037 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HENMT1 |
0.243629049344884 |
|
10038 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRPF38B |
0.243629049344884 |
|
10039 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FNDC7 |
0.243629049344884 |
|
10040 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STXBP3 |
0.243629049344884 |
|
10041 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKNAD1 |
0.243629049344884 |
|
10042 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA42 |
0.243629049344884 |
|
10043 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPSM2 |
0.243629049344884 |
|
10044 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLCC1 |
0.243629049344884 |
|
10045 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR47 |
0.243629049344884 |
|
10046 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAF13 |
0.243629049344884 |
|
10047 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf194 |
0.243629049344884 |
|
10048 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1324 |
0.243629049344884 |
|
10049 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA2 |
0.243629049344884 |
|
10050 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM167B |
0.243629049344884 |
|
10051 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SARS |
0.243629049344884 |
|
10052 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CELSR2 |
0.243629049344884 |
|
10053 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSRC1 |
0.243629049344884 |
|
10054 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYBPHL |
0.243629049344884 |
|
10055 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SORT1 |
0.243629049344884 |
|
10056 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMA5 |
0.243629049344884 |
|
10057 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYPL2 |
0.243629049344884 |
|
10058 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATXN7L2 |
0.243629049344884 |
|
10059 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYB561D1 |
0.243629049344884 |
|
10060 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMIGO1 |
0.243629049344884 |
|
10061 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR61 |
0.243629049344884 |
|
10062 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNAI3 |
0.243629049344884 |
|
10063 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6V |
0.243629049344884 |
|
10064 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR197 |
0.243629049344884 |
|
10065 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNAT2 |
0.243629049344884 |
|
10066 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMPD2 |
0.243629049344884 |
|
10067 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSTM1 |
0.243629049344884 |
|
10068 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSTM2 |
0.243629049344884 |
|
10069 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSTM4 |
0.243629049344884 |
|
10070 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSTM5 |
0.243629049344884 |
|
10071 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSTM3 |
0.243629049344884 |
|
10072 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPS8L3 |
0.243629049344884 |
|
10073 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSF1 |
0.243629049344884 |
|
10074 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AHCYL1 |
0.243629049344884 |
|
10075 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STRIP1 |
0.243629049344884 |
|
10076 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALX3 |
0.243629049344884 |
|
10077 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBL4B |
0.243629049344884 |
|
10078 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC6A17 |
0.243629049344884 |
|
10079 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNC4 |
0.243629049344884 |
|
10080 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA25|ENSG00000200536.1 |
0.243629049344884 |
|
10081 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM15 |
0.243629049344884 |
|
10082 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC16A4 |
0.243629049344884 |
|
10083 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAMTOR5 |
0.243629049344884 |
|
10084 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PROK1 |
0.243629049344884 |
|
10085 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYMP |
0.243629049344884 |
|
10086 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNA10 |
0.243629049344884 |
|
10087 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNA2 |
0.243629049344884 |
|
10088 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNA3 |
0.243629049344884 |
|
10089 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD53 |
0.243629049344884 |
|
10090 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRIF1 |
0.243629049344884 |
|
10091 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP54 |
0.243629049344884 |
|
10092 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DRAM2 |
0.243629049344884 |
|
10093 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEPT1 |
0.243629049344884 |
|
10094 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DENND2D |
0.243629049344884 |
|
10095 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHI3L2 |
0.243629049344884 |
|
10096 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHIAP2 |
0.243629049344884 |
|
10097 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHIA |
0.243629049344884 |
|
10098 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIFO |
0.243629049344884 |
|
10099 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGCP1 |
0.243629049344884 |
|
10100 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OVGP1 |
0.243629049344884 |
|
10101 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR77 |
0.243629049344884 |
|
10102 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP5F1 |
0.243629049344884 |
|
10103 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf162 |
0.243629049344884 |
|
10104 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADORA3 |
0.243629049344884 |
|
10105 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAP1A |
0.243629049344884 |
|
10106 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM212B |
0.243629049344884 |
|
10107 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX20 |
0.243629049344884 |
|
10108 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCND3 |
0.243629049344884 |
|
10109 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239111.1 |
0.243629049344884 |
|
10110 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238761.1 |
0.243629049344884 |
|
10111 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTTNBP2NL |
0.243629049344884 |
|
10112 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WNT2B |
0.243629049344884 |
|
10113 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST7L |
0.243629049344884 |
|
10114 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPZA1 |
0.243629049344884 |
|
10115 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238975.1 |
0.243629049344884 |
|
10116 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOV10 |
0.243629049344884 |
|
10117 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHOC |
0.243629049344884 |
|
10118 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPM1J |
0.243629049344884 |
|
10119 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM19A3 |
0.243629049344884 |
|
10120 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC16A1 |
0.243629049344884 |
|
10121 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRIG2 |
0.243629049344884 |
|
10122 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGI3 |
0.243629049344884 |
|
10123 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHTF1 |
0.243629049344884 |
|
10124 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RSBN1 |
0.243629049344884 |
|
10125 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPN22 |
0.243629049344884 |
|
10126 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCL2L15 |
0.243629049344884 |
|
10127 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP4B1 |
0.243629049344884 |
|
10128 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCLRE1B |
0.243629049344884 |
|
10129 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIPK1 |
0.243629049344884 |
|
10130 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OLFML3 |
0.243629049344884 |
|
10131 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYT6 |
0.243629049344884 |
|
10132 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM33 |
0.243629049344884 |
|
10133 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCAS2 |
0.243629049344884 |
|
10134 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DENND2C |
0.243629049344884 |
|
10135 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMPD1 |
0.243629049344884 |
|
10136 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL432P |
0.243629049344884 |
|
10137 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRAS |
0.243629049344884 |
|
10138 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSDE1 |
0.243629049344884 |
|
10139 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIKE1 |
0.243629049344884 |
|
10140 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYCP1 |
0.243629049344884 |
|
10141 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSHB |
0.243629049344884 |
|
10142 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPAN2 |
0.243629049344884 |
|
10143 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NGF |
0.243629049344884 |
|
10144 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL420P |
0.243629049344884 |
|
10145 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA42|ENSG00000207502.1 |
0.243629049344884 |
|
10146 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VANGL1 |
0.243629049344884 |
|
10147 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASQ2 |
0.243629049344884 |
|
10148 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NHLH2 |
0.243629049344884 |
|
10149 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC22A15 |
0.243629049344884 |
|
10150 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAB21L3 |
0.243629049344884 |
|
10151 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000221040.1 |
0.243629049344884 |
|
10152 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP1A1 |
0.243629049344884 |
|
10153 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP1A1OS |
0.243629049344884 |
|
10154 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD58 |
0.243629049344884 |
|
10155 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548AC |
0.243629049344884 |
|
10156 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGSF3 |
0.243629049344884 |
|
10157 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR320B1 |
0.243629049344884 |
|
10158 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf137 |
0.243629049344884 |
|
10159 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD2 |
0.243629049344884 |
|
10160 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTGFRN |
0.243629049344884 |
|
10161 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP55 |
0.243629049344884 |
|
10162 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD101 |
0.243629049344884 |
|
10163 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTF2 |
0.243629049344884 |
|
10164 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR942 |
0.243629049344884 |
|
10165 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM45 |
0.243629049344884 |
|
10166 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VTCN1 |
0.243629049344884 |
|
10167 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAN1A2 |
0.243629049344884 |
|
10168 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM46C |
0.243629049344884 |
|
10169 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA40|ENSG00000212266.1 |
0.243629049344884 |
|
10170 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GDAP2 |
0.243629049344884 |
|
10171 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR3 |
0.243629049344884 |
|
10172 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPAG17 |
0.243629049344884 |
|
10173 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP56 |
0.243629049344884 |
|
10174 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBX15 |
0.243629049344884 |
|
10175 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WARS2 |
0.243629049344884 |
|
10176 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238679.1 |
0.243629049344884 |
|
10177 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAO2 |
0.243629049344884 |
|
10178 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSD3B2 |
0.243629049344884 |
|
10179 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSD3B1 |
0.243629049344884 |
|
10180 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00622 |
0.243629049344884 |
|
10181 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF697 |
0.243629049344884 |
|
10182 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHGDH |
0.243629049344884 |
|
10183 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMGCS2 |
0.243629049344884 |
|
10184 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REG4 |
0.243629049344884 |
|
10185 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM30 |
0.243629049344884 |
|
10186 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHL1 |
0.243755530757191 |
|
10187 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNTN4 |
0.243755530757191 |
|
10188 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNTN6 |
0.243755530757191 |
|
10189 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP144 |
0.243755530757191 |
|
10190 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL120P |
0.243755530757191 |
|
10191 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUSP5 |
0.244507507269606 |
|
10192 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMC3 |
0.244507507269606 |
|
10193 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR143 |
0.24466198722009 |
|
10194 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHROOM2 |
0.24466198722009 |
|
10195 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLCN4 |
0.24466198722009 |
|
10196 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MID1 |
0.24466198722009 |
|
10197 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WWC3 |
0.24466198722009 |
|
10198 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA22|ENSG00000199571.1 |
0.246124823810087 |
|
10199 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRM7 |
0.24640461448672 |
|
10200 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL753P |
0.248452654966887 |
|
10201 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL40P |
0.248452654966887 |
|
10202 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRPF40A |
0.250524136179331 |
|
10203 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL6IP6 |
0.250524136179331 |
|
10204 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD56|ENSG00000200377.1 |
0.250524136179331 |
|
10205 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPRM |
0.250524136179331 |
|
10206 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALNT13 |
0.250524136179331 |
|
10207 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP107 |
0.250524136179331 |
|
10208 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNJ3 |
0.250524136179331 |
|
10209 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238543.1 |
0.250524136179331 |
|
10210 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238481.1 |
0.250524136179331 |
|
10211 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPD2 |
0.250524136179331 |
|
10212 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALNT5 |
0.250524136179331 |
|
10213 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP281 |
0.250524136179331 |
|
10214 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERMN |
0.250524136179331 |
|
10215 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYTIP |
0.250524136179331 |
|
10216 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACVR1C |
0.250524136179331 |
|
10217 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACVR1 |
0.250524136179331 |
|
10218 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UPP2 |
0.250524136179331 |
|
10219 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC148 |
0.250524136179331 |
|
10220 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL393P |
0.250524136179331 |
|
10221 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKP4 |
0.250524136179331 |
|
10222 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoZ5 |
0.250524136179331 |
|
10223 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DAPL1 |
0.250524136179331 |
|
10224 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TANC1 |
0.250524136179331 |
|
10225 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDSUB1 |
0.250524136179331 |
|
10226 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAZ2B |
0.250524136179331 |
|
10227 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MARCH7 |
0.250524136179331 |
|
10228 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD302 |
0.250524136179331 |
|
10229 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LY75 |
0.250524136179331 |
|
10230 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLA2R1 |
0.250524136179331 |
|
10231 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGB6 |
0.250524136179331 |
|
10232 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBMS1 |
0.250524136179331 |
|
10233 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RMRPP3 |
0.250524136179331 |
|
10234 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4785 |
0.250524136179331 |
|
10235 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL423P |
0.250524136179331 |
|
10236 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TANK |
0.250524136179331 |
|
10237 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMD14 |
0.250524136179331 |
|
10238 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBR1 |
0.250524136179331 |
|
10239 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238570.1 |
0.250524136179331 |
|
10240 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC4A10 |
0.250524136179331 |
|
10241 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPP4 |
0.250524136179331 |
|
10242 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCG |
0.250524136179331 |
|
10243 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAP |
0.250524136179331 |
|
10244 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFIH1 |
0.250524136179331 |
|
10245 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCA |
0.250524136179331 |
|
10246 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNH7 |
0.250524136179331 |
|
10247 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP109 |
0.250524136179331 |
|
10248 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FIGN |
0.250524136179331 |
|
10249 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRB14 |
0.250524136179331 |
|
10250 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COBLL1 |
0.250524136179331 |
|
10251 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70F |
0.250524136179331 |
|
10252 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP110 |
0.250524136179331 |
|
10253 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP111 |
0.250524136179331 |
|
10254 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC38A11 |
0.250524136179331 |
|
10255 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCN3A |
0.250524136179331 |
|
10256 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL455P |
0.250524136179331 |
|
10257 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCN2A |
0.250524136179331 |
|
10258 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSRNP3 |
0.250524136179331 |
|
10259 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALNT3 |
0.250524136179331 |
|
10260 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XIRP2 |
0.250524136179331 |
|
10261 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B3GALT1 |
0.250524136179331 |
|
10262 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STK39 |
0.250524136179331 |
|
10263 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL95P |
0.250524136179331 |
|
10264 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL813P |
0.250524136179331 |
|
10265 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CERS6 |
0.250524136179331 |
|
10266 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4774 |
0.250524136179331 |
|
10267 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOSTRIN |
0.250524136179331 |
|
10268 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPC25 |
0.250524136179331 |
|
10269 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
G6PC2 |
0.250524136179331 |
|
10270 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCB11 |
0.250524136179331 |
|
10271 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHRS9 |
0.250524136179331 |
|
10272 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRP2 |
0.250524136179331 |
|
10273 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BBS5 |
0.250524136179331 |
|
10274 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL41 |
0.250524136179331 |
|
10275 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FASTKD1 |
0.250524136179331 |
|
10276 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPIG |
0.250524136179331 |
|
10277 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC173 |
0.250524136179331 |
|
10278 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL23 |
0.250524136179331 |
|
10279 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHOSPHO2 |
0.250524136179331 |
|
10280 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA51|ENSG00000206961.1 |
0.250524136179331 |
|
10281 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSB |
0.250524136179331 |
|
10282 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL5 |
0.250524136179331 |
|
10283 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000252981.1 |
0.250524136179331 |
|
10284 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBR3 |
0.250524136179331 |
|
10285 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYO3B |
0.250524136179331 |
|
10286 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SP5 |
0.250524136179331 |
|
10287 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERICH2 |
0.250524136179331 |
|
10288 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAD1 |
0.250524136179331 |
|
10289 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GORASP2 |
0.250524136179331 |
|
10290 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLK1 |
0.250524136179331 |
|
10291 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238567.1 |
0.250524136179331 |
|
10292 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL8 |
0.250524136179331 |
|
10293 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCAF17 |
0.250524136179331 |
|
10294 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYBRD1 |
0.250524136179331 |
|
10295 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DYNC1I2 |
0.250524136179331 |
|
10296 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL5RA |
0.250628130804696 |
|
10297 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA43|ENSG00000253049.1 |
0.250628130804696 |
|
10298 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRNT1 |
0.250628130804696 |
|
10299 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRBN |
0.250628130804696 |
|
10300 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUMF1 |
0.250628130804696 |
|
10301 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRN1 |
0.250628130804696 |
|
10302 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SETMAR |
0.250628130804696 |
|
10303 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KDM2A |
0.250857174128078 |
|
10304 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238892.1 |
0.250857174128078 |
|
10305 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADRBK1 |
0.250857174128078 |
|
10306 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD13D |
0.250857174128078 |
|
10307 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSH3 |
0.250857174128078 |
|
10308 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLD4 |
0.250857174128078 |
|
10309 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP239 |
0.250857174128078 |
|
10310 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLCF1 |
0.250857174128078 |
|
10311 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAD9A |
0.250857174128078 |
|
10312 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1CA |
0.250857174128078 |
|
10313 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D10C |
0.250857174128078 |
|
10314 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CARNS1 |
0.250857174128078 |
|
10315 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS6KB2 |
0.250857174128078 |
|
10316 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CORO1B |
0.250857174128078 |
|
10317 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPRCAP |
0.250857174128078 |
|
10318 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CABP4 |
0.250857174128078 |
|
10319 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR152 |
0.250857174128078 |
|
10320 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM134 |
0.250857174128078 |
|
10321 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AIP |
0.250857174128078 |
|
10322 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PITPNM1 |
0.250857174128078 |
|
10323 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK2AP2 |
0.250857174128078 |
|
10324 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CABP2 |
0.250857174128078 |
|
10325 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACY3 |
0.250857174128078 |
|
10326 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALDH3B2 |
0.250857174128078 |
|
10327 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf72 |
0.250857174128078 |
|
10328 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOC2GP |
0.250857174128078 |
|
10329 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM86C2P |
0.250857174128078 |
|
10330 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSTP1 |
0.250857174128078 |
|
10331 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFV1 |
0.250857174128078 |
|
10332 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDT8 |
0.250857174128078 |
|
10333 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL59P |
0.250857174128078 |
|
10334 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBX10 |
0.250857174128078 |
|
10335 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UNC93B1 |
0.250857174128078 |
|
10336 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALDH3B1 |
0.250857174128078 |
|
10337 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFS8 |
0.250857174128078 |
|
10338 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4691 |
0.250857174128078 |
|
10339 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCIRG1 |
0.250857174128078 |
|
10340 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DSC3 |
0.251171378671801 |
|
10341 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DSC2 |
0.251171378671801 |
|
10342 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238376.1 |
0.251171378671801 |
|
10343 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DSC1 |
0.251171378671801 |
|
10344 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DSG1 |
0.251171378671801 |
|
10345 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DSG4 |
0.251171378671801 |
|
10346 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DSG3 |
0.251171378671801 |
|
10347 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DSG2 |
0.251171378671801 |
|
10348 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTR |
0.251171378671801 |
|
10349 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B4GALT6 |
0.251171378671801 |
|
10350 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP44 |
0.251171378671801 |
|
10351 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC37A7P |
0.251171378671801 |
|
10352 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A52 |
0.251171378671801 |
|
10353 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAPPC8 |
0.251171378671801 |
|
10354 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF125 |
0.251171378671801 |
|
10355 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF138 |
0.251171378671801 |
|
10356 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238982.1 |
0.251171378671801 |
|
10357 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAREM |
0.251171378671801 |
|
10358 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP453 |
0.251171378671801 |
|
10359 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEP1B |
0.251171378671801 |
|
10360 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WBP11P1 |
0.251171378671801 |
|
10361 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL14 |
0.251171378671801 |
|
10362 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC178 |
0.251171378671801 |
|
10363 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASXL3 |
0.251171378671801 |
|
10364 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOL4 |
0.251171378671801 |
|
10365 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DTNA |
0.251171378671801 |
|
10366 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPRE2 |
0.251171378671801 |
|
10367 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF397 |
0.251171378671801 |
|
10368 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSCAN30 |
0.251171378671801 |
|
10369 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF271 |
0.251171378671801 |
|
10370 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF24 |
0.251171378671801 |
|
10371 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF396 |
0.251171378671801 |
|
10372 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INO80C |
0.251171378671801 |
|
10373 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALNT1 |
0.251171378671801 |
|
10374 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR187 |
0.251171378671801 |
|
10375 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3929 |
0.251171378671801 |
|
10376 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C18orf21 |
0.251171378671801 |
|
10377 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPRD1A |
0.251171378671801 |
|
10378 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC39A6 |
0.251171378671801 |
|
10379 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELP2 |
0.251171378671801 |
|
10380 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOCOS |
0.251171378671801 |
|
10381 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FHOD3 |
0.251171378671801 |
|
10382 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252078.1 |
0.251171378671801 |
|
10383 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPGS2 |
0.251171378671801 |
|
10384 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP456 |
0.254315070456413 |
|
10385 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTIF |
0.254315070456413 |
|
10386 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4743 |
0.254315070456413 |
|
10387 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMAD7 |
0.254315070456413 |
|
10388 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DYM |
0.254315070456413 |
|
10389 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4744 |
0.254315070456413 |
|
10390 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C18orf32 |
0.254315070456413 |
|
10391 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1539 |
0.254315070456413 |
|
10392 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL17 |
0.254315070456413 |
|
10393 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD58C |
0.254315070456413 |
|
10394 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD58A |
0.254315070456413 |
|
10395 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD58B |
0.254315070456413 |
|
10396 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIPG |
0.254315070456413 |
|
10397 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACAA2 |
0.254315070456413 |
|
10398 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA17|ENSG00000251992.1 |
0.254315070456413 |
|
10399 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA17|ENSG00000267322.1 |
0.254315070456413 |
|
10400 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA18|ENSG00000252139.1 |
0.254315070456413 |
|
10401 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYO5B |
0.254315070456413 |
|
10402 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP457 |
0.254315070456413 |
|
10403 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL310P |
0.254315070456413 |
|
10404 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC11 |
0.254315070456413 |
|
10405 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBD1 |
0.254315070456413 |
|
10406 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXXC1 |
0.254315070456413 |
|
10407 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP458 |
0.254315070456413 |
|
10408 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SKA1 |
0.254315070456413 |
|
10409 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00308 |
0.255752093161633 |
|
10410 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL609P |
0.255752093161633 |
|
10411 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00113 |
0.255752093161633 |
|
10412 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00314 |
0.255752093161633 |
|
10413 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00161 |
0.255752093161633 |
|
10414 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
N6AMT1 |
0.255752093161633 |
|
10415 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LTN1 |
0.255752093161633 |
|
10416 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RWDD2B |
0.255752093161633 |
|
10417 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP16 |
0.255752093161633 |
|
10418 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCT8 |
0.255752093161633 |
|
10419 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP3K7CL |
0.255752093161633 |
|
10420 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000212479.1 |
0.255752093161633 |
|
10421 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BACH1 |
0.255752093161633 |
|
10422 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00189 |
0.255752093161633 |
|
10423 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239171.1 |
0.255752093161633 |
|
10424 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRIK1 |
0.255752093161633 |
|
10425 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLDN17 |
0.255752093161633 |
|
10426 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00307 |
0.255752093161633 |
|
10427 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLDN8 |
0.255752093161633 |
|
10428 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4327 |
0.255752093161633 |
|
10429 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOD1 |
0.255752093161633 |
|
10430 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCAF4 |
0.255752093161633 |
|
10431 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA81|ENSG00000238390.1 |
0.255752093161633 |
|
10432 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HUNK |
0.255752093161633 |
|
10433 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EVA1C |
0.255752093161633 |
|
10434 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA33|ENSG00000252045.1 |
0.255752093161633 |
|
10435 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP490 |
0.255752093161633 |
|
10436 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00846 |
0.255752093161633 |
|
10437 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCP10L |
0.255752093161633 |
|
10438 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C21ORF59 |
0.255752093161633 |
|
10439 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C21orf59 |
0.255752093161633 |
|
10440 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYNJ1 |
0.255752093161633 |
|
10441 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAXBP1 |
0.255752093161633 |
|
10442 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C21orf49 |
0.255752093161633 |
|
10443 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C21orf62 |
0.255752093161633 |
|
10444 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000207098.1 |
0.255752093161633 |
|
10445 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OLIG2 |
0.255752093161633 |
|
10446 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00945 |
0.255752093161633 |
|
10447 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OLIG1 |
0.255752093161633 |
|
10448 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C21orf54 |
0.255752093161633 |
|
10449 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNAR2 |
0.255752093161633 |
|
10450 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL10RB |
0.255752093161633 |
|
10451 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNAR1 |
0.255752093161633 |
|
10452 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNGR2 |
0.255752093161633 |
|
10453 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM50B |
0.255752093161633 |
|
10454 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC28 |
0.255752093161633 |
|
10455 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GART |
0.255752093161633 |
|
10456 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SON |
0.255752093161633 |
|
10457 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DONSON |
0.255752093161633 |
|
10458 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRYZL1 |
0.255752093161633 |
|
10459 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITSN1 |
0.255752093161633 |
|
10460 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP5O |
0.255752093161633 |
|
10461 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00649 |
0.255752093161633 |
|
10462 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL740P |
0.255752093161633 |
|
10463 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS6 |
0.255752093161633 |
|
10464 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC5A3 |
0.255752093161633 |
|
10465 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00310 |
0.255752093161633 |
|
10466 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNE1 |
0.255752093161633 |
|
10467 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNE2 |
0.255752093161633 |
|
10468 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RCAN1 |
0.255752093161633 |
|
10469 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMIM11 |
0.255752093161633 |
|
10470 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA11|ENSG00000221398.1 |
0.255752093161633 |
|
10471 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLIC6 |
0.255752093161633 |
|
10472 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00160 |
0.255752093161633 |
|
10473 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RUNX1 |
0.255752093161633 |
|
10474 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR802 |
0.255752093161633 |
|
10475 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FKSG68 |
0.255752093161633 |
|
10476 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SETD4 |
0.255752093161633 |
|
10477 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBR1 |
0.255752093161633 |
|
10478 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBR3 |
0.255752093161633 |
|
10479 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOPEY2 |
0.255752093161633 |
|
10480 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL73P |
0.255752093161633 |
|
10481 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238851.1 |
0.255752093161633 |
|
10482 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MORC3 |
0.255752093161633 |
|
10483 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHAF1B |
0.255752093161633 |
|
10484 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLDN14 |
0.255752093161633 |
|
10485 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIM2 |
0.255752093161633 |
|
10486 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HLCS |
0.255752093161633 |
|
10487 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP491 |
0.255752093161633 |
|
10488 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIPPLY3 |
0.255752093161633 |
|
10489 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIGP |
0.255752093161633 |
|
10490 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC3 |
0.255752093161633 |
|
10491 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DSCR9 |
0.255752093161633 |
|
10492 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL678P |
0.255752093161633 |
|
10493 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DSCR3 |
0.255752093161633 |
|
10494 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DYRK1A |
0.255752093161633 |
|
10495 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC18B1 |
0.25588542225254 |
|
10496 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP431 |
0.258297645662807 |
|
10497 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAF |
0.258297645662807 |
|
10498 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DYNLRB2 |
0.258297645662807 |
|
10499 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDYL2 |
0.258297645662807 |
|
10500 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CMC2 |
0.258297645662807 |
|
10501 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CENPN |
0.258297645662807 |
|
10502 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATMIN |
0.258297645662807 |
|
10503 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf46 |
0.258297645662807 |
|
10504 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCSH |
0.258297645662807 |
|
10505 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKD1L2 |
0.258297645662807 |
|
10506 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCMO1 |
0.258297645662807 |
|
10507 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAN |
0.258297645662807 |
|
10508 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4720 |
0.258297645662807 |
|
10509 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CMIP |
0.258297645662807 |
|
10510 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLCG2 |
0.258297645662807 |
|
10511 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
7SK|ENSG00000260682.2 |
0.258297645662807 |
|
10512 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDR42E1 |
0.258297645662807 |
|
10513 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSD17B2 |
0.258297645662807 |
|
10514 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPHOSPH6 |
0.258297645662807 |
|
10515 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP190 |
0.258297645662807 |
|
10516 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238321.1 |
0.258297645662807 |
|
10517 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL134P |
0.258297645662807 |
|
10518 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3182 |
0.258297645662807 |
|
10519 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSBP1 |
0.258297645662807 |
|
10520 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLYCD |
0.258297645662807 |
|
10521 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSGIN1 |
0.258297645662807 |
|
10522 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NECAB2 |
0.258297645662807 |
|
10523 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBTPS1 |
0.258297645662807 |
|
10524 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP432 |
0.258297645662807 |
|
10525 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC38A8 |
0.258297645662807 |
|
10526 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSDL1 |
0.258297645662807 |
|
10527 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAAF1 |
0.258297645662807 |
|
10528 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAD2 |
0.258297645662807 |
|
10529 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP2C2 |
0.258297645662807 |
|
10530 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COTL1 |
0.258297645662807 |
|
10531 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRISPLD2 |
0.258297645662807 |
|
10532 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNG4 |
0.258297645662807 |
|
10533 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL36 |
0.258297645662807 |
|
10534 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP433 |
0.258297645662807 |
|
10535 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAF1C |
0.258297645662807 |
|
10536 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLDC1 |
0.258297645662807 |
|
10537 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP10 |
0.258297645662807 |
|
10538 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WFDC1 |
0.258297645662807 |
|
10539 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDHHC7 |
0.258297645662807 |
|
10540 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0513 |
0.258297645662807 |
|
10541 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM92B |
0.258297645662807 |
|
10542 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00311 |
0.258297645662807 |
|
10543 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5093 |
0.258297645662807 |
|
10544 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL381P |
0.258297645662807 |
|
10545 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1910 |
0.258297645662807 |
|
10546 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMC8 |
0.258297645662807 |
|
10547 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX4I1 |
0.258297645662807 |
|
10548 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRF8 |
0.258297645662807 |
|
10549 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00917 |
0.258297645662807 |
|
10550 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FENDRR |
0.258297645662807 |
|
10551 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXF1 |
0.258297645662807 |
|
10552 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTHFSD |
0.258297645662807 |
|
10553 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXC2 |
0.258297645662807 |
|
10554 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXL1 |
0.258297645662807 |
|
10555 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf95 |
0.258297645662807 |
|
10556 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239186.1 |
0.258297645662807 |
|
10557 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO31 |
0.258297645662807 |
|
10558 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP1LC3B |
0.258297645662807 |
|
10559 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZCCHC14 |
0.258297645662807 |
|
10560 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JPH3 |
0.258297645662807 |
|
10561 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLJ00104 |
0.258297645662807 |
|
10562 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLG2 |
0.259216340230234 |
|
10563 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LARGE |
0.259805228988279 |
|
10564 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4764 |
0.259805228988279 |
|
10565 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA76|ENSG00000253007.2 |
0.259805228988279 |
|
10566 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCD |
0.261406719708341 |
|
10567 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUCL1 |
0.261406719708341 |
|
10568 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TESPA1 |
0.261406719708341 |
|
10569 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEUROD4 |
0.261406719708341 |
|
10570 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR9K2 |
0.261406719708341 |
|
10571 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10A7 |
0.261406719708341 |
|
10572 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6C74 |
0.261406719708341 |
|
10573 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6C6 |
0.261406719708341 |
|
10574 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6C1 |
0.261406719708341 |
|
10575 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6C3 |
0.261406719708341 |
|
10576 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6C75 |
0.261406719708341 |
|
10577 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6C65 |
0.261406719708341 |
|
10578 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6C76 |
0.261406719708341 |
|
10579 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6C2 |
0.261406719708341 |
|
10580 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6C70 |
0.261406719708341 |
|
10581 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6C68 |
0.261406719708341 |
|
10582 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6C4 |
0.261406719708341 |
|
10583 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2AP1 |
0.261406719708341 |
|
10584 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10P1 |
0.261406719708341 |
|
10585 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL7B |
0.261406719708341 |
|
10586 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGA7 |
0.261406719708341 |
|
10587 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BLOC1S1 |
0.261406719708341 |
|
10588 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RDH5 |
0.261406719708341 |
|
10589 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD63 |
0.261406719708341 |
|
10590 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GDF11 |
0.261406719708341 |
|
10591 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SARNP |
0.261406719708341 |
|
10592 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC14 |
0.261406719708341 |
|
10593 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ORMDL2 |
0.261406719708341 |
|
10594 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM198B |
0.261406719708341 |
|
10595 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMP19 |
0.261406719708341 |
|
10596 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WIBG |
0.261406719708341 |
|
10597 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DGKA |
0.261406719708341 |
|
10598 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PMEL |
0.261406719708341 |
|
10599 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK2 |
0.261406719708341 |
|
10600 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB5B |
0.261406719708341 |
|
10601 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUOX |
0.261406719708341 |
|
10602 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IKZF4 |
0.261406719708341 |
|
10603 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS26 |
0.261406719708341 |
|
10604 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERBB3 |
0.261406719708341 |
|
10605 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PA2G4 |
0.261406719708341 |
|
10606 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL41 |
0.261406719708341 |
|
10607 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ESYT1 |
0.261406719708341 |
|
10608 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZC3H10 |
0.261406719708341 |
|
10609 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYL6B |
0.261406719708341 |
|
10610 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYL6 |
0.261406719708341 |
|
10611 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMARCC2 |
0.261406719708341 |
|
10612 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL770P |
0.261406719708341 |
|
10613 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF41 |
0.261406719708341 |
|
10614 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NABP2 |
0.261406719708341 |
|
10615 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC39A5 |
0.261406719708341 |
|
10616 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD52 |
0.261406719708341 |
|
10617 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COQ10A |
0.261406719708341 |
|
10618 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CS |
0.261406719708341 |
|
10619 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNPY2 |
0.261406719708341 |
|
10620 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAN2 |
0.261406719708341 |
|
10621 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL23A |
0.261406719708341 |
|
10622 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAT2 |
0.261406719708341 |
|
10623 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOF |
0.261406719708341 |
|
10624 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIMELESS |
0.261406719708341 |
|
10625 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIP |
0.261406719708341 |
|
10626 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPRYD4 |
0.261406719708341 |
|
10627 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLS2 |
0.261406719708341 |
|
10628 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBMS2 |
0.261406719708341 |
|
10629 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAZ2A |
0.261406719708341 |
|
10630 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP5B |
0.261406719708341 |
|
10631 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD59A |
0.261406719708341 |
|
10632 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTGES3 |
0.261406719708341 |
|
10633 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL809P |
0.261406719708341 |
|
10634 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NACA |
0.261406719708341 |
|
10635 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRIM1 |
0.261406719708341 |
|
10636 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSD17B6 |
0.261406719708341 |
|
10637 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA48|ENSG00000212383.1 |
0.261406719708341 |
|
10638 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDR9C7 |
0.261406719708341 |
|
10639 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RDH16 |
0.261406719708341 |
|
10640 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR182 |
0.261406719708341 |
|
10641 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HBCBP |
0.261406719708341 |
|
10642 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB39 |
0.261406719708341 |
|
10643 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAC3 |
0.261406719708341 |
|
10644 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYO1A |
0.261406719708341 |
|
10645 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM194A |
0.261406719708341 |
|
10646 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAB2 |
0.261406719708341 |
|
10647 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAT6 |
0.261406719708341 |
|
10648 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRP1 |
0.261406719708341 |
|
10649 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1228 |
0.261406719708341 |
|
10650 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NXPH4 |
0.261406719708341 |
|
10651 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHMT2 |
0.261406719708341 |
|
10652 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFA4L2 |
0.261406719708341 |
|
10653 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAC3 |
0.261406719708341 |
|
10654 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA19|ENSG00000251822.1 |
0.261406719708341 |
|
10655 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM19A2 |
0.261406719708341 |
|
10656 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252883.1 |
0.261406719708341 |
|
10657 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP15 |
0.261406719708341 |
|
10658 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MON2 |
0.261406719708341 |
|
10659 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf61 |
0.261406719708341 |
|
10660 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIRLET7I |
0.261406719708341 |
|
10661 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPM1H |
0.261406719708341 |
|
10662 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238475.1 |
0.261406719708341 |
|
10663 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LDHAL6CP |
0.261406719708341 |
|
10664 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AVPR1A |
0.261406719708341 |
|
10665 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPY19L2 |
0.261406719708341 |
|
10666 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM5 |
0.261406719708341 |
|
10667 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRGAP1 |
0.261406719708341 |
|
10668 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCER1 |
0.261406719708341 |
|
10669 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00615 |
0.261406719708341 |
|
10670 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPYC |
0.261406719708341 |
|
10671 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KERA |
0.261406719708341 |
|
10672 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LUM |
0.261406719708341 |
|
10673 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCN |
0.261406719708341 |
|
10674 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf79 |
0.261406719708341 |
|
10675 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTG1 |
0.261406719708341 |
|
10676 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLLU1OS |
0.261406719708341 |
|
10677 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLLU1 |
0.261406719708341 |
|
10678 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238865.1 |
0.261406719708341 |
|
10679 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf74 |
0.261406719708341 |
|
10680 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHG7 |
0.261406719708341 |
|
10681 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EEA1 |
0.261406719708341 |
|
10682 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD74|ENSG00000201502.1 |
0.261406719708341 |
|
10683 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238361.1 |
0.261406719708341 |
|
10684 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239073.1 |
0.261406719708341 |
|
10685 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDT4 |
0.261406719708341 |
|
10686 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2N |
0.261406719708341 |
|
10687 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL42 |
0.261406719708341 |
|
10688 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL737P |
0.261406719708341 |
|
10689 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOCS2 |
0.261406719708341 |
|
10690 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRADD |
0.261406719708341 |
|
10691 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL630P |
0.261406719708341 |
|
10692 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP263 |
0.261406719708341 |
|
10693 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLXNC1 |
0.261406719708341 |
|
10694 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC41 |
0.261406719708341 |
|
10695 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL330P |
0.261406719708341 |
|
10696 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL483P |
0.261406719708341 |
|
10697 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5700 |
0.261406719708341 |
|
10698 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMCC3 |
0.261406719708341 |
|
10699 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT19P2 |
0.261406719708341 |
|
10700 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR492 |
0.261406719708341 |
|
10701 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFA12 |
0.261406719708341 |
|
10702 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NR2C1 |
0.261406719708341 |
|
10703 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGD6 |
0.261406719708341 |
|
10704 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VEZT |
0.261406719708341 |
|
10705 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR331 |
0.261406719708341 |
|
10706 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3685 |
0.261406719708341 |
|
10707 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METAP2 |
0.261406719708341 |
|
10708 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP44 |
0.261406719708341 |
|
10709 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGAM1P5 |
0.261406719708341 |
|
10710 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NTN4 |
0.261406719708341 |
|
10711 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNRPF |
0.261406719708341 |
|
10712 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC38 |
0.261406719708341 |
|
10713 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMDHD1 |
0.261406719708341 |
|
10714 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAL |
0.261406719708341 |
|
10715 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LTA4H |
0.261406719708341 |
|
10716 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL88P |
0.261406719708341 |
|
10717 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELK3 |
0.261406719708341 |
|
10718 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK17 |
0.261406719708341 |
|
10719 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP11 |
0.261406719708341 |
|
10720 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf55 |
0.261406719708341 |
|
10721 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf63 |
0.261406719708341 |
|
10722 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEDD1 |
0.261406719708341 |
|
10723 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RMST |
0.261406719708341 |
|
10724 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1251 |
0.261406719708341 |
|
10725 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR135A2 |
0.261406719708341 |
|
10726 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4495 |
0.261406719708341 |
|
10727 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4303 |
0.261406719708341 |
|
10728 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC9A7P1 |
0.261406719708341 |
|
10729 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMPO |
0.261406719708341 |
|
10730 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL179P |
0.261406719708341 |
|
10731 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A3 |
0.261406719708341 |
|
10732 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA53 |
0.261406719708341 |
|
10733 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IKBIP |
0.261406719708341 |
|
10734 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APAF1 |
0.261406719708341 |
|
10735 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKS1B |
0.261406719708341 |
|
10736 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP366 |
0.261406719708341 |
|
10737 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM71C |
0.261406719708341 |
|
10738 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UHRF1BP1L |
0.261406719708341 |
|
10739 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA2B |
0.261406719708341 |
|
10740 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL176P |
0.261406719708341 |
|
10741 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTR6 |
0.261406719708341 |
|
10742 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEPDC4 |
0.261406719708341 |
|
10743 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCYL2 |
0.261406719708341 |
|
10744 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC17A8 |
0.261406719708341 |
|
10745 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238748.1 |
0.261406719708341 |
|
10746 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NR1H4 |
0.261406719708341 |
|
10747 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAS2L3 |
0.261406719708341 |
|
10748 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANO4 |
0.261406719708341 |
|
10749 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC5A8 |
0.261406719708341 |
|
10750 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UTP20 |
0.261406719708341 |
|
10751 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238800.1 |
0.261406719708341 |
|
10752 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL1 |
0.261406719708341 |
|
10753 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP367 |
0.261406719708341 |
|
10754 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPIC |
0.261406719708341 |
|
10755 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYBPC1 |
0.261406719708341 |
|
10756 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHPT1 |
0.261406719708341 |
|
10757 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYCP3 |
0.261406719708341 |
|
10758 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNPTAB |
0.261406719708341 |
|
10759 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP368 |
0.261406719708341 |
|
10760 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238940.1 |
0.261406719708341 |
|
10761 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP369 |
0.261406719708341 |
|
10762 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DRAM1 |
0.261406719708341 |
|
10763 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC53 |
0.261406719708341 |
|
10764 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUP37 |
0.261406719708341 |
|
10765 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARPBP |
0.261406719708341 |
|
10766 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PMCH |
0.261406719708341 |
|
10767 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL793P |
0.261406719708341 |
|
10768 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGF1 |
0.261406719708341 |
|
10769 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00485 |
0.261406719708341 |
|
10770 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAH |
0.261406719708341 |
|
10771 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASCL1 |
0.261406719708341 |
|
10772 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf42 |
0.261406719708341 |
|
10773 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAB2 |
0.261406719708341 |
|
10774 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000212594.1 |
0.261406719708341 |
|
10775 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238914.1 |
0.261406719708341 |
|
10776 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NT5DC3 |
0.261406719708341 |
|
10777 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSP90B1 |
0.261406719708341 |
|
10778 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3652 |
0.261406719708341 |
|
10779 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf73 |
0.261406719708341 |
|
10780 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TDG |
0.261406719708341 |
|
10781 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLT8D2 |
0.261406719708341 |
|
10782 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCFC2 |
0.261406719708341 |
|
10783 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFYB |
0.261406719708341 |
|
10784 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP370 |
0.261406719708341 |
|
10785 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TXNRD1 |
0.261406719708341 |
|
10786 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EID3 |
0.261406719708341 |
|
10787 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHST11 |
0.261406719708341 |
|
10788 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3922 |
0.261406719708341 |
|
10789 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC41A2 |
0.261406719708341 |
|
10790 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf45 |
0.261406719708341 |
|
10791 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALDH1L2 |
0.261406719708341 |
|
10792 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1033 |
0.261406719708341 |
|
10793 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APPL2 |
0.261406719708341 |
|
10794 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf75 |
0.261406719708341 |
|
10795 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUAK1 |
0.261406719708341 |
|
10796 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CKAP4 |
0.261406719708341 |
|
10797 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCP11L2 |
0.261406719708341 |
|
10798 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR3B |
0.261406719708341 |
|
10799 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFX4 |
0.261406719708341 |
|
10800 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIC8B |
0.261406719708341 |
|
10801 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf23 |
0.261406719708341 |
|
10802 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTERFD3 |
0.261406719708341 |
|
10803 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRY1 |
0.261406719708341 |
|
10804 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTBD11 |
0.261406719708341 |
|
10805 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD74|ENSG00000200897.1 |
0.261406719708341 |
|
10806 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP371 |
0.261406719708341 |
|
10807 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PWP1 |
0.261406719708341 |
|
10808 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRDM4 |
0.261406719708341 |
|
10809 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASCL4 |
0.261406719708341 |
|
10810 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WSCD2 |
0.261406719708341 |
|
10811 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CMKLR1 |
0.261406719708341 |
|
10812 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FICD |
0.261406719708341 |
|
10813 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SART3 |
0.261406719708341 |
|
10814 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ISCU |
0.261406719708341 |
|
10815 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM119 |
0.261406719708341 |
|
10816 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SELPLG |
0.261406719708341 |
|
10817 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CORO1C |
0.261406719708341 |
|
10818 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA40|ENSG00000264043.2 |
0.261406719708341 |
|
10819 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSH1 |
0.261406719708341 |
|
10820 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR619 |
0.261406719708341 |
|
10821 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DAO |
0.261406719708341 |
|
10822 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SVOP |
0.261406719708341 |
|
10823 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP30 |
0.261406719708341 |
|
10824 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP372 |
0.261406719708341 |
|
10825 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALKBH2 |
0.261406719708341 |
|
10826 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UNG |
0.261406719708341 |
|
10827 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACACB |
0.261406719708341 |
|
10828 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXN4 |
0.261406719708341 |
|
10829 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYO1H |
0.261406719708341 |
|
10830 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCTD10 |
0.261406719708341 |
|
10831 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE3B |
0.261406719708341 |
|
10832 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMAB |
0.261406719708341 |
|
10833 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MVK |
0.261406719708341 |
|
10834 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP250 |
0.261406719708341 |
|
10835 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM222A |
0.261406719708341 |
|
10836 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPV4 |
0.261406719708341 |
|
10837 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4497 |
0.261406719708341 |
|
10838 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLTP |
0.261406719708341 |
|
10839 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL441P |
0.261406719708341 |
|
10840 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCHP |
0.261406719708341 |
|
10841 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GIT2 |
0.261406719708341 |
|
10842 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD13A |
0.261406719708341 |
|
10843 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf76 |
0.261406719708341 |
|
10844 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFT81 |
0.261406719708341 |
|
10845 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP2A2 |
0.261406719708341 |
|
10846 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL769P |
0.261406719708341 |
|
10847 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANAPC7 |
0.261406719708341 |
|
10848 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARPC3 |
0.261406719708341 |
|
10849 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPN3 |
0.261406719708341 |
|
10850 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM216A |
0.261406719708341 |
|
10851 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS29 |
0.261406719708341 |
|
10852 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD50|ENSG00000202335.1 |
0.261406719708341 |
|
10853 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAD9B |
0.261406719708341 |
|
10854 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPTC7 |
0.261406719708341 |
|
10855 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCTN1 |
0.261406719708341 |
|
10856 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HVCN1 |
0.261406719708341 |
|
10857 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL387P |
0.261406719708341 |
|
10858 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1CC |
0.261406719708341 |
|
10859 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC63 |
0.261406719708341 |
|
10860 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYL2 |
0.261406719708341 |
|
10861 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CUX2 |
0.261406719708341 |
|
10862 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP373 |
0.261406719708341 |
|
10863 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM109A |
0.261406719708341 |
|
10864 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH2B3 |
0.261406719708341 |
|
10865 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATXN2 |
0.261406719708341 |
|
10866 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U7|ENSG00000272215.1 |
0.261406719708341 |
|
10867 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRAP |
0.261406719708341 |
|
10868 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACAD10 |
0.261406719708341 |
|
10869 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALDH2 |
0.261406719708341 |
|
10870 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPKAPK5 |
0.261406719708341 |
|
10871 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM1A |
0.261406719708341 |
|
10872 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM116 |
0.261406719708341 |
|
10873 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERP29 |
0.261406719708341 |
|
10874 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAA25 |
0.261406719708341 |
|
10875 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3657 |
0.261406719708341 |
|
10876 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAFD1 |
0.261406719708341 |
|
10877 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HECTD4 |
0.261406719708341 |
|
10878 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP71 |
0.261406719708341 |
|
10879 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPN11 |
0.261406719708341 |
|
10880 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL6 |
0.261406719708341 |
|
10881 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPH3A |
0.261406719708341 |
|
10882 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OAS1 |
0.261406719708341 |
|
10883 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OAS3 |
0.261406719708341 |
|
10884 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OAS2 |
0.261406719708341 |
|
10885 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DTX1 |
0.261406719708341 |
|
10886 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASAL1 |
0.261406719708341 |
|
10887 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC42B |
0.261406719708341 |
|
10888 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX54 |
0.261406719708341 |
|
10889 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf52 |
0.261406719708341 |
|
10890 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IQCD |
0.261406719708341 |
|
10891 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPCN1 |
0.261406719708341 |
|
10892 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC24A6 |
0.261406719708341 |
|
10893 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLBD2 |
0.261406719708341 |
|
10894 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDS |
0.261406719708341 |
|
10895 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDSL |
0.261406719708341 |
|
10896 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LHX5 |
0.261406719708341 |
|
10897 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM19 |
0.261406719708341 |
|
10898 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBX5 |
0.261406719708341 |
|
10899 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP216 |
0.261406719708341 |
|
10900 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBX3 |
0.261406719708341 |
|
10901 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA27|ENSG00000252459.1 |
0.261406719708341 |
|
10902 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL865P |
0.261406719708341 |
|
10903 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD56|ENSG00000200112.1 |
0.261406719708341 |
|
10904 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED13L |
0.261406719708341 |
|
10905 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR620 |
0.261406719708341 |
|
10906 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00173 |
0.261406719708341 |
|
10907 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP1LC3B2 |
0.261406719708341 |
|
10908 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf49 |
0.261406719708341 |
|
10909 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNFT2 |
0.261406719708341 |
|
10910 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HRK |
0.261406719708341 |
|
10911 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXW8 |
0.261406719708341 |
|
10912 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TESC |
0.261406719708341 |
|
10913 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO21 |
0.261406719708341 |
|
10914 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOS1 |
0.261406719708341 |
|
10915 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KSR2 |
0.261406719708341 |
|
10916 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFC5 |
0.261406719708341 |
|
10917 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WSB2 |
0.261406719708341 |
|
10918 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VSIG10 |
0.261406719708341 |
|
10919 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEBP1 |
0.261406719708341 |
|
10920 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAOK3 |
0.261406719708341 |
|
10921 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUDS3 |
0.261406719708341 |
|
10922 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP374 |
0.261406719708341 |
|
10923 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA38|ENSG00000201042.1 |
0.261406719708341 |
|
10924 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRRM4 |
0.261406719708341 |
|
10925 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL508P |
0.261406719708341 |
|
10926 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPB8 |
0.261406719708341 |
|
10927 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC60 |
0.261406719708341 |
|
10928 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM233 |
0.261406719708341 |
|
10929 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP197 |
0.261406719708341 |
|
10930 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKAB1 |
0.261406719708341 |
|
10931 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CIT |
0.261406719708341 |
|
10932 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1178 |
0.261406719708341 |
|
10933 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC64 |
0.261406719708341 |
|
10934 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000272464.1 |
0.261406719708341 |
|
10935 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB35 |
0.261406719708341 |
|
10936 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCN1L1 |
0.261406719708341 |
|
10937 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4498 |
0.261406719708341 |
|
10938 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPLP0 |
0.261406719708341 |
|
10939 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PXN |
0.261406719708341 |
|
10940 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIRT4 |
0.261406719708341 |
|
10941 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLA2G1B |
0.261406719708341 |
|
10942 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSI1 |
0.261406719708341 |
|
10943 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS27P25 |
0.261406719708341 |
|
10944 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX6A1 |
0.261406719708341 |
|
10945 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GATC |
0.261406719708341 |
|
10946 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIAP1 |
0.261406719708341 |
|
10947 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRSF9 |
0.261406719708341 |
|
10948 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DYNLL1 |
0.261406719708341 |
|
10949 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COQ5 |
0.261406719708341 |
|
10950 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF10 |
0.261406719708341 |
|
10951 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POP5 |
0.261406719708341 |
|
10952 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CABP1 |
0.261406719708341 |
|
10953 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLEC |
0.261406719708341 |
|
10954 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UNC119B |
0.261406719708341 |
|
10955 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4700 |
0.261406719708341 |
|
10956 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACADS |
0.261406719708341 |
|
10957 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1328 |
0.263559881144365 |
|
10958 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CELF4 |
0.263559881144365 |
|
10959 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4318 |
0.263559881144365 |
|
10960 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP182 |
0.263559881144365 |
|
10961 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIK3C3 |
0.263559881144365 |
|
10962 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00907 |
0.263559881144365 |
|
10963 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP454 |
0.263559881144365 |
|
10964 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIT2 |
0.263559881144365 |
|
10965 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYT4 |
0.263559881144365 |
|
10966 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP455 |
0.263559881144365 |
|
10967 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SETBP1 |
0.263559881144365 |
|
10968 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4319 |
0.263559881144365 |
|
10969 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC14A2 |
0.263559881144365 |
|
10970 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC14A1 |
0.263559881144365 |
|
10971 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIGLEC15 |
0.263559881144365 |
|
10972 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPG5 |
0.263559881144365 |
|
10973 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSTPIP2 |
0.263559881144365 |
|
10974 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP26 |
0.263559881144365 |
|
10975 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP5A1 |
0.263559881144365 |
|
10976 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAUS1 |
0.263559881144365 |
|
10977 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C18orf25 |
0.263559881144365 |
|
10978 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF165 |
0.263559881144365 |
|
10979 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LOXHD1 |
0.263559881144365 |
|
10980 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST8SIA5 |
0.263559881144365 |
|
10981 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIAS2 |
0.263559881144365 |
|
10982 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KATNAL2 |
0.263559881144365 |
|
10983 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCEB3B |
0.263559881144365 |
|
10984 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCEB3CL2 |
0.263559881144365 |
|
10985 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCEB3CL |
0.263559881144365 |
|
10986 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCEB3C |
0.263559881144365 |
|
10987 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HDHD2 |
0.263559881144365 |
|
10988 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IER3IP1 |
0.263559881144365 |
|
10989 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SKOR2 |
0.263559881144365 |
|
10990 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4527 |
0.263559881144365 |
|
10991 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMAD2 |
0.263559881144365 |
|
10992 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB7C |
0.263559881144365 |
|
10993 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE6D |
0.264271866987096 |
|
10994 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COPS7B |
0.264271866987096 |
|
10995 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1471 |
0.264271866987096 |
|
10996 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPPC |
0.264271866987096 |
|
10997 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DIS3L2 |
0.264271866987096 |
|
10998 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR562 |
0.264271866987096 |
|
10999 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALPPL2 |
0.264271866987096 |
|
11000 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALPP |
0.264271866987096 |
|
11001 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ECEL1P2 |
0.264271866987096 |
|
11002 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALPI |
0.264271866987096 |
|
11003 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ECEL1 |
0.264271866987096 |
|
11004 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS56 |
0.264271866987096 |
|
11005 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRND |
0.264271866987096 |
|
11006 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRNG |
0.264271866987096 |
|
11007 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIGD1 |
0.264271866987096 |
|
11008 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF4E2 |
0.264271866987096 |
|
11009 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5001 |
0.264271866987096 |
|
11010 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFHD1 |
0.264271866987096 |
|
11011 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL359P |
0.264271866987096 |
|
11012 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239170.1 |
0.264271866987096 |
|
11013 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GIGYF2 |
0.264271866987096 |
|
11014 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNJ13 |
0.264271866987096 |
|
11015 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf82 |
0.264271866987096 |
|
11016 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NGEF |
0.264271866987096 |
|
11017 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3BP4 |
0.264271866987096 |
|
11018 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFA10 |
0.264271866987096 |
|
11019 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4786 |
0.264271866987096 |
|
11020 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6B2 |
0.264271866987096 |
|
11021 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR21 |
0.264271866987096 |
|
11022 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6B3 |
0.264271866987096 |
|
11023 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYEOV2 |
0.264271866987096 |
|
11024 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OTOS |
0.264271866987096 |
|
11025 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADCY5 |
0.265244363396385 |
|
11026 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPLB |
0.265244363396385 |
|
11027 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYLK |
0.265244363396385 |
|
11028 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA5 |
0.265244363396385 |
|
11029 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC14 |
0.265244363396385 |
|
11030 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ROPN1 |
0.265244363396385 |
|
11031 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KALRN |
0.265244363396385 |
|
11032 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5002 |
0.265244363396385 |
|
11033 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UMPS |
0.265244363396385 |
|
11034 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR544B |
0.265244363396385 |
|
11035 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGB5 |
0.265244363396385 |
|
11036 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUC13 |
0.265244363396385 |
|
11037 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HEG1 |
0.265244363396385 |
|
11038 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP137 |
0.265244363396385 |
|
11039 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC12A8 |
0.265244363396385 |
|
11040 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5092 |
0.265244363396385 |
|
11041 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF148 |
0.265244363396385 |
|
11042 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX4 |
0.265244363396385 |
|
11043 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238992.1 |
0.265244363396385 |
|
11044 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSBPL11 |
0.265244363396385 |
|
11045 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548I1 |
0.265244363396385 |
|
11046 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALG1L |
0.265244363396385 |
|
11047 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM86JP |
0.265244363396385 |
|
11048 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ROPN1B |
0.265244363396385 |
|
11049 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC41A3 |
0.265244363396385 |
|
11050 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALDH1L1 |
0.265244363396385 |
|
11051 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U1|ENSG00000272020.1 |
0.265244363396385 |
|
11052 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLF15 |
0.265244363396385 |
|
11053 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC37 |
0.265244363396385 |
|
11054 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZXDC |
0.265244363396385 |
|
11055 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UROC1 |
0.265244363396385 |
|
11056 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf22 |
0.265244363396385 |
|
11057 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHST13 |
0.265244363396385 |
|
11058 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP138 |
0.265244363396385 |
|
11059 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TXNRD3NB |
0.265244363396385 |
|
11060 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TXNRD3 |
0.265244363396385 |
|
11061 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUP210P1 |
0.265244363396385 |
|
11062 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHCHD6 |
0.265244363396385 |
|
11063 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLXNA1 |
0.265244363396385 |
|
11064 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf56 |
0.265244363396385 |
|
11065 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPRA1 |
0.265244363396385 |
|
11066 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCM2 |
0.265244363396385 |
|
11067 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PODXL2 |
0.265244363396385 |
|
11068 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABTB1 |
0.265244363396385 |
|
11069 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MGLL |
0.265244363396385 |
|
11070 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KBTBD12 |
0.265244363396385 |
|
11071 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP139 |
0.265244363396385 |
|
11072 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC61A1 |
0.265244363396385 |
|
11073 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RUVBL1 |
0.265244363396385 |
|
11074 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EEFSEC |
0.265244363396385 |
|
11075 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1280 |
0.265244363396385 |
|
11076 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJB8 |
0.265244363396385 |
|
11077 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GATA2 |
0.265244363396385 |
|
11078 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf27 |
0.265244363396385 |
|
11079 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPN1 |
0.265244363396385 |
|
11080 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA24|ENSG00000207130.1 |
0.265244363396385 |
|
11081 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB7A |
0.265244363396385 |
|
11082 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL698P |
0.265244363396385 |
|
11083 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACAD9 |
0.265244363396385 |
|
11084 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1257 |
0.265244363396385 |
|
11085 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFCC1 |
0.265244363396385 |
|
11086 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GP9 |
0.265244363396385 |
|
11087 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000252435.1 |
0.265244363396385 |
|
11088 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238874.1 |
0.265244363396385 |
|
11089 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB43 |
0.265244363396385 |
|
11090 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ISY1 |
0.265244363396385 |
|
11091 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNBP |
0.265244363396385 |
|
11092 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COPG1 |
0.265244363396385 |
|
11093 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf37 |
0.265244363396385 |
|
11094 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
H1FX |
0.265244363396385 |
|
11095 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL32P3 |
0.265244363396385 |
|
11096 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA7B |
0.265244363396385 |
|
11097 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFCAB12 |
0.265244363396385 |
|
11098 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBD4 |
0.265244363396385 |
|
11099 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFT122 |
0.265244363396385 |
|
11100 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHO |
0.265244363396385 |
|
11101 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
H1FOO |
0.265244363396385 |
|
11102 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLXND1 |
0.265244363396385 |
|
11103 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL752P |
0.265244363396385 |
|
11104 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMCC1 |
0.265244363396385 |
|
11105 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRH |
0.265244363396385 |
|
11106 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALG1L2 |
0.265244363396385 |
|
11107 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM86HP |
0.265244363396385 |
|
11108 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL6A4P2 |
0.265244363396385 |
|
11109 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL6A5 |
0.265244363396385 |
|
11110 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL6A6 |
0.265244363396385 |
|
11111 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIK3R4 |
0.265244363396385 |
|
11112 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP212 |
0.265244363396385 |
|
11113 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP2C1 |
0.265244363396385 |
|
11114 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASTE1 |
0.265244363396385 |
|
11115 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEK11 |
0.265244363396385 |
|
11116 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDT16P |
0.265244363396385 |
|
11117 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDT16 |
0.265244363396385 |
|
11118 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL3 |
0.265244363396385 |
|
11119 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA58|ENSG00000249020.1 |
0.265244363396385 |
|
11120 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NYAP2 |
0.266487866533311 |
|
11121 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5702 |
0.266487866533311 |
|
11122 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRS1 |
0.266487866533311 |
|
11123 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHBDD1 |
0.266487866533311 |
|
11124 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA48|ENSG00000212391.1 |
0.266487866533311 |
|
11125 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL4A4 |
0.266487866533311 |
|
11126 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL4A3 |
0.266487866533311 |
|
11127 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFF |
0.266487866533311 |
|
11128 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TM4SF20 |
0.266487866533311 |
|
11129 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGFG1 |
0.266487866533311 |
|
11130 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5703 |
0.266487866533311 |
|
11131 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf83 |
0.266487866533311 |
|
11132 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC19A3 |
0.266487866533311 |
|
11133 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP121 |
0.266487866533311 |
|
11134 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL20 |
0.266487866533311 |
|
11135 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DAW1 |
0.266487866533311 |
|
11136 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA25|ENSG00000272237.1 |
0.266487866533311 |
|
11137 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPHKAP |
0.266487866533311 |
|
11138 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000251801.1 |
0.266487866533311 |
|
11139 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PID1 |
0.266487866533311 |
|
11140 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP283 |
0.266487866533311 |
|
11141 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNER |
0.266487866533311 |
|
11142 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO36 |
0.266487866533311 |
|
11143 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIP12 |
0.266487866533311 |
|
11144 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC16A14 |
0.266487866533311 |
|
11145 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P19 |
0.266487866533311 |
|
11146 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SP110 |
0.266487866533311 |
|
11147 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SP140 |
0.266487866533311 |
|
11148 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SP140L |
0.266487866533311 |
|
11149 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SP100 |
0.266487866533311 |
|
11150 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL834P |
0.266487866533311 |
|
11151 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAB39 |
0.266487866533311 |
|
11152 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITM2C |
0.266487866533311 |
|
11153 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR55 |
0.266487866533311 |
|
11154 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA3 |
0.266487866533311 |
|
11155 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf72 |
0.266487866533311 |
|
11156 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMD1 |
0.266487866533311 |
|
11157 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTR2B |
0.266487866533311 |
|
11158 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARMC9 |
0.266487866533311 |
|
11159 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4777 |
0.266487866533311 |
|
11160 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B3GNT7 |
0.266487866533311 |
|
11161 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCL |
0.266487866533311 |
|
11162 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA75|ENSG00000206885.1 |
0.266487866533311 |
|
11163 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD20 |
0.266487866533311 |
|
11164 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD82 |
0.266487866533311 |
|
11165 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf57 |
0.266487866533311 |
|
11166 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00471 |
0.266487866533311 |
|
11167 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NMUR1 |
0.266487866533311 |
|
11168 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL499P |
0.266487866533311 |
|
11169 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MGC4771 |
0.266487866533311 |
|
11170 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTMA |
0.266487866533311 |
|
11171 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEU2 |
0.266487866533311 |
|
11172 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INPP5D |
0.266487866533311 |
|
11173 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL32P |
0.266487866533311 |
|
11174 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATG16L1 |
0.266487866533311 |
|
11175 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA5 |
0.266487866533311 |
|
11176 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA6|ENSG00000251791.1 |
0.266487866533311 |
|
11177 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAG |
0.266487866533311 |
|
11178 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DGKD |
0.266487866533311 |
|
11179 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP40 |
0.266487866533311 |
|
11180 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGT1A10 |
0.266487866533311 |
|
11181 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGT1A8 |
0.266487866533311 |
|
11182 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGT1A9 |
0.266487866533311 |
|
11183 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGT1A7 |
0.266487866533311 |
|
11184 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGT1A6 |
0.266487866533311 |
|
11185 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGT1A5 |
0.266487866533311 |
|
11186 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGT1A4 |
0.266487866533311 |
|
11187 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGT1A3 |
0.266487866533311 |
|
11188 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJB3 |
0.266487866533311 |
|
11189 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGT1A1 |
0.266487866533311 |
|
11190 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MROH2A |
0.266487866533311 |
|
11191 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HJURP |
0.266487866533311 |
|
11192 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSL3P1 |
0.266487866533311 |
|
11193 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPM8 |
0.266487866533311 |
|
11194 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPP2 |
0.266487866533311 |
|
11195 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL4C |
0.266487866533311 |
|
11196 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGAP1 |
0.266487866533311 |
|
11197 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL204P |
0.266487866533311 |
|
11198 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GBX2 |
0.266487866533311 |
|
11199 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASB18 |
0.266487866533311 |
|
11200 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IQCA1 |
0.266487866533311 |
|
11201 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACKR3 |
0.266487866533311 |
|
11202 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COPS8 |
0.266487866533311 |
|
11203 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL6A3 |
0.266487866533311 |
|
11204 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLPH |
0.266487866533311 |
|
11205 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRLH |
0.266487866533311 |
|
11206 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB17 |
0.266487866533311 |
|
11207 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRFIP1 |
0.266487866533311 |
|
11208 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM44 |
0.266487866533311 |
|
11209 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAMP1 |
0.266487866533311 |
|
11210 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD39|ENSG00000263723.1 |
0.266487866533311 |
|
11211 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2F |
0.266487866533311 |
|
11212 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCLY |
0.266487866533311 |
|
11213 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ESPNL |
0.266487866533311 |
|
11214 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL30 |
0.266487866533311 |
|
11215 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM132B |
0.266487866533311 |
|
11216 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ILKAP |
0.266487866533311 |
|
11217 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HES6 |
0.266487866533311 |
|
11218 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PER2 |
0.266487866533311 |
|
11219 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAF3IP1 |
0.266487866533311 |
|
11220 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASB1 |
0.266487866533311 |
|
11221 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HDAC4 |
0.266487866533311 |
|
11222 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4440 |
0.266487866533311 |
|
11223 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4441 |
0.266487866533311 |
|
11224 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TWIST2 |
0.266487866533311 |
|
11225 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4269 |
0.266487866533311 |
|
11226 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR2467 |
0.266487866533311 |
|
11227 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PASK |
0.266487866533311 |
|
11228 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R7 |
0.266487866533311 |
|
11229 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANO7 |
0.266487866533311 |
|
11230 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HDLBP |
0.266487866533311 |
|
11231 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEPT2 |
0.266487866533311 |
|
11232 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATG4B |
0.266487866533311 |
|
11233 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BOK |
0.266487866533311 |
|
11234 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXXC11 |
0.266487866533311 |
|
11235 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
D2HGDH |
0.266487866533311 |
|
11236 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DTYMK |
0.266487866533311 |
|
11237 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAL3ST2 |
0.266487866533311 |
|
11238 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ING5 |
0.266487866533311 |
|
11239 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEU4 |
0.266487866533311 |
|
11240 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDCD1 |
0.266487866533311 |
|
11241 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP122 |
0.266487866533311 |
|
11242 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THAP4 |
0.266487866533311 |
|
11243 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC21B |
0.266689019574536 |
|
11244 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCN1A |
0.266689019574536 |
|
11245 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP152 |
0.266689019574536 |
|
11246 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCN9A |
0.266689019574536 |
|
11247 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238662.1 |
0.266689019574536 |
|
11248 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCN7A |
0.266689019574536 |
|
11249 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDH13 |
0.26700330870483 |
|
11250 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF142 |
0.267496379048307 |
|
11251 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCS1L |
0.267496379048307 |
|
11252 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF25 |
0.267496379048307 |
|
11253 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STK36 |
0.267496379048307 |
|
11254 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTLL4 |
0.267496379048307 |
|
11255 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPHA4 |
0.271018782806961 |
|
11256 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAX3 |
0.271018782806961 |
|
11257 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC140 |
0.271018782806961 |
|
11258 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGPP2 |
0.271018782806961 |
|
11259 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FARSB |
0.271018782806961 |
|
11260 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOGAT1 |
0.271018782806961 |
|
11261 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238852.1 |
0.271018782806961 |
|
11262 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACSL3 |
0.271018782806961 |
|
11263 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNE4 |
0.271018782806961 |
|
11264 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL807P |
0.271018782806961 |
|
11265 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCG2 |
0.271018782806961 |
|
11266 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP1S3 |
0.271018782806961 |
|
11267 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDFY1 |
0.271018782806961 |
|
11268 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL44 |
0.271018782806961 |
|
11269 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINE2 |
0.271018782806961 |
|
11270 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM124B |
0.271018782806961 |
|
11271 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CUL3 |
0.271018782806961 |
|
11272 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOCK10 |
0.271018782806961 |
|
11273 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4439 |
0.271018782806961 |
|
11274 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL7R |
0.273177644715622 |
|
11275 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPSL |
0.273177644715622 |
|
11276 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGT3A1 |
0.273177644715622 |
|
11277 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGT3A2 |
0.273177644715622 |
|
11278 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMBRD2 |
0.273177644715622 |
|
11279 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR580 |
0.273177644715622 |
|
11280 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SKP2 |
0.273177644715622 |
|
11281 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NADK2 |
0.273177644715622 |
|
11282 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RANBP3L |
0.273177644715622 |
|
11283 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP181 |
0.273177644715622 |
|
11284 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC1A3 |
0.273177644715622 |
|
11285 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NIPBL |
0.273177644715622 |
|
11286 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf42 |
0.273177644715622 |
|
11287 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL37P |
0.273177644715622 |
|
11288 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUP155 |
0.273177644715622 |
|
11289 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR70 |
0.273177644715622 |
|
11290 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GDNF |
0.273177644715622 |
|
11291 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EGFLAM |
0.273177644715622 |
|
11292 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIFR |
0.273177644715622 |
|
11293 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3650 |
0.273177644715622 |
|
11294 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSMR |
0.273177644715622 |
|
11295 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RICTOR |
0.273177644715622 |
|
11296 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FYB |
0.273177644715622 |
|
11297 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9 |
0.273177644715622 |
|
11298 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DAB2 |
0.273177644715622 |
|
11299 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00603 |
0.273177644715622 |
|
11300 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00604 |
0.273177644715622 |
|
11301 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA63|ENSG00000199552.1 |
0.273177644715622 |
|
11302 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTGER4 |
0.273177644715622 |
|
11303 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC33 |
0.273177644715622 |
|
11304 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKAA1 |
0.273177644715622 |
|
11305 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA57|ENSG00000212567.1 |
0.273177644715622 |
|
11306 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL37 |
0.273177644715622 |
|
11307 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD72 |
0.273177644715622 |
|
11308 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CARD6 |
0.273177644715622 |
|
11309 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C7 |
0.273177644715622 |
|
11310 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MROH2B |
0.273177644715622 |
|
11311 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6 |
0.273177644715622 |
|
11312 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLCXD3 |
0.273177644715622 |
|
11313 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OXCT1 |
0.273177644715622 |
|
11314 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf51 |
0.273177644715622 |
|
11315 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO4 |
0.273177644715622 |
|
11316 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GHR |
0.273177644715622 |
|
11317 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC152 |
0.273177644715622 |
|
11318 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEPP1 |
0.273177644715622 |
|
11319 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANXA2R |
0.273177644715622 |
|
11320 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF131 |
0.273177644715622 |
|
11321 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NIM1 |
0.273177644715622 |
|
11322 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMGCS1 |
0.273177644715622 |
|
11323 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL28 |
0.273177644715622 |
|
11324 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf28 |
0.273177644715622 |
|
11325 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf34 |
0.273177644715622 |
|
11326 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAIP1 |
0.273177644715622 |
|
11327 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NNT |
0.273177644715622 |
|
11328 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGF10 |
0.273177644715622 |
|
11329 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL383P |
0.273177644715622 |
|
11330 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS30 |
0.273177644715622 |
|
11331 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KYNU |
0.274678146857326 |
|
11332 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP15 |
0.274678146857326 |
|
11333 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTDC1 |
0.274678146857326 |
|
11334 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZEB2 |
0.274678146857326 |
|
11335 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX41 |
0.274678146857326 |
|
11336 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snR65|ENSG00000253036.1 |
0.274678146857326 |
|
11337 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238860.1 |
0.274678146857326 |
|
11338 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP106 |
0.274678146857326 |
|
11339 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACVR2A |
0.274678146857326 |
|
11340 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ORC4 |
0.274678146857326 |
|
11341 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBD5 |
0.274678146857326 |
|
11342 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA48|ENSG00000212181.1 |
0.274678146857326 |
|
11343 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPC2 |
0.274678146857326 |
|
11344 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF5C |
0.274678146857326 |
|
11345 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYPD6B |
0.274678146857326 |
|
11346 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYPD6 |
0.274678146857326 |
|
11347 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMADHC |
0.274678146857326 |
|
11348 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RND3 |
0.274678146857326 |
|
11349 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM43 |
0.274678146857326 |
|
11350 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NMI |
0.274678146857326 |
|
11351 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFAIP6 |
0.274678146857326 |
|
11352 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL124P |
0.274678146857326 |
|
11353 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIF1 |
0.274678146857326 |
|
11354 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEB |
0.274678146857326 |
|
11355 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAM2 |
0.274678146857326 |
|
11356 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FMNL2 |
0.274678146857326 |
|
11357 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPK4 |
0.275486167562171 |
|
11358 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRO |
0.275486167562171 |
|
11359 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ME2 |
0.275486167562171 |
|
11360 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELAC1 |
0.275486167562171 |
|
11361 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMAD4 |
0.275486167562171 |
|
11362 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL695P |
0.275486167562171 |
|
11363 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEX3C |
0.275486167562171 |
|
11364 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238885.1 |
0.275486167562171 |
|
11365 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCC |
0.275486167562171 |
|
11366 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBD2 |
0.275486167562171 |
|
11367 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA37 |
0.275486167562171 |
|
11368 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLI |
0.275486167562171 |
|
11369 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STARD6 |
0.275486167562171 |
|
11370 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C18orf54 |
0.275486167562171 |
|
11371 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DYNAP |
0.275486167562171 |
|
11372 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB27B |
0.275486167562171 |
|
11373 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC68 |
0.275486167562171 |
|
11374 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP459 |
0.275486167562171 |
|
11375 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCF4 |
0.275486167562171 |
|
11376 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4529 |
0.275486167562171 |
|
11377 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA73|ENSG00000201816.1 |
0.275486167562171 |
|
11378 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TXNL1 |
0.275486167562171 |
|
11379 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR7 |
0.275486167562171 |
|
11380 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000212539.1 |
0.275486167562171 |
|
11381 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BOD1L2 |
0.275486167562171 |
|
11382 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST8SIA3 |
0.275486167562171 |
|
11383 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ONECUT2 |
0.275486167562171 |
|
11384 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FECH |
0.275486167562171 |
|
11385 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NARS |
0.275486167562171 |
|
11386 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP8B1 |
0.275486167562171 |
|
11387 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEDD4L |
0.275486167562171 |
|
11388 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR122 |
0.275486167562171 |
|
11389 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALPK2 |
0.275486167562171 |
|
11390 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD28|ENSG00000252284.1 |
0.275486167562171 |
|
11391 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MALT1 |
0.275486167562171 |
|
11392 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL112P |
0.275486167562171 |
|
11393 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000199713.1 |
0.275486167562171 |
|
11394 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF532 |
0.275486167562171 |
|
11395 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OACYLP |
0.275486167562171 |
|
11396 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC11C |
0.275486167562171 |
|
11397 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRP |
0.275486167562171 |
|
11398 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAX |
0.275486167562171 |
|
11399 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPLX4 |
0.275486167562171 |
|
11400 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMAN1 |
0.275486167562171 |
|
11401 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCBE1 |
0.275486167562171 |
|
11402 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PMAIP1 |
0.275486167562171 |
|
11403 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL342P |
0.275486167562171 |
|
11404 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MC4R |
0.275486167562171 |
|
11405 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDH20 |
0.275486167562171 |
|
11406 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF152 |
0.275486167562171 |
|
11407 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIGN |
0.275486167562171 |
|
11408 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1468 |
0.275486167562171 |
|
11409 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFRSF11A |
0.275486167562171 |
|
11410 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZCCHC2 |
0.275486167562171 |
|
11411 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL705P |
0.275486167562171 |
|
11412 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHLPP1 |
0.275486167562171 |
|
11413 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCL2 |
0.275486167562171 |
|
11414 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238988.1 |
0.275486167562171 |
|
11415 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KDSR |
0.275486167562171 |
|
11416 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS4B |
0.275486167562171 |
|
11417 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINB5 |
0.275486167562171 |
|
11418 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINB12 |
0.275486167562171 |
|
11419 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINB13 |
0.275486167562171 |
|
11420 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINB4 |
0.275486167562171 |
|
11421 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINB11 |
0.275486167562171 |
|
11422 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINB3 |
0.275486167562171 |
|
11423 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINB7 |
0.275486167562171 |
|
11424 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINB2 |
0.275486167562171 |
|
11425 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINB10 |
0.275486167562171 |
|
11426 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMSD |
0.275486167562171 |
|
11427 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINB8 |
0.275486167562171 |
|
11428 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00305 |
0.275486167562171 |
|
11429 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDH7 |
0.275486167562171 |
|
11430 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDH19 |
0.275486167562171 |
|
11431 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5011 |
0.275486167562171 |
|
11432 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DSEL |
0.275486167562171 |
|
11433 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMX3 |
0.275486167562171 |
|
11434 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC102B |
0.275486167562171 |
|
11435 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOK6 |
0.275486167562171 |
|
11436 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD226 |
0.275486167562171 |
|
11437 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RTTN |
0.275486167562171 |
|
11438 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOCS6 |
0.275486167562171 |
|
11439 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL795P |
0.275486167562171 |
|
11440 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTSCR1 |
0.275486167562171 |
|
11441 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRBA |
0.278904900419924 |
|
11442 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS3A |
0.278904900419924 |
|
11443 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3D19 |
0.278904900419924 |
|
11444 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD73A |
0.278904900419924 |
|
11445 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD73 |
0.278904900419924 |
|
11446 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS48 |
0.278904900419924 |
|
11447 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM160A1 |
0.278904900419924 |
|
11448 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP35 |
0.278904900419924 |
|
11449 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PET112 |
0.278904900419924 |
|
11450 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYEOV |
0.279840384469593 |
|
11451 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCND1 |
0.279840384469593 |
|
11452 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ORAOV1 |
0.279840384469593 |
|
11453 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGF19 |
0.279840384469593 |
|
11454 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGF4 |
0.279840384469593 |
|
11455 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGF3 |
0.279840384469593 |
|
11456 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANO1 |
0.279840384469593 |
|
11457 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FADD |
0.279840384469593 |
|
11458 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPFIA1 |
0.279840384469593 |
|
11459 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548K |
0.279840384469593 |
|
11460 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTTN |
0.279840384469593 |
|
11461 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHANK2 |
0.279840384469593 |
|
11462 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3664 |
0.279840384469593 |
|
11463 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLYCTK |
0.280102944169873 |
|
11464 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR135A1 |
0.280102944169873 |
|
11465 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAH1 |
0.280102944169873 |
|
11466 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAP1 |
0.280102944169873 |
|
11467 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHF7 |
0.280102944169873 |
|
11468 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEMA3G |
0.280102944169873 |
|
11469 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNNC1 |
0.280102944169873 |
|
11470 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NISCH |
0.280102944169873 |
|
11471 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAB1 |
0.280102944169873 |
|
11472 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4264 |
0.281137540441062 |
|
11473 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRTM1 |
0.281137540441062 |
|
11474 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP99 |
0.281137540441062 |
|
11475 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL201P |
0.281137540441062 |
|
11476 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252298.1 |
0.281137540441062 |
|
11477 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FUNDC2P2 |
0.281137540441062 |
|
11478 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUCLG1 |
0.281137540441062 |
|
11479 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAH6 |
0.281137540441062 |
|
11480 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRABD2A |
0.281137540441062 |
|
11481 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMSB10 |
0.281137540441062 |
|
11482 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCMF1 |
0.281137540441062 |
|
11483 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCF7L1 |
0.281137540441062 |
|
11484 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TGOLN2 |
0.281137540441062 |
|
11485 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RETSAT |
0.281137540441062 |
|
11486 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELMOD3 |
0.281137540441062 |
|
11487 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL113P |
0.281137540441062 |
|
11488 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPG |
0.281137540441062 |
|
11489 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH2D6 |
0.281137540441062 |
|
11490 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL251P |
0.281137540441062 |
|
11491 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL830P |
0.281137540441062 |
|
11492 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAT2A |
0.281137540441062 |
|
11493 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GGCX |
0.281137540441062 |
|
11494 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VAMP8 |
0.281137540441062 |
|
11495 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL126P |
0.281137540441062 |
|
11496 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VAMP5 |
0.281137540441062 |
|
11497 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF181 |
0.281137540441062 |
|
11498 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf68 |
0.281137540441062 |
|
11499 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM150A |
0.281137540441062 |
|
11500 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP39 |
0.281137540441062 |
|
11501 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFTPB |
0.281137540441062 |
|
11502 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNLY |
0.281137540441062 |
|
11503 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATOH8 |
0.281137540441062 |
|
11504 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP83 |
0.281137540441062 |
|
11505 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST3GAL5 |
0.281137540441062 |
|
11506 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR1A |
0.281137540441062 |
|
11507 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IMMT |
0.281137540441062 |
|
11508 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4779 |
0.281137540441062 |
|
11509 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL35 |
0.281137540441062 |
|
11510 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTCD3 |
0.281137540441062 |
|
11511 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REEP1 |
0.281137540441062 |
|
11512 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD94 |
0.281137540441062 |
|
11513 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000202537.1 |
0.281137540441062 |
|
11514 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA19|ENSG00000251974.1 |
0.281137540441062 |
|
11515 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KDM3A |
0.281137540441062 |
|
11516 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHMP3 |
0.281137540441062 |
|
11517 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF103 |
0.281137540441062 |
|
11518 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RMND5A |
0.281137540441062 |
|
11519 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD8A |
0.281137540441062 |
|
11520 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD8B |
0.281137540441062 |
|
11521 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX37 |
0.281137540441062 |
|
11522 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF2AK3 |
0.281137540441062 |
|
11523 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPIA |
0.281137540441062 |
|
11524 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD36BP2 |
0.281137540441062 |
|
11525 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4436A |
0.281137540441062 |
|
11526 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABRA2 |
0.282159181049858 |
|
11527 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX7B2 |
0.282159181049858 |
|
11528 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABRA4 |
0.282159181049858 |
|
11529 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABRB1 |
0.282159181049858 |
|
11530 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COMMD8 |
0.282159181049858 |
|
11531 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP10D |
0.282159181049858 |
|
11532 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CORIN |
0.282159181049858 |
|
11533 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FARP2 |
0.283108652582841 |
|
11534 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3133 |
0.283108652582841 |
|
11535 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STK25 |
0.283108652582841 |
|
11536 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP27C1 |
0.283956903558394 |
|
11537 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERCC3 |
0.283956903558394 |
|
11538 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
R3HDM2 |
0.28482154925868 |
|
11539 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INHBC |
0.28482154925868 |
|
11540 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INHBE |
0.28482154925868 |
|
11541 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLI1 |
0.28482154925868 |
|
11542 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP9 |
0.28482154925868 |
|
11543 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MARS |
0.28482154925868 |
|
11544 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL312P |
0.28482154925868 |
|
11545 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDIT3 |
0.28482154925868 |
|
11546 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBD6 |
0.28482154925868 |
|
11547 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR616 |
0.28482154925868 |
|
11548 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCTN2 |
0.28482154925868 |
|
11549 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF5A |
0.28482154925868 |
|
11550 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIP4K2C |
0.28482154925868 |
|
11551 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DTX3 |
0.28482154925868 |
|
11552 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF25 |
0.28482154925868 |
|
11553 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B4GALNT1 |
0.28482154925868 |
|
11554 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC26A10 |
0.28482154925868 |
|
11555 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238436.1 |
0.28482154925868 |
|
11556 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OS9 |
0.28482154925868 |
|
11557 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGAP2 |
0.28482154925868 |
|
11558 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPAN31 |
0.28482154925868 |
|
11559 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK4 |
0.28482154925868 |
|
11560 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MARCH9 |
0.28482154925868 |
|
11561 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP27B1 |
0.28482154925868 |
|
11562 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL1 |
0.28482154925868 |
|
11563 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL21B |
0.28482154925868 |
|
11564 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSFM |
0.28482154925868 |
|
11565 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AVIL |
0.28482154925868 |
|
11566 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTDSP2 |
0.28482154925868 |
|
11567 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR26A2 |
0.28482154925868 |
|
11568 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XRCC6BP1 |
0.28482154925868 |
|
11569 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP65 |
0.28482154925868 |
|
11570 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NR4A2 |
0.286350351851996 |
|
11571 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL18A1 |
0.286636843737461 |
|
11572 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00205 |
0.286636843737461 |
|
11573 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00315 |
0.286636843737461 |
|
11574 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00316 |
0.286636843737461 |
|
11575 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00334 |
0.286636843737461 |
|
11576 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCBP3 |
0.286636843737461 |
|
11577 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POFUT2 |
0.286636843737461 |
|
11578 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC19A1 |
0.286636843737461 |
|
11579 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRED60 |
0.286636843737461 |
|
11580 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRED62 |
0.286636843737461 |
|
11581 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL6A1 |
0.286636843737461 |
|
11582 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL6A2 |
0.286636843737461 |
|
11583 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FTCD |
0.286636843737461 |
|
11584 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATC1L |
0.286636843737461 |
|
11585 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LSS |
0.286636843737461 |
|
11586 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCM3AP |
0.286636843737461 |
|
11587 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C21orf58 |
0.286636843737461 |
|
11588 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DIP2A |
0.286636843737461 |
|
11589 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCNT |
0.286636843737461 |
|
11590 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRMT2 |
0.286636843737461 |
|
11591 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S100B |
0.286636843737461 |
|
11592 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YBEY |
0.286636843737461 |
|
11593 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALG8 |
0.286647693042933 |
|
11594 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCTD21 |
0.286647693042933 |
|
11595 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP35 |
0.286647693042933 |
|
11596 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAB2 |
0.286647693042933 |
|
11597 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RELB |
0.29056394407807 |
|
11598 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP201 |
0.291919405796759 |
|
11599 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLASRP |
0.294169522367036 |
|
11600 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF296 |
0.294169522367036 |
|
11601 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GEMIN7 |
0.294169522367036 |
|
11602 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R37 |
0.294169522367036 |
|
11603 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00971 |
0.29433691601023 |
|
11604 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CADM2 |
0.29433691601023 |
|
11605 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5688 |
0.29433691601023 |
|
11606 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoZ40 |
0.29433691601023 |
|
11607 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRIG3 |
0.29579838526184 |
|
11608 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC16A7 |
0.29579838526184 |
|
11609 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFAND4 |
0.296632586799894 |
|
11610 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGAP10 |
0.296632586799894 |
|
11611 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGAP4 |
0.296632586799894 |
|
11612 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGAP9 |
0.296632586799894 |
|
11613 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANTXRLP1 |
0.296632586799894 |
|
11614 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANTXRL |
0.296632586799894 |
|
11615 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANXA8L1 |
0.296632586799894 |
|
11616 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANXA8L2 |
0.296632586799894 |
|
11617 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANXA8 |
0.296632586799894 |
|
11618 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASAH2C |
0.296632586799894 |
|
11619 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BMS1P1 |
0.296632586799894 |
|
11620 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BMS1P2 |
0.296632586799894 |
|
11621 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf43 |
0.296632586799894 |
|
11622 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM21B |
0.296632586799894 |
|
11623 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM21C |
0.296632586799894 |
|
11624 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM25B |
0.296632586799894 |
|
11625 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM25E |
0.296632586799894 |
|
11626 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM25G |
0.296632586799894 |
|
11627 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM35BP |
0.296632586799894 |
|
11628 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPRIN2 |
0.296632586799894 |
|
11629 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00842 |
0.296632586799894 |
|
11630 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPY4R |
0.296632586799894 |
|
11631 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPN20A |
0.296632586799894 |
|
11632 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBP3 |
0.296632586799894 |
|
11633 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL248P |
0.296632586799894 |
|
11634 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL453P |
0.296632586799894 |
|
11635 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP310 |
0.296632586799894 |
|
11636 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP311 |
0.296632586799894 |
|
11637 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP312 |
0.296632586799894 |
|
11638 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP313 |
0.296632586799894 |
|
11639 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYT15 |
0.296632586799894 |
|
11640 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF488 |
0.296632586799894 |
|
11641 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARG |
0.296632586799894 |
|
11642 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGAP7 |
0.296632586799894 |
|
11643 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGAP8 |
0.296632586799894 |
|
11644 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM21D |
0.296632586799894 |
|
11645 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM25D |
0.296632586799894 |
|
11646 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSMB |
0.296632586799894 |
|
11647 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP316 |
0.296632586799894 |
|
11648 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA74|ENSG00000223182.1 |
0.296632586799894 |
|
11649 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIMM23B |
0.296632586799894 |
|
11650 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCOA4 |
0.296632586799894 |
|
11651 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM13C |
0.296632586799894 |
|
11652 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC16A9 |
0.296632586799894 |
|
11653 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00948 |
0.296632586799894 |
|
11654 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC6 |
0.296632586799894 |
|
11655 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf40 |
0.296632586799894 |
|
11656 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1CB |
0.297426385964568 |
|
11657 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM179A |
0.297426385964568 |
|
11658 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD53 |
0.297426385964568 |
|
11659 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD92 |
0.297426385964568 |
|
11660 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPDYA |
0.297426385964568 |
|
11661 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRMT61B |
0.297426385964568 |
|
11662 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR43 |
0.297426385964568 |
|
11663 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf71 |
0.297426385964568 |
|
11664 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLIP4 |
0.297426385964568 |
|
11665 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALK |
0.297426385964568 |
|
11666 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL516P |
0.297426385964568 |
|
11667 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YPEL5 |
0.297426385964568 |
|
11668 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA64|ENSG00000207187.1 |
0.297426385964568 |
|
11669 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LBH |
0.297426385964568 |
|
11670 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCLAT1 |
0.297426385964568 |
|
11671 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPN13 |
0.297426385964568 |
|
11672 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALNT14 |
0.297426385964568 |
|
11673 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPN14 |
0.297426385964568 |
|
11674 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP90 |
0.297426385964568 |
|
11675 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EHD3 |
0.297426385964568 |
|
11676 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XDH |
0.297426385964568 |
|
11677 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRD5A2 |
0.297426385964568 |
|
11678 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPY30 |
0.297426385964568 |
|
11679 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEMO1 |
0.297426385964568 |
|
11680 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPAST |
0.297426385964568 |
|
11681 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC30A6 |
0.297426385964568 |
|
11682 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NLRC4 |
0.297426385964568 |
|
11683 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YIPF4 |
0.297426385964568 |
|
11684 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BIRC6 |
0.297426385964568 |
|
11685 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00486 |
0.297426385964568 |
|
11686 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LTBP1 |
0.297426385964568 |
|
11687 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4765 |
0.297426385964568 |
|
11688 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR558 |
0.297426385964568 |
|
11689 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252502.1 |
0.297426385964568 |
|
11690 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC27 |
0.297426385964568 |
|
11691 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP91 |
0.297426385964568 |
|
11692 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP92 |
0.297426385964568 |
|
11693 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASGRP3 |
0.297426385964568 |
|
11694 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM98A |
0.297426385964568 |
|
11695 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYADML |
0.297426385964568 |
|
11696 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL602P |
0.297426385964568 |
|
11697 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548AD |
0.297426385964568 |
|
11698 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRIM1 |
0.297426385964568 |
|
11699 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FEZ2 |
0.297426385964568 |
|
11700 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VIT |
0.297426385964568 |
|
11701 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STRN |
0.297426385964568 |
|
11702 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HEATR5B |
0.297426385964568 |
|
11703 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPATCH11 |
0.297426385964568 |
|
11704 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF2AK2 |
0.297426385964568 |
|
11705 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SULT6B1 |
0.297426385964568 |
|
11706 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEBPZ |
0.297426385964568 |
|
11707 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFAF7 |
0.297426385964568 |
|
11708 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKD3 |
0.297426385964568 |
|
11709 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
QPCT |
0.297426385964568 |
|
11710 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC42EP3 |
0.297426385964568 |
|
11711 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00211 |
0.297426385964568 |
|
11712 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RMDN2 |
0.297426385964568 |
|
11713 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP1B1 |
0.297426385964568 |
|
11714 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATL2 |
0.297426385964568 |
|
11715 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPLL |
0.297426385964568 |
|
11716 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALM |
0.297426385964568 |
|
11717 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GEMIN6 |
0.297426385964568 |
|
11718 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRSF7 |
0.297426385964568 |
|
11719 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHX57 |
0.297426385964568 |
|
11720 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MORN2 |
0.297426385964568 |
|
11721 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF33 |
0.297426385964568 |
|
11722 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL96P |
0.297426385964568 |
|
11723 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOS1 |
0.297426385964568 |
|
11724 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDKL4 |
0.297426385964568 |
|
11725 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP4K3 |
0.297426385964568 |
|
11726 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA67|ENSG00000252473.1 |
0.297426385964568 |
|
11727 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM178A |
0.297426385964568 |
|
11728 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THUMPD2 |
0.297426385964568 |
|
11729 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC8A1 |
0.297426385964568 |
|
11730 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPA1P57 |
0.297426385964568 |
|
11731 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoZ247 |
0.297426385964568 |
|
11732 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf91 |
0.297426385964568 |
|
11733 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKDCC |
0.297426385964568 |
|
11734 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EML4 |
0.297426385964568 |
|
11735 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX7A2L |
0.297426385964568 |
|
11736 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNG3 |
0.297426385964568 |
|
11737 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD75|ENSG00000221300.1 |
0.297426385964568 |
|
11738 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTA3 |
0.297426385964568 |
|
11739 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OXER1 |
0.297426385964568 |
|
11740 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAAO |
0.297426385964568 |
|
11741 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THADA |
0.297426385964568 |
|
11742 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFP36L2 |
0.297426385964568 |
|
11743 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHH2 |
0.297426385964568 |
|
11744 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP66 |
0.297426385964568 |
|
11745 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DYNC2LI1 |
0.297426385964568 |
|
11746 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCG5 |
0.297426385964568 |
|
11747 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCG8 |
0.297426385964568 |
|
11748 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRPPRC |
0.297426385964568 |
|
11749 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPM1B |
0.297426385964568 |
|
11750 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239052.1 |
0.297426385964568 |
|
11751 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC3A1 |
0.297426385964568 |
|
11752 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PREPL |
0.297426385964568 |
|
11753 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAMKMT |
0.297426385964568 |
|
11754 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIX3 |
0.297426385964568 |
|
11755 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIX2 |
0.297426385964568 |
|
11756 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRBD1 |
0.297426385964568 |
|
11757 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL414P |
0.297426385964568 |
|
11758 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKCE |
0.297426385964568 |
|
11759 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPAS1 |
0.297426385964568 |
|
11760 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM247 |
0.297426385964568 |
|
11761 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL817P |
0.297426385964568 |
|
11762 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6V1E2 |
0.297426385964568 |
|
11763 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHOQ |
0.297426385964568 |
|
11764 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIGF |
0.297426385964568 |
|
11765 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRIPT |
0.297426385964568 |
|
11766 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOCS5 |
0.297426385964568 |
|
11767 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCFD2 |
0.297426385964568 |
|
11768 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC7A |
0.297426385964568 |
|
11769 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CALM2 |
0.297426385964568 |
|
11770 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf61 |
0.297426385964568 |
|
11771 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCYRN1 |
0.297426385964568 |
|
11772 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPCAM |
0.297426385964568 |
|
11773 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP119 |
0.297426385964568 |
|
11774 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR559 |
0.297426385964568 |
|
11775 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSH2 |
0.297426385964568 |
|
11776 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNK12 |
0.297426385964568 |
|
11777 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSH6 |
0.297426385964568 |
|
11778 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO11 |
0.297426385964568 |
|
11779 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP224 |
0.297426385964568 |
|
11780 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXN2 |
0.297426385964568 |
|
11781 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R21 |
0.297426385964568 |
|
11782 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STON1 |
0.297426385964568 |
|
11783 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF2A1L |
0.297426385964568 |
|
11784 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LHCGR |
0.297426385964568 |
|
11785 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FSHR |
0.297426385964568 |
|
11786 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA75|ENSG00000212580.1 |
0.297426385964568 |
|
11787 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRXN1 |
0.297426385964568 |
|
11788 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4431 |
0.297426385964568 |
|
11789 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA16|ENSG00000251942.1 |
0.297426385964568 |
|
11790 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASB3 |
0.297426385964568 |
|
11791 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHAC2 |
0.297426385964568 |
|
11792 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERLEC1 |
0.297426385964568 |
|
11793 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238756.1 |
0.297426385964568 |
|
11794 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3682 |
0.297426385964568 |
|
11795 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR75 |
0.297426385964568 |
|
11796 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSME4 |
0.297426385964568 |
|
11797 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACYP2 |
0.297426385964568 |
|
11798 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf73 |
0.297426385964568 |
|
11799 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPTBN1 |
0.297426385964568 |
|
11800 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPYL6 |
0.297426385964568 |
|
11801 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EML6 |
0.297426385964568 |
|
11802 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RTN4 |
0.297426385964568 |
|
11803 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLHC1 |
0.297426385964568 |
|
11804 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS27A |
0.297426385964568 |
|
11805 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTIF2 |
0.297426385964568 |
|
11806 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRORSD1P |
0.297426385964568 |
|
11807 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC88A |
0.297426385964568 |
|
11808 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC104 |
0.297426385964568 |
|
11809 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMEK2 |
0.297426385964568 |
|
11810 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA12|ENSG00000212175.1 |
0.297426385964568 |
|
11811 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNPT1 |
0.297426385964568 |
|
11812 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFEMP1 |
0.297426385964568 |
|
11813 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP208 |
0.297426385964568 |
|
11814 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR216A |
0.297426385964568 |
|
11815 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR217 |
0.297426385964568 |
|
11816 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR216B |
0.297426385964568 |
|
11817 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC85A |
0.297426385964568 |
|
11818 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP93 |
0.297426385964568 |
|
11819 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238690.1 |
0.297426385964568 |
|
11820 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD78|ENSG00000212168.1 |
0.297426385964568 |
|
11821 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VRK2 |
0.297426385964568 |
|
11822 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FANCL |
0.297426385964568 |
|
11823 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP94 |
0.297426385964568 |
|
11824 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4432 |
0.297426385964568 |
|
11825 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCL11A |
0.297426385964568 |
|
11826 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADD3 |
0.303941733776013 |
|
11827 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL450P |
0.303941733776013 |
|
11828 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM6 |
0.306912022521282 |
|
11829 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM5 |
0.306912022521282 |
|
11830 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEMA3F |
0.306912022521282 |
|
11831 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR566 |
0.306912022521282 |
|
11832 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNAT1 |
0.306912022521282 |
|
11833 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC38A3 |
0.306912022521282 |
|
11834 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNAI2 |
0.306912022521282 |
|
11835 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEMA3B |
0.306912022521282 |
|
11836 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LSMEM2 |
0.306912022521282 |
|
11837 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFRD2 |
0.306912022521282 |
|
11838 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HYAL3 |
0.306912022521282 |
|
11839 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HYAL1 |
0.306912022521282 |
|
11840 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAT6 |
0.306912022521282 |
|
11841 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HYAL2 |
0.306912022521282 |
|
11842 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUSC2 |
0.306912022521282 |
|
11843 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASSF1 |
0.306912022521282 |
|
11844 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZMYND10 |
0.306912022521282 |
|
11845 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPRL2 |
0.306912022521282 |
|
11846 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYB561D2 |
0.306912022521282 |
|
11847 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM115 |
0.306912022521282 |
|
11848 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNA2D2 |
0.306912022521282 |
|
11849 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP131 |
0.306912022521282 |
|
11850 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf18 |
0.306912022521282 |
|
11851 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HEMK1 |
0.306912022521282 |
|
11852 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CISH |
0.306912022521282 |
|
11853 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPKAPK3 |
0.306912022521282 |
|
11854 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOCK3 |
0.306912022521282 |
|
11855 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4787 |
0.306912022521282 |
|
11856 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MANF |
0.306912022521282 |
|
11857 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM15B |
0.306912022521282 |
|
11858 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPRBP |
0.306912022521282 |
|
11859 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAD54L2 |
0.306912022521282 |
|
11860 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC29P |
0.306912022521282 |
|
11861 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX264 |
0.306912022521282 |
|
11862 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP132 |
0.306912022521282 |
|
11863 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRM2 |
0.306912022521282 |
|
11864 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IQCF6 |
0.306912022521282 |
|
11865 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IQCF3 |
0.306912022521282 |
|
11866 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IQCF2 |
0.306912022521282 |
|
11867 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL504P |
0.306912022521282 |
|
11868 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IQCF5 |
0.306912022521282 |
|
11869 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IQCF1 |
0.306912022521282 |
|
11870 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRP9 |
0.306912022521282 |
|
11871 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARP3 |
0.306912022521282 |
|
11872 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR62 |
0.306912022521282 |
|
11873 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCBP4 |
0.306912022521282 |
|
11874 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABHD14B |
0.306912022521282 |
|
11875 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABHD14A |
0.306912022521282 |
|
11876 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACY1 |
0.306912022521282 |
|
11877 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL29 |
0.306912022521282 |
|
11878 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUSP7 |
0.306912022521282 |
|
11879 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00696 |
0.306912022521282 |
|
11880 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POC1A |
0.306912022521282 |
|
11881 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALAS1 |
0.306912022521282 |
|
11882 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLR9 |
0.306912022521282 |
|
11883 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TWF2 |
0.306912022521282 |
|
11884 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPM1M |
0.306912022521282 |
|
11885 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR82 |
0.306912022521282 |
|
11886 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIRLET7G |
0.306912022521282 |
|
11887 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NT5DC2 |
0.306912022521282 |
|
11888 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMIM4 |
0.306912022521282 |
|
11889 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PBRM1 |
0.306912022521282 |
|
11890 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC16P |
0.306912022521282 |
|
11891 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNL3 |
0.306912022521282 |
|
11892 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD19B|ENSG00000238862.1 |
0.306912022521282 |
|
11893 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD19B|ENSG00000252787.1 |
0.306912022521282 |
|
11894 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD19|ENSG00000212493.1 |
0.306912022521282 |
|
11895 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD19|ENSG00000222345.1 |
0.306912022521282 |
|
11896 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD69 |
0.306912022521282 |
|
11897 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLT8D1 |
0.306912022521282 |
|
11898 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPCS1 |
0.306912022521282 |
|
11899 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEK4 |
0.306912022521282 |
|
11900 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITIH1 |
0.306912022521282 |
|
11901 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITIH3 |
0.306912022521282 |
|
11902 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITIH4 |
0.306912022521282 |
|
11903 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUSTN1 |
0.306912022521282 |
|
11904 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM110 |
0.306912022521282 |
|
11905 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFMBT1 |
0.306912022521282 |
|
11906 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFT1 |
0.306912022521282 |
|
11907 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKCD |
0.306912022521282 |
|
11908 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TKT |
0.306912022521282 |
|
11909 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238565.1 |
0.306912022521282 |
|
11910 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCP1A |
0.306912022521282 |
|
11911 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL821P |
0.306912022521282 |
|
11912 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD38|ENSG00000207109.1 |
0.306912022521282 |
|
11913 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA26|ENSG00000212608.1 |
0.306912022521282 |
|
11914 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNA1D |
0.306912022521282 |
|
11915 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD63|ENSG00000251987.1 |
0.306912022521282 |
|
11916 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHDH |
0.306912022521282 |
|
11917 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL17RB |
0.306912022521282 |
|
11918 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTR8 |
0.306912022521282 |
|
11919 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SELK |
0.306912022521282 |
|
11920 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNA2D3 |
0.306912022521282 |
|
11921 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ESRG |
0.306912022521282 |
|
11922 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRTM1 |
0.306912022521282 |
|
11923 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WNT5A |
0.306912022521282 |
|
11924 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERC2 |
0.306912022521282 |
|
11925 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3938 |
0.306912022521282 |
|
11926 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP45 |
0.306912022521282 |
|
11927 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP133 |
0.306912022521282 |
|
11928 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC66 |
0.306912022521282 |
|
11929 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM208A |
0.306912022521282 |
|
11930 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF3 |
0.306912022521282 |
|
11931 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA12 |
0.306912022521282 |
|
11932 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL17RD |
0.306912022521282 |
|
11933 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HESX1 |
0.306912022521282 |
|
11934 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APPL1 |
0.306912022521282 |
|
11935 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASB14 |
0.306912022521282 |
|
11936 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAH12 |
0.306912022521282 |
|
11937 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238905.1 |
0.306912022521282 |
|
11938 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE12 |
0.306912022521282 |
|
11939 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARF4 |
0.306912022521282 |
|
11940 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC26P |
0.306912022521282 |
|
11941 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DENND6A |
0.306912022521282 |
|
11942 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLMAP |
0.306912022521282 |
|
11943 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLNB |
0.306912022521282 |
|
11944 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNASE1L3 |
0.306912022521282 |
|
11945 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABHD6 |
0.306912022521282 |
|
11946 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPP14 |
0.306912022521282 |
|
11947 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PXK |
0.306912022521282 |
|
11948 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDHB |
0.306912022521282 |
|
11949 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCTD6 |
0.306912022521282 |
|
11950 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACOX2 |
0.306912022521282 |
|
11951 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM107A |
0.306912022521282 |
|
11952 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM3D |
0.306912022521282 |
|
11953 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf67 |
0.306912022521282 |
|
11954 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FHIT |
0.306912022521282 |
|
11955 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf14 |
0.307846068911474 |
|
11956 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FEZF2 |
0.307846068911474 |
|
11957 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CADPS |
0.307846068911474 |
|
11958 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL863P |
0.307846068911474 |
|
11959 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00698 |
0.307846068911474 |
|
11960 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYNPR |
0.307846068911474 |
|
11961 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP134 |
0.307846068911474 |
|
11962 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNTN |
0.307846068911474 |
|
11963 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf49 |
0.307846068911474 |
|
11964 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THOC7 |
0.307846068911474 |
|
11965 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATXN7 |
0.307846068911474 |
|
11966 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMD6 |
0.307846068911474 |
|
11967 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000200222.1 |
0.307846068911474 |
|
11968 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRICKLE2 |
0.307846068911474 |
|
11969 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAMTS9 |
0.307846068911474 |
|
11970 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGI1 |
0.307846068911474 |
|
11971 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A26 |
0.307846068911474 |
|
11972 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL482P |
0.307846068911474 |
|
11973 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRIG1 |
0.307846068911474 |
|
11974 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KBTBD8 |
0.307846068911474 |
|
11975 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUCLG2 |
0.307846068911474 |
|
11976 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM19A1 |
0.307846068911474 |
|
11977 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM19A4 |
0.307846068911474 |
|
11978 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP135 |
0.307846068911474 |
|
11979 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EOGT |
0.307846068911474 |
|
11980 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMF1 |
0.307846068911474 |
|
11981 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3136 |
0.307846068911474 |
|
11982 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBA3 |
0.307846068911474 |
|
11983 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL6IP5 |
0.307846068911474 |
|
11984 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMOD3 |
0.307846068911474 |
|
11985 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRMD4B |
0.307846068911474 |
|
11986 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MITF |
0.307846068911474 |
|
11987 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL418P |
0.307846068911474 |
|
11988 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXP1 |
0.307846068911474 |
|
11989 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1284 |
0.307846068911474 |
|
11990 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF4E3 |
0.307846068911474 |
|
11991 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR27 |
0.307846068911474 |
|
11992 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PROK2 |
0.307846068911474 |
|
11993 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL271P |
0.307846068911474 |
|
11994 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00877 |
0.307846068911474 |
|
11995 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00870 |
0.307846068911474 |
|
11996 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RYBP |
0.307846068911474 |
|
11997 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238568.1 |
0.307846068911474 |
|
11998 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP136 |
0.307846068911474 |
|
11999 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHQ1 |
0.307846068911474 |
|
12000 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GXYLT2 |
0.307846068911474 |
|
12001 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP4R2 |
0.307846068911474 |
|
12002 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EBLN2 |
0.307846068911474 |
|
12003 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238416.1 |
0.307846068911474 |
|
12004 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDZRN3 |
0.307846068911474 |
|
12005 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNTN3 |
0.307846068911474 |
|
12006 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL294P |
0.307846068911474 |
|
12007 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM86DP |
0.307846068911474 |
|
12008 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRG2C |
0.307846068911474 |
|
12009 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00960 |
0.307846068911474 |
|
12010 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1324 |
0.307846068911474 |
|
12011 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4273 |
0.307846068911474 |
|
12012 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL92P |
0.307846068911474 |
|
12013 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF717 |
0.307846068911474 |
|
12014 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ROBO2 |
0.307846068911474 |
|
12015 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL647P |
0.307846068911474 |
|
12016 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP61 |
0.307846068911474 |
|
12017 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ROBO1 |
0.307846068911474 |
|
12018 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL751P |
0.307846068911474 |
|
12019 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL841P |
0.308138361870835 |
|
12020 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRX6 |
0.308138361870835 |
|
12021 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMP2 |
0.308138361870835 |
|
12022 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPCAT2 |
0.308138361870835 |
|
12023 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPNS2 |
0.308138361870835 |
|
12024 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC6A2 |
0.308138361870835 |
|
12025 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CES1P1 |
0.308138361870835 |
|
12026 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CES1 |
0.308138361870835 |
|
12027 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CES5A |
0.308138361870835 |
|
12028 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNAO1 |
0.308138361870835 |
|
12029 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3935 |
0.308138361870835 |
|
12030 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMFR |
0.308138361870835 |
|
12031 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDT21 |
0.308138361870835 |
|
12032 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OGFOD1 |
0.308138361870835 |
|
12033 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BBS2 |
0.308138361870835 |
|
12034 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MT4 |
0.308138361870835 |
|
12035 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MT3 |
0.308138361870835 |
|
12036 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MT2A |
0.308138361870835 |
|
12037 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MT1L |
0.308138361870835 |
|
12038 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MT1E |
0.308138361870835 |
|
12039 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MT1M |
0.308138361870835 |
|
12040 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MT1JP |
0.308138361870835 |
|
12041 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MT1A |
0.308138361870835 |
|
12042 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MT1DP |
0.308138361870835 |
|
12043 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MT1B |
0.308138361870835 |
|
12044 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MT1F |
0.308138361870835 |
|
12045 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MT1G |
0.308138361870835 |
|
12046 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MT1H |
0.308138361870835 |
|
12047 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MT1X |
0.308138361870835 |
|
12048 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUP93 |
0.308138361870835 |
|
12049 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC12A3 |
0.308138361870835 |
|
12050 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00159 |
0.309014174644414 |
|
12051 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIS18A |
0.309014174644414 |
|
12052 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRAP |
0.309014174644414 |
|
12053 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
URB1 |
0.309014174644414 |
|
12054 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL109P |
0.309014174644414 |
|
12055 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA80 |
0.309014174644414 |
|
12056 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C21orf119 |
0.309014174644414 |
|
12057 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP264 |
0.310174148220616 |
|
12058 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNU1 |
0.310174148220616 |
|
12059 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GDF2 |
0.310888407357543 |
|
12060 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GDF10 |
0.310888407357543 |
|
12061 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BMS1P5 |
0.310888407357543 |
|
12062 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM25C |
0.310888407357543 |
|
12063 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRMPD2 |
0.310888407357543 |
|
12064 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLUD1P2 |
0.310888407357543 |
|
12065 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPN20B |
0.310888407357543 |
|
12066 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL527P |
0.310888407357543 |
|
12067 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP314 |
0.310888407357543 |
|
12068 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP315 |
0.310888407357543 |
|
12069 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPK8 |
0.310888407357543 |
|
12070 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP22 |
0.310888407357543 |
|
12071 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDFY4 |
0.310888407357543 |
|
12072 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC18 |
0.310888407357543 |
|
12073 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4294 |
0.310888407357543 |
|
12074 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VSTM4 |
0.310888407357543 |
|
12075 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM170B |
0.310888407357543 |
|
12076 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf128 |
0.310888407357543 |
|
12077 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf71 |
0.310888407357543 |
|
12078 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DRGX |
0.310888407357543 |
|
12079 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERCC6 |
0.310888407357543 |
|
12080 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGBD3 |
0.310888407357543 |
|
12081 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHAT |
0.310888407357543 |
|
12082 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC18A3 |
0.310888407357543 |
|
12083 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf53 |
0.310888407357543 |
|
12084 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OGDHL |
0.310888407357543 |
|
12085 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGAP6 |
0.310888407357543 |
|
12086 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASAH2 |
0.310888407357543 |
|
12087 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM21A |
0.310888407357543 |
|
12088 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00843 |
0.310888407357543 |
|
12089 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RMRPP4 |
0.310888407357543 |
|
12090 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP317 |
0.310888407357543 |
|
12091 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGMS1 |
0.310888407357543 |
|
12092 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA74|ENSG00000223111.1 |
0.310888407357543 |
|
12093 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIMM23 |
0.310888407357543 |
|
12094 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASAH2B |
0.310888407357543 |
|
12095 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
A1CF |
0.310888407357543 |
|
12096 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKG1 |
0.310888407357543 |
|
12097 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR605 |
0.310888407357543 |
|
12098 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSTF2T |
0.310888407357543 |
|
12099 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DKK1 |
0.310888407357543 |
|
12100 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBL2 |
0.310888407357543 |
|
12101 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP318 |
0.310888407357543 |
|
12102 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDH15 |
0.310888407357543 |
|
12103 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548F1 |
0.310888407357543 |
|
12104 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238355.1 |
0.310888407357543 |
|
12105 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTRNR2L5 |
0.310888407357543 |
|
12106 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZWINT |
0.310888407357543 |
|
12107 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD2|ENSG00000238707.1 |
0.310888407357543 |
|
12108 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3924 |
0.310888407357543 |
|
12109 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IPMK |
0.310888407357543 |
|
12110 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238970.1 |
0.310888407357543 |
|
12111 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CISD1 |
0.310888407357543 |
|
12112 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2D1 |
0.310888407357543 |
|
12113 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFAM |
0.310888407357543 |
|
12114 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BICC1 |
0.310888407357543 |
|
12115 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP196 |
0.310888407357543 |
|
12116 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00844 |
0.310888407357543 |
|
12117 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHYHIPL |
0.310888407357543 |
|
12118 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK1 |
0.310888407357543 |
|
12119 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHOBTB1 |
0.310888407357543 |
|
12120 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00845 |
0.310888407357543 |
|
12121 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM26 |
0.310888407357543 |
|
12122 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf107 |
0.310888407357543 |
|
12123 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARID5B |
0.310888407357543 |
|
12124 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RTKN2 |
0.310888407357543 |
|
12125 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDH9 |
0.31283051904901 |
|
12126 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00669 |
0.314603994245816 |
|
12127 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BLM |
0.315817387248772 |
|
12128 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD18|ENSG00000200677.1 |
0.315817387248772 |
|
12129 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL363P |
0.315817387248772 |
|
12130 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FURIN |
0.315817387248772 |
|
12131 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NARS2 |
0.319302795104658 |
|
12132 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR2117 |
0.319583784440839 |
|
12133 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHX8 |
0.319583784440839 |
|
12134 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ETV4 |
0.319583784440839 |
|
12135 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYO7A |
0.319613951191946 |
|
12136 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GDPD4 |
0.319613951191946 |
|
12137 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAK1 |
0.319613951191946 |
|
12138 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DKFZP434E1119 |
0.319613951191946 |
|
12139 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLNS1A |
0.319613951191946 |
|
12140 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AQP11 |
0.319613951191946 |
|
12141 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RSF1 |
0.319613951191946 |
|
12142 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AAMDC |
0.319613951191946 |
|
12143 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INTS4 |
0.319613951191946 |
|
12144 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCTD14 |
0.319613951191946 |
|
12145 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THRSP |
0.319613951191946 |
|
12146 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFC2 |
0.319613951191946 |
|
12147 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4300 |
0.320633784075087 |
|
12148 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252592.1 |
0.320633784075087 |
|
12149 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM181B |
0.320633784075087 |
|
12150 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRCP |
0.320633784075087 |
|
12151 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238995.1 |
0.320633784075087 |
|
12152 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf82 |
0.320633784075087 |
|
12153 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB30 |
0.320633784075087 |
|
12154 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70E |
0.320633784075087 |
|
12155 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCF11 |
0.320633784075087 |
|
12156 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD42 |
0.320633784075087 |
|
12157 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC90B |
0.320633784075087 |
|
12158 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAD |
0.32125354310096 |
|
12159 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR137 |
0.32125354310096 |
|
12160 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNK4 |
0.32125354310096 |
|
12161 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX40 |
0.32125354310096 |
|
12162 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ESRRA |
0.32125354310096 |
|
12163 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRDX5 |
0.32125354310096 |
|
12164 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRMT112 |
0.32125354310096 |
|
12165 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DACH1 |
0.321892044501964 |
|
12166 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP32 |
0.321892044501964 |
|
12167 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD37|ENSG00000212377.1 |
0.321892044501964 |
|
12168 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA68|ENSG00000251715.1 |
0.321892044501964 |
|
12169 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA9|ENSG00000199282.1 |
0.321892044501964 |
|
12170 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MZT1 |
0.321892044501964 |
|
12171 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BORA |
0.321892044501964 |
|
12172 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DIS3 |
0.321892044501964 |
|
12173 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIBF1 |
0.321892044501964 |
|
12174 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00392 |
0.321892044501964 |
|
12175 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TXNDC16 |
0.322944611099337 |
|
12176 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FUT8 |
0.322944611099337 |
|
12177 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TANGO6 |
0.32483348683816 |
|
12178 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS2P45 |
0.32483348683816 |
|
12179 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAS3 |
0.32483348683816 |
|
12180 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHTF8 |
0.32483348683816 |
|
12181 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CIRH1A |
0.32483348683816 |
|
12182 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WWOX |
0.32483348683816 |
|
12183 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL16 |
0.325058326349094 |
|
12184 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STARD5 |
0.325058326349094 |
|
12185 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMC3 |
0.325058326349094 |
|
12186 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEX3B |
0.325058326349094 |
|
12187 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFTUD1 |
0.325058326349094 |
|
12188 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM154B |
0.325058326349094 |
|
12189 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSPG4P8 |
0.325058326349094 |
|
12190 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA6L10|ENSG00000205281.6 |
0.325058326349094 |
|
12191 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA6L10|ENSG00000254374.2 |
0.325058326349094 |
|
12192 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA6L9|ENSG00000196648.6 |
0.325058326349094 |
|
12193 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA6L9|ENSG00000197978.8 |
0.325058326349094 |
|
12194 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL256P |
0.325058326349094 |
|
12195 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL410P |
0.325058326349094 |
|
12196 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL61P |
0.325058326349094 |
|
12197 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS17 |
0.325058326349094 |
|
12198 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2Q2P2 |
0.325058326349094 |
|
12199 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2Q2P3 |
0.325058326349094 |
|
12200 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPEB1 |
0.325058326349094 |
|
12201 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS17L |
0.325058326349094 |
|
12202 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP3B2 |
0.325058326349094 |
|
12203 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA15|ENSG00000252690.2 |
0.325058326349094 |
|
12204 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FSD2 |
0.325058326349094 |
|
12205 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WHAMM |
0.325058326349094 |
|
12206 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOMER2 |
0.325058326349094 |
|
12207 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C15orf40 |
0.325058326349094 |
|
12208 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM103A1 |
0.325058326349094 |
|
12209 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTBD1 |
0.325058326349094 |
|
12210 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4515 |
0.325058326349094 |
|
12211 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TM6SF1 |
0.325058326349094 |
|
12212 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HDGFRP3 |
0.325058326349094 |
|
12213 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BNC1 |
0.325058326349094 |
|
12214 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3GL3 |
0.325058326349094 |
|
12215 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAMTSL3 |
0.325058326349094 |
|
12216 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFTUD1P1 |
0.325058326349094 |
|
12217 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSPG4P5 |
0.325058326349094 |
|
12218 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA6L4 |
0.325058326349094 |
|
12219 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA6L5 |
0.325058326349094 |
|
12220 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL331P |
0.325058326349094 |
|
12221 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL417P |
0.325058326349094 |
|
12222 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2Q2P1 |
0.325058326349094 |
|
12223 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00933 |
0.325058326349094 |
|
12224 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSCAN2 |
0.325058326349094 |
|
12225 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCAND2P |
0.325058326349094 |
|
12226 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR73 |
0.325058326349094 |
|
12227 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NMB |
0.325058326349094 |
|
12228 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC11A |
0.325058326349094 |
|
12229 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF592 |
0.325058326349094 |
|
12230 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALPK3 |
0.325058326349094 |
|
12231 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA25|ENSG00000200991.1 |
0.325058326349094 |
|
12232 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC28A1 |
0.325058326349094 |
|
12233 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE8A |
0.325058326349094 |
|
12234 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSPG4P12 |
0.325058326349094 |
|
12235 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL428P |
0.325058326349094 |
|
12236 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKAP13 |
0.325058326349094 |
|
12237 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL25 |
0.325058326349094 |
|
12238 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1276 |
0.325058326349094 |
|
12239 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548AP |
0.325058326349094 |
|
12240 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGBL1 |
0.325058326349094 |
|
12241 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP400 |
0.325058326349094 |
|
12242 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD74|ENSG00000200206.1 |
0.325058326349094 |
|
12243 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00052 |
0.325058326349094 |
|
12244 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NTRK3 |
0.325058326349094 |
|
12245 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL46 |
0.325058326349094 |
|
12246 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS11 |
0.325058326349094 |
|
12247 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DET1 |
0.325058326349094 |
|
12248 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1179 |
0.325058326349094 |
|
12249 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AEN |
0.325058326349094 |
|
12250 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ISG20 |
0.325058326349094 |
|
12251 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACAN |
0.325058326349094 |
|
12252 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAPLN3 |
0.325058326349094 |
|
12253 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFGE8 |
0.325058326349094 |
|
12254 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABHD2 |
0.325058326349094 |
|
12255 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RLBP1 |
0.325058326349094 |
|
12256 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FANCI |
0.325058326349094 |
|
12257 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLG |
0.325058326349094 |
|
12258 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00925 |
0.325058326349094 |
|
12259 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHCG |
0.325058326349094 |
|
12260 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00928 |
0.325058326349094 |
|
12261 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TICRR |
0.325058326349094 |
|
12262 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF7 |
0.325058326349094 |
|
12263 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLIN1 |
0.325058326349094 |
|
12264 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEX11A |
0.325058326349094 |
|
12265 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR93 |
0.325058326349094 |
|
12266 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MESP1 |
0.325058326349094 |
|
12267 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MESP2 |
0.325058326349094 |
|
12268 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANPEP |
0.325058326349094 |
|
12269 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP3S2 |
0.325058326349094 |
|
12270 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5094 |
0.325058326349094 |
|
12271 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5009 |
0.325058326349094 |
|
12272 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C15orf38 |
0.325058326349094 |
|
12273 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF710 |
0.325058326349094 |
|
12274 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3174 |
0.325058326349094 |
|
12275 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IDH2 |
0.325058326349094 |
|
12276 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL755P |
0.325058326349094 |
|
12277 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEMA4B |
0.325058326349094 |
|
12278 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL346P |
0.325058326349094 |
|
12279 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CIB1 |
0.325058326349094 |
|
12280 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GDPGP1 |
0.325058326349094 |
|
12281 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTLL13 |
0.325058326349094 |
|
12282 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NGRN |
0.325058326349094 |
|
12283 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL736P |
0.325058326349094 |
|
12284 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABARAPL3 |
0.325058326349094 |
|
12285 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IQGAP1 |
0.325058326349094 |
|
12286 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF774 |
0.325058326349094 |
|
12287 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRTC3 |
0.325058326349094 |
|
12288 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FES |
0.325058326349094 |
|
12289 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAN2A2 |
0.325058326349094 |
|
12290 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HDDC3 |
0.325058326349094 |
|
12291 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UNC45A |
0.325058326349094 |
|
12292 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RCCD1 |
0.325058326349094 |
|
12293 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRC1 |
0.325058326349094 |
|
12294 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS33B |
0.325058326349094 |
|
12295 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SV2B |
0.325058326349094 |
|
12296 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238981.1 |
0.325058326349094 |
|
12297 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLCO3A1 |
0.325058326349094 |
|
12298 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST8SIA2 |
0.325058326349094 |
|
12299 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU109|ENSG00000239197.1 |
0.325058326349094 |
|
12300 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C15orf32 |
0.325058326349094 |
|
12301 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00930 |
0.325058326349094 |
|
12302 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM174B |
0.325058326349094 |
|
12303 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL599P |
0.325058326349094 |
|
12304 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHD2 |
0.325058326349094 |
|
12305 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3175 |
0.325058326349094 |
|
12306 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGMA |
0.325058326349094 |
|
12307 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCTP2 |
0.325058326349094 |
|
12308 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00924 |
0.325058326349094 |
|
12309 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NR2F2 |
0.325058326349094 |
|
12310 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1469 |
0.325058326349094 |
|
12311 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP254 |
0.325058326349094 |
|
12312 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA8 |
0.325058326349094 |
|
12313 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP181 |
0.325058326349094 |
|
12314 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL677P |
0.325058326349094 |
|
12315 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP401 |
0.325058326349094 |
|
12316 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00923 |
0.325058326349094 |
|
12317 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARRDC4 |
0.325058326349094 |
|
12318 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM169B |
0.325058326349094 |
|
12319 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGF1R |
0.325058326349094 |
|
12320 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4714 |
0.325058326349094 |
|
12321 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGPEP1L |
0.325058326349094 |
|
12322 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYNM |
0.325058326349094 |
|
12323 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC23 |
0.325058326349094 |
|
12324 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC28 |
0.325058326349094 |
|
12325 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEF2A |
0.325058326349094 |
|
12326 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DKFZP779J2370 |
0.325058326349094 |
|
12327 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYSMD4 |
0.325058326349094 |
|
12328 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNM1P46 |
0.325058326349094 |
|
12329 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL484P |
0.325058326349094 |
|
12330 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAMTS17 |
0.325058326349094 |
|
12331 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP402 |
0.325058326349094 |
|
12332 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CERS3 |
0.325058326349094 |
|
12333 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA41 |
0.325058326349094 |
|
12334 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINS |
0.325058326349094 |
|
12335 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASB7 |
0.325058326349094 |
|
12336 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALDH1A3 |
0.325058326349094 |
|
12337 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRK1 |
0.325058326349094 |
|
12338 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHSY1 |
0.325058326349094 |
|
12339 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VIMP |
0.325058326349094 |
|
12340 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNRPA1 |
0.325058326349094 |
|
12341 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCSK6 |
0.325058326349094 |
|
12342 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX11L9 |
0.325058326349094 |
|
12343 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNM1P47 |
0.325058326349094 |
|
12344 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM138E |
0.325058326349094 |
|
12345 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4F13P |
0.325058326349094 |
|
12346 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4F15 |
0.325058326349094 |
|
12347 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4F4 |
0.325058326349094 |
|
12348 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4F6 |
0.325058326349094 |
|
12349 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL209P |
0.325058326349094 |
|
12350 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TARSL2 |
0.325058326349094 |
|
12351 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TM2D3 |
0.325058326349094 |
|
12352 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WASH3P |
0.325058326349094 |
|
12353 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238502.1 |
0.325058326349094 |
|
12354 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADO |
0.325910017786558 |
|
12355 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EGR2 |
0.325910017786558 |
|
12356 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRBF2 |
0.325910017786558 |
|
12357 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JMJD1C |
0.325910017786558 |
|
12358 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1296 |
0.325910017786558 |
|
12359 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REEP3 |
0.325910017786558 |
|
12360 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTNNA3 |
0.325910017786558 |
|
12361 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoR442|ENSG00000252203.1 |
0.325910017786558 |
|
12362 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239000.1 |
0.325910017786558 |
|
12363 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRTM3 |
0.325910017786558 |
|
12364 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC12 |
0.325910017786558 |
|
12365 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL394P |
0.325910017786558 |
|
12366 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIRT1 |
0.325910017786558 |
|
12367 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HERC4 |
0.325910017786558 |
|
12368 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL220P |
0.325910017786558 |
|
12369 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYPN |
0.325910017786558 |
|
12370 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP202 |
0.325910017786558 |
|
12371 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATOH7 |
0.325910017786558 |
|
12372 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PBLD |
0.325910017786558 |
|
12373 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPH3 |
0.325910017786558 |
|
12374 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RUFY2 |
0.325910017786558 |
|
12375 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNA2 |
0.325910017786558 |
|
12376 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP319 |
0.325910017786558 |
|
12377 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00849 |
0.325910017786558 |
|
12378 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A16 |
0.325910017786558 |
|
12379 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TET1 |
0.325910017786558 |
|
12380 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000251926.1 |
0.325910017786558 |
|
12381 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCAR1 |
0.325910017786558 |
|
12382 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD98 |
0.325910017786558 |
|
12383 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STOX1 |
0.325910017786558 |
|
12384 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX50 |
0.325910017786558 |
|
12385 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX21 |
0.325910017786558 |
|
12386 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL373P |
0.325910017786558 |
|
12387 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1279 |
0.325910017786558 |
|
12388 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRGN |
0.325910017786558 |
|
12389 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS26A |
0.325910017786558 |
|
12390 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUPV3L1 |
0.325910017786558 |
|
12391 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HKDC1 |
0.325910017786558 |
|
12392 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HK1 |
0.325910017786558 |
|
12393 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TACR2 |
0.325910017786558 |
|
12394 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPAN15 |
0.325910017786558 |
|
12395 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEUROG3 |
0.325910017786558 |
|
12396 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf35 |
0.325910017786558 |
|
12397 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL13A1 |
0.325910017786558 |
|
12398 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
H2AFY2 |
0.325910017786558 |
|
12399 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AIFM2 |
0.325910017786558 |
|
12400 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TYSND1 |
0.325910017786558 |
|
12401 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAR1A |
0.325910017786558 |
|
12402 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPA1 |
0.325910017786558 |
|
12403 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPFFR1 |
0.325910017786558 |
|
12404 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC20 |
0.325910017786558 |
|
12405 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF4EBP2 |
0.325910017786558 |
|
12406 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NODAL |
0.325910017786558 |
|
12407 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PALD1 |
0.325910017786558 |
|
12408 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRF1 |
0.325910017786558 |
|
12409 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAMTS14 |
0.325910017786558 |
|
12410 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBATA |
0.325910017786558 |
|
12411 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGPL1 |
0.325910017786558 |
|
12412 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCBD1 |
0.325910017786558 |
|
12413 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UNC5B |
0.325910017786558 |
|
12414 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC29A3 |
0.325910017786558 |
|
12415 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238918.1 |
0.325910017786558 |
|
12416 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDH23 |
0.325910017786558 |
|
12417 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf105 |
0.325910017786558 |
|
12418 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf54 |
0.325910017786558 |
|
12419 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSAP |
0.325910017786558 |
|
12420 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHST3 |
0.325910017786558 |
|
12421 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPOCK2 |
0.325910017786558 |
|
12422 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASCC1 |
0.325910017786558 |
|
12423 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA36|ENSG00000200294.1 |
0.325910017786558 |
|
12424 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANAPC16 |
0.325910017786558 |
|
12425 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDIT4 |
0.325910017786558 |
|
12426 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJB12 |
0.325910017786558 |
|
12427 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MICU1 |
0.325910017786558 |
|
12428 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCU |
0.325910017786558 |
|
12429 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4676 |
0.325910017786558 |
|
12430 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OIT3 |
0.325910017786558 |
|
12431 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLA2G12B |
0.325910017786558 |
|
12432 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
P4HA1 |
0.325910017786558 |
|
12433 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDT13 |
0.325910017786558 |
|
12434 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA11|ENSG00000221164.1 |
0.325910017786558 |
|
12435 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ECD |
0.325910017786558 |
|
12436 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM149B1 |
0.325910017786558 |
|
12437 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC9 |
0.325910017786558 |
|
12438 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS16 |
0.325910017786558 |
|
12439 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC18 |
0.325910017786558 |
|
12440 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238983.1 |
0.325910017786558 |
|
12441 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANXA7 |
0.325910017786558 |
|
12442 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSS51 |
0.325910017786558 |
|
12443 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP3CB |
0.325910017786558 |
|
12444 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP54 |
0.325910017786558 |
|
12445 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYOZ1 |
0.325910017786558 |
|
12446 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYNPO2L |
0.325910017786558 |
|
12447 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGAP5 |
0.325910017786558 |
|
12448 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP320 |
0.325910017786558 |
|
12449 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BMS1P4 |
0.325910017786558 |
|
12450 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLUD1P3 |
0.325910017786558 |
|
12451 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC24C |
0.325910017786558 |
|
12452 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FUT11 |
0.325910017786558 |
|
12453 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RMRPP1 |
0.325910017786558 |
|
12454 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHCHD1 |
0.325910017786558 |
|
12455 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSWIM8 |
0.325910017786558 |
|
12456 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDST2 |
0.325910017786558 |
|
12457 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAMK2G |
0.325910017786558 |
|
12458 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf55 |
0.325910017786558 |
|
12459 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLAU |
0.325910017786558 |
|
12460 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VCL |
0.325910017786558 |
|
12461 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP3M1 |
0.325910017786558 |
|
12462 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADK |
0.325910017786558 |
|
12463 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KAT6B |
0.325910017786558 |
|
12464 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUPD1 |
0.325910017786558 |
|
12465 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUSP13 |
0.325910017786558 |
|
12466 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAMD8 |
0.325910017786558 |
|
12467 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VDAC2 |
0.325910017786558 |
|
12468 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COMTD1 |
0.325910017786558 |
|
12469 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF503 |
0.325910017786558 |
|
12470 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL518P |
0.325910017786558 |
|
12471 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000252888.1 |
0.325910017786558 |
|
12472 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNMA1 |
0.325910017786558 |
|
12473 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP321 |
0.325910017786558 |
|
12474 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLG5 |
0.325910017786558 |
|
12475 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL284P |
0.325910017786558 |
|
12476 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR3A |
0.325910017786558 |
|
12477 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS24 |
0.325910017786558 |
|
12478 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00856 |
0.325910017786558 |
|
12479 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00595 |
0.325910017786558 |
|
12480 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA71|ENSG00000201393.1 |
0.325910017786558 |
|
12481 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZMIZ1 |
0.325910017786558 |
|
12482 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPIF |
0.325910017786558 |
|
12483 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZCCHC24 |
0.325910017786558 |
|
12484 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANXA11 |
0.325910017786558 |
|
12485 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF5AL1 |
0.325910017786558 |
|
12486 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00857 |
0.325910017786558 |
|
12487 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBL1P |
0.325910017786558 |
|
12488 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUTM2B |
0.325910017786558 |
|
12489 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUTM2E |
0.325910017786558 |
|
12490 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLAC9 |
0.325910017786558 |
|
12491 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFTPA1 |
0.325910017786558 |
|
12492 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFTPA2 |
0.325910017786558 |
|
12493 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFTPD |
0.325910017786558 |
|
12494 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM254 |
0.325910017786558 |
|
12495 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAT1A |
0.325910017786558 |
|
12496 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DYDC1 |
0.325910017786558 |
|
12497 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DYDC2 |
0.325910017786558 |
|
12498 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM213A |
0.325910017786558 |
|
12499 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPAN14 |
0.325910017786558 |
|
12500 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH2D4B |
0.325910017786558 |
|
12501 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRG3 |
0.325910017786558 |
|
12502 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BLOC1S2 |
0.325910017786558 |
|
12503 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKD2L1 |
0.325910017786558 |
|
12504 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCD |
0.325910017786558 |
|
12505 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00263 |
0.325910017786558 |
|
12506 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WNT8B |
0.325910017786558 |
|
12507 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC31B |
0.325910017786558 |
|
12508 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFB8 |
0.325910017786558 |
|
12509 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIF1AN |
0.325910017786558 |
|
12510 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAX2 |
0.325910017786558 |
|
12511 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM178A |
0.325910017786558 |
|
12512 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR608 |
0.325910017786558 |
|
12513 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL43 |
0.325910017786558 |
|
12514 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEMA4G |
0.325910017786558 |
|
12515 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf2 |
0.325910017786558 |
|
12516 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LZTS2 |
0.325910017786558 |
|
12517 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDZD7 |
0.325910017786558 |
|
12518 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFXN3 |
0.325910017786558 |
|
12519 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KAZALD1 |
0.325910017786558 |
|
12520 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLX1NB |
0.325910017786558 |
|
12521 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HUG1 |
0.325910017786558 |
|
12522 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLX1 |
0.325910017786558 |
|
12523 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LBX1 |
0.325910017786558 |
|
12524 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252844.1 |
0.325910017786558 |
|
12525 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTRC |
0.325910017786558 |
|
12526 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239091.1 |
0.325910017786558 |
|
12527 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPCD |
0.325910017786558 |
|
12528 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLL |
0.325910017786558 |
|
12529 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXW4 |
0.325910017786558 |
|
12530 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGF8 |
0.325910017786558 |
|
12531 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MGEA5 |
0.325910017786558 |
|
12532 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPM3 |
0.325910017786558 |
|
12533 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNIP2 |
0.325910017786558 |
|
12534 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFKB2 |
0.325910017786558 |
|
12535 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSD |
0.325910017786558 |
|
12536 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CUEDC2 |
0.325910017786558 |
|
12537 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXL15 |
0.325910017786558 |
|
12538 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR146B |
0.325910017786558 |
|
12539 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf95 |
0.325910017786558 |
|
12540 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM180 |
0.325910017786558 |
|
12541 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTR1A |
0.325910017786558 |
|
12542 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUFU |
0.325910017786558 |
|
12543 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL21P |
0.325910017786558 |
|
12544 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM8 |
0.325910017786558 |
|
12545 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL3 |
0.325910017786558 |
|
12546 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFXN2 |
0.325910017786558 |
|
12547 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WBP1L |
0.325910017786558 |
|
12548 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP17A1 |
0.325910017786558 |
|
12549 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10ORF32 |
0.325910017786558 |
|
12550 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf32 |
0.325910017786558 |
|
12551 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AS3MT |
0.325910017786558 |
|
12552 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNNM2 |
0.325910017786558 |
|
12553 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NT5C2 |
0.325910017786558 |
|
12554 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INA |
0.325910017786558 |
|
12555 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCGF6 |
0.325910017786558 |
|
12556 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAF5 |
0.325910017786558 |
|
12557 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CALHM1 |
0.325910017786558 |
|
12558 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CALHM2 |
0.325910017786558 |
|
12559 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1307 |
0.325910017786558 |
|
12560 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDCD11 |
0.325910017786558 |
|
12561 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USMG5 |
0.325910017786558 |
|
12562 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CALHM3 |
0.325910017786558 |
|
12563 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEURL |
0.325910017786558 |
|
12564 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3PXD2A |
0.325910017786558 |
|
12565 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OBFC1 |
0.325910017786558 |
|
12566 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLK |
0.325910017786558 |
|
12567 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL524P |
0.325910017786558 |
|
12568 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL17A1 |
0.325910017786558 |
|
12569 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR936 |
0.325910017786558 |
|
12570 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFR1 |
0.325910017786558 |
|
12571 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR96 |
0.325910017786558 |
|
12572 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPNE2 |
0.328482880719422 |
|
12573 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM192A |
0.328482880719422 |
|
12574 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RSPRY1 |
0.328482880719422 |
|
12575 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL2BP |
0.328482880719422 |
|
12576 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLLP |
0.328482880719422 |
|
12577 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL22 |
0.328482880719422 |
|
12578 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CX3CL1 |
0.328482880719422 |
|
12579 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL17 |
0.328482880719422 |
|
12580 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CIAPIN1 |
0.328482880719422 |
|
12581 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COQ9 |
0.328482880719422 |
|
12582 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR2C |
0.328482880719422 |
|
12583 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOK4 |
0.328482880719422 |
|
12584 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC102A |
0.328482880719422 |
|
12585 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR114 |
0.328482880719422 |
|
12586 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR56 |
0.328482880719422 |
|
12587 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR97 |
0.328482880719422 |
|
12588 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC135 |
0.328482880719422 |
|
12589 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KATNB1 |
0.328482880719422 |
|
12590 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIFC3 |
0.328482880719422 |
|
12591 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNGB1 |
0.328482880719422 |
|
12592 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEPP |
0.328482880719422 |
|
12593 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USB1 |
0.328482880719422 |
|
12594 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF319 |
0.328482880719422 |
|
12595 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMP15 |
0.328482880719422 |
|
12596 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf80 |
0.328482880719422 |
|
12597 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSNK2A2 |
0.328482880719422 |
|
12598 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL645P |
0.328482880719422 |
|
12599 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC113 |
0.328482880719422 |
|
12600 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS54 |
0.328482880719422 |
|
12601 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GINS3 |
0.328482880719422 |
|
12602 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDRG4 |
0.328482880719422 |
|
12603 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SETD6 |
0.328482880719422 |
|
12604 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNOT1 |
0.328482880719422 |
|
12605 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA46|ENSG00000207493.1 |
0.328482880719422 |
|
12606 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA50|ENSG00000206952.2 |
0.328482880719422 |
|
12607 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239121.1 |
0.328482880719422 |
|
12608 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC38A7 |
0.328482880719422 |
|
12609 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOT2 |
0.328482880719422 |
|
12610 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL143P |
0.328482880719422 |
|
12611 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDH8 |
0.328482880719422 |
|
12612 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP76 |
0.328482880719422 |
|
12613 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238507.1 |
0.328482880719422 |
|
12614 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDH11 |
0.328482880719422 |
|
12615 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00922 |
0.328482880719422 |
|
12616 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP428 |
0.328482880719422 |
|
12617 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDH5 |
0.328482880719422 |
|
12618 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00920 |
0.328482880719422 |
|
12619 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BEAN1 |
0.328482880719422 |
|
12620 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TK2 |
0.328482880719422 |
|
12621 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CKLF |
0.328482880719422 |
|
12622 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CMTM1 |
0.328482880719422 |
|
12623 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CMTM2 |
0.328482880719422 |
|
12624 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CMTM3 |
0.328482880719422 |
|
12625 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CMTM4 |
0.328482880719422 |
|
12626 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DYNC1LI2 |
0.328482880719422 |
|
12627 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC79 |
0.328482880719422 |
|
12628 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAE1 |
0.328482880719422 |
|
12629 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CA7 |
0.328482880719422 |
|
12630 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDP2 |
0.328482880719422 |
|
12631 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDH16 |
0.328482880719422 |
|
12632 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRAD |
0.328482880719422 |
|
12633 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM96B |
0.328482880719422 |
|
12634 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CES2 |
0.328482880719422 |
|
12635 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CES3 |
0.328482880719422 |
|
12636 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CES4A |
0.328482880719422 |
|
12637 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL543P |
0.328482880719422 |
|
12638 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBFB |
0.328482880719422 |
|
12639 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf70 |
0.328482880719422 |
|
12640 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B3GNT9 |
0.328482880719422 |
|
12641 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXL8 |
0.328482880719422 |
|
12642 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRADD |
0.328482880719422 |
|
12643 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSF4 |
0.328482880719422 |
|
12644 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOL3 |
0.328482880719422 |
|
12645 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0895L |
0.328482880719422 |
|
12646 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXOC3L1 |
0.328482880719422 |
|
12647 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
E2F4 |
0.328482880719422 |
|
12648 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELMO3 |
0.328482880719422 |
|
12649 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR328 |
0.328482880719422 |
|
12650 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC29 |
0.328482880719422 |
|
12651 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM208 |
0.328482880719422 |
|
12652 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FHOD1 |
0.328482880719422 |
|
12653 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC9A5 |
0.328482880719422 |
|
12654 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHG4 |
0.328482880719422 |
|
12655 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCTD19 |
0.328482880719422 |
|
12656 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP118 |
0.328482880719422 |
|
12657 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC36 |
0.328482880719422 |
|
12658 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPPP3 |
0.328482880719422 |
|
12659 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDHHC1 |
0.328482880719422 |
|
12660 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSD11B2 |
0.328482880719422 |
|
12661 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6V0D1 |
0.328482880719422 |
|
12662 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGRP |
0.328482880719422 |
|
12663 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM65A |
0.328482880719422 |
|
12664 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTCF |
0.328482880719422 |
|
12665 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RLTPR |
0.328482880719422 |
|
12666 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACD |
0.328482880719422 |
|
12667 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf86 |
0.328482880719422 |
|
12668 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENKD1 |
0.328482880719422 |
|
12669 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARD6A |
0.328482880719422 |
|
12670 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GFOD2 |
0.328482880719422 |
|
12671 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RANBP10 |
0.328482880719422 |
|
12672 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSNAXIP1 |
0.328482880719422 |
|
12673 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CENPT |
0.328482880719422 |
|
12674 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THAP11 |
0.328482880719422 |
|
12675 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUTF2 |
0.328482880719422 |
|
12676 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EDC4 |
0.328482880719422 |
|
12677 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRN1L |
0.328482880719422 |
|
12678 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSKH1 |
0.328482880719422 |
|
12679 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTRL |
0.328482880719422 |
|
12680 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMB10 |
0.328482880719422 |
|
12681 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCAT |
0.328482880719422 |
|
12682 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC12A4 |
0.328482880719422 |
|
12683 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPEP3 |
0.328482880719422 |
|
12684 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPEP2 |
0.328482880719422 |
|
12685 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUS2L |
0.328482880719422 |
|
12686 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX28 |
0.328482880719422 |
|
12687 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFATC3 |
0.328482880719422 |
|
12688 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA48|ENSG00000212445.1 |
0.328482880719422 |
|
12689 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ESRP2 |
0.328482880719422 |
|
12690 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLA2G15 |
0.328482880719422 |
|
12691 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC7A6 |
0.328482880719422 |
|
12692 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC7A6OS |
0.328482880719422 |
|
12693 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRMT7 |
0.328482880719422 |
|
12694 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238343.1 |
0.328482880719422 |
|
12695 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMPD3 |
0.328482880719422 |
|
12696 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFP90 |
0.328482880719422 |
|
12697 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU109|ENSG00000252040.1 |
0.328482880719422 |
|
12698 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU109|ENSG00000252640.1 |
0.328482880719422 |
|
12699 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDH3 |
0.328482880719422 |
|
12700 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDH1 |
0.328482880719422 |
|
12701 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP429 |
0.328482880719422 |
|
12702 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC22A9 |
0.330863030978429 |
|
12703 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HRASLS5 |
0.330863030978429 |
|
12704 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGALS12 |
0.330863030978429 |
|
12705 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RARRES3 |
0.330863030978429 |
|
12706 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HRASLS2 |
0.330863030978429 |
|
12707 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLA2G16 |
0.330863030978429 |
|
12708 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATL3 |
0.330863030978429 |
|
12709 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RTN3 |
0.330863030978429 |
|
12710 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf95 |
0.330863030978429 |
|
12711 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL596P |
0.330863030978429 |
|
12712 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf84 |
0.330863030978429 |
|
12713 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MARK2 |
0.330863030978429 |
|
12714 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RCOR2 |
0.330863030978429 |
|
12715 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAA40 |
0.330863030978429 |
|
12716 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX8A |
0.330863030978429 |
|
12717 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OTUB1 |
0.330863030978429 |
|
12718 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC88B |
0.330863030978429 |
|
12719 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS6KA4 |
0.330863030978429 |
|
12720 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1237 |
0.330863030978429 |
|
12721 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC22A11 |
0.330863030978429 |
|
12722 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC22A12 |
0.330863030978429 |
|
12723 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRXN2 |
0.330863030978429 |
|
12724 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASGRP2 |
0.330863030978429 |
|
12725 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PYGM |
0.330863030978429 |
|
12726 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SF1 |
0.330863030978429 |
|
12727 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP4K2 |
0.330863030978429 |
|
12728 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEN1 |
0.330863030978429 |
|
12729 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC42BPG |
0.330863030978429 |
|
12730 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP5B1 |
0.330863030978429 |
|
12731 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL2 |
0.330863030978429 |
|
12732 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATG2A |
0.330863030978429 |
|
12733 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BATF2 |
0.330863030978429 |
|
12734 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf85 |
0.330863030978429 |
|
12735 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPN1 |
0.330863030978429 |
|
12736 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC85B |
0.330863030978429 |
|
12737 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC42EP2 |
0.330863030978429 |
|
12738 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDCA5 |
0.330863030978429 |
|
12739 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CFL1 |
0.330863030978429 |
|
12740 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTSW |
0.330863030978429 |
|
12741 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPF2 |
0.330863030978429 |
|
12742 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFEMP2 |
0.330863030978429 |
|
12743 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EHBP1L1 |
0.330863030978429 |
|
12744 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EHD1 |
0.330863030978429 |
|
12745 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM89B |
0.330863030978429 |
|
12746 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAU |
0.330863030978429 |
|
12747 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FIBP |
0.330863030978429 |
|
12748 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOSL1 |
0.330863030978429 |
|
12749 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRMD8 |
0.330863030978429 |
|
12750 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPHA2 |
0.330863030978429 |
|
12751 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KAT5 |
0.330863030978429 |
|
12752 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNK7 |
0.330863030978429 |
|
12753 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LTBP3 |
0.330863030978429 |
|
12754 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MALAT1 |
0.330863030978429 |
|
12755 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP3K11 |
0.330863030978429 |
|
12756 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR192 |
0.330863030978429 |
|
12757 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4489 |
0.330863030978429 |
|
12758 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4690 |
0.330863030978429 |
|
12759 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL49 |
0.330863030978429 |
|
12760 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUS81 |
0.330863030978429 |
|
12761 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAALADL1 |
0.330863030978429 |
|
12762 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEAT1 |
0.330863030978429 |
|
12763 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OVOL1 |
0.330863030978429 |
|
12764 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCNXL3 |
0.330863030978429 |
|
12765 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLA2 |
0.330863030978429 |
|
12766 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP2R5B |
0.330863030978429 |
|
12767 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RELA |
0.330863030978429 |
|
12768 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL114P |
0.330863030978429 |
|
12769 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL309P |
0.330863030978429 |
|
12770 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNASEH2C |
0.330863030978429 |
|
12771 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAC3D1 |
0.330863030978429 |
|
12772 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCYL1 |
0.330863030978429 |
|
12773 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIPA1 |
0.330863030978429 |
|
12774 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC22A20 |
0.330863030978429 |
|
12775 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A45 |
0.330863030978429 |
|
12776 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX15 |
0.330863030978429 |
|
12777 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX32 |
0.330863030978429 |
|
12778 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPDYC |
0.330863030978429 |
|
12779 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSSCA1 |
0.330863030978429 |
|
12780 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYVN1 |
0.330863030978429 |
|
12781 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIGD3 |
0.330863030978429 |
|
12782 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TM7SF2 |
0.330863030978429 |
|
12783 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS51 |
0.330863030978429 |
|
12784 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFPL1 |
0.330863030978429 |
|
12785 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNHIT2 |
0.330863030978429 |
|
12786 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANK3 |
0.332471950480117 |
|
12787 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKRIR |
0.334139961317902 |
|
12788 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf30 |
0.334139961317902 |
|
12789 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC32 |
0.334139961317902 |
|
12790 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GUCY2EP |
0.334139961317902 |
|
12791 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSKU |
0.334139961317902 |
|
12792 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACER3 |
0.334139961317902 |
|
12793 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B3GNT6 |
0.334139961317902 |
|
12794 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPN5 |
0.334139961317902 |
|
12795 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OMP |
0.334139961317902 |
|
12796 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00395 |
0.337228191959124 |
|
12797 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00355 |
0.337228191959124 |
|
12798 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548X2 |
0.337228191959124 |
|
12799 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4704 |
0.337228191959124 |
|
12800 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5694 |
0.341987145647467 |
|
12801 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM229B |
0.341987145647467 |
|
12802 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MARK4 |
0.342797705029421 |
|
12803 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL10L |
0.34548721240589 |
|
12804 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA25|ENSG00000251735.1 |
0.34548721240589 |
|
12805 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00648 |
0.34548721240589 |
|
12806 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548Y |
0.34548721240589 |
|
12807 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000251824.1 |
0.34548721240589 |
|
12808 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP384 |
0.34548721240589 |
|
12809 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS29 |
0.34548721240589 |
|
12810 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL1 |
0.34548721240589 |
|
12811 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRR1 |
0.34548721240589 |
|
12812 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MGAT2 |
0.34548721240589 |
|
12813 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL36AL |
0.34548721240589 |
|
12814 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAAF2 |
0.34548721240589 |
|
12815 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLE2 |
0.34548721240589 |
|
12816 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC30P |
0.34548721240589 |
|
12817 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHDC1 |
0.34548721240589 |
|
12818 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHDC2 |
0.34548721240589 |
|
12819 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEMF |
0.34548721240589 |
|
12820 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL3 |
0.34548721240589 |
|
12821 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL2 |
0.34548721240589 |
|
12822 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARF6 |
0.34548721240589 |
|
12823 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C14orf182 |
0.34548721240589 |
|
12824 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP193 |
0.34548721240589 |
|
12825 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C14orf183 |
0.34548721240589 |
|
12826 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL21D |
0.34548721240589 |
|
12827 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOS2 |
0.34548721240589 |
|
12828 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
L2HGDH |
0.34548721240589 |
|
12829 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4504 |
0.34548721240589 |
|
12830 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP5S |
0.34548721240589 |
|
12831 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDKL1 |
0.34548721240589 |
|
12832 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP4K5 |
0.34548721240589 |
|
12833 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATL1 |
0.34548721240589 |
|
12834 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAV1 |
0.34548721240589 |
|
12835 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL452P |
0.34548721240589 |
|
12836 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NIN |
0.34548721240589 |
|
12837 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU83B |
0.34548721240589 |
|
12838 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PYGL |
0.34548721240589 |
|
12839 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABHD12B |
0.34548721240589 |
|
12840 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM9 |
0.34548721240589 |
|
12841 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000201376.1 |
0.34548721240589 |
|
12842 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMX1 |
0.34548721240589 |
|
12843 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00519 |
0.34548721240589 |
|
12844 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00640 |
0.34548721240589 |
|
12845 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRMD6 |
0.34548721240589 |
|
12846 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP385 |
0.34548721240589 |
|
12847 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNG2 |
0.34548721240589 |
|
12848 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C14orf166 |
0.34548721240589 |
|
12849 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NID2 |
0.34548721240589 |
|
12850 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR606 |
0.347916919444428 |
|
12851 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf11 |
0.347916919444428 |
|
12852 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLF5 |
0.348039212317016 |
|
12853 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY1P8 |
0.348039212317016 |
|
12854 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00393 |
0.348039212317016 |
|
12855 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf223 |
0.349188282814591 |
|
12856 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNTB2 |
0.349308875887771 |
|
12857 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS4A |
0.349308875887771 |
|
12858 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COG8 |
0.349308875887771 |
|
12859 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDF |
0.349308875887771 |
|
12860 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NIP7 |
0.349308875887771 |
|
12861 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMED6 |
0.349308875887771 |
|
12862 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TERF2 |
0.349308875887771 |
|
12863 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYB5B |
0.349308875887771 |
|
12864 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1538 |
0.349308875887771 |
|
12865 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFAT5 |
0.349308875887771 |
|
12866 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NQO1 |
0.349308875887771 |
|
12867 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238683.1 |
0.349308875887771 |
|
12868 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOB1 |
0.349308875887771 |
|
12869 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WWP2 |
0.349308875887771 |
|
12870 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA62|ENSG00000252443.1 |
0.349308875887771 |
|
12871 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR140 |
0.349308875887771 |
|
12872 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC18A |
0.349308875887771 |
|
12873 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC18C |
0.349308875887771 |
|
12874 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDPR |
0.349308875887771 |
|
12875 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDXDC2P |
0.349308875887771 |
|
12876 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FKSG63 |
0.349308875887771 |
|
12877 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238734.1 |
0.349308875887771 |
|
12878 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AARS |
0.349308875887771 |
|
12879 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXOSC6 |
0.349308875887771 |
|
12880 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL407P |
0.349308875887771 |
|
12881 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL279P |
0.349308875887771 |
|
12882 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX19B |
0.349308875887771 |
|
12883 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX19A |
0.349308875887771 |
|
12884 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST3GAL2 |
0.349308875887771 |
|
12885 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FUK |
0.349308875887771 |
|
12886 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COG4 |
0.349308875887771 |
|
12887 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SF3B3 |
0.349308875887771 |
|
12888 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD111B |
0.349308875887771 |
|
12889 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD111|ENSG00000221066.1 |
0.349308875887771 |
|
12890 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL34 |
0.349308875887771 |
|
12891 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLJ00418 |
0.349308875887771 |
|
12892 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTSS1L |
0.349308875887771 |
|
12893 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VAC14 |
0.349308875887771 |
|
12894 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HYDIN |
0.349308875887771 |
|
12895 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC25P |
0.349308875887771 |
|
12896 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000251700.1 |
0.349308875887771 |
|
12897 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FTSJD1 |
0.349308875887771 |
|
12898 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CALB2 |
0.349308875887771 |
|
12899 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF23 |
0.349308875887771 |
|
12900 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF19 |
0.349308875887771 |
|
12901 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHST4 |
0.349308875887771 |
|
12902 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAT |
0.349308875887771 |
|
12903 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MARVELD3 |
0.349308875887771 |
|
12904 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHLPP2 |
0.349308875887771 |
|
12905 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70D |
0.349308875887771 |
|
12906 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP1G1 |
0.349308875887771 |
|
12907 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD71 |
0.349308875887771 |
|
12908 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATXN1L |
0.349308875887771 |
|
12909 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF821 |
0.349308875887771 |
|
12910 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IST1 |
0.349308875887771 |
|
12911 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKD1L3 |
0.349308875887771 |
|
12912 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHODH |
0.349308875887771 |
|
12913 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TXNL4B |
0.349308875887771 |
|
12914 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HPR |
0.349308875887771 |
|
12915 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HP |
0.349308875887771 |
|
12916 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PMFBP1 |
0.349308875887771 |
|
12917 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFHX3 |
0.349308875887771 |
|
12918 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCCAT5 |
0.349308875887771 |
|
12919 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf47 |
0.349308875887771 |
|
12920 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC18B |
0.349308875887771 |
|
12921 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPIPB15 |
0.349308875887771 |
|
12922 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMD7 |
0.349308875887771 |
|
12923 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLG1 |
0.349308875887771 |
|
12924 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFWD3 |
0.349308875887771 |
|
12925 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLKL |
0.349308875887771 |
|
12926 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FA2H |
0.349308875887771 |
|
12927 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR59 |
0.349308875887771 |
|
12928 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNRF1 |
0.349308875887771 |
|
12929 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LDHD |
0.349308875887771 |
|
12930 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFP1 |
0.349308875887771 |
|
12931 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTRB1 |
0.349308875887771 |
|
12932 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTRB2 |
0.349308875887771 |
|
12933 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCAR1 |
0.349308875887771 |
|
12934 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CFDP1 |
0.349308875887771 |
|
12935 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA76|ENSG00000252122.1 |
0.349308875887771 |
|
12936 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM170A |
0.349308875887771 |
|
12937 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHST6 |
0.349308875887771 |
|
12938 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHST5 |
0.349308875887771 |
|
12939 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM231 |
0.349308875887771 |
|
12940 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABARAPL2 |
0.349308875887771 |
|
12941 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAT1 |
0.349308875887771 |
|
12942 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KARS |
0.349308875887771 |
|
12943 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TERF2IP |
0.349308875887771 |
|
12944 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL520P |
0.349308875887771 |
|
12945 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP430 |
0.349308875887771 |
|
12946 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNTNAP4 |
0.349308875887771 |
|
12947 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP233 |
0.349308875887771 |
|
12948 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD33|ENSG00000252022.1 |
0.349308875887771 |
|
12949 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4719 |
0.349308875887771 |
|
12950 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MON1B |
0.349308875887771 |
|
12951 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYCE1L |
0.349308875887771 |
|
12952 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAMTS18 |
0.349308875887771 |
|
12953 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDT7 |
0.349308875887771 |
|
12954 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VAT1L |
0.349308875887771 |
|
12955 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC3A |
0.349308875887771 |
|
12956 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MDGA2 |
0.351086714324973 |
|
12957 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238702.1 |
0.354695376360049 |
|
12958 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ISL1 |
0.354695376360049 |
|
12959 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP182 |
0.354695376360049 |
|
12960 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGA1 |
0.354695376360049 |
|
12961 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PELO |
0.354695376360049 |
|
12962 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGA2 |
0.354695376360049 |
|
12963 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOCS2 |
0.354695376360049 |
|
12964 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FST |
0.354695376360049 |
|
12965 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFS4 |
0.354695376360049 |
|
12966 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR581 |
0.354695376360049 |
|
12967 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPB3 |
0.354695376360049 |
|
12968 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GHITM |
0.357666259081712 |
|
12969 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf99 |
0.357666259081712 |
|
12970 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDHR1 |
0.357666259081712 |
|
12971 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRIT2 |
0.357666259081712 |
|
12972 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRIT1 |
0.357666259081712 |
|
12973 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGR |
0.357666259081712 |
|
12974 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00858 |
0.357666259081712 |
|
12975 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCSER2 |
0.357666259081712 |
|
12976 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP84 |
0.357666259081712 |
|
12977 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRID1 |
0.357666259081712 |
|
12978 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP238 |
0.357666259081712 |
|
12979 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP322 |
0.357666259081712 |
|
12980 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR346 |
0.357666259081712 |
|
12981 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WAPAL |
0.357666259081712 |
|
12982 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OPN4 |
0.357666259081712 |
|
12983 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LDB3 |
0.357666259081712 |
|
12984 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000252189.1 |
0.357666259081712 |
|
12985 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BMPR1A |
0.357666259081712 |
|
12986 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMRN2 |
0.357666259081712 |
|
12987 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNCG |
0.357666259081712 |
|
12988 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADIRF |
0.357666259081712 |
|
12989 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGAP11 |
0.357666259081712 |
|
12990 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM25A |
0.357666259081712 |
|
12991 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLUD1 |
0.357666259081712 |
|
12992 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM35A |
0.357666259081712 |
|
12993 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00863 |
0.357666259081712 |
|
12994 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUTM2A |
0.357666259081712 |
|
12995 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUTM2D |
0.357666259081712 |
|
12996 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL733P |
0.357666259081712 |
|
12997 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCGF5 |
0.357666259081712 |
|
12998 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HECTD2 |
0.357666259081712 |
|
12999 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R3C |
0.357666259081712 |
|
13000 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNKS2 |
0.357666259081712 |
|
13001 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGFBP3 |
0.357666259081712 |
|
13002 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTAF1 |
0.357666259081712 |
|
13003 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPEB3 |
0.357666259081712 |
|
13004 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA25|ENSG00000252993.1 |
0.357666259081712 |
|
13005 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MARCH5 |
0.357666259081712 |
|
13006 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HHEX |
0.357666259081712 |
|
13007 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IDE |
0.357666259081712 |
|
13008 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF11 |
0.357666259081712 |
|
13009 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL644P |
0.357666259081712 |
|
13010 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXOC6 |
0.357666259081712 |
|
13011 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP26C1 |
0.357666259081712 |
|
13012 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP26A1 |
0.357666259081712 |
|
13013 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYOF |
0.357666259081712 |
|
13014 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP55 |
0.357666259081712 |
|
13015 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP323 |
0.357666259081712 |
|
13016 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FFAR4 |
0.357666259081712 |
|
13017 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBP4 |
0.357666259081712 |
|
13018 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE6C |
0.357666259081712 |
|
13019 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRA10AC1 |
0.357666259081712 |
|
13020 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGI1 |
0.357666259081712 |
|
13021 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35G1 |
0.357666259081712 |
|
13022 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIPSL |
0.357666259081712 |
|
13023 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLCE1 |
0.357666259081712 |
|
13024 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P26 |
0.357666259081712 |
|
13025 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOC3L |
0.357666259081712 |
|
13026 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D12 |
0.357666259081712 |
|
13027 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HELLS |
0.357666259081712 |
|
13028 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP2C18 |
0.357666259081712 |
|
13029 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP2C19 |
0.357666259081712 |
|
13030 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP2C9 |
0.357666259081712 |
|
13031 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP2C8 |
0.357666259081712 |
|
13032 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf129 |
0.357666259081712 |
|
13033 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDLIM1 |
0.357666259081712 |
|
13034 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SORBS1 |
0.357666259081712 |
|
13035 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALDH18A1 |
0.357666259081712 |
|
13036 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCTN3 |
0.357666259081712 |
|
13037 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENTPD1 |
0.357666259081712 |
|
13038 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf131 |
0.357666259081712 |
|
13039 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CC2D2B |
0.357666259081712 |
|
13040 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNJ |
0.357666259081712 |
|
13041 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3157 |
0.357666259081712 |
|
13042 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF518A |
0.357666259081712 |
|
13043 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BLNK |
0.357666259081712 |
|
13044 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNTT |
0.357666259081712 |
|
13045 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OPALIN |
0.357666259081712 |
|
13046 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLL2 |
0.357666259081712 |
|
13047 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TM9SF3 |
0.357666259081712 |
|
13048 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIK3AP1 |
0.357666259081712 |
|
13049 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP324 |
0.357666259081712 |
|
13050 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR607 |
0.357666259081712 |
|
13051 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCOR |
0.357666259081712 |
|
13052 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf12 |
0.357666259081712 |
|
13053 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLIT1 |
0.357666259081712 |
|
13054 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP19 |
0.357666259081712 |
|
13055 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRAT1 |
0.357666259081712 |
|
13056 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRAT2 |
0.357666259081712 |
|
13057 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRP12 |
0.357666259081712 |
|
13058 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGAM1 |
0.357666259081712 |
|
13059 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXOSC1 |
0.357666259081712 |
|
13060 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDHHC16 |
0.357666259081712 |
|
13061 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMS19 |
0.357666259081712 |
|
13062 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBTD1 |
0.357666259081712 |
|
13063 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD2 |
0.357666259081712 |
|
13064 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOGA1 |
0.357666259081712 |
|
13065 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PI4K2A |
0.357666259081712 |
|
13066 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf62 |
0.357666259081712 |
|
13067 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MORN4 |
0.357666259081712 |
|
13068 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AVPI1 |
0.357666259081712 |
|
13069 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MARVELD1 |
0.357666259081712 |
|
13070 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFYVE27 |
0.357666259081712 |
|
13071 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFRP5 |
0.357666259081712 |
|
13072 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00866 |
0.357666259081712 |
|
13073 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA7B |
0.357666259081712 |
|
13074 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRTAC1 |
0.357666259081712 |
|
13075 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
R3HCC1L |
0.357666259081712 |
|
13076 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LOXL4 |
0.357666259081712 |
|
13077 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PYROXD2 |
0.357666259081712 |
|
13078 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1287 |
0.357666259081712 |
|
13079 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HPS1 |
0.357666259081712 |
|
13080 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4685 |
0.357666259081712 |
|
13081 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HPSE2 |
0.357666259081712 |
|
13082 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNNM1 |
0.357666259081712 |
|
13083 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOT1 |
0.357666259081712 |
|
13084 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238588.1 |
0.357666259081712 |
|
13085 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A28 |
0.357666259081712 |
|
13086 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENTPD7 |
0.357666259081712 |
|
13087 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CUTC |
0.357666259081712 |
|
13088 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX15 |
0.357666259081712 |
|
13089 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCC2 |
0.357666259081712 |
|
13090 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNMBP |
0.357666259081712 |
|
13091 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238472.1 |
0.357666259081712 |
|
13092 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPN1 |
0.357666259081712 |
|
13093 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERLIN1 |
0.357666259081712 |
|
13094 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHUK |
0.357666259081712 |
|
13095 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CWF19L1 |
0.357666259081712 |
|
13096 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA12|ENSG00000212464.1 |
0.357666259081712 |
|
13097 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHBDF2 |
0.357736274147134 |
|
13098 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYGB |
0.357736274147134 |
|
13099 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRCD |
0.357736274147134 |
|
13100 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNHG16 |
0.357736274147134 |
|
13101 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD1B |
0.357736274147134 |
|
13102 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST6GALNAC2 |
0.357736274147134 |
|
13103 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST6GALNAC1 |
0.357736274147134 |
|
13104 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MXRA7 |
0.357736274147134 |
|
13105 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JMJD6 |
0.357736274147134 |
|
13106 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL23 |
0.357736274147134 |
|
13107 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFSD11 |
0.357736274147134 |
|
13108 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR636 |
0.357736274147134 |
|
13109 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRSF2 |
0.357736274147134 |
|
13110 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00868 |
0.357736274147134 |
|
13111 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MGAT5B |
0.357736274147134 |
|
13112 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00338 |
0.357736274147134 |
|
13113 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC14L1 |
0.357736274147134 |
|
13114 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEPT9 |
0.357736274147134 |
|
13115 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4316 |
0.357736274147134 |
|
13116 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLJ45079 |
0.357736274147134 |
|
13117 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNRC6C |
0.357736274147134 |
|
13118 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMC6 |
0.357736274147134 |
|
13119 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMC8 |
0.357736274147134 |
|
13120 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf99 |
0.357736274147134 |
|
13121 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYNGR2 |
0.357736274147134 |
|
13122 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TK1 |
0.357736274147134 |
|
13123 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AFMID |
0.357736274147134 |
|
13124 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BIRC5 |
0.357736274147134 |
|
13125 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM235 |
0.357736274147134 |
|
13126 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOCS3 |
0.357736274147134 |
|
13127 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL236P |
0.357736274147134 |
|
13128 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGS1 |
0.357736274147134 |
|
13129 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA30|ENSG00000200063.1 |
0.357736274147134 |
|
13130 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAH17 |
0.357736274147134 |
|
13131 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL454P |
0.357736274147134 |
|
13132 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYTH1 |
0.357736274147134 |
|
13133 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP36 |
0.357736274147134 |
|
13134 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIMP2 |
0.357736274147134 |
|
13135 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDC8 |
0.357736274147134 |
|
13136 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGALS3BP |
0.357736274147134 |
|
13137 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CANT1 |
0.357736274147134 |
|
13138 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1QTNF1 |
0.357736274147134 |
|
13139 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENGASE |
0.357736274147134 |
|
13140 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBFOX3 |
0.357736274147134 |
|
13141 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4739 |
0.357736274147134 |
|
13142 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239173.1 |
0.357736274147134 |
|
13143 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENPP7 |
0.357736274147134 |
|
13144 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBX2 |
0.357736274147134 |
|
13145 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBX8 |
0.357736274147134 |
|
13146 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYPD8 |
0.358773437234496 |
|
13147 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3124 |
0.358773437234496 |
|
13148 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR11L1 |
0.358773437234496 |
|
13149 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR13G1 |
0.358773437234496 |
|
13150 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR14A16 |
0.358773437234496 |
|
13151 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR14A2 |
0.358773437234496 |
|
13152 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR14C36 |
0.358773437234496 |
|
13153 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR14I1 |
0.358773437234496 |
|
13154 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR14K1 |
0.358773437234496 |
|
13155 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1C1 |
0.358773437234496 |
|
13156 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2AJ1 |
0.358773437234496 |
|
13157 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2AK2 |
0.358773437234496 |
|
13158 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2G6 |
0.358773437234496 |
|
13159 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2L13 |
0.358773437234496 |
|
13160 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2L2 |
0.358773437234496 |
|
13161 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2L3 |
0.358773437234496 |
|
13162 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2L5 |
0.358773437234496 |
|
13163 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2L8 |
0.358773437234496 |
|
13164 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2M2 |
0.358773437234496 |
|
13165 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2M3 |
0.358773437234496 |
|
13166 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2M4 |
0.358773437234496 |
|
13167 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2M5 |
0.358773437234496 |
|
13168 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2M7 |
0.358773437234496 |
|
13169 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2T10 |
0.358773437234496 |
|
13170 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2T11 |
0.358773437234496 |
|
13171 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2T12 |
0.358773437234496 |
|
13172 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2T1 |
0.358773437234496 |
|
13173 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2T27 |
0.358773437234496 |
|
13174 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2T29 |
0.358773437234496 |
|
13175 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2T2 |
0.358773437234496 |
|
13176 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2T33 |
0.358773437234496 |
|
13177 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2T34 |
0.358773437234496 |
|
13178 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2T35 |
0.358773437234496 |
|
13179 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2T3 |
0.358773437234496 |
|
13180 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2T4 |
0.358773437234496 |
|
13181 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2T5 |
0.358773437234496 |
|
13182 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2T6 |
0.358773437234496 |
|
13183 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2T7 |
0.358773437234496 |
|
13184 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2T8 |
0.358773437234496 |
|
13185 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2W3 |
0.358773437234496 |
|
13186 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6F1 |
0.358773437234496 |
|
13187 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGBD2 |
0.358773437234496 |
|
13188 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3BP5L |
0.358773437234496 |
|
13189 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM58 |
0.358773437234496 |
|
13190 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF672 |
0.358773437234496 |
|
13191 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF692 |
0.358773437234496 |
|
13192 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HERPUD1 |
0.358986384247435 |
|
13193 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CETP |
0.358986384247435 |
|
13194 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NLRC5 |
0.358986384247435 |
|
13195 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHDC4 |
0.359069565630309 |
|
13196 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC7A5 |
0.359069565630309 |
|
13197 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CA5A |
0.359069565630309 |
|
13198 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BANP |
0.359069565630309 |
|
13199 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF469 |
0.359069565630309 |
|
13200 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFPM1 |
0.359069565630309 |
|
13201 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACSF3 |
0.359069565630309 |
|
13202 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APRT |
0.359069565630309 |
|
13203 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBFA2T3 |
0.359069565630309 |
|
13204 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDH15 |
0.359069565630309 |
|
13205 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDT1 |
0.359069565630309 |
|
13206 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTU2 |
0.359069565630309 |
|
13207 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYBA |
0.359069565630309 |
|
13208 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALNS |
0.359069565630309 |
|
13209 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL17C |
0.359069565630309 |
|
13210 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00304 |
0.359069565630309 |
|
13211 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4722 |
0.359069565630309 |
|
13212 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5189 |
0.359069565630309 |
|
13213 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MVD |
0.359069565630309 |
|
13214 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PABPN1L |
0.359069565630309 |
|
13215 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIEZO1 |
0.359069565630309 |
|
13216 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF166 |
0.359069565630309 |
|
13217 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC22A31 |
0.359069565630309 |
|
13218 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNAI3 |
0.359069565630309 |
|
13219 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAPPC2L |
0.359069565630309 |
|
13220 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZC3H18 |
0.359069565630309 |
|
13221 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF778 |
0.359069565630309 |
|
13222 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD11 |
0.359069565630309 |
|
13223 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AFG3L1P |
0.359069565630309 |
|
13224 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf3 |
0.359069565630309 |
|
13225 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK10 |
0.359069565630309 |
|
13226 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CENPBD1 |
0.359069565630309 |
|
13227 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHMP1A |
0.359069565630309 |
|
13228 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPNE7 |
0.359069565630309 |
|
13229 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DBNDD1 |
0.359069565630309 |
|
13230 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEF8 |
0.359069565630309 |
|
13231 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPEP1 |
0.359069565630309 |
|
13232 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM157C |
0.359069565630309 |
|
13233 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FANCA |
0.359069565630309 |
|
13234 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAS8 |
0.359069565630309 |
|
13235 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MC1R |
0.359069565630309 |
|
13236 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRDM7 |
0.359069565630309 |
|
13237 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL13 |
0.359069565630309 |
|
13238 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD68 |
0.359069565630309 |
|
13239 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA2L |
0.359069565630309 |
|
13240 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA33 |
0.359069565630309 |
|
13241 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPG7 |
0.359069565630309 |
|
13242 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPIRE2 |
0.359069565630309 |
|
13243 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCF25 |
0.359069565630309 |
|
13244 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBB3 |
0.359069565630309 |
|
13245 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBB8P7 |
0.359069565630309 |
|
13246 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
URAHP |
0.359069565630309 |
|
13247 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS9D1 |
0.359069565630309 |
|
13248 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF276 |
0.359069565630309 |
|
13249 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL591P |
0.359954648306253 |
|
13250 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF365 |
0.359954648306253 |
|
13251 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf66 |
0.360085412214068 |
|
13252 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBWD1 |
0.360085412214068 |
|
13253 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOCK8 |
0.360085412214068 |
|
13254 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM138C |
0.360085412214068 |
|
13255 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXD4 |
0.360085412214068 |
|
13256 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KANK1 |
0.360085412214068 |
|
13257 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL412P |
0.360085412214068 |
|
13258 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DMRT1 |
0.360085412214068 |
|
13259 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DMRT2 |
0.360085412214068 |
|
13260 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DMRT3 |
0.360085412214068 |
|
13261 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP279 |
0.360085412214068 |
|
13262 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMARCA2 |
0.360085412214068 |
|
13263 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL592P |
0.360085412214068 |
|
13264 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VLDLR |
0.360085412214068 |
|
13265 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNV2 |
0.360085412214068 |
|
13266 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0020 |
0.360085412214068 |
|
13267 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CARM1P1 |
0.360085412214068 |
|
13268 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252359.1 |
0.360735502645273 |
|
13269 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMX1A |
0.360735502645273 |
|
13270 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RXRG |
0.360735502645273 |
|
13271 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC52 |
0.360735502645273 |
|
13272 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MGST3 |
0.360735502645273 |
|
13273 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALDH9A1 |
0.360735502645273 |
|
13274 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMCO1 |
0.360735502645273 |
|
13275 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UCK2 |
0.360735502645273 |
|
13276 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP64 |
0.360735502645273 |
|
13277 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM78B |
0.360735502645273 |
|
13278 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR921 |
0.360735502645273 |
|
13279 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FMO9P |
0.360735502645273 |
|
13280 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POGK |
0.360735502645273 |
|
13281 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TADA1 |
0.360735502645273 |
|
13282 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ILDR2 |
0.360735502645273 |
|
13283 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAEL |
0.360735502645273 |
|
13284 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP65 |
0.360735502645273 |
|
13285 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238325.1 |
0.360735502645273 |
|
13286 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPA33 |
0.360735502645273 |
|
13287 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUSP27 |
0.360735502645273 |
|
13288 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POU2F1 |
0.360735502645273 |
|
13289 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD247 |
0.360735502645273 |
|
13290 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CREG1 |
0.360735502645273 |
|
13291 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RCSD1 |
0.360735502645273 |
|
13292 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPZL1 |
0.360735502645273 |
|
13293 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADCY10 |
0.360735502645273 |
|
13294 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPC2 |
0.360735502645273 |
|
13295 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCAF6 |
0.360735502645273 |
|
13296 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1255B2 |
0.360735502645273 |
|
13297 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR161 |
0.360735502645273 |
|
13298 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIPRL |
0.360735502645273 |
|
13299 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFT2D2 |
0.360735502645273 |
|
13300 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD36BP1 |
0.360735502645273 |
|
13301 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBX19 |
0.360735502645273 |
|
13302 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR557 |
0.360735502645273 |
|
13303 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XCL2 |
0.360735502645273 |
|
13304 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XCL1 |
0.360735502645273 |
|
13305 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPT |
0.360735502645273 |
|
13306 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00626 |
0.360735502645273 |
|
13307 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00970 |
0.360735502645273 |
|
13308 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP66 |
0.360735502645273 |
|
13309 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP1B1 |
0.360735502645273 |
|
13310 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NME7 |
0.360735502645273 |
|
13311 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BLZF1 |
0.360735502645273 |
|
13312 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC181 |
0.360735502645273 |
|
13313 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC19A2 |
0.360735502645273 |
|
13314 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
F5 |
0.360735502645273 |
|
13315 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SELP |
0.360735502645273 |
|
13316 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf112 |
0.360735502645273 |
|
13317 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SELL |
0.360735502645273 |
|
13318 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SELE |
0.360735502645273 |
|
13319 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL18 |
0.360735502645273 |
|
13320 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCYL3 |
0.360735502645273 |
|
13321 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL333P |
0.360735502645273 |
|
13322 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIFAP3 |
0.360735502645273 |
|
13323 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL269P |
0.360735502645273 |
|
13324 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL11B |
0.360735502645273 |
|
13325 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GORAB |
0.360735502645273 |
|
13326 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRRX1 |
0.360735502645273 |
|
13327 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MROH9 |
0.360735502645273 |
|
13328 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FMO3 |
0.360735502645273 |
|
13329 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1295A |
0.360735502645273 |
|
13330 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FMO6P |
0.360735502645273 |
|
13331 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FMO2 |
0.360735502645273 |
|
13332 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FMO1 |
0.360735502645273 |
|
13333 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FMO4 |
0.360735502645273 |
|
13334 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238859.1 |
0.360735502645273 |
|
13335 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRRC2C |
0.360735502645273 |
|
13336 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL425P |
0.360735502645273 |
|
13337 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYOC |
0.360735502645273 |
|
13338 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VAMP4 |
0.360735502645273 |
|
13339 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA20|ENSG00000253060.1 |
0.360735502645273 |
|
13340 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL13 |
0.360735502645273 |
|
13341 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNM3 |
0.360735502645273 |
|
13342 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNM3OS |
0.360735502645273 |
|
13343 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR214 |
0.360735502645273 |
|
13344 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR199A2 |
0.360735502645273 |
|
13345 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252354.1 |
0.360735502645273 |
|
13346 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIGC |
0.360735502645273 |
|
13347 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf105 |
0.360735502645273 |
|
13348 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUCO |
0.360735502645273 |
|
13349 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FASLG |
0.360735502645273 |
|
13350 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFSF18 |
0.360735502645273 |
|
13351 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFSF4 |
0.360735502645273 |
|
13352 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRDX6 |
0.360735502645273 |
|
13353 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC9C2 |
0.360735502645273 |
|
13354 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD45 |
0.360735502645273 |
|
13355 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238430.1 |
0.360735502645273 |
|
13356 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL20 |
0.360735502645273 |
|
13357 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP160 |
0.360735502645273 |
|
13358 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CENPL |
0.360735502645273 |
|
13359 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DARS2 |
0.360735502645273 |
|
13360 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAS5 |
0.360735502645273 |
|
13361 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD78|ENSG00000208317.1 |
0.360735502645273 |
|
13362 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB37 |
0.360735502645273 |
|
13363 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINC1 |
0.360735502645273 |
|
13364 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP67 |
0.360735502645273 |
|
13365 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RC3H1 |
0.360735502645273 |
|
13366 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP68 |
0.360735502645273 |
|
13367 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RABGAP1L |
0.360735502645273 |
|
13368 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238872.1 |
0.360735502645273 |
|
13369 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR52 |
0.360735502645273 |
|
13370 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACYBP |
0.360735502645273 |
|
13371 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS14 |
0.360735502645273 |
|
13372 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNN |
0.360735502645273 |
|
13373 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0040 |
0.360735502645273 |
|
13374 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFWD2 |
0.360735502645273 |
|
13375 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA3 |
0.360735502645273 |
|
13376 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAPPA2 |
0.360735502645273 |
|
13377 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASTN1 |
0.360735502645273 |
|
13378 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR488 |
0.360735502645273 |
|
13379 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM5B |
0.360735502645273 |
|
13380 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC16B |
0.360735502645273 |
|
13381 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASAL2 |
0.360735502645273 |
|
13382 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00083 |
0.360735502645273 |
|
13383 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX35 |
0.360735502645273 |
|
13384 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1ORF220 |
0.360735502645273 |
|
13385 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf220 |
0.360735502645273 |
|
13386 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP69 |
0.360735502645273 |
|
13387 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4424 |
0.360735502645273 |
|
13388 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RALGPS2 |
0.360735502645273 |
|
13389 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA63|ENSG00000201791.1 |
0.360735502645273 |
|
13390 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANGPTL1 |
0.360735502645273 |
|
13391 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM20B |
0.360735502645273 |
|
13392 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOR3A |
0.360735502645273 |
|
13393 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABL2 |
0.360735502645273 |
|
13394 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA67|ENSG00000201619.1 |
0.360735502645273 |
|
13395 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA67|ENSG00000212338.1 |
0.360735502645273 |
|
13396 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOAT1 |
0.360735502645273 |
|
13397 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AXDND1 |
0.360735502645273 |
|
13398 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL374P |
0.360735502645273 |
|
13399 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPHS2 |
0.360735502645273 |
|
13400 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TDRD5 |
0.360735502645273 |
|
13401 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM163A |
0.360735502645273 |
|
13402 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOR1AIP2 |
0.360735502645273 |
|
13403 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFRG15 |
0.360735502645273 |
|
13404 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOR1AIP1 |
0.360735502645273 |
|
13405 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL230P |
0.360735502645273 |
|
13406 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP350 |
0.360735502645273 |
|
13407 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
QSOX1 |
0.360735502645273 |
|
13408 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LHX4 |
0.360735502645273 |
|
13409 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACBD6 |
0.360735502645273 |
|
13410 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3121 |
0.360735502645273 |
|
13411 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XPR1 |
0.360735502645273 |
|
13412 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U6|ENSG00000272292.1 |
0.360735502645273 |
|
13413 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1614 |
0.360735502645273 |
|
13414 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STX6 |
0.360735502645273 |
|
13415 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MR1 |
0.360735502645273 |
|
13416 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IER5 |
0.360735502645273 |
|
13417 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNA1E |
0.360735502645273 |
|
13418 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP70 |
0.360735502645273 |
|
13419 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP229 |
0.360735502645273 |
|
13420 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF648 |
0.360735502645273 |
|
13421 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLUL |
0.360735502645273 |
|
13422 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEDDM1 |
0.360735502645273 |
|
13423 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00272 |
0.360735502645273 |
|
13424 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGSL1 |
0.360735502645273 |
|
13425 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNASEL |
0.360735502645273 |
|
13426 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGS16 |
0.360735502645273 |
|
13427 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGS8 |
0.360735502645273 |
|
13428 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPL |
0.360735502645273 |
|
13429 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHX9 |
0.360735502645273 |
|
13430 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHCBP1L |
0.360735502645273 |
|
13431 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP71 |
0.360735502645273 |
|
13432 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAMC1 |
0.360735502645273 |
|
13433 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAMC2 |
0.360735502645273 |
|
13434 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NMNAT2 |
0.360735502645273 |
|
13435 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMG7 |
0.360735502645273 |
|
13436 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCF2 |
0.360735502645273 |
|
13437 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARPC5 |
0.360735502645273 |
|
13438 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGL1 |
0.360735502645273 |
|
13439 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOBEC4 |
0.360735502645273 |
|
13440 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COLGALT2 |
0.360735502645273 |
|
13441 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSEN15 |
0.360735502645273 |
|
13442 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL654P |
0.360735502645273 |
|
13443 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf21 |
0.360735502645273 |
|
13444 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252790.1 |
0.360735502645273 |
|
13445 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EDEM3 |
0.360735502645273 |
|
13446 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP72 |
0.360735502645273 |
|
13447 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF2 |
0.360735502645273 |
|
13448 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRMT1L |
0.360735502645273 |
|
13449 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SWT1 |
0.360735502645273 |
|
13450 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IVNS1ABP |
0.360735502645273 |
|
13451 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMCN1 |
0.360735502645273 |
|
13452 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRG4 |
0.360735502645273 |
|
13453 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPR |
0.360735502645273 |
|
13454 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf27 |
0.360735502645273 |
|
13455 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OCLM |
0.360735502645273 |
|
13456 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDC |
0.360735502645273 |
|
13457 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTGS2 |
0.360735502645273 |
|
13458 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLA2G4A |
0.360735502645273 |
|
13459 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP156 |
0.360735502645273 |
|
13460 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP73 |
0.360735502645273 |
|
13461 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM5C |
0.360735502645273 |
|
13462 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGS18 |
0.360735502645273 |
|
13463 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGS21 |
0.360735502645273 |
|
13464 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGS1 |
0.360735502645273 |
|
13465 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGS13 |
0.360735502645273 |
|
13466 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGS2 |
0.360735502645273 |
|
13467 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP126 |
0.360735502645273 |
|
13468 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UCHL5 |
0.360735502645273 |
|
13469 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU109|ENSG00000238754.1 |
0.360735502645273 |
|
13470 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TROVE2 |
0.360735502645273 |
|
13471 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLRX2 |
0.360735502645273 |
|
13472 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC73 |
0.360735502645273 |
|
13473 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1278 |
0.360735502645273 |
|
13474 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B3GALT2 |
0.360735502645273 |
|
13475 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000252241.1 |
0.360735502645273 |
|
13476 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNT2 |
0.360735502645273 |
|
13477 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4735 |
0.360735502645273 |
|
13478 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CFH |
0.360735502645273 |
|
13479 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CFHR1 |
0.360735502645273 |
|
13480 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CFHR2 |
0.360735502645273 |
|
13481 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CFHR3 |
0.360735502645273 |
|
13482 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CFHR4 |
0.360735502645273 |
|
13483 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CFHR5 |
0.360735502645273 |
|
13484 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
F13B |
0.360735502645273 |
|
13485 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASPM |
0.360735502645273 |
|
13486 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB41 |
0.360735502645273 |
|
13487 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRB1 |
0.360735502645273 |
|
13488 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DENND1B |
0.360735502645273 |
|
13489 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf53 |
0.360735502645273 |
|
13490 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LHX9 |
0.360735502645273 |
|
13491 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEK7 |
0.360735502645273 |
|
13492 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6V1G3 |
0.360735502645273 |
|
13493 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPRC |
0.360735502645273 |
|
13494 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR181A1HG |
0.360735502645273 |
|
13495 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR181A1 |
0.360735502645273 |
|
13496 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR181B1 |
0.360735502645273 |
|
13497 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NR5A2 |
0.360735502645273 |
|
13498 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00862 |
0.360735502645273 |
|
13499 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF281 |
0.360735502645273 |
|
13500 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF14 |
0.360735502645273 |
|
13501 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX59 |
0.360735502645273 |
|
13502 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAMSAP2 |
0.360735502645273 |
|
13503 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR25 |
0.360735502645273 |
|
13504 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf106 |
0.360735502645273 |
|
13505 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF21B |
0.360735502645273 |
|
13506 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNA1S |
0.360735502645273 |
|
13507 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASCL5 |
0.360735502645273 |
|
13508 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM9 |
0.360735502645273 |
|
13509 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGFN1 |
0.360735502645273 |
|
13510 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKP1 |
0.360735502645273 |
|
13511 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNNT2 |
0.360735502645273 |
|
13512 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAD1 |
0.360735502645273 |
|
13513 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNNI1 |
0.360735502645273 |
|
13514 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHLDA3 |
0.360735502645273 |
|
13515 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSRP1 |
0.360735502645273 |
|
13516 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS10P7 |
0.360735502645273 |
|
13517 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAV1 |
0.360735502645273 |
|
13518 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5191 |
0.360735502645273 |
|
13519 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1231 |
0.360735502645273 |
|
13520 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IPO9 |
0.360735502645273 |
|
13521 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHISA4 |
0.360735502645273 |
|
13522 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMOD1 |
0.360735502645273 |
|
13523 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIMM17A |
0.360735502645273 |
|
13524 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000206637.1 |
0.360735502645273 |
|
13525 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNPEP |
0.360735502645273 |
|
13526 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELF3 |
0.360735502645273 |
|
13527 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR37L1 |
0.360735502645273 |
|
13528 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL8A |
0.360735502645273 |
|
13529 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPN7 |
0.360735502645273 |
|
13530 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPRVP |
0.360735502645273 |
|
13531 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGR6 |
0.360735502645273 |
|
13532 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238571.1 |
0.360735502645273 |
|
13533 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239046.1 |
0.360735502645273 |
|
13534 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2T |
0.360735502645273 |
|
13535 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R12B |
0.360735502645273 |
|
13536 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U6|ENSG00000272262.1 |
0.360735502645273 |
|
13537 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000253042.1 |
0.360735502645273 |
|
13538 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYT2 |
0.360735502645273 |
|
13539 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KDM5B |
0.360735502645273 |
|
13540 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCAT6 |
0.360735502645273 |
|
13541 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RABIF |
0.360735502645273 |
|
13542 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL12 |
0.360735502645273 |
|
13543 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADIPOR1 |
0.360735502645273 |
|
13544 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYB5R1 |
0.360735502645273 |
|
13545 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM183A |
0.360735502645273 |
|
13546 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPFIA4 |
0.360735502645273 |
|
13547 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYOG |
0.360735502645273 |
|
13548 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADORA1 |
0.360735502645273 |
|
13549 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYBPH |
0.360735502645273 |
|
13550 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHI3L1 |
0.360735502645273 |
|
13551 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHIT1 |
0.360735502645273 |
|
13552 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTG2 |
0.360735502645273 |
|
13553 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FMOD |
0.360735502645273 |
|
13554 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRELP |
0.360735502645273 |
|
13555 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OPTC |
0.360735502645273 |
|
13556 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP2B4 |
0.360735502645273 |
|
13557 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA77|ENSG00000221643.1 |
0.360735502645273 |
|
13558 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAX1 |
0.360735502645273 |
|
13559 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBED6 |
0.360735502645273 |
|
13560 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZC3H11A |
0.360735502645273 |
|
13561 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNRPE |
0.360735502645273 |
|
13562 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00303 |
0.360735502645273 |
|
13563 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOX13 |
0.360735502645273 |
|
13564 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ETNK2 |
0.360735502645273 |
|
13565 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REN |
0.360735502645273 |
|
13566 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KISS1 |
0.360735502645273 |
|
13567 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLT1A |
0.360735502645273 |
|
13568 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHA6 |
0.360735502645273 |
|
13569 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R15B |
0.360735502645273 |
|
13570 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIK3C2B |
0.360735502645273 |
|
13571 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MDM4 |
0.360735502645273 |
|
13572 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP74 |
0.360735502645273 |
|
13573 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRN2 |
0.360735502645273 |
|
13574 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP75 |
0.360735502645273 |
|
13575 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA20|ENSG00000251861.1 |
0.360735502645273 |
|
13576 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFASC |
0.360735502645273 |
|
13577 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252946.1 |
0.360735502645273 |
|
13578 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNTN2 |
0.360735502645273 |
|
13579 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM81 |
0.360735502645273 |
|
13580 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBBP5 |
0.360735502645273 |
|
13581 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DSTYK |
0.360735502645273 |
|
13582 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMCC2 |
0.360735502645273 |
|
13583 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUAK2 |
0.360735502645273 |
|
13584 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHDC8A |
0.360735502645273 |
|
13585 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LEMD1 |
0.360735502645273 |
|
13586 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR135B |
0.360735502645273 |
|
13587 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK18 |
0.360735502645273 |
|
13588 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFSD4 |
0.360735502645273 |
|
13589 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELK4 |
0.360735502645273 |
|
13590 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC45A3 |
0.360735502645273 |
|
13591 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUCKS1 |
0.360735502645273 |
|
13592 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA72|ENSG00000201944.1 |
0.360735502645273 |
|
13593 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB7L1 |
0.360735502645273 |
|
13594 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC41A1 |
0.360735502645273 |
|
13595 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PM20D1 |
0.360735502645273 |
|
13596 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC26A9 |
0.360735502645273 |
|
13597 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM72A |
0.360735502645273 |
|
13598 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AVPR1B |
0.360735502645273 |
|
13599 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf186 |
0.360735502645273 |
|
13600 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD60|ENSG00000252692.1 |
0.360735502645273 |
|
13601 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTSE |
0.360735502645273 |
|
13602 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRGAP2 |
0.360735502645273 |
|
13603 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IKBKE |
0.360735502645273 |
|
13604 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf147 |
0.360735502645273 |
|
13605 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASSF5 |
0.360735502645273 |
|
13606 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF2D |
0.360735502645273 |
|
13607 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DYRK3 |
0.360735502645273 |
|
13608 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252853.1 |
0.360735502645273 |
|
13609 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPKAPK2 |
0.360735502645273 |
|
13610 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL10 |
0.360735502645273 |
|
13611 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL19 |
0.360735502645273 |
|
13612 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL20 |
0.360735502645273 |
|
13613 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL24 |
0.360735502645273 |
|
13614 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAIM3 |
0.360735502645273 |
|
13615 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIGR |
0.360735502645273 |
|
13616 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCAMR |
0.360735502645273 |
|
13617 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf116 |
0.360735502645273 |
|
13618 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238401.1 |
0.360735502645273 |
|
13619 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YOD1 |
0.360735502645273 |
|
13620 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PFKFB2 |
0.360735502645273 |
|
13621 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C4BPB |
0.360735502645273 |
|
13622 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C4BPA |
0.360735502645273 |
|
13623 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD55 |
0.360735502645273 |
|
13624 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CR2 |
0.360735502645273 |
|
13625 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CR1 |
0.360735502645273 |
|
13626 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CR1L |
0.360735502645273 |
|
13627 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD46 |
0.360735502645273 |
|
13628 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR29B2 |
0.360735502645273 |
|
13629 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR29C |
0.360735502645273 |
|
13630 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf132 |
0.360735502645273 |
|
13631 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD34 |
0.360735502645273 |
|
13632 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLXNA2 |
0.360735502645273 |
|
13633 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FH |
0.360735502645273 |
|
13634 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KMO |
0.360735502645273 |
|
13635 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OPN3 |
0.360735502645273 |
|
13636 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHML |
0.360735502645273 |
|
13637 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR64 |
0.360735502645273 |
|
13638 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXO1 |
0.360735502645273 |
|
13639 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP1LC3C |
0.360735502645273 |
|
13640 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLD5 |
0.360735502645273 |
|
13641 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP81 |
0.360735502645273 |
|
13642 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP12 |
0.360735502645273 |
|
13643 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP170 |
0.360735502645273 |
|
13644 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDCCAG8 |
0.360735502645273 |
|
13645 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4677 |
0.360735502645273 |
|
13646 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKT3 |
0.360735502645273 |
|
13647 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB18 |
0.360735502645273 |
|
13648 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL148P |
0.360735502645273 |
|
13649 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf100 |
0.360735502645273 |
|
13650 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADSS |
0.360735502645273 |
|
13651 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf101 |
0.360735502645273 |
|
13652 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DESI2 |
0.360735502645273 |
|
13653 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX20 |
0.360735502645273 |
|
13654 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPU |
0.360735502645273 |
|
13655 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP55 |
0.360735502645273 |
|
13656 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFCAB2 |
0.360735502645273 |
|
13657 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF26B |
0.360735502645273 |
|
13658 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF670 |
0.360735502645273 |
|
13659 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF695 |
0.360735502645273 |
|
13660 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF669 |
0.360735502645273 |
|
13661 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1orf229 |
0.360735502645273 |
|
13662 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF124 |
0.360735502645273 |
|
13663 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3916 |
0.360735502645273 |
|
13664 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP82 |
0.360735502645273 |
|
13665 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF496 |
0.360735502645273 |
|
13666 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NLRP3 |
0.360735502645273 |
|
13667 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2B11 |
0.360735502645273 |
|
13668 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2W5 |
0.360735502645273 |
|
13669 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCSAML |
0.360735502645273 |
|
13670 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2C3 |
0.360735502645273 |
|
13671 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2G2 |
0.360735502645273 |
|
13672 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2G3 |
0.360735502645273 |
|
13673 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALS2CR11 |
0.361984038258433 |
|
13674 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM237 |
0.361984038258433 |
|
13675 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPP4 |
0.361984038258433 |
|
13676 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALS2 |
0.361984038258433 |
|
13677 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK15 |
0.361984038258433 |
|
13678 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FZD7 |
0.361984038258433 |
|
13679 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238770.1 |
0.361984038258433 |
|
13680 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUMO1 |
0.361984038258433 |
|
13681 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOP58 |
0.361984038258433 |
|
13682 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD70|ENSG00000212534.1 |
0.361984038258433 |
|
13683 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD70|ENSG00000212309.1 |
0.361984038258433 |
|
13684 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD11B |
0.361984038258433 |
|
13685 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD11|ENSG00000238317.1 |
0.361984038258433 |
|
13686 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BMPR2 |
0.361984038258433 |
|
13687 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM117B |
0.361984038258433 |
|
13688 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ICA1L |
0.361984038258433 |
|
13689 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR12 |
0.361984038258433 |
|
13690 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CARF |
0.361984038258433 |
|
13691 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBEAL1 |
0.361984038258433 |
|
13692 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA1|ENSG00000202059.1 |
0.361984038258433 |
|
13693 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP20A1 |
0.361984038258433 |
|
13694 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL670P |
0.361984038258433 |
|
13695 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABI2 |
0.361984038258433 |
|
13696 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAPH1 |
0.361984038258433 |
|
13697 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD28 |
0.361984038258433 |
|
13698 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTLA4 |
0.361984038258433 |
|
13699 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ICOS |
0.361984038258433 |
|
13700 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARD3B |
0.361984038258433 |
|
13701 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRP2 |
0.361984038258433 |
|
13702 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP178 |
0.361984038258433 |
|
13703 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INO80D |
0.361984038258433 |
|
13704 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
Vault|ENSG00000252485.1 |
0.361984038258433 |
|
13705 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFS1 |
0.361984038258433 |
|
13706 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EEF1B2 |
0.361984038258433 |
|
13707 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA41|ENSG00000207406.1 |
0.361984038258433 |
|
13708 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD51|ENSG00000207047.2 |
0.361984038258433 |
|
13709 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR1 |
0.361984038258433 |
|
13710 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP200 |
0.361984038258433 |
|
13711 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP260 |
0.361984038258433 |
|
13712 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDBF2 |
0.361984038258433 |
|
13713 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM23 |
0.361984038258433 |
|
13714 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DYTN |
0.361984038258433 |
|
13715 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MDH1B |
0.361984038258433 |
|
13716 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FASTKD2 |
0.361984038258433 |
|
13717 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPO |
0.361984038258433 |
|
13718 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLF7 |
0.361984038258433 |
|
13719 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR2355 |
0.361984038258433 |
|
13720 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CREB1 |
0.361984038258433 |
|
13721 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL21A |
0.361984038258433 |
|
13722 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNYL1 |
0.361984038258433 |
|
13723 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4775 |
0.361984038258433 |
|
13724 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FZD5 |
0.361984038258433 |
|
13725 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHM3 |
0.361984038258433 |
|
13726 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP116 |
0.361984038258433 |
|
13727 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238582.1 |
0.361984038258433 |
|
13728 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRYGEP |
0.361984038258433 |
|
13729 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRYGD |
0.361984038258433 |
|
13730 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRYGC |
0.361984038258433 |
|
13731 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRYGB |
0.361984038258433 |
|
13732 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRYGA |
0.361984038258433 |
|
13733 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf80 |
0.361984038258433 |
|
13734 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IDH1 |
0.361984038258433 |
|
13735 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIKFYVE |
0.361984038258433 |
|
13736 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTH2R |
0.361984038258433 |
|
13737 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP117 |
0.361984038258433 |
|
13738 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP2 |
0.361984038258433 |
|
13739 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP118 |
0.361984038258433 |
|
13740 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UNC80 |
0.361984038258433 |
|
13741 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPE |
0.361984038258433 |
|
13742 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KANSL1L |
0.361984038258433 |
|
13743 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACADL |
0.361984038258433 |
|
13744 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYL1 |
0.361984038258433 |
|
13745 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LANCL1 |
0.361984038258433 |
|
13746 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD20A1 |
0.362813012430514 |
|
13747 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD20A2 |
0.362813012430514 |
|
13748 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD20A3 |
0.362813012430514 |
|
13749 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD20A4 |
0.362813012430514 |
|
13750 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBWD3 |
0.362813012430514 |
|
13751 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBWD5 |
0.362813012430514 |
|
13752 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBWD6 |
0.362813012430514 |
|
13753 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBWD7 |
0.362813012430514 |
|
13754 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNTNAP3B |
0.362813012430514 |
|
13755 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNTNAP3 |
0.362813012430514 |
|
13756 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM27A |
0.362813012430514 |
|
13757 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM27B |
0.362813012430514 |
|
13758 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM27C |
0.362813012430514 |
|
13759 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM27D1 |
0.362813012430514 |
|
13760 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM27E1 |
0.362813012430514 |
|
13761 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM27E2 |
0.362813012430514 |
|
13762 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM27E3 |
0.362813012430514 |
|
13763 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM74A1 |
0.362813012430514 |
|
13764 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM74A2 |
0.362813012430514 |
|
13765 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM74A3 |
0.362813012430514 |
|
13766 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM74A4 |
0.362813012430514 |
|
13767 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM74A5 |
0.362813012430514 |
|
13768 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM74A6 |
0.362813012430514 |
|
13769 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM95B1 |
0.362813012430514 |
|
13770 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXD4L2 |
0.362813012430514 |
|
13771 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXD4L3 |
0.362813012430514 |
|
13772 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXD4L4 |
0.362813012430514 |
|
13773 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXD4L5 |
0.362813012430514 |
|
13774 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXD4L6 |
0.362813012430514 |
|
13775 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1299 |
0.362813012430514 |
|
13776 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4477A |
0.362813012430514 |
|
13777 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGM5P2 |
0.362813012430514 |
|
13778 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGM5 |
0.362813012430514 |
|
13779 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL343P |
0.362813012430514 |
|
13780 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL422P |
0.362813012430514 |
|
13781 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL462P |
0.362813012430514 |
|
13782 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL544P |
0.362813012430514 |
|
13783 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL565P |
0.362813012430514 |
|
13784 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL640P |
0.362813012430514 |
|
13785 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL722P |
0.362813012430514 |
|
13786 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL763P |
0.362813012430514 |
|
13787 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL787P |
0.362813012430514 |
|
13788 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP283 |
0.362813012430514 |
|
13789 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP284 |
0.362813012430514 |
|
13790 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000252133.1 |
0.362813012430514 |
|
13791 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000252617.1 |
0.362813012430514 |
|
13792 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000252724.1 |
0.362813012430514 |
|
13793 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000252878.1 |
0.362813012430514 |
|
13794 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA31A1 |
0.362813012430514 |
|
13795 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA31A2 |
0.362813012430514 |
|
13796 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA31A3 |
0.362813012430514 |
|
13797 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA31A4 |
0.362813012430514 |
|
13798 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA31A5 |
0.362813012430514 |
|
13799 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA31A6 |
0.362813012430514 |
|
13800 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA31A7 |
0.362813012430514 |
|
13801 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF658 |
0.362813012430514 |
|
13802 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM181A |
0.364816702712445 |
|
13803 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASB2 |
0.364816702712445 |
|
13804 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4506 |
0.364816702712445 |
|
13805 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00521 |
0.364816702712445 |
|
13806 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OTUB2 |
0.364816702712445 |
|
13807 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX24 |
0.364816702712445 |
|
13808 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFI27L1 |
0.364816702712445 |
|
13809 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFI27 |
0.364816702712445 |
|
13810 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFI27L2 |
0.364816702712445 |
|
13811 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP4R4 |
0.364816702712445 |
|
13812 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINA10 |
0.364816702712445 |
|
13813 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINA6 |
0.364816702712445 |
|
13814 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINA1 |
0.364816702712445 |
|
13815 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINA11 |
0.364816702712445 |
|
13816 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINA9 |
0.364816702712445 |
|
13817 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINA12 |
0.364816702712445 |
|
13818 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINA4 |
0.364816702712445 |
|
13819 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINA5 |
0.364816702712445 |
|
13820 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINA3 |
0.364816702712445 |
|
13821 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINA13P |
0.364816702712445 |
|
13822 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSC |
0.364816702712445 |
|
13823 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DICER1 |
0.364816702712445 |
|
13824 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3173 |
0.364816702712445 |
|
13825 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLMN |
0.364816702712445 |
|
13826 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00341 |
0.364816702712445 |
|
13827 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYNE3 |
0.364816702712445 |
|
13828 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNHG10 |
0.364816702712445 |
|
13829 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA13 |
0.364816702712445 |
|
13830 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLRX5 |
0.364816702712445 |
|
13831 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCL6 |
0.364816702712445 |
|
13832 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCL1B |
0.364816702712445 |
|
13833 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCL1A |
0.364816702712445 |
|
13834 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00617 |
0.364816702712445 |
|
13835 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C14orf132 |
0.364816702712445 |
|
13836 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BDKRB2 |
0.364816702712445 |
|
13837 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BDKRB1 |
0.364816702712445 |
|
13838 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DKFZP434O1614 |
0.364816702712445 |
|
13839 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATG2B |
0.364816702712445 |
|
13840 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238776.1 |
0.364816702712445 |
|
13841 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSKIP |
0.364816702712445 |
|
13842 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AK7 |
0.364816702712445 |
|
13843 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAPOLA |
0.364816702712445 |
|
13844 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP108 |
0.364816702712445 |
|
13845 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VRK1 |
0.364816702712445 |
|
13846 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00618 |
0.364816702712445 |
|
13847 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL710P |
0.364816702712445 |
|
13848 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C14orf64 |
0.364816702712445 |
|
13849 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL714P |
0.364816702712445 |
|
13850 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C14orf177 |
0.364816702712445 |
|
13851 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCL11B |
0.364816702712445 |
|
13852 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SETD3 |
0.364816702712445 |
|
13853 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U6|ENSG00000272439.1 |
0.364816702712445 |
|
13854 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNK |
0.364816702712445 |
|
13855 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC85C |
0.364816702712445 |
|
13856 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HHIPL1 |
0.364816702712445 |
|
13857 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP46A1 |
0.364816702712445 |
|
13858 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EML1 |
0.364816702712445 |
|
13859 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EVL |
0.364816702712445 |
|
13860 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR151B |
0.364816702712445 |
|
13861 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR342 |
0.364816702712445 |
|
13862 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEGS2 |
0.364816702712445 |
|
13863 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YY1 |
0.364816702712445 |
|
13864 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A29 |
0.364816702712445 |
|
13865 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR345 |
0.364816702712445 |
|
13866 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL523P |
0.364816702712445 |
|
13867 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A47 |
0.364816702712445 |
|
13868 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WARS |
0.364816702712445 |
|
13869 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR25 |
0.364816702712445 |
|
13870 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP92 |
0.364816702712445 |
|
13871 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BEGAIN |
0.364816702712445 |
|
13872 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00523 |
0.364816702712445 |
|
13873 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLK1 |
0.364816702712445 |
|
13874 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEG3 |
0.364816702712445 |
|
13875 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR2392 |
0.364816702712445 |
|
13876 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR770 |
0.364816702712445 |
|
13877 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR493 |
0.364816702712445 |
|
13878 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR337 |
0.364816702712445 |
|
13879 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR431 |
0.364816702712445 |
|
13880 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR433 |
0.364816702712445 |
|
13881 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR665 |
0.364816702712445 |
|
13882 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RTL1 |
0.364816702712445 |
|
13883 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR127 |
0.364816702712445 |
|
13884 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR136 |
0.364816702712445 |
|
13885 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR432 |
0.364816702712445 |
|
13886 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEG8 |
0.364816702712445 |
|
13887 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR370 |
0.364816702712445 |
|
13888 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000251769.1 |
0.364816702712445 |
|
13889 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252873.1 |
0.364816702712445 |
|
13890 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000251949.1 |
0.364816702712445 |
|
13891 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252144.1 |
0.364816702712445 |
|
13892 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000251918.1 |
0.364816702712445 |
|
13893 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD113|ENSG00000200150.1 |
0.364816702712445 |
|
13894 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD113|ENSG00000201036.1 |
0.364816702712445 |
|
13895 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD113|ENSG00000201500.1 |
0.364816702712445 |
|
13896 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD113|ENSG00000201710.1 |
0.364816702712445 |
|
13897 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD113|ENSG00000222095.1 |
0.364816702712445 |
|
13898 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252009.1 |
0.364816702712445 |
|
13899 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD113|ENSG00000222185.1 |
0.364816702712445 |
|
13900 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR379 |
0.364816702712445 |
|
13901 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR411 |
0.364816702712445 |
|
13902 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR299 |
0.364816702712445 |
|
13903 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR380 |
0.364816702712445 |
|
13904 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1197 |
0.364816702712445 |
|
13905 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR323A |
0.364816702712445 |
|
13906 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR758 |
0.364816702712445 |
|
13907 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1193 |
0.364816702712445 |
|
13908 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR494 |
0.364816702712445 |
|
13909 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR495 |
0.364816702712445 |
|
13910 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR543 |
0.364816702712445 |
|
13911 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR300 |
0.364816702712445 |
|
13912 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR376A1 |
0.364816702712445 |
|
13913 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR376C |
0.364816702712445 |
|
13914 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR654 |
0.364816702712445 |
|
13915 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR381HG |
0.364816702712445 |
|
13916 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR381 |
0.364816702712445 |
|
13917 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR487B |
0.364816702712445 |
|
13918 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR539 |
0.364816702712445 |
|
13919 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR889 |
0.364816702712445 |
|
13920 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR544A |
0.364816702712445 |
|
13921 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR655 |
0.364816702712445 |
|
13922 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR487A |
0.364816702712445 |
|
13923 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR134 |
0.364816702712445 |
|
13924 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR382 |
0.364816702712445 |
|
13925 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR485 |
0.364816702712445 |
|
13926 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR323B |
0.364816702712445 |
|
13927 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR154 |
0.364816702712445 |
|
13928 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR377 |
0.364816702712445 |
|
13929 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR496 |
0.364816702712445 |
|
13930 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR369 |
0.364816702712445 |
|
13931 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR409 |
0.364816702712445 |
|
13932 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR410 |
0.364816702712445 |
|
13933 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR412 |
0.364816702712445 |
|
13934 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR541 |
0.364816702712445 |
|
13935 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR656 |
0.364816702712445 |
|
13936 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEG9 |
0.364816702712445 |
|
13937 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000206761.1 |
0.364816702712445 |
|
13938 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00524 |
0.364816702712445 |
|
13939 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DIO3OS |
0.364816702712445 |
|
13940 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DIO3 |
0.364816702712445 |
|
13941 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP2R5C |
0.364816702712445 |
|
13942 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DYNC1H1 |
0.364816702712445 |
|
13943 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL472P |
0.364816702712445 |
|
13944 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSP90AA1 |
0.364816702712445 |
|
13945 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR20 |
0.364816702712445 |
|
13946 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOK |
0.364816702712445 |
|
13947 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF839 |
0.364816702712445 |
|
13948 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CINP |
0.364816702712445 |
|
13949 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239061.1 |
0.364816702712445 |
|
13950 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TECPR2 |
0.364816702712445 |
|
13951 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD9 |
0.364816702712445 |
|
13952 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4309 |
0.364816702712445 |
|
13953 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL546P |
0.364816702712445 |
|
13954 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RCOR1 |
0.364816702712445 |
|
13955 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAF3 |
0.364816702712445 |
|
13956 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238853.1 |
0.364816702712445 |
|
13957 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMN |
0.364816702712445 |
|
13958 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC42BPB |
0.364816702712445 |
|
13959 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXOC3L4 |
0.364816702712445 |
|
13960 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00677 |
0.364816702712445 |
|
13961 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFAIP2 |
0.364816702712445 |
|
13962 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00605 |
0.364816702712445 |
|
13963 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF5 |
0.364816702712445 |
|
13964 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA28 |
0.364816702712445 |
|
13965 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MARK3 |
0.364816702712445 |
|
13966 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CKB |
0.364816702712445 |
|
13967 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRMT61A |
0.364816702712445 |
|
13968 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAG5 |
0.364816702712445 |
|
13969 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLC1 |
0.364816702712445 |
|
13970 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOPT1 |
0.364816702712445 |
|
13971 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XRCC3 |
0.364816702712445 |
|
13972 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFYVE21 |
0.364816702712445 |
|
13973 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R13B |
0.364816702712445 |
|
13974 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD51|ENSG00000202275.1 |
0.364816702712445 |
|
13975 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00637 |
0.364816702712445 |
|
13976 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C14orf2 |
0.364816702712445 |
|
13977 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TDRD9 |
0.364816702712445 |
|
13978 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RD3L |
0.364816702712445 |
|
13979 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL634P |
0.364816702712445 |
|
13980 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASPG |
0.364816702712445 |
|
13981 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR203 |
0.364816702712445 |
|
13982 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF26A |
0.364816702712445 |
|
13983 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C14orf144 |
0.364816702712445 |
|
13984 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM179 |
0.364816702712445 |
|
13985 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C14orf180 |
0.364816702712445 |
|
13986 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4710 |
0.364816702712445 |
|
13987 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INF2 |
0.364816702712445 |
|
13988 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADSSL1 |
0.364816702712445 |
|
13989 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIVA1 |
0.364816702712445 |
|
13990 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKT1 |
0.364816702712445 |
|
13991 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB42 |
0.364816702712445 |
|
13992 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00638 |
0.364816702712445 |
|
13993 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP170B |
0.364816702712445 |
|
13994 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLD4 |
0.364816702712445 |
|
13995 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AHNAK2 |
0.364816702712445 |
|
13996 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C14orf79 |
0.364816702712445 |
|
13997 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDCA4 |
0.364816702712445 |
|
13998 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR132 |
0.364816702712445 |
|
13999 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JAG2 |
0.364816702712445 |
|
14000 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDT14 |
0.364816702712445 |
|
14001 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRF1 |
0.364816702712445 |
|
14002 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTBD6 |
0.364816702712445 |
|
14003 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PACS2 |
0.364816702712445 |
|
14004 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX22 |
0.364816702712445 |
|
14005 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTA1 |
0.364816702712445 |
|
14006 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRIP2 |
0.364816702712445 |
|
14007 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT81 |
0.366607038615548 |
|
14008 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT83 |
0.366607038615548 |
|
14009 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT84 |
0.366607038615548 |
|
14010 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT85 |
0.366607038615548 |
|
14011 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT82 |
0.366607038615548 |
|
14012 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT6B |
0.366607038615548 |
|
14013 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT6C |
0.366607038615548 |
|
14014 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT75 |
0.366607038615548 |
|
14015 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT6A |
0.366607038615548 |
|
14016 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT5 |
0.366607038615548 |
|
14017 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT71 |
0.366607038615548 |
|
14018 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT74 |
0.366607038615548 |
|
14019 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT72 |
0.366607038615548 |
|
14020 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT73 |
0.366607038615548 |
|
14021 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT2 |
0.366607038615548 |
|
14022 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT1 |
0.366607038615548 |
|
14023 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT77 |
0.366607038615548 |
|
14024 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT76 |
0.366607038615548 |
|
14025 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT3 |
0.366607038615548 |
|
14026 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT4 |
0.366607038615548 |
|
14027 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT79 |
0.366607038615548 |
|
14028 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT78 |
0.366607038615548 |
|
14029 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT8 |
0.366607038615548 |
|
14030 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT18 |
0.366607038615548 |
|
14031 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF4B |
0.366607038615548 |
|
14032 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGFBP6 |
0.366607038615548 |
|
14033 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOAT2 |
0.366607038615548 |
|
14034 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPRYD3 |
0.366607038615548 |
|
14035 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TENC1 |
0.366607038615548 |
|
14036 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSAD |
0.366607038615548 |
|
14037 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF740 |
0.366607038615548 |
|
14038 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGB7 |
0.366607038615548 |
|
14039 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RARG |
0.366607038615548 |
|
14040 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFSD5 |
0.366607038615548 |
|
14041 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ESPL1 |
0.366607038615548 |
|
14042 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PFDN5 |
0.366607038615548 |
|
14043 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf10 |
0.366607038615548 |
|
14044 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AAAS |
0.366607038615548 |
|
14045 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SP7 |
0.366607038615548 |
|
14046 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SP1 |
0.366607038615548 |
|
14047 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMHR2 |
0.366607038615548 |
|
14048 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCBP2 |
0.366607038615548 |
|
14049 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR13 |
0.366607038615548 |
|
14050 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP3K12 |
0.366607038615548 |
|
14051 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TARBP2 |
0.366607038615548 |
|
14052 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPFF |
0.366607038615548 |
|
14053 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATF7 |
0.366607038615548 |
|
14054 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP5G2 |
0.366607038615548 |
|
14055 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CALCOCO1 |
0.366607038615548 |
|
14056 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD81|ENSG00000223213.1 |
0.366607038615548 |
|
14057 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP289 |
0.366607038615548 |
|
14058 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXC13 |
0.366607038615548 |
|
14059 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXC12 |
0.366607038615548 |
|
14060 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOTAIR |
0.366607038615548 |
|
14061 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXC11 |
0.366607038615548 |
|
14062 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXC10 |
0.366607038615548 |
|
14063 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXC5 |
0.366607038615548 |
|
14064 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXC6 |
0.366607038615548 |
|
14065 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR196A2 |
0.366607038615548 |
|
14066 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXC9 |
0.366607038615548 |
|
14067 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXC8 |
0.366607038615548 |
|
14068 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOXC4 |
0.366607038615548 |
|
14069 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR615 |
0.366607038615548 |
|
14070 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMUG1 |
0.366607038615548 |
|
14071 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBX5 |
0.366607038615548 |
|
14072 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL390P |
0.366607038615548 |
|
14073 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPA1 |
0.366607038615548 |
|
14074 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFE2 |
0.366607038615548 |
|
14075 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COPZ1 |
0.366607038615548 |
|
14076 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR148B |
0.366607038615548 |
|
14077 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL744P |
0.366607038615548 |
|
14078 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR84 |
0.366607038615548 |
|
14079 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF385A |
0.366607038615548 |
|
14080 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGA5 |
0.366607038615548 |
|
14081 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTSF1 |
0.366607038615548 |
|
14082 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCKAP1L |
0.366607038615548 |
|
14083 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE1B |
0.366607038615548 |
|
14084 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R1A |
0.366607038615548 |
|
14085 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLYCAM1 |
0.366607038615548 |
|
14086 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LACRT |
0.366607038615548 |
|
14087 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLTSCR1 |
0.367078685140185 |
|
14088 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EHD2 |
0.367078685140185 |
|
14089 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLTSCR2 |
0.367078685140185 |
|
14090 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD23|ENSG00000221803.1 |
0.367078685140185 |
|
14091 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEPW1 |
0.367078685140185 |
|
14092 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPRX1 |
0.367078685140185 |
|
14093 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRX |
0.367078685140185 |
|
14094 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPRX2P |
0.367078685140185 |
|
14095 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SULT2A1 |
0.367078685140185 |
|
14096 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALDH16A1 |
0.367078685140185 |
|
14097 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLT3LG |
0.367078685140185 |
|
14098 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL13A |
0.367078685140185 |
|
14099 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD32A |
0.367078685140185 |
|
14100 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD33|ENSG00000199631.1 |
0.367078685140185 |
|
14101 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD34 |
0.367078685140185 |
|
14102 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD35A |
0.367078685140185 |
|
14103 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS11 |
0.367078685140185 |
|
14104 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD35B |
0.367078685140185 |
|
14105 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCGRT |
0.367078685140185 |
|
14106 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR150 |
0.367078685140185 |
|
14107 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RCN3 |
0.367078685140185 |
|
14108 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOSIP |
0.367078685140185 |
|
14109 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRRG2 |
0.367078685140185 |
|
14110 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR12 |
0.367078685140185 |
|
14111 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRAS |
0.367078685140185 |
|
14112 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCAF1 |
0.367078685140185 |
|
14113 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADM5 |
0.367078685140185 |
|
14114 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCL2L12 |
0.367078685140185 |
|
14115 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPT1C |
0.367078685140185 |
|
14116 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRF3 |
0.367078685140185 |
|
14117 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5088 |
0.367078685140185 |
|
14118 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRMT1 |
0.367078685140185 |
|
14119 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00871 |
0.367328911311815 |
|
14120 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00635 |
0.368932107029096 |
|
14121 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00636 |
0.368932107029096 |
|
14122 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1524 |
0.368932107029096 |
|
14123 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000202379.1 |
0.368932107029096 |
|
14124 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DZIP3 |
0.368932107029096 |
|
14125 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RETNLB |
0.368932107029096 |
|
14126 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAT1 |
0.368932107029096 |
|
14127 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPPA2 |
0.368932107029096 |
|
14128 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GUCA1C |
0.368932107029096 |
|
14129 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00488 |
0.368932107029096 |
|
14130 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MORC1 |
0.368932107029096 |
|
14131 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000221633.1 |
0.368932107029096 |
|
14132 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPPA4 |
0.368932107029096 |
|
14133 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4445 |
0.368932107029096 |
|
14134 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC15P |
0.368932107029096 |
|
14135 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PVRL3 |
0.368932107029096 |
|
14136 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD96 |
0.368932107029096 |
|
14137 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBED2 |
0.368932107029096 |
|
14138 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLCXD2 |
0.368932107029096 |
|
14139 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHLDB2 |
0.368932107029096 |
|
14140 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABHD10 |
0.368932107029096 |
|
14141 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAGLN3 |
0.368932107029096 |
|
14142 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMPRSS7 |
0.368932107029096 |
|
14143 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf52 |
0.368932107029096 |
|
14144 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR567 |
0.368932107029096 |
|
14145 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCSAM |
0.368932107029096 |
|
14146 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC9C1 |
0.368932107029096 |
|
14147 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD200 |
0.368932107029096 |
|
14148 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTLA |
0.368932107029096 |
|
14149 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATG3 |
0.368932107029096 |
|
14150 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35A5 |
0.368932107029096 |
|
14151 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC80 |
0.368932107029096 |
|
14152 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD200R1L |
0.368932107029096 |
|
14153 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD200R1 |
0.368932107029096 |
|
14154 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTPBP8 |
0.368932107029096 |
|
14155 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf17 |
0.368932107029096 |
|
14156 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000253076.1 |
0.368932107029096 |
|
14157 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BOC |
0.368932107029096 |
|
14158 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR52 |
0.368932107029096 |
|
14159 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPICE1 |
0.368932107029096 |
|
14160 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIDT1 |
0.368932107029096 |
|
14161 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4446 |
0.368932107029096 |
|
14162 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL767P |
0.368932107029096 |
|
14163 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA2018 |
0.368932107029096 |
|
14164 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAA50 |
0.368932107029096 |
|
14165 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6V1A |
0.368932107029096 |
|
14166 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRAMD1C |
0.368932107029096 |
|
14167 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDHHC23 |
0.368932107029096 |
|
14168 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1407 |
0.368932107029096 |
|
14169 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
QTRTD1 |
0.368932107029096 |
|
14170 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DRD3 |
0.368932107029096 |
|
14171 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF80 |
0.368932107029096 |
|
14172 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIGIT |
0.368932107029096 |
|
14173 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR568 |
0.368932107029096 |
|
14174 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4796 |
0.368932107029096 |
|
14175 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAP43 |
0.368932107029096 |
|
14176 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LSAMP |
0.368932107029096 |
|
14177 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL815P |
0.368932107029096 |
|
14178 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00903 |
0.368932107029096 |
|
14179 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL582P |
0.368932107029096 |
|
14180 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUSC7 |
0.368932107029096 |
|
14181 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4447 |
0.368932107029096 |
|
14182 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00901 |
0.368932107029096 |
|
14183 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGSF11 |
0.368932107029096 |
|
14184 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf30 |
0.368932107029096 |
|
14185 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UPK1B |
0.368932107029096 |
|
14186 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B4GALT4 |
0.368932107029096 |
|
14187 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP31 |
0.368932107029096 |
|
14188 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM39A |
0.368932107029096 |
|
14189 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POGLUT1 |
0.368932107029096 |
|
14190 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIMMDC1 |
0.368932107029096 |
|
14191 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD80 |
0.368932107029096 |
|
14192 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADPRH |
0.368932107029096 |
|
14193 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLA1A |
0.368932107029096 |
|
14194 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POPDC2 |
0.368932107029096 |
|
14195 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX17 |
0.368932107029096 |
|
14196 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAATS1 |
0.368932107029096 |
|
14197 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NR1I2 |
0.368932107029096 |
|
14198 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSK3B |
0.368932107029096 |
|
14199 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL762P |
0.368932107029096 |
|
14200 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL397P |
0.368932107029096 |
|
14201 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR156 |
0.368932107029096 |
|
14202 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC58 |
0.368932107029096 |
|
14203 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FSTL1 |
0.368932107029096 |
|
14204 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFB4 |
0.368932107029096 |
|
14205 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HGD |
0.368932107029096 |
|
14206 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RABL3 |
0.368932107029096 |
|
14207 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF2E1 |
0.368932107029096 |
|
14208 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STXBP5L |
0.368932107029096 |
|
14209 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5682 |
0.368932107029096 |
|
14210 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLQ |
0.368932107029096 |
|
14211 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARGFX |
0.368932107029096 |
|
14212 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO40 |
0.368932107029096 |
|
14213 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGB1 |
0.368932107029096 |
|
14214 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCLS1 |
0.368932107029096 |
|
14215 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL172P |
0.368932107029096 |
|
14216 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238670.1 |
0.368932107029096 |
|
14217 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ILDR1 |
0.368932107029096 |
|
14218 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD86 |
0.368932107029096 |
|
14219 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASR |
0.368932107029096 |
|
14220 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252170.1 |
0.368932107029096 |
|
14221 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSTA |
0.368932107029096 |
|
14222 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC58 |
0.368932107029096 |
|
14223 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM162A |
0.368932107029096 |
|
14224 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR5B |
0.368932107029096 |
|
14225 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KPNA1 |
0.368932107029096 |
|
14226 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARP9 |
0.368932107029096 |
|
14227 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DTX3L |
0.368932107029096 |
|
14228 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARP15 |
0.368932107029096 |
|
14229 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARP14 |
0.368932107029096 |
|
14230 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPBAP1 |
0.368932107029096 |
|
14231 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238480.1 |
0.368932107029096 |
|
14232 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DIRC2 |
0.368932107029096 |
|
14233 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEMA5B |
0.368932107029096 |
|
14234 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDIA5 |
0.368932107029096 |
|
14235 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC22A |
0.368932107029096 |
|
14236 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHCBP1 |
0.368992884147369 |
|
14237 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS35 |
0.368992884147369 |
|
14238 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ORC6 |
0.368992884147369 |
|
14239 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYLK3 |
0.368992884147369 |
|
14240 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf87 |
0.368992884147369 |
|
14241 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPT2 |
0.368992884147369 |
|
14242 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJA2 |
0.368992884147369 |
|
14243 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NETO2 |
0.368992884147369 |
|
14244 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238834.1 |
0.368992884147369 |
|
14245 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCC12 |
0.368992884147369 |
|
14246 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCC11 |
0.368992884147369 |
|
14247 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LONP2 |
0.368992884147369 |
|
14248 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIAH1 |
0.368992884147369 |
|
14249 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL54P |
0.368992884147369 |
|
14250 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239013.1 |
0.368992884147369 |
|
14251 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
N4BP1 |
0.368992884147369 |
|
14252 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239038.1 |
0.368992884147369 |
|
14253 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBLN1 |
0.368992884147369 |
|
14254 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf78 |
0.368992884147369 |
|
14255 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF423 |
0.368992884147369 |
|
14256 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNEP1R1 |
0.368992884147369 |
|
14257 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HEATR3 |
0.368992884147369 |
|
14258 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P3 |
0.368992884147369 |
|
14259 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000252526.1 |
0.368992884147369 |
|
14260 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAPD5 |
0.368992884147369 |
|
14261 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADCY7 |
0.368992884147369 |
|
14262 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRD7 |
0.368992884147369 |
|
14263 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238544.1 |
0.368992884147369 |
|
14264 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252077.1 |
0.368992884147369 |
|
14265 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NKD1 |
0.368992884147369 |
|
14266 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX20 |
0.368992884147369 |
|
14267 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOD2 |
0.368992884147369 |
|
14268 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYLD |
0.368992884147369 |
|
14269 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP426 |
0.368992884147369 |
|
14270 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SALL1 |
0.368992884147369 |
|
14271 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPA1P48 |
0.368992884147369 |
|
14272 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP142 |
0.368992884147369 |
|
14273 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf97 |
0.368992884147369 |
|
14274 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00919 |
0.368992884147369 |
|
14275 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOX3 |
0.368992884147369 |
|
14276 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASC16 |
0.368992884147369 |
|
14277 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP427 |
0.368992884147369 |
|
14278 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238645.1 |
0.368992884147369 |
|
14279 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBL2 |
0.368992884147369 |
|
14280 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKTIP |
0.368992884147369 |
|
14281 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPGRIP1L |
0.368992884147369 |
|
14282 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FTO |
0.368992884147369 |
|
14283 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRX3 |
0.368992884147369 |
|
14284 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRNDE |
0.368992884147369 |
|
14285 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRX5 |
0.368992884147369 |
|
14286 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFCAB1 |
0.369547863775743 |
|
14287 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNAI2 |
0.369547863775743 |
|
14288 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C8orf22 |
0.369547863775743 |
|
14289 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYO1D |
0.372381473064544 |
|
14290 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOMM40 |
0.372588288704616 |
|
14291 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOE |
0.372588288704616 |
|
14292 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOC1 |
0.372588288704616 |
|
14293 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOC1P1 |
0.372588288704616 |
|
14294 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOC4 |
0.372588288704616 |
|
14295 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOC2 |
0.372588288704616 |
|
14296 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLPTM1 |
0.372588288704616 |
|
14297 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL356P |
0.373150749399962 |
|
14298 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRF2BPL |
0.373150749399962 |
|
14299 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1737 |
0.373150749399962 |
|
14300 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM63C |
0.373150749399962 |
|
14301 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDHHC22 |
0.373150749399962 |
|
14302 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA32|ENSG00000201384.1 |
0.373150749399962 |
|
14303 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1260A |
0.373150749399962 |
|
14304 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NGB |
0.373150749399962 |
|
14305 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POMT2 |
0.373150749399962 |
|
14306 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSTZ1 |
0.373150749399962 |
|
14307 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMED8 |
0.373150749399962 |
|
14308 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL137P |
0.373150749399962 |
|
14309 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAMD15 |
0.373150749399962 |
|
14310 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOXRED1 |
0.373150749399962 |
|
14311 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FKSG61 |
0.373150749399962 |
|
14312 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VIPAS39 |
0.373150749399962 |
|
14313 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AHSA1 |
0.373150749399962 |
|
14314 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA46|ENSG00000212371.1 |
0.373150749399962 |
|
14315 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ISM2 |
0.373150749399962 |
|
14316 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPTLC2 |
0.373150749399962 |
|
14317 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL587P |
0.373150749399962 |
|
14318 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALKBH1 |
0.373150749399962 |
|
14319 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLIRP |
0.373150749399962 |
|
14320 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNW1 |
0.373150749399962 |
|
14321 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C14orf178 |
0.373150749399962 |
|
14322 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADCK1 |
0.373150749399962 |
|
14323 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP388 |
0.373150749399962 |
|
14324 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRXN3 |
0.373150749399962 |
|
14325 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DIO2 |
0.373150749399962 |
|
14326 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP128 |
0.373150749399962 |
|
14327 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C14orf80 |
0.373150749399962 |
|
14328 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRIP1 |
0.373150749399962 |
|
14329 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM6 |
0.373150749399962 |
|
14330 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGHA1 |
0.373150749399962 |
|
14331 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGHA2 |
0.373150749399962 |
|
14332 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGHD |
0.373150749399962 |
|
14333 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGHE |
0.373150749399962 |
|
14334 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGHG1 |
0.373150749399962 |
|
14335 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGHG2 |
0.373150749399962 |
|
14336 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGHG3 |
0.373150749399962 |
|
14337 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGHG4 |
0.373150749399962 |
|
14338 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGHJ1 |
0.373150749399962 |
|
14339 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGHJ2 |
0.373150749399962 |
|
14340 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGHJ3 |
0.373150749399962 |
|
14341 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGHJ4 |
0.373150749399962 |
|
14342 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGHJ5 |
0.373150749399962 |
|
14343 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGHJ6 |
0.373150749399962 |
|
14344 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGHM |
0.373150749399962 |
|
14345 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0125 |
0.373150749399962 |
|
14346 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00221 |
0.373150749399962 |
|
14347 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00226 |
0.373150749399962 |
|
14348 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP389 |
0.373150749399962 |
|
14349 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM121 |
0.373150749399962 |
|
14350 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNNM3 |
0.374610192541889 |
|
14351 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD23 |
0.374610192541889 |
|
14352 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD39 |
0.374610192541889 |
|
14353 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEMA4C |
0.374610192541889 |
|
14354 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM178B |
0.374610192541889 |
|
14355 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NKPD1 |
0.376747052267868 |
|
14356 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAPPC6A |
0.376747052267868 |
|
14357 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BLOC1S3 |
0.376747052267868 |
|
14358 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CKM |
0.376747052267868 |
|
14359 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD3EAP |
0.376747052267868 |
|
14360 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERCC1 |
0.376747052267868 |
|
14361 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERCC2 |
0.376747052267868 |
|
14362 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLC3 |
0.376747052267868 |
|
14363 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R13L |
0.376747052267868 |
|
14364 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOSB |
0.376747052267868 |
|
14365 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RTN2 |
0.376747052267868 |
|
14366 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPM1N |
0.376747052267868 |
|
14367 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VASP |
0.376747052267868 |
|
14368 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OPA3 |
0.376747052267868 |
|
14369 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR4 |
0.376747052267868 |
|
14370 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EML2 |
0.376747052267868 |
|
14371 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR330 |
0.376747052267868 |
|
14372 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL836P |
0.376747052267868 |
|
14373 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GIPR |
0.376747052267868 |
|
14374 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR642A |
0.376747052267868 |
|
14375 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNRPD2 |
0.376747052267868 |
|
14376 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
QPCTL |
0.376747052267868 |
|
14377 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO46 |
0.376747052267868 |
|
14378 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DMPK |
0.376747052267868 |
|
14379 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIX5 |
0.376747052267868 |
|
14380 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DMWD |
0.376747052267868 |
|
14381 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RSPH6A |
0.376747052267868 |
|
14382 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYMPK |
0.376747052267868 |
|
14383 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXA3 |
0.376747052267868 |
|
14384 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRF2BP1 |
0.376747052267868 |
|
14385 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYPOP |
0.376747052267868 |
|
14386 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NANOS2 |
0.376747052267868 |
|
14387 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOVA2 |
0.376747052267868 |
|
14388 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC61 |
0.376747052267868 |
|
14389 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR769 |
0.376747052267868 |
|
14390 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGLYRP1 |
0.376747052267868 |
|
14391 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGFL4 |
0.376747052267868 |
|
14392 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGFL3 |
0.376747052267868 |
|
14393 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGFL2 |
0.376747052267868 |
|
14394 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGFL1 |
0.376747052267868 |
|
14395 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIF3A |
0.376747052267868 |
|
14396 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP5C |
0.376747052267868 |
|
14397 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC8 |
0.376747052267868 |
|
14398 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNMAL1 |
0.376747052267868 |
|
14399 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNMAL2 |
0.376747052267868 |
|
14400 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP5D1 |
0.376747052267868 |
|
14401 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CALM3 |
0.376747052267868 |
|
14402 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTGIR |
0.376747052267868 |
|
14403 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNG8 |
0.376747052267868 |
|
14404 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DACT3 |
0.376747052267868 |
|
14405 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKD2 |
0.376747052267868 |
|
14406 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL364P |
0.376747052267868 |
|
14407 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR320E |
0.376747052267868 |
|
14408 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STRN4 |
0.376747052267868 |
|
14409 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FKRP |
0.376747052267868 |
|
14410 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC1A5 |
0.376747052267868 |
|
14411 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP2S1 |
0.376747052267868 |
|
14412 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP35 |
0.376747052267868 |
|
14413 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000252071.1 |
0.376747052267868 |
|
14414 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPAS1 |
0.376747052267868 |
|
14415 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM160 |
0.376747052267868 |
|
14416 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZC3H4 |
0.376747052267868 |
|
14417 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL533P |
0.376747052267868 |
|
14418 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAE1 |
0.376747052267868 |
|
14419 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BBC3 |
0.376747052267868 |
|
14420 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3191 |
0.376747052267868 |
|
14421 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC9 |
0.376747052267868 |
|
14422 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR24 |
0.376747052267868 |
|
14423 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5AR1 |
0.376747052267868 |
|
14424 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5AR2 |
0.376747052267868 |
|
14425 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHX34 |
0.376747052267868 |
|
14426 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEIS3 |
0.376747052267868 |
|
14427 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC8A2 |
0.376747052267868 |
|
14428 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KPTN |
0.376747052267868 |
|
14429 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAPA |
0.376747052267868 |
|
14430 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF541 |
0.376747052267868 |
|
14431 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL322P |
0.376747052267868 |
|
14432 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BSPH1 |
0.376747052267868 |
|
14433 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELSPBP1 |
0.376747052267868 |
|
14434 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CABP5 |
0.376747052267868 |
|
14435 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLA2G4C |
0.376747052267868 |
|
14436 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIG1 |
0.376747052267868 |
|
14437 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf68 |
0.376747052267868 |
|
14438 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF114 |
0.376747052267868 |
|
14439 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CARD8 |
0.376747052267868 |
|
14440 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC114 |
0.376747052267868 |
|
14441 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMP3 |
0.376747052267868 |
|
14442 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM143 |
0.376747052267868 |
|
14443 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYNGR4 |
0.376747052267868 |
|
14444 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KDELR1 |
0.376747052267868 |
|
14445 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRIN2D |
0.376747052267868 |
|
14446 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRWD1 |
0.376747052267868 |
|
14447 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNJ14 |
0.376747052267868 |
|
14448 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYTH2 |
0.376747052267868 |
|
14449 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMTK3 |
0.376747052267868 |
|
14450 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SULT2B1 |
0.376747052267868 |
|
14451 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM83E |
0.376747052267868 |
|
14452 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPACA4 |
0.376747052267868 |
|
14453 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL18 |
0.376747052267868 |
|
14454 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPHK2 |
0.376747052267868 |
|
14455 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DBP |
0.376747052267868 |
|
14456 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CA11 |
0.376747052267868 |
|
14457 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC1P |
0.376747052267868 |
|
14458 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NTN5 |
0.376747052267868 |
|
14459 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FUT2 |
0.376747052267868 |
|
14460 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL345P |
0.376747052267868 |
|
14461 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAMSTR |
0.376747052267868 |
|
14462 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASIP1 |
0.376747052267868 |
|
14463 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IZUMO1 |
0.376747052267868 |
|
14464 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FUT1 |
0.376747052267868 |
|
14465 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGF21 |
0.376747052267868 |
|
14466 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCAT2 |
0.376747052267868 |
|
14467 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSD17B14 |
0.376747052267868 |
|
14468 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHA4 |
0.376747052267868 |
|
14469 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R15A |
0.376747052267868 |
|
14470 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TULP2 |
0.376747052267868 |
|
14471 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUCB1 |
0.376747052267868 |
|
14472 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHDH |
0.376747052267868 |
|
14473 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAX |
0.376747052267868 |
|
14474 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FTL |
0.376747052267868 |
|
14475 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GYS1 |
0.376747052267868 |
|
14476 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RUVBL2 |
0.376747052267868 |
|
14477 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LHB |
0.376747052267868 |
|
14478 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CGB2 |
0.376747052267868 |
|
14479 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CGB |
0.376747052267868 |
|
14480 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CGB1 |
0.376747052267868 |
|
14481 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CGB5 |
0.376747052267868 |
|
14482 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CGB7 |
0.376747052267868 |
|
14483 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CGB8 |
0.376747052267868 |
|
14484 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NTF4 |
0.376747052267868 |
|
14485 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNA7 |
0.376747052267868 |
|
14486 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL708P |
0.376747052267868 |
|
14487 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNRNP70 |
0.376747052267868 |
|
14488 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIN7B |
0.376747052267868 |
|
14489 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf73 |
0.376747052267868 |
|
14490 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPFIA3 |
0.376747052267868 |
|
14491 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HRC |
0.376747052267868 |
|
14492 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPM4 |
0.376747052267868 |
|
14493 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC6A16 |
0.376747052267868 |
|
14494 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4324 |
0.376747052267868 |
|
14495 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD37 |
0.376747052267868 |
|
14496 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEAD2 |
0.376747052267868 |
|
14497 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DKKL1 |
0.376747052267868 |
|
14498 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC155 |
0.376747052267868 |
|
14499 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTH2 |
0.376747052267868 |
|
14500 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC17A7 |
0.376747052267868 |
|
14501 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIH1D1 |
0.376747052267868 |
|
14502 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSKS |
0.376747052267868 |
|
14503 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP2A1 |
0.376747052267868 |
|
14504 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FUZ |
0.376747052267868 |
|
14505 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED25 |
0.376747052267868 |
|
14506 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTOV1 |
0.376747052267868 |
|
14507 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4749 |
0.376747052267868 |
|
14508 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNKP |
0.376747052267868 |
|
14509 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKT1S1 |
0.376747052267868 |
|
14510 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATF5 |
0.376747052267868 |
|
14511 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL4I1 |
0.376747052267868 |
|
14512 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4750 |
0.376747052267868 |
|
14513 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4751 |
0.376747052267868 |
|
14514 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUP62 |
0.376747052267868 |
|
14515 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIGLEC11 |
0.376747052267868 |
|
14516 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIGLEC16 |
0.376747052267868 |
|
14517 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D17 |
0.376747052267868 |
|
14518 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000221125.1 |
0.376747052267868 |
|
14519 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VRK3 |
0.376747052267868 |
|
14520 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF473 |
0.376747052267868 |
|
14521 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IZUMO2 |
0.376747052267868 |
|
14522 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYH14 |
0.376747052267868 |
|
14523 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNC3 |
0.376747052267868 |
|
14524 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAPSB |
0.376747052267868 |
|
14525 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NR1H2 |
0.376747052267868 |
|
14526 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAPSA |
0.376747052267868 |
|
14527 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLD1 |
0.376747052267868 |
|
14528 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL324P |
0.376747052267868 |
|
14529 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPIB |
0.376747052267868 |
|
14530 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYBPC2 |
0.376747052267868 |
|
14531 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM71E1 |
0.376747052267868 |
|
14532 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMC10 |
0.376747052267868 |
|
14533 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JOSD2 |
0.376747052267868 |
|
14534 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASPDH |
0.376747052267868 |
|
14535 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC4B |
0.376747052267868 |
|
14536 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYT3 |
0.376747052267868 |
|
14537 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf81 |
0.376747052267868 |
|
14538 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHANK1 |
0.376747052267868 |
|
14539 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC11A |
0.376747052267868 |
|
14540 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR32 |
0.376747052267868 |
|
14541 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACPT |
0.376747052267868 |
|
14542 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf48 |
0.376747052267868 |
|
14543 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD88A |
0.376747052267868 |
|
14544 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD88B |
0.376747052267868 |
|
14545 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD88C |
0.376747052267868 |
|
14546 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLK1 |
0.376747052267868 |
|
14547 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLK15 |
0.376747052267868 |
|
14548 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLK2 |
0.376747052267868 |
|
14549 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLK3 |
0.376747052267868 |
|
14550 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLK4 |
0.376747052267868 |
|
14551 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLKP1 |
0.376747052267868 |
|
14552 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLK5 |
0.376747052267868 |
|
14553 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLK6 |
0.376747052267868 |
|
14554 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLK7 |
0.376747052267868 |
|
14555 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLK8 |
0.376747052267868 |
|
14556 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLK9 |
0.376747052267868 |
|
14557 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLK10 |
0.376747052267868 |
|
14558 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLK11 |
0.376747052267868 |
|
14559 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLK12 |
0.376747052267868 |
|
14560 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLK13 |
0.376747052267868 |
|
14561 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLK14 |
0.376747052267868 |
|
14562 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTU1 |
0.376747052267868 |
|
14563 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIGLEC7 |
0.376747052267868 |
|
14564 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIGLEC9 |
0.376747052267868 |
|
14565 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIGLEC17P |
0.376747052267868 |
|
14566 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIGLEC22P |
0.376747052267868 |
|
14567 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD33 |
0.376747052267868 |
|
14568 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIGLECL1 |
0.376747052267868 |
|
14569 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGLON5 |
0.376747052267868 |
|
14570 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VSIG10L |
0.376747052267868 |
|
14571 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ETFB |
0.376747052267868 |
|
14572 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLDND2 |
0.376747052267868 |
|
14573 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NKG7 |
0.376747052267868 |
|
14574 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIM2 |
0.376747052267868 |
|
14575 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIGLEC10 |
0.376747052267868 |
|
14576 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIGLEC8 |
0.376747052267868 |
|
14577 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEACAM18 |
0.376747052267868 |
|
14578 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIGLEC12 |
0.376747052267868 |
|
14579 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIGLEC6 |
0.376747052267868 |
|
14580 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF175 |
0.376747052267868 |
|
14581 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIGLEC5 |
0.376747052267868 |
|
14582 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIGLEC14 |
0.376747052267868 |
|
14583 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238486.1 |
0.376747052267868 |
|
14584 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00085 |
0.376747052267868 |
|
14585 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR125A |
0.376747052267868 |
|
14586 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR99B |
0.376747052267868 |
|
14587 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIRLET7E |
0.376747052267868 |
|
14588 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAS1 |
0.376747052267868 |
|
14589 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FPR1 |
0.376747052267868 |
|
14590 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FPR2 |
0.376747052267868 |
|
14591 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FPR3 |
0.376747052267868 |
|
14592 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCCAT3 |
0.376747052267868 |
|
14593 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF350 |
0.376747052267868 |
|
14594 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF432 |
0.376747052267868 |
|
14595 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF577 |
0.376747052267868 |
|
14596 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF613 |
0.376747052267868 |
|
14597 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF614 |
0.376747052267868 |
|
14598 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF615 |
0.376747052267868 |
|
14599 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF616 |
0.376747052267868 |
|
14600 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF649 |
0.376747052267868 |
|
14601 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF841 |
0.376747052267868 |
|
14602 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238630.1 |
0.376747052267868 |
|
14603 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF836 |
0.376747052267868 |
|
14604 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP2R1A |
0.376747052267868 |
|
14605 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF766 |
0.376747052267868 |
|
14606 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR643 |
0.376747052267868 |
|
14607 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF480 |
0.376747052267868 |
|
14608 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF610 |
0.376747052267868 |
|
14609 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF528 |
0.376747052267868 |
|
14610 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF534 |
0.376747052267868 |
|
14611 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF578 |
0.376747052267868 |
|
14612 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF880 |
0.376747052267868 |
|
14613 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF808 |
0.376747052267868 |
|
14614 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF701 |
0.376747052267868 |
|
14615 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF137P |
0.376747052267868 |
|
14616 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF28 |
0.376747052267868 |
|
14617 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF320 |
0.376747052267868 |
|
14618 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF321P |
0.376747052267868 |
|
14619 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF468 |
0.376747052267868 |
|
14620 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF600 |
0.376747052267868 |
|
14621 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF611 |
0.376747052267868 |
|
14622 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF702P |
0.376747052267868 |
|
14623 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF816 |
0.376747052267868 |
|
14624 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF888 |
0.376747052267868 |
|
14625 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF160 |
0.376747052267868 |
|
14626 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF347 |
0.376747052267868 |
|
14627 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF415 |
0.376747052267868 |
|
14628 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF665 |
0.376747052267868 |
|
14629 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF677 |
0.376747052267868 |
|
14630 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VN1R2 |
0.376747052267868 |
|
14631 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VN1R4 |
0.376747052267868 |
|
14632 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM90A27P |
0.376747052267868 |
|
14633 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BIRC8 |
0.376747052267868 |
|
14634 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM90A28P |
0.376747052267868 |
|
14635 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF845 |
0.376747052267868 |
|
14636 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF525 |
0.376747052267868 |
|
14637 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF765 |
0.376747052267868 |
|
14638 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPM3P9 |
0.376747052267868 |
|
14639 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF761 |
0.376747052267868 |
|
14640 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF813 |
0.376747052267868 |
|
14641 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF331 |
0.376747052267868 |
|
14642 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPRX |
0.376747052267868 |
|
14643 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1323 |
0.376747052267868 |
|
14644 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR371A |
0.376747052267868 |
|
14645 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR371B |
0.376747052267868 |
|
14646 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR372 |
0.376747052267868 |
|
14647 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR373 |
0.376747052267868 |
|
14648 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR498 |
0.376747052267868 |
|
14649 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR516A1 |
0.376747052267868 |
|
14650 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR516A2 |
0.376747052267868 |
|
14651 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR516B1 |
0.376747052267868 |
|
14652 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR516B2 |
0.376747052267868 |
|
14653 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR517A |
0.376747052267868 |
|
14654 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR517B |
0.376747052267868 |
|
14655 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR517C |
0.376747052267868 |
|
14656 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR518A1 |
0.376747052267868 |
|
14657 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR518A2 |
0.376747052267868 |
|
14658 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR518B |
0.376747052267868 |
|
14659 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR518C |
0.376747052267868 |
|
14660 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR518D |
0.376747052267868 |
|
14661 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR518E |
0.376747052267868 |
|
14662 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR518F |
0.376747052267868 |
|
14663 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR519A1 |
0.376747052267868 |
|
14664 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR519A2 |
0.376747052267868 |
|
14665 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR519B |
0.376747052267868 |
|
14666 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR519C |
0.376747052267868 |
|
14667 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR519D |
0.376747052267868 |
|
14668 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR519E |
0.376747052267868 |
|
14669 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR520A |
0.376747052267868 |
|
14670 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR520B |
0.376747052267868 |
|
14671 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR520C |
0.376747052267868 |
|
14672 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR520D |
0.376747052267868 |
|
14673 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR520E |
0.376747052267868 |
|
14674 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR520F |
0.376747052267868 |
|
14675 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR520G |
0.376747052267868 |
|
14676 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR520H |
0.376747052267868 |
|
14677 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR522 |
0.376747052267868 |
|
14678 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR523 |
0.376747052267868 |
|
14679 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR524 |
0.376747052267868 |
|
14680 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR525 |
0.376747052267868 |
|
14681 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR526A1 |
0.376747052267868 |
|
14682 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR526A2 |
0.376747052267868 |
|
14683 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR526B |
0.376747052267868 |
|
14684 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR527 |
0.376747052267868 |
|
14685 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NLRP12 |
0.376747052267868 |
|
14686 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL317P |
0.376747052267868 |
|
14687 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYADM |
0.376747052267868 |
|
14688 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKCG |
0.376747052267868 |
|
14689 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNG7 |
0.376747052267868 |
|
14690 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNG8 |
0.376747052267868 |
|
14691 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNG6 |
0.376747052267868 |
|
14692 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR935 |
0.376747052267868 |
|
14693 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VSTM1 |
0.376747052267868 |
|
14694 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TARM1 |
0.376747052267868 |
|
14695 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSCAR |
0.376747052267868 |
|
14696 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFA3 |
0.376747052267868 |
|
14697 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFPT |
0.376747052267868 |
|
14698 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRPF31 |
0.376747052267868 |
|
14699 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNOT3 |
0.376747052267868 |
|
14700 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LENG1 |
0.376747052267868 |
|
14701 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMC4 |
0.376747052267868 |
|
14702 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBOAT7 |
0.376747052267868 |
|
14703 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSEN34 |
0.376747052267868 |
|
14704 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS9 |
0.376747052267868 |
|
14705 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LILRA3 |
0.376747052267868 |
|
14706 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LILRA4 |
0.376747052267868 |
|
14707 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LILRA5 |
0.376747052267868 |
|
14708 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LILRA6 |
0.376747052267868 |
|
14709 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LILRB2 |
0.376747052267868 |
|
14710 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LILRB3 |
0.376747052267868 |
|
14711 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LILRB5 |
0.376747052267868 |
|
14712 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4752 |
0.376747052267868 |
|
14713 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAIR1 |
0.376747052267868 |
|
14714 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTYH1 |
0.376747052267868 |
|
14715 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LENG8 |
0.376747052267868 |
|
14716 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC42EP5 |
0.376747052267868 |
|
14717 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LENG9 |
0.376747052267868 |
|
14718 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAIR2 |
0.376747052267868 |
|
14719 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIR3DX1 |
0.376747052267868 |
|
14720 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LILRA2 |
0.376747052267868 |
|
14721 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LILRB1 |
0.376747052267868 |
|
14722 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LILRA1 |
0.376747052267868 |
|
14723 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LILRB4 |
0.376747052267868 |
|
14724 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCAR |
0.376747052267868 |
|
14725 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIR2DL1 |
0.376747052267868 |
|
14726 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIR2DL3 |
0.376747052267868 |
|
14727 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIR2DL4 |
0.376747052267868 |
|
14728 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIR2DS4 |
0.376747052267868 |
|
14729 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIR3DL1 |
0.376747052267868 |
|
14730 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIR3DL2 |
0.376747052267868 |
|
14731 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIR3DL3 |
0.376747052267868 |
|
14732 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCR1 |
0.376747052267868 |
|
14733 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NLRP7 |
0.376747052267868 |
|
14734 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NLRP2 |
0.376747052267868 |
|
14735 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GP6 |
0.376747052267868 |
|
14736 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABHD13 |
0.376976292518826 |
|
14737 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFSF13B |
0.376976292518826 |
|
14738 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HS3ST2 |
0.378880525145892 |
|
14739 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP31 |
0.378880525145892 |
|
14740 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCNN1G |
0.378880525145892 |
|
14741 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCNN1B |
0.378880525145892 |
|
14742 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COG7 |
0.378880525145892 |
|
14743 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP23 |
0.378880525145892 |
|
14744 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA75|ENSG00000212593.1 |
0.378880525145892 |
|
14745 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GGA2 |
0.378880525145892 |
|
14746 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EARS2 |
0.378880525145892 |
|
14747 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBFD1 |
0.378880525145892 |
|
14748 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFAB1 |
0.378880525145892 |
|
14749 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PALB2 |
0.378880525145892 |
|
14750 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCTN5 |
0.378880525145892 |
|
14751 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLK1 |
0.378880525145892 |
|
14752 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERN2 |
0.378880525145892 |
|
14753 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHP2 |
0.378880525145892 |
|
14754 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKCB |
0.378880525145892 |
|
14755 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNG3 |
0.378880525145892 |
|
14756 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA1|ENSG00000201541.1 |
0.378880525145892 |
|
14757 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBBP6 |
0.378880525145892 |
|
14758 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNRC6A |
0.378880525145892 |
|
14759 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC5A11 |
0.378880525145892 |
|
14760 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP17 |
0.378880525145892 |
|
14761 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCMT1 |
0.378880525145892 |
|
14762 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL557P |
0.378880525145892 |
|
14763 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AQP8 |
0.378880525145892 |
|
14764 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZKSCAN2 |
0.378880525145892 |
|
14765 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HS3ST4 |
0.378880525145892 |
|
14766 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548W |
0.378880525145892 |
|
14767 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP405 |
0.378880525145892 |
|
14768 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf82 |
0.378880525145892 |
|
14769 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KDM8 |
0.378880525145892 |
|
14770 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NSMCE1 |
0.378880525145892 |
|
14771 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL4R |
0.378880525145892 |
|
14772 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL21R |
0.378880525145892 |
|
14773 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF3C1 |
0.378880525145892 |
|
14774 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0556 |
0.378880525145892 |
|
14775 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSG1L |
0.378880525145892 |
|
14776 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XPO6 |
0.378880525145892 |
|
14777 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA25|ENSG00000200652.1 |
0.378880525145892 |
|
14778 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SBK1 |
0.378880525145892 |
|
14779 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPIPB6 |
0.378880525145892 |
|
14780 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPQ |
0.37896455248847 |
|
14781 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPYL5 |
0.37896455248847 |
|
14782 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000207215.1 |
0.37896455248847 |
|
14783 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTDH |
0.37896455248847 |
|
14784 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAPTM4B |
0.37896455248847 |
|
14785 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX18 |
0.379932079370123 |
|
14786 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNH5 |
0.380410156304086 |
|
14787 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHOJ |
0.380410156304086 |
|
14788 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DAAM1 |
0.380795953357349 |
|
14789 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPHB5 |
0.380809506928189 |
|
14790 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP2R5E |
0.380809506928189 |
|
14791 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL540P |
0.380809506928189 |
|
14792 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA20|ENSG00000252800.1 |
0.380809506928189 |
|
14793 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR89 |
0.380809506928189 |
|
14794 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000200693.1 |
0.380809506928189 |
|
14795 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGPP1 |
0.380809506928189 |
|
14796 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYNE2 |
0.380809506928189 |
|
14797 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ESR2 |
0.380809506928189 |
|
14798 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548H1 |
0.380809506928189 |
|
14799 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTHFD1 |
0.380809506928189 |
|
14800 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB25 |
0.380809506928189 |
|
14801 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKAP5 |
0.380809506928189 |
|
14802 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB1 |
0.380809506928189 |
|
14803 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPA2 |
0.380809506928189 |
|
14804 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R36 |
0.380809506928189 |
|
14805 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHG3 |
0.380809506928189 |
|
14806 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPTB |
0.380809506928189 |
|
14807 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHURC1 |
0.380809506928189 |
|
14808 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPX2 |
0.380809506928189 |
|
14809 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB15 |
0.380809506928189 |
|
14810 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FNTB |
0.380809506928189 |
|
14811 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAX |
0.380809506928189 |
|
14812 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4706 |
0.380809506928189 |
|
14813 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4708 |
0.380809506928189 |
|
14814 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR625 |
0.380809506928189 |
|
14815 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00238 |
0.380809506928189 |
|
14816 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPHN |
0.380809506928189 |
|
14817 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM71D |
0.380809506928189 |
|
14818 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPP5 |
0.380809506928189 |
|
14819 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6V1D |
0.380809506928189 |
|
14820 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF2S1 |
0.380809506928189 |
|
14821 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEK2 |
0.380809506928189 |
|
14822 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHH1 |
0.380809506928189 |
|
14823 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIGH |
0.380809506928189 |
|
14824 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARG2 |
0.380809506928189 |
|
14825 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VTI1B |
0.380809506928189 |
|
14826 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RDH11 |
0.380809506928189 |
|
14827 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RDH12 |
0.380809506928189 |
|
14828 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL369P |
0.380809506928189 |
|
14829 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFYVE26 |
0.380809506928189 |
|
14830 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000252792.1 |
0.380809506928189 |
|
14831 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL213P |
0.380809506928189 |
|
14832 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAD51B |
0.380809506928189 |
|
14833 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL706P |
0.380809506928189 |
|
14834 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL108P |
0.380809506928189 |
|
14835 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFP36L1 |
0.380809506928189 |
|
14836 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL224P |
0.380809506928189 |
|
14837 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTN1 |
0.380809506928189 |
|
14838 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCAF5 |
0.380809506928189 |
|
14839 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXD2 |
0.380809506928189 |
|
14840 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALNT16 |
0.380809506928189 |
|
14841 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERH |
0.380809506928189 |
|
14842 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC39A9 |
0.380809506928189 |
|
14843 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHD1 |
0.380809506928189 |
|
14844 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC177|ENSG00000255994.1 |
0.380809506928189 |
|
14845 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC177|ENSG00000267909.1 |
0.380809506928189 |
|
14846 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0247 |
0.380809506928189 |
|
14847 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRSF5 |
0.380809506928189 |
|
14848 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC10A1 |
0.380809506928189 |
|
14849 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA11|ENSG00000221060.1 |
0.380809506928189 |
|
14850 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMOC1 |
0.380809506928189 |
|
14851 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC8A3 |
0.380809506928189 |
|
14852 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM21P1 |
0.380809506928189 |
|
14853 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX16 |
0.380809506928189 |
|
14854 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYNJ2BP |
0.380809506928189 |
|
14855 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM21 |
0.380809506928189 |
|
14856 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM20P1 |
0.380809506928189 |
|
14857 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM20 |
0.380809506928189 |
|
14858 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED6 |
0.380809506928189 |
|
14859 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL77P |
0.380809506928189 |
|
14860 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC9 |
0.380809506928189 |
|
14861 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP3K9 |
0.380809506928189 |
|
14862 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCNX |
0.380809506928189 |
|
14863 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIPA1L1 |
0.380809506928189 |
|
14864 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD56B |
0.380809506928189 |
|
14865 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL683P |
0.380809506928189 |
|
14866 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGS6 |
0.380809506928189 |
|
14867 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPF3 |
0.380809506928189 |
|
14868 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238972.1 |
0.380809506928189 |
|
14869 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCAF4 |
0.380809506928189 |
|
14870 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFYVE1 |
0.380809506928189 |
|
14871 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL586P |
0.380809506928189 |
|
14872 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM25 |
0.380809506928189 |
|
14873 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSEN1 |
0.380809506928189 |
|
14874 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAPLN |
0.380809506928189 |
|
14875 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUMB |
0.380809506928189 |
|
14876 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HEATR4 |
0.380809506928189 |
|
14877 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C14orf169 |
0.380809506928189 |
|
14878 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACOT1 |
0.380809506928189 |
|
14879 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACOT2 |
0.380809506928189 |
|
14880 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACOT4 |
0.380809506928189 |
|
14881 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACOT6 |
0.380809506928189 |
|
14882 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAL1 |
0.380809506928189 |
|
14883 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNMA1 |
0.380809506928189 |
|
14884 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELMSAN1 |
0.380809506928189 |
|
14885 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4505 |
0.380809506928189 |
|
14886 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238330.1 |
0.380809506928189 |
|
14887 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTGR2 |
0.380809506928189 |
|
14888 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF410 |
0.380809506928189 |
|
14889 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM161B |
0.380809506928189 |
|
14890 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COQ6 |
0.380809506928189 |
|
14891 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENTPD5 |
0.380809506928189 |
|
14892 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC176 |
0.380809506928189 |
|
14893 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALDH6A1 |
0.380809506928189 |
|
14894 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIN52 |
0.380809506928189 |
|
14895 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL530P |
0.380809506928189 |
|
14896 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VSX2 |
0.380809506928189 |
|
14897 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCD4 |
0.380809506928189 |
|
14898 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VRTN |
0.380809506928189 |
|
14899 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYNDIG1L |
0.380809506928189 |
|
14900 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPC2 |
0.380809506928189 |
|
14901 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4709 |
0.380809506928189 |
|
14902 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ISCA2 |
0.380809506928189 |
|
14903 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LTBP2 |
0.380809506928189 |
|
14904 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AREL1 |
0.380809506928189 |
|
14905 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCF1 |
0.380809506928189 |
|
14906 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA7|ENSG00000222604.1 |
0.380809506928189 |
|
14907 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YLPM1 |
0.380809506928189 |
|
14908 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PROX2 |
0.380809506928189 |
|
14909 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLST |
0.380809506928189 |
|
14910 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS6KL1 |
0.380809506928189 |
|
14911 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGF |
0.380809506928189 |
|
14912 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF2B2 |
0.380809506928189 |
|
14913 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLH3 |
0.380809506928189 |
|
14914 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACYP1 |
0.380809506928189 |
|
14915 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZC2HC1C |
0.380809506928189 |
|
14916 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEK9 |
0.380809506928189 |
|
14917 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMED10 |
0.380809506928189 |
|
14918 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU4ATAC14P |
0.380809506928189 |
|
14919 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOS |
0.380809506928189 |
|
14920 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JDP2 |
0.380809506928189 |
|
14921 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BATF |
0.380809506928189 |
|
14922 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLVCR2 |
0.380809506928189 |
|
14923 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP387 |
0.380809506928189 |
|
14924 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTLL5 |
0.380809506928189 |
|
14925 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C14orf1 |
0.380809506928189 |
|
14926 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFT43 |
0.380809506928189 |
|
14927 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TGFB3 |
0.380809506928189 |
|
14928 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPATCH2L |
0.380809506928189 |
|
14929 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ESRRB |
0.380809506928189 |
|
14930 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL747P |
0.380809506928189 |
|
14931 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VASH1 |
0.380809506928189 |
|
14932 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANGEL1 |
0.380809506928189 |
|
14933 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C14orf166B |
0.380809506928189 |
|
14934 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP17 |
0.380809506928189 |
|
14935 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HHAT |
0.382172631567512 |
|
14936 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00864 |
0.38574809446295 |
|
14937 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MINPP1 |
0.38574809446295 |
|
14938 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAPSS2 |
0.38574809446295 |
|
14939 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATAD1 |
0.38574809446295 |
|
14940 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CFL1P1 |
0.38574809446295 |
|
14941 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL78P |
0.38574809446295 |
|
14942 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLLN |
0.38574809446295 |
|
14943 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTEN |
0.38574809446295 |
|
14944 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD74|ENSG00000200891.1 |
0.38574809446295 |
|
14945 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNLS |
0.38574809446295 |
|
14946 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIPJ |
0.38574809446295 |
|
14947 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIPF |
0.38574809446295 |
|
14948 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIPK |
0.38574809446295 |
|
14949 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIPN |
0.38574809446295 |
|
14950 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIPM |
0.38574809446295 |
|
14951 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD22 |
0.38574809446295 |
|
14952 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAMBPL1 |
0.38574809446295 |
|
14953 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTA2 |
0.38574809446295 |
|
14954 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAS |
0.38574809446295 |
|
14955 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238991.1 |
0.38574809446295 |
|
14956 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CH25H |
0.38574809446295 |
|
14957 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIPA |
0.38574809446295 |
|
14958 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFIT2 |
0.38574809446295 |
|
14959 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFIT3 |
0.38574809446295 |
|
14960 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFIT1B |
0.38574809446295 |
|
14961 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFIT1 |
0.38574809446295 |
|
14962 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFIT5 |
0.38574809446295 |
|
14963 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC16A12 |
0.38574809446295 |
|
14964 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PANK1 |
0.38574809446295 |
|
14965 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR107 |
0.38574809446295 |
|
14966 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF20B |
0.38574809446295 |
|
14967 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00865 |
0.38574809446295 |
|
14968 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP143 |
0.38574809446295 |
|
14969 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTR7 |
0.38574809446295 |
|
14970 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPP30 |
0.38574809446295 |
|
14971 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD1 |
0.38574809446295 |
|
14972 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00502 |
0.38574809446295 |
|
14973 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBX4 |
0.386092631055246 |
|
14974 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D16 |
0.386092631055246 |
|
14975 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC40 |
0.386092631055246 |
|
14976 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAA |
0.386092631055246 |
|
14977 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF4A3 |
0.386092631055246 |
|
14978 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CARD14 |
0.386092631055246 |
|
14979 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGSH |
0.386092631055246 |
|
14980 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC26A11 |
0.386092631055246 |
|
14981 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF213 |
0.386092631055246 |
|
14982 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENDOV |
0.386092631055246 |
|
14983 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4730 |
0.386092631055246 |
|
14984 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPTX1 |
0.386092631055246 |
|
14985 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPTOR |
0.386092631055246 |
|
14986 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHMP6 |
0.386092631055246 |
|
14987 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAIAP2 |
0.386092631055246 |
|
14988 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AATK |
0.386092631055246 |
|
14989 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1250 |
0.386092631055246 |
|
14990 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR338 |
0.386092631055246 |
|
14991 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR657 |
0.386092631055246 |
|
14992 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AZI1 |
0.386092631055246 |
|
14993 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENTHD2 |
0.386092631055246 |
|
14994 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf89 |
0.386092631055246 |
|
14995 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC38A10 |
0.386092631055246 |
|
14996 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00482 |
0.386092631055246 |
|
14997 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM105 |
0.386092631055246 |
|
14998 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4740 |
0.386092631055246 |
|
14999 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3186 |
0.386092631055246 |
|
15000 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTG1 |
0.386092631055246 |
|
15001 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FSCN2 |
0.386092631055246 |
|
15002 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf70 |
0.386092631055246 |
|
15003 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPLOC4 |
0.386092631055246 |
|
15004 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPAN10 |
0.386092631055246 |
|
15005 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE6G |
0.386092631055246 |
|
15006 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OXLD1 |
0.386092631055246 |
|
15007 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC137 |
0.386092631055246 |
|
15008 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL16 |
0.386092631055246 |
|
15009 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HGS |
0.386092631055246 |
|
15010 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL12 |
0.386092631055246 |
|
15011 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A10 |
0.386092631055246 |
|
15012 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM195B |
0.386092631055246 |
|
15013 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCGR |
0.386092631055246 |
|
15014 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
P4HB |
0.386092631055246 |
|
15015 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R27 |
0.386092631055246 |
|
15016 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGDIA |
0.386092631055246 |
|
15017 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALYREF |
0.386092631055246 |
|
15018 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANAPC11 |
0.386092631055246 |
|
15019 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPB |
0.386092631055246 |
|
15020 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCYT2 |
0.386092631055246 |
|
15021 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIRT7 |
0.386092631055246 |
|
15022 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAFG |
0.386092631055246 |
|
15023 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYADML2 |
0.386092631055246 |
|
15024 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PYCR1 |
0.386092631055246 |
|
15025 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOTUM |
0.386092631055246 |
|
15026 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASPSCR1 |
0.386092631055246 |
|
15027 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STRA13 |
0.386092631055246 |
|
15028 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCXR |
0.386092631055246 |
|
15029 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC45 |
0.386092631055246 |
|
15030 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAC3 |
0.386092631055246 |
|
15031 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFNG |
0.386092631055246 |
|
15032 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPS1 |
0.386092631055246 |
|
15033 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUS1L |
0.386092631055246 |
|
15034 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FASN |
0.386092631055246 |
|
15035 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC57 |
0.386092631055246 |
|
15036 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSNK1D |
0.386092631055246 |
|
15037 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC16A3 |
0.386092631055246 |
|
15038 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238947.1 |
0.386092631055246 |
|
15039 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD7 |
0.386092631055246 |
|
15040 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SECTM1 |
0.386092631055246 |
|
15041 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX19 |
0.386092631055246 |
|
15042 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UTS2R |
0.386092631055246 |
|
15043 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OGFOD3 |
0.386092631055246 |
|
15044 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HEXDC |
0.386092631055246 |
|
15045 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf62 |
0.386092631055246 |
|
15046 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NARF |
0.386092631055246 |
|
15047 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXK2 |
0.386092631055246 |
|
15048 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238403.1 |
0.386092631055246 |
|
15049 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR45B |
0.386092631055246 |
|
15050 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB40B |
0.386092631055246 |
|
15051 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4525 |
0.386092631055246 |
|
15052 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FN3KRP |
0.386092631055246 |
|
15053 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FN3K |
0.386092631055246 |
|
15054 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARA3 |
0.396317888575158 |
|
15055 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3622B |
0.396317888575158 |
|
15056 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC25 |
0.396317888575158 |
|
15057 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238624.1 |
0.396317888575158 |
|
15058 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ESCO2 |
0.396317888575158 |
|
15059 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PBK |
0.396317888575158 |
|
15060 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARA5 |
0.396317888575158 |
|
15061 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4287 |
0.396317888575158 |
|
15062 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUGGC |
0.396317888575158 |
|
15063 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELP3 |
0.396317888575158 |
|
15064 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNOC |
0.396317888575158 |
|
15065 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF395 |
0.396317888575158 |
|
15066 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO16 |
0.396317888575158 |
|
15067 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FZD3 |
0.396317888575158 |
|
15068 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4288 |
0.396317888575158 |
|
15069 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP259 |
0.396317888575158 |
|
15070 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXTL3 |
0.396317888575158 |
|
15071 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INTS9 |
0.396317888575158 |
|
15072 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMBOX1 |
0.396317888575158 |
|
15073 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP260 |
0.396317888575158 |
|
15074 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF13B |
0.396317888575158 |
|
15075 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL781P |
0.396317888575158 |
|
15076 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUSP4 |
0.396317888575158 |
|
15077 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00589 |
0.396317888575158 |
|
15078 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM183CP |
0.396317888575158 |
|
15079 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3148 |
0.396317888575158 |
|
15080 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM66 |
0.396317888575158 |
|
15081 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LEPROTL1 |
0.396317888575158 |
|
15082 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBOAT4 |
0.396317888575158 |
|
15083 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCTN6 |
0.396317888575158 |
|
15084 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBBP1 |
0.396317888575158 |
|
15085 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBPMS |
0.396317888575158 |
|
15086 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF2E2 |
0.396317888575158 |
|
15087 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMIM18 |
0.396317888575158 |
|
15088 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSR |
0.396317888575158 |
|
15089 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBXN8 |
0.396317888575158 |
|
15090 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP2CB |
0.396317888575158 |
|
15091 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX15 |
0.396317888575158 |
|
15092 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PURG |
0.396317888575158 |
|
15093 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WRN |
0.396317888575158 |
|
15094 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP261 |
0.396317888575158 |
|
15095 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRG1 |
0.396317888575158 |
|
15096 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP262 |
0.396317888575158 |
|
15097 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP263 |
0.396317888575158 |
|
15098 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FUT10 |
0.396317888575158 |
|
15099 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTI2 |
0.396317888575158 |
|
15100 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAK16 |
0.396317888575158 |
|
15101 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD13 |
0.396317888575158 |
|
15102 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000252505.1 |
0.396317888575158 |
|
15103 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF122 |
0.396317888575158 |
|
15104 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL621P |
0.396317888575158 |
|
15105 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUSP26 |
0.396317888575158 |
|
15106 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL457P |
0.396317888575158 |
|
15107 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITFG1 |
0.397561002056403 |
|
15108 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP424 |
0.397561002056403 |
|
15109 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHKB |
0.397561002056403 |
|
15110 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP425 |
0.397561002056403 |
|
15111 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EBF2 |
0.400681522961698 |
|
15112 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP258 |
0.400681522961698 |
|
15113 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP2R2A |
0.400681522961698 |
|
15114 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BNIP3L |
0.400681522961698 |
|
15115 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDAD1P1 |
0.400681522961698 |
|
15116 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNMA2 |
0.400681522961698 |
|
15117 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPYSL2 |
0.400681522961698 |
|
15118 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADRA1A |
0.400681522961698 |
|
15119 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548H4 |
0.400681522961698 |
|
15120 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STMN4 |
0.400681522961698 |
|
15121 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM35 |
0.400681522961698 |
|
15122 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTK2B |
0.400681522961698 |
|
15123 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRNA2 |
0.400681522961698 |
|
15124 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPHX2 |
0.400681522961698 |
|
15125 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLU |
0.400681522961698 |
|
15126 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGALS13 |
0.402878447273846 |
|
15127 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGALS16 |
0.402878447273846 |
|
15128 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGALS17A |
0.402878447273846 |
|
15129 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR123 |
0.405955780099716 |
|
15130 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KNDC1 |
0.405955780099716 |
|
15131 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UTF1 |
0.405955780099716 |
|
15132 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VENTX |
0.405955780099716 |
|
15133 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR202 |
0.405955780099716 |
|
15134 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM8 |
0.405955780099716 |
|
15135 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBGCP2 |
0.405955780099716 |
|
15136 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3944 |
0.405955780099716 |
|
15137 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAOX |
0.405955780099716 |
|
15138 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTG1 |
0.405955780099716 |
|
15139 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP2E1 |
0.405955780099716 |
|
15140 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRG2B |
0.405955780099716 |
|
15141 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPRN |
0.405955780099716 |
|
15142 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYCE1 |
0.405955780099716 |
|
15143 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00293 |
0.407694059157335 |
|
15144 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP32 |
0.407694059157335 |
|
15145 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPIDR |
0.407694059157335 |
|
15146 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEBPD |
0.407694059157335 |
|
15147 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKDC |
0.407694059157335 |
|
15148 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCM4 |
0.407694059157335 |
|
15149 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2V2 |
0.407694059157335 |
|
15150 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGALS14 |
0.408527391996524 |
|
15151 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLC |
0.408527391996524 |
|
15152 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LEUTX |
0.408527391996524 |
|
15153 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DYRK1B |
0.408527391996524 |
|
15154 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBL |
0.408527391996524 |
|
15155 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCGBP |
0.408527391996524 |
|
15156 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMC4 |
0.408527391996524 |
|
15157 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF546 |
0.408527391996524 |
|
15158 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF780B |
0.408527391996524 |
|
15159 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF780A |
0.408527391996524 |
|
15160 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP3K10 |
0.408527391996524 |
|
15161 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC9B |
0.408527391996524 |
|
15162 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNTD2 |
0.408527391996524 |
|
15163 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKT2 |
0.408527391996524 |
|
15164 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR641 |
0.408527391996524 |
|
15165 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf47 |
0.408527391996524 |
|
15166 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLD3 |
0.408527391996524 |
|
15167 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIPK4 |
0.408527391996524 |
|
15168 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRX |
0.408527391996524 |
|
15169 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERTAD1 |
0.408527391996524 |
|
15170 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERTAD3 |
0.408527391996524 |
|
15171 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BLVRB |
0.408527391996524 |
|
15172 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPTBN4 |
0.408527391996524 |
|
15173 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL5A |
0.416877256799535 |
|
15174 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNB4 |
0.416877256799535 |
|
15175 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCT8L2 |
0.417127652413139 |
|
15176 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSFY1P1 |
0.417127652413139 |
|
15177 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNMB3P1 |
0.417127652413139 |
|
15178 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR11H1 |
0.417127652413139 |
|
15179 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POTEH |
0.417127652413139 |
|
15180 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPTEP1 |
0.417127652413139 |
|
15181 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XKR3 |
0.417127652413139 |
|
15182 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAB4 |
0.417127652413139 |
|
15183 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CECR7 |
0.417127652413139 |
|
15184 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL17RA |
0.417127652413139 |
|
15185 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CECR6 |
0.417127652413139 |
|
15186 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CECR5 |
0.417127652413139 |
|
15187 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CECR1 |
0.417127652413139 |
|
15188 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CECR3 |
0.417127652413139 |
|
15189 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CECR9 |
0.417127652413139 |
|
15190 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL843P |
0.417127652413139 |
|
15191 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CECR2 |
0.417127652413139 |
|
15192 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A18 |
0.417127652413139 |
|
15193 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6V1E1 |
0.417127652413139 |
|
15194 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCL2L13 |
0.417127652413139 |
|
15195 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000251737.1 |
0.417127652413139 |
|
15196 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BID |
0.417127652413139 |
|
15197 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00528 |
0.417127652413139 |
|
15198 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MICAL3 |
0.417127652413139 |
|
15199 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR648 |
0.417127652413139 |
|
15200 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TXK |
0.431688726125149 |
|
15201 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CWH43 |
0.431688726125149 |
|
15202 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRYL |
0.431688726125149 |
|
15203 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OCIAD1 |
0.431688726125149 |
|
15204 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OCIAD2 |
0.431688726125149 |
|
15205 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLAIN2 |
0.431688726125149 |
|
15206 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC10A4 |
0.431688726125149 |
|
15207 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEC |
0.431688726125149 |
|
15208 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZAR1 |
0.431688726125149 |
|
15209 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL424P |
0.431688726125149 |
|
15210 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KDR |
0.431688726125149 |
|
15211 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL822P |
0.431688726125149 |
|
15212 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRD5A3 |
0.431688726125149 |
|
15213 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM165 |
0.431688726125149 |
|
15214 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B4GALNT3 |
0.433918788037323 |
|
15215 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC77 |
0.433918788037323 |
|
15216 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM138D |
0.433918788037323 |
|
15217 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IQSEC3 |
0.433918788037323 |
|
15218 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KDM5A |
0.433918788037323 |
|
15219 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NINJ2 |
0.433918788037323 |
|
15220 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU4ATAC16P |
0.433918788037323 |
|
15221 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC6A12 |
0.433918788037323 |
|
15222 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC6A13 |
0.433918788037323 |
|
15223 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB38 |
0.435019522414298 |
|
15224 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3166 |
0.435019522414298 |
|
15225 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTSC |
0.435019522414298 |
|
15226 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRM5 |
0.435019522414298 |
|
15227 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TYR |
0.435019522414298 |
|
15228 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOX4 |
0.435019522414298 |
|
15229 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOLH1B |
0.435019522414298 |
|
15230 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM49C |
0.435019522414298 |
|
15231 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM49D1 |
0.435019522414298 |
|
15232 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM49 |
0.435019522414298 |
|
15233 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM64B |
0.435019522414298 |
|
15234 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM77 |
0.435019522414298 |
|
15235 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD56|ENSG00000207299.1 |
0.435019522414298 |
|
15236 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAALAD2 |
0.435019522414298 |
|
15237 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHORDC1 |
0.435019522414298 |
|
15238 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DISC1FP1 |
0.435019522414298 |
|
15239 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4490 |
0.435019522414298 |
|
15240 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1261 |
0.435019522414298 |
|
15241 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239086.1 |
0.435019522414298 |
|
15242 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAK7 |
0.43579527672247 |
|
15243 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCUN1D4 |
0.43837284690341 |
|
15244 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC66 |
0.43837284690341 |
|
15245 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGCB |
0.43837284690341 |
|
15246 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA18 |
0.43837284690341 |
|
15247 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239068.1 |
0.43837284690341 |
|
15248 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP46 |
0.43837284690341 |
|
15249 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DANCR |
0.43837284690341 |
|
15250 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4449 |
0.43837284690341 |
|
15251 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA26|ENSG00000212588.1 |
0.43837284690341 |
|
15252 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA26|ENSG00000212490.1 |
0.43837284690341 |
|
15253 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASL11B |
0.43837284690341 |
|
15254 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCFD2 |
0.43837284690341 |
|
15255 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FIP1L1 |
0.43837284690341 |
|
15256 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LNX1 |
0.43837284690341 |
|
15257 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHIC2 |
0.43837284690341 |
|
15258 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSX2 |
0.43837284690341 |
|
15259 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238753.1 |
0.43837284690341 |
|
15260 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDGFRA |
0.43837284690341 |
|
15261 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIT |
0.43837284690341 |
|
15262 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCGB2B2 |
0.443193715526342 |
|
15263 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF302 |
0.443193715526342 |
|
15264 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF181 |
0.443193715526342 |
|
15265 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF599 |
0.443193715526342 |
|
15266 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00904 |
0.443193715526342 |
|
15267 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF30 |
0.443193715526342 |
|
15268 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF792 |
0.443193715526342 |
|
15269 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRAMD1A |
0.443193715526342 |
|
15270 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCN1B |
0.443193715526342 |
|
15271 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HPN |
0.443193715526342 |
|
15272 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FXYD3 |
0.443193715526342 |
|
15273 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGI4 |
0.443193715526342 |
|
15274 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FXYD1 |
0.443193715526342 |
|
15275 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FXYD7 |
0.443193715526342 |
|
15276 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FXYD5 |
0.443193715526342 |
|
15277 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM187B |
0.443193715526342 |
|
15278 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LSR |
0.443193715526342 |
|
15279 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USF2 |
0.443193715526342 |
|
15280 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAMP |
0.443193715526342 |
|
15281 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAG |
0.443193715526342 |
|
15282 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD22 |
0.443193715526342 |
|
15283 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5196 |
0.443193715526342 |
|
15284 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FFAR1 |
0.443193715526342 |
|
15285 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FFAR3 |
0.443193715526342 |
|
15286 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR42 |
0.443193715526342 |
|
15287 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL491P |
0.443193715526342 |
|
15288 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FFAR2 |
0.443193715526342 |
|
15289 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRTDAP |
0.443193715526342 |
|
15290 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DMKN |
0.443193715526342 |
|
15291 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SBSN |
0.443193715526342 |
|
15292 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAPDHS |
0.443193715526342 |
|
15293 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM147 |
0.443193715526342 |
|
15294 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP4A |
0.443193715526342 |
|
15295 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAUS5 |
0.443193715526342 |
|
15296 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM42 |
0.443193715526342 |
|
15297 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ETV2 |
0.443193715526342 |
|
15298 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX6B1 |
0.443193715526342 |
|
15299 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL765P |
0.443193715526342 |
|
15300 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UPK1A |
0.443193715526342 |
|
15301 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB32 |
0.443193715526342 |
|
15302 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KMT2B |
0.443193715526342 |
|
15303 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WBP7 |
0.443193715526342 |
|
15304 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGFLR1 |
0.443193715526342 |
|
15305 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIN37 |
0.443193715526342 |
|
15306 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSENEN |
0.443193715526342 |
|
15307 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U2AF1L4 |
0.443193715526342 |
|
15308 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf55 |
0.443193715526342 |
|
15309 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPB6 |
0.443193715526342 |
|
15310 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP33 |
0.443193715526342 |
|
15311 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRODH2 |
0.443193715526342 |
|
15312 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPHS1 |
0.443193715526342 |
|
15313 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIRREL2 |
0.443193715526342 |
|
15314 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APLP1 |
0.443193715526342 |
|
15315 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL402P |
0.443193715526342 |
|
15316 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFKBID |
0.443193715526342 |
|
15317 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCST |
0.443193715526342 |
|
15318 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TYROBP |
0.443193715526342 |
|
15319 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRFN3 |
0.443193715526342 |
|
15320 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF461 |
0.443193715526342 |
|
15321 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF567 |
0.443193715526342 |
|
15322 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF850 |
0.443193715526342 |
|
15323 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF790 |
0.443193715526342 |
|
15324 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF345 |
0.443193715526342 |
|
15325 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF829 |
0.443193715526342 |
|
15326 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF568 |
0.443193715526342 |
|
15327 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF420 |
0.443193715526342 |
|
15328 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF585A |
0.443193715526342 |
|
15329 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF585B |
0.443193715526342 |
|
15330 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF383 |
0.443193715526342 |
|
15331 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SARS2 |
0.443193715526342 |
|
15332 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO17 |
0.443193715526342 |
|
15333 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO27 |
0.443193715526342 |
|
15334 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAPL |
0.443193715526342 |
|
15335 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000251709.1 |
0.443193715526342 |
|
15336 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAK4 |
0.443193715526342 |
|
15337 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCCRP1 |
0.443193715526342 |
|
15338 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYCN |
0.443193715526342 |
|
15339 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNL3 |
0.443193715526342 |
|
15340 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNL4 |
0.443193715526342 |
|
15341 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNL2 |
0.443193715526342 |
|
15342 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNL1 |
0.443193715526342 |
|
15343 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRFN1 |
0.443193715526342 |
|
15344 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GMFG |
0.443193715526342 |
|
15345 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAMD4B |
0.443193715526342 |
|
15346 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL566P |
0.443193715526342 |
|
15347 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAF1 |
0.443193715526342 |
|
15348 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED29 |
0.443193715526342 |
|
15349 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4530 |
0.443193715526342 |
|
15350 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHG2 |
0.443193715526342 |
|
15351 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFP36 |
0.443193715526342 |
|
15352 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS16 |
0.443193715526342 |
|
15353 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUPT5H |
0.443193715526342 |
|
15354 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLL3 |
0.443193715526342 |
|
15355 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIMM50 |
0.443193715526342 |
|
15356 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SELV |
0.443193715526342 |
|
15357 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EID2B |
0.443193715526342 |
|
15358 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EID2 |
0.443193715526342 |
|
15359 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHD9 |
0.445371199552903 |
|
15360 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERG |
0.447185309792238 |
|
15361 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OARD1 |
0.448276574463066 |
|
15362 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UNC5CL |
0.448276574463066 |
|
15363 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPO2 |
0.448276574463066 |
|
15364 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOBEC2 |
0.448276574463066 |
|
15365 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFYA |
0.448276574463066 |
|
15366 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADCY10P1 |
0.448276574463066 |
|
15367 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TREML1 |
0.448276574463066 |
|
15368 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TREM2 |
0.448276574463066 |
|
15369 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TREML2 |
0.448276574463066 |
|
15370 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TREML3P |
0.448276574463066 |
|
15371 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TREML4 |
0.448276574463066 |
|
15372 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP207 |
0.448276574463066 |
|
15373 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TREM1 |
0.448276574463066 |
|
15374 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCR2 |
0.448276574463066 |
|
15375 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXP4 |
0.448276574463066 |
|
15376 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4641 |
0.448276574463066 |
|
15377 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MDFI |
0.448276574463066 |
|
15378 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFEB |
0.448276574463066 |
|
15379 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGC |
0.448276574463066 |
|
15380 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRS3 |
0.448276574463066 |
|
15381 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRICKLE4 |
0.448276574463066 |
|
15382 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOMM6 |
0.448276574463066 |
|
15383 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP49 |
0.448276574463066 |
|
15384 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA8|ENSG00000206977.1 |
0.448276574463066 |
|
15385 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED20 |
0.448276574463066 |
|
15386 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BYSL |
0.448276574463066 |
|
15387 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCND3 |
0.448276574463066 |
|
15388 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAF8 |
0.448276574463066 |
|
15389 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf132 |
0.448276574463066 |
|
15390 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GUCA1A |
0.448276574463066 |
|
15391 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GUCA1B |
0.448276574463066 |
|
15392 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS10 |
0.448276574463066 |
|
15393 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRERF1 |
0.448276574463066 |
|
15394 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000221252.1 |
0.448276574463066 |
|
15395 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238611.1 |
0.448276574463066 |
|
15396 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBR2 |
0.448276574463066 |
|
15397 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRPH2 |
0.448276574463066 |
|
15398 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBCC |
0.448276574463066 |
|
15399 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLTSCR1L |
0.448276574463066 |
|
15400 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL7L1 |
0.448276574463066 |
|
15401 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf226 |
0.448276574463066 |
|
15402 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTCRA |
0.448276574463066 |
|
15403 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNPY3 |
0.448276574463066 |
|
15404 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNMT |
0.448276574463066 |
|
15405 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEX6 |
0.448276574463066 |
|
15406 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP2R5D |
0.448276574463066 |
|
15407 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEA1 |
0.448276574463066 |
|
15408 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHDC3 |
0.448276574463066 |
|
15409 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRP36 |
0.448276574463066 |
|
15410 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL403P |
0.448276574463066 |
|
15411 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CUL7 |
0.448276574463066 |
|
15412 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLC4 |
0.448276574463066 |
|
15413 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL2 |
0.448276574463066 |
|
15414 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTK7 |
0.448276574463066 |
|
15415 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRF |
0.448276574463066 |
|
15416 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CUL9 |
0.448276574463066 |
|
15417 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNPH1 |
0.448276574463066 |
|
15418 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTBK1 |
0.448276574463066 |
|
15419 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC22A7 |
0.448276574463066 |
|
15420 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRIP3 |
0.448276574463066 |
|
15421 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF318 |
0.448276574463066 |
|
15422 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCC10 |
0.448276574463066 |
|
15423 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLK2 |
0.448276574463066 |
|
15424 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TJAP1 |
0.448276574463066 |
|
15425 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC73 |
0.448276574463066 |
|
15426 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR1C |
0.448276574463066 |
|
15427 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YIPF3 |
0.448276574463066 |
|
15428 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XPO5 |
0.448276574463066 |
|
15429 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA15|ENSG00000252218.1 |
0.448276574463066 |
|
15430 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLH |
0.448276574463066 |
|
15431 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTPBP2 |
0.448276574463066 |
|
15432 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAD2L1BP |
0.448276574463066 |
|
15433 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RSPH9 |
0.448276574463066 |
|
15434 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS18A |
0.448276574463066 |
|
15435 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VEGFA |
0.448276574463066 |
|
15436 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL14 |
0.448276574463066 |
|
15437 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM63B |
0.448276574463066 |
|
15438 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPN11 |
0.448276574463066 |
|
15439 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC29A1 |
0.448276574463066 |
|
15440 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSP90AB1 |
0.448276574463066 |
|
15441 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4647 |
0.448276574463066 |
|
15442 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35B2 |
0.448276574463066 |
|
15443 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFKBIE |
0.448276574463066 |
|
15444 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM151B |
0.448276574463066 |
|
15445 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCTE1 |
0.448276574463066 |
|
15446 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AARS2 |
0.448276574463066 |
|
15447 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATS1 |
0.448276574463066 |
|
15448 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC5L |
0.448276574463066 |
|
15449 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4642 |
0.448276574463066 |
|
15450 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUPT3H |
0.448276574463066 |
|
15451 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR586 |
0.448276574463066 |
|
15452 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RUNX2 |
0.448276574463066 |
|
15453 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLIC5 |
0.448276574463066 |
|
15454 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENPP4 |
0.448276574463066 |
|
15455 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENPP5 |
0.448276574463066 |
|
15456 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RCAN2 |
0.448276574463066 |
|
15457 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0355 |
0.448662772233581 |
|
15458 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPI |
0.448662772233581 |
|
15459 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDCD2L |
0.448662772233581 |
|
15460 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL154P |
0.448662772233581 |
|
15461 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBA2 |
0.448662772233581 |
|
15462 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WTIP |
0.448662772233581 |
|
15463 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCGB1B2P |
0.448662772233581 |
|
15464 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD111|ENSG00000252230.1 |
0.448662772233581 |
|
15465 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF565 |
0.448662772233581 |
|
15466 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00665 |
0.448662772233581 |
|
15467 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFP14 |
0.448662772233581 |
|
15468 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFP82 |
0.448662772233581 |
|
15469 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF566 |
0.448662772233581 |
|
15470 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF260 |
0.448662772233581 |
|
15471 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF529 |
0.448662772233581 |
|
15472 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF382 |
0.448662772233581 |
|
15473 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIPA1L3 |
0.448662772233581 |
|
15474 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPF1 |
0.448662772233581 |
|
15475 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL663P |
0.448662772233581 |
|
15476 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPINT2 |
0.448662772233581 |
|
15477 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R14A |
0.448662772233581 |
|
15478 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf33 |
0.448662772233581 |
|
15479 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YIF1B |
0.448662772233581 |
|
15480 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNK6 |
0.448662772233581 |
|
15481 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CATSPERG |
0.448662772233581 |
|
15482 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238838.1 |
0.448662772233581 |
|
15483 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMD8 |
0.448662772233581 |
|
15484 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GGN |
0.448662772233581 |
|
15485 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPRED3 |
0.448662772233581 |
|
15486 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM98C |
0.448662772233581 |
|
15487 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASGRP4 |
0.448662772233581 |
|
15488 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RYR1 |
0.448662772233581 |
|
15489 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP4K1 |
0.448662772233581 |
|
15490 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF3K |
0.448662772233581 |
|
15491 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTN4 |
0.448662772233581 |
|
15492 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPN12 |
0.448662772233581 |
|
15493 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGALS7 |
0.448662772233581 |
|
15494 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGALS7B |
0.448662772233581 |
|
15495 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGALS4 |
0.448662772233581 |
|
15496 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ECH1 |
0.448662772233581 |
|
15497 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPL |
0.448662772233581 |
|
15498 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RINL |
0.448662772233581 |
|
15499 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIRT2 |
0.448662772233581 |
|
15500 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFKBIB |
0.448662772233581 |
|
15501 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS12 |
0.448662772233581 |
|
15502 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IQCB1 |
0.449560885746055 |
|
15503 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EAF2 |
0.449560885746055 |
|
15504 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC15A2 |
0.449560885746055 |
|
15505 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD47 |
0.450100239667625 |
|
15506 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFT57 |
0.450100239667625 |
|
15507 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HHLA2 |
0.450100239667625 |
|
15508 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYH15 |
0.450100239667625 |
|
15509 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUSP22 |
0.45067568280873 |
|
15510 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXOC2 |
0.45067568280873 |
|
15511 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HUS1B |
0.45067568280873 |
|
15512 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRF4 |
0.45067568280873 |
|
15513 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238438.1 |
0.45067568280873 |
|
15514 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXQ1 |
0.45067568280873 |
|
15515 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXF2 |
0.45067568280873 |
|
15516 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL352P |
0.45067568280873 |
|
15517 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXC1 |
0.45067568280873 |
|
15518 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf195 |
0.45067568280873 |
|
15519 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYLK4 |
0.45067568280873 |
|
15520 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WRNIP1 |
0.45067568280873 |
|
15521 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINB1 |
0.45067568280873 |
|
15522 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4645 |
0.45067568280873 |
|
15523 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINB9 |
0.45067568280873 |
|
15524 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINB6 |
0.45067568280873 |
|
15525 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NQO2 |
0.45067568280873 |
|
15526 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIPK1 |
0.45067568280873 |
|
15527 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP201 |
0.45067568280873 |
|
15528 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BPHL |
0.45067568280873 |
|
15529 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBB2A |
0.45067568280873 |
|
15530 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBB2B |
0.45067568280873 |
|
15531 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMG4 |
0.45067568280873 |
|
15532 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC22A23 |
0.45067568280873 |
|
15533 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PXDC1 |
0.45067568280873 |
|
15534 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM50B |
0.45067568280873 |
|
15535 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6ORF50 |
0.45067568280873 |
|
15536 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRPF4B |
0.45067568280873 |
|
15537 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM217A |
0.45067568280873 |
|
15538 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000252668.1 |
0.45067568280873 |
|
15539 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf201 |
0.45067568280873 |
|
15540 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ECI2 |
0.45067568280873 |
|
15541 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP202 |
0.45067568280873 |
|
15542 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238801.1 |
0.45067568280873 |
|
15543 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDYL |
0.45067568280873 |
|
15544 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPP40 |
0.45067568280873 |
|
15545 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RMRPP2 |
0.45067568280873 |
|
15546 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R3G |
0.45067568280873 |
|
15547 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYRM4 |
0.45067568280873 |
|
15548 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3691 |
0.45067568280873 |
|
15549 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL221P |
0.45067568280873 |
|
15550 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRN1 |
0.45067568280873 |
|
15551 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
F13A1 |
0.45067568280873 |
|
15552 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5683 |
0.45067568280873 |
|
15553 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LY86 |
0.45067568280873 |
|
15554 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL554P |
0.45067568280873 |
|
15555 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000251762.1 |
0.45067568280873 |
|
15556 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RREB1 |
0.45067568280873 |
|
15557 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSR1 |
0.45067568280873 |
|
15558 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAGE1 |
0.45067568280873 |
|
15559 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIOK1 |
0.45067568280873 |
|
15560 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DSP |
0.45067568280873 |
|
15561 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNRNP48 |
0.45067568280873 |
|
15562 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BMP6 |
0.45067568280873 |
|
15563 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TXNDC5 |
0.45067568280873 |
|
15564 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BLOC1S5 |
0.45067568280873 |
|
15565 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EEF1E1 |
0.45067568280873 |
|
15566 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35B3 |
0.45067568280873 |
|
15567 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HULC |
0.45067568280873 |
|
15568 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OFCC1 |
0.45067568280873 |
|
15569 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC21P |
0.45067568280873 |
|
15570 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFAP2A |
0.45067568280873 |
|
15571 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00518 |
0.45067568280873 |
|
15572 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5689 |
0.45067568280873 |
|
15573 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCNT2 |
0.45067568280873 |
|
15574 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf52 |
0.45067568280873 |
|
15575 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCNT6 |
0.45067568280873 |
|
15576 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAK1IP1 |
0.45067568280873 |
|
15577 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM14C |
0.45067568280873 |
|
15578 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYCP2L |
0.45067568280873 |
|
15579 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM14B |
0.45067568280873 |
|
15580 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP203 |
0.45067568280873 |
|
15581 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAK |
0.45067568280873 |
|
15582 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCM2 |
0.45067568280873 |
|
15583 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELOVL2 |
0.45067568280873 |
|
15584 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238896.1 |
0.45067568280873 |
|
15585 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMIM13 |
0.45067568280873 |
|
15586 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEDD9 |
0.45067568280873 |
|
15587 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM170B |
0.45067568280873 |
|
15588 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA67|ENSG00000207419.1 |
0.45067568280873 |
|
15589 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIVEP1 |
0.45067568280873 |
|
15590 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EDN1 |
0.45067568280873 |
|
15591 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP293 |
0.45067568280873 |
|
15592 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHACTR1 |
0.45067568280873 |
|
15593 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D7 |
0.45067568280873 |
|
15594 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNR |
0.453140946925769 |
|
15595 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00163 |
0.453888978978139 |
|
15596 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00162 |
0.453888978978139 |
|
15597 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSR4P1 |
0.453888978978139 |
|
15598 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADARB1 |
0.453888978978139 |
|
15599 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLOCK |
0.457007472815554 |
|
15600 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP30 |
0.457007472815554 |
|
15601 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDCL2 |
0.457007472815554 |
|
15602 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NMU |
0.457007472815554 |
|
15603 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNJ6 |
0.458931549167997 |
|
15604 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DSCR4 |
0.458931549167997 |
|
15605 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DSCR8 |
0.458931549167997 |
|
15606 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNJ15 |
0.458931549167997 |
|
15607 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238581.1 |
0.458931549167997 |
|
15608 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DSCR10 |
0.458931549167997 |
|
15609 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00114 |
0.458931549167997 |
|
15610 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ETS2 |
0.458931549167997 |
|
15611 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA62|ENSG00000272015.1 |
0.458931549167997 |
|
15612 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMG1 |
0.458931549167997 |
|
15613 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRWD1 |
0.458931549167997 |
|
15614 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMGN1 |
0.458931549167997 |
|
15615 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238556.1 |
0.458931549167997 |
|
15616 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WRB |
0.458931549167997 |
|
15617 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCA5L |
0.458931549167997 |
|
15618 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3BGR |
0.458931549167997 |
|
15619 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B3GALT5 |
0.458931549167997 |
|
15620 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C21orf88 |
0.458931549167997 |
|
15621 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGSF5 |
0.458931549167997 |
|
15622 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCP4 |
0.458931549167997 |
|
15623 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DSCAM |
0.458931549167997 |
|
15624 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4760 |
0.458931549167997 |
|
15625 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA51|ENSG00000207147.1 |
0.458931549167997 |
|
15626 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00323 |
0.458931549167997 |
|
15627 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BACE2 |
0.458931549167997 |
|
15628 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3197 |
0.458931549167997 |
|
15629 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM3B |
0.458931549167997 |
|
15630 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MX2 |
0.458931549167997 |
|
15631 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MX1 |
0.458931549167997 |
|
15632 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMPRSS2 |
0.458931549167997 |
|
15633 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA32|ENSG00000207503.1 |
0.458931549167997 |
|
15634 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000252771.1 |
0.458931549167997 |
|
15635 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00111 |
0.458931549167997 |
|
15636 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00479 |
0.458931549167997 |
|
15637 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00112 |
0.458931549167997 |
|
15638 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIPK4 |
0.458931549167997 |
|
15639 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRDM15 |
0.458931549167997 |
|
15640 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA3|ENSG00000251778.1 |
0.458931549167997 |
|
15641 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2CD2 |
0.458931549167997 |
|
15642 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB21 |
0.458931549167997 |
|
15643 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UMODL1 |
0.458931549167997 |
|
15644 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C21orf128 |
0.458931549167997 |
|
15645 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCG1 |
0.458931549167997 |
|
15646 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP492 |
0.458931549167997 |
|
15647 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFF3 |
0.458931549167997 |
|
15648 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFF2 |
0.458931549167997 |
|
15649 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFF1 |
0.458931549167997 |
|
15650 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMPRSS3 |
0.458931549167997 |
|
15651 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBASH3A |
0.458931549167997 |
|
15652 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RSPH1 |
0.458931549167997 |
|
15653 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC37A1 |
0.458931549167997 |
|
15654 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE9A |
0.458931549167997 |
|
15655 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR4 |
0.458931549167997 |
|
15656 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFV3 |
0.458931549167997 |
|
15657 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5692B |
0.458931549167997 |
|
15658 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKNOX1 |
0.458931549167997 |
|
15659 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBS |
0.458931549167997 |
|
15660 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U2AF1 |
0.458931549167997 |
|
15661 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRYAA |
0.458931549167997 |
|
15662 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00313 |
0.458931549167997 |
|
15663 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00319 |
0.458931549167997 |
|
15664 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00322 |
0.458931549167997 |
|
15665 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIK1 |
0.458931549167997 |
|
15666 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSF2BP |
0.458931549167997 |
|
15667 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRP1B |
0.458931549167997 |
|
15668 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDXK |
0.458931549167997 |
|
15669 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSTB |
0.458931549167997 |
|
15670 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRP1 |
0.458931549167997 |
|
15671 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGPAT3 |
0.458931549167997 |
|
15672 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAPPC10 |
0.458931549167997 |
|
15673 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PWP2 |
0.458931549167997 |
|
15674 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C21orf33 |
0.458931549167997 |
|
15675 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ICOSLG |
0.458931549167997 |
|
15676 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNMT3L |
0.458931549167997 |
|
15677 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AIRE |
0.458931549167997 |
|
15678 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PFKL |
0.458931549167997 |
|
15679 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C21orf2 |
0.458931549167997 |
|
15680 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPM2 |
0.458931549167997 |
|
15681 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoZ6|ENSG00000264452.1 |
0.458931549167997 |
|
15682 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoZ6|ENSG00000266692.1 |
0.458931549167997 |
|
15683 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC3 |
0.458931549167997 |
|
15684 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC3DN |
0.458931549167997 |
|
15685 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPEAR |
0.458931549167997 |
|
15686 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C21orf90 |
0.458931549167997 |
|
15687 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2G2 |
0.458931549167997 |
|
15688 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUMO3 |
0.458931549167997 |
|
15689 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTTG1IP |
0.458931549167997 |
|
15690 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGB2 |
0.458931549167997 |
|
15691 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C21orf67 |
0.458931549167997 |
|
15692 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM207A |
0.458931549167997 |
|
15693 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRED57 |
0.458931549167997 |
|
15694 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRED58 |
0.458931549167997 |
|
15695 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM126B |
0.459051371628496 |
|
15696 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM126A |
0.459051371628496 |
|
15697 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CREBZF |
0.459051371628496 |
|
15698 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC89 |
0.459051371628496 |
|
15699 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYTL2 |
0.459051371628496 |
|
15700 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC83 |
0.459051371628496 |
|
15701 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PICALM |
0.459051371628496 |
|
15702 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238666.1 |
0.459051371628496 |
|
15703 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EED |
0.459051371628496 |
|
15704 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf73 |
0.459051371628496 |
|
15705 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL225P |
0.459051371628496 |
|
15706 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC81 |
0.459051371628496 |
|
15707 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ME3 |
0.459051371628496 |
|
15708 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS23 |
0.459051371628496 |
|
15709 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FZD4 |
0.459051371628496 |
|
15710 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM135 |
0.459051371628496 |
|
15711 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UNC5D |
0.459388771769378 |
|
15712 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOTCH1 |
0.461810526083196 |
|
15713 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4673 |
0.461810526083196 |
|
15714 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4674 |
0.461810526083196 |
|
15715 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000252440.1 |
0.461810526083196 |
|
15716 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGPAT2 |
0.461810526083196 |
|
15717 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EGFL7 |
0.461810526083196 |
|
15718 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR126 |
0.461810526083196 |
|
15719 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM69B |
0.461810526083196 |
|
15720 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNHG7 |
0.461810526083196 |
|
15721 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCN10 |
0.461810526083196 |
|
15722 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCN6 |
0.461810526083196 |
|
15723 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCN8 |
0.461810526083196 |
|
15724 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCN15 |
0.461810526083196 |
|
15725 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM141 |
0.461810526083196 |
|
15726 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1984 |
0.461810526083196 |
|
15727 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RABL6 |
0.461810526083196 |
|
15728 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf172 |
0.461810526083196 |
|
15729 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EDF1 |
0.461810526083196 |
|
15730 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAMDC4 |
0.461810526083196 |
|
15731 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4292 |
0.461810526083196 |
|
15732 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHPT1 |
0.461810526083196 |
|
15733 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4479 |
0.461810526083196 |
|
15734 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAF2 |
0.461810526083196 |
|
15735 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C8G |
0.461810526083196 |
|
15736 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXW5 |
0.461810526083196 |
|
15737 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCN12 |
0.461810526083196 |
|
15738 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf141 |
0.461810526083196 |
|
15739 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCNL1 |
0.461810526083196 |
|
15740 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTGDS |
0.461810526083196 |
|
15741 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf142 |
0.461810526083196 |
|
15742 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLIC3 |
0.461810526083196 |
|
15743 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCA2 |
0.461810526083196 |
|
15744 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf139 |
0.461810526083196 |
|
15745 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FUT7 |
0.461810526083196 |
|
15746 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPDC1 |
0.461810526083196 |
|
15747 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENTPD2 |
0.461810526083196 |
|
15748 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAPCD2 |
0.461810526083196 |
|
15749 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UAP1L1 |
0.461810526083196 |
|
15750 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAN1B1 |
0.461810526083196 |
|
15751 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD62 |
0.461810526083196 |
|
15752 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPP7 |
0.461810526083196 |
|
15753 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238824.1 |
0.461810526083196 |
|
15754 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRIN1 |
0.461810526083196 |
|
15755 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANAPC2 |
0.461810526083196 |
|
15756 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC26 |
0.461810526083196 |
|
15757 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3621 |
0.461810526083196 |
|
15758 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSNA1 |
0.461810526083196 |
|
15759 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM210 |
0.461810526083196 |
|
15760 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf169 |
0.461810526083196 |
|
15761 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM166A |
0.461810526083196 |
|
15762 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDOR1 |
0.461810526083196 |
|
15763 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF208 |
0.461810526083196 |
|
15764 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF224 |
0.461810526083196 |
|
15765 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC34A3 |
0.461810526083196 |
|
15766 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM203 |
0.461810526083196 |
|
15767 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPRN |
0.461810526083196 |
|
15768 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBB4B |
0.461810526083196 |
|
15769 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf173 |
0.461810526083196 |
|
15770 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NELFB |
0.461810526083196 |
|
15771 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXD3 |
0.461810526083196 |
|
15772 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRARP |
0.461810526083196 |
|
15773 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOR4A |
0.461810526083196 |
|
15774 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOXA1 |
0.461810526083196 |
|
15775 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000272272.1 |
0.461810526083196 |
|
15776 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENTPD8 |
0.461810526083196 |
|
15777 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NSMF |
0.461810526083196 |
|
15778 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNPLA7 |
0.461810526083196 |
|
15779 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPH7 |
0.461810526083196 |
|
15780 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL41 |
0.461810526083196 |
|
15781 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZMYND19 |
0.461810526083196 |
|
15782 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARRDC1 |
0.461810526083196 |
|
15783 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf37 |
0.461810526083196 |
|
15784 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EHMT1 |
0.461810526083196 |
|
15785 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR602 |
0.461810526083196 |
|
15786 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNA1B |
0.461810526083196 |
|
15787 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM157B |
0.461810526083196 |
|
15788 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBBP5 |
0.461810526083196 |
|
15789 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00364 |
0.462162876342548 |
|
15790 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL761P |
0.462162876342548 |
|
15791 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL1 |
0.462162876342548 |
|
15792 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY3P10 |
0.462162876342548 |
|
15793 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATXN8OS |
0.462162876342548 |
|
15794 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERC1 |
0.463755915306964 |
|
15795 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL852P |
0.463755915306964 |
|
15796 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXL14 |
0.463755915306964 |
|
15797 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00942 |
0.463755915306964 |
|
15798 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3649 |
0.463755915306964 |
|
15799 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WNT5B |
0.463755915306964 |
|
15800 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRMT8 |
0.463755915306964 |
|
15801 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFCAB4B |
0.463755915306964 |
|
15802 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARP11 |
0.463755915306964 |
|
15803 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCND2 |
0.463755915306964 |
|
15804 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf5 |
0.463755915306964 |
|
15805 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGF23 |
0.463755915306964 |
|
15806 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGF6 |
0.463755915306964 |
|
15807 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf4 |
0.463755915306964 |
|
15808 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAD51AP1 |
0.463755915306964 |
|
15809 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DYRK4 |
0.463755915306964 |
|
15810 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFA9 |
0.463755915306964 |
|
15811 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKAP3 |
0.463755915306964 |
|
15812 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALNT8 |
0.463755915306964 |
|
15813 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNA6 |
0.463755915306964 |
|
15814 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNA1 |
0.463755915306964 |
|
15815 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNA5 |
0.463755915306964 |
|
15816 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NTF3 |
0.463755915306964 |
|
15817 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANO2 |
0.463755915306964 |
|
15818 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VWF |
0.463755915306964 |
|
15819 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL69P |
0.463755915306964 |
|
15820 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD9 |
0.463755915306964 |
|
15821 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHG6 |
0.463755915306964 |
|
15822 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFRSF1A |
0.463755915306964 |
|
15823 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL391P |
0.463755915306964 |
|
15824 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCNN1A |
0.463755915306964 |
|
15825 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LTBR |
0.463755915306964 |
|
15826 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD27 |
0.463755915306964 |
|
15827 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAPBPL |
0.463755915306964 |
|
15828 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VAMP1 |
0.463755915306964 |
|
15829 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL51 |
0.463755915306964 |
|
15830 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCAPD2 |
0.463755915306964 |
|
15831 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA10 |
0.463755915306964 |
|
15832 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAPDH |
0.463755915306964 |
|
15833 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFFO1 |
0.463755915306964 |
|
15834 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOP2 |
0.463755915306964 |
|
15835 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHD4 |
0.463755915306964 |
|
15836 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA11|ENSG00000251898.1 |
0.463755915306964 |
|
15837 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPAR5 |
0.463755915306964 |
|
15838 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACRBP |
0.463755915306964 |
|
15839 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ING4 |
0.463755915306964 |
|
15840 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF384 |
0.463755915306964 |
|
15841 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIANP |
0.463755915306964 |
|
15842 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COPS7A |
0.463755915306964 |
|
15843 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLF2 |
0.463755915306964 |
|
15844 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTMS |
0.463755915306964 |
|
15845 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAG3 |
0.463755915306964 |
|
15846 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL380P |
0.463755915306964 |
|
15847 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD4 |
0.463755915306964 |
|
15848 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR162 |
0.463755915306964 |
|
15849 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LEPREL2 |
0.463755915306964 |
|
15850 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNB3 |
0.463755915306964 |
|
15851 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDCA3 |
0.463755915306964 |
|
15852 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP5 |
0.463755915306964 |
|
15853 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPSB2 |
0.463755915306964 |
|
15854 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPI1 |
0.463755915306964 |
|
15855 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC23 |
0.463755915306964 |
|
15856 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL13P5 |
0.463755915306964 |
|
15857 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DSTNP2 |
0.463755915306964 |
|
15858 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENO2 |
0.463755915306964 |
|
15859 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATN1 |
0.463755915306964 |
|
15860 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf57 |
0.463755915306964 |
|
15861 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPN6 |
0.463755915306964 |
|
15862 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR141 |
0.463755915306964 |
|
15863 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR200C |
0.463755915306964 |
|
15864 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHB2 |
0.463755915306964 |
|
15865 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA12 |
0.463755915306964 |
|
15866 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMG1 |
0.463755915306964 |
|
15867 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPCAT3 |
0.463755915306964 |
|
15868 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1S |
0.463755915306964 |
|
15869 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1R |
0.463755915306964 |
|
15870 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1RL |
0.463755915306964 |
|
15871 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBP5 |
0.463755915306964 |
|
15872 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLSTN3 |
0.463755915306964 |
|
15873 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEX5 |
0.463755915306964 |
|
15874 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACSM4 |
0.463755915306964 |
|
15875 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD163L1 |
0.463755915306964 |
|
15876 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD163 |
0.463755915306964 |
|
15877 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOBEC1 |
0.463755915306964 |
|
15878 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GDF3 |
0.463755915306964 |
|
15879 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPPA3 |
0.463755915306964 |
|
15880 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC4C |
0.463755915306964 |
|
15881 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NANOGNB |
0.463755915306964 |
|
15882 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NANOG |
0.463755915306964 |
|
15883 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NANOGP1 |
0.463755915306964 |
|
15884 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC2A14 |
0.463755915306964 |
|
15885 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC2A3 |
0.463755915306964 |
|
15886 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXJ2 |
0.463755915306964 |
|
15887 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3AR1 |
0.463755915306964 |
|
15888 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NECAP1 |
0.463755915306964 |
|
15889 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC4A |
0.463755915306964 |
|
15890 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF705A |
0.463755915306964 |
|
15891 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM66C |
0.463755915306964 |
|
15892 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM86FP |
0.463755915306964 |
|
15893 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM90A1 |
0.463755915306964 |
|
15894 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00937 |
0.463755915306964 |
|
15895 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC6A |
0.463755915306964 |
|
15896 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC4D |
0.463755915306964 |
|
15897 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC4E |
0.463755915306964 |
|
15898 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA11|ENSG00000252727.1 |
0.463755915306964 |
|
15899 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AICDA |
0.463755915306964 |
|
15900 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFAP5 |
0.463755915306964 |
|
15901 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIMKLB |
0.463755915306964 |
|
15902 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
A2ML1 |
0.463755915306964 |
|
15903 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHC1 |
0.463755915306964 |
|
15904 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
M6PR |
0.463755915306964 |
|
15905 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLRG1 |
0.463755915306964 |
|
15906 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00612 |
0.463755915306964 |
|
15907 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
A2M |
0.463755915306964 |
|
15908 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PZP |
0.463755915306964 |
|
15909 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
A2MP1 |
0.463755915306964 |
|
15910 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00987 |
0.463755915306964 |
|
15911 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA75|ENSG00000212432.1 |
0.463755915306964 |
|
15912 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA75|ENSG00000212440.1 |
0.463755915306964 |
|
15913 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLRB1 |
0.463755915306964 |
|
15914 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC2D |
0.463755915306964 |
|
15915 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLECL1 |
0.463755915306964 |
|
15916 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGDIG |
0.466252488567642 |
|
15917 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AXIN1 |
0.466252488567642 |
|
15918 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf11 |
0.466252488567642 |
|
15919 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPN15 |
0.466252488567642 |
|
15920 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX11L10 |
0.466252488567642 |
|
15921 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DECR2 |
0.466252488567642 |
|
15922 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HBA1 |
0.466252488567642 |
|
15923 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HBA2 |
0.466252488567642 |
|
15924 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HBM |
0.466252488567642 |
|
15925 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HBQ1 |
0.466252488567642 |
|
15926 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HBZ |
0.466252488567642 |
|
15927 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITFG3 |
0.466252488567642 |
|
15928 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LUC7L |
0.466252488567642 |
|
15929 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3176 |
0.466252488567642 |
|
15930 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5587 |
0.466252488567642 |
|
15931 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPG |
0.466252488567642 |
|
15932 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL28 |
0.466252488567642 |
|
15933 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NHLRC4 |
0.466252488567642 |
|
15934 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NME4 |
0.466252488567642 |
|
15935 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPRL3 |
0.466252488567642 |
|
15936 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDIA2 |
0.466252488567642 |
|
15937 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIGQ |
0.466252488567642 |
|
15938 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR3K |
0.466252488567642 |
|
15939 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB11FIP3 |
0.466252488567642 |
|
15940 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB40C |
0.466252488567642 |
|
15941 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGS11 |
0.466252488567642 |
|
15942 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHBDF1 |
0.466252488567642 |
|
15943 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNRNP25 |
0.466252488567642 |
|
15944 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM8A |
0.466252488567642 |
|
15945 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WASH4P |
0.466252488567642 |
|
15946 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WASIR2 |
0.466252488567642 |
|
15947 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf13 |
0.466252488567642 |
|
15948 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM195A |
0.466252488567642 |
|
15949 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR90 |
0.466252488567642 |
|
15950 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WFIKKN1 |
0.466252488567642 |
|
15951 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHOT2 |
0.466252488567642 |
|
15952 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JMJD8 |
0.466252488567642 |
|
15953 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHBDL1 |
0.466252488567642 |
|
15954 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STUB1 |
0.466252488567642 |
|
15955 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXL16 |
0.466252488567642 |
|
15956 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR24 |
0.466252488567642 |
|
15957 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METRN |
0.466252488567642 |
|
15958 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC78 |
0.466252488567642 |
|
15959 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM173A |
0.466252488567642 |
|
15960 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAGHL |
0.466252488567642 |
|
15961 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NARFL |
0.466252488567642 |
|
15962 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHTF18 |
0.466252488567642 |
|
15963 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNG13 |
0.466252488567642 |
|
15964 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR662 |
0.466252488567642 |
|
15965 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSLNL |
0.466252488567642 |
|
15966 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSLN |
0.466252488567642 |
|
15967 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR25 |
0.466252488567642 |
|
15968 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPUSD1 |
0.466252488567642 |
|
15969 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMF1 |
0.466252488567642 |
|
15970 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOX8 |
0.466252488567642 |
|
15971 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSTR5 |
0.466252488567642 |
|
15972 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1QTNF8 |
0.466252488567642 |
|
15973 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNA1H |
0.466252488567642 |
|
15974 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS29P |
0.466252488567642 |
|
15975 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPSAB1 |
0.466252488567642 |
|
15976 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPSB2 |
0.466252488567642 |
|
15977 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPSD1 |
0.466252488567642 |
|
15978 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPSG1 |
0.466252488567642 |
|
15979 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2I |
0.466252488567642 |
|
15980 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAIAP3 |
0.466252488567642 |
|
15981 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNPTG |
0.466252488567642 |
|
15982 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSR3 |
0.466252488567642 |
|
15983 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UNKL |
0.466252488567642 |
|
15984 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf91 |
0.466252488567642 |
|
15985 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC154 |
0.466252488567642 |
|
15986 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLCN7 |
0.466252488567642 |
|
15987 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTX4 |
0.466252488567642 |
|
15988 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TELO2 |
0.466252488567642 |
|
15989 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFT140 |
0.466252488567642 |
|
15990 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM204 |
0.466252488567642 |
|
15991 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRAMP1L |
0.466252488567642 |
|
15992 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HN1L |
0.466252488567642 |
|
15993 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPK8IP3 |
0.466252488567642 |
|
15994 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3177 |
0.466252488567642 |
|
15995 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EME2 |
0.466252488567642 |
|
15996 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS34 |
0.466252488567642 |
|
15997 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NME3 |
0.466252488567642 |
|
15998 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUBP2 |
0.466252488567642 |
|
15999 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPSB3 |
0.466252488567642 |
|
16000 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAGH |
0.466252488567642 |
|
16001 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGFALS |
0.466252488567642 |
|
16002 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAHD1 |
0.466252488567642 |
|
16003 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEIOB |
0.466252488567642 |
|
16004 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL367P |
0.466252488567642 |
|
16005 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HS3ST6 |
0.466252488567642 |
|
16006 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSRB1 |
0.466252488567642 |
|
16007 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL3L |
0.466252488567642 |
|
16008 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFB10 |
0.466252488567642 |
|
16009 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF151 |
0.466252488567642 |
|
16010 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS2 |
0.466252488567642 |
|
16011 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNHG9 |
0.466252488567642 |
|
16012 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA10 |
0.466252488567642 |
|
16013 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA64|ENSG00000207405.1 |
0.466252488567642 |
|
16014 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBL3 |
0.466252488567642 |
|
16015 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOXO1 |
0.466252488567642 |
|
16016 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GFER |
0.466252488567642 |
|
16017 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYNGR3 |
0.466252488567642 |
|
16018 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPW |
0.466252488567642 |
|
16019 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF598 |
0.466252488567642 |
|
16020 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL219P |
0.466252488567642 |
|
16021 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC9A3R2 |
0.466252488567642 |
|
16022 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NTHL1 |
0.466252488567642 |
|
16023 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSC2 |
0.466252488567642 |
|
16024 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1225 |
0.466252488567642 |
|
16025 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKD1 |
0.466252488567642 |
|
16026 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASKIN1 |
0.466252488567642 |
|
16027 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4516 |
0.466252488567642 |
|
16028 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB26 |
0.466252488567642 |
|
16029 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD60|ENSG00000206630.1 |
0.466252488567642 |
|
16030 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAF7 |
0.466252488567642 |
|
16031 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLST8 |
0.466252488567642 |
|
16032 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRICD5 |
0.466252488567642 |
|
16033 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGP |
0.466252488567642 |
|
16034 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNASE1L2 |
0.466252488567642 |
|
16035 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
E4F1 |
0.466252488567642 |
|
16036 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ECI1 |
0.466252488567642 |
|
16037 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNPS1 |
0.466252488567642 |
|
16038 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR940 |
0.466252488567642 |
|
16039 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3677 |
0.466252488567642 |
|
16040 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCA3 |
0.466252488567642 |
|
16041 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4717 |
0.466252488567642 |
|
16042 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCA17P |
0.466252488567642 |
|
16043 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNF |
0.466252488567642 |
|
16044 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf59 |
0.466252488567642 |
|
16045 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NTN3 |
0.466252488567642 |
|
16046 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D24 |
0.466252488567642 |
|
16047 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6C |
0.466252488567642 |
|
16048 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6V0C |
0.466252488567642 |
|
16049 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMDHD2 |
0.466252488567642 |
|
16050 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEMP1 |
0.466252488567642 |
|
16051 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3178 |
0.466252488567642 |
|
16052 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDPK1 |
0.466252488567642 |
|
16053 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCTD5 |
0.466252488567642 |
|
16054 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDPK2 |
0.466252488567642 |
|
16055 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS27 |
0.466252488567642 |
|
16056 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRRM2 |
0.466252488567642 |
|
16057 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCEB2 |
0.466252488567642 |
|
16058 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS33 |
0.466252488567642 |
|
16059 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS41 |
0.466252488567642 |
|
16060 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA3|ENSG00000221719.1 |
0.466252488567642 |
|
16061 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS21 |
0.466252488567642 |
|
16062 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZG16B |
0.466252488567642 |
|
16063 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS30P |
0.466252488567642 |
|
16064 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS22 |
0.466252488567642 |
|
16065 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLYWCH2 |
0.466252488567642 |
|
16066 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLYWCH1 |
0.466252488567642 |
|
16067 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KREMEN2 |
0.466252488567642 |
|
16068 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAQR4 |
0.466252488567642 |
|
16069 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKMYT1 |
0.466252488567642 |
|
16070 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00514 |
0.466252488567642 |
|
16071 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLDN6 |
0.466252488567642 |
|
16072 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLDN9 |
0.466252488567642 |
|
16073 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC64B |
0.466252488567642 |
|
16074 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCFC1R1 |
0.466252488567642 |
|
16075 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THOC6 |
0.466252488567642 |
|
16076 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFRSF12A |
0.466252488567642 |
|
16077 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMP25 |
0.466252488567642 |
|
16078 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL32 |
0.466252488567642 |
|
16079 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSCAN10 |
0.466252488567642 |
|
16080 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF205 |
0.466252488567642 |
|
16081 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF213 |
0.466252488567642 |
|
16082 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASP16 |
0.466252488567642 |
|
16083 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1F1 |
0.466252488567642 |
|
16084 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF200 |
0.466252488567642 |
|
16085 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEFV |
0.466252488567642 |
|
16086 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF263 |
0.466252488567642 |
|
16087 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIGD7 |
0.466252488567642 |
|
16088 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF75A |
0.466252488567642 |
|
16089 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2C1 |
0.466252488567642 |
|
16090 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTRNR2L4 |
0.466252488567642 |
|
16091 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSCAN32 |
0.466252488567642 |
|
16092 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF174 |
0.466252488567642 |
|
16093 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF597 |
0.466252488567642 |
|
16094 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAA60 |
0.466252488567642 |
|
16095 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf90 |
0.466252488567642 |
|
16096 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLUAP1 |
0.466252488567642 |
|
16097 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NLRC3 |
0.466252488567642 |
|
16098 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLX4 |
0.466252488567642 |
|
16099 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNASE1 |
0.466252488567642 |
|
16100 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAP1 |
0.466252488567642 |
|
16101 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CREBBP |
0.466252488567642 |
|
16102 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADCY9 |
0.466252488567642 |
|
16103 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRL |
0.466252488567642 |
|
16104 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFAP4 |
0.466252488567642 |
|
16105 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLIS2 |
0.466252488567642 |
|
16106 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAM16 |
0.466252488567642 |
|
16107 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CORO7 |
0.466252488567642 |
|
16108 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VASN |
0.466252488567642 |
|
16109 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJA3 |
0.466252488567642 |
|
16110 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NMRAL1 |
0.466252488567642 |
|
16111 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMOX2 |
0.466252488567642 |
|
16112 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDIP1 |
0.466252488567642 |
|
16113 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf96 |
0.466252488567642 |
|
16114 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBALD1 |
0.466252488567642 |
|
16115 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MGRN1 |
0.466252488567642 |
|
16116 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL850P |
0.466252488567642 |
|
16117 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDT16L1 |
0.466252488567642 |
|
16118 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKS3 |
0.466252488567642 |
|
16119 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf71 |
0.466252488567642 |
|
16120 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF500 |
0.466252488567642 |
|
16121 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEPT12 |
0.466252488567642 |
|
16122 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMIM22 |
0.466252488567642 |
|
16123 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLYR1 |
0.466252488567642 |
|
16124 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ROGDI |
0.466252488567642 |
|
16125 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBN1 |
0.466252488567642 |
|
16126 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPL |
0.466252488567642 |
|
16127 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC14L5 |
0.466252488567642 |
|
16128 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAGPA |
0.466252488567642 |
|
16129 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALG1 |
0.466252488567642 |
|
16130 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf89 |
0.466252488567642 |
|
16131 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM86A |
0.466252488567642 |
|
16132 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBFOX1 |
0.466252488567642 |
|
16133 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA40|ENSG00000252138.1 |
0.466252488567642 |
|
16134 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM114 |
0.466252488567642 |
|
16135 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL22 |
0.466252488567642 |
|
16136 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABAT |
0.466252488567642 |
|
16137 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL743P |
0.466252488567642 |
|
16138 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM186 |
0.466252488567642 |
|
16139 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PMM2 |
0.466252488567642 |
|
16140 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf72 |
0.466252488567642 |
|
16141 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CARHSP1 |
0.466252488567642 |
|
16142 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP7 |
0.466252488567642 |
|
16143 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP403 |
0.466252488567642 |
|
16144 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP404 |
0.466252488567642 |
|
16145 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRIN2A |
0.466252488567642 |
|
16146 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL493P |
0.466252488567642 |
|
16147 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATF7IP2 |
0.466252488567642 |
|
16148 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL99P |
0.466252488567642 |
|
16149 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMP2 |
0.466252488567642 |
|
16150 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEKT5 |
0.466252488567642 |
|
16151 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUBP1 |
0.466252488567642 |
|
16152 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TVP23A |
0.466252488567642 |
|
16153 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RMI2 |
0.466252488567642 |
|
16154 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOCS1 |
0.466252488567642 |
|
16155 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNP2 |
0.466252488567642 |
|
16156 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRM3 |
0.466252488567642 |
|
16157 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA48|ENSG00000212228.1 |
0.466252488567642 |
|
16158 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRM2 |
0.466252488567642 |
|
16159 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRM1 |
0.466252488567642 |
|
16160 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238409.1 |
0.466252488567642 |
|
16161 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548H2 |
0.466252488567642 |
|
16162 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000272310.1 |
0.466252488567642 |
|
16163 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL522P |
0.466252488567642 |
|
16164 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LITAF |
0.466252488567642 |
|
16165 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNN |
0.466252488567642 |
|
16166 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TXNDC11 |
0.466252488567642 |
|
16167 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZC3H7A |
0.466252488567642 |
|
16168 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCAR4 |
0.466252488567642 |
|
16169 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RSL1D1 |
0.466252488567642 |
|
16170 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSPT1 |
0.466252488567642 |
|
16171 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFRSF17 |
0.466252488567642 |
|
16172 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX29 |
0.466252488567642 |
|
16173 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACA64|ENSG00000238685.1 |
0.466252488567642 |
|
16174 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPPED1 |
0.466252488567642 |
|
16175 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4718 |
0.466252488567642 |
|
16176 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA27|ENSG00000199474.1 |
0.466252488567642 |
|
16177 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHISA9 |
0.466252488567642 |
|
16178 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP184 |
0.472342144653936 |
|
16179 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM167A |
0.477586681586534 |
|
16180 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA18|ENSG00000238835.1 |
0.477586681586534 |
|
16181 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XRCC4 |
0.477586681586534 |
|
16182 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VCAN |
0.477586681586534 |
|
16183 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAPLN1 |
0.477586681586534 |
|
16184 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP295 |
0.477586681586534 |
|
16185 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EDIL3 |
0.477586681586534 |
|
16186 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBPF22P |
0.477586681586534 |
|
16187 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX7C |
0.477586681586534 |
|
16188 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3607 |
0.477586681586534 |
|
16189 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF708 |
0.47864814142042 |
|
16190 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF738 |
0.47864814142042 |
|
16191 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF493 |
0.47864814142042 |
|
16192 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C10orf76 |
0.478704545440408 |
|
16193 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HPS6 |
0.478704545440408 |
|
16194 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000253068.1 |
0.478704545440408 |
|
16195 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LDB1 |
0.478704545440408 |
|
16196 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPRC1 |
0.478704545440408 |
|
16197 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOLC1 |
0.478704545440408 |
|
16198 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELOVL3 |
0.478704545440408 |
|
16199 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PITX3 |
0.478704545440408 |
|
16200 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GBF1 |
0.478704545440408 |
|
16201 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CIITA |
0.478723037109228 |
|
16202 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEXI |
0.478723037109228 |
|
16203 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC16A |
0.478723037109228 |
|
16204 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNA2D4 |
0.479104315876233 |
|
16205 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRTM2 |
0.479104315876233 |
|
16206 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00940 |
0.479104315876233 |
|
16207 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCP1B |
0.479104315876233 |
|
16208 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF253 |
0.479159370286091 |
|
16209 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF430 |
0.479159370286091 |
|
16210 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF486 |
0.479159370286091 |
|
16211 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF626 |
0.479159370286091 |
|
16212 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF66 |
0.479159370286091 |
|
16213 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF682 |
0.479159370286091 |
|
16214 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF737 |
0.479159370286091 |
|
16215 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF826P |
0.479159370286091 |
|
16216 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF85 |
0.479159370286091 |
|
16217 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF90 |
0.479159370286091 |
|
16218 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF93 |
0.479159370286091 |
|
16219 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF714 |
0.479159370286091 |
|
16220 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP469 |
0.479159370286091 |
|
16221 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF431 |
0.479159370286091 |
|
16222 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF703 |
0.479755487652024 |
|
16223 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERLIN2 |
0.479755487652024 |
|
16224 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR124 |
0.479755487652024 |
|
16225 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PROSC |
0.479755487652024 |
|
16226 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRF2 |
0.479755487652024 |
|
16227 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB11FIP1 |
0.479755487652024 |
|
16228 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL709P |
0.479755487652024 |
|
16229 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOT1L1 |
0.479755487652024 |
|
16230 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADRB3 |
0.479755487652024 |
|
16231 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF4EBP1 |
0.479755487652024 |
|
16232 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASH2L |
0.479755487652024 |
|
16233 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAR |
0.479755487652024 |
|
16234 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LSM1 |
0.479755487652024 |
|
16235 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAG4 |
0.479755487652024 |
|
16236 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDHD2 |
0.479755487652024 |
|
16237 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPAPDC1B |
0.479755487652024 |
|
16238 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WHSC1L1 |
0.479755487652024 |
|
16239 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LETM2 |
0.479755487652024 |
|
16240 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGFR1 |
0.479755487652024 |
|
16241 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS20P22 |
0.479755487652024 |
|
16242 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C8orf86 |
0.479755487652024 |
|
16243 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNTN5 |
0.482955414930345 |
|
16244 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP53 |
0.482955414930345 |
|
16245 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL222P |
0.482955414930345 |
|
16246 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP42 |
0.482955414930345 |
|
16247 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP115 |
0.482955414930345 |
|
16248 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238388.1 |
0.482955414930345 |
|
16249 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM133 |
0.482955414930345 |
|
16250 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGR |
0.482955414930345 |
|
16251 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPC6 |
0.482955414930345 |
|
16252 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3920 |
0.482955414930345 |
|
16253 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANGPTL5 |
0.482955414930345 |
|
16254 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1377 |
0.482955414930345 |
|
16255 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf70 |
0.482955414930345 |
|
16256 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000252679.1 |
0.482955414930345 |
|
16257 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239154.1 |
0.482955414930345 |
|
16258 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YAP1 |
0.482955414930345 |
|
16259 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BIRC2 |
0.482955414930345 |
|
16260 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BIRC3 |
0.482955414930345 |
|
16261 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM123 |
0.482955414930345 |
|
16262 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMP7 |
0.482955414930345 |
|
16263 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMP20 |
0.482955414930345 |
|
16264 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMP27 |
0.482955414930345 |
|
16265 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMP8 |
0.482955414930345 |
|
16266 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WTAPP1 |
0.482955414930345 |
|
16267 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMP10 |
0.482955414930345 |
|
16268 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMP1 |
0.482955414930345 |
|
16269 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMP3 |
0.482955414930345 |
|
16270 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMP12 |
0.482955414930345 |
|
16271 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMP13 |
0.482955414930345 |
|
16272 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCUN1D5 |
0.482955414930345 |
|
16273 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DYNC2H1 |
0.482955414930345 |
|
16274 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4693 |
0.482955414930345 |
|
16275 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDGFD |
0.482955414930345 |
|
16276 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDI1 |
0.482955414930345 |
|
16277 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP348 |
0.482955414930345 |
|
16278 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASP12 |
0.482955414930345 |
|
16279 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASP4 |
0.482955414930345 |
|
16280 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASP5 |
0.482955414930345 |
|
16281 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASP1 |
0.482955414930345 |
|
16282 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CARD16 |
0.482955414930345 |
|
16283 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CARD17 |
0.482955414930345 |
|
16284 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CARD18 |
0.482955414930345 |
|
16285 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRIA4 |
0.482955414930345 |
|
16286 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSANTD4 |
0.482955414930345 |
|
16287 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KBTBD3 |
0.482955414930345 |
|
16288 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AASDHPPT |
0.482955414930345 |
|
16289 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GUCY1A2 |
0.482955414930345 |
|
16290 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CWF19L2 |
0.482955414930345 |
|
16291 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALKBH8 |
0.482955414930345 |
|
16292 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELMOD1 |
0.482955414930345 |
|
16293 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLN |
0.482955414930345 |
|
16294 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35F2 |
0.482955414930345 |
|
16295 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CUL5 |
0.482955414930345 |
|
16296 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB39A |
0.482955414930345 |
|
16297 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACAT1 |
0.482955414930345 |
|
16298 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPAT |
0.482955414930345 |
|
16299 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATM |
0.482955414930345 |
|
16300 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf65 |
0.482955414930345 |
|
16301 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KDELC2 |
0.482955414930345 |
|
16302 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXPH5 |
0.482955414930345 |
|
16303 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX10 |
0.482955414930345 |
|
16304 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP349 |
0.482955414930345 |
|
16305 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD39|ENSG00000264997.1 |
0.482955414930345 |
|
16306 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf87 |
0.482955414930345 |
|
16307 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZC3H12C |
0.482955414930345 |
|
16308 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RDX |
0.482955414930345 |
|
16309 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FDX1 |
0.482955414930345 |
|
16310 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP20 |
0.482955414930345 |
|
16311 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP350 |
0.482955414930345 |
|
16312 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf53 |
0.482955414930345 |
|
16313 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf92 |
0.482955414930345 |
|
16314 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf93 |
0.482955414930345 |
|
16315 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4491 |
0.482955414930345 |
|
16316 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POU2AF1 |
0.482955414930345 |
|
16317 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTG4 |
0.482955414930345 |
|
16318 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf88 |
0.482955414930345 |
|
16319 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR34B |
0.482955414930345 |
|
16320 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR34C |
0.482955414930345 |
|
16321 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAYN |
0.482955414930345 |
|
16322 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIK2 |
0.482955414930345 |
|
16323 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP273 |
0.482955414930345 |
|
16324 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP2R1B |
0.482955414930345 |
|
16325 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALG9 |
0.482955414930345 |
|
16326 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FDXACB1 |
0.482955414930345 |
|
16327 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf1 |
0.482955414930345 |
|
16328 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRYAB |
0.482955414930345 |
|
16329 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPB2 |
0.482955414930345 |
|
16330 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf52 |
0.482955414930345 |
|
16331 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DIXDC1 |
0.482955414930345 |
|
16332 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP351 |
0.482955414930345 |
|
16333 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLAT |
0.482955414930345 |
|
16334 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIH1D2 |
0.482955414930345 |
|
16335 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf57 |
0.482955414930345 |
|
16336 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIMM8B |
0.482955414930345 |
|
16337 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDHD |
0.482955414930345 |
|
16338 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL18 |
0.482955414930345 |
|
16339 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX12 |
0.482955414930345 |
|
16340 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCO2 |
0.482955414930345 |
|
16341 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTS |
0.482955414930345 |
|
16342 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf34 |
0.482955414930345 |
|
16343 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snosnR66 |
0.482955414930345 |
|
16344 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DENND1A |
0.483814328755788 |
|
16345 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSE1 |
0.486631717953502 |
|
16346 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GINS2 |
0.486631717953502 |
|
16347 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf74 |
0.486631717953502 |
|
16348 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADIPOR2 |
0.488988395756582 |
|
16349 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNA1C |
0.488988395756582 |
|
16350 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBX3P4 |
0.488988395756582 |
|
16351 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FKBP4 |
0.488988395756582 |
|
16352 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITFG2 |
0.488988395756582 |
|
16353 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRIP2 |
0.488988395756582 |
|
16354 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXM1 |
0.488988395756582 |
|
16355 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHNO1 |
0.488988395756582 |
|
16356 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TULP3 |
0.488988395756582 |
|
16357 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEAD4 |
0.488988395756582 |
|
16358 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPAN9 |
0.488988395756582 |
|
16359 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM38B |
0.489654934986997 |
|
16360 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP77 |
0.489654934986997 |
|
16361 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP292 |
0.489654934986997 |
|
16362 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF462 |
0.489654934986997 |
|
16363 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAD23B |
0.489654934986997 |
|
16364 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLF4 |
0.489654934986997 |
|
16365 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL659P |
0.489654934986997 |
|
16366 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP293 |
0.489654934986997 |
|
16367 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTL7B |
0.489654934986997 |
|
16368 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTL7A |
0.489654934986997 |
|
16369 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IKBKAP |
0.489654934986997 |
|
16370 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM206A |
0.489654934986997 |
|
16371 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTNNAL1 |
0.489654934986997 |
|
16372 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM245 |
0.489654934986997 |
|
16373 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR32 |
0.489654934986997 |
|
16374 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRRS1L |
0.489654934986997 |
|
16375 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPB41L4B |
0.489654934986997 |
|
16376 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPN3 |
0.489654934986997 |
|
16377 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3927 |
0.489654934986997 |
|
16378 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PALM2 |
0.489654934986997 |
|
16379 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKAP2 |
0.489654934986997 |
|
16380 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf152 |
0.489654934986997 |
|
16381 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TXNDC8 |
0.489654934986997 |
|
16382 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TXN |
0.489654934986997 |
|
16383 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SVEP1 |
0.489654934986997 |
|
16384 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUSK |
0.489654934986997 |
|
16385 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPAR1 |
0.489654934986997 |
|
16386 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P18 |
0.489654934986997 |
|
16387 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2K2 |
0.489654934986997 |
|
16388 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0368 |
0.489654934986997 |
|
16389 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP294 |
0.489654934986997 |
|
16390 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF483 |
0.489654934986997 |
|
16391 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTGR1 |
0.489654934986997 |
|
16392 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC37A5P |
0.489654934986997 |
|
16393 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC25 |
0.489654934986997 |
|
16394 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNG10 |
0.489654934986997 |
|
16395 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGCG |
0.489654934986997 |
|
16396 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4668 |
0.489654934986997 |
|
16397 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUSD1 |
0.489654934986997 |
|
16398 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTBP3 |
0.489654934986997 |
|
16399 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL57P |
0.489654934986997 |
|
16400 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP295 |
0.489654934986997 |
|
16401 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL430P |
0.489654934986997 |
|
16402 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSDL2 |
0.489654934986997 |
|
16403 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf147 |
0.489654934986997 |
|
16404 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1958 |
0.489654934986997 |
|
16405 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INIP |
0.489654934986997 |
|
16406 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX30 |
0.489654934986997 |
|
16407 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC46A2 |
0.489654934986997 |
|
16408 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM225A |
0.489654934986997 |
|
16409 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM225B |
0.489654934986997 |
|
16410 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFP37 |
0.489654934986997 |
|
16411 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF883 |
0.489654934986997 |
|
16412 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC31A2 |
0.489654934986997 |
|
16413 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FKBP15 |
0.489654934986997 |
|
16414 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC31A1 |
0.489654934986997 |
|
16415 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC26 |
0.489654934986997 |
|
16416 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRPF4 |
0.489654934986997 |
|
16417 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF183 |
0.489654934986997 |
|
16418 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR31 |
0.489654934986997 |
|
16419 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BSPRY |
0.489654934986997 |
|
16420 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HDHD3 |
0.489654934986997 |
|
16421 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALAD |
0.489654934986997 |
|
16422 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf43 |
0.489654934986997 |
|
16423 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLE3 |
0.489654934986997 |
|
16424 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGS3 |
0.489654934986997 |
|
16425 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR455 |
0.489654934986997 |
|
16426 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DFNB31 |
0.489654934986997 |
|
16427 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238530.1 |
0.489654934986997 |
|
16428 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6V1G1 |
0.489654934986997 |
|
16429 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf91 |
0.489654934986997 |
|
16430 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFSF15 |
0.489654934986997 |
|
16431 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFSF8 |
0.489654934986997 |
|
16432 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNC |
0.489654934986997 |
|
16433 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEC1 |
0.489654934986997 |
|
16434 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00474 |
0.489654934986997 |
|
16435 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAPPA |
0.489654934986997 |
|
16436 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASTN2 |
0.489654934986997 |
|
16437 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM32 |
0.489654934986997 |
|
16438 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70C |
0.489654934986997 |
|
16439 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP128 |
0.489654934986997 |
|
16440 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP125 |
0.489654934986997 |
|
16441 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLR4 |
0.489654934986997 |
|
16442 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DBC1 |
0.489654934986997 |
|
16443 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR147A |
0.489654934986997 |
|
16444 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK5RAP2 |
0.489654934986997 |
|
16445 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEGF9 |
0.489654934986997 |
|
16446 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXW2 |
0.489654934986997 |
|
16447 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMD5 |
0.489654934986997 |
|
16448 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHF19 |
0.489654934986997 |
|
16449 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAF1 |
0.489654934986997 |
|
16450 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5 |
0.489654934986997 |
|
16451 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNTRL |
0.489654934986997 |
|
16452 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB14 |
0.489654934986997 |
|
16453 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL181P |
0.489654934986997 |
|
16454 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSN |
0.489654934986997 |
|
16455 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STOM |
0.489654934986997 |
|
16456 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GGTA1P |
0.489654934986997 |
|
16457 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL187P |
0.489654934986997 |
|
16458 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DAB2IP |
0.489654934986997 |
|
16459 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTLL11 |
0.489654934986997 |
|
16460 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4478 |
0.489654934986997 |
|
16461 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFA8 |
0.489654934986997 |
|
16462 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MORN5 |
0.489654934986997 |
|
16463 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LHX6 |
0.489654934986997 |
|
16464 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM18 |
0.489654934986997 |
|
16465 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRRF |
0.489654934986997 |
|
16466 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL227P |
0.489654934986997 |
|
16467 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTGS1 |
0.489654934986997 |
|
16468 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1J1 |
0.489654934986997 |
|
16469 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1J2 |
0.489654934986997 |
|
16470 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1J4 |
0.489654934986997 |
|
16471 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1N1 |
0.489654934986997 |
|
16472 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1N2 |
0.489654934986997 |
|
16473 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1L8 |
0.489654934986997 |
|
16474 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1Q1 |
0.489654934986997 |
|
16475 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1B1 |
0.489654934986997 |
|
16476 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1L1 |
0.489654934986997 |
|
16477 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1L3 |
0.489654934986997 |
|
16478 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1L4 |
0.489654934986997 |
|
16479 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1L6 |
0.489654934986997 |
|
16480 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5C1 |
0.489654934986997 |
|
16481 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1K1 |
0.489654934986997 |
|
16482 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDCL |
0.489654934986997 |
|
16483 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RC3H2 |
0.489654934986997 |
|
16484 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD90 |
0.489654934986997 |
|
16485 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB6 |
0.489654934986997 |
|
16486 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB26 |
0.489654934986997 |
|
16487 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RABGAP1 |
0.489654934986997 |
|
16488 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR21 |
0.489654934986997 |
|
16489 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR600HG |
0.489654934986997 |
|
16490 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STRBP |
0.489654934986997 |
|
16491 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRB2 |
0.489654934986997 |
|
16492 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR601 |
0.489654934986997 |
|
16493 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADTRP |
0.494436101484015 |
|
16494 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF706 |
0.496372197823 |
|
16495 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NACAP1 |
0.496372197823 |
|
16496 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL563P |
0.496372197823 |
|
16497 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCALD |
0.496372197823 |
|
16498 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238372.1 |
0.496372197823 |
|
16499 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5680 |
0.496372197823 |
|
16500 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRM2B |
0.496372197823 |
|
16501 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBR5 |
0.496372197823 |
|
16502 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238533.1 |
0.496372197823 |
|
16503 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC8P |
0.496372197823 |
|
16504 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ODF1 |
0.496372197823 |
|
16505 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLF10 |
0.496372197823 |
|
16506 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AZIN1 |
0.496372197823 |
|
16507 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6V1C1 |
0.496372197823 |
|
16508 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C8orf56 |
0.496372197823 |
|
16509 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAALC |
0.496372197823 |
|
16510 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3151 |
0.496372197823 |
|
16511 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FZD6 |
0.496372197823 |
|
16512 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTHRC1 |
0.496372197823 |
|
16513 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A32 |
0.496372197823 |
|
16514 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCAF13 |
0.496372197823 |
|
16515 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIMS2 |
0.496372197823 |
|
16516 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238687.1 |
0.496372197823 |
|
16517 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPYS |
0.496372197823 |
|
16518 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCSTAMP |
0.496372197823 |
|
16519 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548A3 |
0.496372197823 |
|
16520 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRP12 |
0.496372197823 |
|
16521 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFPM2 |
0.496372197823 |
|
16522 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OXR1 |
0.496372197823 |
|
16523 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABRA |
0.496372197823 |
|
16524 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANGPT1 |
0.496372197823 |
|
16525 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP275 |
0.496372197823 |
|
16526 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RSPO2 |
0.496372197823 |
|
16527 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF3E |
0.496372197823 |
|
16528 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMC2 |
0.496372197823 |
|
16529 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM74 |
0.496372197823 |
|
16530 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRHR |
0.496372197823 |
|
16531 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDCD1 |
0.496372197823 |
|
16532 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENY2 |
0.496372197823 |
|
16533 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKHD1L1 |
0.496372197823 |
|
16534 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EBAG9 |
0.496372197823 |
|
16535 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYBU |
0.496372197823 |
|
16536 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252559.1 |
0.496372197823 |
|
16537 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNV1 |
0.496372197823 |
|
16538 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238656.1 |
0.496372197823 |
|
16539 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR2053 |
0.496372197823 |
|
16540 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPS1 |
0.496372197823 |
|
16541 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00536 |
0.496372197823 |
|
16542 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP276 |
0.496372197823 |
|
16543 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF3H |
0.496372197823 |
|
16544 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UTP23 |
0.496372197823 |
|
16545 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAD21 |
0.496372197823 |
|
16546 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3610 |
0.496372197823 |
|
16547 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AARD |
0.496372197823 |
|
16548 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC30A8 |
0.496372197823 |
|
16549 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL228P |
0.496372197823 |
|
16550 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL826P |
0.496372197823 |
|
16551 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000252852.1 |
0.496372197823 |
|
16552 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED30 |
0.496372197823 |
|
16553 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXT1 |
0.496372197823 |
|
16554 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAMD12 |
0.496372197823 |
|
16555 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFRSF11B |
0.496372197823 |
|
16556 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COLEC10 |
0.496372197823 |
|
16557 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAL2 |
0.496372197823 |
|
16558 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA32|ENSG00000206776.1 |
0.496372197823 |
|
16559 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOV |
0.496372197823 |
|
16560 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENPP2 |
0.496372197823 |
|
16561 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP153 |
0.496372197823 |
|
16562 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAF2 |
0.496372197823 |
|
16563 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DSCC1 |
0.496372197823 |
|
16564 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL396P |
0.496372197823 |
|
16565 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEPTOR |
0.496372197823 |
|
16566 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP277 |
0.496372197823 |
|
16567 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL14A1 |
0.496372197823 |
|
16568 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL13 |
0.496372197823 |
|
16569 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTBP |
0.496372197823 |
|
16570 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNTB1 |
0.496372197823 |
|
16571 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAS2 |
0.496372197823 |
|
16572 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238901.1 |
0.496372197823 |
|
16573 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZHX2 |
0.496372197823 |
|
16574 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DERL1 |
0.496372197823 |
|
16575 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P5 |
0.496372197823 |
|
16576 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D31 |
0.496372197823 |
|
16577 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM83A |
0.496372197823 |
|
16578 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000221461.1 |
0.496372197823 |
|
16579 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4663 |
0.496372197823 |
|
16580 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C8orf76 |
0.496372197823 |
|
16581 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZHX1 |
0.496372197823 |
|
16582 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238422.1 |
0.496372197823 |
|
16583 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATAD2 |
0.496372197823 |
|
16584 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548AA1 |
0.496372197823 |
|
16585 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDYHV1 |
0.496372197823 |
|
16586 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO32 |
0.496372197823 |
|
16587 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP155 |
0.496372197823 |
|
16588 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL38 |
0.496372197823 |
|
16589 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANXA13 |
0.496372197823 |
|
16590 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM91A1 |
0.496372197823 |
|
16591 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FER1L6 |
0.496372197823 |
|
16592 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM65 |
0.496372197823 |
|
16593 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRMT12 |
0.496372197823 |
|
16594 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF139 |
0.496372197823 |
|
16595 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TATDN1 |
0.496372197823 |
|
16596 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFB9 |
0.496372197823 |
|
16597 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTSS1 |
0.496372197823 |
|
16598 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4662B |
0.496372197823 |
|
16599 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00964 |
0.496372197823 |
|
16600 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF572 |
0.496372197823 |
|
16601 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SQLE |
0.496372197823 |
|
16602 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0196 |
0.496372197823 |
|
16603 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NSMCE2 |
0.496372197823 |
|
16604 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HKR1 |
0.499422156014067 |
|
16605 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF527 |
0.499422156014067 |
|
16606 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF569 |
0.499422156014067 |
|
16607 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF570 |
0.499422156014067 |
|
16608 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF793 |
0.499422156014067 |
|
16609 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF540 |
0.499422156014067 |
|
16610 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF571 |
0.499422156014067 |
|
16611 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFP30 |
0.499422156014067 |
|
16612 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF781 |
0.499422156014067 |
|
16613 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF607 |
0.499422156014067 |
|
16614 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF573 |
0.499422156014067 |
|
16615 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR87 |
0.499422156014067 |
|
16616 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP294 |
0.499746357183913 |
|
16617 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNTG1 |
0.499746357183913 |
|
16618 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA7|ENSG00000201316.1 |
0.499746357183913 |
|
16619 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PXDNL |
0.499746357183913 |
|
16620 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCMTD1 |
0.499746357183913 |
|
16621 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST18 |
0.499746357183913 |
|
16622 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM150A |
0.499746357183913 |
|
16623 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RB1CC1 |
0.499746357183913 |
|
16624 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPBWR1 |
0.499746357183913 |
|
16625 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OPRK1 |
0.499746357183913 |
|
16626 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6V1H |
0.499746357183913 |
|
16627 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGS20 |
0.499746357183913 |
|
16628 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCEA1 |
0.499746357183913 |
|
16629 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYPLA1 |
0.499746357183913 |
|
16630 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL15 |
0.499746357183913 |
|
16631 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC32P |
0.499746357183913 |
|
16632 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU105C |
0.499746357183913 |
|
16633 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL250P |
0.499746357183913 |
|
16634 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOX17 |
0.499746357183913 |
|
16635 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RP1 |
0.499746357183913 |
|
16636 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XKR4 |
0.499746357183913 |
|
16637 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM68 |
0.499746357183913 |
|
16638 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP265 |
0.499746357183913 |
|
16639 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TGS1 |
0.499746357183913 |
|
16640 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYN |
0.499746357183913 |
|
16641 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA1|ENSG00000199405.1 |
0.499746357183913 |
|
16642 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL798P |
0.499746357183913 |
|
16643 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL323P |
0.499746357183913 |
|
16644 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS20 |
0.499746357183913 |
|
16645 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD54 |
0.499746357183913 |
|
16646 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOS |
0.499746357183913 |
|
16647 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA3|ENSG00000221093.1 |
0.499746357183913 |
|
16648 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLAG1 |
0.499746357183913 |
|
16649 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHCHD7 |
0.499746357183913 |
|
16650 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDR16C5 |
0.499746357183913 |
|
16651 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDR16C6P |
0.499746357183913 |
|
16652 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PENK |
0.499746357183913 |
|
16653 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00968 |
0.499746357183913 |
|
16654 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IMPAD1 |
0.499746357183913 |
|
16655 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP266 |
0.499746357183913 |
|
16656 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00588 |
0.499746357183913 |
|
16657 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM110B |
0.499746357183913 |
|
16658 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBXN2B |
0.499746357183913 |
|
16659 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP7A1 |
0.499746357183913 |
|
16660 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDCBP |
0.499746357183913 |
|
16661 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NSMAF |
0.499746357183913 |
|
16662 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238433.1 |
0.499746357183913 |
|
16663 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOX |
0.499746357183913 |
|
16664 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA51|ENSG00000206853.1 |
0.499746357183913 |
|
16665 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP267 |
0.499746357183913 |
|
16666 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CA8 |
0.499746357183913 |
|
16667 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB2A |
0.499746357183913 |
|
16668 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHD7 |
0.499746357183913 |
|
16669 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLVS1 |
0.499746357183913 |
|
16670 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASPH |
0.499746357183913 |
|
16671 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP97 |
0.499746357183913 |
|
16672 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4470 |
0.499746357183913 |
|
16673 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NKAIN3 |
0.499746357183913 |
|
16674 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GGH |
0.499746357183913 |
|
16675 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTPA |
0.499746357183913 |
|
16676 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YTHDF3 |
0.499746357183913 |
|
16677 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL135P |
0.499746357183913 |
|
16678 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP135 |
0.499746357183913 |
|
16679 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00966 |
0.499746357183913 |
|
16680 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BHLHE22 |
0.499746357183913 |
|
16681 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP7B1 |
0.499746357183913 |
|
16682 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARMC1 |
0.499746357183913 |
|
16683 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTFR1 |
0.499746357183913 |
|
16684 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE7A |
0.499746357183913 |
|
16685 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC5B |
0.499746357183913 |
|
16686 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM55 |
0.499746357183913 |
|
16687 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRH |
0.499746357183913 |
|
16688 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00967 |
0.499746357183913 |
|
16689 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADHFE1 |
0.499746357183913 |
|
16690 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRS1 |
0.499746357183913 |
|
16691 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C8orf46 |
0.499746357183913 |
|
16692 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYBL1 |
0.499746357183913 |
|
16693 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VCPIP1 |
0.499746357183913 |
|
16694 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C8orf44 |
0.499746357183913 |
|
16695 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGK3 |
0.499746357183913 |
|
16696 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCMDC2 |
0.499746357183913 |
|
16697 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNHG6 |
0.499746357183913 |
|
16698 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD87 |
0.499746357183913 |
|
16699 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCF24 |
0.499746357183913 |
|
16700 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R42 |
0.499746357183913 |
|
16701 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COPS5 |
0.499746357183913 |
|
16702 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSPP1 |
0.499746357183913 |
|
16703 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP268 |
0.499746357183913 |
|
16704 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARFGEF1 |
0.499746357183913 |
|
16705 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPA6 |
0.499746357183913 |
|
16706 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PREX2 |
0.499746357183913 |
|
16707 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C8orf34 |
0.499746357183913 |
|
16708 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP269 |
0.499746357183913 |
|
16709 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SULF1 |
0.499746357183913 |
|
16710 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLCO5A1 |
0.499746357183913 |
|
16711 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP29 |
0.499746357183913 |
|
16712 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL675P |
0.499746357183913 |
|
16713 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP270 |
0.499746357183913 |
|
16714 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRDM14 |
0.499746357183913 |
|
16715 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCOA2 |
0.499746357183913 |
|
16716 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAM1 |
0.499746357183913 |
|
16717 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238450.1 |
0.499746357183913 |
|
16718 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LACTB2 |
0.499746357183913 |
|
16719 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL19P |
0.499746357183913 |
|
16720 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XKR9 |
0.499746357183913 |
|
16721 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EYA1 |
0.499746357183913 |
|
16722 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000200191.1 |
0.499746357183913 |
|
16723 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSC |
0.499746357183913 |
|
16724 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPA1 |
0.499746357183913 |
|
16725 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP271 |
0.499746357183913 |
|
16726 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNB2 |
0.499746357183913 |
|
16727 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TERF1 |
0.499746357183913 |
|
16728 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SBSPON |
0.499746357183913 |
|
16729 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL7 |
0.499746357183913 |
|
16730 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RDH10 |
0.499746357183913 |
|
16731 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAU2 |
0.499746357183913 |
|
16732 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2W |
0.499746357183913 |
|
16733 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCEB1 |
0.499746357183913 |
|
16734 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM70 |
0.499746357183913 |
|
16735 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LY96 |
0.499746357183913 |
|
16736 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JPH1 |
0.499746357183913 |
|
16737 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GDAP1 |
0.499746357183913 |
|
16738 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5681A |
0.499746357183913 |
|
16739 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PI15 |
0.499746357183913 |
|
16740 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRISPLD1 |
0.499746357183913 |
|
16741 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASC9 |
0.499746357183913 |
|
16742 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEX26 |
0.501958881237344 |
|
16743 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBA8 |
0.501958881237344 |
|
16744 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AIFM3 |
0.501958881237344 |
|
16745 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARVCF |
0.501958881237344 |
|
16746 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCRP2 |
0.501958881237344 |
|
16747 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C22orf29 |
0.501958881237344 |
|
16748 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C22orf39 |
0.501958881237344 |
|
16749 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC116 |
0.501958881237344 |
|
16750 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC45 |
0.501958881237344 |
|
16751 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLDN5 |
0.501958881237344 |
|
16752 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLTCL1 |
0.501958881237344 |
|
16753 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COMT |
0.501958881237344 |
|
16754 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRKL |
0.501958881237344 |
|
16755 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DGCR14 |
0.501958881237344 |
|
16756 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DGCR2 |
0.501958881237344 |
|
16757 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DGCR5 |
0.501958881237344 |
|
16758 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DGCR6L |
0.501958881237344 |
|
16759 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DGCR6 |
0.501958881237344 |
|
16760 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DGCR8 |
0.501958881237344 |
|
16761 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM230A |
0.501958881237344 |
|
16762 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM230B |
0.501958881237344 |
|
16763 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM230C |
0.501958881237344 |
|
16764 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GGT2 |
0.501958881237344 |
|
16765 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GGT3P |
0.501958881237344 |
|
16766 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GGTLC3 |
0.501958881237344 |
|
16767 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNB1L |
0.501958881237344 |
|
16768 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GP1BB |
0.501958881237344 |
|
16769 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSC2 |
0.501958881237344 |
|
16770 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIC2 |
0.501958881237344 |
|
16771 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIRA |
0.501958881237344 |
|
16772 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL22 |
0.501958881237344 |
|
16773 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LZTR1 |
0.501958881237344 |
|
16774 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED15 |
0.501958881237344 |
|
16775 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1286 |
0.501958881237344 |
|
16776 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1306 |
0.501958881237344 |
|
16777 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR130B |
0.501958881237344 |
|
16778 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR185 |
0.501958881237344 |
|
16779 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR301B |
0.501958881237344 |
|
16780 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3618 |
0.501958881237344 |
|
16781 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4761 |
0.501958881237344 |
|
16782 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR649 |
0.501958881237344 |
|
16783 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL40 |
0.501958881237344 |
|
16784 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
P2RX6P |
0.501958881237344 |
|
16785 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
P2RX6 |
0.501958881237344 |
|
16786 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PI4KAP1 |
0.501958881237344 |
|
16787 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PI4KAP2 |
0.501958881237344 |
|
16788 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PI4KA |
0.501958881237344 |
|
16789 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POM121L4P |
0.501958881237344 |
|
16790 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POM121L7 |
0.501958881237344 |
|
16791 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPIL2 |
0.501958881237344 |
|
16792 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRODH |
0.501958881237344 |
|
16793 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RANBP1 |
0.501958881237344 |
|
16794 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIMBP3B |
0.501958881237344 |
|
16795 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIMBP3C |
0.501958881237344 |
|
16796 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIMBP3 |
0.501958881237344 |
|
16797 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP131 |
0.501958881237344 |
|
16798 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP221 |
0.501958881237344 |
|
16799 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP63 |
0.501958881237344 |
|
16800 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL168P |
0.501958881237344 |
|
16801 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL280P |
0.501958881237344 |
|
16802 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL389P |
0.501958881237344 |
|
16803 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL812P |
0.501958881237344 |
|
16804 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RTN4R |
0.501958881237344 |
|
16805 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARF2 |
0.501958881237344 |
|
16806 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA17|ENSG00000252020.1 |
0.501958881237344 |
|
16807 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA17|ENSG00000252143.1 |
0.501958881237344 |
|
16808 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA17|ENSG00000252571.1 |
0.501958881237344 |
|
16809 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA18|ENSG00000252024.1 |
0.501958881237344 |
|
16810 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA18|ENSG00000252314.1 |
0.501958881237344 |
|
16811 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA18|ENSG00000252605.1 |
0.501958881237344 |
|
16812 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDF2L1 |
0.501958881237344 |
|
16813 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEPT5 |
0.501958881237344 |
|
16814 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPIND1 |
0.501958881237344 |
|
16815 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A1 |
0.501958881237344 |
|
16816 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC7A4 |
0.501958881237344 |
|
16817 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMPD4P1 |
0.501958881237344 |
|
16818 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNAP29 |
0.501958881237344 |
|
16819 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA15|ENSG00000251940.1 |
0.501958881237344 |
|
16820 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA77|ENSG00000264346.1 |
0.501958881237344 |
|
16821 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TANGO2 |
0.501958881237344 |
|
16822 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBX1 |
0.501958881237344 |
|
16823 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THAP7 |
0.501958881237344 |
|
16824 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM191A |
0.501958881237344 |
|
16825 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM191C |
0.501958881237344 |
|
16826 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRMT2A |
0.501958881237344 |
|
16827 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSSK2 |
0.501958881237344 |
|
16828 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBA3FP |
0.501958881237344 |
|
16829 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TXNRD2 |
0.501958881237344 |
|
16830 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2L3 |
0.501958881237344 |
|
16831 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UFD1L |
0.501958881237344 |
|
16832 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP18 |
0.501958881237344 |
|
16833 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP41 |
0.501958881237344 |
|
16834 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YDJC |
0.501958881237344 |
|
16835 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YPEL1 |
0.501958881237344 |
|
16836 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDHHC8 |
0.501958881237344 |
|
16837 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF74 |
0.501958881237344 |
|
16838 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000252402.1 |
0.501958881237344 |
|
16839 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000252799.1 |
0.501958881237344 |
|
16840 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000271796.1 |
0.501958881237344 |
|
16841 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GMDS |
0.5040158829739 |
|
16842 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FARS2 |
0.5040158829739 |
|
16843 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL15 |
0.504223152296001 |
|
16844 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL801P |
0.504223152296001 |
|
16845 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4459 |
0.504223152296001 |
|
16846 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF618 |
0.505467928439439 |
|
16847 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMBP |
0.505467928439439 |
|
16848 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF12 |
0.505467928439439 |
|
16849 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL27A1 |
0.505467928439439 |
|
16850 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ORM1 |
0.505467928439439 |
|
16851 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ORM2 |
0.505467928439439 |
|
16852 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKNA |
0.505467928439439 |
|
16853 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LHX2 |
0.505467928439439 |
|
16854 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEK6 |
0.505467928439439 |
|
16855 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMB7 |
0.505467928439439 |
|
16856 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR144 |
0.505467928439439 |
|
16857 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NR5A1 |
0.505467928439439 |
|
16858 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NR6A1 |
0.505467928439439 |
|
16859 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL302P |
0.505467928439439 |
|
16860 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR181A2HG |
0.505467928439439 |
|
16861 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR181A2 |
0.505467928439439 |
|
16862 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR181B2 |
0.505467928439439 |
|
16863 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OLFML2A |
0.505467928439439 |
|
16864 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR38 |
0.505467928439439 |
|
16865 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL35 |
0.505467928439439 |
|
16866 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARPC5L |
0.505467928439439 |
|
16867 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA1 |
0.505467928439439 |
|
16868 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCAI |
0.505467928439439 |
|
16869 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP6C |
0.505467928439439 |
|
16870 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RABEPK |
0.505467928439439 |
|
16871 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPA5 |
0.505467928439439 |
|
16872 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAPVD1 |
0.505467928439439 |
|
16873 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPKAP1 |
0.505467928439439 |
|
16874 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL30P |
0.505467928439439 |
|
16875 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PBX3 |
0.505467928439439 |
|
16876 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MVB12B |
0.505467928439439 |
|
16877 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRON |
0.505467928439439 |
|
16878 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD116|ENSG00000252985.1 |
0.505467928439439 |
|
16879 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMX1B |
0.505467928439439 |
|
16880 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB43 |
0.505467928439439 |
|
16881 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB34 |
0.505467928439439 |
|
16882 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RALGPS1 |
0.505467928439439 |
|
16883 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANGPTL2 |
0.505467928439439 |
|
16884 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GARNL3 |
0.505467928439439 |
|
16885 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC2A8 |
0.505467928439439 |
|
16886 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF79 |
0.505467928439439 |
|
16887 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL12 |
0.505467928439439 |
|
16888 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA65 |
0.505467928439439 |
|
16889 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRSAM1 |
0.505467928439439 |
|
16890 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM129B |
0.505467928439439 |
|
16891 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STXBP1 |
0.505467928439439 |
|
16892 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3911 |
0.505467928439439 |
|
16893 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTRH1 |
0.505467928439439 |
|
16894 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf117 |
0.505467928439439 |
|
16895 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC16 |
0.505467928439439 |
|
16896 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOR2A |
0.505467928439439 |
|
16897 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH2D3C |
0.505467928439439 |
|
16898 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK9 |
0.505467928439439 |
|
16899 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3960 |
0.505467928439439 |
|
16900 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FPGS |
0.505467928439439 |
|
16901 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENG |
0.505467928439439 |
|
16902 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP296 |
0.505467928439439 |
|
16903 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AK1 |
0.505467928439439 |
|
16904 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4672 |
0.505467928439439 |
|
16905 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST6GALNAC6 |
0.505467928439439 |
|
16906 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST6GALNAC4 |
0.505467928439439 |
|
16907 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIP5KL1 |
0.505467928439439 |
|
16908 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPM2 |
0.505467928439439 |
|
16909 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM102A |
0.505467928439439 |
|
16910 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAIF1 |
0.505467928439439 |
|
16911 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A25 |
0.505467928439439 |
|
16912 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTGES2 |
0.505467928439439 |
|
16913 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCN2 |
0.505467928439439 |
|
16914 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf16 |
0.505467928439439 |
|
16915 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CIZ1 |
0.505467928439439 |
|
16916 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNM1 |
0.505467928439439 |
|
16917 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR199B |
0.505467928439439 |
|
16918 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3154 |
0.505467928439439 |
|
16919 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA2 |
0.505467928439439 |
|
16920 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SWI5 |
0.505467928439439 |
|
16921 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRUB2 |
0.505467928439439 |
|
16922 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COQ4 |
0.505467928439439 |
|
16923 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC27A4 |
0.505467928439439 |
|
16924 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
URM1 |
0.505467928439439 |
|
16925 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CERCAM |
0.505467928439439 |
|
16926 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ODF2 |
0.505467928439439 |
|
16927 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLE1 |
0.505467928439439 |
|
16928 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPTAN1 |
0.505467928439439 |
|
16929 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR34 |
0.505467928439439 |
|
16930 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMGA1P4 |
0.505467928439439 |
|
16931 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SET |
0.505467928439439 |
|
16932 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKN3 |
0.505467928439439 |
|
16933 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL560P |
0.505467928439439 |
|
16934 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDHHC12 |
0.505467928439439 |
|
16935 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZER1 |
0.505467928439439 |
|
16936 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239055.1 |
0.505467928439439 |
|
16937 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D13 |
0.505467928439439 |
|
16938 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf114 |
0.505467928439439 |
|
16939 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENDOG |
0.505467928439439 |
|
16940 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCBL1 |
0.505467928439439 |
|
16941 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC8A |
0.505467928439439 |
|
16942 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHYHD1 |
0.505467928439439 |
|
16943 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOLK |
0.505467928439439 |
|
16944 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUP188 |
0.505467928439439 |
|
16945 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3GLB2 |
0.505467928439439 |
|
16946 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM73B |
0.505467928439439 |
|
16947 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOLPP1 |
0.505467928439439 |
|
16948 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRAT |
0.505467928439439 |
|
16949 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP2R4 |
0.505467928439439 |
|
16950 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IER5L |
0.505467928439439 |
|
16951 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf106 |
0.505467928439439 |
|
16952 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL159P |
0.505467928439439 |
|
16953 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00963 |
0.505467928439439 |
|
16954 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf50 |
0.505467928439439 |
|
16955 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NTMT1 |
0.505467928439439 |
|
16956 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASB6 |
0.505467928439439 |
|
16957 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRRX2 |
0.505467928439439 |
|
16958 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTGES |
0.505467928439439 |
|
16959 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOR1B |
0.505467928439439 |
|
16960 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOR1A |
0.505467928439439 |
|
16961 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf78 |
0.505467928439439 |
|
16962 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP20 |
0.505467928439439 |
|
16963 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FNBP1 |
0.505467928439439 |
|
16964 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR107 |
0.505467928439439 |
|
16965 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCS1 |
0.505467928439439 |
|
16966 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMCN2 |
0.505467928439439 |
|
16967 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL665P |
0.505467928439439 |
|
16968 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASS1 |
0.505467928439439 |
|
16969 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238298.1 |
0.505467928439439 |
|
16970 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FUBP3 |
0.505467928439439 |
|
16971 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRDM12 |
0.505467928439439 |
|
16972 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXOSC2 |
0.505467928439439 |
|
16973 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABL1 |
0.505467928439439 |
|
16974 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
QRFP |
0.505467928439439 |
|
16975 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FIBCD1 |
0.505467928439439 |
|
16976 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAMC3 |
0.505467928439439 |
|
16977 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000252582.1 |
0.505467928439439 |
|
16978 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AIF1L |
0.505467928439439 |
|
16979 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUP214 |
0.505467928439439 |
|
16980 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM78A |
0.505467928439439 |
|
16981 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPAPDC3 |
0.505467928439439 |
|
16982 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRRC2B |
0.505467928439439 |
|
16983 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD62A |
0.505467928439439 |
|
16984 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD62B |
0.505467928439439 |
|
16985 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POMT1 |
0.505467928439439 |
|
16986 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UCK1 |
0.505467928439439 |
|
16987 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAPGEF1 |
0.505467928439439 |
|
16988 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL328P |
0.505467928439439 |
|
16989 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA67|ENSG00000212395.1 |
0.505467928439439 |
|
16990 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED27 |
0.505467928439439 |
|
16991 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NTNG2 |
0.505467928439439 |
|
16992 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SETX |
0.505467928439439 |
|
16993 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTF1 |
0.505467928439439 |
|
16994 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf171 |
0.505467928439439 |
|
16995 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BARHL1 |
0.505467928439439 |
|
16996 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX31 |
0.505467928439439 |
|
16997 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF3C4 |
0.505467928439439 |
|
16998 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AK8 |
0.505467928439439 |
|
16999 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf9 |
0.505467928439439 |
|
17000 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSC1 |
0.505467928439439 |
|
17001 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GFI1B |
0.505467928439439 |
|
17002 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548AW |
0.505467928439439 |
|
17003 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF3C5 |
0.505467928439439 |
|
17004 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CELP |
0.505467928439439 |
|
17005 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEL |
0.505467928439439 |
|
17006 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RALGDS |
0.505467928439439 |
|
17007 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238657.1 |
0.505467928439439 |
|
17008 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GBGT1 |
0.505467928439439 |
|
17009 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OBP2B |
0.505467928439439 |
|
17010 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABO |
0.505467928439439 |
|
17011 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SURF6 |
0.505467928439439 |
|
17012 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED22 |
0.505467928439439 |
|
17013 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL7A |
0.505467928439439 |
|
17014 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD24 |
0.505467928439439 |
|
17015 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD36A |
0.505467928439439 |
|
17016 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD36B |
0.505467928439439 |
|
17017 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD36C |
0.505467928439439 |
|
17018 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SURF1 |
0.505467928439439 |
|
17019 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SURF2 |
0.505467928439439 |
|
17020 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SURF4 |
0.505467928439439 |
|
17021 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf96 |
0.505467928439439 |
|
17022 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REXO4 |
0.505467928439439 |
|
17023 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAMTS13 |
0.505467928439439 |
|
17024 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACFD1 |
0.505467928439439 |
|
17025 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC2A6 |
0.505467928439439 |
|
17026 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM8C |
0.505467928439439 |
|
17027 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAMTSL2 |
0.505467928439439 |
|
17028 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM163B |
0.505467928439439 |
|
17029 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DBH |
0.505467928439439 |
|
17030 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SARDH |
0.505467928439439 |
|
17031 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VAV2 |
0.505467928439439 |
|
17032 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00094 |
0.505467928439439 |
|
17033 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRD3 |
0.505467928439439 |
|
17034 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR5 |
0.505467928439439 |
|
17035 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC |
0.505467928439439 |
|
17036 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RXRA |
0.505467928439439 |
|
17037 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4669 |
0.505467928439439 |
|
17038 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL5A1 |
0.505467928439439 |
|
17039 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3689A |
0.505467928439439 |
|
17040 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3689B |
0.505467928439439 |
|
17041 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3689C |
0.505467928439439 |
|
17042 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3689D1 |
0.505467928439439 |
|
17043 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3689D2 |
0.505467928439439 |
|
17044 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3689E |
0.505467928439439 |
|
17045 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3689F |
0.505467928439439 |
|
17046 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCN2 |
0.505467928439439 |
|
17047 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCN1 |
0.505467928439439 |
|
17048 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OLFM1 |
0.505467928439439 |
|
17049 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf62 |
0.505467928439439 |
|
17050 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R26 |
0.505467928439439 |
|
17051 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf116 |
0.505467928439439 |
|
17052 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS2 |
0.505467928439439 |
|
17053 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCN1 |
0.505467928439439 |
|
17054 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OBP2A |
0.505467928439439 |
|
17055 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAEP |
0.505467928439439 |
|
17056 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLT6D1 |
0.505467928439439 |
|
17057 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCN9 |
0.505467928439439 |
|
17058 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOHLH1 |
0.505467928439439 |
|
17059 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNT1 |
0.505467928439439 |
|
17060 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAMSAP1 |
0.505467928439439 |
|
17061 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBAC1 |
0.505467928439439 |
|
17062 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NACC2 |
0.505467928439439 |
|
17063 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf69 |
0.505467928439439 |
|
17064 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CARD9 |
0.505467928439439 |
|
17065 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DKFZP434A062 |
0.505467928439439 |
|
17066 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNLZ |
0.505467928439439 |
|
17067 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPSM1 |
0.505467928439439 |
|
17068 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LHX3 |
0.505467928439439 |
|
17069 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
QSOX2 |
0.505467928439439 |
|
17070 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNAPC4 |
0.505467928439439 |
|
17071 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDCCAG3 |
0.505467928439439 |
|
17072 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PMPCA |
0.505467928439439 |
|
17073 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INPP5E |
0.505467928439439 |
|
17074 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC16A |
0.505467928439439 |
|
17075 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf163 |
0.505467928439439 |
|
17076 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHEK2P2 |
0.509453425922636 |
|
17077 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CT60 |
0.509453425922636 |
|
17078 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYFIP1 |
0.509453425922636 |
|
17079 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DKFZP547L112 |
0.509453425922636 |
|
17080 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA6L1 |
0.509453425922636 |
|
17081 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA6L2 |
0.509453425922636 |
|
17082 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA6L6 |
0.509453425922636 |
|
17083 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA8DP |
0.509453425922636 |
|
17084 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA8EP |
0.509453425922636 |
|
17085 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA8I |
0.509453425922636 |
|
17086 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA8S |
0.509453425922636 |
|
17087 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HERC2P2 |
0.509453425922636 |
|
17088 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HERC2P3 |
0.509453425922636 |
|
17089 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1268A |
0.509453425922636 |
|
17090 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBEAP1 |
0.509453425922636 |
|
17091 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NIPA1 |
0.509453425922636 |
|
17092 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NIPA2 |
0.509453425922636 |
|
17093 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4M2 |
0.509453425922636 |
|
17094 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4N4 |
0.509453425922636 |
|
17095 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POTEB2 |
0.509453425922636 |
|
17096 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POTEB |
0.509453425922636 |
|
17097 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL106P |
0.509453425922636 |
|
17098 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL400P |
0.509453425922636 |
|
17099 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL495P |
0.509453425922636 |
|
17100 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL536P |
0.509453425922636 |
|
17101 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL545P |
0.509453425922636 |
|
17102 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL584P |
0.509453425922636 |
|
17103 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL759P |
0.509453425922636 |
|
17104 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBGCP5 |
0.509453425922636 |
|
17105 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WHAMMP3 |
0.509453425922636 |
|
17106 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238960.1 |
0.509453425922636 |
|
17107 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239083.1 |
0.509453425922636 |
|
17108 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
7SK|ENSG00000232512.2 |
0.509664558560029 |
|
17109 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP489 |
0.509664558560029 |
|
17110 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00158 |
0.509664558560029 |
|
17111 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238314.1 |
0.509664558560029 |
|
17112 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR155HG |
0.509664558560029 |
|
17113 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00515 |
0.509664558560029 |
|
17114 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL39 |
0.509664558560029 |
|
17115 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JAM2 |
0.509664558560029 |
|
17116 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP5J |
0.509664558560029 |
|
17117 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABPA |
0.509664558560029 |
|
17118 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APP |
0.509664558560029 |
|
17119 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYYR1 |
0.509664558560029 |
|
17120 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAMTS1 |
0.509664558560029 |
|
17121 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAMTS5 |
0.509664558560029 |
|
17122 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4759 |
0.509664558560029 |
|
17123 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAT3 |
0.51054649760074 |
|
17124 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTNR1B |
0.51054649760074 |
|
17125 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC67 |
0.51054649760074 |
|
17126 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC36A4 |
0.51054649760074 |
|
17127 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMCO4 |
0.51054649760074 |
|
17128 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL223P |
0.51054649760074 |
|
17129 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1731 |
0.51054649760074 |
|
17130 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA9 |
0.51054649760074 |
|
17131 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA25|ENSG00000207112.1 |
0.51054649760074 |
|
17132 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAF1D |
0.51054649760074 |
|
17133 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA1|ENSG00000206834.1 |
0.51054649760074 |
|
17134 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA32|ENSG00000206799.1 |
0.51054649760074 |
|
17135 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA8|ENSG00000207304.1 |
0.51054649760074 |
|
17136 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD6 |
0.51054649760074 |
|
17137 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1304 |
0.51054649760074 |
|
17138 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA18|ENSG00000207145.1 |
0.51054649760074 |
|
17139 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD5|ENSG00000239195.1 |
0.51054649760074 |
|
17140 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA40|ENSG00000210825.1 |
0.51054649760074 |
|
17141 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf54 |
0.51054649760074 |
|
17142 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED17 |
0.51054649760074 |
|
17143 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL195P |
0.51054649760074 |
|
17144 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238437.1 |
0.51054649760074 |
|
17145 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VSTM5 |
0.51054649760074 |
|
17146 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HEPHL1 |
0.51054649760074 |
|
17147 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PANX1 |
0.51054649760074 |
|
17148 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOLR4 |
0.51054649760074 |
|
17149 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR83 |
0.51054649760074 |
|
17150 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRE11A |
0.51054649760074 |
|
17151 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548L |
0.51054649760074 |
|
17152 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD49 |
0.51054649760074 |
|
17153 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FUT4 |
0.51054649760074 |
|
17154 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIWIL4 |
0.51054649760074 |
|
17155 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMOTL1 |
0.51054649760074 |
|
17156 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CWC15 |
0.51054649760074 |
|
17157 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KDM4D |
0.51054649760074 |
|
17158 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KDM4E |
0.51054649760074 |
|
17159 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRSF8 |
0.51054649760074 |
|
17160 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENDOD1 |
0.51054649760074 |
|
17161 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SESN3 |
0.51054649760074 |
|
17162 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM76B |
0.51054649760074 |
|
17163 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP57 |
0.51054649760074 |
|
17164 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTMR2 |
0.51054649760074 |
|
17165 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP345 |
0.51054649760074 |
|
17166 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAML2 |
0.51054649760074 |
|
17167 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1260B |
0.51054649760074 |
|
17168 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC82 |
0.51054649760074 |
|
17169 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JRKL |
0.51054649760074 |
|
17170 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP346 |
0.51054649760074 |
|
17171 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP347 |
0.51054649760074 |
|
17172 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPCDR1 |
0.512401570829953 |
|
17173 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000212211.1 |
0.512401570829953 |
|
17174 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEAD1 |
0.515325894878286 |
|
17175 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA16|ENSG00000252329.1 |
0.515325894878286 |
|
17176 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMYD3 |
0.5164188410662 |
|
17177 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AHCTF1 |
0.5164188410662 |
|
17178 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNST |
0.5164188410662 |
|
17179 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCCPDH |
0.5164188410662 |
|
17180 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA25|ENSG00000252011.1 |
0.5164188410662 |
|
17181 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252495.1 |
0.5164188410662 |
|
17182 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFB2M |
0.5164188410662 |
|
17183 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GFOD1 |
0.516755777987595 |
|
17184 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP204 |
0.516755777987595 |
|
17185 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIRT5 |
0.516755777987595 |
|
17186 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOL7 |
0.516755777987595 |
|
17187 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RANBP9 |
0.516755777987595 |
|
17188 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCUR1 |
0.516755777987595 |
|
17189 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF182 |
0.516755777987595 |
|
17190 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPARA |
0.517004882871945 |
|
17191 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CELSR1 |
0.517004882871945 |
|
17192 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD30B |
0.518420143953199 |
|
17193 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL662P |
0.518420143953199 |
|
17194 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ROCK1 |
0.518420143953199 |
|
17195 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GREB1L |
0.518420143953199 |
|
17196 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD23|ENSG00000221139.1 |
0.518420143953199 |
|
17197 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ESCO1 |
0.518420143953199 |
|
17198 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNRPD1 |
0.518420143953199 |
|
17199 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABHD3 |
0.518420143953199 |
|
17200 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR320C1 |
0.518420143953199 |
|
17201 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIB1 |
0.518420143953199 |
|
17202 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA81|ENSG00000252677.1 |
0.518420143953199 |
|
17203 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL233P |
0.518420143953199 |
|
17204 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA73|ENSG00000199977.1 |
0.518420143953199 |
|
17205 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP451 |
0.518420143953199 |
|
17206 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC20P |
0.518420143953199 |
|
17207 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GATA6 |
0.518420143953199 |
|
17208 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238907.1 |
0.518420143953199 |
|
17209 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTAGE1 |
0.518420143953199 |
|
17210 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBBP8 |
0.518420143953199 |
|
17211 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238537.1 |
0.518420143953199 |
|
17212 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4741 |
0.518420143953199 |
|
17213 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL745P |
0.518420143953199 |
|
17214 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CABLES1 |
0.518420143953199 |
|
17215 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM241 |
0.518420143953199 |
|
17216 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIOK3 |
0.518420143953199 |
|
17217 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C18orf8 |
0.518420143953199 |
|
17218 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPC1 |
0.518420143953199 |
|
17219 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD29 |
0.518420143953199 |
|
17220 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAMA3 |
0.518420143953199 |
|
17221 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF521 |
0.518420143953199 |
|
17222 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL97P |
0.518420143953199 |
|
17223 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SS18 |
0.518420143953199 |
|
17224 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMA8 |
0.518420143953199 |
|
17225 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFX1 |
0.520033447502268 |
|
17226 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL27RA |
0.520033447502268 |
|
17227 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RLN3 |
0.520033447502268 |
|
17228 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD83 |
0.524458498030285 |
|
17229 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL332P |
0.524458498030285 |
|
17230 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JARID2 |
0.524458498030285 |
|
17231 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DTNBP1 |
0.524458498030285 |
|
17232 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYLIP |
0.524458498030285 |
|
17233 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4639 |
0.524458498030285 |
|
17234 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000251793.1 |
0.524458498030285 |
|
17235 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GMPR |
0.524458498030285 |
|
17236 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATXN1 |
0.524458498030285 |
|
17237 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STMND1 |
0.524458498030285 |
|
17238 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM24 |
0.524458498030285 |
|
17239 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAP2 |
0.524458498030285 |
|
17240 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM8A1 |
0.524458498030285 |
|
17241 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUP153 |
0.524458498030285 |
|
17242 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP204 |
0.524458498030285 |
|
17243 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF13A |
0.524458498030285 |
|
17244 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NHLRC1 |
0.524458498030285 |
|
17245 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPMT |
0.524458498030285 |
|
17246 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KDM1B |
0.524458498030285 |
|
17247 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEK |
0.524458498030285 |
|
17248 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF144B |
0.524458498030285 |
|
17249 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238458.1 |
0.524458498030285 |
|
17250 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548A1 |
0.524458498030285 |
|
17251 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP205 |
0.524458498030285 |
|
17252 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ID4 |
0.524458498030285 |
|
17253 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBOAT1 |
0.524458498030285 |
|
17254 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
E2F3 |
0.524458498030285 |
|
17255 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL128P |
0.524458498030285 |
|
17256 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDKAL1 |
0.524458498030285 |
|
17257 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDH18 |
0.525623137359976 |
|
17258 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00616 |
0.525623137359976 |
|
17259 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC7A11 |
0.525623137359976 |
|
17260 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00498 |
0.525623137359976 |
|
17261 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00499 |
0.525623137359976 |
|
17262 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00500 |
0.525623137359976 |
|
17263 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCRN4L |
0.525623137359976 |
|
17264 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELF2 |
0.525623137359976 |
|
17265 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL382P |
0.525623137359976 |
|
17266 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL311P |
0.525623137359976 |
|
17267 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MGARP |
0.525623137359976 |
|
17268 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFC1 |
0.525623137359976 |
|
17269 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAA15 |
0.525623137359976 |
|
17270 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACA64|ENSG00000239005.1 |
0.525623137359976 |
|
17271 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB33B |
0.525623137359976 |
|
17272 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SETD7 |
0.525623137359976 |
|
17273 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MGST2 |
0.525623137359976 |
|
17274 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP237 |
0.525623137359976 |
|
17275 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAML3 |
0.525623137359976 |
|
17276 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP253 |
0.525623137359976 |
|
17277 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCOC |
0.525623137359976 |
|
17278 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252300.1 |
0.525623137359976 |
|
17279 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLGN |
0.525623137359976 |
|
17280 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELMOD2 |
0.525623137359976 |
|
17281 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UCP1 |
0.525623137359976 |
|
17282 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL152P |
0.525623137359976 |
|
17283 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF150 |
0.525623137359976 |
|
17284 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF330 |
0.525623137359976 |
|
17285 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238695.1 |
0.525623137359976 |
|
17286 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL15 |
0.525623137359976 |
|
17287 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INPP4B |
0.525623137359976 |
|
17288 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP38 |
0.525623137359976 |
|
17289 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAB1 |
0.525623137359976 |
|
17290 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3139 |
0.525623137359976 |
|
17291 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMARCA5 |
0.525623137359976 |
|
17292 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GUSBP5 |
0.525623137359976 |
|
17293 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FREM3 |
0.525623137359976 |
|
17294 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GYPA |
0.525623137359976 |
|
17295 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GYPB |
0.525623137359976 |
|
17296 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GYPE |
0.525623137359976 |
|
17297 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HHIP |
0.525623137359976 |
|
17298 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANAPC10 |
0.525623137359976 |
|
17299 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP235 |
0.525623137359976 |
|
17300 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCE1 |
0.525623137359976 |
|
17301 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OTUD4 |
0.525623137359976 |
|
17302 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMAD1 |
0.525623137359976 |
|
17303 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMAA |
0.525623137359976 |
|
17304 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C4orf51 |
0.525623137359976 |
|
17305 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF827 |
0.525623137359976 |
|
17306 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LSM6 |
0.525623137359976 |
|
17307 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POU4F2 |
0.525623137359976 |
|
17308 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC29 |
0.525623137359976 |
|
17309 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548G |
0.525623137359976 |
|
17310 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EDNRA |
0.525623137359976 |
|
17311 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM184C |
0.525623137359976 |
|
17312 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRMT10 |
0.525623137359976 |
|
17313 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP10 |
0.525623137359976 |
|
17314 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP165 |
0.525623137359976 |
|
17315 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4799 |
0.525623137359976 |
|
17316 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL254P |
0.525623137359976 |
|
17317 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NR3C2 |
0.525623137359976 |
|
17318 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP166 |
0.525623137359976 |
|
17319 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC10A7 |
0.52987791678469 |
|
17320 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000201368.1 |
0.531786942938832 |
|
17321 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARVB |
0.5345182524643 |
|
17322 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARVG |
0.5345182524643 |
|
17323 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1644 |
0.5345182524643 |
|
17324 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LDOC1L |
0.5345182524643 |
|
17325 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00207 |
0.5345182524643 |
|
17326 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00229 |
0.5345182524643 |
|
17327 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR5 |
0.5345182524643 |
|
17328 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP8 |
0.5345182524643 |
|
17329 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHF21B |
0.5345182524643 |
|
17330 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUP50 |
0.5345182524643 |
|
17331 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0930 |
0.5345182524643 |
|
17332 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1249 |
0.5345182524643 |
|
17333 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UPK3A |
0.5345182524643 |
|
17334 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM118A |
0.5345182524643 |
|
17335 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMC1B |
0.5345182524643 |
|
17336 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIBC2 |
0.5345182524643 |
|
17337 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBLN1 |
0.5345182524643 |
|
17338 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATXN10 |
0.5345182524643 |
|
17339 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4762 |
0.5345182524643 |
|
17340 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WNT7B |
0.5345182524643 |
|
17341 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00899 |
0.5345182524643 |
|
17342 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C22orf26 |
0.5345182524643 |
|
17343 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLJ27365 |
0.5345182524643 |
|
17344 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3619 |
0.5345182524643 |
|
17345 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4763 |
0.5345182524643 |
|
17346 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIRLET7A3 |
0.5345182524643 |
|
17347 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIRLET7B |
0.5345182524643 |
|
17348 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDPF1 |
0.5345182524643 |
|
17349 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKDREJ |
0.5345182524643 |
|
17350 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC38 |
0.5345182524643 |
|
17351 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTSE1 |
0.5345182524643 |
|
17352 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRMU |
0.5345182524643 |
|
17353 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRAMD4 |
0.5345182524643 |
|
17354 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CERK |
0.5345182524643 |
|
17355 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D22A |
0.5345182524643 |
|
17356 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00898 |
0.5345182524643 |
|
17357 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP167 |
0.535515715340582 |
|
17358 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCLK2 |
0.535515715340582 |
|
17359 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAB21L2 |
0.535515715340582 |
|
17360 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP168 |
0.535515715340582 |
|
17361 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP169 |
0.535515715340582 |
|
17362 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL446P |
0.535515715340582 |
|
17363 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXW7 |
0.535515715340582 |
|
17364 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3140 |
0.535515715340582 |
|
17365 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4453 |
0.535515715340582 |
|
17366 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM154 |
0.535515715340582 |
|
17367 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UQCRFS1 |
0.535641927211909 |
|
17368 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL340P |
0.535641927211909 |
|
17369 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAD18 |
0.537350741652922 |
|
17370 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA43|ENSG00000199815.1 |
0.537350741652922 |
|
17371 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRGAP3 |
0.537350741652922 |
|
17372 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THUMPD3 |
0.537350741652922 |
|
17373 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SETD5 |
0.537350741652922 |
|
17374 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LHFPL4 |
0.537350741652922 |
|
17375 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTMR14 |
0.537350741652922 |
|
17376 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPNE9 |
0.537350741652922 |
|
17377 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRPF1 |
0.537350741652922 |
|
17378 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OGG1 |
0.537350741652922 |
|
17379 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAMK1 |
0.537350741652922 |
|
17380 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TADA3 |
0.537350741652922 |
|
17381 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARPC4 |
0.537350741652922 |
|
17382 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTLL3 |
0.537350741652922 |
|
17383 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPUSD3 |
0.537350741652922 |
|
17384 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CIDEC |
0.537350741652922 |
|
17385 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JAGN1 |
0.537350741652922 |
|
17386 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL17RE |
0.537350741652922 |
|
17387 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL17RC |
0.537350741652922 |
|
17388 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRELD1 |
0.537350741652922 |
|
17389 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRRT3 |
0.537350741652922 |
|
17390 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMC3 |
0.537350741652922 |
|
17391 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CIDECP |
0.537350741652922 |
|
17392 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FANCD2 |
0.537350741652922 |
|
17393 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FANCD2OS |
0.537350741652922 |
|
17394 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRK1 |
0.537350741652922 |
|
17395 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238642.1 |
0.537350741652922 |
|
17396 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VHL |
0.537350741652922 |
|
17397 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238345.1 |
0.537350741652922 |
|
17398 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRAK2 |
0.537350741652922 |
|
17399 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TATDN2 |
0.537350741652922 |
|
17400 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00852 |
0.537350741652922 |
|
17401 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GHRLOS |
0.537350741652922 |
|
17402 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GHRL |
0.537350741652922 |
|
17403 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC13 |
0.537350741652922 |
|
17404 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP2B2 |
0.537350741652922 |
|
17405 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR378B |
0.537350741652922 |
|
17406 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR885 |
0.537350741652922 |
|
17407 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00606 |
0.537350741652922 |
|
17408 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC6A11 |
0.537350741652922 |
|
17409 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC6A1 |
0.537350741652922 |
|
17410 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HRH1 |
0.537350741652922 |
|
17411 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATG7 |
0.537350741652922 |
|
17412 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VGLL4 |
0.537350741652922 |
|
17413 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAMM41 |
0.537350741652922 |
|
17414 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL147P |
0.537350741652922 |
|
17415 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYN2 |
0.537350741652922 |
|
17416 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIMP4 |
0.537350741652922 |
|
17417 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPARG |
0.537350741652922 |
|
17418 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSEN2 |
0.537350741652922 |
|
17419 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP123 |
0.537350741652922 |
|
17420 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf83 |
0.537350741652922 |
|
17421 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MKRN2 |
0.537350741652922 |
|
17422 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAF1 |
0.537350741652922 |
|
17423 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239140.1 |
0.537350741652922 |
|
17424 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM40 |
0.537350741652922 |
|
17425 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAND2 |
0.537350741652922 |
|
17426 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL32 |
0.537350741652922 |
|
17427 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA7A |
0.537350741652922 |
|
17428 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IQSEC1 |
0.537350741652922 |
|
17429 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUP210 |
0.537350741652922 |
|
17430 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HDAC11 |
0.537350741652922 |
|
17431 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBLN2 |
0.537350741652922 |
|
17432 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00620 |
0.537350741652922 |
|
17433 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WNT7A |
0.537350741652922 |
|
17434 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGD5P1 |
0.537350741652922 |
|
17435 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPRXL |
0.537350741652922 |
|
17436 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHCHD4 |
0.537350741652922 |
|
17437 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM43 |
0.537350741652922 |
|
17438 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XPC |
0.537350741652922 |
|
17439 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LSM3 |
0.537350741652922 |
|
17440 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP124 |
0.537350741652922 |
|
17441 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC6A6 |
0.537350741652922 |
|
17442 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRIP2 |
0.537350741652922 |
|
17443 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC174 |
0.537350741652922 |
|
17444 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf20 |
0.537350741652922 |
|
17445 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGD5 |
0.537350741652922 |
|
17446 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NR2C2 |
0.537350741652922 |
|
17447 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS25 |
0.537350741652922 |
|
17448 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFYVE20 |
0.537350741652922 |
|
17449 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL6A4P1 |
0.537350741652922 |
|
17450 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPN7 |
0.537350741652922 |
|
17451 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3BP5 |
0.537350741652922 |
|
17452 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238891.1 |
0.537350741652922 |
|
17453 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL6 |
0.537350741652922 |
|
17454 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EAF1 |
0.537350741652922 |
|
17455 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COLQ |
0.537350741652922 |
|
17456 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4270 |
0.537350741652922 |
|
17457 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL110P |
0.537350741652922 |
|
17458 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HACL1 |
0.537350741652922 |
|
17459 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTD |
0.537350741652922 |
|
17460 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3134 |
0.537350741652922 |
|
17461 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL4P |
0.537350741652922 |
|
17462 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALNT15 |
0.537350741652922 |
|
17463 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPH3 |
0.537350741652922 |
|
17464 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OXNAD1 |
0.537350741652922 |
|
17465 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFTN1 |
0.537350741652922 |
|
17466 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00690 |
0.537350741652922 |
|
17467 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DAZL |
0.537350741652922 |
|
17468 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLCL2 |
0.537350741652922 |
|
17469 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3714 |
0.537350741652922 |
|
17470 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D5 |
0.537350741652922 |
|
17471 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U7|ENSG00000271841.1 |
0.537350741652922 |
|
17472 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SATB1 |
0.537350741652922 |
|
17473 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNH8 |
0.537350741652922 |
|
17474 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4791 |
0.537350741652922 |
|
17475 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP2A1 |
0.538303193436468 |
|
17476 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATXN2L |
0.538303193436468 |
|
17477 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD19 |
0.538303193436468 |
|
17478 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF3C |
0.538303193436468 |
|
17479 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAT |
0.538303193436468 |
|
17480 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4517 |
0.538303193436468 |
|
17481 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4721 |
0.538303193436468 |
|
17482 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFATC2IP |
0.538303193436468 |
|
17483 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPIPB8 |
0.538303193436468 |
|
17484 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPIPB9 |
0.538303193436468 |
|
17485 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RABEP2 |
0.538303193436468 |
|
17486 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRN3P2 |
0.538303193436468 |
|
17487 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH2B1 |
0.538303193436468 |
|
17488 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA43|ENSG00000252461.1 |
0.538303193436468 |
|
17489 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPNS1 |
0.538303193436468 |
|
17490 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUFM |
0.538303193436468 |
|
17491 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238352.1 |
0.538303193436468 |
|
17492 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238684.1 |
0.538303193436468 |
|
17493 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238699.1 |
0.538303193436468 |
|
17494 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX29P2 |
0.538303193436468 |
|
17495 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPIPB11 |
0.538303193436468 |
|
17496 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALDOA |
0.538303193436468 |
|
17497 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASPHD1 |
0.538303193436468 |
|
17498 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BOLA2B |
0.538303193436468 |
|
17499 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BOLA2 |
0.538303193436468 |
|
17500 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf54 |
0.538303193436468 |
|
17501 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf92 |
0.538303193436468 |
|
17502 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDIPT |
0.538303193436468 |
|
17503 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CORO1A |
0.538303193436468 |
|
17504 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOC2A |
0.538303193436468 |
|
17505 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM57B |
0.538303193436468 |
|
17506 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GDPD3 |
0.538303193436468 |
|
17507 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIRIP3 |
0.538303193436468 |
|
17508 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INO80E |
0.538303193436468 |
|
17509 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCTD13 |
0.538303193436468 |
|
17510 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF22 |
0.538303193436468 |
|
17511 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPK3 |
0.538303193436468 |
|
17512 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAZ |
0.538303193436468 |
|
17513 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MVP |
0.538303193436468 |
|
17514 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAGR1 |
0.538303193436468 |
|
17515 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP4C |
0.538303193436468 |
|
17516 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRRT2 |
0.538303193436468 |
|
17517 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
QPRT |
0.538303193436468 |
|
17518 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP127 |
0.538303193436468 |
|
17519 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEZ6L2 |
0.538303193436468 |
|
17520 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLX1A |
0.538303193436468 |
|
17521 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLX1B |
0.538303193436468 |
|
17522 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPN |
0.538303193436468 |
|
17523 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SULT1A3 |
0.538303193436468 |
|
17524 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SULT1A4 |
0.538303193436468 |
|
17525 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAOK2 |
0.538303193436468 |
|
17526 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBX6 |
0.538303193436468 |
|
17527 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM219 |
0.538303193436468 |
|
17528 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YPEL3 |
0.538303193436468 |
|
17529 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZG16 |
0.538303193436468 |
|
17530 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238639.1 |
0.538303193436468 |
|
17531 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239114.1 |
0.538303193436468 |
|
17532 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239193.1 |
0.538303193436468 |
|
17533 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD2BP2 |
0.538303193436468 |
|
17534 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D10B |
0.538303193436468 |
|
17535 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYLPF |
0.538303193436468 |
|
17536 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEPT1 |
0.538303193436468 |
|
17537 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF48 |
0.538303193436468 |
|
17538 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF771 |
0.538303193436468 |
|
17539 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCTPP1 |
0.538303193436468 |
|
17540 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA42|ENSG00000199787.1 |
0.538303193436468 |
|
17541 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEPHS2 |
0.538303193436468 |
|
17542 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGAL |
0.538303193436468 |
|
17543 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4518 |
0.538303193436468 |
|
17544 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF747 |
0.538303193436468 |
|
17545 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF768 |
0.538303193436468 |
|
17546 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF764 |
0.538303193436468 |
|
17547 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF688 |
0.538303193436468 |
|
17548 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF785 |
0.538303193436468 |
|
17549 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF689 |
0.538303193436468 |
|
17550 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBRS |
0.538303193436468 |
|
17551 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR14 |
0.538303193436468 |
|
17552 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRCAP |
0.538303193436468 |
|
17553 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA30|ENSG00000206755.1 |
0.538303193436468 |
|
17554 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHKG2 |
0.538303193436468 |
|
17555 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf93 |
0.538303193436468 |
|
17556 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF40 |
0.538303193436468 |
|
17557 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF629 |
0.538303193436468 |
|
17558 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCL7C |
0.538303193436468 |
|
17559 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4519 |
0.538303193436468 |
|
17560 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR762 |
0.538303193436468 |
|
17561 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTF1 |
0.538303193436468 |
|
17562 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXL19 |
0.538303193436468 |
|
17563 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ORAI3 |
0.538303193436468 |
|
17564 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SETD1A |
0.538303193436468 |
|
17565 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSD3B7 |
0.538303193436468 |
|
17566 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STX1B |
0.538303193436468 |
|
17567 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STX4 |
0.538303193436468 |
|
17568 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF668 |
0.538303193436468 |
|
17569 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS53 |
0.538303193436468 |
|
17570 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF646 |
0.538303193436468 |
|
17571 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VKORC1 |
0.538303193436468 |
|
17572 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCKDK |
0.538303193436468 |
|
17573 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KAT8 |
0.538303193436468 |
|
17574 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS8 |
0.538303193436468 |
|
17575 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS36 |
0.538303193436468 |
|
17576 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FUS |
0.538303193436468 |
|
17577 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf98 |
0.538303193436468 |
|
17578 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PYCARD |
0.538303193436468 |
|
17579 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PYDC1 |
0.538303193436468 |
|
17580 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM72 |
0.538303193436468 |
|
17581 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGAM |
0.538303193436468 |
|
17582 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGAX |
0.538303193436468 |
|
17583 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGAD |
0.538303193436468 |
|
17584 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX6A2 |
0.538303193436468 |
|
17585 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF843 |
0.538303193436468 |
|
17586 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARMC5 |
0.538303193436468 |
|
17587 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TGFB1I1 |
0.538303193436468 |
|
17588 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC5A2 |
0.538303193436468 |
|
17589 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf58 |
0.538303193436468 |
|
17590 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AHSP |
0.538303193436468 |
|
17591 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLUHP3 |
0.538303193436468 |
|
17592 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF720 |
0.538303193436468 |
|
17593 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIGD4 |
0.539218899686079 |
|
17594 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARFIP1 |
0.539218899686079 |
|
17595 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FHDC1 |
0.539218899686079 |
|
17596 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM2 |
0.539218899686079 |
|
17597 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MND1 |
0.539218899686079 |
|
17598 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL419P |
0.539218899686079 |
|
17599 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0922 |
0.539218899686079 |
|
17600 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLR2 |
0.539218899686079 |
|
17601 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF175 |
0.539218899686079 |
|
17602 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFRP2 |
0.539218899686079 |
|
17603 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCHS2 |
0.539218899686079 |
|
17604 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLRG1 |
0.539218899686079 |
|
17605 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGB |
0.539218899686079 |
|
17606 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGA |
0.539218899686079 |
|
17607 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGG |
0.539218899686079 |
|
17608 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRAT |
0.539218899686079 |
|
17609 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM46 |
0.539218899686079 |
|
17610 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPY2R |
0.539218899686079 |
|
17611 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP9 |
0.539218899686079 |
|
17612 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GUCY1A3 |
0.539218899686079 |
|
17613 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GUCY1B3 |
0.539218899686079 |
|
17614 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASIC5 |
0.539218899686079 |
|
17615 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TDO2 |
0.539218899686079 |
|
17616 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTSO |
0.539218899686079 |
|
17617 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDGFC |
0.539218899686079 |
|
17618 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLRB |
0.539218899686079 |
|
17619 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRIA2 |
0.539218899686079 |
|
17620 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM198B |
0.539218899686079 |
|
17621 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM144 |
0.539218899686079 |
|
17622 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RXFP1 |
0.539218899686079 |
|
17623 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C4orf46 |
0.539218899686079 |
|
17624 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ETFDH |
0.539218899686079 |
|
17625 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000271817.1 |
0.539218899686079 |
|
17626 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPID |
0.539218899686079 |
|
17627 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FNIP2 |
0.539218899686079 |
|
17628 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C4orf45 |
0.539218899686079 |
|
17629 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAPGEF2 |
0.539218899686079 |
|
17630 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000251979.1 |
0.539218899686079 |
|
17631 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FSTL5 |
0.539218899686079 |
|
17632 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAF1 |
0.539218899686079 |
|
17633 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPY1R |
0.539218899686079 |
|
17634 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPY5R |
0.539218899686079 |
|
17635 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TKTL2 |
0.539218899686079 |
|
17636 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMA16 |
0.539218899686079 |
|
17637 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MARCH1 |
0.539218899686079 |
|
17638 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP105 |
0.539218899686079 |
|
17639 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM218A |
0.539218899686079 |
|
17640 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM61 |
0.539218899686079 |
|
17641 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM60 |
0.539218899686079 |
|
17642 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM192 |
0.539218899686079 |
|
17643 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL2 |
0.539218899686079 |
|
17644 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSMO1 |
0.539218899686079 |
|
17645 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPE |
0.539218899686079 |
|
17646 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR578 |
0.539218899686079 |
|
17647 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLL1 |
0.539218899686079 |
|
17648 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP170 |
0.539218899686079 |
|
17649 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP171 |
0.539218899686079 |
|
17650 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL776P |
0.539218899686079 |
|
17651 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP188 |
0.539218899686079 |
|
17652 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANXA10 |
0.539218899686079 |
|
17653 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX60 |
0.539218899686079 |
|
17654 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238744.1 |
0.539218899686079 |
|
17655 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX60L |
0.539218899686079 |
|
17656 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA51|ENSG00000207171.1 |
0.539218899686079 |
|
17657 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PALLD |
0.539218899686079 |
|
17658 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBR4 |
0.539218899686079 |
|
17659 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P17 |
0.539218899686079 |
|
17660 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3RF1 |
0.539218899686079 |
|
17661 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEK1 |
0.539218899686079 |
|
17662 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLCN3 |
0.539218899686079 |
|
17663 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C4orf27 |
0.539218899686079 |
|
17664 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFAP3L |
0.539218899686079 |
|
17665 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AADAT |
0.539218899686079 |
|
17666 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSP90AA6P |
0.539218899686079 |
|
17667 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC13P |
0.539218899686079 |
|
17668 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALNTL6 |
0.539218899686079 |
|
17669 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL253P |
0.539218899686079 |
|
17670 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALNT7 |
0.539218899686079 |
|
17671 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548T |
0.539218899686079 |
|
17672 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMGB2 |
0.539218899686079 |
|
17673 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAP30 |
0.539218899686079 |
|
17674 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCRG1 |
0.539218899686079 |
|
17675 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAND2 |
0.539218899686079 |
|
17676 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO8 |
0.539218899686079 |
|
17677 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP44 |
0.539218899686079 |
|
17678 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4276 |
0.539218899686079 |
|
17679 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HPGD |
0.539218899686079 |
|
17680 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLRA3 |
0.539218899686079 |
|
17681 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM29 |
0.539218899686079 |
|
17682 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPM6A |
0.539218899686079 |
|
17683 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR17 |
0.539218899686079 |
|
17684 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA51|ENSG00000201516.1 |
0.539218899686079 |
|
17685 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA4 |
0.539218899686079 |
|
17686 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASB5 |
0.539218899686079 |
|
17687 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPCS3 |
0.539218899686079 |
|
17688 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VEGFC |
0.539218899686079 |
|
17689 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP136 |
0.539218899686079 |
|
17690 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEIL3 |
0.539218899686079 |
|
17691 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP172 |
0.539218899686079 |
|
17692 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000252388.1 |
0.539218899686079 |
|
17693 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EGOT |
0.539233856331322 |
|
17694 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239126.1 |
0.539233856331322 |
|
17695 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BHLHE40 |
0.539233856331322 |
|
17696 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL8B |
0.539233856331322 |
|
17697 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EDEM1 |
0.539233856331322 |
|
17698 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4790 |
0.539233856331322 |
|
17699 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL553P |
0.539233856331322 |
|
17700 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTHFD2P1 |
0.539906851990982 |
|
17701 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTRNR2L12 |
0.539906851990982 |
|
17702 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPHA6 |
0.539906851990982 |
|
17703 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL6 |
0.539906851990982 |
|
17704 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRYBG3|ENSG00000233280.2 |
0.539906851990982 |
|
17705 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRYBG3|ENSG00000080200.5 |
0.539906851990982 |
|
17706 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MINA |
0.539906851990982 |
|
17707 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABRR3 |
0.539906851990982 |
|
17708 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5AC1 |
0.539906851990982 |
|
17709 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5AC2 |
0.539906851990982 |
|
17710 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5H1 |
0.539906851990982 |
|
17711 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5H14 |
0.539906851990982 |
|
17712 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5H15 |
0.539906851990982 |
|
17713 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5H6 |
0.539906851990982 |
|
17714 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5H2 |
0.539906851990982 |
|
17715 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5H8P |
0.539906851990982 |
|
17716 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5K4 |
0.539906851990982 |
|
17717 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5K3 |
0.539906851990982 |
|
17718 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5K1 |
0.539906851990982 |
|
17719 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLDND1 |
0.539906851990982 |
|
17720 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5K2 |
0.539906851990982 |
|
17721 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPOX |
0.539906851990982 |
|
17722 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR15 |
0.539906851990982 |
|
17723 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST3GAL6 |
0.539906851990982 |
|
17724 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCBLD2 |
0.539906851990982 |
|
17725 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00973 |
0.539906851990982 |
|
17726 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL8A1 |
0.539906851990982 |
|
17727 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CMSS1 |
0.539906851990982 |
|
17728 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FILIP1L |
0.539906851990982 |
|
17729 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3921 |
0.539906851990982 |
|
17730 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM30C |
0.539906851990982 |
|
17731 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD61|ENSG00000238377.1 |
0.539906851990982 |
|
17732 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D23 |
0.539906851990982 |
|
17733 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NIT2 |
0.539906851990982 |
|
17734 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOMM70A |
0.539906851990982 |
|
17735 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LNP1 |
0.539906851990982 |
|
17736 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM45A |
0.539906851990982 |
|
17737 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR128 |
0.539906851990982 |
|
17738 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000252989.1 |
0.539906851990982 |
|
17739 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFG |
0.539906851990982 |
|
17740 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABI3BP |
0.539906851990982 |
|
17741 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238312.1 |
0.539906851990982 |
|
17742 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IMPG2 |
0.539906851990982 |
|
17743 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SENP7 |
0.539906851990982 |
|
17744 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238525.1 |
0.539906851990982 |
|
17745 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRMT10C |
0.539906851990982 |
|
17746 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCNP |
0.539906851990982 |
|
17747 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB11 |
0.539906851990982 |
|
17748 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL24 |
0.539906851990982 |
|
17749 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP97 |
0.539906851990982 |
|
17750 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NXPE3 |
0.539906851990982 |
|
17751 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFKBIZ |
0.539906851990982 |
|
17752 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZPLD1 |
0.539906851990982 |
|
17753 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548AB |
0.539906851990982 |
|
17754 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf84 |
0.543574270183144 |
|
17755 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERCC4 |
0.547412607592357 |
|
17756 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MKL2 |
0.547412607592357 |
|
17757 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR193B |
0.547412607592357 |
|
17758 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR365A |
0.547412607592357 |
|
17759 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARN |
0.547412607592357 |
|
17760 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL274P |
0.547412607592357 |
|
17761 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BFAR |
0.547412607592357 |
|
17762 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCC1 |
0.547412607592357 |
|
17763 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCC6P1 |
0.547412607592357 |
|
17764 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCC6 |
0.547412607592357 |
|
17765 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL6IP1 |
0.547412607592357 |
|
17766 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf45 |
0.547412607592357 |
|
17767 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOPNL |
0.547412607592357 |
|
17768 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0430 |
0.547412607592357 |
|
17769 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR484 |
0.547412607592357 |
|
17770 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPV17L |
0.547412607592357 |
|
17771 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYH11 |
0.547412607592357 |
|
17772 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDE1 |
0.547412607592357 |
|
17773 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOMO1 |
0.547412607592357 |
|
17774 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOMO2 |
0.547412607592357 |
|
17775 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOMO3 |
0.547412607592357 |
|
17776 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPIPA1 |
0.547412607592357 |
|
17777 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPIPA2 |
0.547412607592357 |
|
17778 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPIPA3 |
0.547412607592357 |
|
17779 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPIPA5 |
0.547412607592357 |
|
17780 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPIPA7 |
0.547412607592357 |
|
17781 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPIPA8 |
0.547412607592357 |
|
17782 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPIPP1 |
0.547412607592357 |
|
17783 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NTAN1 |
0.547412607592357 |
|
17784 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDXDC1 |
0.547412607592357 |
|
17785 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKD1P5 |
0.547412607592357 |
|
17786 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKD1P6 |
0.547412607592357 |
|
17787 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLA2G10 |
0.547412607592357 |
|
17788 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL90P |
0.547412607592357 |
|
17789 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS15A |
0.547412607592357 |
|
17790 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRN3 |
0.547412607592357 |
|
17791 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XYLT1 |
0.547412607592357 |
|
17792 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMG1 |
0.547412607592357 |
|
17793 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238329.1 |
0.547412607592357 |
|
17794 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMC7 |
0.547412607592357 |
|
17795 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COQ7 |
0.547412607592357 |
|
17796 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITPRIPL2 |
0.547412607592357 |
|
17797 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYT17 |
0.547412607592357 |
|
17798 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC19A |
0.547412607592357 |
|
17799 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMC5 |
0.547412607592357 |
|
17800 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GDE1 |
0.547412607592357 |
|
17801 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCP110 |
0.547412607592357 |
|
17802 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf62 |
0.547412607592357 |
|
17803 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KNOP1 |
0.547412607592357 |
|
17804 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IQCK |
0.547412607592357 |
|
17805 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPRC5B |
0.547412607592357 |
|
17806 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR139 |
0.547412607592357 |
|
17807 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GP2 |
0.547412607592357 |
|
17808 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UMOD |
0.547412607592357 |
|
17809 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDILT |
0.547412607592357 |
|
17810 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACSM5 |
0.547412607592357 |
|
17811 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACSM2A |
0.547412607592357 |
|
17812 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACSM2B |
0.547412607592357 |
|
17813 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACSM1 |
0.547412607592357 |
|
17814 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACSM3 |
0.547412607592357 |
|
17815 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THUMPD1 |
0.547412607592357 |
|
17816 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERI2 |
0.547412607592357 |
|
17817 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCUN1D3 |
0.547412607592357 |
|
17818 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYRM1 |
0.547412607592357 |
|
17819 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAH3 |
0.547412607592357 |
|
17820 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM159 |
0.547412607592357 |
|
17821 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZP2 |
0.547412607592357 |
|
17822 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKS4B |
0.547412607592357 |
|
17823 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRYM |
0.547412607592357 |
|
17824 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C16orf52 |
0.547412607592357 |
|
17825 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDR2 |
0.547412607592357 |
|
17826 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EEF2K |
0.547412607592357 |
|
17827 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGSF6 |
0.547412607592357 |
|
17828 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL9 |
0.547412607592357 |
|
17829 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPIPB3 |
0.547412607592357 |
|
17830 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPIPB4 |
0.547412607592357 |
|
17831 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPIPB5 |
0.547412607592357 |
|
17832 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OTOA |
0.547412607592357 |
|
17833 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDZD9 |
0.547412607592357 |
|
17834 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR3E |
0.547412607592357 |
|
17835 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL245P |
0.547412607592357 |
|
17836 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRN3P1 |
0.547412607592357 |
|
17837 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRN3P3 |
0.547412607592357 |
|
17838 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA6|ENSG00000252798.1 |
0.547412607592357 |
|
17839 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDR42E2 |
0.547412607592357 |
|
17840 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMG1P1 |
0.547412607592357 |
|
17841 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UQCRC2 |
0.547412607592357 |
|
17842 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VWA3A |
0.547412607592357 |
|
17843 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238712.1 |
0.547412607592357 |
|
17844 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238954.1 |
0.547412607592357 |
|
17845 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239172.1 |
0.547412607592357 |
|
17846 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLN3 |
0.547412607592357 |
|
17847 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF3CL |
0.547412607592357 |
|
17848 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPIPB7 |
0.547412607592357 |
|
17849 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238703.1 |
0.547412607592357 |
|
17850 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOBR |
0.547412607592357 |
|
17851 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL27 |
0.547412607592357 |
|
17852 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUPR1 |
0.547412607592357 |
|
17853 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC101 |
0.547412607592357 |
|
17854 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SULT1A2 |
0.547412607592357 |
|
17855 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SULT1A1 |
0.547412607592357 |
|
17856 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP34 |
0.547537678319618 |
|
17857 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4280 |
0.547537678319618 |
|
17858 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASA1 |
0.547537678319618 |
|
17859 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL629P |
0.547537678319618 |
|
17860 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNH |
0.547537678319618 |
|
17861 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM161B |
0.547537678319618 |
|
17862 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP187 |
0.547537678319618 |
|
17863 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000206958.1 |
0.547537678319618 |
|
17864 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00461 |
0.547537678319618 |
|
17865 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEF2C |
0.547537678319618 |
|
17866 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3660 |
0.547537678319618 |
|
17867 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CETN3 |
0.547537678319618 |
|
17868 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBLAC2 |
0.547537678319618 |
|
17869 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR3G |
0.547537678319618 |
|
17870 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYSMD3 |
0.547537678319618 |
|
17871 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR98 |
0.547537678319618 |
|
17872 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LUCAT1 |
0.547537678319618 |
|
17873 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARRDC3 |
0.547537678319618 |
|
17874 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NR2F1 |
0.547537678319618 |
|
17875 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR2277 |
0.547537678319618 |
|
17876 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POU5F2 |
0.547537678319618 |
|
17877 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD32 |
0.547537678319618 |
|
17878 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCTP1 |
0.547537678319618 |
|
17879 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM81B |
0.547537678319618 |
|
17880 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC37 |
0.547537678319618 |
|
17881 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARSK |
0.547537678319618 |
|
17882 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR150 |
0.547537678319618 |
|
17883 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFESD |
0.547537678319618 |
|
17884 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA9 |
0.547537678319618 |
|
17885 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHOBTB3 |
0.547537678319618 |
|
17886 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLRX |
0.547537678319618 |
|
17887 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf27 |
0.547537678319618 |
|
17888 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELL2 |
0.547537678319618 |
|
17889 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR583 |
0.547537678319618 |
|
17890 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCSK1 |
0.547537678319618 |
|
17891 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAST |
0.547537678319618 |
|
17892 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERAP1 |
0.547537678319618 |
|
17893 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERAP2 |
0.547537678319618 |
|
17894 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LNPEP |
0.547537678319618 |
|
17895 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIX1 |
0.547537678319618 |
|
17896 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIOK2 |
0.547537678319618 |
|
17897 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGMB |
0.547537678319618 |
|
17898 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHD1 |
0.547537678319618 |
|
17899 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM174A |
0.547537678319618 |
|
17900 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP62 |
0.547537678319618 |
|
17901 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST8SIA4 |
0.547537678319618 |
|
17902 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548P |
0.547537678319618 |
|
17903 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL802P |
0.547537678319618 |
|
17904 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP188 |
0.547537678319618 |
|
17905 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP189 |
0.547537678319618 |
|
17906 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000252337.1 |
0.547537678319618 |
|
17907 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFNA5 |
0.547537678319618 |
|
17908 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL782P |
0.547537678319618 |
|
17909 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP122 |
0.547537678319618 |
|
17910 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FER |
0.547537678319618 |
|
17911 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFAIP8 |
0.547537678319618 |
|
17912 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL174P |
0.547537678319618 |
|
17913 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP190 |
0.547537678319618 |
|
17914 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSD17B4 |
0.547537678319618 |
|
17915 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239084.1 |
0.547537678319618 |
|
17916 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239067.1 |
0.547537678319618 |
|
17917 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM170A |
0.547537678319618 |
|
17918 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR16 |
0.547537678319618 |
|
17919 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FTMT |
0.547537678319618 |
|
17920 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRFBP1 |
0.547537678319618 |
|
17921 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LOX |
0.547537678319618 |
|
17922 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF474 |
0.547537678319618 |
|
17923 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNCAIP |
0.547537678319618 |
|
17924 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX2 |
0.547537678319618 |
|
17925 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000252295.1 |
0.547537678319618 |
|
17926 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX24 |
0.547537678319618 |
|
17927 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239103.1 |
0.547537678319618 |
|
17928 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPIC |
0.547537678319618 |
|
17929 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL689P |
0.547537678319618 |
|
17930 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL711P |
0.547537678319618 |
|
17931 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRDM6 |
0.547537678319618 |
|
17932 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP120 |
0.547537678319618 |
|
17933 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSNK1G3 |
0.547537678319618 |
|
17934 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF608 |
0.547537678319618 |
|
17935 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP117 |
0.547537678319618 |
|
17936 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRAMD3 |
0.547537678319618 |
|
17937 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALDH7A1 |
0.547537678319618 |
|
17938 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHAX |
0.547537678319618 |
|
17939 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf48 |
0.547537678319618 |
|
17940 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMNB1 |
0.547537678319618 |
|
17941 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MARCH3 |
0.547537678319618 |
|
17942 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf63 |
0.547537678319618 |
|
17943 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEGF10 |
0.547537678319618 |
|
17944 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRRC1 |
0.547537678319618 |
|
17945 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTXN3 |
0.547537678319618 |
|
17946 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC12A2 |
0.547537678319618 |
|
17947 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBN2 |
0.547537678319618 |
|
17948 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC27A6 |
0.547537678319618 |
|
17949 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ISOC1 |
0.547537678319618 |
|
17950 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4633 |
0.547537678319618 |
|
17951 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4460 |
0.547537678319618 |
|
17952 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAMTS19 |
0.547537678319618 |
|
17953 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1024L |
0.547537678319618 |
|
17954 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHSY3 |
0.547537678319618 |
|
17955 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC10P |
0.547537678319618 |
|
17956 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP191 |
0.547537678319618 |
|
17957 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HINT1 |
0.547537678319618 |
|
17958 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYRM7 |
0.547537678319618 |
|
17959 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC42SE2 |
0.547537678319618 |
|
17960 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAPGEF6 |
0.547537678319618 |
|
17961 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FNIP1 |
0.547537678319618 |
|
17962 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACSL6 |
0.547537678319618 |
|
17963 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL3 |
0.547537678319618 |
|
17964 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSF2 |
0.547537678319618 |
|
17965 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoZ6|ENSG00000253067.1 |
0.547537678319618 |
|
17966 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
P4HA2 |
0.547537678319618 |
|
17967 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDLIM4 |
0.547537678319618 |
|
17968 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC22A4 |
0.547537678319618 |
|
17969 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3936 |
0.547537678319618 |
|
17970 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC22A5 |
0.547537678319618 |
|
17971 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf56 |
0.547537678319618 |
|
17972 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRF1 |
0.547537678319618 |
|
17973 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL5 |
0.547537678319618 |
|
17974 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAD50 |
0.547537678319618 |
|
17975 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL13 |
0.547537678319618 |
|
17976 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL4 |
0.547537678319618 |
|
17977 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF3A |
0.547537678319618 |
|
17978 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNI2 |
0.547537678319618 |
|
17979 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEPT8 |
0.547537678319618 |
|
17980 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOWAHA |
0.547537678319618 |
|
17981 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHROOM1 |
0.547537678319618 |
|
17982 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP192 |
0.547537678319618 |
|
17983 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GDF9 |
0.547537678319618 |
|
17984 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UQCRQ |
0.547537678319618 |
|
17985 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LEAP2 |
0.547537678319618 |
|
17986 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AFF4 |
0.547537678319618 |
|
17987 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZCCHC10 |
0.547537678319618 |
|
17988 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPA4 |
0.547537678319618 |
|
17989 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FSTL4 |
0.547537678319618 |
|
17990 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238796.1 |
0.547537678319618 |
|
17991 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf15 |
0.547537678319618 |
|
17992 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VDAC1 |
0.547537678319618 |
|
17993 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCF7 |
0.547537678319618 |
|
17994 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SKP1 |
0.547537678319618 |
|
17995 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP2CA |
0.547537678319618 |
|
17996 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDKL3 |
0.547537678319618 |
|
17997 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3661 |
0.547537678319618 |
|
17998 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2B |
0.547537678319618 |
|
17999 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDKN2AIPNL |
0.547537678319618 |
|
18000 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL541P |
0.547537678319618 |
|
18001 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHF15 |
0.547537678319618 |
|
18002 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAR1B |
0.547537678319618 |
|
18003 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC24A |
0.547537678319618 |
|
18004 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAMLG |
0.547537678319618 |
|
18005 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX46 |
0.547537678319618 |
|
18006 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf24 |
0.547537678319618 |
|
18007 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TXNDC15 |
0.547537678319618 |
|
18008 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCBD2 |
0.547537678319618 |
|
18009 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4461 |
0.547537678319618 |
|
18010 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CATSPER3 |
0.547537678319618 |
|
18011 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PITX1 |
0.547537678319618 |
|
18012 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
H2AFY |
0.547537678319618 |
|
18013 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf20 |
0.547537678319618 |
|
18014 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIFAB |
0.547537678319618 |
|
18015 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEUROG1 |
0.547537678319618 |
|
18016 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXCL14 |
0.547537678319618 |
|
18017 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5692C1 |
0.547537678319618 |
|
18018 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A48 |
0.547537678319618 |
|
18019 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL9 |
0.547537678319618 |
|
18020 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LECT2 |
0.547537678319618 |
|
18021 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXL21 |
0.547537678319618 |
|
18022 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TGFBI |
0.547537678319618 |
|
18023 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMAD5 |
0.547537678319618 |
|
18024 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPC7 |
0.547537678319618 |
|
18025 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP193 |
0.547537678319618 |
|
18026 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPOCK1 |
0.547537678319618 |
|
18027 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL3 |
0.547537678319618 |
|
18028 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR874 |
0.547537678319618 |
|
18029 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPA0 |
0.547537678319618 |
|
18030 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPY6R |
0.547537678319618 |
|
18031 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYOT |
0.547537678319618 |
|
18032 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKD2L2 |
0.547537678319618 |
|
18033 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM13B |
0.547537678319618 |
|
18034 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WNT8A |
0.547537678319618 |
|
18035 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NME5 |
0.547537678319618 |
|
18036 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238605.1 |
0.547537678319618 |
|
18037 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRD8 |
0.547537678319618 |
|
18038 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF20A |
0.547537678319618 |
|
18039 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC23 |
0.547537678319618 |
|
18040 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GFRA3 |
0.547537678319618 |
|
18041 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL682P |
0.547537678319618 |
|
18042 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC25C |
0.547537678319618 |
|
18043 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM53C |
0.547537678319618 |
|
18044 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KDM3B |
0.547537678319618 |
|
18045 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REEP2 |
0.547537678319618 |
|
18046 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EGR1 |
0.547537678319618 |
|
18047 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ETF1 |
0.547537678319618 |
|
18048 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPA9 |
0.547537678319618 |
|
18049 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD63|ENSG00000222937.1 |
0.547537678319618 |
|
18050 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD63|ENSG00000206989.1 |
0.547537678319618 |
|
18051 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTNNA1 |
0.547537678319618 |
|
18052 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238745.1 |
0.547537678319618 |
|
18053 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL867P |
0.547537678319618 |
|
18054 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRTM2 |
0.547537678319618 |
|
18055 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP194 |
0.547537678319618 |
|
18056 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MATR3 |
0.547537678319618 |
|
18057 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA74|ENSG00000252213.1 |
0.547537678319618 |
|
18058 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA74A |
0.547537678319618 |
|
18059 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP195 |
0.547537678319618 |
|
18060 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP64 |
0.547537678319618 |
|
18061 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAIP2 |
0.547537678319618 |
|
18062 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC23A1 |
0.547537678319618 |
|
18063 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MZB1 |
0.547537678319618 |
|
18064 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PROB1 |
0.547537678319618 |
|
18065 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA24 |
0.547537678319618 |
|
18066 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC18 |
0.547537678319618 |
|
18067 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ECSCR |
0.547537678319618 |
|
18068 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM173 |
0.547537678319618 |
|
18069 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2D2 |
0.547537678319618 |
|
18070 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXXC5 |
0.547537678319618 |
|
18071 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSD2 |
0.547537678319618 |
|
18072 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRG2 |
0.547537678319618 |
|
18073 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PURA |
0.547537678319618 |
|
18074 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGIP |
0.547537678319618 |
|
18075 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYSTM1 |
0.547537678319618 |
|
18076 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PFDN1 |
0.547537678319618 |
|
18077 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HBEGF |
0.547537678319618 |
|
18078 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC4A9 |
0.547537678319618 |
|
18079 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKHD1 |
0.547537678319618 |
|
18080 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD45|ENSG00000200051.1 |
0.547537678319618 |
|
18081 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRA1 |
0.547537678319618 |
|
18082 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF4EBP3 |
0.547537678319618 |
|
18083 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APBB3 |
0.547537678319618 |
|
18084 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35A4 |
0.547537678319618 |
|
18085 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA27|ENSG00000200235.1 |
0.547537678319618 |
|
18086 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD14 |
0.547537678319618 |
|
18087 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFA2 |
0.547537678319618 |
|
18088 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMCO6 |
0.547537678319618 |
|
18089 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IK |
0.547537678319618 |
|
18090 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3655 |
0.547537678319618 |
|
18091 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR55 |
0.547537678319618 |
|
18092 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DND1 |
0.547537678319618 |
|
18093 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HARS |
0.547537678319618 |
|
18094 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HARS2 |
0.547537678319618 |
|
18095 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZMAT2 |
0.547537678319618 |
|
18096 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHA1 |
0.547537678319618 |
|
18097 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHA2 |
0.547537678319618 |
|
18098 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHA3 |
0.547537678319618 |
|
18099 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHA4 |
0.547537678319618 |
|
18100 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHA10 |
0.547537678319618 |
|
18101 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHA11 |
0.547537678319618 |
|
18102 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHA14 |
0.547537678319618 |
|
18103 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHA5 |
0.547537678319618 |
|
18104 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHA6 |
0.547537678319618 |
|
18105 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHA7 |
0.547537678319618 |
|
18106 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHA8 |
0.547537678319618 |
|
18107 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHA9 |
0.547537678319618 |
|
18108 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHA12 |
0.547537678319618 |
|
18109 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHA13 |
0.547537678319618 |
|
18110 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHAC1 |
0.547537678319618 |
|
18111 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHAC2 |
0.547537678319618 |
|
18112 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHB1 |
0.547537678319618 |
|
18113 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHB2 |
0.547537678319618 |
|
18114 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHB3 |
0.547537678319618 |
|
18115 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHB17 |
0.547537678319618 |
|
18116 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHB4 |
0.547537678319618 |
|
18117 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHB5 |
0.547537678319618 |
|
18118 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHB6 |
0.547537678319618 |
|
18119 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHB7 |
0.547537678319618 |
|
18120 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHB16 |
0.547537678319618 |
|
18121 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHB8 |
0.547537678319618 |
|
18122 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHB10 |
0.547537678319618 |
|
18123 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHB11 |
0.547537678319618 |
|
18124 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHB12 |
0.547537678319618 |
|
18125 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHB13 |
0.547537678319618 |
|
18126 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHB14 |
0.547537678319618 |
|
18127 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHB18 |
0.547537678319618 |
|
18128 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHB15 |
0.547537678319618 |
|
18129 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A2 |
0.547537678319618 |
|
18130 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAF7 |
0.547537678319618 |
|
18131 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHGA1 |
0.547537678319618 |
|
18132 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHGA2 |
0.547537678319618 |
|
18133 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHGA3 |
0.547537678319618 |
|
18134 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHGB1 |
0.547537678319618 |
|
18135 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHGA4 |
0.547537678319618 |
|
18136 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHGB2 |
0.547537678319618 |
|
18137 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHGA5 |
0.547537678319618 |
|
18138 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHGB3 |
0.547537678319618 |
|
18139 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHGA6 |
0.547537678319618 |
|
18140 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHGA7 |
0.547537678319618 |
|
18141 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHGB4 |
0.547537678319618 |
|
18142 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHGA8 |
0.547537678319618 |
|
18143 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHGA9 |
0.547537678319618 |
|
18144 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHGA10 |
0.547537678319618 |
|
18145 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHGA11 |
0.547537678319618 |
|
18146 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHGB6 |
0.547537678319618 |
|
18147 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHGB7 |
0.547537678319618 |
|
18148 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHGB8P |
0.547537678319618 |
|
18149 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHGA12 |
0.547537678319618 |
|
18150 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHGC3 |
0.547537678319618 |
|
18151 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL68P |
0.547537678319618 |
|
18152 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHGC4 |
0.547537678319618 |
|
18153 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDHGC5 |
0.547537678319618 |
|
18154 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DIAPH1 |
0.547537678319618 |
|
18155 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HDAC3 |
0.547537678319618 |
|
18156 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RELL2 |
0.547537678319618 |
|
18157 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCHSD1 |
0.547537678319618 |
|
18158 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARAP3 |
0.547537678319618 |
|
18159 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDH1 |
0.547537678319618 |
|
18160 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0141 |
0.547537678319618 |
|
18161 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDH12 |
0.547537678319618 |
|
18162 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF14 |
0.547537678319618 |
|
18163 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNPDA1 |
0.547537678319618 |
|
18164 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDFIP1 |
0.547537678319618 |
|
18165 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPRY4 |
0.547537678319618 |
|
18166 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGF1 |
0.547537678319618 |
|
18167 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP26 |
0.547537678319618 |
|
18168 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NR3C1 |
0.547537678319618 |
|
18169 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5197 |
0.547537678319618 |
|
18170 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMHB1 |
0.547537678319618 |
|
18171 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL87P |
0.547537678319618 |
|
18172 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YIPF5 |
0.547537678319618 |
|
18173 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCTD16 |
0.547537678319618 |
|
18174 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP246 |
0.547537678319618 |
|
18175 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRELID2 |
0.547537678319618 |
|
18176 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRXCR2 |
0.547537678319618 |
|
18177 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3RF2 |
0.547537678319618 |
|
18178 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLAC8L1 |
0.547537678319618 |
|
18179 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LARS |
0.547537678319618 |
|
18180 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM27 |
0.547537678319618 |
|
18181 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POU4F3 |
0.547537678319618 |
|
18182 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCERG1 |
0.547537678319618 |
|
18183 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR151 |
0.547537678319618 |
|
18184 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP196 |
0.547537678319618 |
|
18185 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP2R2B |
0.547537678319618 |
|
18186 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL791P |
0.547537678319618 |
|
18187 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STK32A |
0.547537678319618 |
|
18188 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPYSL3 |
0.547537678319618 |
|
18189 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JAKMIP2 |
0.547537678319618 |
|
18190 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPINK1 |
0.547537678319618 |
|
18191 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCGB3A2 |
0.547537678319618 |
|
18192 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf46 |
0.547537678319618 |
|
18193 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPINK5 |
0.547537678319618 |
|
18194 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPINK14 |
0.547537678319618 |
|
18195 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPINK6 |
0.547537678319618 |
|
18196 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPINK13 |
0.547537678319618 |
|
18197 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPINK7 |
0.547537678319618 |
|
18198 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPINK9 |
0.547537678319618 |
|
18199 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO38 |
0.547537678319618 |
|
18200 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTR4 |
0.547537678319618 |
|
18201 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADRB2 |
0.547537678319618 |
|
18202 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3TC2 |
0.547537678319618 |
|
18203 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR584 |
0.547537678319618 |
|
18204 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP145 |
0.547537678319618 |
|
18205 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABLIM3 |
0.547537678319618 |
|
18206 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AFAP1L1 |
0.547537678319618 |
|
18207 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRPEL2 |
0.547537678319618 |
|
18208 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCYOX1L |
0.547537678319618 |
|
18209 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL17B |
0.547537678319618 |
|
18210 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR143HG |
0.547537678319618 |
|
18211 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR143 |
0.547537678319618 |
|
18212 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR145 |
0.547537678319618 |
|
18213 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VSTM2B |
0.548046846036273 |
|
18214 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POP4 |
0.548046846036273 |
|
18215 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD28 |
0.549226748918068 |
|
18216 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR563 |
0.549226748918068 |
|
18217 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC24A1 |
0.550612345072543 |
|
18218 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DENND4A |
0.550612345072543 |
|
18219 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238311.1 |
0.550612345072543 |
|
18220 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4511 |
0.550612345072543 |
|
18221 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB11A |
0.550612345072543 |
|
18222 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEGF11 |
0.550612345072543 |
|
18223 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4311 |
0.550612345072543 |
|
18224 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DIS3L |
0.550612345072543 |
|
18225 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIPIN |
0.550612345072543 |
|
18226 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA14 |
0.550612345072543 |
|
18227 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP2K1 |
0.550612345072543 |
|
18228 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNAPC5 |
0.550612345072543 |
|
18229 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4512 |
0.550612345072543 |
|
18230 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL4 |
0.550612345072543 |
|
18231 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD18C |
0.550612345072543 |
|
18232 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD16 |
0.550612345072543 |
|
18233 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD18A |
0.550612345072543 |
|
18234 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD18B |
0.550612345072543 |
|
18235 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZWILCH |
0.550612345072543 |
|
18236 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCTL |
0.550612345072543 |
|
18237 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMAD6 |
0.550612345072543 |
|
18238 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMAD3 |
0.550612345072543 |
|
18239 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AAGAB |
0.550612345072543 |
|
18240 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IQCH |
0.550612345072543 |
|
18241 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C15orf61 |
0.550612345072543 |
|
18242 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP2K5 |
0.550612345072543 |
|
18243 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SKOR1 |
0.550612345072543 |
|
18244 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIAS1 |
0.550612345072543 |
|
18245 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CALML4 |
0.550612345072543 |
|
18246 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLN6 |
0.550612345072543 |
|
18247 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FEM1B |
0.550612345072543 |
|
18248 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGA11 |
0.550612345072543 |
|
18249 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CORO2B |
0.550612345072543 |
|
18250 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANP32A |
0.550612345072543 |
|
18251 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4312 |
0.550612345072543 |
|
18252 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPESP1 |
0.550612345072543 |
|
18253 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOX5 |
0.550612345072543 |
|
18254 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00277 |
0.550612345072543 |
|
18255 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLCE |
0.550612345072543 |
|
18256 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL438P |
0.550612345072543 |
|
18257 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAQR5 |
0.550612345072543 |
|
18258 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA77|ENSG00000221376.1 |
0.550612345072543 |
|
18259 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP398 |
0.550612345072543 |
|
18260 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF23 |
0.550612345072543 |
|
18261 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPLP1 |
0.550612345072543 |
|
18262 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000207119.1 |
0.550612345072543 |
|
18263 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00593 |
0.550612345072543 |
|
18264 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLE3 |
0.550612345072543 |
|
18265 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR629 |
0.550612345072543 |
|
18266 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UACA |
0.550612345072543 |
|
18267 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL29P30 |
0.550612345072543 |
|
18268 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LARP6 |
0.550612345072543 |
|
18269 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC49 |
0.550612345072543 |
|
18270 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THAP10 |
0.550612345072543 |
|
18271 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THSD4 |
0.550612345072543 |
|
18272 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CT62 |
0.550612345072543 |
|
18273 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NR2E3 |
0.550612345072543 |
|
18274 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYO9A |
0.550612345072543 |
|
18275 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP399 |
0.550612345072543 |
|
18276 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SENP8 |
0.550612345072543 |
|
18277 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRAMD2 |
0.550612345072543 |
|
18278 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKM |
0.550612345072543 |
|
18279 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARP6 |
0.550612345072543 |
|
18280 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CELF6 |
0.550612345072543 |
|
18281 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HEXA |
0.550612345072543 |
|
18282 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM202 |
0.550612345072543 |
|
18283 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARIH1 |
0.550612345072543 |
|
18284 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR630 |
0.550612345072543 |
|
18285 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA6B |
0.550612345072543 |
|
18286 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL485P |
0.550612345072543 |
|
18287 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL853P |
0.550612345072543 |
|
18288 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIGD2B |
0.550612345072543 |
|
18289 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BBS4 |
0.550612345072543 |
|
18290 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADPGK |
0.550612345072543 |
|
18291 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEO1 |
0.550612345072543 |
|
18292 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCN4 |
0.550612345072543 |
|
18293 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C15orf60 |
0.550612345072543 |
|
18294 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPTN |
0.550612345072543 |
|
18295 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD276 |
0.550612345072543 |
|
18296 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C15orf59 |
0.550612345072543 |
|
18297 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D21 |
0.550612345072543 |
|
18298 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LOXL1 |
0.550612345072543 |
|
18299 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STOML1 |
0.550612345072543 |
|
18300 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PML |
0.550612345072543 |
|
18301 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA6A |
0.550612345072543 |
|
18302 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ISLR2 |
0.550612345072543 |
|
18303 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL429P |
0.550612345072543 |
|
18304 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ISLR |
0.550612345072543 |
|
18305 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STRA6 |
0.550612345072543 |
|
18306 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC33 |
0.550612345072543 |
|
18307 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP11A1 |
0.550612345072543 |
|
18308 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEMA7A |
0.550612345072543 |
|
18309 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBL7 |
0.550612345072543 |
|
18310 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD77|ENSG00000212279.2 |
0.550612345072543 |
|
18311 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARID3B |
0.550612345072543 |
|
18312 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLK3 |
0.550612345072543 |
|
18313 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EDC3 |
0.550612345072543 |
|
18314 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP1A1 |
0.550612345072543 |
|
18315 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP1A2 |
0.550612345072543 |
|
18316 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSK |
0.550612345072543 |
|
18317 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4513 |
0.550612345072543 |
|
18318 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMAN1L |
0.550612345072543 |
|
18319 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPLX3 |
0.550612345072543 |
|
18320 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ULK3 |
0.550612345072543 |
|
18321 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCAMP2 |
0.550612345072543 |
|
18322 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPI |
0.550612345072543 |
|
18323 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM219B |
0.550612345072543 |
|
18324 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX5A |
0.550612345072543 |
|
18325 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPP25 |
0.550612345072543 |
|
18326 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCAMP5 |
0.550612345072543 |
|
18327 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPCDC |
0.550612345072543 |
|
18328 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA20|ENSG00000252722.1 |
0.550612345072543 |
|
18329 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C15orf39 |
0.550612345072543 |
|
18330 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNM1P34 |
0.550612345072543 |
|
18331 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA6C |
0.550612345072543 |
|
18332 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA6D |
0.550612345072543 |
|
18333 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL327P |
0.550612345072543 |
|
18334 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL489P |
0.550612345072543 |
|
18335 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANP32BP1 |
0.550612345072543 |
|
18336 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COMMD4 |
0.550612345072543 |
|
18337 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEIL1 |
0.550612345072543 |
|
18338 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAN2C1 |
0.550612345072543 |
|
18339 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR631 |
0.550612345072543 |
|
18340 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIN3A |
0.550612345072543 |
|
18341 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPN9 |
0.550612345072543 |
|
18342 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNUPN |
0.550612345072543 |
|
18343 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IMP3 |
0.550612345072543 |
|
18344 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX33 |
0.550612345072543 |
|
18345 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSPG4 |
0.550612345072543 |
|
18346 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ODF3L1 |
0.550612345072543 |
|
18347 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNM1P35 |
0.550612345072543 |
|
18348 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4313 |
0.550612345072543 |
|
18349 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL319P |
0.550612345072543 |
|
18350 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252372.1 |
0.550612345072543 |
|
18351 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2Q2 |
0.550612345072543 |
|
18352 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL510P |
0.550612345072543 |
|
18353 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO22 |
0.550612345072543 |
|
18354 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRG4 |
0.550612345072543 |
|
18355 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C15orf27 |
0.550612345072543 |
|
18356 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ETFA |
0.550612345072543 |
|
18357 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ISL2 |
0.550612345072543 |
|
18358 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCAPER |
0.550612345072543 |
|
18359 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3713 |
0.550612345072543 |
|
18360 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP217 |
0.550612345072543 |
|
18361 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RCN2 |
0.550612345072543 |
|
18362 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL278P |
0.550612345072543 |
|
18363 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSTPIP1 |
0.550612345072543 |
|
18364 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPAN3 |
0.550612345072543 |
|
18365 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEAK1 |
0.550612345072543 |
|
18366 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMG20A |
0.550612345072543 |
|
18367 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINGO1 |
0.550612345072543 |
|
18368 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL214P |
0.550612345072543 |
|
18369 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D2B |
0.550612345072543 |
|
18370 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1827 |
0.550612345072543 |
|
18371 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH2D7 |
0.550612345072543 |
|
18372 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA63|ENSG00000199633.1 |
0.550612345072543 |
|
18373 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CIB2 |
0.550612345072543 |
|
18374 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IDH3A |
0.550612345072543 |
|
18375 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACSBG1 |
0.550612345072543 |
|
18376 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJA4 |
0.550612345072543 |
|
18377 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR61 |
0.550612345072543 |
|
18378 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRABP1 |
0.550612345072543 |
|
18379 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IREB2 |
0.550612345072543 |
|
18380 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HYKK |
0.550612345072543 |
|
18381 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMA4 |
0.550612345072543 |
|
18382 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRNA5 |
0.550612345072543 |
|
18383 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRNA3 |
0.550612345072543 |
|
18384 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRNB4 |
0.550612345072543 |
|
18385 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAMTS7 |
0.550612345072543 |
|
18386 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MORF4L1 |
0.550612345072543 |
|
18387 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTSH |
0.550612345072543 |
|
18388 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASGRF1 |
0.550612345072543 |
|
18389 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR184 |
0.550612345072543 |
|
18390 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD34C |
0.550612345072543 |
|
18391 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMED3 |
0.550612345072543 |
|
18392 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1024 |
0.550612345072543 |
|
18393 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTHFS |
0.550612345072543 |
|
18394 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST20 |
0.550612345072543 |
|
18395 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C15ORF37 |
0.550612345072543 |
|
18396 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C15orf37 |
0.550612345072543 |
|
18397 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCL2A1 |
0.550612345072543 |
|
18398 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFAND6 |
0.550612345072543 |
|
18399 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000251881.1 |
0.550612345072543 |
|
18400 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAH |
0.550612345072543 |
|
18401 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00927 |
0.550612345072543 |
|
18402 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARNT2 |
0.550612345072543 |
|
18403 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABHD17C |
0.550612345072543 |
|
18404 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1199 |
0.550612345072543 |
|
18405 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR549 |
0.550612345072543 |
|
18406 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MESDC2 |
0.550612345072543 |
|
18407 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4514 |
0.550612345072543 |
|
18408 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MESDC1 |
0.550612345072543 |
|
18409 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C15orf26 |
0.550612345072543 |
|
18410 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238514.1 |
0.551886578041486 |
|
18411 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00906 |
0.551886578041486 |
|
18412 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP470 |
0.551886578041486 |
|
18413 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHF1 |
0.551886578041486 |
|
18414 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf12 |
0.551886578041486 |
|
18415 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNE1 |
0.551886578041486 |
|
18416 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF563 |
0.552545034260969 |
|
18417 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF442 |
0.552545034260969 |
|
18418 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF443 |
0.552545034260969 |
|
18419 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF799 |
0.552545034260969 |
|
18420 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF709 |
0.552545034260969 |
|
18421 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF564 |
0.552545034260969 |
|
18422 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF490 |
0.552545034260969 |
|
18423 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF791 |
0.552545034260969 |
|
18424 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAN2B1 |
0.552545034260969 |
|
18425 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR83OS |
0.552545034260969 |
|
18426 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR83 |
0.552545034260969 |
|
18427 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHPS |
0.552545034260969 |
|
18428 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXW9 |
0.552545034260969 |
|
18429 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNPO2 |
0.552545034260969 |
|
18430 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD41|ENSG00000209702.1 |
0.552545034260969 |
|
18431 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf43 |
0.552545034260969 |
|
18432 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASNA1 |
0.552545034260969 |
|
18433 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BEST2 |
0.552545034260969 |
|
18434 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOOK2 |
0.552545034260969 |
|
18435 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5684 |
0.552545034260969 |
|
18436 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JUNB |
0.552545034260969 |
|
18437 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRDX2 |
0.552545034260969 |
|
18438 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNASEH2A |
0.552545034260969 |
|
18439 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RTBDN |
0.552545034260969 |
|
18440 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAST1 |
0.552545034260969 |
|
18441 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNASE2 |
0.552545034260969 |
|
18442 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLF1 |
0.552545034260969 |
|
18443 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCDH |
0.552545034260969 |
|
18444 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYCE2 |
0.552545034260969 |
|
18445 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FARSA |
0.552545034260969 |
|
18446 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5695 |
0.552545034260969 |
|
18447 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CALR |
0.552545034260969 |
|
18448 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAD23A |
0.552545034260969 |
|
18449 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GADD45GIP1 |
0.552545034260969 |
|
18450 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DAND5 |
0.552545034260969 |
|
18451 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFIX |
0.552545034260969 |
|
18452 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYL1 |
0.552545034260969 |
|
18453 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRMT1 |
0.552545034260969 |
|
18454 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NACC1 |
0.552545034260969 |
|
18455 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STX10 |
0.552545034260969 |
|
18456 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IER2 |
0.552545034260969 |
|
18457 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNA1A |
0.552545034260969 |
|
18458 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC130 |
0.552545034260969 |
|
18459 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRI1 |
0.552545034260969 |
|
18460 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf53 |
0.552545034260969 |
|
18461 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSWIM4 |
0.552545034260969 |
|
18462 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL619P |
0.552545034260969 |
|
18463 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR27A |
0.552545034260969 |
|
18464 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR23A |
0.552545034260969 |
|
18465 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NANOS3 |
0.552545034260969 |
|
18466 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR181C |
0.552545034260969 |
|
18467 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR181D |
0.552545034260969 |
|
18468 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf57 |
0.552545034260969 |
|
18469 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CC2D1A |
0.552545034260969 |
|
18470 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PODNL1 |
0.552545034260969 |
|
18471 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCAF15 |
0.552545034260969 |
|
18472 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PALM3 |
0.552545034260969 |
|
18473 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf67 |
0.552545034260969 |
|
18474 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKACA |
0.552545034260969 |
|
18475 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAMD1 |
0.552545034260969 |
|
18476 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASF1B |
0.552545034260969 |
|
18477 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPHN1 |
0.552545034260969 |
|
18478 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL231P |
0.552545034260969 |
|
18479 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD97 |
0.552545034260969 |
|
18480 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX39A |
0.552545034260969 |
|
18481 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKN1 |
0.552545034260969 |
|
18482 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GIPC1 |
0.552545034260969 |
|
18483 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTGER1 |
0.552545034260969 |
|
18484 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJB1 |
0.552545034260969 |
|
18485 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR639 |
0.552545034260969 |
|
18486 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TECR |
0.552545034260969 |
|
18487 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFB7 |
0.552545034260969 |
|
18488 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC17A |
0.552545034260969 |
|
18489 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL337P |
0.552545034260969 |
|
18490 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL842P |
0.552545034260969 |
|
18491 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMR3 |
0.552545034260969 |
|
18492 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF333 |
0.552545034260969 |
|
18493 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMR2 |
0.552545034260969 |
|
18494 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR7A5 |
0.552545034260969 |
|
18495 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR7C1 |
0.552545034260969 |
|
18496 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR7A10 |
0.552545034260969 |
|
18497 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR7A17 |
0.552545034260969 |
|
18498 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR7C2 |
0.552545034260969 |
|
18499 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC1A6 |
0.552545034260969 |
|
18500 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC105 |
0.552545034260969 |
|
18501 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASP14 |
0.552545034260969 |
|
18502 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1I1 |
0.552545034260969 |
|
18503 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYDE1 |
0.552545034260969 |
|
18504 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ILVBL |
0.552545034260969 |
|
18505 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOTCH3 |
0.552545034260969 |
|
18506 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPHX3 |
0.552545034260969 |
|
18507 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRD4 |
0.552545034260969 |
|
18508 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKAP8 |
0.552545034260969 |
|
18509 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKAP8L |
0.552545034260969 |
|
18510 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WIZ |
0.552545034260969 |
|
18511 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1470 |
0.552545034260969 |
|
18512 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASAL3 |
0.552545034260969 |
|
18513 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGLYRP2 |
0.552545034260969 |
|
18514 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP4F22 |
0.552545034260969 |
|
18515 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP4F23P |
0.552545034260969 |
|
18516 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP4F8 |
0.552545034260969 |
|
18517 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP4F3 |
0.552545034260969 |
|
18518 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP4F12 |
0.552545034260969 |
|
18519 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10H2 |
0.552545034260969 |
|
18520 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10H3 |
0.552545034260969 |
|
18521 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP4F24P |
0.552545034260969 |
|
18522 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10H5 |
0.552545034260969 |
|
18523 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10H1 |
0.552545034260969 |
|
18524 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UCA1 |
0.552545034260969 |
|
18525 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP4F2 |
0.552545034260969 |
|
18526 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP4F11 |
0.552545034260969 |
|
18527 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10H4 |
0.552545034260969 |
|
18528 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00661 |
0.552545034260969 |
|
18529 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00905 |
0.552545034260969 |
|
18530 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPM4 |
0.552545034260969 |
|
18531 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB8A |
0.552545034260969 |
|
18532 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSH2D |
0.552545034260969 |
|
18533 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CIB3 |
0.552545034260969 |
|
18534 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM32A |
0.552545034260969 |
|
18535 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP1M1 |
0.552545034260969 |
|
18536 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLF2 |
0.552545034260969 |
|
18537 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPS15L1 |
0.552545034260969 |
|
18538 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL844P |
0.552545034260969 |
|
18539 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CALR3 |
0.552545034260969 |
|
18540 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf44 |
0.552545034260969 |
|
18541 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHERP |
0.552545034260969 |
|
18542 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL146P |
0.552545034260969 |
|
18543 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35E1 |
0.552545034260969 |
|
18544 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED26 |
0.552545034260969 |
|
18545 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMIM7 |
0.552545034260969 |
|
18546 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM38A |
0.552545034260969 |
|
18547 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NWD1 |
0.552545034260969 |
|
18548 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIN3B |
0.552545034260969 |
|
18549 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
F2RL3 |
0.552545034260969 |
|
18550 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPAMD8 |
0.552545034260969 |
|
18551 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL835P |
0.552545034260969 |
|
18552 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL823P |
0.552545034260969 |
|
18553 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAUS8 |
0.552545034260969 |
|
18554 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYO9B |
0.552545034260969 |
|
18555 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OCEL1 |
0.552545034260969 |
|
18556 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USE1 |
0.552545034260969 |
|
18557 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NR2F6 |
0.552545034260969 |
|
18558 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USHBP1 |
0.552545034260969 |
|
18559 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BABAM1 |
0.552545034260969 |
|
18560 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKLE1 |
0.552545034260969 |
|
18561 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABHD8 |
0.552545034260969 |
|
18562 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL34 |
0.552545034260969 |
|
18563 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDA1 |
0.552545034260969 |
|
18564 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANO8 |
0.552545034260969 |
|
18565 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTPBP3 |
0.552545034260969 |
|
18566 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLVAP |
0.552545034260969 |
|
18567 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BST2 |
0.552545034260969 |
|
18568 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MVB12A |
0.552545034260969 |
|
18569 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM221 |
0.552545034260969 |
|
18570 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NXNL1 |
0.552545034260969 |
|
18571 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC27A1 |
0.552545034260969 |
|
18572 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGLS |
0.552545034260969 |
|
18573 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM129C |
0.552545034260969 |
|
18574 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COLGALT1 |
0.552545034260969 |
|
18575 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UNC13A |
0.552545034260969 |
|
18576 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP1S |
0.552545034260969 |
|
18577 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCHO1 |
0.552545034260969 |
|
18578 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B3GNT3 |
0.552545034260969 |
|
18579 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INSL3 |
0.552545034260969 |
|
18580 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JAK3 |
0.552545034260969 |
|
18581 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL18A |
0.552545034260969 |
|
18582 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA68|ENSG00000207166.1 |
0.552545034260969 |
|
18583 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC5A5 |
0.552545034260969 |
|
18584 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC124 |
0.552545034260969 |
|
18585 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP468 |
0.552545034260969 |
|
18586 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARRDC2 |
0.552545034260969 |
|
18587 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL12RB1 |
0.552545034260969 |
|
18588 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAST3 |
0.552545034260969 |
|
18589 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIK3R2 |
0.552545034260969 |
|
18590 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFI30 |
0.552545034260969 |
|
18591 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPV17L2 |
0.552545034260969 |
|
18592 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB3A |
0.552545034260969 |
|
18593 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE4C |
0.552545034260969 |
|
18594 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1683 |
0.552545034260969 |
|
18595 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JUND |
0.552545034260969 |
|
18596 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3188 |
0.552545034260969 |
|
18597 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LSM4 |
0.552545034260969 |
|
18598 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL513P |
0.552545034260969 |
|
18599 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGPEP1 |
0.552545034260969 |
|
18600 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GDF15 |
0.552545034260969 |
|
18601 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3189 |
0.552545034260969 |
|
18602 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC25 |
0.552545034260969 |
|
18603 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSBP4 |
0.552545034260969 |
|
18604 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELL |
0.552545034260969 |
|
18605 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ISYNA1 |
0.552545034260969 |
|
18606 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FKBP8 |
0.552545034260969 |
|
18607 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KXD1 |
0.552545034260969 |
|
18608 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRLF1 |
0.552545034260969 |
|
18609 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBA52 |
0.552545034260969 |
|
18610 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf60 |
0.552545034260969 |
|
18611 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM59L |
0.552545034260969 |
|
18612 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL155P |
0.552545034260969 |
|
18613 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL26 |
0.552545034260969 |
|
18614 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRTC1 |
0.552545034260969 |
|
18615 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COMP |
0.552545034260969 |
|
18616 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UPF1 |
0.552545034260969 |
|
18617 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CERS1 |
0.552545034260969 |
|
18618 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GDF1 |
0.552545034260969 |
|
18619 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COPE |
0.552545034260969 |
|
18620 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX49 |
0.552545034260969 |
|
18621 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOMER3 |
0.552545034260969 |
|
18622 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL70P |
0.552545034260969 |
|
18623 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUGP2 |
0.552545034260969 |
|
18624 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARMC6 |
0.552545034260969 |
|
18625 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A42 |
0.552545034260969 |
|
18626 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM161A |
0.552545034260969 |
|
18627 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEF2B |
0.552545034260969 |
|
18628 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEF2BNB |
0.552545034260969 |
|
18629 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFXANK |
0.552545034260969 |
|
18630 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NR2C2AP |
0.552545034260969 |
|
18631 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCAN |
0.552545034260969 |
|
18632 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAPLN4 |
0.552545034260969 |
|
18633 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TM6SF2 |
0.552545034260969 |
|
18634 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUGP1 |
0.552545034260969 |
|
18635 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAU2 |
0.552545034260969 |
|
18636 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GATAD2A |
0.552545034260969 |
|
18637 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR640 |
0.552545034260969 |
|
18638 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFA13 |
0.552545034260969 |
|
18639 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSSK6 |
0.552545034260969 |
|
18640 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YJEFN3 |
0.552545034260969 |
|
18641 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CILP2 |
0.552545034260969 |
|
18642 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PBX4 |
0.552545034260969 |
|
18643 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPAR2 |
0.552545034260969 |
|
18644 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GMIP |
0.552545034260969 |
|
18645 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP13A1 |
0.552545034260969 |
|
18646 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF101 |
0.552545034260969 |
|
18647 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00663 |
0.552545034260969 |
|
18648 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF14 |
0.552545034260969 |
|
18649 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF506 |
0.552545034260969 |
|
18650 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00664 |
0.552545034260969 |
|
18651 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF429 |
0.552545034260969 |
|
18652 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF100 |
0.552545034260969 |
|
18653 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF43 |
0.552545034260969 |
|
18654 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF208 |
0.552545034260969 |
|
18655 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF257 |
0.552545034260969 |
|
18656 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF676 |
0.552545034260969 |
|
18657 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF729 |
0.552545034260969 |
|
18658 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
URI1 |
0.552545034260969 |
|
18659 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF536 |
0.552545034260969 |
|
18660 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSHZ3 |
0.552545034260969 |
|
18661 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THEG5 |
0.552545034260969 |
|
18662 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP471 |
0.552545034260969 |
|
18663 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP472 |
0.552545034260969 |
|
18664 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF507 |
0.552545034260969 |
|
18665 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPY19L3 |
0.552545034260969 |
|
18666 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDCD5 |
0.552545034260969 |
|
18667 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA68|ENSG00000201388.1 |
0.552545034260969 |
|
18668 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL789P |
0.552545034260969 |
|
18669 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGS9BP |
0.552545034260969 |
|
18670 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDT19 |
0.552545034260969 |
|
18671 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TDRD12 |
0.552545034260969 |
|
18672 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC7A9 |
0.552545034260969 |
|
18673 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP22 |
0.552545034260969 |
|
18674 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP89 |
0.552545034260969 |
|
18675 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf40 |
0.552545034260969 |
|
18676 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHPN2 |
0.552545034260969 |
|
18677 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPATCH1 |
0.552545034260969 |
|
18678 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR88 |
0.552545034260969 |
|
18679 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRP3 |
0.552545034260969 |
|
18680 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC7A10 |
0.552545034260969 |
|
18681 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEBPA |
0.552545034260969 |
|
18682 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEBPG |
0.552545034260969 |
|
18683 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEPD |
0.552545034260969 |
|
18684 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHST8 |
0.552545034260969 |
|
18685 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCTD15 |
0.552545034260969 |
|
18686 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL150P |
0.552545034260969 |
|
18687 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LSM14A |
0.552545034260969 |
|
18688 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU4ATAC17P |
0.554698381857444 |
|
18689 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMCD1 |
0.554698381857444 |
|
18690 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00312 |
0.554698381857444 |
|
18691 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSUH2 |
0.554698381857444 |
|
18692 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAV3 |
0.554698381857444 |
|
18693 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OXTR |
0.554698381857444 |
|
18694 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP199 |
0.560743538128251 |
|
18695 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABRG1 |
0.560743538128251 |
|
18696 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238301.1 |
0.560743538128251 |
|
18697 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP215 |
0.560743538128251 |
|
18698 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFXL1 |
0.560743538128251 |
|
18699 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NIPAL1 |
0.560743538128251 |
|
18700 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNGA1 |
0.560743538128251 |
|
18701 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PROS1 |
0.564004309960766 |
|
18702 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM172A |
0.564715732269034 |
|
18703 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0825 |
0.564715732269034 |
|
18704 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHX38 |
0.564889898298862 |
|
18705 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDADC1 |
0.573934741266357 |
|
18706 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAB39L |
0.573934741266357 |
|
18707 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SETDB2 |
0.573934741266357 |
|
18708 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHF11 |
0.573934741266357 |
|
18709 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RCBTB1 |
0.573934741266357 |
|
18710 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL11 |
0.573934741266357 |
|
18711 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EBPL |
0.573934741266357 |
|
18712 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KPNA3 |
0.573934741266357 |
|
18713 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P30 |
0.573934741266357 |
|
18714 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P9 |
0.573934741266357 |
|
18715 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPRYD7 |
0.573934741266357 |
|
18716 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLEU1 |
0.573934741266357 |
|
18717 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLEU2 |
0.573934741266357 |
|
18718 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLEU7 |
0.573934741266357 |
|
18719 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GUCY1B2 |
0.573934741266357 |
|
18720 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNRG |
0.573934741266357 |
|
18721 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3613 |
0.573934741266357 |
|
18722 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP28 |
0.573934741266357 |
|
18723 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP29 |
0.573934741266357 |
|
18724 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNASEH2B |
0.573934741266357 |
|
18725 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM13 |
0.573934741266357 |
|
18726 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RARB |
0.576215194593114 |
|
18727 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD5|ENSG00000272166.1 |
0.576215194593114 |
|
18728 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOP2B |
0.576215194593114 |
|
18729 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLK2 |
0.57891121558328 |
|
18730 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRC2 |
0.57891121558328 |
|
18731 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MARCH10 |
0.57891121558328 |
|
18732 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THEGL |
0.581489640767222 |
|
18733 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOPX |
0.581489640767222 |
|
18734 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548AG1 |
0.581489640767222 |
|
18735 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL492P |
0.581627820578228 |
|
18736 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL357P |
0.581627820578228 |
|
18737 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPINK2 |
0.581627820578228 |
|
18738 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REST |
0.581627820578228 |
|
18739 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOA1 |
0.581627820578228 |
|
18740 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR2B |
0.581627820578228 |
|
18741 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238579.1 |
0.581627820578228 |
|
18742 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGFBP7 |
0.581627820578228 |
|
18743 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238541.1 |
0.581627820578228 |
|
18744 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238925.1 |
0.581627820578228 |
|
18745 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBLN2 |
0.58193369489217 |
|
18746 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548AV |
0.58193369489217 |
|
18747 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NETO1 |
0.58193369489217 |
|
18748 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP460 |
0.58193369489217 |
|
18749 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL401P |
0.58193369489217 |
|
18750 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO15 |
0.58193369489217 |
|
18751 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIMM21 |
0.58193369489217 |
|
18752 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL551P |
0.58193369489217 |
|
18753 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYB5A |
0.58193369489217 |
|
18754 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C18orf63 |
0.58193369489217 |
|
18755 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM69C |
0.58193369489217 |
|
18756 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNDP2 |
0.58193369489217 |
|
18757 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNDP1 |
0.58193369489217 |
|
18758 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00909 |
0.58193369489217 |
|
18759 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF407 |
0.58193369489217 |
|
18760 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZADH2 |
0.58193369489217 |
|
18761 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSHZ1 |
0.58193369489217 |
|
18762 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMIM21 |
0.58193369489217 |
|
18763 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSNK1G1 |
0.585711091894577 |
|
18764 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA48|ENSG00000252774.1 |
0.585711091894577 |
|
18765 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB116 |
0.586959466989029 |
|
18766 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP480 |
0.586959466989029 |
|
18767 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB118 |
0.586959466989029 |
|
18768 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB119 |
0.586959466989029 |
|
18769 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA40|ENSG00000212134.1 |
0.586959466989029 |
|
18770 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB121 |
0.586959466989029 |
|
18771 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB122 |
0.586959466989029 |
|
18772 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB123 |
0.586959466989029 |
|
18773 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB124 |
0.586959466989029 |
|
18774 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REM1 |
0.586959466989029 |
|
18775 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00028 |
0.586959466989029 |
|
18776 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HM13 |
0.586959466989029 |
|
18777 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ID1 |
0.586959466989029 |
|
18778 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3193 |
0.586959466989029 |
|
18779 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX4I2 |
0.586959466989029 |
|
18780 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCL2L1 |
0.586959466989029 |
|
18781 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPX2 |
0.586959466989029 |
|
18782 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYLK2 |
0.586959466989029 |
|
18783 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXS1 |
0.586959466989029 |
|
18784 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUSP15 |
0.586959466989029 |
|
18785 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTLL9 |
0.586959466989029 |
|
18786 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDRG1 |
0.586959466989029 |
|
18787 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XKR7 |
0.586959466989029 |
|
18788 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP481 |
0.586959466989029 |
|
18789 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCM2L |
0.586959466989029 |
|
18790 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCK |
0.586959466989029 |
|
18791 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP482 |
0.586959466989029 |
|
18792 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TM9SF4 |
0.586959466989029 |
|
18793 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPY26P |
0.586959466989029 |
|
18794 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLAGL2 |
0.586959466989029 |
|
18795 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POFUT1 |
0.586959466989029 |
|
18796 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1825 |
0.586959466989029 |
|
18797 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF3B |
0.586959466989029 |
|
18798 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASXL1 |
0.586959466989029 |
|
18799 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C20orf112 |
0.586959466989029 |
|
18800 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C20orf203 |
0.586959466989029 |
|
18801 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COMMD7 |
0.586959466989029 |
|
18802 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNMT3B |
0.586959466989029 |
|
18803 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPRE1 |
0.586959466989029 |
|
18804 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFCAB8 |
0.586959466989029 |
|
18805 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUN5 |
0.586959466989029 |
|
18806 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BPIFB2 |
0.586959466989029 |
|
18807 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BPIFB6 |
0.586959466989029 |
|
18808 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BPIFB3 |
0.586959466989029 |
|
18809 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BPIFB4 |
0.586959466989029 |
|
18810 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BPIFA2 |
0.586959466989029 |
|
18811 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BPIFA4P |
0.586959466989029 |
|
18812 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BPIFA3 |
0.586959466989029 |
|
18813 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BPIFA1 |
0.586959466989029 |
|
18814 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BPIFB1 |
0.586959466989029 |
|
18815 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK5RAP1 |
0.586959466989029 |
|
18816 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNTA1 |
0.586959466989029 |
|
18817 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL511P |
0.586959466989029 |
|
18818 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBFA2T2 |
0.586959466989029 |
|
18819 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NECAB3 |
0.586959466989029 |
|
18820 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C20orf144 |
0.586959466989029 |
|
18821 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTL10 |
0.586959466989029 |
|
18822 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
E2F1 |
0.586959466989029 |
|
18823 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PXMP4 |
0.586959466989029 |
|
18824 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF341 |
0.586959466989029 |
|
18825 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHMP4B |
0.586959466989029 |
|
18826 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RALY |
0.586959466989029 |
|
18827 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4755 |
0.586959466989029 |
|
18828 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF2S2 |
0.586959466989029 |
|
18829 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASIP |
0.586959466989029 |
|
18830 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AHCY |
0.586959466989029 |
|
18831 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITCH |
0.586959466989029 |
|
18832 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR644A |
0.586959466989029 |
|
18833 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DYNLRB1 |
0.586959466989029 |
|
18834 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP1LC3A |
0.586959466989029 |
|
18835 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIGU |
0.586959466989029 |
|
18836 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCOA6 |
0.586959466989029 |
|
18837 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TP53INP2 |
0.586959466989029 |
|
18838 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GGT7 |
0.586959466989029 |
|
18839 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACSS2 |
0.586959466989029 |
|
18840 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSS |
0.586959466989029 |
|
18841 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYH7B |
0.586959466989029 |
|
18842 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR499A |
0.586959466989029 |
|
18843 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPC4AP |
0.586959466989029 |
|
18844 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EDEM2 |
0.586959466989029 |
|
18845 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD56|ENSG00000201151.1 |
0.586959466989029 |
|
18846 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PROCR |
0.586959466989029 |
|
18847 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP483 |
0.586959466989029 |
|
18848 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMP24 |
0.586959466989029 |
|
18849 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF6 |
0.586959466989029 |
|
18850 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM83C |
0.586959466989029 |
|
18851 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UQCC |
0.586959466989029 |
|
18852 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GDF5OS |
0.586959466989029 |
|
18853 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GDF5 |
0.586959466989029 |
|
18854 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP250 |
0.586959466989029 |
|
18855 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C20orf173 |
0.586959466989029 |
|
18856 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERGIC3 |
0.586959466989029 |
|
18857 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FER1L4 |
0.586959466989029 |
|
18858 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPAG4 |
0.586959466989029 |
|
18859 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPNE1 |
0.586959466989029 |
|
18860 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFS1 |
0.586959466989029 |
|
18861 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP271 |
0.586959466989029 |
|
18862 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM12 |
0.586959466989029 |
|
18863 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM39 |
0.586959466989029 |
|
18864 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ROMO1 |
0.586959466989029 |
|
18865 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238549.1 |
0.586959466989029 |
|
18866 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHF20 |
0.586959466989029 |
|
18867 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCAND1 |
0.586959466989029 |
|
18868 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNBD2 |
0.586959466989029 |
|
18869 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00657 |
0.586959466989029 |
|
18870 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPB41L1 |
0.586959466989029 |
|
18871 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239089.1 |
0.586959466989029 |
|
18872 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AAR2 |
0.586959466989029 |
|
18873 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLGAP4 |
0.586959466989029 |
|
18874 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYL9 |
0.586959466989029 |
|
18875 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TGIF2 |
0.586959466989029 |
|
18876 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C20orf24 |
0.586959466989029 |
|
18877 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLA2 |
0.586959466989029 |
|
18878 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDRG3 |
0.586959466989029 |
|
18879 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DSN1 |
0.586959466989029 |
|
18880 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOGA1 |
0.586959466989029 |
|
18881 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL156P |
0.586959466989029 |
|
18882 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLDC2 |
0.586959466989029 |
|
18883 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAMHD1 |
0.586959466989029 |
|
18884 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBL1 |
0.586959466989029 |
|
18885 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPK10 |
0.588607181746008 |
|
18886 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4452 |
0.588607181746008 |
|
18887 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPN13 |
0.588607181746008 |
|
18888 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00349 |
0.588900625489936 |
|
18889 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00387 |
0.588900625489936 |
|
18890 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00388 |
0.588900625489936 |
|
18891 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHF2P2 |
0.588900625489936 |
|
18892 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00442 |
0.588900625489936 |
|
18893 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP24 |
0.588900625489936 |
|
18894 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBA3C |
0.588900625489936 |
|
18895 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00421 |
0.588900625489936 |
|
18896 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPTE2 |
0.588900625489936 |
|
18897 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00350 |
0.588900625489936 |
|
18898 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPHOSPH8 |
0.588900625489936 |
|
18899 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSPC1 |
0.588900625489936 |
|
18900 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL166P |
0.588900625489936 |
|
18901 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZMYM5 |
0.588900625489936 |
|
18902 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238665.1 |
0.588900625489936 |
|
18903 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZMYM2 |
0.588900625489936 |
|
18904 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GJA3 |
0.588900625489936 |
|
18905 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00556 |
0.588900625489936 |
|
18906 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GJB2 |
0.588900625489936 |
|
18907 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRYL1 |
0.588900625489936 |
|
18908 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GJB6 |
0.588900625489936 |
|
18909 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4499 |
0.588900625489936 |
|
18910 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL17D |
0.588900625489936 |
|
18911 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
N6AMT2 |
0.588900625489936 |
|
18912 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XPO4 |
0.588900625489936 |
|
18913 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPA1P30 |
0.588900625489936 |
|
18914 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LATS2 |
0.588900625489936 |
|
18915 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238893.1 |
0.588900625489936 |
|
18916 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL80P |
0.588900625489936 |
|
18917 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAP18 |
0.588900625489936 |
|
18918 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD27|ENSG00000252128.1 |
0.588900625489936 |
|
18919 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SKA3 |
0.588900625489936 |
|
18920 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRP63 |
0.588900625489936 |
|
18921 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ESRRAP2 |
0.588900625489936 |
|
18922 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIPEPP3 |
0.588900625489936 |
|
18923 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP25 |
0.588900625489936 |
|
18924 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDHHC20 |
0.588900625489936 |
|
18925 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MICU2 |
0.588900625489936 |
|
18926 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238878.1 |
0.588900625489936 |
|
18927 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGF9 |
0.588900625489936 |
|
18928 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL766P |
0.588900625489936 |
|
18929 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00424 |
0.588900625489936 |
|
18930 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00621 |
0.588900625489936 |
|
18931 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD36|ENSG00000253094.1 |
0.588900625489936 |
|
18932 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY3P4 |
0.588900625489936 |
|
18933 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00362 |
0.588900625489936 |
|
18934 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGCG |
0.588900625489936 |
|
18935 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SACS |
0.588900625489936 |
|
18936 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00327 |
0.588900625489936 |
|
18937 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00352 |
0.588900625489936 |
|
18938 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS6KA2 |
0.589913169069831 |
|
18939 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNASET2 |
0.589913169069831 |
|
18940 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGFR1OP |
0.589913169069831 |
|
18941 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3939 |
0.589913169069831 |
|
18942 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B3GNTL1 |
0.590291602887532 |
|
18943 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METRNL |
0.590291602887532 |
|
18944 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXOC1 |
0.591335441818409 |
|
18945 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP135 |
0.591335441818409 |
|
18946 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP161 |
0.591335441818409 |
|
18947 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1211 |
0.591335441818409 |
|
18948 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP162 |
0.591335441818409 |
|
18949 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AASDH |
0.591335441818409 |
|
18950 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPAT |
0.591335441818409 |
|
18951 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEIS2 |
0.593521725033913 |
|
18952 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMCO5A |
0.593521725033913 |
|
18953 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPRED1 |
0.593521725033913 |
|
18954 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM98B |
0.593521725033913 |
|
18955 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASGRP1 |
0.593521725033913 |
|
18956 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C15orf53 |
0.593521725033913 |
|
18957 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C15orf54 |
0.593521725033913 |
|
18958 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THBS1 |
0.593521725033913 |
|
18959 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FSIP1 |
0.593521725033913 |
|
18960 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR176 |
0.593521725033913 |
|
18961 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF2AK4 |
0.593521725033913 |
|
18962 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238564.1 |
0.593521725033913 |
|
18963 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRP14 |
0.593521725033913 |
|
18964 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BMF |
0.593521725033913 |
|
18965 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BUB1B |
0.593521725033913 |
|
18966 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAK6 |
0.593521725033913 |
|
18967 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C15orf56 |
0.593521725033913 |
|
18968 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLCB2 |
0.593521725033913 |
|
18969 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD63 |
0.593521725033913 |
|
18970 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00984 |
0.593521725033913 |
|
18971 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C15orf52 |
0.593521725033913 |
|
18972 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP392 |
0.593521725033913 |
|
18973 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHGR1 |
0.593521725033913 |
|
18974 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DISP2 |
0.593521725033913 |
|
18975 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00594 |
0.593521725033913 |
|
18976 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KNSTRN |
0.593521725033913 |
|
18977 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SORD |
0.593521725033913 |
|
18978 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUOX2 |
0.593521725033913 |
|
18979 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUOXA2 |
0.593521725033913 |
|
18980 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUOXA1 |
0.593521725033913 |
|
18981 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUOX1 |
0.593521725033913 |
|
18982 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHF |
0.593521725033913 |
|
18983 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA11|ENSG00000261709.2 |
0.593521725033913 |
|
18984 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC28A2 |
0.593521725033913 |
|
18985 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GATM |
0.593521725033913 |
|
18986 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA5L1 |
0.593521725033913 |
|
18987 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C15orf48 |
0.593521725033913 |
|
18988 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR147B |
0.593521725033913 |
|
18989 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC30A4 |
0.593521725033913 |
|
18990 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238583.1 |
0.593521725033913 |
|
18991 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMGN2P46 |
0.593521725033913 |
|
18992 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA41|ENSG00000207516.1 |
0.593521725033913 |
|
18993 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BLOC1S6 |
0.593521725033913 |
|
18994 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SQRDL |
0.593521725033913 |
|
18995 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD11|ENSG00000238819.1 |
0.593521725033913 |
|
18996 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP101 |
0.593521725033913 |
|
18997 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FKSG62 |
0.593521725033913 |
|
18998 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEMA6D |
0.593521725033913 |
|
18999 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP139 |
0.593521725033913 |
|
19000 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC24A5 |
0.593521725033913 |
|
19001 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYEF2 |
0.593521725033913 |
|
19002 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTXN2 |
0.593521725033913 |
|
19003 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC12A1 |
0.593521725033913 |
|
19004 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUT |
0.593521725033913 |
|
19005 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAICS |
0.594891723371835 |
|
19006 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRP72 |
0.594891723371835 |
|
19007 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL9 |
0.594891723371835 |
|
19008 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENAM |
0.595762255541921 |
|
19009 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGJ |
0.595762255541921 |
|
19010 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTNNA2 |
0.603185404917712 |
|
19011 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
H1FNT |
0.604463938405429 |
|
19012 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF641 |
0.604463938405429 |
|
19013 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANP32D |
0.604463938405429 |
|
19014 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf54 |
0.604463938405429 |
|
19015 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR8S1 |
0.604463938405429 |
|
19016 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LALBA |
0.604463938405429 |
|
19017 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KANSL2 |
0.604463938405429 |
|
19018 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA34 |
0.604463938405429 |
|
19019 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA2A |
0.604463938405429 |
|
19020 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA2B |
0.604463938405429 |
|
19021 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNT1 |
0.604463938405429 |
|
19022 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00935 |
0.604463938405429 |
|
19023 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADCY6 |
0.604463938405429 |
|
19024 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4701 |
0.604463938405429 |
|
19025 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNB3 |
0.604463938405429 |
|
19026 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX23 |
0.604463938405429 |
|
19027 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RND1 |
0.604463938405429 |
|
19028 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARF3 |
0.604463938405429 |
|
19029 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC65 |
0.604463938405429 |
|
19030 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FKBP11 |
0.604463938405429 |
|
19031 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238395.1 |
0.604463938405429 |
|
19032 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WNT10B |
0.604463938405429 |
|
19033 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COLEC12 |
0.605238350031802 |
|
19034 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ROCK1P1 |
0.605238350031802 |
|
19035 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THOC1 |
0.605238350031802 |
|
19036 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP14 |
0.605238350031802 |
|
19037 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C18orf56 |
0.605238350031802 |
|
19038 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CETN1 |
0.605238350031802 |
|
19039 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLUL1 |
0.605238350031802 |
|
19040 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENOSF1 |
0.605238350031802 |
|
19041 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP146 |
0.605238350031802 |
|
19042 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TYMS |
0.605238350031802 |
|
19043 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YES1 |
0.605238350031802 |
|
19044 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADCYAP1 |
0.605238350031802 |
|
19045 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IVD |
0.6057803439514 |
|
19046 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAHD1 |
0.6057803439514 |
|
19047 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHST14 |
0.6057803439514 |
|
19048 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C15orf57 |
0.6057803439514 |
|
19049 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPUSD2 |
0.6057803439514 |
|
19050 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASC5 |
0.6057803439514 |
|
19051 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238559.1 |
0.6057803439514 |
|
19052 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL376P |
0.6057803439514 |
|
19053 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAD51 |
0.6057803439514 |
|
19054 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RMDN3 |
0.6057803439514 |
|
19055 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCHFR |
0.6057803439514 |
|
19056 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C15orf62 |
0.6057803439514 |
|
19057 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC17 |
0.6057803439514 |
|
19058 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFYVE19 |
0.6057803439514 |
|
19059 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R14D |
0.6057803439514 |
|
19060 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPINT1 |
0.6057803439514 |
|
19061 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHOV |
0.6057803439514 |
|
19062 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS18 |
0.6057803439514 |
|
19063 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLL4 |
0.6057803439514 |
|
19064 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHAC1 |
0.6057803439514 |
|
19065 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INO80 |
0.6057803439514 |
|
19066 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXD1 |
0.6057803439514 |
|
19067 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL497P |
0.6057803439514 |
|
19068 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHP1 |
0.6057803439514 |
|
19069 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OIP5 |
0.6057803439514 |
|
19070 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUSAP1 |
0.6057803439514 |
|
19071 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFAF1 |
0.6057803439514 |
|
19072 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RTF1 |
0.6057803439514 |
|
19073 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITPKA |
0.6057803439514 |
|
19074 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LTK |
0.6057803439514 |
|
19075 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPAP1 |
0.6057803439514 |
|
19076 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TYRO3 |
0.6057803439514 |
|
19077 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MGA |
0.6057803439514 |
|
19078 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR626 |
0.6057803439514 |
|
19079 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPKBP1 |
0.6057803439514 |
|
19080 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JMJD7 |
0.6057803439514 |
|
19081 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLA2G4B |
0.6057803439514 |
|
19082 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP393 |
0.6057803439514 |
|
19083 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPTBN5 |
0.6057803439514 |
|
19084 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4310 |
0.6057803439514 |
|
19085 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EHD4 |
0.6057803439514 |
|
19086 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLA2G4E |
0.6057803439514 |
|
19087 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLA2G4D |
0.6057803439514 |
|
19088 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLA2G4F |
0.6057803439514 |
|
19089 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS39 |
0.6057803439514 |
|
19090 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR627 |
0.6057803439514 |
|
19091 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM87A |
0.6057803439514 |
|
19092 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GANC |
0.6057803439514 |
|
19093 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPN3 |
0.6057803439514 |
|
19094 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF106 |
0.6057803439514 |
|
19095 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNAP23 |
0.6057803439514 |
|
19096 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC57 |
0.6057803439514 |
|
19097 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAUS2 |
0.6057803439514 |
|
19098 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STARD9 |
0.6057803439514 |
|
19099 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239025.1 |
0.6057803439514 |
|
19100 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDAN1 |
0.6057803439514 |
|
19101 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTBK2 |
0.6057803439514 |
|
19102 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBR1 |
0.6057803439514 |
|
19103 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPB42 |
0.6057803439514 |
|
19104 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM62 |
0.6057803439514 |
|
19105 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNDBP1 |
0.6057803439514 |
|
19106 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TGM5 |
0.6057803439514 |
|
19107 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TGM7 |
0.6057803439514 |
|
19108 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCMT2 |
0.6057803439514 |
|
19109 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAL |
0.6057803439514 |
|
19110 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSCAN29 |
0.6057803439514 |
|
19111 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBGCP4 |
0.6057803439514 |
|
19112 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL487P |
0.6057803439514 |
|
19113 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TP53BP1 |
0.6057803439514 |
|
19114 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP1A |
0.6057803439514 |
|
19115 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPIP5K1 |
0.6057803439514 |
|
19116 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CATSPER2P1 |
0.6057803439514 |
|
19117 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CATSPER2 |
0.6057803439514 |
|
19118 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CKMT1A |
0.6057803439514 |
|
19119 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CKMT1B |
0.6057803439514 |
|
19120 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STRC |
0.6057803439514 |
|
19121 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238494.1 |
0.6057803439514 |
|
19122 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238535.1 |
0.6057803439514 |
|
19123 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDIA3 |
0.6057803439514 |
|
19124 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELL3 |
0.6057803439514 |
|
19125 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERF2 |
0.6057803439514 |
|
19126 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HYPK |
0.6057803439514 |
|
19127 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1282 |
0.6057803439514 |
|
19128 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERINC4 |
0.6057803439514 |
|
19129 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFAP1 |
0.6057803439514 |
|
19130 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR76 |
0.6057803439514 |
|
19131 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRMD5 |
0.6057803439514 |
|
19132 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASC4 |
0.6057803439514 |
|
19133 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTDSPL2 |
0.6057803439514 |
|
19134 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL347P |
0.6057803439514 |
|
19135 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF3J |
0.6057803439514 |
|
19136 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPG11 |
0.6057803439514 |
|
19137 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PATL2 |
0.6057803439514 |
|
19138 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B2M |
0.6057803439514 |
|
19139 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM69 |
0.6057803439514 |
|
19140 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C15orf43 |
0.6057803439514 |
|
19141 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL329P |
0.608490629606793 |
|
19142 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIB1 |
0.608490629606793 |
|
19143 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL590P |
0.608490629606793 |
|
19144 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00861 |
0.608490629606793 |
|
19145 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM84B |
0.608490629606793 |
|
19146 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCAT1 |
0.608490629606793 |
|
19147 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCAT2 |
0.608490629606793 |
|
19148 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCAT1 |
0.608490629606793 |
|
19149 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASC8 |
0.608490629606793 |
|
19150 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POU5F1B |
0.608490629606793 |
|
19151 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYC |
0.608490629606793 |
|
19152 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1208 |
0.608490629606793 |
|
19153 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP226 |
0.608490629606793 |
|
19154 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00977 |
0.608490629606793 |
|
19155 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP206 |
0.608490629606793 |
|
19156 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC26 |
0.608490629606793 |
|
19157 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3686 |
0.608490629606793 |
|
19158 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSDMC |
0.608490629606793 |
|
19159 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM49B |
0.608490629606793 |
|
19160 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA25|ENSG00000200075.1 |
0.608490629606793 |
|
19161 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5194 |
0.608490629606793 |
|
19162 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASAP1 |
0.608490629606793 |
|
19163 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA12|ENSG00000212342.1 |
0.608490629606793 |
|
19164 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADCY8 |
0.608490629606793 |
|
19165 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA72|ENSG00000252158.1 |
0.608490629606793 |
|
19166 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFR3A |
0.608490629606793 |
|
19167 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OC90 |
0.608490629606793 |
|
19168 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HHLA1 |
0.608490629606793 |
|
19169 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNQ3 |
0.608490629606793 |
|
19170 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HPYR1 |
0.608490629606793 |
|
19171 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC6 |
0.608490629606793 |
|
19172 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM71 |
0.608490629606793 |
|
19173 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHF20L1 |
0.608490629606793 |
|
19174 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TG |
0.608490629606793 |
|
19175 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLA |
0.608490629606793 |
|
19176 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WISP1 |
0.608490629606793 |
|
19177 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDRG1 |
0.608490629606793 |
|
19178 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST3GAL1 |
0.608490629606793 |
|
19179 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA40|ENSG00000212273.1 |
0.608490629606793 |
|
19180 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFAT |
0.608490629606793 |
|
19181 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR30B |
0.608490629606793 |
|
19182 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR30D |
0.608490629606793 |
|
19183 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KHDRBS3 |
0.608490629606793 |
|
19184 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DIAPH3 |
0.609903360295815 |
|
19185 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FNTA |
0.610935014308079 |
|
19186 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HGSNAT |
0.610935014308079 |
|
19187 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POTEA |
0.610935014308079 |
|
19188 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP41 |
0.610935014308079 |
|
19189 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGK196 |
0.610935014308079 |
|
19190 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000201329.1 |
0.610935014308079 |
|
19191 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00470 |
0.612769418069263 |
|
19192 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP72 |
0.612769418069263 |
|
19193 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL4 |
0.612769418069263 |
|
19194 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBX3P2 |
0.612769418069263 |
|
19195 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDC80 |
0.612769418069263 |
|
19196 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMCHD1 |
0.612769418069263 |
|
19197 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU109|ENSG00000238575.1 |
0.612769418069263 |
|
19198 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238425.1 |
0.612769418069263 |
|
19199 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMILIN2 |
0.612769418069263 |
|
19200 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPIN2 |
0.612769418069263 |
|
19201 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000252258.1 |
0.612769418069263 |
|
19202 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYOM1 |
0.612769418069263 |
|
19203 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYL12A |
0.612769418069263 |
|
19204 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYL12B |
0.612769418069263 |
|
19205 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TGIF1 |
0.612769418069263 |
|
19206 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238863.1 |
0.612769418069263 |
|
19207 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLGAP1 |
0.612769418069263 |
|
19208 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL39P |
0.612769418069263 |
|
19209 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238445.1 |
0.612769418069263 |
|
19210 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238790.1 |
0.612769418069263 |
|
19211 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C18orf42 |
0.612769418069263 |
|
19212 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00667 |
0.612769418069263 |
|
19213 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00526 |
0.612769418069263 |
|
19214 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB14 |
0.612769418069263 |
|
19215 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPB41L3 |
0.612769418069263 |
|
19216 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snR65|ENSG00000252576.1 |
0.612769418069263 |
|
19217 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252572.1 |
0.612769418069263 |
|
19218 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3976 |
0.612769418069263 |
|
19219 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM200C |
0.612769418069263 |
|
19220 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
L3MBTL4 |
0.612769418069263 |
|
19221 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL282P |
0.612769418069263 |
|
19222 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL723P |
0.612769418069263 |
|
19223 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL6P27 |
0.612769418069263 |
|
19224 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFHB |
0.612987309764582 |
|
19225 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB5A |
0.612987309764582 |
|
19226 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PP2D1 |
0.612987309764582 |
|
19227 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KAT2B |
0.612987309764582 |
|
19228 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3135A |
0.612987309764582 |
|
19229 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGOL1 |
0.612987309764582 |
|
19230 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P22 |
0.612987309764582 |
|
19231 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF98 |
0.616980297822464 |
|
19232 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL860P |
0.616980297822464 |
|
19233 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF492 |
0.616980297822464 |
|
19234 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF99 |
0.616980297822464 |
|
19235 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF728 |
0.616980297822464 |
|
19236 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF730 |
0.616980297822464 |
|
19237 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF724P |
0.616980297822464 |
|
19238 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF91 |
0.616980297822464 |
|
19239 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF675 |
0.616980297822464 |
|
19240 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF681 |
0.616980297822464 |
|
19241 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPSAP58 |
0.616980297822464 |
|
19242 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00371 |
0.618985590463811 |
|
19243 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM124A |
0.618985590463811 |
|
19244 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERPINE3 |
0.618985590463811 |
|
19245 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5693 |
0.618985590463811 |
|
19246 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INTS6 |
0.618985590463811 |
|
19247 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS4XP16 |
0.618985590463811 |
|
19248 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL320P |
0.618985590463811 |
|
19249 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4703 |
0.618985590463811 |
|
19250 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY1P6 |
0.618985590463811 |
|
19251 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDFY2 |
0.618985590463811 |
|
19252 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL413P |
0.618985590463811 |
|
19253 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHRS12 |
0.618985590463811 |
|
19254 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC70 |
0.618985590463811 |
|
19255 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP7B |
0.618985590463811 |
|
19256 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALG11 |
0.618985590463811 |
|
19257 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UTP14C |
0.618985590463811 |
|
19258 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEK5 |
0.618985590463811 |
|
19259 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEK3 |
0.618985590463811 |
|
19260 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THSD1 |
0.618985590463811 |
|
19261 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P24 |
0.618985590463811 |
|
19262 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS36 |
0.618985590463811 |
|
19263 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CKAP2 |
0.618985590463811 |
|
19264 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00345 |
0.618985590463811 |
|
19265 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPA1L2 |
0.618985590463811 |
|
19266 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUGT1 |
0.618985590463811 |
|
19267 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LECT1 |
0.618985590463811 |
|
19268 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR759 |
0.618985590463811 |
|
19269 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDH8 |
0.618985590463811 |
|
19270 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OLFM4 |
0.618985590463811 |
|
19271 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL618P |
0.618985590463811 |
|
19272 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00558 |
0.618985590463811 |
|
19273 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00458 |
0.618985590463811 |
|
19274 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5007 |
0.618985590463811 |
|
19275 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238455.1 |
0.618985590463811 |
|
19276 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP6 |
0.618985590463811 |
|
19277 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR20A |
0.618985590463811 |
|
19278 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR20B |
0.618985590463811 |
|
19279 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR20C |
0.618985590463811 |
|
19280 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR20D |
0.618985590463811 |
|
19281 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR20E |
0.618985590463811 |
|
19282 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDH17 |
0.618985590463811 |
|
19283 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP30 |
0.618985590463811 |
|
19284 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P29 |
0.618985590463811 |
|
19285 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL375P |
0.618985590463811 |
|
19286 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P28 |
0.618985590463811 |
|
19287 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00434 |
0.618985590463811 |
|
19288 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TDRD3 |
0.618985590463811 |
|
19289 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP31 |
0.618985590463811 |
|
19290 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00378 |
0.618985590463811 |
|
19291 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY3P5 |
0.618985590463811 |
|
19292 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P31 |
0.618985590463811 |
|
19293 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3169 |
0.618985590463811 |
|
19294 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDH20 |
0.618985590463811 |
|
19295 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00358 |
0.618985590463811 |
|
19296 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00459 |
0.618985590463811 |
|
19297 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00448 |
0.618985590463811 |
|
19298 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDH12 |
0.622915644917058 |
|
19299 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PMCHL1 |
0.622915644917058 |
|
19300 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL572P |
0.622915644917058 |
|
19301 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRDM9 |
0.622915644917058 |
|
19302 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf17 |
0.622915644917058 |
|
19303 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA40|ENSG00000252083.1 |
0.622915644917058 |
|
19304 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDH10 |
0.622915644917058 |
|
19305 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD29 |
0.622915644917058 |
|
19306 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDH9 |
0.622915644917058 |
|
19307 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA18|ENSG00000252601.1 |
0.622915644917058 |
|
19308 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP207 |
0.622915644917058 |
|
19309 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDH6 |
0.622915644917058 |
|
19310 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DROSHA |
0.622915644917058 |
|
19311 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf22 |
0.622915644917058 |
|
19312 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDZD2 |
0.622915644917058 |
|
19313 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238864.1 |
0.622915644917058 |
|
19314 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4279 |
0.622915644917058 |
|
19315 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLPH3 |
0.622915644917058 |
|
19316 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTMR12 |
0.622915644917058 |
|
19317 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFR |
0.622915644917058 |
|
19318 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR579 |
0.622915644917058 |
|
19319 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUB1 |
0.622915644917058 |
|
19320 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPR3 |
0.622915644917058 |
|
19321 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TARS |
0.622915644917058 |
|
19322 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAMTS12 |
0.622915644917058 |
|
19323 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RXFP3 |
0.622915644917058 |
|
19324 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMACR |
0.622915644917058 |
|
19325 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1QTNF3 |
0.622915644917058 |
|
19326 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAI14 |
0.622915644917058 |
|
19327 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC45A2 |
0.622915644917058 |
|
19328 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC23L |
0.622915644917058 |
|
19329 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAD1 |
0.622915644917058 |
|
19330 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRIX1 |
0.622915644917058 |
|
19331 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC21 |
0.622915644917058 |
|
19332 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGXT2 |
0.622915644917058 |
|
19333 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRLR |
0.622915644917058 |
|
19334 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPEF2 |
0.622915644917058 |
|
19335 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WNK1 |
0.627510080831014 |
|
19336 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAD52 |
0.627510080831014 |
|
19337 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPK1 |
0.628767700750453 |
|
19338 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP493 |
0.628767700750453 |
|
19339 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPM1F |
0.628767700750453 |
|
19340 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCR |
0.628767700750453 |
|
19341 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CES5AP1 |
0.628767700750453 |
|
19342 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GGTLC2 |
0.628767700750453 |
|
19343 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNAZ |
0.628767700750453 |
|
19344 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGLC1 |
0.628767700750453 |
|
19345 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGLC2 |
0.628767700750453 |
|
19346 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGLC3 |
0.628767700750453 |
|
19347 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGLC7 |
0.628767700750453 |
|
19348 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGLJ1 |
0.628767700750453 |
|
19349 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGLJ2 |
0.628767700750453 |
|
19350 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGLJ3 |
0.628767700750453 |
|
19351 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGLJ4 |
0.628767700750453 |
|
19352 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGLJ5 |
0.628767700750453 |
|
19353 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGLJ6 |
0.628767700750453 |
|
19354 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGLJ7 |
0.628767700750453 |
|
19355 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGLL5 |
0.628767700750453 |
|
19356 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR650 |
0.628767700750453 |
|
19357 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POM121L1P |
0.628767700750453 |
|
19358 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAMEF24P |
0.628767700750453 |
|
19359 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAME |
0.628767700750453 |
|
19360 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB36 |
0.628767700750453 |
|
19361 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL263P |
0.628767700750453 |
|
19362 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RTDR1 |
0.628767700750453 |
|
19363 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOP3B |
0.628767700750453 |
|
19364 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPREB1 |
0.628767700750453 |
|
19365 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDHHC8P1 |
0.628767700750453 |
|
19366 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF280A |
0.628767700750453 |
|
19367 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF280B |
0.628767700750453 |
|
19368 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239066.1 |
0.628767700750453 |
|
19369 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C22orf43 |
0.628767700750453 |
|
19370 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GUSBP11 |
0.628767700750453 |
|
19371 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGLL1 |
0.628767700750453 |
|
19372 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGL4 |
0.628767700750453 |
|
19373 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPREB3 |
0.628767700750453 |
|
19374 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF70 |
0.628767700750453 |
|
19375 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C22orf15 |
0.628767700750453 |
|
19376 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHCHD10 |
0.628767700750453 |
|
19377 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMP11 |
0.628767700750453 |
|
19378 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMARCB1 |
0.628767700750453 |
|
19379 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DERL3 |
0.628767700750453 |
|
19380 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC2A11 |
0.628767700750453 |
|
19381 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL268P |
0.628767700750453 |
|
19382 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIF |
0.628767700750453 |
|
19383 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CABIN1 |
0.628767700750453 |
|
19384 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDTL |
0.628767700750453 |
|
19385 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDT |
0.628767700750453 |
|
19386 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSTT1 |
0.628767700750453 |
|
19387 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSTT2B |
0.628767700750453 |
|
19388 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSTT2 |
0.628767700750453 |
|
19389 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSTTP2 |
0.628767700750453 |
|
19390 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUSD2 |
0.628767700750453 |
|
19391 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GGT5 |
0.628767700750453 |
|
19392 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POM121L9P |
0.628767700750453 |
|
19393 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPECC1L |
0.628767700750453 |
|
19394 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADORA2A |
0.628767700750453 |
|
19395 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UPB1 |
0.628767700750453 |
|
19396 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GUCD1 |
0.628767700750453 |
|
19397 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNRPD3 |
0.628767700750453 |
|
19398 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM211B |
0.628767700750453 |
|
19399 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GGT1 |
0.628767700750453 |
|
19400 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIWIL3 |
0.628767700750453 |
|
19401 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGSM1 |
0.628767700750453 |
|
19402 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD56|ENSG00000199783.1 |
0.628767700750453 |
|
19403 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM211 |
0.628767700750453 |
|
19404 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1671 |
0.628767700750453 |
|
19405 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRYBB3 |
0.628767700750453 |
|
19406 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRYBB2 |
0.628767700750453 |
|
19407 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADRBK2 |
0.628767700750453 |
|
19408 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRYBB2P1 |
0.628767700750453 |
|
19409 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRP5L |
0.628767700750453 |
|
19410 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP494 |
0.628767700750453 |
|
19411 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYO18B |
0.628767700750453 |
|
19412 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP169 |
0.628767700750453 |
|
19413 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEZ6L |
0.628767700750453 |
|
19414 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP495 |
0.628767700750453 |
|
19415 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASPHD2 |
0.628767700750453 |
|
19416 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HPS4 |
0.628767700750453 |
|
19417 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRRD |
0.628767700750453 |
|
19418 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFIP11 |
0.628767700750453 |
|
19419 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPST2 |
0.628767700750453 |
|
19420 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548J |
0.628767700750453 |
|
19421 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRYBB1 |
0.628767700750453 |
|
19422 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRYBA4 |
0.628767700750453 |
|
19423 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIAT |
0.628767700750453 |
|
19424 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MN1 |
0.628767700750453 |
|
19425 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PITPNB |
0.628767700750453 |
|
19426 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC28 |
0.628767700750453 |
|
19427 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL757P |
0.628767700750453 |
|
19428 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD42|ENSG00000201209.1 |
0.628767700750453 |
|
19429 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL162P |
0.628767700750453 |
|
19430 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHEK2 |
0.628767700750453 |
|
19431 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSCB |
0.628767700750453 |
|
19432 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC117 |
0.628767700750453 |
|
19433 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XBP1 |
0.628767700750453 |
|
19434 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNRF3 |
0.628767700750453 |
|
19435 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C22orf31 |
0.628767700750453 |
|
19436 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KREMEN1 |
0.628767700750453 |
|
19437 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMID1 |
0.628767700750453 |
|
19438 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHBDD3 |
0.628767700750453 |
|
19439 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EWSR1 |
0.628767700750453 |
|
19440 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAS2L1 |
0.628767700750453 |
|
19441 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASL10A |
0.628767700750453 |
|
19442 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP1B1 |
0.628767700750453 |
|
19443 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD125 |
0.628767700750453 |
|
19444 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFPL1S |
0.628767700750453 |
|
19445 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFPL1 |
0.628767700750453 |
|
19446 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEFH |
0.628767700750453 |
|
19447 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THOC5 |
0.628767700750453 |
|
19448 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NIPSNAP1 |
0.628767700750453 |
|
19449 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NF2 |
0.628767700750453 |
|
19450 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CABP7 |
0.628767700750453 |
|
19451 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZMAT5 |
0.628767700750453 |
|
19452 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UQCR10 |
0.628767700750453 |
|
19453 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASCC2 |
0.628767700750453 |
|
19454 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTMR3 |
0.628767700750453 |
|
19455 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HORMAD2 |
0.628767700750453 |
|
19456 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIF |
0.628767700750453 |
|
19457 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MGC20647 |
0.628767700750453 |
|
19458 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSM |
0.628767700750453 |
|
19459 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GATSL3 |
0.628767700750453 |
|
19460 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D10A |
0.628767700750453 |
|
19461 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SF3A1 |
0.628767700750453 |
|
19462 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC157 |
0.628767700750453 |
|
19463 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF215 |
0.628767700750453 |
|
19464 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC14L2 |
0.628767700750453 |
|
19465 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1658 |
0.628767700750453 |
|
19466 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTFP1 |
0.628767700750453 |
|
19467 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC14L3 |
0.628767700750453 |
|
19468 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC14L4 |
0.628767700750453 |
|
19469 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC14L6 |
0.628767700750453 |
|
19470 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAL3ST1 |
0.628767700750453 |
|
19471 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PES1 |
0.628767700750453 |
|
19472 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCN2 |
0.628767700750453 |
|
19473 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35E4 |
0.628767700750453 |
|
19474 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUSP18 |
0.628767700750453 |
|
19475 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSBP2 |
0.628767700750453 |
|
19476 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3200 |
0.628767700750453 |
|
19477 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MORC2 |
0.628767700750453 |
|
19478 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUG1 |
0.628767700750453 |
|
19479 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL633P |
0.628767700750453 |
|
19480 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMTN |
0.628767700750453 |
|
19481 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INPP5J |
0.628767700750453 |
|
19482 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLA2G3 |
0.628767700750453 |
|
19483 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3928 |
0.628767700750453 |
|
19484 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF185 |
0.628767700750453 |
|
19485 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIMK2 |
0.628767700750453 |
|
19486 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIK3IP1 |
0.628767700750453 |
|
19487 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP496 |
0.628767700750453 |
|
19488 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PATZ1 |
0.628767700750453 |
|
19489 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DRG1 |
0.628767700750453 |
|
19490 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF4ENIF1 |
0.628767700750453 |
|
19491 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFI1 |
0.628767700750453 |
|
19492 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PISD |
0.628767700750453 |
|
19493 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR14L |
0.628767700750453 |
|
19494 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEPDC5 |
0.628767700750453 |
|
19495 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL20P |
0.628767700750453 |
|
19496 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C22orf24 |
0.628767700750453 |
|
19497 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YWHAH |
0.628767700750453 |
|
19498 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238910.1 |
0.628767700750453 |
|
19499 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL305P |
0.628767700750453 |
|
19500 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC5A1 |
0.628767700750453 |
|
19501 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP1B1P1 |
0.628767700750453 |
|
19502 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C22orf42 |
0.628767700750453 |
|
19503 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFPL2 |
0.628767700750453 |
|
19504 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC5A4 |
0.628767700750453 |
|
19505 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFPL3 |
0.628767700750453 |
|
19506 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFPL3S |
0.628767700750453 |
|
19507 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RTCB |
0.628767700750453 |
|
19508 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BPIFC |
0.628767700750453 |
|
19509 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO7 |
0.628767700750453 |
|
19510 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYN3 |
0.628767700750453 |
|
19511 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP497 |
0.628767700750453 |
|
19512 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIMP3 |
0.628767700750453 |
|
19513 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ISX |
0.628767700750453 |
|
19514 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMGXB4 |
0.628767700750453 |
|
19515 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOM1 |
0.628767700750453 |
|
19516 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3909 |
0.628767700750453 |
|
19517 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMOX1 |
0.628767700750453 |
|
19518 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCM5 |
0.628767700750453 |
|
19519 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASD2 |
0.628767700750453 |
|
19520 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOL6 |
0.628767700750453 |
|
19521 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MB |
0.628767700750453 |
|
19522 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOL5 |
0.628767700750453 |
|
19523 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBFOX2 |
0.628767700750453 |
|
19524 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOL3 |
0.628767700750453 |
|
19525 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOL4 |
0.628767700750453 |
|
19526 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOL1 |
0.628767700750453 |
|
19527 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOL2 |
0.628767700750453 |
|
19528 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYH9 |
0.628767700750453 |
|
19529 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL349P |
0.628767700750453 |
|
19530 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TXN2 |
0.628767700750453 |
|
19531 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXRED2 |
0.628767700750453 |
|
19532 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF3D |
0.628767700750453 |
|
19533 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNG2 |
0.628767700750453 |
|
19534 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFT27 |
0.628767700750453 |
|
19535 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PVALB |
0.628767700750453 |
|
19536 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCF4 |
0.628767700750453 |
|
19537 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSF2RB |
0.628767700750453 |
|
19538 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239056.1 |
0.628767700750453 |
|
19539 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX33 |
0.628767700750453 |
|
19540 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TST |
0.628767700750453 |
|
19541 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPST |
0.628767700750453 |
|
19542 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCTD17 |
0.628767700750453 |
|
19543 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP214 |
0.628767700750453 |
|
19544 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMPRSS6 |
0.628767700750453 |
|
19545 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL2RB |
0.628767700750453 |
|
19546 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1QTNF6 |
0.628767700750453 |
|
19547 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSTR3 |
0.628767700750453 |
|
19548 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAC2 |
0.628767700750453 |
|
19549 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYTH4 |
0.628767700750453 |
|
19550 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELFN2 |
0.628767700750453 |
|
19551 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFNG |
0.628767700750453 |
|
19552 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CARD10 |
0.628767700750453 |
|
19553 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC42EP1 |
0.628767700750453 |
|
19554 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGALS2 |
0.628767700750453 |
|
19555 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GGA1 |
0.628767700750453 |
|
19556 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3BP1 |
0.628767700750453 |
|
19557 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDXP |
0.628767700750453 |
|
19558 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL385P |
0.628767700750453 |
|
19559 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGALS1 |
0.628767700750453 |
|
19560 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOL12 |
0.628767700750453 |
|
19561 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIOBP |
0.628767700750453 |
|
19562 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238569.1 |
0.628767700750453 |
|
19563 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCAT |
0.628767700750453 |
|
19564 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
H1F0 |
0.628767700750453 |
|
19565 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD54 |
0.628767700750453 |
|
19566 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALR3 |
0.628767700750453 |
|
19567 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR658 |
0.628767700750453 |
|
19568 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF3L |
0.628767700750453 |
|
19569 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR659 |
0.628767700750453 |
|
19570 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MICALL1 |
0.628767700750453 |
|
19571 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C22orf23 |
0.628767700750453 |
|
19572 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR2F |
0.628767700750453 |
|
19573 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOX10 |
0.628767700750453 |
|
19574 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4534 |
0.628767700750453 |
|
19575 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PICK1 |
0.628767700750453 |
|
19576 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC16A8 |
0.628767700750453 |
|
19577 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAIAP2L2 |
0.628767700750453 |
|
19578 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLA2G6 |
0.628767700750453 |
|
19579 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAFF |
0.628767700750453 |
|
19580 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM184B |
0.628767700750453 |
|
19581 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL704P |
0.628767700750453 |
|
19582 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSNK1E |
0.628767700750453 |
|
19583 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNJ4 |
0.628767700750453 |
|
19584 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KDELR3 |
0.628767700750453 |
|
19585 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX17 |
0.628767700750453 |
|
19586 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DMC1 |
0.628767700750453 |
|
19587 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM227A |
0.628767700750453 |
|
19588 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBY1 |
0.628767700750453 |
|
19589 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOMM22 |
0.628767700750453 |
|
19590 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JOSD1 |
0.628767700750453 |
|
19591 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTPBP1 |
0.628767700750453 |
|
19592 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUN2 |
0.628767700750453 |
|
19593 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAL4 |
0.628767700750453 |
|
19594 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPTXR |
0.628767700750453 |
|
19595 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBX6 |
0.628767700750453 |
|
19596 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOBEC3A |
0.628767700750453 |
|
19597 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOBEC3B |
0.628767700750453 |
|
19598 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOBEC3C |
0.628767700750453 |
|
19599 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOBEC3D |
0.628767700750453 |
|
19600 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOBEC3F |
0.628767700750453 |
|
19601 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOBEC3G |
0.628767700750453 |
|
19602 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOBEC3H |
0.628767700750453 |
|
19603 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBX7 |
0.628767700750453 |
|
19604 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDGFB |
0.628767700750453 |
|
19605 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL3 |
0.628767700750453 |
|
19606 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD83B |
0.628767700750453 |
|
19607 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD83A |
0.628767700750453 |
|
19608 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD43|ENSG00000263764.1 |
0.628767700750453 |
|
19609 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYNGR1 |
0.628767700750453 |
|
19610 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAB1 |
0.628767700750453 |
|
19611 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MGAT3 |
0.628767700750453 |
|
19612 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMCR7L |
0.628767700750453 |
|
19613 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATF4 |
0.628767700750453 |
|
19614 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS19BP1 |
0.628767700750453 |
|
19615 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNA1I |
0.628767700750453 |
|
19616 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENTHD1 |
0.628767700750453 |
|
19617 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP210 |
0.628767700750453 |
|
19618 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRAP2 |
0.628767700750453 |
|
19619 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM83F |
0.628767700750453 |
|
19620 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNRC6B |
0.628767700750453 |
|
19621 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADSL |
0.628767700750453 |
|
19622 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGSM3 |
0.628767700750453 |
|
19623 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MKL1 |
0.628767700750453 |
|
19624 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCHR1 |
0.628767700750453 |
|
19625 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A17 |
0.628767700750453 |
|
19626 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4766 |
0.628767700750453 |
|
19627 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST13 |
0.628767700750453 |
|
19628 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJB7 |
0.628767700750453 |
|
19629 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XPNPEP3 |
0.628767700750453 |
|
19630 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238887.1 |
0.628767700750453 |
|
19631 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBX1 |
0.628767700750453 |
|
19632 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EP300 |
0.628767700750453 |
|
19633 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1281 |
0.628767700750453 |
|
19634 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
L3MBTL2 |
0.628767700750453 |
|
19635 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHADL |
0.628767700750453 |
|
19636 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RANGAP1 |
0.628767700750453 |
|
19637 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZC3H7B |
0.628767700750453 |
|
19638 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEF |
0.628767700750453 |
|
19639 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOB2 |
0.628767700750453 |
|
19640 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHF5A |
0.628767700750453 |
|
19641 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACO2 |
0.628767700750453 |
|
19642 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR3H |
0.628767700750453 |
|
19643 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSDC2 |
0.628767700750453 |
|
19644 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PMM1 |
0.628767700750453 |
|
19645 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DESI1 |
0.628767700750453 |
|
19646 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XRCC6 |
0.628767700750453 |
|
19647 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NHP2L1 |
0.628767700750453 |
|
19648 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C22orf46 |
0.628767700750453 |
|
19649 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEI1 |
0.628767700750453 |
|
19650 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC22P |
0.628767700750453 |
|
19651 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC134 |
0.628767700750453 |
|
19652 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SREBF2 |
0.628767700750453 |
|
19653 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CENPM |
0.628767700750453 |
|
19654 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00634 |
0.628767700750453 |
|
19655 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR33A |
0.628767700750453 |
|
19656 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR378I |
0.628767700750453 |
|
19657 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEPT3 |
0.628767700750453 |
|
19658 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHISA8 |
0.628767700750453 |
|
19659 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFRSF13C |
0.628767700750453 |
|
19660 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WBP2NL |
0.628767700750453 |
|
19661 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAGA |
0.628767700750453 |
|
19662 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM109B |
0.628767700750453 |
|
19663 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238498.1 |
0.628767700750453 |
|
19664 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMDT1 |
0.628767700750453 |
|
19665 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFA6 |
0.628767700750453 |
|
19666 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP2D6 |
0.628767700750453 |
|
19667 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP2D7P1 |
0.628767700750453 |
|
19668 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCF20 |
0.628767700750453 |
|
19669 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFAM1 |
0.628767700750453 |
|
19670 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLDIP3 |
0.628767700750453 |
|
19671 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP80 |
0.628767700750453 |
|
19672 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRP7A |
0.628767700750453 |
|
19673 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRP7B |
0.628767700750453 |
|
19674 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERHL2 |
0.628767700750453 |
|
19675 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERHL |
0.628767700750453 |
|
19676 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU12 |
0.628767700750453 |
|
19677 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYB5R3 |
0.628767700750453 |
|
19678 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP5L2 |
0.628767700750453 |
|
19679 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
A4GALT |
0.628767700750453 |
|
19680 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARFGAP3 |
0.628767700750453 |
|
19681 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PACSIN2 |
0.628767700750453 |
|
19682 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTLL1 |
0.628767700750453 |
|
19683 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BIK |
0.628767700750453 |
|
19684 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCAT |
0.628767700750453 |
|
19685 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPO |
0.628767700750453 |
|
19686 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTLL12 |
0.628767700750453 |
|
19687 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCUBE1 |
0.628767700750453 |
|
19688 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPPED1 |
0.628767700750453 |
|
19689 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFCAB6 |
0.628767700750453 |
|
19690 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SULT4A1 |
0.628767700750453 |
|
19691 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNPLA5 |
0.628767700750453 |
|
19692 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNPLA3 |
0.628767700750453 |
|
19693 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAMM50 |
0.628767700750453 |
|
19694 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4508 |
0.633183956971425 |
|
19695 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MKRN3 |
0.633183956971425 |
|
19696 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAGEL2 |
0.633183956971425 |
|
19697 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDN |
0.633183956971425 |
|
19698 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PWRN1 |
0.633183956971425 |
|
19699 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PWRN2 |
0.633183956971425 |
|
19700 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPAP1 |
0.633183956971425 |
|
19701 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNRPN |
0.633183956971425 |
|
19702 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238615.1 |
0.633183956971425 |
|
19703 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNURF |
0.633183956971425 |
|
19704 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNHG14 |
0.633183956971425 |
|
19705 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD64|ENSG00000270704.2 |
0.633183956971425 |
|
19706 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD108 |
0.633183956971425 |
|
19707 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD109A |
0.633183956971425 |
|
19708 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD115|ENSG00000212428.1 |
0.633183956971425 |
|
19709 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD109B |
0.633183956971425 |
|
19710 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE3A |
0.633183956971425 |
|
19711 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP10A |
0.633183956971425 |
|
19712 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP390 |
0.633183956971425 |
|
19713 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4715 |
0.633183956971425 |
|
19714 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA48|ENSG00000212604.1 |
0.633183956971425 |
|
19715 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00929 |
0.633183956971425 |
|
19716 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABRB3 |
0.633183956971425 |
|
19717 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABRA5 |
0.633183956971425 |
|
19718 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABRG3 |
0.633183956971425 |
|
19719 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP391 |
0.633183956971425 |
|
19720 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OCA2 |
0.633183956971425 |
|
19721 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HERC2 |
0.633183956971425 |
|
19722 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APBA2 |
0.633183956971425 |
|
19723 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP11B |
0.633183956971425 |
|
19724 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRFAM7A |
0.633183956971425 |
|
19725 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM189A1 |
0.633183956971425 |
|
19726 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA6L7P |
0.633183956971425 |
|
19727 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA8F |
0.633183956971425 |
|
19728 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA8G |
0.633183956971425 |
|
19729 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA8H |
0.633183956971425 |
|
19730 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA8J |
0.633183956971425 |
|
19731 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA8M |
0.633183956971425 |
|
19732 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA8Q |
0.633183956971425 |
|
19733 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA8R |
0.633183956971425 |
|
19734 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA8T |
0.633183956971425 |
|
19735 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HERC2P9 |
0.633183956971425 |
|
19736 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDNL2 |
0.633183956971425 |
|
19737 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL196P |
0.633183956971425 |
|
19738 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL238P |
0.633183956971425 |
|
19739 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL469P |
0.633183956971425 |
|
19740 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL628P |
0.633183956971425 |
|
19741 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL673P |
0.633183956971425 |
|
19742 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL719P |
0.633183956971425 |
|
19743 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL796P |
0.633183956971425 |
|
19744 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL829P |
0.633183956971425 |
|
19745 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL82P |
0.633183956971425 |
|
19746 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TJP1 |
0.633183956971425 |
|
19747 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000207430.1 |
0.633183956971425 |
|
19748 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000207432.1 |
0.633183956971425 |
|
19749 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000238519.1 |
0.633183956971425 |
|
19750 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000252602.1 |
0.633183956971425 |
|
19751 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ULK4P2 |
0.633183956971425 |
|
19752 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ULK4P3 |
0.633183956971425 |
|
19753 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WHAMMP2 |
0.633183956971425 |
|
19754 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoZ278 |
0.633183956971425 |
|
19755 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAN1 |
0.633183956971425 |
|
19756 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTMR10 |
0.633183956971425 |
|
19757 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPM1 |
0.633183956971425 |
|
19758 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR211 |
0.633183956971425 |
|
19759 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLF13 |
0.633183956971425 |
|
19760 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OTUD7A |
0.633183956971425 |
|
19761 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP11A |
0.633183956971425 |
|
19762 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRNA7 |
0.633183956971425 |
|
19763 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA8K |
0.633183956971425 |
|
19764 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA8N |
0.633183956971425 |
|
19765 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA8O |
0.633183956971425 |
|
19766 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL185P |
0.633183956971425 |
|
19767 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL286P |
0.633183956971425 |
|
19768 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL539P |
0.633183956971425 |
|
19769 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA18|ENSG00000206849.1 |
0.633183956971425 |
|
19770 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000206987.1 |
0.633183956971425 |
|
19771 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ULK4P1 |
0.633183956971425 |
|
19772 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCG5 |
0.633183956971425 |
|
19773 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GREM1 |
0.633183956971425 |
|
19774 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FMN1 |
0.633183956971425 |
|
19775 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238342.1 |
0.633183956971425 |
|
19776 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD77|ENSG00000212415.1 |
0.633183956971425 |
|
19777 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMCO5B |
0.633183956971425 |
|
19778 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RYR3 |
0.633183956971425 |
|
19779 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AVEN |
0.633183956971425 |
|
19780 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRM5 |
0.633183956971425 |
|
19781 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMC7 |
0.633183956971425 |
|
19782 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGBD4 |
0.633183956971425 |
|
19783 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KATNBL1 |
0.633183956971425 |
|
19784 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMC4 |
0.633183956971425 |
|
19785 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC12A6 |
0.633183956971425 |
|
19786 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOP10 |
0.633183956971425 |
|
19787 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUTM1 |
0.633183956971425 |
|
19788 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPCAT4 |
0.633183956971425 |
|
19789 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA8A |
0.633183956971425 |
|
19790 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA8B |
0.633183956971425 |
|
19791 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA18|ENSG00000252425.1 |
0.633183956971425 |
|
19792 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GJD2 |
0.633183956971425 |
|
19793 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTC1 |
0.633183956971425 |
|
19794 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AQR |
0.633183956971425 |
|
19795 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF770 |
0.633183956971425 |
|
19796 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANP32AP1 |
0.633183956971425 |
|
19797 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPH6 |
0.633183956971425 |
|
19798 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3942 |
0.633183956971425 |
|
19799 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4510 |
0.633183956971425 |
|
19800 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C15orf41 |
0.633183956971425 |
|
19801 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSNK1A1P1 |
0.633183956971425 |
|
19802 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000212511.1 |
0.633183956971425 |
|
19803 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP28 |
0.634860968160075 |
|
19804 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00668 |
0.634860968160075 |
|
19805 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAMA1 |
0.634860968160075 |
|
19806 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL537P |
0.634860968160075 |
|
19807 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC30 |
0.634860968160075 |
|
19808 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA48|ENSG00000212626.1 |
0.634860968160075 |
|
19809 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPRM |
0.634860968160075 |
|
19810 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000199856.1 |
0.634860968160075 |
|
19811 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLK4 |
0.63491266431471 |
|
19812 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP70 |
0.63491266431471 |
|
19813 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF354A |
0.63491266431471 |
|
19814 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AACSP1 |
0.63491266431471 |
|
19815 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF354B |
0.63491266431471 |
|
19816 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFP2 |
0.63491266431471 |
|
19817 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF454 |
0.63491266431471 |
|
19818 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRM6 |
0.63491266431471 |
|
19819 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF879 |
0.63491266431471 |
|
19820 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF354C |
0.63491266431471 |
|
19821 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAMTS2 |
0.63491266431471 |
|
19822 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL71P |
0.63491266431471 |
|
19823 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RUFY1 |
0.63491266431471 |
|
19824 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPH1 |
0.63491266431471 |
|
19825 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf60 |
0.63491266431471 |
|
19826 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CANX |
0.63491266431471 |
|
19827 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBY3 |
0.63491266431471 |
|
19828 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMGB3P22 |
0.63491266431471 |
|
19829 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAML1 |
0.63491266431471 |
|
19830 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LTC4S |
0.63491266431471 |
|
19831 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MGAT4B |
0.63491266431471 |
|
19832 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1229 |
0.63491266431471 |
|
19833 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SQSTM1 |
0.63491266431471 |
|
19834 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf45 |
0.63491266431471 |
|
19835 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP150 |
0.63491266431471 |
|
19836 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D9B |
0.63491266431471 |
|
19837 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF130 |
0.63491266431471 |
|
19838 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR340 |
0.63491266431471 |
|
19839 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASGEF1C |
0.63491266431471 |
|
19840 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPK9 |
0.63491266431471 |
|
19841 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GFPT2 |
0.63491266431471 |
|
19842 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNOT6 |
0.63491266431471 |
|
19843 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCGB3A1 |
0.63491266431471 |
|
19844 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLT4 |
0.63491266431471 |
|
19845 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MGAT1 |
0.63491266431471 |
|
19846 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2Y1 |
0.63491266431471 |
|
19847 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00847 |
0.63491266431471 |
|
19848 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFP62 |
0.63491266431471 |
|
19849 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTNL8 |
0.63491266431471 |
|
19850 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTNL3 |
0.63491266431471 |
|
19851 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTNL9 |
0.63491266431471 |
|
19852 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNB2L1 |
0.63491266431471 |
|
19853 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4638 |
0.63491266431471 |
|
19854 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2V1 |
0.63491266431471 |
|
19855 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2V2 |
0.63491266431471 |
|
19856 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4F3 |
0.63491266431471 |
|
19857 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD95|ENSG00000264549.1 |
0.63491266431471 |
|
19858 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD96A |
0.63491266431471 |
|
19859 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM41 |
0.63491266431471 |
|
19860 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM52 |
0.63491266431471 |
|
19861 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM7 |
0.63491266431471 |
|
19862 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF561 |
0.635961838350408 |
|
19863 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf82 |
0.635961838350408 |
|
19864 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF562 |
0.635961838350408 |
|
19865 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF812 |
0.635961838350408 |
|
19866 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF846 |
0.635961838350408 |
|
19867 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXL12 |
0.635961838350408 |
|
19868 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000200237.1 |
0.635961838350408 |
|
19869 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL94P |
0.635961838350408 |
|
19870 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBL5 |
0.635961838350408 |
|
19871 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIN1 |
0.635961838350408 |
|
19872 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OLFM2 |
0.635961838350408 |
|
19873 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL5A3 |
0.635961838350408 |
|
19874 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RDH8 |
0.635961838350408 |
|
19875 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3P1 |
0.635961838350408 |
|
19876 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5589 |
0.635961838350408 |
|
19877 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf66 |
0.635961838350408 |
|
19878 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANGPTL6 |
0.635961838350408 |
|
19879 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPAN |
0.635961838350408 |
|
19880 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD105 |
0.635961838350408 |
|
19881 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
P2RY11 |
0.635961838350408 |
|
19882 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD105B |
0.635961838350408 |
|
19883 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF3G |
0.635961838350408 |
|
19884 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNMT1 |
0.635961838350408 |
|
19885 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S1PR2 |
0.635961838350408 |
|
19886 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4322 |
0.635961838350408 |
|
19887 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL4 |
0.635961838350408 |
|
19888 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ICAM1 |
0.635961838350408 |
|
19889 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ICAM4 |
0.635961838350408 |
|
19890 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ICAM5 |
0.635961838350408 |
|
19891 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZGLP1 |
0.635961838350408 |
|
19892 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FDX1L |
0.635961838350408 |
|
19893 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAVER1 |
0.635961838350408 |
|
19894 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ICAM3 |
0.635961838350408 |
|
19895 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TYK2 |
0.635961838350408 |
|
19896 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC37 |
0.635961838350408 |
|
19897 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1181 |
0.635961838350408 |
|
19898 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE4A |
0.635961838350408 |
|
19899 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KEAP1 |
0.635961838350408 |
|
19900 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S1PR5 |
0.635961838350408 |
|
19901 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATG4D |
0.635961838350408 |
|
19902 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1238 |
0.635961838350408 |
|
19903 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRI1 |
0.635961838350408 |
|
19904 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP1M2 |
0.635961838350408 |
|
19905 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDKN2D |
0.635961838350408 |
|
19906 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC44A2 |
0.635961838350408 |
|
19907 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ILF3 |
0.635961838350408 |
|
19908 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
QTRT1 |
0.635961838350408 |
|
19909 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNM2 |
0.635961838350408 |
|
19910 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR638 |
0.635961838350408 |
|
19911 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4748 |
0.635961838350408 |
|
19912 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR199A1 |
0.635961838350408 |
|
19913 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf38 |
0.635961838350408 |
|
19914 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMED1 |
0.635961838350408 |
|
19915 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CARM1 |
0.635961838350408 |
|
19916 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YIPF2 |
0.635961838350408 |
|
19917 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf52 |
0.635961838350408 |
|
19918 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMARCA4 |
0.635961838350408 |
|
19919 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL192P |
0.635961838350408 |
|
19920 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFC3 |
0.64058143732262 |
|
19921 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA25|ENSG00000199196.1 |
0.64058143732262 |
|
19922 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00457 |
0.64058143732262 |
|
19923 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBEA |
0.64058143732262 |
|
19924 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C8orf4 |
0.643570860126252 |
|
19925 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFT88 |
0.643917609070904 |
|
19926 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACTIN |
0.647856406117358 |
|
19927 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIP5K1C |
0.647856406117358 |
|
19928 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TJP3 |
0.647856406117358 |
|
19929 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APBA3 |
0.647856406117358 |
|
19930 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL54 |
0.647856406117358 |
|
19931 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAX2 |
0.647856406117358 |
|
19932 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MATK |
0.647856406117358 |
|
19933 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFR2 |
0.647856406117358 |
|
19934 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATCAY |
0.647856406117358 |
|
19935 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL202P |
0.647856406117358 |
|
19936 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NMRK2 |
0.647856406117358 |
|
19937 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DAPK3 |
0.647856406117358 |
|
19938 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR637 |
0.647856406117358 |
|
19939 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EEF2 |
0.647856406117358 |
|
19940 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD37|ENSG00000206775.1 |
0.647856406117358 |
|
19941 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIAS4 |
0.647856406117358 |
|
19942 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB7A |
0.647856406117358 |
|
19943 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP2K2 |
0.647856406117358 |
|
19944 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CREB3L3 |
0.647856406117358 |
|
19945 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIRT6 |
0.647856406117358 |
|
19946 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD24 |
0.647856406117358 |
|
19947 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL84P |
0.647856406117358 |
|
19948 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EBI3 |
0.647856406117358 |
|
19949 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC94 |
0.647856406117358 |
|
19950 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHD |
0.647856406117358 |
|
19951 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMIGD2 |
0.647856406117358 |
|
19952 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FSD1 |
0.647856406117358 |
|
19953 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAP2 |
0.647856406117358 |
|
19954 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPND |
0.647856406117358 |
|
19955 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3GL1 |
0.647856406117358 |
|
19956 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHAF1A |
0.647856406117358 |
|
19957 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf10 |
0.647856406117358 |
|
19958 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HDGFRP2 |
0.647856406117358 |
|
19959 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRG1 |
0.647856406117358 |
|
19960 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4746 |
0.647856406117358 |
|
19961 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLIN4 |
0.647856406117358 |
|
19962 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLIN5 |
0.647856406117358 |
|
19963 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL121P |
0.647856406117358 |
|
19964 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL528P |
0.647856406117358 |
|
19965 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEMA6B |
0.647856406117358 |
|
19966 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFAIP8L1 |
0.647856406117358 |
|
19967 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBXN6 |
0.647856406117358 |
|
19968 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPP9 |
0.647856406117358 |
|
19969 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FEM1A |
0.647856406117358 |
|
19970 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TICAM1 |
0.647856406117358 |
|
19971 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLIN3 |
0.647856406117358 |
|
19972 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARRDC5 |
0.647856406117358 |
|
19973 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UHRF1 |
0.647856406117358 |
|
19974 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4747 |
0.647856406117358 |
|
19975 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KDM4B |
0.647856406117358 |
|
19976 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKS1A |
0.649834150005172 |
|
19977 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXL17 |
0.652444185461974 |
|
19978 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIL1 |
0.652444185461974 |
|
19979 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TACC1 |
0.653451726629219 |
|
19980 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHA2 |
0.653451726629219 |
|
19981 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTRA4 |
0.653451726629219 |
|
19982 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TM2D2 |
0.653451726629219 |
|
19983 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM9 |
0.653451726629219 |
|
19984 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD38|ENSG00000207199.1 |
0.653451726629219 |
|
19985 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM32 |
0.653451726629219 |
|
19986 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM5 |
0.653451726629219 |
|
19987 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM3A |
0.653451726629219 |
|
19988 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM18 |
0.653451726629219 |
|
19989 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM2 |
0.653451726629219 |
|
19990 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IDO1 |
0.653451726629219 |
|
19991 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IDO2 |
0.653451726629219 |
|
19992 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZMAT4 |
0.653451726629219 |
|
19993 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFRP1 |
0.653451726629219 |
|
19994 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548AO |
0.653451726629219 |
|
19995 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD65|ENSG00000238936.1 |
0.653451726629219 |
|
19996 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA7 |
0.653451726629219 |
|
19997 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GINS4 |
0.653451726629219 |
|
19998 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGPAT6 |
0.653451726629219 |
|
19999 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANK1 |
0.653451726629219 |
|
20000 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR486 |
0.653451726629219 |
|
20001 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL149P |
0.653451726629219 |
|
20002 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KAT6A |
0.653451726629219 |
|
20003 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000238966.1 |
0.653451726629219 |
|
20004 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP3M2 |
0.653451726629219 |
|
20005 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLAT |
0.653451726629219 |
|
20006 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238714.1 |
0.653451726629219 |
|
20007 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IKBKB |
0.653451726629219 |
|
20008 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLB |
0.653451726629219 |
|
20009 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DKK4 |
0.653451726629219 |
|
20010 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VDAC3 |
0.653451726629219 |
|
20011 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC20A2 |
0.653451726629219 |
|
20012 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMIM19 |
0.653451726629219 |
|
20013 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRNB3 |
0.653451726629219 |
|
20014 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRNA6 |
0.653451726629219 |
|
20015 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THAP1 |
0.653451726629219 |
|
20016 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF170 |
0.653451726629219 |
|
20017 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL806P |
0.653451726629219 |
|
20018 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HOOK3 |
0.653451726629219 |
|
20019 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4469 |
0.653451726629219 |
|
20020 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPC1 |
0.656091212145749 |
|
20021 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR149 |
0.656091212145749 |
|
20022 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKMY1 |
0.656091212145749 |
|
20023 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUSP28 |
0.656091212145749 |
|
20024 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNPEPL1 |
0.656091212145749 |
|
20025 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPN10 |
0.656091212145749 |
|
20026 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR35 |
0.656091212145749 |
|
20027 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AQP12A |
0.656091212145749 |
|
20028 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AQP12B |
0.656091212145749 |
|
20029 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF1A |
0.656091212145749 |
|
20030 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGXT |
0.656091212145749 |
|
20031 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf54 |
0.656091212145749 |
|
20032 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF511 |
0.657689035635345 |
|
20033 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CALY |
0.657689035635345 |
|
20034 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAP1 |
0.657689035635345 |
|
20035 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FUOM |
0.657689035635345 |
|
20036 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ECHS1 |
0.657689035635345 |
|
20037 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00702 |
0.658723488406792 |
|
20038 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00703 |
0.658723488406792 |
|
20039 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00704 |
0.658723488406792 |
|
20040 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00705 |
0.658723488406792 |
|
20041 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKR1E2 |
0.658723488406792 |
|
20042 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKR1C1 |
0.658723488406792 |
|
20043 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000238840.1 |
0.658723488406792 |
|
20044 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKR1C2 |
0.658723488406792 |
|
20045 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000239148.1 |
0.658723488406792 |
|
20046 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKR1C3 |
0.658723488406792 |
|
20047 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000251740.1 |
0.658723488406792 |
|
20048 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000239142.1 |
0.658723488406792 |
|
20049 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKR1CL1 |
0.658723488406792 |
|
20050 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKR1C4 |
0.658723488406792 |
|
20051 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000251909.1 |
0.658723488406792 |
|
20052 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKR1C7P |
0.658723488406792 |
|
20053 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UCN3 |
0.658723488406792 |
|
20054 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBAL3 |
0.658723488406792 |
|
20055 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NET1 |
0.658723488406792 |
|
20056 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CALML5 |
0.658723488406792 |
|
20057 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CALML3 |
0.658723488406792 |
|
20058 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASB13 |
0.658723488406792 |
|
20059 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL445P |
0.658723488406792 |
|
20060 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM208B |
0.658723488406792 |
|
20061 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GDI2 |
0.658723488406792 |
|
20062 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD16 |
0.658723488406792 |
|
20063 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO18 |
0.658723488406792 |
|
20064 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL15RA |
0.658723488406792 |
|
20065 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL2RA |
0.658723488406792 |
|
20066 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA14 |
0.658723488406792 |
|
20067 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM17 |
0.658723488406792 |
|
20068 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PFKFB3 |
0.658723488406792 |
|
20069 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP78 |
0.658723488406792 |
|
20070 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3155A |
0.658723488406792 |
|
20071 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DKFZP667F0711 |
0.658723488406792 |
|
20072 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKCQ |
0.658723488406792 |
|
20073 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00707 |
0.658723488406792 |
|
20074 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFMBT2 |
0.658723488406792 |
|
20075 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITIH5 |
0.658723488406792 |
|
20076 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITIH2 |
0.658723488406792 |
|
20077 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIN |
0.658723488406792 |
|
20078 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP5C1 |
0.658723488406792 |
|
20079 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAF3 |
0.658723488406792 |
|
20080 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GATA3 |
0.658723488406792 |
|
20081 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAB21L1 |
0.659027858753861 |
|
20082 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00445 |
0.659027858753861 |
|
20083 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCLK1 |
0.659027858753861 |
|
20084 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOHLH2 |
0.659027858753861 |
|
20085 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC169 |
0.659027858753861 |
|
20086 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPG20 |
0.659027858753861 |
|
20087 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPG20OS |
0.659027858753861 |
|
20088 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNA1 |
0.659027858753861 |
|
20089 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERTM1 |
0.659027858753861 |
|
20090 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL2BPP3 |
0.659027858753861 |
|
20091 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFXAP |
0.659027858753861 |
|
20092 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMAD9 |
0.659027858753861 |
|
20093 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALG5 |
0.659027858753861 |
|
20094 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXOSC8 |
0.659027858753861 |
|
20095 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUPT20H |
0.659027858753861 |
|
20096 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSNK1A1L |
0.659027858753861 |
|
20097 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP1 |
0.659027858753861 |
|
20098 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POSTN |
0.659027858753861 |
|
20099 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPC4 |
0.659027858753861 |
|
20100 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP26 |
0.659027858753861 |
|
20101 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00571 |
0.659027858753861 |
|
20102 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UFM1 |
0.659027858753861 |
|
20103 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00366 |
0.659027858753861 |
|
20104 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FREM2 |
0.659027858753861 |
|
20105 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STOML3 |
0.659027858753861 |
|
20106 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PROSER1 |
0.659027858753861 |
|
20107 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NHLRC3 |
0.659027858753861 |
|
20108 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LHFP |
0.659027858753861 |
|
20109 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238408.1 |
0.659027858753861 |
|
20110 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COG6 |
0.659027858753861 |
|
20111 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4305 |
0.659027858753861 |
|
20112 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P14 |
0.659027858753861 |
|
20113 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD116|ENSG00000212553.1 |
0.659027858753861 |
|
20114 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00332 |
0.659027858753861 |
|
20115 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY3P9 |
0.659027858753861 |
|
20116 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP2 |
0.659027858753861 |
|
20117 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00598 |
0.659027858753861 |
|
20118 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXO1 |
0.659027858753861 |
|
20119 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR320D1 |
0.659027858753861 |
|
20120 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS31 |
0.659027858753861 |
|
20121 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A15 |
0.659027858753861 |
|
20122 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR621 |
0.659027858753861 |
|
20123 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPTE2P5 |
0.659027858753861 |
|
20124 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUGT1P3 |
0.659027858753861 |
|
20125 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELF1 |
0.659027858753861 |
|
20126 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WBP4 |
0.659027858753861 |
|
20127 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3168 |
0.659027858753861 |
|
20128 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL597P |
0.659027858753861 |
|
20129 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KBTBD6 |
0.659027858753861 |
|
20130 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238651.1 |
0.659027858753861 |
|
20131 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KBTBD7 |
0.659027858753861 |
|
20132 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTRF1 |
0.659027858753861 |
|
20133 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAA16 |
0.659027858753861 |
|
20134 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGCC |
0.659027858753861 |
|
20135 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VWA8 |
0.659027858753861 |
|
20136 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5006 |
0.659027858753861 |
|
20137 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL515P |
0.659027858753861 |
|
20138 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DGKH |
0.659027858753861 |
|
20139 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKAP11 |
0.659027858753861 |
|
20140 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFSF11 |
0.659027858753861 |
|
20141 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM216B |
0.659027858753861 |
|
20142 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC15 |
0.659027858753861 |
|
20143 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENOX1 |
0.659027858753861 |
|
20144 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPSTI1 |
0.659027858753861 |
|
20145 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00400 |
0.659027858753861 |
|
20146 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC122 |
0.659027858753861 |
|
20147 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LACC1 |
0.659027858753861 |
|
20148 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00284 |
0.659027858753861 |
|
20149 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMIM2 |
0.659027858753861 |
|
20150 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERP2 |
0.659027858753861 |
|
20151 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSC22D1 |
0.659027858753861 |
|
20152 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238932.1 |
0.659027858753861 |
|
20153 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00330 |
0.659027858753861 |
|
20154 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUFIP1 |
0.659027858753861 |
|
20155 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1704 |
0.659027858753861 |
|
20156 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL49P |
0.659027858753861 |
|
20157 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP3 |
0.659027858753861 |
|
20158 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF2F2 |
0.659027858753861 |
|
20159 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
7SK|ENSG00000271818.1 |
0.659027858753861 |
|
20160 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCTD4 |
0.659027858753861 |
|
20161 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000253051.1 |
0.659027858753861 |
|
20162 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPT1 |
0.659027858753861 |
|
20163 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000199477.1 |
0.659027858753861 |
|
20164 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A30 |
0.659027858753861 |
|
20165 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COG3 |
0.659027858753861 |
|
20166 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM194B |
0.659027858753861 |
|
20167 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP27 |
0.659027858753861 |
|
20168 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPERT |
0.659027858753861 |
|
20169 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIAH3 |
0.659027858753861 |
|
20170 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZC3H13 |
0.659027858753861 |
|
20171 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPB2 |
0.659027858753861 |
|
20172 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCP1 |
0.659027858753861 |
|
20173 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL288P |
0.659027858753861 |
|
20174 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC63 |
0.659027858753861 |
|
20175 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238483.1 |
0.659027858753861 |
|
20176 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP5 |
0.659027858753861 |
|
20177 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00563 |
0.659027858753861 |
|
20178 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0226L |
0.659027858753861 |
|
20179 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRCH1 |
0.659027858753861 |
|
20180 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ESD |
0.659027858753861 |
|
20181 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTR2A |
0.659027858753861 |
|
20182 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL700P |
0.659027858753861 |
|
20183 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00444 |
0.659027858753861 |
|
20184 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00562 |
0.659027858753861 |
|
20185 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUCLA2 |
0.659027858753861 |
|
20186 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDT15 |
0.659027858753861 |
|
20187 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED4 |
0.659027858753861 |
|
20188 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITM2B |
0.659027858753861 |
|
20189 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00441 |
0.659027858753861 |
|
20190 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RB1 |
0.659027858753861 |
|
20191 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPAR6 |
0.659027858753861 |
|
20192 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RCBTB2 |
0.659027858753861 |
|
20193 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00462 |
0.659027858753861 |
|
20194 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYSLTR2 |
0.659027858753861 |
|
20195 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FNDC3A |
0.659027858753861 |
|
20196 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY3P2 |
0.659027858753861 |
|
20197 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLNR |
0.659027858753861 |
|
20198 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SORL1 |
0.6599399985947 |
|
20199 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR125B1 |
0.6599399985947 |
|
20200 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BLID |
0.6599399985947 |
|
20201 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIRLET7A2 |
0.6599399985947 |
|
20202 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR100 |
0.6599399985947 |
|
20203 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU4ATAC10P |
0.6599399985947 |
|
20204 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU4ATAC5P |
0.6599399985947 |
|
20205 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBASH3B |
0.6599399985947 |
|
20206 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239079.1 |
0.6599399985947 |
|
20207 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRTAM |
0.6599399985947 |
|
20208 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf63 |
0.6599399985947 |
|
20209 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BSX |
0.6599399985947 |
|
20210 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPA8 |
0.6599399985947 |
|
20211 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD14E |
0.6599399985947 |
|
20212 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD14C |
0.6599399985947 |
|
20213 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD14D |
0.6599399985947 |
|
20214 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLMP |
0.6599399985947 |
|
20215 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000200496.1 |
0.6599399985947 |
|
20216 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4493 |
0.6599399985947 |
|
20217 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRAMD1B |
0.6599399985947 |
|
20218 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCN3B |
0.6599399985947 |
|
20219 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF202 |
0.6599399985947 |
|
20220 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6X1 |
0.6599399985947 |
|
20221 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIO |
0.660597900794568 |
|
20222 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM105A |
0.660597900794568 |
|
20223 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM105B |
0.660597900794568 |
|
20224 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKH |
0.660597900794568 |
|
20225 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR8B2 |
0.663033231979788 |
|
20226 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR8B3 |
0.663033231979788 |
|
20227 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR8B4 |
0.663033231979788 |
|
20228 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR8B8 |
0.663033231979788 |
|
20229 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR8B12 |
0.663033231979788 |
|
20230 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR8A1 |
0.663033231979788 |
|
20231 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PANX3 |
0.663033231979788 |
|
20232 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBRG1 |
0.663033231979788 |
|
20233 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIAE |
0.663033231979788 |
|
20234 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP352 |
0.663033231979788 |
|
20235 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPA17 |
0.663033231979788 |
|
20236 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRGN |
0.663033231979788 |
|
20237 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VSIG2 |
0.663033231979788 |
|
20238 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ESAM |
0.663033231979788 |
|
20239 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSANTD2 |
0.663033231979788 |
|
20240 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ROBO3 |
0.663033231979788 |
|
20241 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ROBO4 |
0.663033231979788 |
|
20242 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HEPACAM |
0.663033231979788 |
|
20243 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HEPN1 |
0.663033231979788 |
|
20244 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC15 |
0.663033231979788 |
|
20245 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC37A2 |
0.663033231979788 |
|
20246 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM218 |
0.663033231979788 |
|
20247 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT18P59 |
0.663033231979788 |
|
20248 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKNOX2 |
0.663033231979788 |
|
20249 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FEZ1 |
0.663033231979788 |
|
20250 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EI24 |
0.663033231979788 |
|
20251 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STT3A |
0.663033231979788 |
|
20252 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHEK1 |
0.663033231979788 |
|
20253 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACRV1 |
0.663033231979788 |
|
20254 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PATE1 |
0.663033231979788 |
|
20255 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PATE2 |
0.663033231979788 |
|
20256 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PATE3 |
0.663033231979788 |
|
20257 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PATE4 |
0.663033231979788 |
|
20258 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HYLS1 |
0.663033231979788 |
|
20259 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PUS3 |
0.663033231979788 |
|
20260 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX25 |
0.663033231979788 |
|
20261 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDON |
0.663033231979788 |
|
20262 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPUSD4 |
0.663033231979788 |
|
20263 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM118B |
0.663033231979788 |
|
20264 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL351P |
0.663033231979788 |
|
20265 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRPR |
0.663033231979788 |
|
20266 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXRED1 |
0.663033231979788 |
|
20267 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIRAP |
0.663033231979788 |
|
20268 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238855.1 |
0.663033231979788 |
|
20269 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCPS |
0.663033231979788 |
|
20270 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST3GAL4 |
0.663033231979788 |
|
20271 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIRREL3 |
0.663033231979788 |
|
20272 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3167 |
0.663033231979788 |
|
20273 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ETS1 |
0.663033231979788 |
|
20274 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLI1 |
0.663033231979788 |
|
20275 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNJ1 |
0.663033231979788 |
|
20276 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNJ5 |
0.663033231979788 |
|
20277 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf45 |
0.663033231979788 |
|
20278 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TP53AIP1 |
0.663033231979788 |
|
20279 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP32 |
0.663033231979788 |
|
20280 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BARX2 |
0.663033231979788 |
|
20281 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM45B |
0.663033231979788 |
|
20282 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFRKB |
0.663033231979788 |
|
20283 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRDM10 |
0.663033231979788 |
|
20284 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00167 |
0.663033231979788 |
|
20285 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APLP2 |
0.663033231979788 |
|
20286 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ST14 |
0.663033231979788 |
|
20287 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB44 |
0.663033231979788 |
|
20288 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAMTS8 |
0.663033231979788 |
|
20289 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAMTS15 |
0.663033231979788 |
|
20290 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf44 |
0.663033231979788 |
|
20291 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX19 |
0.663033231979788 |
|
20292 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL167P |
0.663033231979788 |
|
20293 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNED1 |
0.663462617719012 |
|
20294 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTERFD2 |
0.663462617719012 |
|
20295 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF385D |
0.664272736692186 |
|
20296 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMGB1P5 |
0.664272736692186 |
|
20297 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2E2 |
0.664272736692186 |
|
20298 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2E1 |
0.664272736692186 |
|
20299 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NKIRAS1 |
0.664272736692186 |
|
20300 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL15 |
0.664272736692186 |
|
20301 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NR1D2 |
0.664272736692186 |
|
20302 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00691 |
0.664272736692186 |
|
20303 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THRB |
0.664272736692186 |
|
20304 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4792 |
0.664272736692186 |
|
20305 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL216P |
0.664272736692186 |
|
20306 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP125 |
0.664272736692186 |
|
20307 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP126 |
0.664272736692186 |
|
20308 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4442 |
0.664272736692186 |
|
20309 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NGLY1 |
0.664272736692186 |
|
20310 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OXSM |
0.664272736692186 |
|
20311 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00692 |
0.664272736692186 |
|
20312 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC3B |
0.664272736692186 |
|
20313 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEK10 |
0.664272736692186 |
|
20314 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC4A7 |
0.664272736692186 |
|
20315 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL859P |
0.664272736692186 |
|
20316 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EOMES |
0.664272736692186 |
|
20317 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CMC1 |
0.664272736692186 |
|
20318 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AZI2 |
0.664272736692186 |
|
20319 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZCWPW2 |
0.664272736692186 |
|
20320 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00693 |
0.664272736692186 |
|
20321 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBMS3 |
0.664272736692186 |
|
20322 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STT3B |
0.664272736692186 |
|
20323 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSBPL10 |
0.664272736692186 |
|
20324 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF860 |
0.664272736692186 |
|
20325 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA25|ENSG00000201701.1 |
0.664272736692186 |
|
20326 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPD1L |
0.664272736692186 |
|
20327 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238646.1 |
0.664272736692186 |
|
20328 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CMTM8 |
0.664272736692186 |
|
20329 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CMTM7 |
0.664272736692186 |
|
20330 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CMTM6 |
0.664272736692186 |
|
20331 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DYNC1LI1 |
0.664272736692186 |
|
20332 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNOT10 |
0.664272736692186 |
|
20333 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM71 |
0.664272736692186 |
|
20334 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCR4 |
0.664272736692186 |
|
20335 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLB1 |
0.664272736692186 |
|
20336 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMPPE |
0.664272736692186 |
|
20337 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL296P |
0.664272736692186 |
|
20338 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRTAP |
0.664272736692186 |
|
20339 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUSD5 |
0.664272736692186 |
|
20340 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXL2 |
0.664272736692186 |
|
20341 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBP1 |
0.664272736692186 |
|
20342 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP128 |
0.664272736692186 |
|
20343 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLASP2 |
0.664272736692186 |
|
20344 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDCD6IP |
0.664272736692186 |
|
20345 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARPP21 |
0.664272736692186 |
|
20346 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAC |
0.664272736692186 |
|
20347 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP227 |
0.664272736692186 |
|
20348 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCLK3 |
0.664272736692186 |
|
20349 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPD1P6 |
0.664272736692186 |
|
20350 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRANK1 |
0.664272736692186 |
|
20351 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC4P |
0.664272736692186 |
|
20352 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPM2AIP1 |
0.664272736692186 |
|
20353 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLH1 |
0.664272736692186 |
|
20354 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRFIP2 |
0.664272736692186 |
|
20355 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238929.1 |
0.664272736692186 |
|
20356 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLGA4 |
0.664272736692186 |
|
20357 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP129 |
0.664272736692186 |
|
20358 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf35 |
0.664272736692186 |
|
20359 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGA9 |
0.664272736692186 |
|
20360 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTDSPL |
0.664272736692186 |
|
20361 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR26A1 |
0.664272736692186 |
|
20362 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VILL |
0.664272736692186 |
|
20363 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLCD1 |
0.664272736692186 |
|
20364 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLEC1 |
0.664272736692186 |
|
20365 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACAA1 |
0.664272736692186 |
|
20366 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYD88 |
0.664272736692186 |
|
20367 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OXSR1 |
0.664272736692186 |
|
20368 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC22A13 |
0.664272736692186 |
|
20369 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC22A14 |
0.664272736692186 |
|
20370 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XYLB |
0.664272736692186 |
|
20371 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACVR2B |
0.664272736692186 |
|
20372 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXOG |
0.664272736692186 |
|
20373 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCN5A |
0.664272736692186 |
|
20374 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCN10A |
0.664272736692186 |
|
20375 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCN11A |
0.664272736692186 |
|
20376 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR48 |
0.664272736692186 |
|
20377 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GORASP1 |
0.664272736692186 |
|
20378 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC21A |
0.664272736692186 |
|
20379 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSRNP1 |
0.664272736692186 |
|
20380 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XIRP1 |
0.664272736692186 |
|
20381 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CX3CR1 |
0.664272736692186 |
|
20382 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCR8 |
0.664272736692186 |
|
20383 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A38 |
0.664272736692186 |
|
20384 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPSA |
0.664272736692186 |
|
20385 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA62|ENSG00000202363.1 |
0.664272736692186 |
|
20386 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA6 |
0.664272736692186 |
|
20387 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOBP |
0.664272736692186 |
|
20388 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYRIP |
0.664272736692186 |
|
20389 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL411P |
0.664272736692186 |
|
20390 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA64|ENSG00000202517.1 |
0.664272736692186 |
|
20391 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF1B |
0.664272736692186 |
|
20392 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENTPD3 |
0.664272736692186 |
|
20393 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL14 |
0.664272736692186 |
|
20394 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF619 |
0.664272736692186 |
|
20395 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF620 |
0.664272736692186 |
|
20396 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF621 |
0.664272736692186 |
|
20397 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTNNB1 |
0.664272736692186 |
|
20398 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ULK4 |
0.664272736692186 |
|
20399 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA21|ENSG00000252409.1 |
0.664272736692186 |
|
20400 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP58 |
0.664272736692186 |
|
20401 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAK1 |
0.664272736692186 |
|
20402 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000212145.2 |
0.664272736692186 |
|
20403 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCK |
0.664272736692186 |
|
20404 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYZL4 |
0.664272736692186 |
|
20405 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VIPR1 |
0.664272736692186 |
|
20406 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC22C |
0.664272736692186 |
|
20407 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SS18L2 |
0.664272736692186 |
|
20408 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NKTR |
0.664272736692186 |
|
20409 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB47 |
0.664272736692186 |
|
20410 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL567P |
0.664272736692186 |
|
20411 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL40 |
0.664272736692186 |
|
20412 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC13 |
0.664272736692186 |
|
20413 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HHATL |
0.664272736692186 |
|
20414 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIGD1A |
0.664272736692186 |
|
20415 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACKR2 |
0.664272736692186 |
|
20416 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRBOX1 |
0.664272736692186 |
|
20417 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP8B1 |
0.664272736692186 |
|
20418 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF662 |
0.664272736692186 |
|
20419 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM198A |
0.664272736692186 |
|
20420 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTDC2 |
0.664272736692186 |
|
20421 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNRK |
0.664272736692186 |
|
20422 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL517P |
0.664272736692186 |
|
20423 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANO10 |
0.664272736692186 |
|
20424 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABHD5 |
0.664272736692186 |
|
20425 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOPAZ1 |
0.664272736692186 |
|
20426 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCAIM |
0.664272736692186 |
|
20427 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00694 |
0.664272736692186 |
|
20428 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF445 |
0.664272736692186 |
|
20429 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF852 |
0.664272736692186 |
|
20430 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZKSCAN7 |
0.664272736692186 |
|
20431 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF660 |
0.664272736692186 |
|
20432 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF197 |
0.664272736692186 |
|
20433 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF35 |
0.664272736692186 |
|
20434 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF502 |
0.664272736692186 |
|
20435 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF501 |
0.664272736692186 |
|
20436 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1143 |
0.664272736692186 |
|
20437 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF15 |
0.664272736692186 |
|
20438 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR564 |
0.664272736692186 |
|
20439 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM42 |
0.664272736692186 |
|
20440 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TGM4 |
0.664272736692186 |
|
20441 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDHHC3 |
0.664272736692186 |
|
20442 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXOSC7 |
0.664272736692186 |
|
20443 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC3B |
0.664272736692186 |
|
20444 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDCP1 |
0.664272736692186 |
|
20445 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM158 |
0.664272736692186 |
|
20446 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000202268.1 |
0.664272736692186 |
|
20447 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LARS2 |
0.664272736692186 |
|
20448 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIMD1 |
0.664272736692186 |
|
20449 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SACM1L |
0.664272736692186 |
|
20450 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL145P |
0.664272736692186 |
|
20451 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC6A20 |
0.664272736692186 |
|
20452 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LZTFL1 |
0.664272736692186 |
|
20453 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCR9 |
0.664272736692186 |
|
20454 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FYCO1 |
0.664272736692186 |
|
20455 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXCR6 |
0.664272736692186 |
|
20456 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XCR1 |
0.664272736692186 |
|
20457 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCR3 |
0.664272736692186 |
|
20458 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCR1 |
0.664272736692186 |
|
20459 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCR2 |
0.664272736692186 |
|
20460 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCR5 |
0.664272736692186 |
|
20461 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACKR5 |
0.664272736692186 |
|
20462 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LTF |
0.664272736692186 |
|
20463 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RTP3 |
0.664272736692186 |
|
20464 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC2 |
0.664272736692186 |
|
20465 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LUZPP1 |
0.664272736692186 |
|
20466 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TDGF1 |
0.664272736692186 |
|
20467 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD77|ENSG00000251967.1 |
0.664272736692186 |
|
20468 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALS2CL |
0.664272736692186 |
|
20469 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMIE |
0.664272736692186 |
|
20470 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS50 |
0.664272736692186 |
|
20471 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS46 |
0.664272736692186 |
|
20472 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS42 |
0.664272736692186 |
|
20473 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS44 |
0.664272736692186 |
|
20474 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS45 |
0.664272736692186 |
|
20475 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYL3 |
0.664272736692186 |
|
20476 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTH1R |
0.664272736692186 |
|
20477 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC12 |
0.664272736692186 |
|
20478 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBEAL2 |
0.664272736692186 |
|
20479 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SETD2 |
0.664272736692186 |
|
20480 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000251938.1 |
0.664272736692186 |
|
20481 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF9 |
0.664272736692186 |
|
20482 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239128.1 |
0.664272736692186 |
|
20483 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHX30 |
0.664272736692186 |
|
20484 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP4 |
0.664272736692186 |
|
20485 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1226 |
0.664272736692186 |
|
20486 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL664P |
0.664272736692186 |
|
20487 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC25A |
0.664272736692186 |
|
20488 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4443 |
0.664272736692186 |
|
20489 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAMP |
0.664272736692186 |
|
20490 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF589 |
0.664272736692186 |
|
20491 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NME6 |
0.664272736692186 |
|
20492 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR2115 |
0.664272736692186 |
|
20493 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPINK8 |
0.664272736692186 |
|
20494 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXW12 |
0.664272736692186 |
|
20495 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL321P |
0.664272736692186 |
|
20496 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLXNB1 |
0.664272736692186 |
|
20497 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC51 |
0.664272736692186 |
|
20498 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMA7 |
0.664272736692186 |
|
20499 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATRIP |
0.664272736692186 |
|
20500 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHISA5 |
0.664272736692186 |
|
20501 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TREX1 |
0.664272736692186 |
|
20502 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PFKFB4 |
0.664272736692186 |
|
20503 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UCN2 |
0.664272736692186 |
|
20504 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL7A1 |
0.664272736692186 |
|
20505 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR711 |
0.664272736692186 |
|
20506 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UQCRC1 |
0.664272736692186 |
|
20507 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM89 |
0.664272736692186 |
|
20508 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC26A6 |
0.664272736692186 |
|
20509 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CELSR3 |
0.664272736692186 |
|
20510 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4793 |
0.664272736692186 |
|
20511 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCKIPSD |
0.664272736692186 |
|
20512 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IP6K2 |
0.664272736692186 |
|
20513 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKAR2A |
0.664272736692186 |
|
20514 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A20 |
0.664272736692186 |
|
20515 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARIH2OS |
0.664272736692186 |
|
20516 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARIH2 |
0.664272736692186 |
|
20517 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
P4HTM |
0.664272736692186 |
|
20518 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR6 |
0.664272736692186 |
|
20519 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DALRD3 |
0.664272736692186 |
|
20520 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR191 |
0.664272736692186 |
|
20521 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR425 |
0.664272736692186 |
|
20522 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFAF3 |
0.664272736692186 |
|
20523 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IMPDH2 |
0.664272736692186 |
|
20524 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
QRICH1 |
0.664272736692186 |
|
20525 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL182P |
0.664272736692186 |
|
20526 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
QARS |
0.664272736692186 |
|
20527 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP19 |
0.664272736692186 |
|
20528 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAMB2 |
0.664272736692186 |
|
20529 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC71 |
0.664272736692186 |
|
20530 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHDC8B |
0.664272736692186 |
|
20531 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf84 |
0.664272736692186 |
|
20532 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC36 |
0.664272736692186 |
|
20533 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3orf62 |
0.664272736692186 |
|
20534 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4271 |
0.664272736692186 |
|
20535 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP4 |
0.664272736692186 |
|
20536 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPX1 |
0.664272736692186 |
|
20537 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHOA |
0.664272736692186 |
|
20538 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCTA |
0.664272736692186 |
|
20539 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMT |
0.664272736692186 |
|
20540 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NICN1 |
0.664272736692186 |
|
20541 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DAG1 |
0.664272736692186 |
|
20542 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP130 |
0.664272736692186 |
|
20543 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BSN |
0.664272736692186 |
|
20544 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APEH |
0.664272736692186 |
|
20545 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MST1 |
0.664272736692186 |
|
20546 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF123 |
0.664272736692186 |
|
20547 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMIGO3 |
0.664272736692186 |
|
20548 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GMPPB |
0.664272736692186 |
|
20549 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IP6K1 |
0.664272736692186 |
|
20550 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDHR4 |
0.664272736692186 |
|
20551 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM212A |
0.664272736692186 |
|
20552 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5193 |
0.664272736692186 |
|
20553 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBA7 |
0.664272736692186 |
|
20554 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAIP |
0.664272736692186 |
|
20555 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAMKV |
0.664272736692186 |
|
20556 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL217P |
0.664272736692186 |
|
20557 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MST1R |
0.664272736692186 |
|
20558 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MON1A |
0.664272736692186 |
|
20559 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARSG |
0.66648400582823 |
|
20560 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC16A6 |
0.66648400582823 |
|
20561 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKAR1A |
0.66648400582823 |
|
20562 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WIPI1 |
0.66648400582823 |
|
20563 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR635 |
0.66648400582823 |
|
20564 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM20A |
0.66648400582823 |
|
20565 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCA8 |
0.66648400582823 |
|
20566 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCA9 |
0.66648400582823 |
|
20567 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCA6 |
0.66648400582823 |
|
20568 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4524B |
0.66648400582823 |
|
20569 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCA10 |
0.66648400582823 |
|
20570 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCA5 |
0.66648400582823 |
|
20571 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA40|ENSG00000252352.1 |
0.66648400582823 |
|
20572 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP2K6 |
0.66648400582823 |
|
20573 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNJ16 |
0.66648400582823 |
|
20574 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNJ2 |
0.66648400582823 |
|
20575 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOX9 |
0.66648400582823 |
|
20576 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC39A11 |
0.66648400582823 |
|
20577 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP180 |
0.66648400582823 |
|
20578 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA24|ENSG00000252274.1 |
0.66648400582823 |
|
20579 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf68 |
0.6693718932536 |
|
20580 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DRAP1 |
0.6693718932536 |
|
20581 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSGA10IP |
0.6693718932536 |
|
20582 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SART1 |
0.6693718932536 |
|
20583 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF1AD |
0.6693718932536 |
|
20584 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BANF1 |
0.6693718932536 |
|
20585 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CST6 |
0.6693718932536 |
|
20586 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CATSPER1 |
0.6693718932536 |
|
20587 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAL3ST3 |
0.6693718932536 |
|
20588 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SF3B2 |
0.6693718932536 |
|
20589 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238752.1 |
0.6693718932536 |
|
20590 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PACS1 |
0.6693718932536 |
|
20591 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238763.1 |
0.6693718932536 |
|
20592 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLC2 |
0.6693718932536 |
|
20593 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB1B |
0.6693718932536 |
|
20594 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNIH2 |
0.6693718932536 |
|
20595 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YIF1A |
0.6693718932536 |
|
20596 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM151A |
0.6693718932536 |
|
20597 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD248 |
0.6693718932536 |
|
20598 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIN1 |
0.6693718932536 |
|
20599 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRMS1 |
0.6693718932536 |
|
20600 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B3GNT1 |
0.6693718932536 |
|
20601 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC29A2 |
0.6693718932536 |
|
20602 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD38 |
0.672402093225629 |
|
20603 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00662 |
0.673488803675165 |
|
20604 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF254 |
0.673488803675165 |
|
20605 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF726 |
0.673488803675165 |
|
20606 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPOCK3 |
0.674576800221453 |
|
20607 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALCAM |
0.674634282368133 |
|
20608 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBLB |
0.674634282368133 |
|
20609 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00882 |
0.674634282368133 |
|
20610 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00883 |
0.674634282368133 |
|
20611 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC54 |
0.674634282368133 |
|
20612 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRHL2 |
0.675407295551796 |
|
20613 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX14 |
0.679424935534988 |
|
20614 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYNCRIP |
0.679424935534988 |
|
20615 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNHG5 |
0.679424935534988 |
|
20616 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP45 |
0.679424935534988 |
|
20617 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSTD3 |
0.679424935534988 |
|
20618 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNC |
0.679424935534988 |
|
20619 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRDM13 |
0.679424935534988 |
|
20620 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCHR2 |
0.679424935534988 |
|
20621 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIM1 |
0.679424935534988 |
|
20622 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASCC3 |
0.679424935534988 |
|
20623 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238999.1 |
0.679424935534988 |
|
20624 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRIK2 |
0.679424935534988 |
|
20625 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA33|ENSG00000202283.1 |
0.679424935534988 |
|
20626 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HACE1 |
0.679424935534988 |
|
20627 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00577 |
0.679424935534988 |
|
20628 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIN28B |
0.679424935534988 |
|
20629 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BVES |
0.679424935534988 |
|
20630 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POPDC3 |
0.679424935534988 |
|
20631 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PREP |
0.679424935534988 |
|
20632 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP211 |
0.679424935534988 |
|
20633 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRDM1 |
0.679424935534988 |
|
20634 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATG5 |
0.679424935534988 |
|
20635 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL47P |
0.679424935534988 |
|
20636 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP211 |
0.679424935534988 |
|
20637 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AIM1 |
0.679424935534988 |
|
20638 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RTN4IP1 |
0.679424935534988 |
|
20639 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
QRSL1 |
0.679424935534988 |
|
20640 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR587 |
0.679424935534988 |
|
20641 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf203 |
0.679424935534988 |
|
20642 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BEND3 |
0.679424935534988 |
|
20643 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDSS2 |
0.679424935534988 |
|
20644 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOBP |
0.679424935534988 |
|
20645 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCML4 |
0.679424935534988 |
|
20646 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC63 |
0.679424935534988 |
|
20647 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA73|ENSG00000253090.1 |
0.679424935534988 |
|
20648 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSTM1 |
0.679424935534988 |
|
20649 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NR2E1 |
0.679424935534988 |
|
20650 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX3 |
0.679424935534988 |
|
20651 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238974.1 |
0.679424935534988 |
|
20652 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP212 |
0.679424935534988 |
|
20653 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LACE1 |
0.679424935534988 |
|
20654 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXO3 |
0.679424935534988 |
|
20655 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00222 |
0.679424935534988 |
|
20656 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF259P1 |
0.679424935534988 |
|
20657 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARMC2 |
0.679424935534988 |
|
20658 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SESN1 |
0.679424935534988 |
|
20659 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP57L1 |
0.679424935534988 |
|
20660 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf183 |
0.679424935534988 |
|
20661 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC162P |
0.679424935534988 |
|
20662 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238474.1 |
0.679424935534988 |
|
20663 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD164 |
0.679424935534988 |
|
20664 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPIL6 |
0.679424935534988 |
|
20665 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMPD2 |
0.679424935534988 |
|
20666 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MICAL1 |
0.679424935534988 |
|
20667 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB24 |
0.679424935534988 |
|
20668 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AK9 |
0.679424935534988 |
|
20669 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FIG4 |
0.679424935534988 |
|
20670 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR6 |
0.679424935534988 |
|
20671 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WASF1 |
0.679424935534988 |
|
20672 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC40 |
0.679424935534988 |
|
20673 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL24 |
0.679424935534988 |
|
20674 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDO |
0.679424935534988 |
|
20675 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC22A16 |
0.679424935534988 |
|
20676 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL617P |
0.679424935534988 |
|
20677 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK19 |
0.679424935534988 |
|
20678 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA40|ENSG00000212587.1 |
0.679424935534988 |
|
20679 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMD1 |
0.679424935534988 |
|
20680 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF3C6 |
0.679424935534988 |
|
20681 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238775.1 |
0.679424935534988 |
|
20682 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPF2 |
0.679424935534988 |
|
20683 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC16A10 |
0.679424935534988 |
|
20684 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1919 |
0.679424935534988 |
|
20685 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REV3L |
0.679424935534988 |
|
20686 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAF3IP2 |
0.679424935534988 |
|
20687 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf3 |
0.679424935534988 |
|
20688 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239015.1 |
0.679424935534988 |
|
20689 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FYN |
0.679424935534988 |
|
20690 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WISP3 |
0.679424935534988 |
|
20691 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBE1 |
0.679424935534988 |
|
20692 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM229B |
0.679424935534988 |
|
20693 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAMA4 |
0.679424935534988 |
|
20694 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFPL4B |
0.679424935534988 |
|
20695 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239095.1 |
0.679424935534988 |
|
20696 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000253091.1 |
0.679424935534988 |
|
20697 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238563.1 |
0.679424935534988 |
|
20698 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MARCKS |
0.679424935534988 |
|
20699 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HDAC2 |
0.679424935534988 |
|
20700 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HS3ST5 |
0.679424935534988 |
|
20701 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP213 |
0.679424935534988 |
|
20702 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRK |
0.679424935534988 |
|
20703 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NT5DC1 |
0.679424935534988 |
|
20704 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL10A1 |
0.679424935534988 |
|
20705 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPYL4 |
0.679424935534988 |
|
20706 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DSE |
0.679424935534988 |
|
20707 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPYL1 |
0.679424935534988 |
|
20708 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM26F |
0.679424935534988 |
|
20709 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAPPC3L |
0.679424935534988 |
|
20710 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM26E |
0.679424935534988 |
|
20711 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM26D |
0.679424935534988 |
|
20712 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RWDD1 |
0.679424935534988 |
|
20713 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RSPH4A |
0.679424935534988 |
|
20714 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZUFSP |
0.679424935534988 |
|
20715 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KPNA5 |
0.679424935534988 |
|
20716 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM162B |
0.679424935534988 |
|
20717 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPRC6A |
0.679424935534988 |
|
20718 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFX6 |
0.679424935534988 |
|
20719 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP214 |
0.679424935534988 |
|
20720 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VGLL2 |
0.679424935534988 |
|
20721 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ROS1 |
0.679424935534988 |
|
20722 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP18 |
0.679424935534988 |
|
20723 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP51 |
0.679424935534988 |
|
20724 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOPC |
0.679424935534988 |
|
20725 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCBLD1 |
0.679424935534988 |
|
20726 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUS1 |
0.679424935534988 |
|
20727 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35F1 |
0.679424935534988 |
|
20728 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP85L |
0.679424935534988 |
|
20729 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCM9 |
0.679424935534988 |
|
20730 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLN |
0.679424935534988 |
|
20731 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASF1A |
0.679424935534988 |
|
20732 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM184A |
0.679424935534988 |
|
20733 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548B |
0.679424935534988 |
|
20734 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAN1A1 |
0.679424935534988 |
|
20735 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3144 |
0.679424935534988 |
|
20736 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP215 |
0.679424935534988 |
|
20737 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D32 |
0.679424935534988 |
|
20738 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIGLECP3 |
0.679424935534988 |
|
20739 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GJA1 |
0.679424935534988 |
|
20740 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSF2 |
0.679424935534988 |
|
20741 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERINC1 |
0.679424935534988 |
|
20742 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKIB |
0.679424935534988 |
|
20743 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL564P |
0.679424935534988 |
|
20744 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FABP7 |
0.679424935534988 |
|
20745 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMPDL3A |
0.679424935534988 |
|
20746 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLVS2 |
0.679424935534988 |
|
20747 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRDN |
0.679424935534988 |
|
20748 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NKAIN2 |
0.679424935534988 |
|
20749 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF217 |
0.679424935534988 |
|
20750 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPD52L1 |
0.679424935534988 |
|
20751 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HDDC2 |
0.679424935534988 |
|
20752 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HEY2 |
0.679424935534988 |
|
20753 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCOA7 |
0.679424935534988 |
|
20754 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP56 |
0.679424935534988 |
|
20755 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HINT3 |
0.679424935534988 |
|
20756 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP216 |
0.679424935534988 |
|
20757 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRMT11 |
0.679424935534988 |
|
20758 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CENPW |
0.679424935534988 |
|
20759 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR588 |
0.679424935534988 |
|
20760 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRELID1P1 |
0.679424935534988 |
|
20761 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RSPO3 |
0.679424935534988 |
|
20762 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF146 |
0.679424935534988 |
|
20763 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ECHDC1 |
0.679424935534988 |
|
20764 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP217 |
0.679424935534988 |
|
20765 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOGA3 |
0.679424935534988 |
|
20766 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0408 |
0.679424935534988 |
|
20767 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf58 |
0.679424935534988 |
|
20768 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THEMIS |
0.679424935534988 |
|
20769 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238938.1 |
0.679424935534988 |
|
20770 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP18 |
0.679424935534988 |
|
20771 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM244 |
0.679424935534988 |
|
20772 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
L3MBTL3 |
0.679424935534988 |
|
20773 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAMD3 |
0.679424935534988 |
|
20774 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM200A |
0.679424935534988 |
|
20775 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMLR1 |
0.679424935534988 |
|
20776 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPB41L2 |
0.679424935534988 |
|
20777 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKAP7 |
0.679424935534988 |
|
20778 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARG1 |
0.679424935534988 |
|
20779 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED23 |
0.679424935534988 |
|
20780 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENPP3 |
0.679424935534988 |
|
20781 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2A4 |
0.679424935534988 |
|
20782 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTAGE9 |
0.679424935534988 |
|
20783 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548H5 |
0.679424935534988 |
|
20784 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENPP1 |
0.679424935534988 |
|
20785 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP245 |
0.679424935534988 |
|
20786 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTGF |
0.679424935534988 |
|
20787 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548AJ1 |
0.679424935534988 |
|
20788 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOXD1 |
0.679424935534988 |
|
20789 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STX7 |
0.679424935534988 |
|
20790 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAAR9 |
0.679424935534988 |
|
20791 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAAR8 |
0.679424935534988 |
|
20792 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAAR6 |
0.679424935534988 |
|
20793 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAAR5 |
0.679424935534988 |
|
20794 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAAR3 |
0.679424935534988 |
|
20795 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAAR2 |
0.679424935534988 |
|
20796 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAAR1 |
0.679424935534988 |
|
20797 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VNN1 |
0.679424935534988 |
|
20798 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VNN3 |
0.679424935534988 |
|
20799 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VNN2 |
0.679424935534988 |
|
20800 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS12 |
0.679424935534988 |
|
20801 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA33|ENSG00000200534.1 |
0.679424935534988 |
|
20802 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD100 |
0.679424935534988 |
|
20803 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD101 |
0.679424935534988 |
|
20804 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00326 |
0.679424935534988 |
|
20805 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EYA4 |
0.679424935534988 |
|
20806 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCF21 |
0.679424935534988 |
|
20807 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBPL1 |
0.679424935534988 |
|
20808 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC2A12 |
0.679424935534988 |
|
20809 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL408P |
0.679424935534988 |
|
20810 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGK1 |
0.679424935534988 |
|
20811 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238631.1 |
0.679424935534988 |
|
20812 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP218 |
0.679424935534988 |
|
20813 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALDH8A1 |
0.679424935534988 |
|
20814 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HBS1L |
0.679424935534988 |
|
20815 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYB |
0.679424935534988 |
|
20816 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548A2 |
0.679424935534988 |
|
20817 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AHI1 |
0.679424935534988 |
|
20818 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00271 |
0.679424935534988 |
|
20819 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE7B |
0.679424935534988 |
|
20820 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX5BP2 |
0.679424935534988 |
|
20821 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTFR2 |
0.679424935534988 |
|
20822 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCLAF1 |
0.679424935534988 |
|
20823 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP7 |
0.679424935534988 |
|
20824 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
7SK|ENSG00000271765.1 |
0.679424935534988 |
|
20825 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP3K5 |
0.679424935534988 |
|
20826 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP219 |
0.679424935534988 |
|
20827 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEX7 |
0.679424935534988 |
|
20828 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA27|ENSG00000201807.1 |
0.679424935534988 |
|
20829 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35D3 |
0.679424935534988 |
|
20830 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL20RA |
0.679424935534988 |
|
20831 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL22RA2 |
0.679424935534988 |
|
20832 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFNGR1 |
0.679424935534988 |
|
20833 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OLIG3 |
0.679424935534988 |
|
20834 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252476.1 |
0.679424935534988 |
|
20835 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFAIP3 |
0.679424935534988 |
|
20836 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PERP |
0.679424935534988 |
|
20837 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1244 |
0.679424935534988 |
|
20838 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PBOV1 |
0.679424935534988 |
|
20839 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HEBP2 |
0.679424935534988 |
|
20840 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NHSL1 |
0.679424935534988 |
|
20841 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3145 |
0.679424935534988 |
|
20842 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC28A |
0.679424935534988 |
|
20843 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ECT2L |
0.679424935534988 |
|
20844 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REPS1 |
0.679424935534988 |
|
20845 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABRACL |
0.679424935534988 |
|
20846 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HECA |
0.679424935534988 |
|
20847 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TXLNB |
0.679424935534988 |
|
20848 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CITED2 |
0.679424935534988 |
|
20849 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP220 |
0.679424935534988 |
|
20850 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3668 |
0.679424935534988 |
|
20851 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP106 |
0.679424935534988 |
|
20852 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NMBR |
0.679424935534988 |
|
20853 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GJE1 |
0.679424935534988 |
|
20854 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VTA1 |
0.679424935534988 |
|
20855 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR126 |
0.679424935534988 |
|
20856 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIVEP2 |
0.679424935534988 |
|
20857 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AIG1 |
0.679424935534988 |
|
20858 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAT2 |
0.679424935534988 |
|
20859 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEX3 |
0.679424935534988 |
|
20860 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP221 |
0.679424935534988 |
|
20861 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FUCA2 |
0.679424935534988 |
|
20862 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHACTR2 |
0.679424935534988 |
|
20863 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LTV1 |
0.679424935534988 |
|
20864 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZC2HC1B |
0.679424935534988 |
|
20865 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLAGL1 |
0.679424935534988 |
|
20866 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SF3B5 |
0.679424935534988 |
|
20867 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STX11 |
0.679424935534988 |
|
20868 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UTRN |
0.679424935534988 |
|
20869 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPM2A |
0.679424935534988 |
|
20870 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO30 |
0.679424935534988 |
|
20871 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHPRH |
0.679424935534988 |
|
20872 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRM1 |
0.679424935534988 |
|
20873 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP222 |
0.679424935534988 |
|
20874 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB32 |
0.679424935534988 |
|
20875 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADGB |
0.679424935534988 |
|
20876 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STXBP5 |
0.679424935534988 |
|
20877 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAMD5 |
0.679424935534988 |
|
20878 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SASH1 |
0.679424935534988 |
|
20879 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UST |
0.679424935534988 |
|
20880 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAB2 |
0.679424935534988 |
|
20881 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL234P |
0.679424935534988 |
|
20882 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUMO4 |
0.679424935534988 |
|
20883 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZC3H12D |
0.679424935534988 |
|
20884 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPIL4 |
0.679424935534988 |
|
20885 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GINM1 |
0.679424935534988 |
|
20886 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA2|ENSG00000202343.1 |
0.679424935534988 |
|
20887 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KATNA1 |
0.679424935534988 |
|
20888 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRP11 |
0.679424935534988 |
|
20889 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAET1E |
0.679424935534988 |
|
20890 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAET1G |
0.679424935534988 |
|
20891 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ULBP2 |
0.679424935534988 |
|
20892 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ULBP1 |
0.679424935534988 |
|
20893 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAET1K |
0.679424935534988 |
|
20894 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAET1L |
0.679424935534988 |
|
20895 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ULBP3 |
0.679424935534988 |
|
20896 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R14C |
0.679424935534988 |
|
20897 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238594.1 |
0.679424935534988 |
|
20898 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IYD |
0.679424935534988 |
|
20899 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHG1 |
0.679424935534988 |
|
20900 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTHFD1L |
0.679424935534988 |
|
20901 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKAP12 |
0.679424935534988 |
|
20902 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P20 |
0.679424935534988 |
|
20903 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP268 |
0.679424935534988 |
|
20904 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238939.1 |
0.679424935534988 |
|
20905 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB2 |
0.679424935534988 |
|
20906 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RMND1 |
0.679424935534988 |
|
20907 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf211 |
0.679424935534988 |
|
20908 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC170 |
0.679424935534988 |
|
20909 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ESR1 |
0.679424935534988 |
|
20910 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYNE1 |
0.679424935534988 |
|
20911 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP223 |
0.679424935534988 |
|
20912 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYCT1 |
0.679424935534988 |
|
20913 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VIP |
0.679424935534988 |
|
20914 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO5 |
0.679424935534988 |
|
20915 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTRF1L |
0.679424935534988 |
|
20916 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGS17 |
0.679424935534988 |
|
20917 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP224 |
0.679424935534988 |
|
20918 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP225 |
0.679424935534988 |
|
20919 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OPRM1 |
0.679424935534988 |
|
20920 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IPCEF1 |
0.679424935534988 |
|
20921 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNKSR3 |
0.679424935534988 |
|
20922 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCAF8 |
0.679424935534988 |
|
20923 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIAM2 |
0.679424935534988 |
|
20924 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1273C |
0.679424935534988 |
|
20925 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000238963.1 |
0.679424935534988 |
|
20926 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFB1M |
0.679424935534988 |
|
20927 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOX3 |
0.679424935534988 |
|
20928 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1202 |
0.679424935534988 |
|
20929 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD28|ENSG00000212295.1 |
0.679424935534988 |
|
20930 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARID1B |
0.679424935534988 |
|
20931 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4466 |
0.679424935534988 |
|
20932 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM242 |
0.679424935534988 |
|
20933 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000252609.1 |
0.679424935534988 |
|
20934 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDHHC14 |
0.679424935534988 |
|
20935 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3692 |
0.679424935534988 |
|
20936 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX9 |
0.679424935534988 |
|
20937 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYNJ2 |
0.679424935534988 |
|
20938 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERAC1 |
0.679424935534988 |
|
20939 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF2H5 |
0.679424935534988 |
|
20940 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TULP4 |
0.679424935534988 |
|
20941 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL173P |
0.679424935534988 |
|
20942 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM181 |
0.679424935534988 |
|
20943 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DYNLT1 |
0.679424935534988 |
|
20944 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYTL3 |
0.679424935534988 |
|
20945 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EZR |
0.679424935534988 |
|
20946 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3918 |
0.679424935534988 |
|
20947 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSTCP1 |
0.679424935534988 |
|
20948 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf99 |
0.679424935534988 |
|
20949 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RSPH3 |
0.679424935534988 |
|
20950 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAGAP |
0.679424935534988 |
|
20951 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FNDC1 |
0.679424935534988 |
|
20952 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOD2 |
0.679424935534988 |
|
20953 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU4ATAC18P |
0.679424935534988 |
|
20954 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WTAP |
0.679424935534988 |
|
20955 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACAT2 |
0.679424935534988 |
|
20956 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCP1 |
0.679424935534988 |
|
20957 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA20|ENSG00000207392.1 |
0.679424935534988 |
|
20958 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA29 |
0.679424935534988 |
|
20959 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL18 |
0.679424935534988 |
|
20960 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNLDC1 |
0.679424935534988 |
|
20961 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAS1 |
0.679424935534988 |
|
20962 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGF2R |
0.679424935534988 |
|
20963 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AIRN |
0.679424935534988 |
|
20964 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC22A1 |
0.679424935534988 |
|
20965 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC22A2 |
0.679424935534988 |
|
20966 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC22A3 |
0.679424935534988 |
|
20967 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPAL2 |
0.679424935534988 |
|
20968 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPA |
0.679424935534988 |
|
20969 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLG |
0.679424935534988 |
|
20970 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP3K4 |
0.679424935534988 |
|
20971 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCAS1 |
0.682324836798619 |
|
20972 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4756 |
0.682324836798619 |
|
20973 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP24A1 |
0.682324836798619 |
|
20974 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PFDN4 |
0.682324836798619 |
|
20975 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOK5 |
0.682324836798619 |
|
20976 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU4ATAC7P |
0.682324836798619 |
|
20977 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBLN4 |
0.682324836798619 |
|
20978 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP487 |
0.682324836798619 |
|
20979 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MC3R |
0.682324836798619 |
|
20980 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM210B |
0.682324836798619 |
|
20981 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AURKA |
0.682324836798619 |
|
20982 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSTF1 |
0.682324836798619 |
|
20983 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASS4 |
0.682324836798619 |
|
20984 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RTFDC1 |
0.682324836798619 |
|
20985 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238294.1 |
0.682324836798619 |
|
20986 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCNT7 |
0.682324836798619 |
|
20987 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM209A |
0.682324836798619 |
|
20988 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM209B |
0.682324836798619 |
|
20989 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000252536.1 |
0.682324836798619 |
|
20990 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFAP2C |
0.682324836798619 |
|
20991 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL170P |
0.682324836798619 |
|
20992 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BMP7 |
0.682324836798619 |
|
20993 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4325 |
0.682324836798619 |
|
20994 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPO11 |
0.682324836798619 |
|
20995 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAE1 |
0.682324836798619 |
|
20996 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTRNR2L3 |
0.682324836798619 |
|
20997 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM38 |
0.682324836798619 |
|
20998 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTCFL |
0.682324836798619 |
|
20999 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCK1 |
0.682324836798619 |
|
21000 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBP1 |
0.682324836798619 |
|
21001 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PMEPA1 |
0.682324836798619 |
|
21002 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4532 |
0.682324836798619 |
|
21003 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C20orf85 |
0.682324836798619 |
|
21004 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD60 |
0.682324836798619 |
|
21005 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP4R1L |
0.682324836798619 |
|
21006 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB22A |
0.682324836798619 |
|
21007 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VAPB |
0.682324836798619 |
|
21008 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APCDD1L |
0.682324836798619 |
|
21009 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MGC4294 |
0.682324836798619 |
|
21010 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STX16 |
0.682324836798619 |
|
21011 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPEPL1 |
0.682324836798619 |
|
21012 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR296 |
0.682324836798619 |
|
21013 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR298 |
0.682324836798619 |
|
21014 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNAS |
0.682324836798619 |
|
21015 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NELFCD |
0.682324836798619 |
|
21016 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTSZ |
0.682324836798619 |
|
21017 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBB1 |
0.682324836798619 |
|
21018 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP5E |
0.682324836798619 |
|
21019 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLMO2 |
0.682324836798619 |
|
21020 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF831 |
0.682324836798619 |
|
21021 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EDN3 |
0.682324836798619 |
|
21022 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHACTR3 |
0.682324836798619 |
|
21023 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYCP2 |
0.682324836798619 |
|
21024 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM217B |
0.682324836798619 |
|
21025 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R3D |
0.682324836798619 |
|
21026 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDH26 |
0.682324836798619 |
|
21027 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C20orf197 |
0.682324836798619 |
|
21028 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR646 |
0.682324836798619 |
|
21029 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4533 |
0.682324836798619 |
|
21030 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548AG2 |
0.682324836798619 |
|
21031 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDH4 |
0.682324836798619 |
|
21032 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1257 |
0.682324836798619 |
|
21033 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAF4 |
0.682324836798619 |
|
21034 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LSM14B |
0.682324836798619 |
|
21035 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMA7 |
0.682324836798619 |
|
21036 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SS18L1 |
0.682324836798619 |
|
21037 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTG2 |
0.682324836798619 |
|
21038 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HRH3 |
0.682324836798619 |
|
21039 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSBPL2 |
0.682324836798619 |
|
21040 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADRM1 |
0.682324836798619 |
|
21041 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAMA5 |
0.682324836798619 |
|
21042 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4758 |
0.682324836798619 |
|
21043 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR633 |
0.68350239253615 |
|
21044 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TANC2 |
0.68350239253615 |
|
21045 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYB561 |
0.68350239253615 |
|
21046 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACE |
0.68350239253615 |
|
21047 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNH6 |
0.68350239253615 |
|
21048 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCAF7 |
0.68350239253615 |
|
21049 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TACO1 |
0.68350239253615 |
|
21050 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP3K3 |
0.68350239253615 |
|
21051 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIMD2 |
0.68350239253615 |
|
21052 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STRADA |
0.68350239253615 |
|
21053 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC47 |
0.68350239253615 |
|
21054 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX42 |
0.68350239253615 |
|
21055 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FTSJ3 |
0.68350239253615 |
|
21056 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMC5 |
0.68350239253615 |
|
21057 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMARCD2 |
0.68350239253615 |
|
21058 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL805P |
0.68350239253615 |
|
21059 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCAM1P |
0.68350239253615 |
|
21060 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSH1 |
0.68350239253615 |
|
21061 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSH2 |
0.68350239253615 |
|
21062 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSHL1 |
0.68350239253615 |
|
21063 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GH2 |
0.68350239253615 |
|
21064 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GH1 |
0.68350239253615 |
|
21065 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD79B |
0.68350239253615 |
|
21066 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCN4A |
0.68350239253615 |
|
21067 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf72 |
0.68350239253615 |
|
21068 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ICAM2 |
0.68350239253615 |
|
21069 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERN1 |
0.68350239253615 |
|
21070 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA76|ENSG00000266402.2 |
0.68350239253615 |
|
21071 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD104 |
0.68350239253615 |
|
21072 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX2 |
0.68350239253615 |
|
21073 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MILR1 |
0.68350239253615 |
|
21074 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLG2 |
0.68350239253615 |
|
21075 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX5 |
0.68350239253615 |
|
21076 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3064 |
0.68350239253615 |
|
21077 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5047 |
0.68350239253615 |
|
21078 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP95 |
0.68350239253615 |
|
21079 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMURF2 |
0.68350239253615 |
|
21080 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHM1P |
0.68350239253615 |
|
21081 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL409P |
0.68350239253615 |
|
21082 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC37A3 |
0.68350239253615 |
|
21083 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL404P |
0.68350239253615 |
|
21084 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC16A6P1 |
0.68350239253615 |
|
21085 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMZ2P1 |
0.68350239253615 |
|
21086 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNA13 |
0.68350239253615 |
|
21087 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGS9 |
0.68350239253615 |
|
21088 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AXIN2 |
0.68350239253615 |
|
21089 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP112 |
0.68350239253615 |
|
21090 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOH |
0.68350239253615 |
|
21091 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP444 |
0.68350239253615 |
|
21092 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKCA |
0.68350239253615 |
|
21093 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL735P |
0.68350239253615 |
|
21094 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP445 |
0.68350239253615 |
|
21095 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR634 |
0.68350239253615 |
|
21096 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNG5 |
0.68350239253615 |
|
21097 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP446 |
0.68350239253615 |
|
21098 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNG4 |
0.68350239253615 |
|
21099 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CACNG1 |
0.68350239253615 |
|
21100 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HELZ |
0.68350239253615 |
|
21101 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP447 |
0.68350239253615 |
|
21102 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA8|ENSG00000207410.1 |
0.68350239253615 |
|
21103 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMD12 |
0.68350239253615 |
|
21104 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PITPNC1 |
0.68350239253615 |
|
21105 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238612.1 |
0.68350239253615 |
|
21106 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL756P |
0.68350239253615 |
|
21107 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548D2 |
0.68350239253615 |
|
21108 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOL11 |
0.68350239253615 |
|
21109 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA38B |
0.68350239253615 |
|
21110 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BPTF |
0.68350239253615 |
|
21111 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL622P |
0.68350239253615 |
|
21112 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf58 |
0.68350239253615 |
|
21113 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KPNA2 |
0.68350239253615 |
|
21114 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00674 |
0.68350239253615 |
|
21115 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC37A16P |
0.68350239253615 |
|
21116 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMZ2 |
0.68350239253615 |
|
21117 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL12A1 |
0.684053539974375 |
|
21118 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX7A2 |
0.684053539974375 |
|
21119 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM30A |
0.684053539974375 |
|
21120 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FILIP1 |
0.684053539974375 |
|
21121 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000221332.1 |
0.684053539974375 |
|
21122 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4463 |
0.684053539974375 |
|
21123 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SENP6 |
0.684053539974375 |
|
21124 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP163 |
0.684053539974375 |
|
21125 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYO6 |
0.684053539974375 |
|
21126 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP209 |
0.684053539974375 |
|
21127 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239132.1 |
0.684053539974375 |
|
21128 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IMPG1 |
0.684053539974375 |
|
21129 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U6|ENSG00000272445.1 |
0.684053539974375 |
|
21130 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTR1B |
0.684053539974375 |
|
21131 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252932.1 |
0.684053539974375 |
|
21132 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRAK1BP1 |
0.684053539974375 |
|
21133 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHIP |
0.684053539974375 |
|
21134 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMGN3 |
0.684053539974375 |
|
21135 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCA5 |
0.684053539974375 |
|
21136 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3BGRL2 |
0.684053539974375 |
|
21137 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELOVL4 |
0.684053539974375 |
|
21138 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTK |
0.684053539974375 |
|
21139 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCKDHB |
0.684053539974375 |
|
21140 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM46A |
0.684053539974375 |
|
21141 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP210 |
0.684053539974375 |
|
21142 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000206886.1 |
0.684053539974375 |
|
21143 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IBTK |
0.684053539974375 |
|
21144 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPBG |
0.684053539974375 |
|
21145 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE3D |
0.684053539974375 |
|
21146 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOPEY1 |
0.684053539974375 |
|
21147 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGM3 |
0.684053539974375 |
|
21148 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RWDD2A |
0.684053539974375 |
|
21149 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ME1 |
0.684053539974375 |
|
21150 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS35 |
0.684053539974375 |
|
21151 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNAP91 |
0.684053539974375 |
|
21152 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIPPLY2 |
0.684053539974375 |
|
21153 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYB5R4 |
0.684053539974375 |
|
21154 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRAP2 |
0.684053539974375 |
|
21155 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1009 |
0.684053539974375 |
|
21156 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBX18 |
0.684053539974375 |
|
21157 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NT5E |
0.684053539974375 |
|
21158 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL643P |
0.684053539974375 |
|
21159 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTR1E |
0.684053539974375 |
|
21160 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP209 |
0.684053539974375 |
|
21161 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CGA |
0.684053539974375 |
|
21162 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF292 |
0.684053539974375 |
|
21163 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GJB7 |
0.684053539974375 |
|
21164 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMIM8 |
0.684053539974375 |
|
21165 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf163 |
0.684053539974375 |
|
21166 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf164 |
0.684053539974375 |
|
21167 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6ORF165 |
0.684053539974375 |
|
21168 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf165 |
0.684053539974375 |
|
21169 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35A1 |
0.684053539974375 |
|
21170 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RARS2 |
0.684053539974375 |
|
21171 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ORC3 |
0.684053539974375 |
|
21172 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKIRIN2 |
0.684053539974375 |
|
21173 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238628.1 |
0.684053539974375 |
|
21174 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL183P |
0.684053539974375 |
|
21175 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPACA1 |
0.684053539974375 |
|
21176 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNR1 |
0.684053539974375 |
|
21177 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNGTT |
0.684053539974375 |
|
21178 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA73|ENSG00000222145.1 |
0.684053539974375 |
|
21179 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNRC1 |
0.684053539974375 |
|
21180 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL336P |
0.684053539974375 |
|
21181 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRSF12 |
0.684053539974375 |
|
21182 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PM20D2 |
0.684053539974375 |
|
21183 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABRR1 |
0.684053539974375 |
|
21184 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABRR2 |
0.684053539974375 |
|
21185 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2J1 |
0.684053539974375 |
|
21186 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRAGD |
0.684053539974375 |
|
21187 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD6 |
0.684053539974375 |
|
21188 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL11P |
0.684053539974375 |
|
21189 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYRM2 |
0.684053539974375 |
|
21190 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MDN1 |
0.684053539974375 |
|
21191 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASP8AP2 |
0.684053539974375 |
|
21192 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238747.1 |
0.684053539974375 |
|
21193 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GJA10 |
0.684053539974375 |
|
21194 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BACH2 |
0.684053539974375 |
|
21195 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP110 |
0.684053539974375 |
|
21196 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4464 |
0.684053539974375 |
|
21197 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP3K7 |
0.684053539974375 |
|
21198 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4643 |
0.684053539974375 |
|
21199 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL415P |
0.684053539974375 |
|
21200 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000200492.1 |
0.684053539974375 |
|
21201 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000221455.1 |
0.684053539974375 |
|
21202 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPHA7 |
0.684053539974375 |
|
21203 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA18|ENSG00000252249.1 |
0.684053539974375 |
|
21204 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MANEA |
0.684053539974375 |
|
21205 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FUT9 |
0.684053539974375 |
|
21206 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL797P |
0.684053539974375 |
|
21207 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UFL1 |
0.684053539974375 |
|
21208 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FHL5 |
0.684053539974375 |
|
21209 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR63 |
0.684053539974375 |
|
21210 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFAF4 |
0.684053539974375 |
|
21211 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL509P |
0.684053539974375 |
|
21212 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL32 |
0.684053539974375 |
|
21213 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMS22L |
0.684053539974375 |
|
21214 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR2113 |
0.684053539974375 |
|
21215 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POU3F2 |
0.684053539974375 |
|
21216 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXL4 |
0.684053539974375 |
|
21217 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548AI |
0.684053539974375 |
|
21218 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAXC |
0.684053539974375 |
|
21219 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COQ3 |
0.684053539974375 |
|
21220 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNISR |
0.684053539974375 |
|
21221 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCN1 |
0.684433534618034 |
|
21222 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMB |
0.684433534618034 |
|
21223 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARP8 |
0.684433534618034 |
|
21224 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4465 |
0.685149783615606 |
|
21225 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LATS1 |
0.685149783615606 |
|
21226 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUP43 |
0.685149783615606 |
|
21227 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCMT1 |
0.685149783615606 |
|
21228 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STPG2 |
0.690082248609039 |
|
21229 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TENM4 |
0.690460109427458 |
|
21230 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR708 |
0.690460109427458 |
|
21231 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5579 |
0.690460109427458 |
|
21232 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDH7 |
0.690757368761128 |
|
21233 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAMA2 |
0.691996632450389 |
|
21234 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPRS |
0.692522886839317 |
|
21235 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL626P |
0.692522886839317 |
|
21236 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNRF4 |
0.692522886839317 |
|
21237 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TINCR |
0.692522886839317 |
|
21238 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAFB2 |
0.692522886839317 |
|
21239 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAFB |
0.692522886839317 |
|
21240 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL36 |
0.692522886839317 |
|
21241 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf70 |
0.692522886839317 |
|
21242 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSD11B1L |
0.692522886839317 |
|
21243 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LONP1 |
0.692522886839317 |
|
21244 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CATSPERD |
0.692522886839317 |
|
21245 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUS3L |
0.692522886839317 |
|
21246 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR22 |
0.692522886839317 |
|
21247 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRTN |
0.692522886839317 |
|
21248 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FUT3 |
0.692522886839317 |
|
21249 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FUT5 |
0.692522886839317 |
|
21250 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FUT6 |
0.692522886839317 |
|
21251 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFA11 |
0.692522886839317 |
|
21252 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAPS |
0.692522886839317 |
|
21253 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VMAC |
0.692522886839317 |
|
21254 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RANBP3 |
0.692522886839317 |
|
21255 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFX2 |
0.692522886839317 |
|
21256 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACSBG2 |
0.692522886839317 |
|
21257 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLLT1 |
0.692522886839317 |
|
21258 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACER1 |
0.692522886839317 |
|
21259 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLPP |
0.692522886839317 |
|
21260 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALKBH7 |
0.692522886839317 |
|
21261 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF2F1 |
0.692522886839317 |
|
21262 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSPN |
0.692522886839317 |
|
21263 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KHSRP |
0.692522886839317 |
|
21264 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3940 |
0.692522886839317 |
|
21265 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A41 |
0.692522886839317 |
|
21266 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A23 |
0.692522886839317 |
|
21267 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRB3 |
0.692522886839317 |
|
21268 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DENND1C |
0.692522886839317 |
|
21269 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBB4A |
0.692522886839317 |
|
21270 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFSF9 |
0.692522886839317 |
|
21271 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD70 |
0.692522886839317 |
|
21272 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFSF14 |
0.692522886839317 |
|
21273 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C3 |
0.692522886839317 |
|
21274 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR108 |
0.692522886839317 |
|
21275 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIP10 |
0.692522886839317 |
|
21276 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH2D3A |
0.692522886839317 |
|
21277 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VAV1 |
0.692522886839317 |
|
21278 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMR1 |
0.692522886839317 |
|
21279 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMR4P |
0.692522886839317 |
|
21280 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBD3L2 |
0.692522886839317 |
|
21281 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBD3L3 |
0.692522886839317 |
|
21282 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBD3L4 |
0.692522886839317 |
|
21283 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBD3L5 |
0.692522886839317 |
|
21284 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF557 |
0.692522886839317 |
|
21285 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INSR |
0.692522886839317 |
|
21286 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF18 |
0.692522886839317 |
|
21287 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEX11G |
0.692522886839317 |
|
21288 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf45 |
0.692522886839317 |
|
21289 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF358 |
0.692522886839317 |
|
21290 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCOLN1 |
0.692522886839317 |
|
21291 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNPLA6 |
0.692522886839317 |
|
21292 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAMSAP3 |
0.692522886839317 |
|
21293 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XAB2 |
0.692522886839317 |
|
21294 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCP2 |
0.692522886839317 |
|
21295 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PET100 |
0.692522886839317 |
|
21296 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STXBP2 |
0.692522886839317 |
|
21297 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RETN |
0.692522886839317 |
|
21298 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf59 |
0.692522886839317 |
|
21299 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAPPC5 |
0.692522886839317 |
|
21300 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FCER2 |
0.692522886839317 |
|
21301 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC4G |
0.692522886839317 |
|
21302 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD209 |
0.692522886839317 |
|
21303 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLEC4M |
0.692522886839317 |
|
21304 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EVI5L |
0.692522886839317 |
|
21305 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC8E |
0.692522886839317 |
|
21306 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP463 |
0.692522886839317 |
|
21307 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAP2K7 |
0.692522886839317 |
|
21308 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL115P |
0.692522886839317 |
|
21309 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TGFBR3L |
0.692522886839317 |
|
21310 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNAPC2 |
0.692522886839317 |
|
21311 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTXN1 |
0.692522886839317 |
|
21312 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIMM44 |
0.692522886839317 |
|
21313 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELAVL1 |
0.692522886839317 |
|
21314 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCL25 |
0.692522886839317 |
|
21315 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBN3 |
0.692522886839317 |
|
21316 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CERS4 |
0.692522886839317 |
|
21317 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD320 |
0.692522886839317 |
|
21318 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFA7 |
0.692522886839317 |
|
21319 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS28 |
0.692522886839317 |
|
21320 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KANK3 |
0.692522886839317 |
|
21321 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANGPTL4 |
0.692522886839317 |
|
21322 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4999 |
0.692522886839317 |
|
21323 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB11B |
0.692522886839317 |
|
21324 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MARCH2 |
0.692522886839317 |
|
21325 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPM |
0.692522886839317 |
|
21326 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRAM1 |
0.692522886839317 |
|
21327 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF414 |
0.692522886839317 |
|
21328 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYO1F |
0.692522886839317 |
|
21329 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAMTS10 |
0.692522886839317 |
|
21330 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTL9 |
0.692522886839317 |
|
21331 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2Z1 |
0.692522886839317 |
|
21332 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF558 |
0.692522886839317 |
|
21333 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBD3L1 |
0.692522886839317 |
|
21334 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUC16 |
0.692522886839317 |
|
21335 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR1M1 |
0.692522886839317 |
|
21336 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR7G2 |
0.692522886839317 |
|
21337 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR7G1 |
0.692522886839317 |
|
21338 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR7G3 |
0.692522886839317 |
|
21339 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF317 |
0.692522886839317 |
|
21340 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR7D2 |
0.692522886839317 |
|
21341 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR7D4 |
0.692522886839317 |
|
21342 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR7E24 |
0.692522886839317 |
|
21343 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR7E19P |
0.692522886839317 |
|
21344 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF699 |
0.692522886839317 |
|
21345 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF177 |
0.692522886839317 |
|
21346 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF559 |
0.692522886839317 |
|
21347 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF266 |
0.692522886839317 |
|
21348 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF560 |
0.692522886839317 |
|
21349 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF426 |
0.692522886839317 |
|
21350 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF121 |
0.692522886839317 |
|
21351 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LDLR |
0.692522886839317 |
|
21352 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPC24 |
0.692522886839317 |
|
21353 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KANK2 |
0.692522886839317 |
|
21354 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOCK6 |
0.692522886839317 |
|
21355 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL298P |
0.692522886839317 |
|
21356 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf80 |
0.692522886839317 |
|
21357 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPAN16 |
0.692522886839317 |
|
21358 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB3D |
0.692522886839317 |
|
21359 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC159 |
0.692522886839317 |
|
21360 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM205 |
0.692522886839317 |
|
21361 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DKFZP761J1410 |
0.692522886839317 |
|
21362 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPOR |
0.692522886839317 |
|
21363 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SWSAP1 |
0.692522886839317 |
|
21364 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGL3 |
0.692522886839317 |
|
21365 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC151 |
0.692522886839317 |
|
21366 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKCSH |
0.692522886839317 |
|
21367 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238349.1 |
0.692522886839317 |
|
21368 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELAVL3 |
0.692522886839317 |
|
21369 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL669P |
0.692522886839317 |
|
21370 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF653 |
0.692522886839317 |
|
21371 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ECSIT |
0.692522886839317 |
|
21372 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL833P |
0.692522886839317 |
|
21373 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNN1 |
0.692522886839317 |
|
21374 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELOF1 |
0.692522886839317 |
|
21375 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF627 |
0.692522886839317 |
|
21376 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACP5 |
0.692522886839317 |
|
21377 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF833P |
0.692522886839317 |
|
21378 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF823 |
0.692522886839317 |
|
21379 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF441 |
0.692522886839317 |
|
21380 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF491 |
0.692522886839317 |
|
21381 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF439 |
0.692522886839317 |
|
21382 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF440 |
0.692522886839317 |
|
21383 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF69 |
0.692522886839317 |
|
21384 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF700 |
0.692522886839317 |
|
21385 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF763 |
0.692522886839317 |
|
21386 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP464 |
0.692522886839317 |
|
21387 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF433 |
0.692522886839317 |
|
21388 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP465 |
0.692522886839317 |
|
21389 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF878 |
0.692522886839317 |
|
21390 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP466 |
0.692522886839317 |
|
21391 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF844 |
0.692522886839317 |
|
21392 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF788 |
0.692522886839317 |
|
21393 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF20 |
0.692522886839317 |
|
21394 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP467 |
0.692522886839317 |
|
21395 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF625 |
0.692522886839317 |
|
21396 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF136 |
0.692522886839317 |
|
21397 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF44 |
0.692522886839317 |
|
21398 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP248 |
0.696386818414339 |
|
21399 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRID2 |
0.696386818414339 |
|
21400 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP164 |
0.696386818414339 |
|
21401 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATOH1 |
0.696386818414339 |
|
21402 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMARCAD1 |
0.696386818414339 |
|
21403 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HPGDS |
0.696386818414339 |
|
21404 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDLIM5 |
0.696386818414339 |
|
21405 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BMPR1B |
0.696386818414339 |
|
21406 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UNC5C |
0.696386818414339 |
|
21407 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDHA2 |
0.696386818414339 |
|
21408 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP28 |
0.696386818414339 |
|
21409 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAP1GDS1 |
0.696386818414339 |
|
21410 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPAN5 |
0.696386818414339 |
|
21411 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF4E |
0.696386818414339 |
|
21412 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METAP1 |
0.696386818414339 |
|
21413 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3684 |
0.696386818414339 |
|
21414 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADH5 |
0.696386818414339 |
|
21415 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADH4 |
0.696386818414339 |
|
21416 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCNAP1 |
0.696386818414339 |
|
21417 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADH6 |
0.696386818414339 |
|
21418 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADH1A |
0.696386818414339 |
|
21419 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADH1B |
0.696386818414339 |
|
21420 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADH1C |
0.696386818414339 |
|
21421 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADH7 |
0.696386818414339 |
|
21422 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C4orf17 |
0.696386818414339 |
|
21423 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRMT10A |
0.696386818414339 |
|
21424 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTTP |
0.696386818414339 |
|
21425 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DAPP1 |
0.696386818414339 |
|
21426 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAMTOR3 |
0.696386818414339 |
|
21427 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJB14 |
0.696386818414339 |
|
21428 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
H2AFZ |
0.696386818414339 |
|
21429 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDIT4L |
0.696386818414339 |
|
21430 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMCN |
0.696386818414339 |
|
21431 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP3CA |
0.696386818414339 |
|
21432 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1255A |
0.696386818414339 |
|
21433 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BANK1 |
0.696386818414339 |
|
21434 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC39A8 |
0.696386818414339 |
|
21435 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL728P |
0.696386818414339 |
|
21436 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFKB1 |
0.696386818414339 |
|
21437 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MANBA |
0.696386818414339 |
|
21438 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2D3 |
0.696386818414339 |
|
21439 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CISD2 |
0.696386818414339 |
|
21440 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238948.1 |
0.696386818414339 |
|
21441 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC9B1 |
0.696386818414339 |
|
21442 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC9B2 |
0.696386818414339 |
|
21443 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BDH2 |
0.696386818414339 |
|
21444 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CENPE |
0.696386818414339 |
|
21445 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TACR3 |
0.696386818414339 |
|
21446 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXXC4 |
0.696386818414339 |
|
21447 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000252136.1 |
0.696386818414339 |
|
21448 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TET2 |
0.696386818414339 |
|
21449 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL89P |
0.696386818414339 |
|
21450 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPA2 |
0.696386818414339 |
|
21451 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF38 |
0.696386818414339 |
|
21452 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INTS12 |
0.696386818414339 |
|
21453 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSTCD |
0.696386818414339 |
|
21454 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPNT |
0.696386818414339 |
|
21455 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBCK |
0.696386818414339 |
|
21456 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AIMP1 |
0.696386818414339 |
|
21457 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GIMD1 |
0.696386818414339 |
|
21458 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DKK2 |
0.696386818414339 |
|
21459 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252566.1 |
0.696386818414339 |
|
21460 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAPSS1 |
0.696386818414339 |
|
21461 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGMS2 |
0.696386818414339 |
|
21462 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP2U1 |
0.696386818414339 |
|
21463 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HADH |
0.696386818414339 |
|
21464 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LEF1 |
0.696386818414339 |
|
21465 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL34 |
0.696386818414339 |
|
21466 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSTC |
0.696386818414339 |
|
21467 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ETNPPL |
0.696386818414339 |
|
21468 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL25A1 |
0.696386818414339 |
|
21469 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC24B |
0.696386818414339 |
|
21470 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL55P |
0.696386818414339 |
|
21471 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR576 |
0.696386818414339 |
|
21472 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC109B |
0.696386818414339 |
|
21473 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASP6 |
0.696386818414339 |
|
21474 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLA2G12A |
0.696386818414339 |
|
21475 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CFI |
0.696386818414339 |
|
21476 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAR1 |
0.696386818414339 |
|
21477 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRH |
0.696386818414339 |
|
21478 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRIT3 |
0.696386818414339 |
|
21479 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EGF |
0.696386818414339 |
|
21480 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELOVL6 |
0.696386818414339 |
|
21481 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL275P |
0.696386818414339 |
|
21482 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENPEP |
0.696386818414339 |
|
21483 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PITX2 |
0.696386818414339 |
|
21484 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR297 |
0.696386818414339 |
|
21485 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C4orf32 |
0.696386818414339 |
|
21486 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP1AR |
0.696386818414339 |
|
21487 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIFA |
0.696386818414339 |
|
21488 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALPK1 |
0.696386818414339 |
|
21489 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEUROG2 |
0.696386818414339 |
|
21490 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C4orf21 |
0.696386818414339 |
|
21491 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LARP7 |
0.696386818414339 |
|
21492 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR302A |
0.696386818414339 |
|
21493 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR302B |
0.696386818414339 |
|
21494 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR302C |
0.696386818414339 |
|
21495 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR302D |
0.696386818414339 |
|
21496 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR367 |
0.696386818414339 |
|
21497 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANK2 |
0.696386818414339 |
|
21498 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL184P |
0.696386818414339 |
|
21499 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAMK2D |
0.696386818414339 |
|
21500 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WNT1 |
0.696680113067997 |
|
21501 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDN |
0.696680113067997 |
|
21502 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKAG1 |
0.696680113067997 |
|
21503 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KMT2D |
0.696680113067997 |
|
21504 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHEBL1 |
0.696680113067997 |
|
21505 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHH |
0.696680113067997 |
|
21506 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMBR1L |
0.696680113067997 |
|
21507 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBA1B |
0.696680113067997 |
|
21508 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBA1A |
0.696680113067997 |
|
21509 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBA1C |
0.696680113067997 |
|
21510 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRPH |
0.696680113067997 |
|
21511 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1QL4 |
0.696680113067997 |
|
21512 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TROAP |
0.696680113067997 |
|
21513 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC22 |
0.696680113067997 |
|
21514 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATS2 |
0.696680113067997 |
|
21515 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNH3 |
0.696680113067997 |
|
21516 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCRS1 |
0.696680113067997 |
|
21517 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRPF40B |
0.696680113067997 |
|
21518 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM186B |
0.696680113067997 |
|
21519 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FMNL3 |
0.696680113067997 |
|
21520 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMBIM6 |
0.696680113067997 |
|
21521 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCKAP5L |
0.696680113067997 |
|
21522 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCDIN3D |
0.696680113067997 |
|
21523 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAIM2 |
0.696680113067997 |
|
21524 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AQP2 |
0.696680113067997 |
|
21525 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AQP5 |
0.696680113067997 |
|
21526 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AQP6 |
0.696680113067997 |
|
21527 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RACGAP1 |
0.696680113067997 |
|
21528 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASIC1 |
0.696680113067997 |
|
21529 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMARCD1 |
0.696680113067997 |
|
21530 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX14 |
0.696680113067997 |
|
21531 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPD1 |
0.696680113067997 |
|
21532 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CERS5 |
0.696680113067997 |
|
21533 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIMA1 |
0.696680113067997 |
|
21534 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1293 |
0.696680113067997 |
|
21535 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM186A |
0.696680113067997 |
|
21536 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LARP4 |
0.696680113067997 |
|
21537 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DIP2B |
0.696680113067997 |
|
21538 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATF1 |
0.696680113067997 |
|
21539 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL519P |
0.696680113067997 |
|
21540 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMPRSS12 |
0.696680113067997 |
|
21541 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL7A |
0.696680113067997 |
|
21542 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIGD1C |
0.696680113067997 |
|
21543 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC11A2 |
0.696680113067997 |
|
21544 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U6|ENSG00000272028.1 |
0.696680113067997 |
|
21545 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LETMD1 |
0.696680113067997 |
|
21546 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSRNP2 |
0.696680113067997 |
|
21547 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFCP2 |
0.696680113067997 |
|
21548 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POU6F1 |
0.696680113067997 |
|
21549 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DAZAP2 |
0.696680113067997 |
|
21550 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMAGP |
0.696680113067997 |
|
21551 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BIN2 |
0.696680113067997 |
|
21552 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CELA1 |
0.696680113067997 |
|
21553 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALNT6 |
0.696680113067997 |
|
21554 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC4A8 |
0.696680113067997 |
|
21555 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCN8A |
0.696680113067997 |
|
21556 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACVRL1 |
0.696680113067997 |
|
21557 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD33 |
0.696680113067997 |
|
21558 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACVR1B |
0.696680113067997 |
|
21559 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRASP |
0.696680113067997 |
|
21560 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NR4A1 |
0.696680113067997 |
|
21561 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf44 |
0.696680113067997 |
|
21562 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR7E47P |
0.696680113067997 |
|
21563 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT80 |
0.696680113067997 |
|
21564 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C12orf80 |
0.696680113067997 |
|
21565 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00592 |
0.696680113067997 |
|
21566 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT7 |
0.696680113067997 |
|
21567 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT121P |
0.696680113067997 |
|
21568 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KRT86 |
0.696680113067997 |
|
21569 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM189A2 |
0.697819843334194 |
|
21570 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APBA1 |
0.697819843334194 |
|
21571 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTAR1 |
0.697819843334194 |
|
21572 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf135 |
0.697819843334194 |
|
21573 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL570P |
0.697819843334194 |
|
21574 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAMDC2 |
0.697819843334194 |
|
21575 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMC5 |
0.697819843334194 |
|
21576 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLF9 |
0.697819843334194 |
|
21577 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf57 |
0.697819843334194 |
|
21578 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GDA |
0.697819843334194 |
|
21579 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP285 |
0.697819843334194 |
|
21580 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFAND5 |
0.697819843334194 |
|
21581 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMC1 |
0.697819843334194 |
|
21582 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238402.1 |
0.697819843334194 |
|
21583 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALDH1A1 |
0.697819843334194 |
|
21584 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANXA1 |
0.697819843334194 |
|
21585 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP286 |
0.697819843334194 |
|
21586 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RORB |
0.697819843334194 |
|
21587 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPM6 |
0.697819843334194 |
|
21588 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP47 |
0.697819843334194 |
|
21589 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P1 |
0.697819843334194 |
|
21590 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf40 |
0.697819843334194 |
|
21591 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf41 |
0.697819843334194 |
|
21592 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NMRK1 |
0.697819843334194 |
|
21593 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSTF1 |
0.697819843334194 |
|
21594 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238598.1 |
0.697819843334194 |
|
21595 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCSK5 |
0.697819843334194 |
|
21596 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFK |
0.697819843334194 |
|
21597 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCNT1 |
0.697819843334194 |
|
21598 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRUNE2 |
0.697819843334194 |
|
21599 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCA3 |
0.697819843334194 |
|
21600 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXB2 |
0.697819843334194 |
|
21601 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS13A |
0.697819843334194 |
|
21602 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNA14 |
0.697819843334194 |
|
21603 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNAQ |
0.697819843334194 |
|
21604 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP59 |
0.697819843334194 |
|
21605 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP78 |
0.697819843334194 |
|
21606 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSAT1 |
0.697819843334194 |
|
21607 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLE4 |
0.697819843334194 |
|
21608 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLE1 |
0.697819843334194 |
|
21609 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP287 |
0.697819843334194 |
|
21610 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD95|ENSG00000200969.1 |
0.697819843334194 |
|
21611 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA31D5P |
0.697819843334194 |
|
21612 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA31D4 |
0.697819843334194 |
|
21613 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA31D3 |
0.697819843334194 |
|
21614 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA31D1 |
0.697819843334194 |
|
21615 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASEF |
0.697819843334194 |
|
21616 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP242 |
0.697819843334194 |
|
21617 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRMD3 |
0.697819843334194 |
|
21618 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238608.1 |
0.697819843334194 |
|
21619 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252256.1 |
0.697819843334194 |
|
21620 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IDNK |
0.697819843334194 |
|
21621 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBQLN1 |
0.697819843334194 |
|
21622 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GKAP1 |
0.697819843334194 |
|
21623 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF27 |
0.697819843334194 |
|
21624 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf64 |
0.697819843334194 |
|
21625 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPK |
0.697819843334194 |
|
21626 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RMI1 |
0.697819843334194 |
|
21627 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC28A3 |
0.697819843334194 |
|
21628 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238694.1 |
0.698042191811364 |
|
21629 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NTRK2 |
0.700476198470867 |
|
21630 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGTPBP1 |
0.700476198470867 |
|
21631 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAA35 |
0.700476198470867 |
|
21632 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GOLM1 |
0.700476198470867 |
|
21633 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf153 |
0.700476198470867 |
|
21634 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP264 |
0.700476198470867 |
|
21635 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ISCA1 |
0.700476198470867 |
|
21636 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZCCHC6 |
0.700476198470867 |
|
21637 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAS1 |
0.700476198470867 |
|
21638 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf170 |
0.700476198470867 |
|
21639 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA26|ENSG00000212421.1 |
0.700476198470867 |
|
21640 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARSJ |
0.702083434616448 |
|
21641 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGT8 |
0.702083434616448 |
|
21642 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR577 |
0.702083434616448 |
|
21643 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL808P |
0.702083434616448 |
|
21644 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDST4 |
0.702083434616448 |
|
21645 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTRNR2L13 |
0.702083434616448 |
|
21646 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAM1L1 |
0.702083434616448 |
|
21647 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NT5C3AP1 |
0.702083434616448 |
|
21648 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDST3 |
0.702083434616448 |
|
21649 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNHG8 |
0.702083434616448 |
|
21650 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS12 |
0.702083434616448 |
|
21651 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP170P1 |
0.702083434616448 |
|
21652 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
METTL14 |
0.702083434616448 |
|
21653 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC24D |
0.702083434616448 |
|
21654 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYNPO2 |
0.702083434616448 |
|
21655 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYOZ2 |
0.702083434616448 |
|
21656 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP53 |
0.702083434616448 |
|
21657 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C4orf3 |
0.702083434616448 |
|
21658 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FABP2 |
0.702083434616448 |
|
21659 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE5A |
0.702083434616448 |
|
21660 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA11|ENSG00000221245.1 |
0.702083434616448 |
|
21661 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAD2L1 |
0.702083434616448 |
|
21662 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRDM5 |
0.702083434616448 |
|
21663 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDNF |
0.702083434616448 |
|
21664 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP137 |
0.702083434616448 |
|
21665 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNIP3 |
0.702083434616448 |
|
21666 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
QRFPR |
0.702083434616448 |
|
21667 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANXA5 |
0.702083434616448 |
|
21668 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM155 |
0.702083434616448 |
|
21669 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXOSC9 |
0.702083434616448 |
|
21670 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNA2 |
0.702083434616448 |
|
21671 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BBS7 |
0.702083434616448 |
|
21672 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPC3 |
0.702083434616448 |
|
21673 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL335P |
0.702083434616448 |
|
21674 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1109 |
0.702083434616448 |
|
21675 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAD1 |
0.702083434616448 |
|
21676 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL2 |
0.702083434616448 |
|
21677 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL21 |
0.702083434616448 |
|
21678 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BBS12 |
0.702083434616448 |
|
21679 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGF2 |
0.702083434616448 |
|
21680 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDT6 |
0.702083434616448 |
|
21681 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA5 |
0.702083434616448 |
|
21682 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPRY1 |
0.702083434616448 |
|
21683 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD50 |
0.702083434616448 |
|
21684 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAT4 |
0.702083434616448 |
|
21685 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INTU |
0.702083434616448 |
|
21686 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A31 |
0.702083434616448 |
|
21687 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPA4L |
0.702083434616448 |
|
21688 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLK4 |
0.702083434616448 |
|
21689 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFSD8 |
0.702083434616448 |
|
21690 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C4orf29 |
0.702083434616448 |
|
21691 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LARP1B |
0.702083434616448 |
|
21692 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGRMC2 |
0.702083434616448 |
|
21693 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238802.1 |
0.702083434616448 |
|
21694 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHF17 |
0.702083434616448 |
|
21695 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCLT1 |
0.702083434616448 |
|
21696 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C4orf33 |
0.702083434616448 |
|
21697 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY5P4 |
0.702083434616448 |
|
21698 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL205P |
0.702083434616448 |
|
21699 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000252014.1 |
0.702083434616448 |
|
21700 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCDH10 |
0.702083434616448 |
|
21701 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PABPC4L |
0.702083434616448 |
|
21702 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00613 |
0.702083434616448 |
|
21703 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCA11P |
0.708675569037498 |
|
21704 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP5I |
0.708675569037498 |
|
21705 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPLX1 |
0.708675569037498 |
|
21706 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DGKQ |
0.708675569037498 |
|
21707 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGFRL1 |
0.708675569037498 |
|
21708 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAK |
0.708675569037498 |
|
21709 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IDUA |
0.708675569037498 |
|
21710 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFSD7 |
0.708675569037498 |
|
21711 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR571 |
0.708675569037498 |
|
21712 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYL5 |
0.708675569037498 |
|
21713 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCGF3 |
0.708675569037498 |
|
21714 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE6B |
0.708675569037498 |
|
21715 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIGG |
0.708675569037498 |
|
21716 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL358P |
0.708675569037498 |
|
21717 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF212 |
0.708675569037498 |
|
21718 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC26A1 |
0.708675569037498 |
|
21719 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM175 |
0.708675569037498 |
|
21720 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF141 |
0.708675569037498 |
|
21721 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF595 |
0.708675569037498 |
|
21722 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF718 |
0.708675569037498 |
|
21723 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF721 |
0.708675569037498 |
|
21724 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF732 |
0.708675569037498 |
|
21725 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF876P |
0.708675569037498 |
|
21726 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMED11P |
0.708675569037498 |
|
21727 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA48|ENSG00000212458.1 |
0.708675569037498 |
|
21728 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPON2 |
0.708675569037498 |
|
21729 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTBP1 |
0.708675569037498 |
|
21730 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAEA |
0.708675569037498 |
|
21731 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRIPAK |
0.708675569037498 |
|
21732 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UVSSA |
0.708675569037498 |
|
21733 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM53A |
0.708675569037498 |
|
21734 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLBP |
0.708675569037498 |
|
21735 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM129 |
0.708675569037498 |
|
21736 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TACC3 |
0.708675569037498 |
|
21737 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGFR3 |
0.708675569037498 |
|
21738 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LETM1 |
0.708675569037498 |
|
21739 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL671P |
0.708675569037498 |
|
21740 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WHSC1 |
0.708675569037498 |
|
21741 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA22 |
0.708675569037498 |
|
21742 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR943 |
0.708675569037498 |
|
21743 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NELFA |
0.708675569037498 |
|
21744 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C4orf48 |
0.708675569037498 |
|
21745 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAT8L |
0.708675569037498 |
|
21746 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLN |
0.708675569037498 |
|
21747 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAUS3 |
0.708675569037498 |
|
21748 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MXD4 |
0.708675569037498 |
|
21749 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4800 |
0.708675569037498 |
|
21750 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFYVE28 |
0.708675569037498 |
|
21751 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL589P |
0.708675569037498 |
|
21752 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF4 |
0.708675569037498 |
|
21753 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM193A |
0.708675569037498 |
|
21754 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNIP2 |
0.708675569037498 |
|
21755 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3BP2 |
0.708675569037498 |
|
21756 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADD1 |
0.708675569037498 |
|
21757 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFSD10 |
0.708675569037498 |
|
21758 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOP14 |
0.708675569037498 |
|
21759 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRK4 |
0.708675569037498 |
|
21760 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTT |
0.708675569037498 |
|
21761 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSANTD1 |
0.708675569037498 |
|
21762 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGS12 |
0.708675569037498 |
|
21763 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HGFAC |
0.708675569037498 |
|
21764 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOK7 |
0.708675569037498 |
|
21765 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRPAP1 |
0.708675569037498 |
|
21766 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00955 |
0.708675569037498 |
|
21767 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADRA2C |
0.708675569037498 |
|
21768 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM86EP |
0.708675569037498 |
|
21769 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OTOP1 |
0.708675569037498 |
|
21770 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM128 |
0.708675569037498 |
|
21771 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYAR |
0.708675569037498 |
|
21772 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB49 |
0.708675569037498 |
|
21773 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NSG1 |
0.708675569037498 |
|
21774 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STX18 |
0.708675569037498 |
|
21775 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSX1 |
0.708675569037498 |
|
21776 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP113 |
0.708675569037498 |
|
21777 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYTL1 |
0.708675569037498 |
|
21778 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STK32B |
0.708675569037498 |
|
21779 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP275 |
0.708675569037498 |
|
21780 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C4orf6 |
0.708675569037498 |
|
21781 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EVC2 |
0.708675569037498 |
|
21782 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EVC |
0.708675569037498 |
|
21783 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRMP1 |
0.708675569037498 |
|
21784 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR378D1 |
0.708675569037498 |
|
21785 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C4orf50 |
0.708675569037498 |
|
21786 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JAKMIP1 |
0.708675569037498 |
|
21787 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WFS1 |
0.708675569037498 |
|
21788 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP2R2C |
0.708675569037498 |
|
21789 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAN2B2 |
0.708675569037498 |
|
21790 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRFAP1 |
0.708675569037498 |
|
21791 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S100P |
0.708675569037498 |
|
21792 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRFAP1L1 |
0.708675569037498 |
|
21793 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BLOC1S4 |
0.708675569037498 |
|
21794 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0232 |
0.708675569037498 |
|
21795 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D14 |
0.708675569037498 |
|
21796 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP292 |
0.708675569037498 |
|
21797 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC96 |
0.708675569037498 |
|
21798 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TADA2B |
0.708675569037498 |
|
21799 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRPEL1 |
0.708675569037498 |
|
21800 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP36 |
0.708675569037498 |
|
21801 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SORCS2 |
0.708675569037498 |
|
21802 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4798 |
0.708675569037498 |
|
21803 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4274 |
0.708675569037498 |
|
21804 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSAPL1 |
0.708675569037498 |
|
21805 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AFAP1 |
0.708675569037498 |
|
21806 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABLIM2 |
0.708675569037498 |
|
21807 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR95 |
0.708675569037498 |
|
21808 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3TC1 |
0.708675569037498 |
|
21809 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTRA3 |
0.708675569037498 |
|
21810 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACOX3 |
0.708675569037498 |
|
21811 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP152 |
0.708675569037498 |
|
21812 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRMT44 |
0.708675569037498 |
|
21813 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR78 |
0.708675569037498 |
|
21814 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPZ |
0.708675569037498 |
|
21815 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB131 |
0.708675569037498 |
|
21816 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM90A26 |
0.708675569037498 |
|
21817 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMX1 |
0.708675569037498 |
|
21818 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548I2 |
0.708675569037498 |
|
21819 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP153 |
0.708675569037498 |
|
21820 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP17L10 |
0.708675569037498 |
|
21821 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP17L11 |
0.708675569037498 |
|
21822 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP17L12 |
0.708675569037498 |
|
21823 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP17L13 |
0.708675569037498 |
|
21824 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP17L15 |
0.708675569037498 |
|
21825 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP17L17 |
0.708675569037498 |
|
21826 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP17L18 |
0.708675569037498 |
|
21827 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP17L19 |
0.708675569037498 |
|
21828 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP17L20 |
0.708675569037498 |
|
21829 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP17L21 |
0.708675569037498 |
|
21830 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP17L22 |
0.708675569037498 |
|
21831 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP17L23 |
0.708675569037498 |
|
21832 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP17L24 |
0.708675569037498 |
|
21833 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP17L25 |
0.708675569037498 |
|
21834 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP17L26 |
0.708675569037498 |
|
21835 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP17L27 |
0.708675569037498 |
|
21836 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP17L28 |
0.708675569037498 |
|
21837 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP17L29 |
0.708675569037498 |
|
21838 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP17L30 |
0.708675569037498 |
|
21839 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP17L5 |
0.708675569037498 |
|
21840 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC2A9 |
0.708675569037498 |
|
21841 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DRD5 |
0.708675569037498 |
|
21842 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP154 |
0.708675569037498 |
|
21843 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR1 |
0.708675569037498 |
|
21844 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3138 |
0.708675569037498 |
|
21845 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP155 |
0.708675569037498 |
|
21846 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF518B |
0.708675569037498 |
|
21847 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR572 |
0.708675569037498 |
|
21848 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HS3ST1 |
0.708675569037498 |
|
21849 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP156 |
0.708675569037498 |
|
21850 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSP90AB2P |
0.708675569037498 |
|
21851 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB28 |
0.708675569037498 |
|
21852 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BOD1L1 |
0.708675569037498 |
|
21853 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5091 |
0.708675569037498 |
|
21854 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00504 |
0.708675569037498 |
|
21855 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA63|ENSG00000202449.1 |
0.708675569037498 |
|
21856 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPEB2 |
0.708675569037498 |
|
21857 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP170 |
0.708675569037498 |
|
21858 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1QTNF7 |
0.708675569037498 |
|
21859 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CC2D2A |
0.708675569037498 |
|
21860 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXL5 |
0.708675569037498 |
|
21861 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM200B |
0.708675569037498 |
|
21862 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BST1 |
0.708675569037498 |
|
21863 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGFBP1 |
0.708675569037498 |
|
21864 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGFBP2 |
0.708675569037498 |
|
21865 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PROM1 |
0.708675569037498 |
|
21866 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAPT1 |
0.708675569037498 |
|
21867 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZEB2P1 |
0.708675569037498 |
|
21868 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LDB2 |
0.708675569037498 |
|
21869 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA75|ENSG00000206780.1 |
0.708675569037498 |
|
21870 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
QDPR |
0.708675569037498 |
|
21871 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLRN2 |
0.708675569037498 |
|
21872 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238536.1 |
0.708675569037498 |
|
21873 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAP3 |
0.708675569037498 |
|
21874 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL315P |
0.708675569037498 |
|
21875 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED28 |
0.708675569037498 |
|
21876 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM184B |
0.708675569037498 |
|
21877 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCAF16 |
0.708675569037498 |
|
21878 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCAPG |
0.708675569037498 |
|
21879 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCORL |
0.708675569037498 |
|
21880 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP157 |
0.708675569037498 |
|
21881 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLIT2 |
0.708675569037498 |
|
21882 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PACRGL |
0.708675569037498 |
|
21883 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNIP4 |
0.708675569037498 |
|
21884 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR125 |
0.708675569037498 |
|
21885 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238383.1 |
0.708675569037498 |
|
21886 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GBA3 |
0.708675569037498 |
|
21887 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPARGC1A |
0.708675569037498 |
|
21888 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHX15 |
0.708675569037498 |
|
21889 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR573 |
0.708675569037498 |
|
21890 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL16P |
0.708675569037498 |
|
21891 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOD3 |
0.708675569037498 |
|
21892 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC149 |
0.708675569037498 |
|
21893 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGI2 |
0.708675569037498 |
|
21894 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEPSECS |
0.708675569037498 |
|
21895 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PI4K2B |
0.708675569037498 |
|
21896 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZCCHC4 |
0.708675569037498 |
|
21897 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANAPC4 |
0.708675569037498 |
|
21898 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC34A2 |
0.708675569037498 |
|
21899 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEL1L3 |
0.708675569037498 |
|
21900 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMIM20 |
0.708675569037498 |
|
21901 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBPJ |
0.708675569037498 |
|
21902 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCKAR |
0.708675569037498 |
|
21903 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D19 |
0.708675569037498 |
|
21904 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD74|ENSG00000200999.1 |
0.708675569037498 |
|
21905 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STIM2 |
0.708675569037498 |
|
21906 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL101P |
0.708675569037498 |
|
21907 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC110 |
0.710178719965921 |
|
21908 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDLIM3 |
0.710178719965921 |
|
21909 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SORBS2 |
0.710178719965921 |
|
21910 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239034.1 |
0.710178719965921 |
|
21911 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLR3 |
0.710178719965921 |
|
21912 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM149A |
0.710178719965921 |
|
21913 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000253013.1 |
0.710178719965921 |
|
21914 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP4V2 |
0.710178719965921 |
|
21915 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLKB1 |
0.710178719965921 |
|
21916 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
F11 |
0.710178719965921 |
|
21917 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTNR1A |
0.710178719965921 |
|
21918 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAT1 |
0.710178719965921 |
|
21919 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUX4L2 |
0.710178719965921 |
|
21920 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUX4L3 |
0.710178719965921 |
|
21921 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUX4L4 |
0.710178719965921 |
|
21922 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUX4L5 |
0.710178719965921 |
|
21923 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUX4L6 |
0.710178719965921 |
|
21924 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUX4L7 |
0.710178719965921 |
|
21925 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUX4 |
0.710178719965921 |
|
21926 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRG1 |
0.710178719965921 |
|
21927 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRG2 |
0.710178719965921 |
|
21928 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSP90AA4P |
0.710178719965921 |
|
21929 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP174 |
0.710178719965921 |
|
21930 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP175 |
0.710178719965921 |
|
21931 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIML1 |
0.710178719965921 |
|
21932 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIML2 |
0.710178719965921 |
|
21933 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFP42 |
0.710178719965921 |
|
21934 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000199927.1 |
0.713749458040182 |
|
21935 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TGFBR2 |
0.713749458040182 |
|
21936 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GADL1 |
0.713749458040182 |
|
21937 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP127 |
0.713749458040182 |
|
21938 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DAPK1 |
0.714302122198516 |
|
21939 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTSL |
0.714302122198516 |
|
21940 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTSL3P |
0.714302122198516 |
|
21941 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA31E1 |
0.714302122198516 |
|
21942 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA31C1 |
0.714302122198516 |
|
21943 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK20 |
0.714302122198516 |
|
21944 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U6|ENSG00000271923.1 |
0.714302122198516 |
|
21945 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000252299.1 |
0.714302122198516 |
|
21946 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP475 |
0.71737908121112 |
|
21947 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF16B |
0.71737908121112 |
|
21948 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNRPB2 |
0.71737908121112 |
|
21949 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OTOR |
0.71737908121112 |
|
21950 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000212165.1 |
0.71737908121112 |
|
21951 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCSK2 |
0.71737908121112 |
|
21952 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BFSP1 |
0.71737908121112 |
|
21953 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DSTN |
0.71737908121112 |
|
21954 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP69 |
0.71737908121112 |
|
21955 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RRBP1 |
0.71737908121112 |
|
21956 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BANF2 |
0.71737908121112 |
|
21957 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX5 |
0.71737908121112 |
|
21958 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OVOL2 |
0.71737908121112 |
|
21959 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD17 |
0.71737908121112 |
|
21960 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MGME1 |
0.71737908121112 |
|
21961 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSRP2BP |
0.71737908121112 |
|
21962 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PET117 |
0.71737908121112 |
|
21963 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL14P |
0.71737908121112 |
|
21964 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF133 |
0.71737908121112 |
|
21965 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP74 |
0.71737908121112 |
|
21966 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P11 |
0.71737908121112 |
|
21967 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DZANK1 |
0.71737908121112 |
|
21968 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00851 |
0.71737908121112 |
|
21969 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP476 |
0.71737908121112 |
|
21970 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR3F |
0.71737908121112 |
|
21971 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3192 |
0.71737908121112 |
|
21972 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBBP9 |
0.71737908121112 |
|
21973 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC23B |
0.71737908121112 |
|
21974 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00493 |
0.71737908121112 |
|
21975 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DTD1 |
0.71737908121112 |
|
21976 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL638P |
0.71737908121112 |
|
21977 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC34P |
0.71737908121112 |
|
21978 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00652 |
0.71737908121112 |
|
21979 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C20orf78 |
0.71737908121112 |
|
21980 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCP2D1 |
0.71737908121112 |
|
21981 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC24A3 |
0.71737908121112 |
|
21982 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIN2 |
0.71737908121112 |
|
21983 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAA20 |
0.71737908121112 |
|
21984 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRNKL1 |
0.71737908121112 |
|
21985 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C20orf26 |
0.71737908121112 |
|
21986 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL690P |
0.71737908121112 |
|
21987 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INSM1 |
0.71737908121112 |
|
21988 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RALGAPA2 |
0.71737908121112 |
|
21989 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL607P |
0.71737908121112 |
|
21990 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00237 |
0.71737908121112 |
|
21991 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLK1S1 |
0.71737908121112 |
|
21992 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP477 |
0.71737908121112 |
|
21993 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XRN2 |
0.71737908121112 |
|
21994 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP140 |
0.71737908121112 |
|
21995 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAX1 |
0.71737908121112 |
|
21996 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD65|ENSG00000212229.1 |
0.718593894554616 |
|
21997 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP208 |
0.718593894554616 |
|
21998 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGA |
0.719467932310725 |
|
21999 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU105B |
0.722354608909885 |
|
22000 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLCB4 |
0.722354608909885 |
|
22001 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LAMP5 |
0.722354608909885 |
|
22002 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKEF1 |
0.722354608909885 |
|
22003 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNAP25 |
0.722354608909885 |
|
22004 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MKKS |
0.722354608909885 |
|
22005 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C20orf187 |
0.722354608909885 |
|
22006 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00687 |
0.722354608909885 |
|
22007 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP111 |
0.722354608909885 |
|
22008 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTBD3 |
0.722354608909885 |
|
22009 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPTLC3 |
0.722354608909885 |
|
22010 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ISM1 |
0.722354608909885 |
|
22011 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TASP1 |
0.722354608909885 |
|
22012 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ESF1 |
0.722354608909885 |
|
22013 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFAF5 |
0.722354608909885 |
|
22014 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEL1L2 |
0.722354608909885 |
|
22015 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MACROD2 |
0.722354608909885 |
|
22016 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL864P |
0.722354608909885 |
|
22017 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLRT3 |
0.722354608909885 |
|
22018 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM252 |
0.724600518417827 |
|
22019 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIP5K1B |
0.724600518417827 |
|
22020 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM122A |
0.724600518417827 |
|
22021 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKACG |
0.724600518417827 |
|
22022 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FXN |
0.724600518417827 |
|
22023 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TJP2 |
0.724600518417827 |
|
22024 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPM3 |
0.724600518417827 |
|
22025 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR204 |
0.724600518417827 |
|
22026 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM2 |
0.724600518417827 |
|
22027 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABHD17B |
0.724600518417827 |
|
22028 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf85 |
0.724600518417827 |
|
22029 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGPAT4 |
0.726377990128732 |
|
22030 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARK2 |
0.726377990128732 |
|
22031 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLX4IP |
0.726507513280777 |
|
22032 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JAG1 |
0.726507513280777 |
|
22033 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLNK |
0.728333831117854 |
|
22034 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EYS |
0.732435322195736 |
|
22035 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPIN1 |
0.73390142277403 |
|
22036 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NXNL2 |
0.73390142277403 |
|
22037 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4289 |
0.73390142277403 |
|
22038 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf47 |
0.73390142277403 |
|
22039 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S1PR3 |
0.73390142277403 |
|
22040 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHC3 |
0.73390142277403 |
|
22041 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CKS2 |
0.73390142277403 |
|
22042 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3153 |
0.73390142277403 |
|
22043 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SECISBP2 |
0.73390142277403 |
|
22044 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEMA4D |
0.73390142277403 |
|
22045 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GADD45G |
0.73390142277403 |
|
22046 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4290 |
0.73390142277403 |
|
22047 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DIRAS2 |
0.73390142277403 |
|
22048 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYK |
0.73390142277403 |
|
22049 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00484 |
0.73390142277403 |
|
22050 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AUH |
0.73390142277403 |
|
22051 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFIL3 |
0.73390142277403 |
|
22052 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ROR2 |
0.73390142277403 |
|
22053 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPTLC1 |
0.73390142277403 |
|
22054 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00475 |
0.73390142277403 |
|
22055 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238996.1 |
0.73390142277403 |
|
22056 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IARS |
0.73390142277403 |
|
22057 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA84 |
0.73390142277403 |
|
22058 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOL8 |
0.73390142277403 |
|
22059 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASPN |
0.73390142277403 |
|
22060 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CENPP |
0.73390142277403 |
|
22061 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ECM2 |
0.73390142277403 |
|
22062 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4670 |
0.73390142277403 |
|
22063 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OGN |
0.73390142277403 |
|
22064 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OMD |
0.73390142277403 |
|
22065 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IPPK |
0.73390142277403 |
|
22066 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BICD2 |
0.73390142277403 |
|
22067 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD19P |
0.73390142277403 |
|
22068 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF484 |
0.73390142277403 |
|
22069 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGD3 |
0.73390142277403 |
|
22070 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUSD3 |
0.73390142277403 |
|
22071 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf89 |
0.73390142277403 |
|
22072 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NINJ1 |
0.73390142277403 |
|
22073 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WNK2 |
0.73390142277403 |
|
22074 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf129 |
0.73390142277403 |
|
22075 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM120AOS |
0.73390142277403 |
|
22076 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM120A |
0.73390142277403 |
|
22077 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHF2 |
0.73390142277403 |
|
22078 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4291 |
0.73390142277403 |
|
22079 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BARX1 |
0.73390142277403 |
|
22080 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPDC1 |
0.73390142277403 |
|
22081 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUT |
0.735720745758315 |
|
22082 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CENPQ |
0.735720745758315 |
|
22083 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLYATL3 |
0.735720745758315 |
|
22084 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf141 |
0.735720745758315 |
|
22085 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHAG |
0.735720745758315 |
|
22086 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRISP2 |
0.735720745758315 |
|
22087 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRISP3 |
0.735720745758315 |
|
22088 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGK2 |
0.735720745758315 |
|
22089 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRISP1 |
0.735720745758315 |
|
22090 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB133 |
0.735720745758315 |
|
22091 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB114 |
0.735720745758315 |
|
22092 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB113 |
0.735720745758315 |
|
22093 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB110 |
0.735720745758315 |
|
22094 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB112 |
0.735720745758315 |
|
22095 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFAP2D |
0.735720745758315 |
|
22096 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TFAP2B |
0.735720745758315 |
|
22097 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD66|ENSG00000212532.1 |
0.735720745758315 |
|
22098 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKHD1 |
0.735720745758315 |
|
22099 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL580P |
0.735720745758315 |
|
22100 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR206 |
0.735720745758315 |
|
22101 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR133B |
0.735720745758315 |
|
22102 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL17A |
0.735720745758315 |
|
22103 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL17F |
0.735720745758315 |
|
22104 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCM3 |
0.735720745758315 |
|
22105 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAQR8 |
0.735720745758315 |
|
22106 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFHC1 |
0.735720745758315 |
|
22107 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAM2 |
0.735720745758315 |
|
22108 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM14A |
0.735720745758315 |
|
22109 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSTA1 |
0.735720745758315 |
|
22110 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSTA2 |
0.735720745758315 |
|
22111 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSTA5 |
0.735720745758315 |
|
22112 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSTA3 |
0.735720745758315 |
|
22113 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSTA4 |
0.735720745758315 |
|
22114 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SK |
0.735720745758315 |
|
22115 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ICK |
0.735720745758315 |
|
22116 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO9 |
0.735720745758315 |
|
22117 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL244P |
0.735720745758315 |
|
22118 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCM1 |
0.735720745758315 |
|
22119 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000251930.1 |
0.735720745758315 |
|
22120 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELOVL5 |
0.735720745758315 |
|
22121 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5685 |
0.735720745758315 |
|
22122 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP256 |
0.735720745758315 |
|
22123 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCLC |
0.735720745758315 |
|
22124 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL31 |
0.735720745758315 |
|
22125 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC1 |
0.735720745758315 |
|
22126 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BMP5 |
0.735720745758315 |
|
22127 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL21A1 |
0.735720745758315 |
|
22128 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DST |
0.735720745758315 |
|
22129 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BEND6 |
0.735720745758315 |
|
22130 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1586 |
0.735720745758315 |
|
22131 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF451 |
0.735720745758315 |
|
22132 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAG2 |
0.735720745758315 |
|
22133 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB23 |
0.735720745758315 |
|
22134 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRIM2 |
0.735720745758315 |
|
22135 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00680 |
0.735720745758315 |
|
22136 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548U |
0.735720745758315 |
|
22137 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP173 |
0.742920347882369 |
|
22138 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD65|ENSG00000212191.1 |
0.742920347882369 |
|
22139 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00290 |
0.742920347882369 |
|
22140 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP13 |
0.742920347882369 |
|
22141 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TENM3 |
0.742920347882369 |
|
22142 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1305 |
0.742920347882369 |
|
22143 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCTD |
0.742920347882369 |
|
22144 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM92A1P2 |
0.742920347882369 |
|
22145 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP67 |
0.742920347882369 |
|
22146 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000252048.1 |
0.742920347882369 |
|
22147 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WWC2 |
0.742920347882369 |
|
22148 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238319.1 |
0.742920347882369 |
|
22149 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLDN22 |
0.742920347882369 |
|
22150 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLDN24 |
0.742920347882369 |
|
22151 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238596.1 |
0.742920347882369 |
|
22152 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDKN2AIP |
0.742920347882369 |
|
22153 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ING2 |
0.742920347882369 |
|
22154 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239116.1 |
0.742920347882369 |
|
22155 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENPP6 |
0.742920347882369 |
|
22156 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RWDD4 |
0.742920347882369 |
|
22157 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STOX2 |
0.742920347882369 |
|
22158 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAPPC11 |
0.742920347882369 |
|
22159 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL28P |
0.742920347882369 |
|
22160 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRF2 |
0.742920347882369 |
|
22161 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD79 |
0.742920347882369 |
|
22162 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASP3 |
0.742920347882369 |
|
22163 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC111 |
0.742920347882369 |
|
22164 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLF1IP |
0.742920347882369 |
|
22165 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACSL1 |
0.742920347882369 |
|
22166 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HELT |
0.742920347882369 |
|
22167 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1430 |
0.742920347882369 |
|
22168 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRP2BP |
0.742920347882369 |
|
22169 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3945 |
0.742920347882369 |
|
22170 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4455 |
0.742920347882369 |
|
22171 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A4 |
0.742920347882369 |
|
22172 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX25 |
0.742920347882369 |
|
22173 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD37 |
0.742920347882369 |
|
22174 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UFSP2 |
0.742920347882369 |
|
22175 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C4orf47 |
0.742920347882369 |
|
22176 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP25 |
0.755066063319463 |
|
22177 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238591.1 |
0.755066063319463 |
|
22178 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00478 |
0.755066063319463 |
|
22179 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD74|ENSG00000201025.1 |
0.755066063319463 |
|
22180 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR99A |
0.755066063319463 |
|
22181 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIRLET7C |
0.755066063319463 |
|
22182 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR125B2 |
0.755066063319463 |
|
22183 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C21orf37 |
0.755066063319463 |
|
22184 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL163P |
0.755066063319463 |
|
22185 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXADR |
0.755066063319463 |
|
22186 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTG3 |
0.755066063319463 |
|
22187 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C21orf91 |
0.755066063319463 |
|
22188 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548X |
0.755066063319463 |
|
22189 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP147 |
0.755066063319463 |
|
22190 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00320 |
0.755066063319463 |
|
22191 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCAM2 |
0.755066063319463 |
|
22192 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00317 |
0.755066063319463 |
|
22193 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D9 |
0.756622581642486 |
|
22194 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BBX |
0.75689505920022 |
|
22195 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB20 |
0.75689505920022 |
|
22196 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLCO4C1 |
0.757650322900828 |
|
22197 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP68 |
0.757650322900828 |
|
22198 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLCO6A1 |
0.757650322900828 |
|
22199 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00492 |
0.757650322900828 |
|
22200 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00491 |
0.757650322900828 |
|
22201 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAM |
0.757650322900828 |
|
22202 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GIN1 |
0.757650322900828 |
|
22203 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPIP5K2 |
0.757650322900828 |
|
22204 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf30 |
0.757650322900828 |
|
22205 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDT12 |
0.757650322900828 |
|
22206 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL255P |
0.757650322900828 |
|
22207 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PJA2 |
0.757650322900828 |
|
22208 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAN2A1 |
0.757650322900828 |
|
22209 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP230 |
0.757650322900828 |
|
22210 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM232 |
0.757650322900828 |
|
22211 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548F3 |
0.757650322900828 |
|
22212 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA51|ENSG00000207177.1 |
0.757650322900828 |
|
22213 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A46 |
0.757650322900828 |
|
22214 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSLP |
0.757650322900828 |
|
22215 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR36 |
0.757650322900828 |
|
22216 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAMK4 |
0.757650322900828 |
|
22217 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STARD4 |
0.757650322900828 |
|
22218 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NREP |
0.757650322900828 |
|
22219 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP57 |
0.757650322900828 |
|
22220 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPB41L4A |
0.757650322900828 |
|
22221 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA13 |
0.757650322900828 |
|
22222 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLJ11235 |
0.757650322900828 |
|
22223 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APC |
0.757650322900828 |
|
22224 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRP19 |
0.757650322900828 |
|
22225 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REEP5 |
0.757650322900828 |
|
22226 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZRSR1 |
0.757650322900828 |
|
22227 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCP2 |
0.757650322900828 |
|
22228 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCC |
0.757650322900828 |
|
22229 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSSK1B |
0.757650322900828 |
|
22230 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU4ATAC13P |
0.757650322900828 |
|
22231 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YTHDC2 |
0.757650322900828 |
|
22232 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP89 |
0.757650322900828 |
|
22233 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNN2 |
0.757650322900828 |
|
22234 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM36 |
0.757650322900828 |
|
22235 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGGT1B |
0.757650322900828 |
|
22236 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC112 |
0.757650322900828 |
|
22237 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FEM1C |
0.757650322900828 |
|
22238 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TICAM2 |
0.757650322900828 |
|
22239 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMED7 |
0.757650322900828 |
|
22240 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDO1 |
0.757650322900828 |
|
22241 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATG12 |
0.757650322900828 |
|
22242 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP3S1 |
0.757650322900828 |
|
22243 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AQPEP |
0.757650322900828 |
|
22244 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL14EPL |
0.757650322900828 |
|
22245 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COMMD10 |
0.757650322900828 |
|
22246 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEMA6A |
0.757650322900828 |
|
22247 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DTWD2 |
0.757650322900828 |
|
22248 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DMXL1 |
0.757650322900828 |
|
22249 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239011.1 |
0.757650322900828 |
|
22250 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5706 |
0.757650322900828 |
|
22251 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPRK |
0.757783448362291 |
|
22252 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLDN20 |
0.757783448362291 |
|
22253 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCAM1 |
0.757993766066649 |
|
22254 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DIP2C |
0.760986217925885 |
|
22255 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR26 |
0.760986217925885 |
|
22256 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LARP4B |
0.760986217925885 |
|
22257 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTPBP4 |
0.760986217925885 |
|
22258 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADARB2 |
0.760986217925885 |
|
22259 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IDI1 |
0.760986217925885 |
|
22260 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IDI2 |
0.760986217925885 |
|
22261 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00200 |
0.760986217925885 |
|
22262 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR37 |
0.760986217925885 |
|
22263 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00700 |
0.760986217925885 |
|
22264 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00701 |
0.760986217925885 |
|
22265 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PUS10 |
0.762598694038618 |
|
22266 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP95 |
0.762598694038618 |
|
22267 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEX13 |
0.762598694038618 |
|
22268 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1841 |
0.762598694038618 |
|
22269 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2orf74 |
0.762598694038618 |
|
22270 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AHSA2 |
0.762598694038618 |
|
22271 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP34 |
0.762598694038618 |
|
22272 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PACRG |
0.763941509131927 |
|
22273 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239136.1 |
0.763941509131927 |
|
22274 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAHM |
0.763941509131927 |
|
22275 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
QKI |
0.763941509131927 |
|
22276 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL366P |
0.763941509131927 |
|
22277 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf118 |
0.763941509131927 |
|
22278 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE10A |
0.763941509131927 |
|
22279 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP226 |
0.763941509131927 |
|
22280 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDIM1 |
0.763941509131927 |
|
22281 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00473 |
0.763941509131927 |
|
22282 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD45|ENSG00000231297.2 |
0.763941509131927 |
|
22283 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
T |
0.763941509131927 |
|
22284 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR18 |
0.763941509131927 |
|
22285 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFT2D1 |
0.763941509131927 |
|
22286 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPC1 |
0.763941509131927 |
|
22287 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1913 |
0.763941509131927 |
|
22288 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCR6 |
0.763941509131927 |
|
22289 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCP10L2 |
0.763941509131927 |
|
22290 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf123 |
0.763941509131927 |
|
22291 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR31 |
0.763941509131927 |
|
22292 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLLT4 |
0.763941509131927 |
|
22293 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCP10 |
0.763941509131927 |
|
22294 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTLL2 |
0.763941509131927 |
|
22295 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UNC93A |
0.763941509131927 |
|
22296 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DACT2 |
0.763941509131927 |
|
22297 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRMD1 |
0.763941509131927 |
|
22298 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF25 |
0.763941509131927 |
|
22299 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMOC2 |
0.763941509131927 |
|
22300 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THBS2 |
0.763941509131927 |
|
22301 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR27 |
0.763941509131927 |
|
22302 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf120 |
0.763941509131927 |
|
22303 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHF10 |
0.763941509131927 |
|
22304 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCTE3 |
0.763941509131927 |
|
22305 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf70 |
0.763941509131927 |
|
22306 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00242 |
0.763941509131927 |
|
22307 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00574 |
0.763941509131927 |
|
22308 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DLL1 |
0.763941509131927 |
|
22309 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM120B |
0.763941509131927 |
|
22310 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4644 |
0.763941509131927 |
|
22311 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMB1 |
0.763941509131927 |
|
22312 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBP |
0.763941509131927 |
|
22313 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDCD2 |
0.763941509131927 |
|
22314 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIRLET7A1 |
0.776204464956317 |
|
22315 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIRLET7DHG |
0.776204464956317 |
|
22316 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIRLET7F1 |
0.776204464956317 |
|
22317 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIRLET7D |
0.776204464956317 |
|
22318 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238792.1 |
0.776204464956317 |
|
22319 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF169 |
0.776204464956317 |
|
22320 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUTM2F |
0.776204464956317 |
|
22321 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIATL1 |
0.776204464956317 |
|
22322 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCAT7 |
0.776204464956317 |
|
22323 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBP2 |
0.776204464956317 |
|
22324 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBP1 |
0.776204464956317 |
|
22325 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf3 |
0.776204464956317 |
|
22326 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR2278 |
0.776204464956317 |
|
22327 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR23B |
0.776204464956317 |
|
22328 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR27B |
0.776204464956317 |
|
22329 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3074 |
0.776204464956317 |
|
22330 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FANCC |
0.776204464956317 |
|
22331 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP288 |
0.776204464956317 |
|
22332 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238746.1 |
0.776204464956317 |
|
22333 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTCH1 |
0.776204464956317 |
|
22334 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00476 |
0.776204464956317 |
|
22335 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DKFZP434H0512 |
0.776204464956317 |
|
22336 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERCC6L2 |
0.776204464956317 |
|
22337 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP289 |
0.776204464956317 |
|
22338 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00092 |
0.776204464956317 |
|
22339 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSD17B3 |
0.776204464956317 |
|
22340 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35D2 |
0.776204464956317 |
|
22341 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF367 |
0.776204464956317 |
|
22342 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HABP4 |
0.776204464956317 |
|
22343 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC14B |
0.776204464956317 |
|
22344 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AAED1 |
0.776204464956317 |
|
22345 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF510 |
0.776204464956317 |
|
22346 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF782 |
0.776204464956317 |
|
22347 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIATL2 |
0.776204464956317 |
|
22348 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUTM2G |
0.776204464956317 |
|
22349 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTSV |
0.776204464956317 |
|
22350 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC180 |
0.776204464956317 |
|
22351 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TDRD7 |
0.776204464956317 |
|
22352 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMOD1 |
0.776204464956317 |
|
22353 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSTD2 |
0.776204464956317 |
|
22354 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCBP1 |
0.776204464956317 |
|
22355 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XPA |
0.776204464956317 |
|
22356 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXE1 |
0.776204464956317 |
|
22357 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C9orf156 |
0.776204464956317 |
|
22358 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HEMGN |
0.776204464956317 |
|
22359 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANP32B |
0.776204464956317 |
|
22360 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NANS |
0.776204464956317 |
|
22361 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM14 |
0.776204464956317 |
|
22362 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CORO2A |
0.776204464956317 |
|
22363 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D2 |
0.776204464956317 |
|
22364 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABBR2 |
0.776204464956317 |
|
22365 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKS6 |
0.776204464956317 |
|
22366 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALNT12 |
0.776204464956317 |
|
22367 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL15A1 |
0.776204464956317 |
|
22368 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TGFBR1 |
0.776204464956317 |
|
22369 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP290 |
0.776204464956317 |
|
22370 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL794P |
0.776204464956317 |
|
22371 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALG2 |
0.776204464956317 |
|
22372 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC61B |
0.776204464956317 |
|
22373 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP225 |
0.776204464956317 |
|
22374 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NR4A3 |
0.776204464956317 |
|
22375 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STX17 |
0.776204464956317 |
|
22376 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERP44 |
0.776204464956317 |
|
22377 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
INVS |
0.776204464956317 |
|
22378 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL75P |
0.776204464956317 |
|
22379 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX10 |
0.776204464956317 |
|
22380 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSANTD3 |
0.776204464956317 |
|
22381 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEFF1 |
0.776204464956317 |
|
22382 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MURC |
0.776204464956317 |
|
22383 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP87 |
0.776204464956317 |
|
22384 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPPR1 |
0.776204464956317 |
|
22385 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000253041.1 |
0.776204464956317 |
|
22386 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAAT |
0.776204464956317 |
|
22387 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL50 |
0.776204464956317 |
|
22388 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF189 |
0.776204464956317 |
|
22389 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALDOB |
0.776204464956317 |
|
22390 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM246 |
0.776204464956317 |
|
22391 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF20 |
0.776204464956317 |
|
22392 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRIN3A |
0.776204464956317 |
|
22393 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP3R2 |
0.776204464956317 |
|
22394 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00587 |
0.776204464956317 |
|
22395 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYLC2 |
0.776204464956317 |
|
22396 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP291 |
0.776204464956317 |
|
22397 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMC2 |
0.776204464956317 |
|
22398 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR13F1 |
0.776204464956317 |
|
22399 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR13C4 |
0.776204464956317 |
|
22400 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR13C3 |
0.776204464956317 |
|
22401 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR13C8 |
0.776204464956317 |
|
22402 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR13C2 |
0.776204464956317 |
|
22403 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR13C5 |
0.776204464956317 |
|
22404 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR13C9 |
0.776204464956317 |
|
22405 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR13D1 |
0.776204464956317 |
|
22406 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NIPSNAP3A |
0.776204464956317 |
|
22407 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NIPSNAP3B |
0.776204464956317 |
|
22408 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCA1 |
0.776204464956317 |
|
22409 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP191 |
0.776204464956317 |
|
22410 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC44A1 |
0.776204464956317 |
|
22411 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FSD1L |
0.776204464956317 |
|
22412 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FKTN |
0.776204464956317 |
|
22413 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAL2 |
0.776204464956317 |
|
22414 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHODL |
0.778261670500396 |
|
22415 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMPRSS15 |
0.778261670500396 |
|
22416 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS21 |
0.779008651473159 |
|
22417 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CABLES2 |
0.779008651473159 |
|
22418 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBBP8NL |
0.779008651473159 |
|
22419 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GATA5 |
0.779008651473159 |
|
22420 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C20orf166 |
0.779008651473159 |
|
22421 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR133A2 |
0.779008651473159 |
|
22422 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLCO4A1 |
0.779008651473159 |
|
22423 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00686 |
0.779008651473159 |
|
22424 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NTSR1 |
0.779008651473159 |
|
22425 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00659 |
0.779008651473159 |
|
22426 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRGBP |
0.779008651473159 |
|
22427 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OGFR |
0.779008651473159 |
|
22428 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL9A3 |
0.779008651473159 |
|
22429 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCFL5 |
0.779008651473159 |
|
22430 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DIDO1 |
0.779008651473159 |
|
22431 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GID8 |
0.779008651473159 |
|
22432 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC17A9 |
0.779008651473159 |
|
22433 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BHLHE23 |
0.779008651473159 |
|
22434 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00029 |
0.779008651473159 |
|
22435 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAR1A |
0.779008651473159 |
|
22436 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAR1B |
0.779008651473159 |
|
22437 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YTHDF1 |
0.779008651473159 |
|
22438 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BIRC7 |
0.779008651473159 |
|
22439 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3196 |
0.779008651473159 |
|
22440 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NKAIN4 |
0.779008651473159 |
|
22441 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARFGAP1 |
0.779008651473159 |
|
22442 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4326 |
0.779008651473159 |
|
22443 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL20A1 |
0.779008651473159 |
|
22444 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRNA4 |
0.779008651473159 |
|
22445 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNQ2 |
0.779008651473159 |
|
22446 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EEF1A2 |
0.779008651473159 |
|
22447 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPDPF |
0.779008651473159 |
|
22448 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C20orf195 |
0.779008651473159 |
|
22449 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTK6 |
0.779008651473159 |
|
22450 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRMS |
0.779008651473159 |
|
22451 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HELZ2 |
0.779008651473159 |
|
22452 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GMEB2 |
0.779008651473159 |
|
22453 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABHD16B |
0.779008651473159 |
|
22454 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARFRP1 |
0.779008651473159 |
|
22455 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C20ORF135 |
0.779008651473159 |
|
22456 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C20orf201 |
0.779008651473159 |
|
22457 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAJC5 |
0.779008651473159 |
|
22458 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIME1 |
0.779008651473159 |
|
22459 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00176 |
0.779008651473159 |
|
22460 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1914 |
0.779008651473159 |
|
22461 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR647 |
0.779008651473159 |
|
22462 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYT1 |
0.779008651473159 |
|
22463 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPBWR2 |
0.779008651473159 |
|
22464 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OPRL1 |
0.779008651473159 |
|
22465 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCMTD2 |
0.779008651473159 |
|
22466 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRPF6 |
0.779008651473159 |
|
22467 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGS19 |
0.779008651473159 |
|
22468 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RTEL1 |
0.779008651473159 |
|
22469 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAMD10 |
0.779008651473159 |
|
22470 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC2A4RG |
0.779008651473159 |
|
22471 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOX18 |
0.779008651473159 |
|
22472 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STMN3 |
0.779008651473159 |
|
22473 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCEA2 |
0.779008651473159 |
|
22474 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFRSF6B |
0.779008651473159 |
|
22475 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPD52L2 |
0.779008651473159 |
|
22476 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UCKL1 |
0.779008651473159 |
|
22477 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB46 |
0.779008651473159 |
|
22478 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZGPAT |
0.779008651473159 |
|
22479 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF512B |
0.779008651473159 |
|
22480 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00511 |
0.781470279466567 |
|
22481 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAO1 |
0.785267677313245 |
|
22482 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMX4 |
0.785267677313245 |
|
22483 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLCB1 |
0.785267677313245 |
|
22484 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C20orf196 |
0.78930866528558 |
|
22485 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHGB |
0.78930866528558 |
|
22486 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRMT6 |
0.78930866528558 |
|
22487 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCM8 |
0.78930866528558 |
|
22488 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL498P |
0.78930866528558 |
|
22489 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRLS1 |
0.78930866528558 |
|
22490 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRN4 |
0.78930866528558 |
|
22491 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FERMT1 |
0.78930866528558 |
|
22492 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BMP2 |
0.78930866528558 |
|
22493 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoR26 |
0.78930866528558 |
|
22494 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL547P |
0.78930866528558 |
|
22495 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PFKP |
0.789887391749624 |
|
22496 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PITRM1 |
0.789887391749624 |
|
22497 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLF6 |
0.789887391749624 |
|
22498 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSMD3 |
0.793467995010423 |
|
22499 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP96 |
0.809533902894072 |
|
22500 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLIP |
0.815045302497265 |
|
22501 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TINAG |
0.815045302497265 |
|
22502 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM83B |
0.815045302497265 |
|
22503 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCRTR2 |
0.815045302497265 |
|
22504 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GFRAL |
0.815045302497265 |
|
22505 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMGCLL1 |
0.815045302497265 |
|
22506 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00261 |
0.818273993726276 |
|
22507 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXA2 |
0.818273993726276 |
|
22508 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSTR4 |
0.818273993726276 |
|
22509 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THBD |
0.818273993726276 |
|
22510 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD93 |
0.818273993726276 |
|
22511 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00656 |
0.818273993726276 |
|
22512 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP478 |
0.818273993726276 |
|
22513 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NXT1 |
0.818273993726276 |
|
22514 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GZF1 |
0.818273993726276 |
|
22515 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAPB |
0.818273993726276 |
|
22516 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP479 |
0.818273993726276 |
|
22517 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CST11 |
0.818273993726276 |
|
22518 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CST13P |
0.818273993726276 |
|
22519 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CST8 |
0.818273993726276 |
|
22520 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CST9L |
0.818273993726276 |
|
22521 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSTL1 |
0.818273993726276 |
|
22522 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CST9 |
0.818273993726276 |
|
22523 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CST3 |
0.818273993726276 |
|
22524 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CST4 |
0.818273993726276 |
|
22525 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CST1 |
0.818273993726276 |
|
22526 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CST2 |
0.818273993726276 |
|
22527 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CST5 |
0.818273993726276 |
|
22528 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GGTLC1 |
0.818273993726276 |
|
22529 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYNDIG1 |
0.818273993726276 |
|
22530 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CST7 |
0.818273993726276 |
|
22531 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APMAP |
0.818273993726276 |
|
22532 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACSS1 |
0.818273993726276 |
|
22533 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VSX1 |
0.818273993726276 |
|
22534 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENTPD6 |
0.818273993726276 |
|
22535 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABHD12 |
0.818273993726276 |
|
22536 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GINS1 |
0.818273993726276 |
|
22537 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NINL |
0.818273993726276 |
|
22538 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC17P |
0.818273993726276 |
|
22539 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NANP |
0.818273993726276 |
|
22540 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL594P |
0.818273993726276 |
|
22541 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF337 |
0.818273993726276 |
|
22542 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM182B |
0.818273993726276 |
|
22543 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM182A |
0.818273993726276 |
|
22544 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCOR1P1 |
0.818273993726276 |
|
22545 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AKAP17A|ENSG00000197976.6 |
0.818690332719252 |
|
22546 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARSD |
0.818690332719252 |
|
22547 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARSE |
0.818690332719252 |
|
22548 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARSF |
0.818690332719252 |
|
22549 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARSH |
0.818690332719252 |
|
22550 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASMTL|ENSG00000169093.10 |
0.818690332719252 |
|
22551 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ASMT|ENSG00000196433.6 |
0.818690332719252 |
|
22552 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD99P1|ENSG00000223773.2 |
0.818690332719252 |
|
22553 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD99|ENSG00000002586.13 |
0.818690332719252 |
|
22554 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRLF2|ENSG00000205755.6 |
0.818690332719252 |
|
22555 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSF2RA|ENSG00000198223.9 |
0.818690332719252 |
|
22556 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHRSX|ENSG00000169084.8 |
0.818690332719252 |
|
22557 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTPBP6|ENSG00000178605.8 |
0.818690332719252 |
|
22558 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GYG2 |
0.818690332719252 |
|
22559 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL3RA|ENSG00000185291.6 |
0.818690332719252 |
|
22560 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00102|ENSG00000230542.1 |
0.818690332719252 |
|
22561 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00106|ENSG00000236871.2 |
0.818690332719252 |
|
22562 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00685|ENSG00000226179.1 |
0.818690332719252 |
|
22563 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3690|ENSG00000265658.1 |
0.818690332719252 |
|
22564 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
P2RY8|ENSG00000182162.5 |
0.818690332719252 |
|
22565 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLCXD1|ENSG00000182378.8 |
0.818690332719252 |
|
22566 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP2R3B|ENSG00000167393.12 |
0.818690332719252 |
|
22567 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL355P|ENSG00000265350.1 |
0.818690332719252 |
|
22568 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL578P |
0.818690332719252 |
|
22569 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP498|ENSG00000223274.1 |
0.818690332719252 |
|
22570 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHOX|ENSG00000185960.8 |
0.818690332719252 |
|
22571 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A6|ENSG00000169100.8 |
0.818690332719252 |
|
22572 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
XG |
0.818690332719252 |
|
22573 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBED1|ENSG00000214717.4 |
0.818690332719252 |
|
22574 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000251848.1 |
0.818690332719252 |
|
22575 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FKBP1C |
0.819721780230833 |
|
22576 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LGSN |
0.819721780230833 |
|
22577 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTP4A1 |
0.819721780230833 |
|
22578 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHF3 |
0.819721780230833 |
|
22579 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP4R1 |
0.822834249846464 |
|
22580 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB31 |
0.822834249846464 |
|
22581 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL862P |
0.822834249846464 |
|
22582 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP449 |
0.822834249846464 |
|
22583 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TXNDC2 |
0.822834249846464 |
|
22584 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FANCE |
0.826759293516799 |
|
22585 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL10A |
0.826759293516799 |
|
22586 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEAD3 |
0.826759293516799 |
|
22587 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TULP1 |
0.826759293516799 |
|
22588 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3201 |
0.831554930094436 |
|
22589 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM19A5 |
0.831554930094436 |
|
22590 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4535 |
0.831554930094436 |
|
22591 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACR |
0.831554930094436 |
|
22592 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADM2 |
0.831554930094436 |
|
22593 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALG12 |
0.831554930094436 |
|
22594 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARSA |
0.831554930094436 |
|
22595 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRD1 |
0.831554930094436 |
|
22596 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C22orf34 |
0.831554930094436 |
|
22597 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHKB |
0.831554930094436 |
|
22598 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPT1B |
0.831554930094436 |
|
22599 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CRELD2 |
0.831554930094436 |
|
22600 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DENND6B |
0.831554930094436 |
|
22601 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HDAC10 |
0.831554930094436 |
|
22602 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL17REL |
0.831554930094436 |
|
22603 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHDC7B |
0.831554930094436 |
|
22604 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMF2 |
0.831554930094436 |
|
22605 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPK11 |
0.831554930094436 |
|
22606 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPK12 |
0.831554930094436 |
|
22607 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPK8IP2 |
0.831554930094436 |
|
22608 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIOX |
0.831554930094436 |
|
22609 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3667 |
0.831554930094436 |
|
22610 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLC1 |
0.831554930094436 |
|
22611 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOV10L1 |
0.831554930094436 |
|
22612 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCAPH2 |
0.831554930094436 |
|
22613 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ODF3B |
0.831554930094436 |
|
22614 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PANX2 |
0.831554930094436 |
|
22615 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIM3 |
0.831554930094436 |
|
22616 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLXNB2 |
0.831554930094436 |
|
22617 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP6R2 |
0.831554930094436 |
|
22618 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RABL2B |
0.831554930094436 |
|
22619 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP252 |
0.831554930094436 |
|
22620 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL500P |
0.831554930094436 |
|
22621 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SBF1 |
0.831554930094436 |
|
22622 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCO2 |
0.831554930094436 |
|
22623 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHANK3 |
0.831554930094436 |
|
22624 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYCE3 |
0.831554930094436 |
|
22625 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRABD |
0.831554930094436 |
|
22626 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTLL8 |
0.831554930094436 |
|
22627 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBGCP6 |
0.831554930094436 |
|
22628 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TYMP |
0.831554930094436 |
|
22629 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBED4 |
0.831554930094436 |
|
22630 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP24 |
0.834356310867116 |
|
22631 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC10A6 |
0.834356310867116 |
|
22632 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C4orf36 |
0.834356310867116 |
|
22633 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNCA |
0.837701239961933 |
|
22634 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMRN1 |
0.837701239961933 |
|
22635 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCSER1 |
0.837701239961933 |
|
22636 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL50P |
0.83862630805029 |
|
22637 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB12 |
0.83862630805029 |
|
22638 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOGA2 |
0.83862630805029 |
|
22639 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFV2 |
0.83862630805029 |
|
22640 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD12 |
0.83862630805029 |
|
22641 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239087.1 |
0.83862630805029 |
|
22642 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TWSG1 |
0.83862630805029 |
|
22643 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RALBP1 |
0.83862630805029 |
|
22644 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VAPA |
0.83862630805029 |
|
22645 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP450 |
0.83862630805029 |
|
22646 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MC2R |
0.83862630805029 |
|
22647 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF519 |
0.83862630805029 |
|
22648 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD20A5P |
0.83862630805029 |
|
22649 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP4F35P |
0.83862630805029 |
|
22650 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXADRP3 |
0.83862630805029 |
|
22651 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POTEC |
0.83862630805029 |
|
22652 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LARP1 |
0.841584536192486 |
|
22653 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR663A |
0.846352519850287 |
|
22654 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRG1B |
0.846352519850287 |
|
22655 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000252762.1 |
0.847277290966975 |
|
22656 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPD |
0.847277290966975 |
|
22657 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD42|ENSG00000202440.1 |
0.847277290966975 |
|
22658 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPDL |
0.847277290966975 |
|
22659 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ENOPH1 |
0.847277290966975 |
|
22660 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM150C |
0.847277290966975 |
|
22661 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00575 |
0.847277290966975 |
|
22662 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCD5 |
0.847277290966975 |
|
22663 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR575 |
0.847277290966975 |
|
22664 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEC31A |
0.847277290966975 |
|
22665 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THAP9 |
0.847277290966975 |
|
22666 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIN54 |
0.847277290966975 |
|
22667 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoR442|ENSG00000252834.1 |
0.847277290966975 |
|
22668 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COPS4 |
0.847277290966975 |
|
22669 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLAC8 |
0.847277290966975 |
|
22670 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COQ2 |
0.847277290966975 |
|
22671 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HPSE |
0.847277290966975 |
|
22672 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HELQ |
0.847277290966975 |
|
22673 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS18C |
0.847277290966975 |
|
22674 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM175A |
0.847277290966975 |
|
22675 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGPAT9 |
0.847277290966975 |
|
22676 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDS1 |
0.847277290966975 |
|
22677 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDFY3 |
0.847277290966975 |
|
22678 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL552P |
0.847277290966975 |
|
22679 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP48 |
0.847277290966975 |
|
22680 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4451 |
0.847277290966975 |
|
22681 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AFF1 |
0.847277290966975 |
|
22682 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL8 |
0.847277290966975 |
|
22683 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5705 |
0.847277290966975 |
|
22684 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSD17B13 |
0.847277290966975 |
|
22685 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSD17B11 |
0.847277290966975 |
|
22686 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL681P |
0.847277290966975 |
|
22687 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDT9 |
0.847277290966975 |
|
22688 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPARCL1 |
0.847277290966975 |
|
22689 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DSPP |
0.847277290966975 |
|
22690 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DMP1 |
0.847277290966975 |
|
22691 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238652.1 |
0.847277290966975 |
|
22692 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IBSP |
0.847277290966975 |
|
22693 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEPE |
0.847277290966975 |
|
22694 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPP1 |
0.847277290966975 |
|
22695 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKD2 |
0.847277290966975 |
|
22696 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCG2 |
0.847277290966975 |
|
22697 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC31P |
0.847277290966975 |
|
22698 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPM1K |
0.847277290966975 |
|
22699 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HERC6 |
0.847277290966975 |
|
22700 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HERC5 |
0.847277290966975 |
|
22701 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HERC3 |
0.847277290966975 |
|
22702 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIGY |
0.847277290966975 |
|
22703 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PYURF |
0.847277290966975 |
|
22704 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP244 |
0.847277290966975 |
|
22705 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAP1L5 |
0.847277290966975 |
|
22706 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM13A |
0.847277290966975 |
|
22707 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIGD2 |
0.847277290966975 |
|
22708 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPRIN3 |
0.847277290966975 |
|
22709 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C4orf26 |
0.849292160727792 |
|
22710 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C20orf96 |
0.85686517610422 |
|
22711 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB125 |
0.85686517610422 |
|
22712 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB126 |
0.85686517610422 |
|
22713 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB127 |
0.85686517610422 |
|
22714 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB128 |
0.85686517610422 |
|
22715 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB129 |
0.85686517610422 |
|
22716 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB132 |
0.85686517610422 |
|
22717 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRSN2 |
0.85686517610422 |
|
22718 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBCK1 |
0.85686517610422 |
|
22719 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOX12 |
0.85686517610422 |
|
22720 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D20 |
0.85686517610422 |
|
22721 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIB3 |
0.85686517610422 |
|
22722 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZCCHC3 |
0.85686517610422 |
|
22723 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSNK2A1 |
0.85686517610422 |
|
22724 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCF15 |
0.85686517610422 |
|
22725 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRXN1 |
0.85686517610422 |
|
22726 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCRT2 |
0.85686517610422 |
|
22727 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC52A3 |
0.85686517610422 |
|
22728 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM110A |
0.85686517610422 |
|
22729 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANGPT4 |
0.85686517610422 |
|
22730 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RSPO4 |
0.85686517610422 |
|
22731 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C20orf202 |
0.85686517610422 |
|
22732 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMF1 |
0.85686517610422 |
|
22733 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM74B |
0.85686517610422 |
|
22734 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAD21L1 |
0.85686517610422 |
|
22735 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNPH |
0.85686517610422 |
|
22736 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDCBP2 |
0.85686517610422 |
|
22737 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FKBP1A |
0.85686517610422 |
|
22738 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NSFL1C |
0.85686517610422 |
|
22739 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIRPB2 |
0.85686517610422 |
|
22740 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIRPD |
0.85686517610422 |
|
22741 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIRPB1 |
0.85686517610422 |
|
22742 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIRPG |
0.85686517610422 |
|
22743 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL561P |
0.85686517610422 |
|
22744 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIRPA |
0.85686517610422 |
|
22745 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDYN |
0.85686517610422 |
|
22746 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STK35 |
0.85686517610422 |
|
22747 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TGM3 |
0.85686517610422 |
|
22748 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TGM6 |
0.85686517610422 |
|
22749 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNRPB |
0.85686517610422 |
|
22750 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD119 |
0.85686517610422 |
|
22751 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF343 |
0.85686517610422 |
|
22752 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMC2 |
0.85686517610422 |
|
22753 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1292 |
0.85686517610422 |
|
22754 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOP56 |
0.85686517610422 |
|
22755 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA51|ENSG00000271798.1 |
0.85686517610422 |
|
22756 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD110 |
0.85686517610422 |
|
22757 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD86 |
0.85686517610422 |
|
22758 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD56|ENSG00000229686.1 |
0.85686517610422 |
|
22759 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD57 |
0.85686517610422 |
|
22760 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IDH3B |
0.85686517610422 |
|
22761 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EBF4 |
0.85686517610422 |
|
22762 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPXM1 |
0.85686517610422 |
|
22763 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C20orf141 |
0.85686517610422 |
|
22764 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM239 |
0.85686517610422 |
|
22765 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCED1A |
0.85686517610422 |
|
22766 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS16 |
0.85686517610422 |
|
22767 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPRA |
0.85686517610422 |
|
22768 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNRH2 |
0.85686517610422 |
|
22769 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS26 |
0.85686517610422 |
|
22770 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OXT |
0.85686517610422 |
|
22771 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AVP |
0.85686517610422 |
|
22772 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL555P |
0.85686517610422 |
|
22773 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBOX5 |
0.85686517610422 |
|
22774 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FASTKD5 |
0.85686517610422 |
|
22775 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LZTS3 |
0.85686517610422 |
|
22776 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDRGK1 |
0.85686517610422 |
|
22777 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITPA |
0.85686517610422 |
|
22778 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC4A11 |
0.85686517610422 |
|
22779 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C20orf194 |
0.85686517610422 |
|
22780 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL839P |
0.85686517610422 |
|
22781 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000201346.1 |
0.85686517610422 |
|
22782 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATRN |
0.85686517610422 |
|
22783 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSNK1A1 |
0.861252196905857 |
|
22784 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF37 |
0.861252196905857 |
|
22785 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000221043.1 |
0.861252196905857 |
|
22786 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL868P |
0.861252196905857 |
|
22787 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR378A |
0.861252196905857 |
|
22788 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPARGC1B |
0.861252196905857 |
|
22789 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDE6A |
0.861252196905857 |
|
22790 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC26A2 |
0.861252196905857 |
|
22791 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIGD6 |
0.861252196905857 |
|
22792 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMGXB3 |
0.861252196905857 |
|
22793 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238369.1 |
0.861252196905857 |
|
22794 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSF1R |
0.861252196905857 |
|
22795 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDGFRB |
0.861252196905857 |
|
22796 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDX1 |
0.861252196905857 |
|
22797 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC6A7 |
0.861252196905857 |
|
22798 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CAMK2A |
0.861252196905857 |
|
22799 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARSI |
0.861252196905857 |
|
22800 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCOF1 |
0.861252196905857 |
|
22801 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD74 |
0.861252196905857 |
|
22802 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS14 |
0.861252196905857 |
|
22803 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDST1 |
0.861252196905857 |
|
22804 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239191.1 |
0.861252196905857 |
|
22805 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYNPO |
0.861252196905857 |
|
22806 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYOZ3 |
0.861252196905857 |
|
22807 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM22 |
0.861252196905857 |
|
22808 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCTN4 |
0.861252196905857 |
|
22809 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMIM3 |
0.861252196905857 |
|
22810 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRGM |
0.861252196905857 |
|
22811 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF300 |
0.861252196905857 |
|
22812 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF300P1 |
0.861252196905857 |
|
22813 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPX3 |
0.861252196905857 |
|
22814 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNIP1 |
0.861252196905857 |
|
22815 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANXA6 |
0.861252196905857 |
|
22816 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC69 |
0.861252196905857 |
|
22817 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GM2A |
0.861252196905857 |
|
22818 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC36A3 |
0.861252196905857 |
|
22819 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC36A2 |
0.861252196905857 |
|
22820 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC36A1 |
0.861252196905857 |
|
22821 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP197 |
0.861252196905857 |
|
22822 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAT2 |
0.861252196905857 |
|
22823 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPARC |
0.861252196905857 |
|
22824 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP232 |
0.861252196905857 |
|
22825 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATOX1 |
0.861252196905857 |
|
22826 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
G3BP1 |
0.861252196905857 |
|
22827 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLRA1 |
0.861252196905857 |
|
22828 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP198 |
0.861252196905857 |
|
22829 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NMUR2 |
0.861252196905857 |
|
22830 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRIA1 |
0.861252196905857 |
|
22831 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL177P |
0.861252196905857 |
|
22832 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM114A2 |
0.861252196905857 |
|
22833 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFAP3 |
0.861252196905857 |
|
22834 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALNT10 |
0.861252196905857 |
|
22835 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1294 |
0.861252196905857 |
|
22836 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL655P |
0.861252196905857 |
|
22837 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAP30L |
0.861252196905857 |
|
22838 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAND1 |
0.861252196905857 |
|
22839 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3141 |
0.861252196905857 |
|
22840 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1303 |
0.861252196905857 |
|
22841 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL439P |
0.861252196905857 |
|
22842 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAXDC2 |
0.861252196905857 |
|
22843 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR378H |
0.861252196905857 |
|
22844 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNOT8 |
0.861252196905857 |
|
22845 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GEMIN5 |
0.861252196905857 |
|
22846 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL22 |
0.861252196905857 |
|
22847 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF4B |
0.861252196905857 |
|
22848 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP199 |
0.861252196905857 |
|
22849 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGCD |
0.861252196905857 |
|
22850 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIMD4 |
0.861252196905857 |
|
22851 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAVCR1 |
0.861252196905857 |
|
22852 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HAVCR2 |
0.861252196905857 |
|
22853 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED7 |
0.861252196905857 |
|
22854 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITK |
0.861252196905857 |
|
22855 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM71B |
0.861252196905857 |
|
22856 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYFIP2 |
0.861252196905857 |
|
22857 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FNDC9 |
0.861252196905857 |
|
22858 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM19 |
0.861252196905857 |
|
22859 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NIPAL4 |
0.861252196905857 |
|
22860 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOX30 |
0.861252196905857 |
|
22861 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf52 |
0.861252196905857 |
|
22862 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THG1L |
0.861252196905857 |
|
22863 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LSM11 |
0.861252196905857 |
|
22864 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLINT1 |
0.861252196905857 |
|
22865 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EBF1 |
0.861252196905857 |
|
22866 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF145 |
0.861252196905857 |
|
22867 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA68|ENSG00000252458.1 |
0.861252196905857 |
|
22868 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBLCP1 |
0.861252196905857 |
|
22869 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL12B |
0.861252196905857 |
|
22870 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU4ATAC2P |
0.861252196905857 |
|
22871 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADRA1B |
0.861252196905857 |
|
22872 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC1 |
0.861252196905857 |
|
22873 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PWWP2A |
0.861252196905857 |
|
22874 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FABP6 |
0.861252196905857 |
|
22875 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNJL |
0.861252196905857 |
|
22876 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL295P |
0.861252196905857 |
|
22877 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1QTNF2 |
0.861252196905857 |
|
22878 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf54 |
0.861252196905857 |
|
22879 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLU7 |
0.861252196905857 |
|
22880 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTTG1 |
0.861252196905857 |
|
22881 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR146A |
0.861252196905857 |
|
22882 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3142 |
0.861252196905857 |
|
22883 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP10B |
0.861252196905857 |
|
22884 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABRB2 |
0.861252196905857 |
|
22885 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABRA6 |
0.861252196905857 |
|
22886 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABRA1 |
0.861252196905857 |
|
22887 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABRG2 |
0.861252196905857 |
|
22888 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNG1 |
0.861252196905857 |
|
22889 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDCD2 |
0.861252196905857 |
|
22890 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMMR |
0.861252196905857 |
|
22891 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAT2B |
0.861252196905857 |
|
22892 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP60 |
0.861252196905857 |
|
22893 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TENM2 |
0.861252196905857 |
|
22894 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA40|ENSG00000253065.1 |
0.861252196905857 |
|
22895 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WWC1 |
0.861252196905857 |
|
22896 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RARS |
0.861252196905857 |
|
22897 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBLL1 |
0.861252196905857 |
|
22898 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PANK3 |
0.861252196905857 |
|
22899 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR103A1 |
0.861252196905857 |
|
22900 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLIT3 |
0.861252196905857 |
|
22901 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR585 |
0.861252196905857 |
|
22902 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPDL1 |
0.861252196905857 |
|
22903 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOCK2 |
0.861252196905857 |
|
22904 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM196B |
0.861252196905857 |
|
22905 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR378E |
0.861252196905857 |
|
22906 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXI1 |
0.861252196905857 |
|
22907 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf58 |
0.861252196905857 |
|
22908 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LCP2 |
0.861252196905857 |
|
22909 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNIP1 |
0.861252196905857 |
|
22910 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNMB1 |
0.861252196905857 |
|
22911 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4454 |
0.861252196905857 |
|
22912 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABRP |
0.861252196905857 |
|
22913 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RANBP17 |
0.861252196905857 |
|
22914 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL623P |
0.861252196905857 |
|
22915 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000252387.1 |
0.861252196905857 |
|
22916 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLX3 |
0.861252196905857 |
|
22917 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL339P |
0.861252196905857 |
|
22918 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000206909.1 |
0.861252196905857 |
|
22919 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3912 |
0.861252196905857 |
|
22920 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPM1 |
0.861252196905857 |
|
22921 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGF18 |
0.861252196905857 |
|
22922 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf50 |
0.861252196905857 |
|
22923 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXW11 |
0.861252196905857 |
|
22924 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFCAB9 |
0.861252196905857 |
|
22925 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STK10 |
0.861252196905857 |
|
22926 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBTD2 |
0.861252196905857 |
|
22927 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA57|ENSG00000212529.1 |
0.861252196905857 |
|
22928 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SH3PXD2B |
0.861252196905857 |
|
22929 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEURL1B |
0.861252196905857 |
|
22930 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5003 |
0.861252196905857 |
|
22931 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DUSP1 |
0.861252196905857 |
|
22932 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ERGIC1 |
0.861252196905857 |
|
22933 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL26L1 |
0.861252196905857 |
|
22934 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6V0E1 |
0.861252196905857 |
|
22935 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA74B |
0.861252196905857 |
|
22936 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CREBRF |
0.861252196905857 |
|
22937 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BNIP1 |
0.861252196905857 |
|
22938 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP200 |
0.861252196905857 |
|
22939 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STC2 |
0.861252196905857 |
|
22940 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BOD1 |
0.861252196905857 |
|
22941 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPEB4 |
0.861252196905857 |
|
22942 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf47 |
0.861252196905857 |
|
22943 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NSG2 |
0.861252196905857 |
|
22944 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4634 |
0.861252196905857 |
|
22945 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSX2 |
0.861252196905857 |
|
22946 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DRD1 |
0.861252196905857 |
|
22947 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239026.1 |
0.861252196905857 |
|
22948 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFXN1 |
0.861252196905857 |
|
22949 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP148 |
0.861252196905857 |
|
22950 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HRH2 |
0.861252196905857 |
|
22951 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPLX2 |
0.861252196905857 |
|
22952 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THOC3 |
0.861252196905857 |
|
22953 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM153B |
0.861252196905857 |
|
22954 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIMC1 |
0.861252196905857 |
|
22955 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1191 |
0.861252196905857 |
|
22956 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL10 |
0.861252196905857 |
|
22957 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1271 |
0.861252196905857 |
|
22958 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOP16 |
0.861252196905857 |
|
22959 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIGD2A |
0.861252196905857 |
|
22960 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLTB |
0.861252196905857 |
|
22961 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAF2 |
0.861252196905857 |
|
22962 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF44 |
0.861252196905857 |
|
22963 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDHR2 |
0.861252196905857 |
|
22964 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL684P |
0.861252196905857 |
|
22965 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPRIN1 |
0.861252196905857 |
|
22966 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNCB |
0.861252196905857 |
|
22967 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EIF4E1B |
0.861252196905857 |
|
22968 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HK3 |
0.861252196905857 |
|
22969 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4281 |
0.861252196905857 |
|
22970 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSPAN17 |
0.861252196905857 |
|
22971 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UNC5A |
0.861252196905857 |
|
22972 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UIMC1 |
0.861252196905857 |
|
22973 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF346 |
0.861252196905857 |
|
22974 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGFR4 |
0.861252196905857 |
|
22975 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NSD1 |
0.861252196905857 |
|
22976 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MXD3 |
0.861252196905857 |
|
22977 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB24 |
0.861252196905857 |
|
22978 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRELID1 |
0.861252196905857 |
|
22979 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMAN2 |
0.861252196905857 |
|
22980 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL562P |
0.861252196905857 |
|
22981 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGS14 |
0.861252196905857 |
|
22982 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC34A1 |
0.861252196905857 |
|
22983 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
F12 |
0.861252196905857 |
|
22984 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRK6 |
0.861252196905857 |
|
22985 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PFN3 |
0.861252196905857 |
|
22986 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR7 |
0.861252196905857 |
|
22987 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DBN1 |
0.861252196905857 |
|
22988 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDLIM7 |
0.861252196905857 |
|
22989 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOK3 |
0.861252196905857 |
|
22990 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX41 |
0.861252196905857 |
|
22991 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM193B |
0.861252196905857 |
|
22992 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMED9 |
0.861252196905857 |
|
22993 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B4GALT7 |
0.861252196905857 |
|
22994 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM153A |
0.861252196905857 |
|
22995 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PROP1 |
0.861252196905857 |
|
22996 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM153C |
0.861252196905857 |
|
22997 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
N4BP3 |
0.861252196905857 |
|
22998 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RMND5B |
0.861252196905857 |
|
22999 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NHP2 |
0.861252196905857 |
|
23000 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNRNPAB |
0.861252196905857 |
|
23001 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHYKPL |
0.861252196905857 |
|
23002 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL23A1 |
0.861252196905857 |
|
23003 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL646P |
0.861252196905857 |
|
23004 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM135B |
0.861482383089335 |
|
23005 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL22A1 |
0.861482383089335 |
|
23006 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA25|ENSG00000251744.1 |
0.861482383089335 |
|
23007 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNK9 |
0.861482383089335 |
|
23008 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAPPC9 |
0.861482383089335 |
|
23009 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C8orf17 |
0.861482383089335 |
|
23010 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASC7 |
0.861482383089335 |
|
23011 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRAC1 |
0.861482383089335 |
|
23012 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGO2 |
0.861482383089335 |
|
23013 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DENND3 |
0.861482383089335 |
|
23014 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC45A4 |
0.861482383089335 |
|
23015 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR20 |
0.861482383089335 |
|
23016 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00051 |
0.861482383089335 |
|
23017 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MROH5 |
0.861482383089335 |
|
23018 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTP4A3 |
0.861482383089335 |
|
23019 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD5|ENSG00000238854.1 |
0.861482383089335 |
|
23020 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSNARE1 |
0.861482383089335 |
|
23021 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAI1 |
0.861482383089335 |
|
23022 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARC |
0.861482383089335 |
|
23023 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JRK |
0.861482383089335 |
|
23024 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSCA |
0.861482383089335 |
|
23025 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LY6K |
0.861482383089335 |
|
23026 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THEM6 |
0.861482383089335 |
|
23027 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLURP1 |
0.861482383089335 |
|
23028 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYPD2 |
0.861482383089335 |
|
23029 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LY6D |
0.861482383089335 |
|
23030 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYNX1 |
0.861482383089335 |
|
23031 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GML |
0.861482383089335 |
|
23032 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP11B1 |
0.861482383089335 |
|
23033 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP11B2 |
0.861482383089335 |
|
23034 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LY6E |
0.861482383089335 |
|
23035 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C8orf31 |
0.861482383089335 |
|
23036 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LY6H |
0.861482383089335 |
|
23037 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPIHBP1 |
0.861482383089335 |
|
23038 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFP41 |
0.861482383089335 |
|
23039 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLI4 |
0.861482383089335 |
|
23040 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF696 |
0.861482383089335 |
|
23041 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOP1MT |
0.861482383089335 |
|
23042 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHPN1 |
0.861482383089335 |
|
23043 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAFA |
0.861482383089335 |
|
23044 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZC3H3 |
0.861482383089335 |
|
23045 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
7SK|ENSG00000254144.2 |
0.861482383089335 |
|
23046 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GSDMD |
0.861482383089335 |
|
23047 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MROH6 |
0.861482383089335 |
|
23048 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EEF1D |
0.861482383089335 |
|
23049 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAPRT1 |
0.861482383089335 |
|
23050 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIGD5 |
0.861482383089335 |
|
23051 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PYCRL |
0.861482383089335 |
|
23052 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSTA3 |
0.861482383089335 |
|
23053 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF623 |
0.861482383089335 |
|
23054 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC166 |
0.861482383089335 |
|
23055 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM83H |
0.861482383089335 |
|
23056 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPK15 |
0.861482383089335 |
|
23057 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4664 |
0.861482383089335 |
|
23058 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF707 |
0.861482383089335 |
|
23059 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCRIB |
0.861482383089335 |
|
23060 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR937 |
0.861482383089335 |
|
23061 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PUF60 |
0.861482383089335 |
|
23062 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRBP2 |
0.861482383089335 |
|
23063 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPPK1 |
0.861482383089335 |
|
23064 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEC |
0.861482383089335 |
|
23065 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR661 |
0.861482383089335 |
|
23066 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARP10 |
0.861482383089335 |
|
23067 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRINA |
0.861482383089335 |
|
23068 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATC1 |
0.861482383089335 |
|
23069 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OPLAH |
0.861482383089335 |
|
23070 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXOSC4 |
0.861482383089335 |
|
23071 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPAA1 |
0.861482383089335 |
|
23072 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYC1 |
0.861482383089335 |
|
23073 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHARPIN |
0.861482383089335 |
|
23074 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1875 |
0.861482383089335 |
|
23075 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAF1 |
0.861482383089335 |
|
23076 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM203A |
0.861482383089335 |
|
23077 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MROH1 |
0.861482383089335 |
|
23078 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADCK5 |
0.861482383089335 |
|
23079 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP39 |
0.861482383089335 |
|
23080 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BOP1 |
0.861482383089335 |
|
23081 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C8orf33 |
0.861482383089335 |
|
23082 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C8orf82 |
0.861482383089335 |
|
23083 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COMMD5 |
0.861482383089335 |
|
23084 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPSF1 |
0.861482383089335 |
|
23085 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYHR1 |
0.861482383089335 |
|
23086 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DGAT1 |
0.861482383089335 |
|
23087 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM203B |
0.861482383089335 |
|
23088 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXL6 |
0.861482383089335 |
|
23089 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXH1 |
0.861482383089335 |
|
23090 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPT |
0.861482383089335 |
|
23091 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSF1 |
0.861482383089335 |
|
23092 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIFC2 |
0.861482383089335 |
|
23093 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC14 |
0.861482383089335 |
|
23094 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC24 |
0.861482383089335 |
|
23095 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFSD3 |
0.861482383089335 |
|
23096 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1234 |
0.861482383089335 |
|
23097 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR939 |
0.861482383089335 |
|
23098 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R16A |
0.861482383089335 |
|
23099 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RECQL4 |
0.861482383089335 |
|
23100 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL395P |
0.861482383089335 |
|
23101 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL8 |
0.861482383089335 |
|
23102 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCRT1 |
0.861482383089335 |
|
23103 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCXA |
0.861482383089335 |
|
23104 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCXB |
0.861482383089335 |
|
23105 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC39A4 |
0.861482383089335 |
|
23106 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC52A2 |
0.861482383089335 |
|
23107 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM249 |
0.861482383089335 |
|
23108 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TONSL |
0.861482383089335 |
|
23109 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS28 |
0.861482383089335 |
|
23110 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF16 |
0.861482383089335 |
|
23111 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF250 |
0.861482383089335 |
|
23112 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF251 |
0.861482383089335 |
|
23113 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF252P |
0.861482383089335 |
|
23114 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF34 |
0.861482383089335 |
|
23115 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF517 |
0.861482383089335 |
|
23116 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF7 |
0.861482383089335 |
|
23117 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEFB115 |
0.862811638771771 |
|
23118 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD27 |
0.863840282842848 |
|
23119 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GFRA4 |
0.868173590043636 |
|
23120 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM33 |
0.868173590043636 |
|
23121 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIGLEC1 |
0.868173590043636 |
|
23122 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPA12B |
0.868173590043636 |
|
23123 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C20orf27 |
0.868173590043636 |
|
23124 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPEF1 |
0.868173590043636 |
|
23125 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC25B |
0.868173590043636 |
|
23126 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CENPB |
0.868173590043636 |
|
23127 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP5S1 |
0.868173590043636 |
|
23128 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAVS |
0.868173590043636 |
|
23129 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR103A2 |
0.868173590043636 |
|
23130 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PANK2 |
0.868173590043636 |
|
23131 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF24 |
0.868173590043636 |
|
23132 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMOX |
0.868173590043636 |
|
23133 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARL13B |
0.870284452179044 |
|
23134 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STX19 |
0.870284452179044 |
|
23135 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABHD17A |
0.871950184566268 |
|
23136 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAT3 |
0.871950184566268 |
|
23137 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCAMP4 |
0.871950184566268 |
|
23138 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSNK1G2 |
0.871950184566268 |
|
23139 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTBD2 |
0.871950184566268 |
|
23140 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MKNK2 |
0.871950184566268 |
|
23141 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOB3A |
0.871950184566268 |
|
23142 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP3D1 |
0.871950184566268 |
|
23143 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IZUMO4 |
0.871950184566268 |
|
23144 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOT1L |
0.871950184566268 |
|
23145 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1227 |
0.871950184566268 |
|
23146 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHJ1 |
0.871950184566268 |
|
23147 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SF3A2 |
0.871950184566268 |
|
23148 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMH |
0.871950184566268 |
|
23149 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JSRP1 |
0.871950184566268 |
|
23150 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4321 |
0.871950184566268 |
|
23151 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf35 |
0.871950184566268 |
|
23152 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OAZ1 |
0.871950184566268 |
|
23153 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINGO3 |
0.871950184566268 |
|
23154 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LSM7 |
0.871950184566268 |
|
23155 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPPL2B |
0.871950184566268 |
|
23156 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMPRSS9 |
0.871950184566268 |
|
23157 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMNB2 |
0.871950184566268 |
|
23158 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TIMM13 |
0.871950184566268 |
|
23159 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GADD45B |
0.871950184566268 |
|
23160 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNG7 |
0.871950184566268 |
|
23161 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DIRAS1 |
0.871950184566268 |
|
23162 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC39A3 |
0.871950184566268 |
|
23163 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGTA |
0.871950184566268 |
|
23164 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THOP1 |
0.871950184566268 |
|
23165 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF554 |
0.871950184566268 |
|
23166 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF555 |
0.871950184566268 |
|
23167 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF556 |
0.871950184566268 |
|
23168 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF57 |
0.871950184566268 |
|
23169 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF77 |
0.871950184566268 |
|
23170 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLE6 |
0.871950184566268 |
|
23171 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLE2 |
0.871950184566268 |
|
23172 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AES |
0.871950184566268 |
|
23173 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNA11 |
0.871950184566268 |
|
23174 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNA15 |
0.871950184566268 |
|
23175 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
S1PR4 |
0.871950184566268 |
|
23176 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCLN |
0.871950184566268 |
|
23177 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CELF5 |
0.871950184566268 |
|
23178 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFIC |
0.871950184566268 |
|
23179 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF83 |
0.874136019786077 |
|
23180 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOX4 |
0.874453643874424 |
|
23181 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00340 |
0.874453643874424 |
|
23182 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP240 |
0.874453643874424 |
|
23183 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRL |
0.874453643874424 |
|
23184 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HDGFL1 |
0.874453643874424 |
|
23185 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRSN1 |
0.874453643874424 |
|
23186 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD46|ENSG00000251830.1 |
0.874453643874424 |
|
23187 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCDC2 |
0.874453643874424 |
|
23188 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KAAG1 |
0.874453643874424 |
|
23189 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRS2 |
0.874453643874424 |
|
23190 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPLD1 |
0.874453643874424 |
|
23191 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALDH5A1 |
0.874453643874424 |
|
23192 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0319 |
0.874453643874424 |
|
23193 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TDP2 |
0.874453643874424 |
|
23194 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACOT13 |
0.874453643874424 |
|
23195 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf62 |
0.874453643874424 |
|
23196 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GMNN |
0.874453643874424 |
|
23197 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM65B |
0.874453643874424 |
|
23198 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL334P |
0.874453643874424 |
|
23199 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CMAHP |
0.874453643874424 |
|
23200 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY5P5 |
0.874453643874424 |
|
23201 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC16A |
0.874453643874424 |
|
23202 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238322.1 |
0.874453643874424 |
|
23203 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2AA |
0.874453643874424 |
|
23204 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2BA |
0.874453643874424 |
|
23205 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCGN |
0.874453643874424 |
|
23206 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC17A4 |
0.874453643874424 |
|
23207 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC17A1 |
0.874453643874424 |
|
23208 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC17A3 |
0.874453643874424 |
|
23209 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC17A2 |
0.874453643874424 |
|
23210 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM38 |
0.874453643874424 |
|
23211 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H1A |
0.874453643874424 |
|
23212 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H3A |
0.874453643874424 |
|
23213 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H4A |
0.874453643874424 |
|
23214 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H4B |
0.874453643874424 |
|
23215 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2AB |
0.874453643874424 |
|
23216 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H3B |
0.874453643874424 |
|
23217 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H1C |
0.874453643874424 |
|
23218 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2BB |
0.874453643874424 |
|
23219 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H3C |
0.874453643874424 |
|
23220 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HFE |
0.874453643874424 |
|
23221 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H4C |
0.874453643874424 |
|
23222 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H1T |
0.874453643874424 |
|
23223 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2BC |
0.874453643874424 |
|
23224 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2AC |
0.874453643874424 |
|
23225 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H1E |
0.874453643874424 |
|
23226 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2BD |
0.874453643874424 |
|
23227 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2BE |
0.874453643874424 |
|
23228 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H4D |
0.874453643874424 |
|
23229 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H3D |
0.874453643874424 |
|
23230 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2AD |
0.874453643874424 |
|
23231 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2BF |
0.874453643874424 |
|
23232 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H4E |
0.874453643874424 |
|
23233 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2BG |
0.874453643874424 |
|
23234 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2AE |
0.874453643874424 |
|
23235 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H3E |
0.874453643874424 |
|
23236 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H1D |
0.874453643874424 |
|
23237 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H4F |
0.874453643874424 |
|
23238 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H4G |
0.874453643874424 |
|
23239 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H3F |
0.874453643874424 |
|
23240 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2BH |
0.874453643874424 |
|
23241 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2BI |
0.874453643874424 |
|
23242 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H3G |
0.874453643874424 |
|
23243 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H4H |
0.874453643874424 |
|
23244 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTN3A2 |
0.874453643874424 |
|
23245 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTN2A2 |
0.874453643874424 |
|
23246 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTN3A1 |
0.874453643874424 |
|
23247 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTN2A1 |
0.874453643874424 |
|
23248 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTN2A3P |
0.874453643874424 |
|
23249 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTN3A3 |
0.874453643874424 |
|
23250 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTN1A1 |
0.874453643874424 |
|
23251 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCG11 |
0.874453643874424 |
|
23252 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMGN4 |
0.874453643874424 |
|
23253 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABT1 |
0.874453643874424 |
|
23254 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF322 |
0.874453643874424 |
|
23255 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GUSBP2 |
0.874453643874424 |
|
23256 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00240 |
0.874453643874424 |
|
23257 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRNAI2 |
0.874453643874424 |
|
23258 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2BJ |
0.874453643874424 |
|
23259 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2AG |
0.874453643874424 |
|
23260 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2BK |
0.874453643874424 |
|
23261 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H4I |
0.874453643874424 |
|
23262 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2AH |
0.874453643874424 |
|
23263 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3143 |
0.874453643874424 |
|
23264 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS16 |
0.874453643874424 |
|
23265 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POM121L2 |
0.874453643874424 |
|
23266 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF391 |
0.874453643874424 |
|
23267 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF184 |
0.874453643874424 |
|
23268 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRNAI6 |
0.874453643874424 |
|
23269 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2AI |
0.874453643874424 |
|
23270 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2AJ |
0.874453643874424 |
|
23271 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2BL |
0.874453643874424 |
|
23272 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2BM |
0.874453643874424 |
|
23273 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H3H |
0.874453643874424 |
|
23274 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H4J |
0.874453643874424 |
|
23275 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H4K |
0.874453643874424 |
|
23276 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2AK |
0.874453643874424 |
|
23277 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2BN |
0.874453643874424 |
|
23278 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2AL |
0.874453643874424 |
|
23279 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H1B |
0.874453643874424 |
|
23280 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H3I |
0.874453643874424 |
|
23281 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H4L |
0.874453643874424 |
|
23282 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H3J |
0.874453643874424 |
|
23283 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2AM |
0.874453643874424 |
|
23284 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HIST1H2BO |
0.874453643874424 |
|
23285 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2B2 |
0.874453643874424 |
|
23286 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2B6 |
0.874453643874424 |
|
23287 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000199851.1 |
0.874453643874424 |
|
23288 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF165 |
0.874453643874424 |
|
23289 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSCAN12P1 |
0.874453643874424 |
|
23290 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSCAN16 |
0.874453643874424 |
|
23291 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZKSCAN8 |
0.874453643874424 |
|
23292 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF192P1 |
0.874453643874424 |
|
23293 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSCAN9 |
0.874453643874424 |
|
23294 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZKSCAN4 |
0.874453643874424 |
|
23295 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NKAPL |
0.874453643874424 |
|
23296 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGBD1 |
0.874453643874424 |
|
23297 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSCAN31 |
0.874453643874424 |
|
23298 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZKSCAN3 |
0.874453643874424 |
|
23299 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSCAN12 |
0.874453643874424 |
|
23300 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSCAN23 |
0.874453643874424 |
|
23301 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPX6 |
0.874453643874424 |
|
23302 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPX5 |
0.874453643874424 |
|
23303 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCAND3 |
0.874453643874424 |
|
23304 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00533 |
0.874453643874424 |
|
23305 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCG14 |
0.874453643874424 |
|
23306 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM27 |
0.874453643874424 |
|
23307 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf100 |
0.874453643874424 |
|
23308 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL471P |
0.874453643874424 |
|
23309 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCG15 |
0.874453643874424 |
|
23310 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCG16 |
0.874453643874424 |
|
23311 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF311 |
0.874453643874424 |
|
23312 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2W1 |
0.874453643874424 |
|
23313 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2B3 |
0.874453643874424 |
|
23314 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2J1 |
0.874453643874424 |
|
23315 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2J2 |
0.874453643874424 |
|
23316 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2J3 |
0.874453643874424 |
|
23317 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR14J1 |
0.874453643874424 |
|
23318 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR5V1 |
0.874453643874424 |
|
23319 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR12D3 |
0.874453643874424 |
|
23320 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR12D2 |
0.874453643874424 |
|
23321 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR12D1P |
0.874453643874424 |
|
23322 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR11A1 |
0.874453643874424 |
|
23323 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10C1 |
0.874453643874424 |
|
23324 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2H1 |
0.874453643874424 |
|
23325 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAS1L |
0.874453643874424 |
|
23326 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABBR1 |
0.874453643874424 |
|
23327 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBD |
0.874453643874424 |
|
23328 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR2H2 |
0.874453643874424 |
|
23329 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD32B |
0.874453643874424 |
|
23330 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOG |
0.874453643874424 |
|
23331 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFP57 |
0.874453643874424 |
|
23332 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCG9 |
0.874453643874424 |
|
23333 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNRD1 |
0.874453643874424 |
|
23334 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R11 |
0.874453643874424 |
|
23335 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF39 |
0.874453643874424 |
|
23336 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM31 |
0.874453643874424 |
|
23337 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA48|ENSG00000252228.1 |
0.874453643874424 |
|
23338 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM40 |
0.874453643874424 |
|
23339 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM10 |
0.874453643874424 |
|
23340 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM15 |
0.874453643874424 |
|
23341 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM26 |
0.874453643874424 |
|
23342 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCG17 |
0.874453643874424 |
|
23343 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCG18 |
0.874453643874424 |
|
23344 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPP21 |
0.874453643874424 |
|
23345 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM39 |
0.874453643874424 |
|
23346 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNL1 |
0.874453643874424 |
|
23347 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRR3 |
0.874453643874424 |
|
23348 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCF1 |
0.874453643874424 |
|
23349 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR877 |
0.874453643874424 |
|
23350 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R10 |
0.874453643874424 |
|
23351 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS18B |
0.874453643874424 |
|
23352 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATAT1 |
0.874453643874424 |
|
23353 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf136 |
0.874453643874424 |
|
23354 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHX16 |
0.874453643874424 |
|
23355 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRM |
0.874453643874424 |
|
23356 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R18 |
0.874453643874424 |
|
23357 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MDC1 |
0.874453643874424 |
|
23358 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBB |
0.874453643874424 |
|
23359 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FLOT1 |
0.874453643874424 |
|
23360 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IER3 |
0.874453643874424 |
|
23361 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL353P |
0.874453643874424 |
|
23362 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCG20 |
0.874453643874424 |
|
23363 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00243 |
0.874453643874424 |
|
23364 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDR1 |
0.874453643874424 |
|
23365 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP186 |
0.874453643874424 |
|
23366 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4640 |
0.874453643874424 |
|
23367 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF2H4 |
0.874453643874424 |
|
23368 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL175P |
0.874453643874424 |
|
23369 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VARS2 |
0.874453643874424 |
|
23370 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SFTA2 |
0.874453643874424 |
|
23371 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPCR1 |
0.874453643874424 |
|
23372 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCG21 |
0.874453643874424 |
|
23373 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUC21 |
0.874453643874424 |
|
23374 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUC22 |
0.874453643874424 |
|
23375 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCG22 |
0.874453643874424 |
|
23376 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf15 |
0.874453643874424 |
|
23377 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDSN |
0.874453643874424 |
|
23378 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSORS1C1 |
0.874453643874424 |
|
23379 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSORS1C2 |
0.874453643874424 |
|
23380 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCHCR1 |
0.874453643874424 |
|
23381 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCF19 |
0.874453643874424 |
|
23382 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POU5F1 |
0.874453643874424 |
|
23383 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSORS1C3 |
0.874453643874424 |
|
23384 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCG27 |
0.874453643874424 |
|
23385 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABHD16A |
0.874453643874424 |
|
23386 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGER |
0.874453643874424 |
|
23387 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AGPAT1 |
0.874453643874424 |
|
23388 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AIF1 |
0.874453643874424 |
|
23389 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOM |
0.874453643874424 |
|
23390 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATF6B |
0.874453643874424 |
|
23391 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6V1G2 |
0.874453643874424 |
|
23392 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAG6 |
0.874453643874424 |
|
23393 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTNL2 |
0.874453643874424 |
|
23394 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2 |
0.874453643874424 |
|
23395 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C4A |
0.874453643874424 |
|
23396 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C4B |
0.874453643874424 |
|
23397 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf10 |
0.874453643874424 |
|
23398 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf25 |
0.874453643874424 |
|
23399 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf47 |
0.874453643874424 |
|
23400 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf48 |
0.874453643874424 |
|
23401 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CFB |
0.874453643874424 |
|
23402 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLIC1 |
0.874453643874424 |
|
23403 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSNK2B |
0.874453643874424 |
|
23404 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP21A1P |
0.874453643874424 |
|
23405 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP21A2 |
0.874453643874424 |
|
23406 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDAH2 |
0.874453643874424 |
|
23407 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX39B |
0.874453643874424 |
|
23408 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOM3Z |
0.874453643874424 |
|
23409 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EGFL8 |
0.874453643874424 |
|
23410 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EHMT2 |
0.874453643874424 |
|
23411 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FKBPL |
0.874453643874424 |
|
23412 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPANK1 |
0.874453643874424 |
|
23413 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPSM3 |
0.874453643874424 |
|
23414 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCG23 |
0.874453643874424 |
|
23415 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCP5 |
0.874453643874424 |
|
23416 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPA1A |
0.874453643874424 |
|
23417 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPA1B |
0.874453643874424 |
|
23418 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPA1L |
0.874453643874424 |
|
23419 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LSM2 |
0.874453643874424 |
|
23420 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LST1 |
0.874453643874424 |
|
23421 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LTA |
0.874453643874424 |
|
23422 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LTB |
0.874453643874424 |
|
23423 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LY6G5B |
0.874453643874424 |
|
23424 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LY6G5C |
0.874453643874424 |
|
23425 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LY6G6C |
0.874453643874424 |
|
23426 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LY6G6D |
0.874453643874424 |
|
23427 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LY6G6E |
0.874453643874424 |
|
23428 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LY6G6F |
0.874453643874424 |
|
23429 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCCD1 |
0.874453643874424 |
|
23430 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEGT1 |
0.874453643874424 |
|
23431 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MICA |
0.874453643874424 |
|
23432 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MICB |
0.874453643874424 |
|
23433 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1236 |
0.874453643874424 |
|
23434 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3135B |
0.874453643874424 |
|
23435 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4646 |
0.874453643874424 |
|
23436 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MSH5 |
0.874453643874424 |
|
23437 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCR3 |
0.874453643874424 |
|
23438 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NELFE |
0.874453643874424 |
|
23439 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEU1 |
0.874453643874424 |
|
23440 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFKBIL1 |
0.874453643874424 |
|
23441 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NOTCH4 |
0.874453643874424 |
|
23442 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PBX2 |
0.874453643874424 |
|
23443 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R2P1 |
0.874453643874424 |
|
23444 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPT2 |
0.874453643874424 |
|
23445 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRRC2A |
0.874453643874424 |
|
23446 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRRT1 |
0.874453643874424 |
|
23447 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMB8 |
0.874453643874424 |
|
23448 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMB9 |
0.874453643874424 |
|
23449 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP206 |
0.874453643874424 |
|
23450 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF5 |
0.874453643874424 |
|
23451 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAPCD1 |
0.874453643874424 |
|
23452 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SKIV2L |
0.874453643874424 |
|
23453 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC44A4 |
0.874453643874424 |
|
23454 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA38|ENSG00000200816.1 |
0.874453643874424 |
|
23455 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD117 |
0.874453643874424 |
|
23456 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD48 |
0.874453643874424 |
|
23457 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD52 |
0.874453643874424 |
|
23458 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD84 |
0.874453643874424 |
|
23459 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STK19 |
0.874453643874424 |
|
23460 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAP1 |
0.874453643874424 |
|
23461 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAP2 |
0.874453643874424 |
|
23462 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNF |
0.874453643874424 |
|
23463 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNXB |
0.874453643874424 |
|
23464 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VARS |
0.874453643874424 |
|
23465 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VWA7 |
0.874453643874424 |
|
23466 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB12 |
0.874453643874424 |
|
23467 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRD2 |
0.874453643874424 |
|
23468 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCG24 |
0.874453643874424 |
|
23469 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL11A2 |
0.874453643874424 |
|
23470 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RXRB |
0.874453643874424 |
|
23471 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSD17B8 |
0.874453643874424 |
|
23472 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P10 |
0.874453643874424 |
|
23473 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC39A7 |
0.874453643874424 |
|
23474 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RING1 |
0.874453643874424 |
|
23475 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCG25 |
0.874453643874424 |
|
23476 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS52 |
0.874453643874424 |
|
23477 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS18 |
0.874453643874424 |
|
23478 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B3GALT4 |
0.874453643874424 |
|
23479 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR46 |
0.874453643874424 |
|
23480 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PFDN6 |
0.874453643874424 |
|
23481 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGL2 |
0.874453643874424 |
|
23482 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAPBP |
0.874453643874424 |
|
23483 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DAXX |
0.874453643874424 |
|
23484 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB22 |
0.874453643874424 |
|
23485 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIFC1 |
0.874453643874424 |
|
23486 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CUTA |
0.874453643874424 |
|
23487 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHF1 |
0.874453643874424 |
|
23488 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYNGAP1 |
0.874453643874424 |
|
23489 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5004 |
0.874453643874424 |
|
23490 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB9 |
0.874453643874424 |
|
23491 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL26P |
0.874453643874424 |
|
23492 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAK1 |
0.874453643874424 |
|
23493 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GGNBP1 |
0.874453643874424 |
|
23494 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00336 |
0.874453643874424 |
|
23495 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITPR3 |
0.874453643874424 |
|
23496 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MNF1 |
0.874453643874424 |
|
23497 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SBP1 |
0.874453643874424 |
|
23498 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3934 |
0.874453643874424 |
|
23499 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IP6K3 |
0.874453643874424 |
|
23500 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LEMD2 |
0.874453643874424 |
|
23501 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MLN |
0.874453643874424 |
|
23502 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1275 |
0.874453643874424 |
|
23503 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRM4 |
0.874453643874424 |
|
23504 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMGA1 |
0.874453643874424 |
|
23505 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf1 |
0.874453643874424 |
|
23506 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUDT3 |
0.874453643874424 |
|
23507 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS10 |
0.874453643874424 |
|
23508 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PACSIN1 |
0.874453643874424 |
|
23509 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPDEF |
0.874453643874424 |
|
23510 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf106 |
0.874453643874424 |
|
23511 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL200P |
0.874453643874424 |
|
23512 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239059.1 |
0.874453643874424 |
|
23513 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238484.1 |
0.874453643874424 |
|
23514 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNRPC |
0.874453643874424 |
|
23515 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAF11 |
0.874453643874424 |
|
23516 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UHRF1BP1 |
0.874453643874424 |
|
23517 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCP11 |
0.874453643874424 |
|
23518 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCUBE3 |
0.874453643874424 |
|
23519 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF76 |
0.874453643874424 |
|
23520 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DEF6 |
0.874453643874424 |
|
23521 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPARD |
0.874453643874424 |
|
23522 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FKBP5 |
0.874453643874424 |
|
23523 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA40|ENSG00000212579.1 |
0.874453643874424 |
|
23524 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5690 |
0.874453643874424 |
|
23525 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARMC12 |
0.874453643874424 |
|
23526 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLPSL1 |
0.874453643874424 |
|
23527 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLPSL2 |
0.874453643874424 |
|
23528 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLPS |
0.874453643874424 |
|
23529 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LHFPL5 |
0.874453643874424 |
|
23530 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRPK1 |
0.874453643874424 |
|
23531 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC26A8 |
0.874453643874424 |
|
23532 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPK14 |
0.874453643874424 |
|
23533 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPK13 |
0.874453643874424 |
|
23534 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRPF3 |
0.874453643874424 |
|
23535 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PNPLA1 |
0.874453643874424 |
|
23536 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf222 |
0.874453643874424 |
|
23537 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ETV7 |
0.874453643874424 |
|
23538 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PXT1 |
0.874453643874424 |
|
23539 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCTD20 |
0.874453643874424 |
|
23540 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL502P |
0.874453643874424 |
|
23541 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STK38 |
0.874453643874424 |
|
23542 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL748P |
0.874453643874424 |
|
23543 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRSF3 |
0.874453643874424 |
|
23544 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3925 |
0.874453643874424 |
|
23545 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDKN1A |
0.874453643874424 |
|
23546 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB44 |
0.874453643874424 |
|
23547 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPNE5 |
0.874453643874424 |
|
23548 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPIL1 |
0.874453643874424 |
|
23549 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf89 |
0.874453643874424 |
|
23550 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PI16 |
0.874453643874424 |
|
23551 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTCH1 |
0.874453643874424 |
|
23552 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGD2 |
0.874453643874424 |
|
23553 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX6A1P2 |
0.874453643874424 |
|
23554 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIM1 |
0.874453643874424 |
|
23555 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252687.1 |
0.874453643874424 |
|
23556 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM217 |
0.874453643874424 |
|
23557 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238375.1 |
0.874453643874424 |
|
23558 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D22B |
0.874453643874424 |
|
23559 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL273P |
0.874453643874424 |
|
23560 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF8 |
0.874453643874424 |
|
23561 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FTSJD2 |
0.874453643874424 |
|
23562 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC167 |
0.874453643874424 |
|
23563 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4462 |
0.874453643874424 |
|
23564 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MDGA1 |
0.874453643874424 |
|
23565 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFAND3 |
0.874453643874424 |
|
23566 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL285P |
0.874453643874424 |
|
23567 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTBD9 |
0.874453643874424 |
|
23568 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD45|ENSG00000200706.1 |
0.874453643874424 |
|
23569 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLO1 |
0.874453643874424 |
|
23570 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAH8 |
0.874453643874424 |
|
23571 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL465P |
0.874453643874424 |
|
23572 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA8|ENSG00000212586.1 |
0.874453643874424 |
|
23573 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PVT1 |
0.877051678639879 |
|
23574 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM75 |
0.877051678639879 |
|
23575 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1205 |
0.877051678639879 |
|
23576 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1207 |
0.877051678639879 |
|
23577 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHX35 |
0.877287467747698 |
|
23578 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPHA5 |
0.877779830788864 |
|
23579 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1269A |
0.877779830788864 |
|
23580 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CENPC |
0.877779830788864 |
|
23581 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAP1 |
0.877779830788864 |
|
23582 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBA6 |
0.877779830788864 |
|
23583 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNRHR |
0.877779830788864 |
|
23584 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA62|ENSG00000202374.1 |
0.877779830788864 |
|
23585 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMPRSS11D |
0.877779830788864 |
|
23586 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMPRSS11A |
0.877779830788864 |
|
23587 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMPRSS11F |
0.877779830788864 |
|
23588 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMPRSS11GP |
0.877779830788864 |
|
23589 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FTLP10 |
0.877779830788864 |
|
23590 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMPRSS11BNL |
0.877779830788864 |
|
23591 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMPRSS11B |
0.877779830788864 |
|
23592 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YTHDC1 |
0.877779830788864 |
|
23593 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMPRSS11E |
0.877779830788864 |
|
23594 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGT2A3 |
0.877779830788864 |
|
23595 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGT2B10 |
0.877779830788864 |
|
23596 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGT2B11 |
0.877779830788864 |
|
23597 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGT2B15 |
0.877779830788864 |
|
23598 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGT2B17 |
0.877779830788864 |
|
23599 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGT2B28 |
0.877779830788864 |
|
23600 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGT2B7 |
0.877779830788864 |
|
23601 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGT2B4 |
0.877779830788864 |
|
23602 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGT2A1 |
0.877779830788864 |
|
23603 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGT2A2 |
0.877779830788864 |
|
23604 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SULT1B1 |
0.877779830788864 |
|
23605 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SULT1E1 |
0.877779830788864 |
|
23606 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSN1S1 |
0.877779830788864 |
|
23607 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSN2 |
0.877779830788864 |
|
23608 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STATH |
0.877779830788864 |
|
23609 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTN3 |
0.877779830788864 |
|
23610 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTN1 |
0.877779830788864 |
|
23611 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSN1S2AP |
0.877779830788864 |
|
23612 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C4orf40 |
0.877779830788864 |
|
23613 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ODAM |
0.877779830788864 |
|
23614 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FDCSP |
0.877779830788864 |
|
23615 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSN3 |
0.877779830788864 |
|
23616 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CABS1 |
0.877779830788864 |
|
23617 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMR3A |
0.877779830788864 |
|
23618 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMR3B |
0.877779830788864 |
|
23619 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PROL1 |
0.877779830788864 |
|
23620 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUC7 |
0.877779830788864 |
|
23621 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMTN |
0.877779830788864 |
|
23622 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMBN |
0.877779830788864 |
|
23623 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UTP3 |
0.877779830788864 |
|
23624 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RUFY3 |
0.877779830788864 |
|
23625 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238318.1 |
0.877779830788864 |
|
23626 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRSF1 |
0.877779830788864 |
|
23627 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOB1B |
0.877779830788864 |
|
23628 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCK |
0.877779830788864 |
|
23629 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC4A4 |
0.877779830788864 |
|
23630 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GC |
0.877779830788864 |
|
23631 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP163 |
0.877779830788864 |
|
23632 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPFFR2 |
0.877779830788864 |
|
23633 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAMTS3 |
0.877779830788864 |
|
23634 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU4ATAC9P |
0.877779830788864 |
|
23635 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC5P |
0.877779830788864 |
|
23636 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX18 |
0.877779830788864 |
|
23637 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD17 |
0.877779830788864 |
|
23638 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA3|ENSG00000221639.1 |
0.877779830788864 |
|
23639 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALB |
0.877779830788864 |
|
23640 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AFP |
0.877779830788864 |
|
23641 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AFM |
0.877779830788864 |
|
23642 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASSF6 |
0.877779830788864 |
|
23643 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL8 |
0.877779830788864 |
|
23644 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXCL6 |
0.877779830788864 |
|
23645 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PF4V1 |
0.877779830788864 |
|
23646 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXCL1 |
0.877779830788864 |
|
23647 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PF4 |
0.877779830788864 |
|
23648 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPBP |
0.877779830788864 |
|
23649 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXCL5 |
0.877779830788864 |
|
23650 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL218P |
0.877779830788864 |
|
23651 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXCL3 |
0.877779830788864 |
|
23652 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPBPP2 |
0.877779830788864 |
|
23653 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXCL2 |
0.877779830788864 |
|
23654 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTHFD2L |
0.877779830788864 |
|
23655 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPGN |
0.877779830788864 |
|
23656 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EREG |
0.877779830788864 |
|
23657 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AREG |
0.877779830788864 |
|
23658 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AREGB |
0.877779830788864 |
|
23659 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTC |
0.877779830788864 |
|
23660 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARM1 |
0.877779830788864 |
|
23661 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RCHY1 |
0.877779830788864 |
|
23662 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THAP6 |
0.877779830788864 |
|
23663 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDKL2 |
0.877779830788864 |
|
23664 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
G3BP2 |
0.877779830788864 |
|
23665 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USO1 |
0.877779830788864 |
|
23666 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPEF2 |
0.877779830788864 |
|
23667 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAAA |
0.877779830788864 |
|
23668 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDAD1 |
0.877779830788864 |
|
23669 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXCL9 |
0.877779830788864 |
|
23670 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ART3 |
0.877779830788864 |
|
23671 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXCL10 |
0.877779830788864 |
|
23672 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXCL11 |
0.877779830788864 |
|
23673 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUP54 |
0.877779830788864 |
|
23674 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARB2 |
0.877779830788864 |
|
23675 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM47E |
0.877779830788864 |
|
23676 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC158 |
0.877779830788864 |
|
23677 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD50|ENSG00000199857.1 |
0.877779830788864 |
|
23678 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHROOM3 |
0.877779830788864 |
|
23679 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4450 |
0.877779830788864 |
|
23680 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548AH |
0.877779830788864 |
|
23681 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SOWAHB |
0.877779830788864 |
|
23682 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEPT11 |
0.877779830788864 |
|
23683 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNI |
0.877779830788864 |
|
23684 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNG2 |
0.877779830788864 |
|
23685 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXCL13 |
0.877779830788864 |
|
23686 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD75|ENSG00000221711.1 |
0.877779830788864 |
|
23687 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNOT6L |
0.877779830788864 |
|
23688 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL1 |
0.877779830788864 |
|
23689 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FRAS1 |
0.877779830788864 |
|
23690 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANXA3 |
0.877779830788864 |
|
23691 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238816.1 |
0.877779830788864 |
|
23692 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BMP2K |
0.877779830788864 |
|
23693 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5096 |
0.877779830788864 |
|
23694 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAQR3 |
0.877779830788864 |
|
23695 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL127P |
0.877779830788864 |
|
23696 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAA11 |
0.877779830788864 |
|
23697 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GK2 |
0.877779830788864 |
|
23698 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00989 |
0.877779830788864 |
|
23699 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR7E94P |
0.877779830788864 |
|
23700 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCAT4 |
0.877779830788864 |
|
23701 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA75|ENSG00000212620.1 |
0.877779830788864 |
|
23702 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANTXR2 |
0.877779830788864 |
|
23703 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRDM8 |
0.877779830788864 |
|
23704 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGF5 |
0.877779830788864 |
|
23705 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C4orf22 |
0.877779830788864 |
|
23706 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BMP3 |
0.877779830788864 |
|
23707 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRKG2 |
0.877779830788864 |
|
23708 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASGEF1B |
0.877779830788864 |
|
23709 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf77 |
0.87947403254798 |
|
23710 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DOHH |
0.87947403254798 |
|
23711 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL866P |
0.87947403254798 |
|
23712 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FZR1 |
0.87947403254798 |
|
23713 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD38|ENSG00000252408.1 |
0.87947403254798 |
|
23714 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf71 |
0.87947403254798 |
|
23715 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFSD12 |
0.87947403254798 |
|
23716 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GIPC3 |
0.87947403254798 |
|
23717 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMG20B |
0.87947403254798 |
|
23718 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBXA2R |
0.87947403254798 |
|
23719 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AHRR |
0.885833057554196 |
|
23720 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BRD9 |
0.885833057554196 |
|
23721 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf55 |
0.885833057554196 |
|
23722 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC127 |
0.885833057554196 |
|
23723 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP72 |
0.885833057554196 |
|
23724 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXOC3 |
0.885833057554196 |
|
23725 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC14B |
0.885833057554196 |
|
23726 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4456 |
0.885833057554196 |
|
23727 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDCD6 |
0.885833057554196 |
|
23728 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHG4B |
0.885833057554196 |
|
23729 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDHA |
0.885833057554196 |
|
23730 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC9A3 |
0.885833057554196 |
|
23731 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPPP |
0.885833057554196 |
|
23732 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIP13 |
0.885833057554196 |
|
23733 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDHHC11B |
0.885833057554196 |
|
23734 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZDHHC11 |
0.885833057554196 |
|
23735 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NKD2 |
0.885833057554196 |
|
23736 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4635 |
0.885833057554196 |
|
23737 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC12A7 |
0.885833057554196 |
|
23738 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC6A18 |
0.885833057554196 |
|
23739 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC6A19 |
0.885833057554196 |
|
23740 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TERT |
0.885833057554196 |
|
23741 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4457 |
0.885833057554196 |
|
23742 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLPTM1L |
0.885833057554196 |
|
23743 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC6A3 |
0.885833057554196 |
|
23744 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRX4 |
0.885833057554196 |
|
23745 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPCAT1 |
0.885833057554196 |
|
23746 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4277 |
0.885833057554196 |
|
23747 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL36 |
0.885833057554196 |
|
23748 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFS6 |
0.885833057554196 |
|
23749 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDHAP3 |
0.885833057554196 |
|
23750 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf38 |
0.885833057554196 |
|
23751 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRX2 |
0.885833057554196 |
|
23752 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IRX1 |
0.885833057554196 |
|
23753 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP73 |
0.885833057554196 |
|
23754 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAMTS16 |
0.885833057554196 |
|
23755 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0947 |
0.885833057554196 |
|
23756 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED10 |
0.885833057554196 |
|
23757 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2QL1 |
0.885833057554196 |
|
23758 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NSUN2 |
0.885833057554196 |
|
23759 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRD5A1 |
0.885833057554196 |
|
23760 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAPD7 |
0.885833057554196 |
|
23761 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP79 |
0.885833057554196 |
|
23762 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP176 |
0.885833057554196 |
|
23763 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADCY2 |
0.885833057554196 |
|
23764 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C5orf49 |
0.885833057554196 |
|
23765 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTRR |
0.885833057554196 |
|
23766 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FASTKD3 |
0.885833057554196 |
|
23767 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4458 |
0.885833057554196 |
|
23768 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEMA5A |
0.885833057554196 |
|
23769 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4636 |
0.885833057554196 |
|
23770 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD123 |
0.885833057554196 |
|
23771 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAS2R1 |
0.885833057554196 |
|
23772 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP177 |
0.885833057554196 |
|
23773 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM173B |
0.885833057554196 |
|
23774 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCT5 |
0.885833057554196 |
|
23775 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CMBL |
0.885833057554196 |
|
23776 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MARCH6 |
0.885833057554196 |
|
23777 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ROPN1L |
0.885833057554196 |
|
23778 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD33B |
0.885833057554196 |
|
23779 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DAP |
0.885833057554196 |
|
23780 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTNND2 |
0.885833057554196 |
|
23781 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CT49 |
0.885833057554196 |
|
23782 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAH5 |
0.885833057554196 |
|
23783 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4637 |
0.885833057554196 |
|
23784 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U8|ENSG00000202269.1 |
0.885833057554196 |
|
23785 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXL7 |
0.885833057554196 |
|
23786 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR887 |
0.885833057554196 |
|
23787 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP178 |
0.885833057554196 |
|
23788 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MARCH11 |
0.885833057554196 |
|
23789 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF622 |
0.885833057554196 |
|
23790 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM134B |
0.885833057554196 |
|
23791 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYO10 |
0.885833057554196 |
|
23792 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP179 |
0.885833057554196 |
|
23793 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF516 |
0.892577814878021 |
|
23794 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00908 |
0.892577814878021 |
|
23795 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00683 |
0.892577814878021 |
|
23796 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF236 |
0.892577814878021 |
|
23797 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBP |
0.892577814878021 |
|
23798 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALR1 |
0.892577814878021 |
|
23799 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA25|ENSG00000199392.1 |
0.892577814878021 |
|
23800 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP461 |
0.892577814878021 |
|
23801 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SALL3 |
0.892577814878021 |
|
23802 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP9B |
0.892577814878021 |
|
23803 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADNP2 |
0.892577814878021 |
|
23804 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTDP1 |
0.892577814878021 |
|
23805 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSBP1L1 |
0.892577814878021 |
|
23806 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNG2 |
0.892577814878021 |
|
23807 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFATC1 |
0.892577814878021 |
|
23808 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARD6G |
0.892577814878021 |
|
23809 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PQLC1 |
0.892577814878021 |
|
23810 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBFADN |
0.892577814878021 |
|
23811 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBFA |
0.892577814878021 |
|
23812 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TXNL4A |
0.892577814878021 |
|
23813 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DHFRL1 |
0.90715726589712 |
|
23814 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NSUN3 |
0.90715726589712 |
|
23815 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00879 |
0.90715726589712 |
|
23816 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPHN3 |
0.908209946835132 |
|
23817 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TECRL |
0.91389170876057 |
|
23818 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MROH8 |
0.915954475229599 |
|
23819 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPN2 |
0.915954475229599 |
|
23820 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GHRH |
0.915954475229599 |
|
23821 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MANBAL |
0.915954475229599 |
|
23822 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRC |
0.915954475229599 |
|
23823 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BLCAP |
0.915954475229599 |
|
23824 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NNAT |
0.915954475229599 |
|
23825 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00489 |
0.915954475229599 |
|
23826 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTNNBL1 |
0.915954475229599 |
|
23827 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VSTM2L |
0.915954475229599 |
|
23828 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP185 |
0.915954475229599 |
|
23829 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTI1 |
0.915954475229599 |
|
23830 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPRD1B |
0.915954475229599 |
|
23831 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL237P |
0.915954475229599 |
|
23832 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TGM2 |
0.915954475229599 |
|
23833 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1755 |
0.915954475229599 |
|
23834 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BPI |
0.915954475229599 |
|
23835 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LBP |
0.915954475229599 |
|
23836 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNHG17 |
0.915954475229599 |
|
23837 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA71B |
0.915954475229599 |
|
23838 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA71A |
0.915954475229599 |
|
23839 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA71C |
0.915954475229599 |
|
23840 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA71D |
0.915954475229599 |
|
23841 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA71|ENSG00000201811.1 |
0.915954475229599 |
|
23842 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNHG11 |
0.915954475229599 |
|
23843 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA60 |
0.915954475229599 |
|
23844 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RALGAPB |
0.915954475229599 |
|
23845 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR548O2 |
0.915954475229599 |
|
23846 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADIG |
0.915954475229599 |
|
23847 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGAP40 |
0.915954475229599 |
|
23848 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC32A1 |
0.915954475229599 |
|
23849 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACTR5 |
0.915954475229599 |
|
23850 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP173 |
0.915954475229599 |
|
23851 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPP1R16B |
0.915954475229599 |
|
23852 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL116P |
0.915954475229599 |
|
23853 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM83D |
0.915954475229599 |
|
23854 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL680P |
0.915954475229599 |
|
23855 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL194P |
0.915954475229599 |
|
23856 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOP1 |
0.915954475229599 |
|
23857 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLCG1 |
0.915954475229599 |
|
23858 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZHX3 |
0.915954475229599 |
|
23859 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL615P |
0.915954475229599 |
|
23860 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPIN3 |
0.915954475229599 |
|
23861 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EMILIN3 |
0.915954475229599 |
|
23862 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHD6 |
0.915954475229599 |
|
23863 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA26|ENSG00000212224.1 |
0.915954475229599 |
|
23864 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPRT |
0.915954475229599 |
|
23865 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP100 |
0.915954475229599 |
|
23866 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL666P |
0.915954475229599 |
|
23867 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA15|ENSG00000252193.1 |
0.915954475229599 |
|
23868 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRSF6 |
0.915954475229599 |
|
23869 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
L3MBTL1 |
0.915954475229599 |
|
23870 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SGK2 |
0.915954475229599 |
|
23871 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFT52 |
0.915954475229599 |
|
23872 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLP1R |
0.919783966661846 |
|
23873 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAYSD1 |
0.919783966661846 |
|
23874 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNK5 |
0.919783966661846 |
|
23875 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNK17 |
0.919783966661846 |
|
23876 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNK16 |
0.919783966661846 |
|
23877 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF6 |
0.919783966661846 |
|
23878 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DAAM2 |
0.919783966661846 |
|
23879 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOCS1 |
0.919783966661846 |
|
23880 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TDRG1 |
0.919783966661846 |
|
23881 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00951 |
0.919783966661846 |
|
23882 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRFN2 |
0.919783966661846 |
|
23883 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP39A1 |
0.919783966661846 |
|
23884 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A27 |
0.919783966661846 |
|
23885 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TDRD6 |
0.919783966661846 |
|
23886 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLA2G7 |
0.919783966661846 |
|
23887 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD66 |
0.919783966661846 |
|
23888 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEP1A |
0.919783966661846 |
|
23889 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR116 |
0.919783966661846 |
|
23890 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR110 |
0.919783966661846 |
|
23891 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFRSF21 |
0.919783966661846 |
|
23892 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD2AP |
0.919783966661846 |
|
23893 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR111 |
0.919783966661846 |
|
23894 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR115 |
0.919783966661846 |
|
23895 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP116 |
0.919783966661846 |
|
23896 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OPN5 |
0.919783966661846 |
|
23897 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTCHD4 |
0.919783966661846 |
|
23898 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBCD |
0.921917398644891 |
|
23899 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF750 |
0.921917398644891 |
|
23900 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD20A11P |
0.923531529133734 |
|
23901 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD30BP2 |
0.923531529133734 |
|
23902 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAGE2 |
0.923531529133734 |
|
23903 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP4F29P |
0.923531529133734 |
|
23904 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3648 |
0.923531529133734 |
|
23905 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3687 |
0.923531529133734 |
|
23906 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POTED |
0.923531529133734 |
|
23907 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL52P |
0.923531529133734 |
|
23908 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA70|ENSG00000252199.1 |
0.923531529133734 |
|
23909 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEKT4P2 |
0.923531529133734 |
|
23910 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPTE |
0.923531529133734 |
|
23911 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP488 |
0.923531529133734 |
|
23912 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIPI |
0.923531529133734 |
|
23913 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM11 |
0.925582048123031 |
|
23914 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCC13 |
0.925582048123031 |
|
23915 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HSPA13 |
0.925582048123031 |
|
23916 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAMSN1 |
0.925582048123031 |
|
23917 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NRIP1 |
0.925582048123031 |
|
23918 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SRP68 |
0.927230165934329 |
|
23919 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EXOC7 |
0.927230165934329 |
|
23920 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALR2 |
0.927230165934329 |
|
23921 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZACN |
0.927230165934329 |
|
23922 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXJ1 |
0.927230165934329 |
|
23923 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF157 |
0.927230165934329 |
|
23924 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
QRICH2 |
0.927230165934329 |
|
23925 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBALD2 |
0.927230165934329 |
|
23926 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRPSAP1 |
0.927230165934329 |
|
23927 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238418.1 |
0.927230165934329 |
|
23928 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPHK1 |
0.927230165934329 |
|
23929 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2O |
0.927230165934329 |
|
23930 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AANAT |
0.927230165934329 |
|
23931 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF609 |
0.933241557993303 |
|
23932 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OAZ2 |
0.933241557993303 |
|
23933 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBPMS2 |
0.933241557993303 |
|
23934 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1272 |
0.933241557993303 |
|
23935 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIF1 |
0.933241557993303 |
|
23936 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHO2 |
0.933241557993303 |
|
23937 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL348P |
0.933241557993303 |
|
23938 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKDD1A |
0.933241557993303 |
|
23939 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPG21 |
0.933241557993303 |
|
23940 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTFMT |
0.933241557993303 |
|
23941 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC51B |
0.933241557993303 |
|
23942 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASL12 |
0.933241557993303 |
|
23943 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KBTBD13 |
0.933241557993303 |
|
23944 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBAP1L |
0.933241557993303 |
|
23945 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDCD7 |
0.933241557993303 |
|
23946 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLPX |
0.933241557993303 |
|
23947 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CILP |
0.933241557993303 |
|
23948 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARP16 |
0.933241557993303 |
|
23949 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA24|ENSG00000206903.1 |
0.933241557993303 |
|
23950 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGDCC3 |
0.933241557993303 |
|
23951 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGDCC4 |
0.933241557993303 |
|
23952 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPP8 |
0.933241557993303 |
|
23953 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPLAD1 |
0.933241557993303 |
|
23954 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238715.1 |
0.933241557993303 |
|
23955 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VWA9 |
0.933241557993303 |
|
23956 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBN1 |
0.940941302025341 |
|
23957 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP152 |
0.940941302025341 |
|
23958 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHC4 |
0.940941302025341 |
|
23959 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EID1 |
0.940941302025341 |
|
23960 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SECISBP2L |
0.940941302025341 |
|
23961 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL577P |
0.940941302025341 |
|
23962 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COPS2 |
0.940941302025341 |
|
23963 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALK2 |
0.940941302025341 |
|
23964 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4716 |
0.940941302025341 |
|
23965 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL307P |
0.940941302025341 |
|
23966 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM227B |
0.940941302025341 |
|
23967 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGF7 |
0.940941302025341 |
|
23968 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DTWD1 |
0.940941302025341 |
|
23969 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP8B4 |
0.940941302025341 |
|
23970 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP394 |
0.940941302025341 |
|
23971 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC27A2 |
0.940941302025341 |
|
23972 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HDC |
0.940941302025341 |
|
23973 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL494P |
0.940941302025341 |
|
23974 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GABPB1 |
0.940941302025341 |
|
23975 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U6|ENSG00000271819.1 |
0.940941302025341 |
|
23976 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4712 |
0.940941302025341 |
|
23977 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP8 |
0.940941302025341 |
|
23978 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP395 |
0.940941302025341 |
|
23979 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP50 |
0.940941302025341 |
|
23980 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRPM7 |
0.940941302025341 |
|
23981 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL354P |
0.940941302025341 |
|
23982 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPPL2A |
0.940941302025341 |
|
23983 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AP4E1 |
0.940941302025341 |
|
23984 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNFAIP8L3 |
0.940941302025341 |
|
23985 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CYP19A1 |
0.940941302025341 |
|
23986 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4713 |
0.940941302025341 |
|
23987 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLDN |
0.940941302025341 |
|
23988 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DMXL2 |
0.940941302025341 |
|
23989 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCG3 |
0.940941302025341 |
|
23990 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LYSMD2 |
0.940941302025341 |
|
23991 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMOD2 |
0.940941302025341 |
|
23992 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMOD3 |
0.940941302025341 |
|
23993 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U6|ENSG00000272337.1 |
0.940941302025341 |
|
23994 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LEO1 |
0.940941302025341 |
|
23995 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAPK6 |
0.940941302025341 |
|
23996 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCL2L10 |
0.940941302025341 |
|
23997 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNB5 |
0.940941302025341 |
|
23998 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYO5C |
0.940941302025341 |
|
23999 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1266 |
0.940941302025341 |
|
24000 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYO5A |
0.940941302025341 |
|
24001 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARPP19 |
0.940941302025341 |
|
24002 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM214A |
0.940941302025341 |
|
24003 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ONECUT1 |
0.940941302025341 |
|
24004 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR72 |
0.940941302025341 |
|
24005 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UNC13C |
0.940941302025341 |
|
24006 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RSL24D1 |
0.940941302025341 |
|
24007 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIGB |
0.940941302025341 |
|
24008 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCPG1 |
0.940941302025341 |
|
24009 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR628 |
0.940941302025341 |
|
24010 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C15orf65 |
0.940941302025341 |
|
24011 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DYX1C1 |
0.940941302025341 |
|
24012 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PYGO1 |
0.940941302025341 |
|
24013 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRTG |
0.940941302025341 |
|
24014 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEDD4 |
0.940941302025341 |
|
24015 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238513.1 |
0.940941302025341 |
|
24016 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL568P |
0.940941302025341 |
|
24017 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFX7 |
0.940941302025341 |
|
24018 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEX9 |
0.940941302025341 |
|
24019 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MNS1 |
0.940941302025341 |
|
24020 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF280D |
0.940941302025341 |
|
24021 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCF12 |
0.940941302025341 |
|
24022 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239035.1 |
0.940941302025341 |
|
24023 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00926 |
0.940941302025341 |
|
24024 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CGNL1 |
0.940941302025341 |
|
24025 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCOM1 |
0.940941302025341 |
|
24026 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYZAP |
0.940941302025341 |
|
24027 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR2M |
0.940941302025341 |
|
24028 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ALDH1A2 |
0.940941302025341 |
|
24029 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AQP9 |
0.940941302025341 |
|
24030 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIPC |
0.940941302025341 |
|
24031 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAM10 |
0.940941302025341 |
|
24032 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239100.1 |
0.940941302025341 |
|
24033 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP95 |
0.940941302025341 |
|
24034 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000200318.1 |
0.940941302025341 |
|
24035 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM63B |
0.940941302025341 |
|
24036 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF111 |
0.940941302025341 |
|
24037 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLTM |
0.940941302025341 |
|
24038 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCNB2 |
0.940941302025341 |
|
24039 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYO1E |
0.940941302025341 |
|
24040 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C15ORF31 |
0.940941302025341 |
|
24041 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR2116 |
0.940941302025341 |
|
24042 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LDHAL6B |
0.940941302025341 |
|
24043 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM81A |
0.940941302025341 |
|
24044 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238767.1 |
0.940941302025341 |
|
24045 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP396 |
0.940941302025341 |
|
24046 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GCNT3 |
0.940941302025341 |
|
24047 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTF2A2 |
0.940941302025341 |
|
24048 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BNIP2 |
0.940941302025341 |
|
24049 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXB1 |
0.940941302025341 |
|
24050 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANXA2 |
0.940941302025341 |
|
24051 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NARG2 |
0.940941302025341 |
|
24052 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RORA |
0.940941302025341 |
|
24053 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP397 |
0.940941302025341 |
|
24054 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS13C |
0.940941302025341 |
|
24055 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL613P |
0.940941302025341 |
|
24056 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2CD4A |
0.940941302025341 |
|
24057 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2CD4B |
0.940941302025341 |
|
24058 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLN2 |
0.940941302025341 |
|
24059 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR190A |
0.940941302025341 |
|
24060 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPM1 |
0.940941302025341 |
|
24061 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LACTB |
0.940941302025341 |
|
24062 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS27L |
0.940941302025341 |
|
24063 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB8B |
0.940941302025341 |
|
24064 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APH1B |
0.940941302025341 |
|
24065 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CA12 |
0.940941302025341 |
|
24066 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP3 |
0.940941302025341 |
|
24067 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXL22 |
0.940941302025341 |
|
24068 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HERC1 |
0.940941302025341 |
|
24069 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR422A |
0.940941302025341 |
|
24070 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DAPK2 |
0.940941302025341 |
|
24071 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM96A |
0.940941302025341 |
|
24072 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX1 |
0.940941302025341 |
|
24073 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX22 |
0.940941302025341 |
|
24074 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPIB |
0.940941302025341 |
|
24075 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0101 |
0.940941302025341 |
|
24076 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIP4 |
0.940941302025341 |
|
24077 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL595P |
0.940941302025341 |
|
24078 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL707P |
0.940941302025341 |
|
24079 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COX6C |
0.950627239775419 |
|
24080 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RGS22 |
0.950627239775419 |
|
24081 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD77|ENSG00000212414.1 |
0.950627239775419 |
|
24082 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1273A |
0.950627239775419 |
|
24083 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBXO43 |
0.950627239775419 |
|
24084 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM225 |
0.95235834487407 |
|
24085 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR8D4 |
0.95235834487407 |
|
24086 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4D5 |
0.95235834487407 |
|
24087 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6T1 |
0.95235834487407 |
|
24088 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10S1 |
0.95235834487407 |
|
24089 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10G4 |
0.95235834487407 |
|
24090 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10G9 |
0.95235834487407 |
|
24091 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10G8 |
0.95235834487407 |
|
24092 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10G7 |
0.95235834487407 |
|
24093 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VWA5A |
0.95235834487407 |
|
24094 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR10D3 |
0.95235834487407 |
|
24095 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR8D1 |
0.95235834487407 |
|
24096 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR8D2 |
0.95235834487407 |
|
24097 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP121 |
0.95235834487407 |
|
24098 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP279 |
0.95235834487407 |
|
24099 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NTM |
0.95235834487407 |
|
24100 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC12P |
0.95235834487407 |
|
24101 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OPCML |
0.95235834487407 |
|
24102 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238693.1 |
0.95235834487407 |
|
24103 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA19 |
0.95235834487407 |
|
24104 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4697 |
0.95235834487407 |
|
24105 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IGSF9B |
0.95235834487407 |
|
24106 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JAM3 |
0.95235834487407 |
|
24107 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCAPD3 |
0.95235834487407 |
|
24108 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS26B |
0.95235834487407 |
|
24109 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THYN1 |
0.95235834487407 |
|
24110 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACAD8 |
0.95235834487407 |
|
24111 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B3GAT1 |
0.95235834487407 |
|
24112 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLB1L2 |
0.95235834487407 |
|
24113 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GLB1L3 |
0.95235834487407 |
|
24114 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC12 |
0.954728852526672 |
|
24115 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKK1 |
0.954728852526672 |
|
24116 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DRD2 |
0.954728852526672 |
|
24117 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4301 |
0.954728852526672 |
|
24118 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMPRSS5 |
0.954728852526672 |
|
24119 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZW10 |
0.954728852526672 |
|
24120 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CLDN25 |
0.954728852526672 |
|
24121 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATF4P4 |
0.954728852526672 |
|
24122 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP28 |
0.954728852526672 |
|
24123 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTR3B |
0.954728852526672 |
|
24124 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HTR3A |
0.954728852526672 |
|
24125 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB16 |
0.954728852526672 |
|
24126 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NNMT |
0.954728852526672 |
|
24127 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C11orf71 |
0.954728852526672 |
|
24128 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM7 |
0.954728852526672 |
|
24129 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REXO2 |
0.954728852526672 |
|
24130 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NXPE1 |
0.954728852526672 |
|
24131 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238724.1 |
0.954728852526672 |
|
24132 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NXPE4 |
0.954728852526672 |
|
24133 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NXPE2 |
0.954728852526672 |
|
24134 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACA59|ENSG00000252870.1 |
0.954728852526672 |
|
24135 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CADM1 |
0.954728852526672 |
|
24136 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239153.1 |
0.954728852526672 |
|
24137 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00900 |
0.954728852526672 |
|
24138 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238625.1 |
0.954728852526672 |
|
24139 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BUD13 |
0.954728852526672 |
|
24140 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF259 |
0.954728852526672 |
|
24141 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOA5 |
0.954728852526672 |
|
24142 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOA4 |
0.954728852526672 |
|
24143 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOC3 |
0.954728852526672 |
|
24144 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APOA1 |
0.954728852526672 |
|
24145 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIK3 |
0.954728852526672 |
|
24146 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNY4P6 |
0.954728852526672 |
|
24147 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAFAH1B2 |
0.954728852526672 |
|
24148 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SIDT2 |
0.954728852526672 |
|
24149 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TAGLN |
0.954728852526672 |
|
24150 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCSK7 |
0.954728852526672 |
|
24151 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF214 |
0.954728852526672 |
|
24152 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCARNA11|ENSG00000252992.1 |
0.954728852526672 |
|
24153 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BACE1 |
0.954728852526672 |
|
24154 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP164 |
0.954728852526672 |
|
24155 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DSCAML1 |
0.954728852526672 |
|
24156 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FXYD2 |
0.954728852526672 |
|
24157 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FXYD6 |
0.954728852526672 |
|
24158 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMPRSS13 |
0.954728852526672 |
|
24159 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL10RA |
0.954728852526672 |
|
24160 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMPRSS4 |
0.954728852526672 |
|
24161 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCN4B |
0.954728852526672 |
|
24162 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SCN2B |
0.954728852526672 |
|
24163 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AMICA1 |
0.954728852526672 |
|
24164 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPZL3 |
0.954728852526672 |
|
24165 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPZL2 |
0.954728852526672 |
|
24166 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD3E |
0.954728852526672 |
|
24167 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD3D |
0.954728852526672 |
|
24168 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD3G |
0.954728852526672 |
|
24169 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE4A |
0.954728852526672 |
|
24170 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP5L |
0.954728852526672 |
|
24171 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL86P |
0.954728852526672 |
|
24172 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KMT2A |
0.954728852526672 |
|
24173 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM25 |
0.954728852526672 |
|
24174 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTC36 |
0.954728852526672 |
|
24175 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IFT46 |
0.954728852526672 |
|
24176 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARCN1 |
0.954728852526672 |
|
24177 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHLDB1 |
0.954728852526672 |
|
24178 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TREH |
0.954728852526672 |
|
24179 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX6 |
0.954728852526672 |
|
24180 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CXCR5 |
0.954728852526672 |
|
24181 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCL9L |
0.954728852526672 |
|
24182 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4492 |
0.954728852526672 |
|
24183 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UPK2 |
0.954728852526672 |
|
24184 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL688P |
0.954728852526672 |
|
24185 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FOXR1 |
0.954728852526672 |
|
24186 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL529P |
0.954728852526672 |
|
24187 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC84 |
0.954728852526672 |
|
24188 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS25 |
0.954728852526672 |
|
24189 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3656 |
0.954728852526672 |
|
24190 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRAPPC4 |
0.954728852526672 |
|
24191 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC37A4 |
0.954728852526672 |
|
24192 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HYOU1 |
0.954728852526672 |
|
24193 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS11 |
0.954728852526672 |
|
24194 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMBS |
0.954728852526672 |
|
24195 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPAGT1 |
0.954728852526672 |
|
24196 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
H2AFX |
0.954728852526672 |
|
24197 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2CD2L |
0.954728852526672 |
|
24198 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HINFP |
0.954728852526672 |
|
24199 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCG4 |
0.954728852526672 |
|
24200 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NLRX1 |
0.954728852526672 |
|
24201 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDZD3 |
0.954728852526672 |
|
24202 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CCDC153 |
0.954728852526672 |
|
24203 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CBL |
0.954728852526672 |
|
24204 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MCAM |
0.954728852526672 |
|
24205 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACA64|ENSG00000252119.1 |
0.954728852526672 |
|
24206 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF26 |
0.954728852526672 |
|
24207 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C1QTNF5 |
0.954728852526672 |
|
24208 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MFRP |
0.954728852526672 |
|
24209 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USP2 |
0.954728852526672 |
|
24210 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THY1 |
0.954728852526672 |
|
24211 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PVRL1 |
0.954728852526672 |
|
24212 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM29 |
0.954728852526672 |
|
24213 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OAF |
0.954728852526672 |
|
24214 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POU2F3 |
0.954728852526672 |
|
24215 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM136 |
0.954728852526672 |
|
24216 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARHGEF12 |
0.954728852526672 |
|
24217 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRIK4 |
0.954728852526672 |
|
24218 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBCEL |
0.954728852526672 |
|
24219 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TECTA |
0.954728852526672 |
|
24220 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SC5D |
0.954728852526672 |
|
24221 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR6M1 |
0.954728852526672 |
|
24222 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB27A |
0.957288661557946 |
|
24223 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239031.1 |
0.957919767996968 |
|
24224 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APCDD1 |
0.957919767996968 |
|
24225 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAPG |
0.957919767996968 |
|
24226 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIEZO2 |
0.957919767996968 |
|
24227 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NPIPB1P |
0.957919767996968 |
|
24228 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNAL |
0.957919767996968 |
|
24229 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHMP1B |
0.957919767996968 |
|
24230 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MPPE1 |
0.957919767996968 |
|
24231 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IMPA2 |
0.957919767996968 |
|
24232 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD62 |
0.957919767996968 |
|
24233 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CIDEA |
0.957919767996968 |
|
24234 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TUBB6 |
0.957919767996968 |
|
24235 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AFG3L2 |
0.957919767996968 |
|
24236 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLMO1 |
0.957919767996968 |
|
24237 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPIRE1 |
0.957919767996968 |
|
24238 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238309.1 |
0.957919767996968 |
|
24239 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP76 |
0.957919767996968 |
|
24240 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSMG2 |
0.957919767996968 |
|
24241 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPN2 |
0.957919767996968 |
|
24242 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEH1L |
0.957919767996968 |
|
24243 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEP192 |
0.957919767996968 |
|
24244 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LDLRAD4 |
0.957919767996968 |
|
24245 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5190 |
0.957919767996968 |
|
24246 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4526 |
0.957919767996968 |
|
24247 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM210A |
0.957919767996968 |
|
24248 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL362P |
0.957919767996968 |
|
24249 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNMT |
0.957919767996968 |
|
24250 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MC5R |
0.957919767996968 |
|
24251 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BASP1 |
0.961539508369459 |
|
24252 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP180 |
0.961539508369459 |
|
24253 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FTH1P10 |
0.961539508369459 |
|
24254 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP133 |
0.961539508369459 |
|
24255 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD81|ENSG00000212278.1 |
0.961539508369459 |
|
24256 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL58P |
0.961539508369459 |
|
24257 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238674.1 |
0.961539508369459 |
|
24258 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDH18 |
0.961539508369459 |
|
24259 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GUSBP1 |
0.961539508369459 |
|
24260 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIQK |
0.970744864734235 |
|
24261 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C8orf87 |
0.970744864734235 |
|
24262 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00535 |
0.970744864734235 |
|
24263 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP274 |
0.970744864734235 |
|
24264 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM92A1 |
0.970744864734235 |
|
24265 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM12B |
0.970744864734235 |
|
24266 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM67 |
0.970744864734235 |
|
24267 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDP1 |
0.970744864734235 |
|
24268 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR378D2 |
0.970744864734235 |
|
24269 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDH17 |
0.970744864734235 |
|
24270 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GEM |
0.970744864734235 |
|
24271 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FSBP |
0.970744864734235 |
|
24272 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAD54B |
0.970744864734235 |
|
24273 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1429 |
0.970744864734235 |
|
24274 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ESRP1 |
0.970744864734235 |
|
24275 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPY19L4 |
0.970744864734235 |
|
24276 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFAF6 |
0.970744864734235 |
|
24277 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238791.1 |
0.970744864734235 |
|
24278 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TP53INP1 |
0.970744864734235 |
|
24279 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3150B |
0.970744864734235 |
|
24280 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLEKHF2 |
0.970744864734235 |
|
24281 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C8orf37 |
0.970744864734235 |
|
24282 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GDF6 |
0.970744864734235 |
|
24283 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTERFD1 |
0.970744864734235 |
|
24284 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTDSS1 |
0.970744864734235 |
|
24285 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UQCRB |
0.970744864734235 |
|
24286 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDC2 |
0.970744864734235 |
|
24287 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MATN2 |
0.970744864734235 |
|
24288 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL30 |
0.970744864734235 |
|
24289 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA72|ENSG00000207067.1 |
0.970744864734235 |
|
24290 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C8orf47 |
0.970744864734235 |
|
24291 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HRSP12 |
0.970744864734235 |
|
24292 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POP1 |
0.970744864734235 |
|
24293 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NIPAL2 |
0.970744864734235 |
|
24294 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STK3 |
0.970744864734235 |
|
24295 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNS2 |
0.970744864734235 |
|
24296 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP85 |
0.970744864734235 |
|
24297 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSR2 |
0.970744864734235 |
|
24298 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
VPS13B |
0.970744864734235 |
|
24299 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR599 |
0.970744864734235 |
|
24300 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR875 |
0.970744864734235 |
|
24301 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL350P |
0.970744864734235 |
|
24302 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR2K |
0.970744864734235 |
|
24303 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPAG1 |
0.970744864734235 |
|
24304 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF19A |
0.970744864734235 |
|
24305 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4471 |
0.970744864734235 |
|
24306 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ANKRD46 |
0.970744864734235 |
|
24307 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX31 |
0.970744864734235 |
|
24308 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PABPC1 |
0.970744864734235 |
|
24309 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC41P |
0.970744864734235 |
|
24310 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YWHAZ |
0.970744864734235 |
|
24311 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL685P |
0.970744864734235 |
|
24312 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP249 |
0.970744864734235 |
|
24313 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD112|ENSG00000252434.1 |
0.971736408085186 |
|
24314 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MAFB |
0.971736408085186 |
|
24315 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP484 |
0.971736408085186 |
|
24316 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SSTR2 |
0.972264540932665 |
|
24317 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COG1 |
0.972264540932665 |
|
24318 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM104A |
0.972264540932665 |
|
24319 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf80 |
0.972264540932665 |
|
24320 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPSF4L |
0.972264540932665 |
|
24321 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC42EP4 |
0.972264540932665 |
|
24322 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDK2 |
0.972264540932665 |
|
24323 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00469 |
0.972264540932665 |
|
24324 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BTBD17 |
0.972264540932665 |
|
24325 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C17orf77 |
0.972264540932665 |
|
24326 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD300A |
0.972264540932665 |
|
24327 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD300C |
0.972264540932665 |
|
24328 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD300E |
0.972264540932665 |
|
24329 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD300LB |
0.972264540932665 |
|
24330 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD300LD |
0.972264540932665 |
|
24331 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD300LF |
0.972264540932665 |
|
24332 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNAI2 |
0.972264540932665 |
|
24333 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPR142 |
0.972264540932665 |
|
24334 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPRC5C |
0.972264540932665 |
|
24335 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIF19 |
0.972264540932665 |
|
24336 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RAB37 |
0.972264540932665 |
|
24337 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP448 |
0.972264540932665 |
|
24338 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL38 |
0.972264540932665 |
|
24339 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTYH2 |
0.972264540932665 |
|
24340 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3615 |
0.972264540932665 |
|
24341 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC9A3R1 |
0.972264540932665 |
|
24342 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NAT9 |
0.972264540932665 |
|
24343 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM104 |
0.972264540932665 |
|
24344 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRIN2C |
0.972264540932665 |
|
24345 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FDXR |
0.972264540932665 |
|
24346 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FADS6 |
0.972264540932665 |
|
24347 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
USH1G |
0.972264540932665 |
|
24348 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OTOP2 |
0.972264540932665 |
|
24349 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OTOP3 |
0.972264540932665 |
|
24350 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HID1 |
0.972264540932665 |
|
24351 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDR2L |
0.972264540932665 |
|
24352 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ICT1 |
0.972264540932665 |
|
24353 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCTD2 |
0.972264540932665 |
|
24354 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP5H |
0.972264540932665 |
|
24355 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL573P |
0.972264540932665 |
|
24356 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC16A5 |
0.972264540932665 |
|
24357 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARMC7 |
0.972264540932665 |
|
24358 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HN1 |
0.972264540932665 |
|
24359 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NT5C |
0.972264540932665 |
|
24360 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SUMO2 |
0.972264540932665 |
|
24361 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NUP85 |
0.972264540932665 |
|
24362 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GGA3 |
0.972264540932665 |
|
24363 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS7 |
0.972264540932665 |
|
24364 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIF4GD |
0.972264540932665 |
|
24365 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC25A19 |
0.972264540932665 |
|
24366 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRB2 |
0.972264540932665 |
|
24367 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3678 |
0.972264540932665 |
|
24368 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA0195 |
0.972264540932665 |
|
24369 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CASKIN2 |
0.972264540932665 |
|
24370 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSEN54 |
0.972264540932665 |
|
24371 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LLGL2 |
0.972264540932665 |
|
24372 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYO15B |
0.972264540932665 |
|
24373 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RECQL5 |
0.972264540932665 |
|
24374 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMIM5 |
0.972264540932665 |
|
24375 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMIM6 |
0.972264540932665 |
|
24376 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SAP30BP |
0.972264540932665 |
|
24377 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ITGB4 |
0.972264540932665 |
|
24378 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GALK1 |
0.972264540932665 |
|
24379 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
H3F3B |
0.972264540932665 |
|
24380 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4738 |
0.972264540932665 |
|
24381 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UNK |
0.972264540932665 |
|
24382 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UNC13D |
0.972264540932665 |
|
24383 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WBP2 |
0.972264540932665 |
|
24384 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM47 |
0.972264540932665 |
|
24385 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TRIM65 |
0.972264540932665 |
|
24386 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM138F |
0.973452044844354 |
|
24387 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OR4F17 |
0.973452044844354 |
|
24388 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PPAP2C |
0.973452044844354 |
|
24389 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WASH5P |
0.973452044844354 |
|
24390 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIER2 |
0.973452044844354 |
|
24391 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
THEG |
0.973452044844354 |
|
24392 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C2CD4C |
0.973452044844354 |
|
24393 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHC2 |
0.973452044844354 |
|
24394 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP462 |
0.973452044844354 |
|
24395 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ODF3L2 |
0.973452044844354 |
|
24396 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MADCAM1 |
0.973452044844354 |
|
24397 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPGS1 |
0.973452044844354 |
|
24398 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDC34 |
0.973452044844354 |
|
24399 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GZMM |
0.973452044844354 |
|
24400 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BSG |
0.973452044844354 |
|
24401 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HCN2 |
0.973452044844354 |
|
24402 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLRMT |
0.973452044844354 |
|
24403 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FGF22 |
0.973452044844354 |
|
24404 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF126 |
0.973452044844354 |
|
24405 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FSTL3 |
0.973452044844354 |
|
24406 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRSS57 |
0.973452044844354 |
|
24407 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PALM |
0.973452044844354 |
|
24408 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MISP |
0.973452044844354 |
|
24409 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTBP1 |
0.973452044844354 |
|
24410 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4745 |
0.973452044844354 |
|
24411 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
AZU1 |
0.973452044844354 |
|
24412 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LPPR3 |
0.973452044844354 |
|
24413 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3187 |
0.973452044844354 |
|
24414 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARID3A |
0.973452044844354 |
|
24415 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CFD |
0.973452044844354 |
|
24416 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELANE |
0.973452044844354 |
|
24417 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KISS1R |
0.973452044844354 |
|
24418 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MED16 |
0.973452044844354 |
|
24419 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRTN3 |
0.973452044844354 |
|
24420 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
R3HDM4 |
0.973452044844354 |
|
24421 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR18 |
0.973452044844354 |
|
24422 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRIN3B |
0.973452044844354 |
|
24423 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM259 |
0.973452044844354 |
|
24424 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNN2 |
0.973452044844354 |
|
24425 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ABCA7 |
0.973452044844354 |
|
24426 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HMHA1 |
0.973452044844354 |
|
24427 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
POLR2E |
0.973452044844354 |
|
24428 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPX4 |
0.973452044844354 |
|
24429 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SBNO2 |
0.973452044844354 |
|
24430 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STK11 |
0.973452044844354 |
|
24431 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP5D |
0.973452044844354 |
|
24432 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf26 |
0.973452044844354 |
|
24433 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CIRBP |
0.973452044844354 |
|
24434 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIDN |
0.973452044844354 |
|
24435 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf24 |
0.973452044844354 |
|
24436 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EFNA2 |
0.973452044844354 |
|
24437 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MUM1 |
0.973452044844354 |
|
24438 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PYGB |
0.975516782381304 |
|
24439 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CSE1L |
0.975656469810483 |
|
24440 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STAU1 |
0.975656469810483 |
|
24441 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTRNR2L9 |
0.97716781717809 |
|
24442 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KHDRBS2 |
0.97716781717809 |
|
24443 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPL38 |
0.979787307567508 |
|
24444 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FBF1 |
0.979787307567508 |
|
24445 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACOX1 |
0.979787307567508 |
|
24446 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TEN1 |
0.979787307567508 |
|
24447 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDK3 |
0.979787307567508 |
|
24448 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EVPL |
0.979787307567508 |
|
24449 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NDUFS7 |
0.979911391852403 |
|
24450 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GAMT |
0.979911391852403 |
|
24451 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DAZAP1 |
0.979911391852403 |
|
24452 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPS15 |
0.979911391852403 |
|
24453 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APC2 |
0.979911391852403 |
|
24454 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C19orf25 |
0.979911391852403 |
|
24455 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCSK4 |
0.979911391852403 |
|
24456 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REEP6 |
0.979911391852403 |
|
24457 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADAMTSL5 |
0.979911391852403 |
|
24458 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLK5 |
0.979911391852403 |
|
24459 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MEX3D |
0.979911391852403 |
|
24460 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MBD3 |
0.979911391852403 |
|
24461 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL477P |
0.979911391852403 |
|
24462 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UQCR11 |
0.979911391852403 |
|
24463 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TCF3 |
0.979911391852403 |
|
24464 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP8B3 |
0.979911391852403 |
|
24465 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLF16 |
0.979911391852403 |
|
24466 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR1909 |
0.979911391852403 |
|
24467 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ONECUT3 |
0.979911391852403 |
|
24468 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REXO1 |
0.979911391852403 |
|
24469 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL226P |
0.979911391852403 |
|
24470 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR151A |
0.984892345897373 |
|
24471 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTK2 |
0.984892345897373 |
|
24472 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP278 |
0.984892345897373 |
|
24473 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GRXCR1 |
0.993537666248302 |
|
24474 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP82 |
0.993537666248302 |
|
24475 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL691P |
0.993537666248302 |
|
24476 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BAI3 |
0.993662866433612 |
|
24477 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LMBRD1 |
0.993662866433612 |
|
24478 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL19A1 |
0.993662866433612 |
|
24479 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
COL9A1 |
0.993662866433612 |
|
24480 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM135A |
0.993662866433612 |
|
24481 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C6orf57 |
0.993662866433612 |
|
24482 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMAP1 |
0.993662866433612 |
|
24483 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B3GAT2 |
0.993662866433612 |
|
24484 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
U3|ENSG00000221345.1 |
0.993662866433612 |
|
24485 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OGFRL1 |
0.993662866433612 |
|
24486 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00472 |
0.993662866433612 |
|
24487 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR30C2 |
0.993662866433612 |
|
24488 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR30A |
0.993662866433612 |
|
24489 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIMS1 |
0.993662866433612 |
|
24490 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNQ5 |
0.993662866433612 |
|
24491 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4282 |
0.993662866433612 |
|
24492 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KHDC1L |
0.993662866433612 |
|
24493 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KHDC1 |
0.993662866433612 |
|
24494 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPPA5 |
0.993662866433612 |
|
24495 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KHDC3L |
0.993662866433612 |
|
24496 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OOEP |
0.993662866433612 |
|
24497 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX43 |
0.993662866433612 |
|
24498 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238464.1 |
0.993662866433612 |
|
24499 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MB21D1 |
0.993662866433612 |
|
24500 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MTO1 |
0.993662866433612 |
|
24501 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EEF1A1 |
0.993662866433612 |
|
24502 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC17A5 |
0.993662866433612 |
|
24503 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD109 |
0.993662866433612 |
|
24504 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MYBL2 |
0.99444707911102 |
|
24505 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GTSF1L |
0.99444707911102 |
|
24506 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOX2 |
0.99444707911102 |
|
24507 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL443P |
0.99444707911102 |
|
24508 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
JPH2 |
0.99444707911102 |
|
24509 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSER1 |
0.99444707911102 |
|
24510 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GDAP1L1 |
0.99444707911102 |
|
24511 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FITM2 |
0.99444707911102 |
|
24512 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
R3HDML |
0.99444707911102 |
|
24513 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNF4A |
0.99444707911102 |
|
24514 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3646 |
0.99444707911102 |
|
24515 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C20orf62 |
0.99444707911102 |
|
24516 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TTPAL |
0.99444707911102 |
|
24517 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SERINC3 |
0.99444707911102 |
|
24518 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKIG |
0.99444707911102 |
|
24519 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADA |
0.99444707911102 |
|
24520 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WISP2 |
0.99444707911102 |
|
24521 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNK15 |
0.99444707911102 |
|
24522 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIMS4 |
0.99444707911102 |
|
24523 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL31P |
0.99444707911102 |
|
24524 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YWHAB |
0.99444707911102 |
|
24525 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PABPC1L |
0.99444707911102 |
|
24526 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TOMM34 |
0.99444707911102 |
|
24527 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STK4 |
0.99444707911102 |
|
24528 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNS1 |
0.99444707911102 |
|
24529 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WFDC5 |
0.99444707911102 |
|
24530 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WFDC12 |
0.99444707911102 |
|
24531 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PI3 |
0.99444707911102 |
|
24532 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEMG1 |
0.99444707911102 |
|
24533 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SEMG2 |
0.99444707911102 |
|
24534 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLPI |
0.99444707911102 |
|
24535 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MATN4 |
0.99444707911102 |
|
24536 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBPJL |
0.99444707911102 |
|
24537 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SDC4 |
0.99444707911102 |
|
24538 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SYS1 |
0.99444707911102 |
|
24539 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TP53TG5 |
0.99444707911102 |
|
24540 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DBNDD2 |
0.99444707911102 |
|
24541 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PIGT |
0.99444707911102 |
|
24542 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WFDC2 |
0.99444707911102 |
|
24543 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPINT3 |
0.99444707911102 |
|
24544 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WFDC6 |
0.99444707911102 |
|
24545 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EPPIN |
0.99444707911102 |
|
24546 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WFDC8 |
0.99444707911102 |
|
24547 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP485 |
0.99444707911102 |
|
24548 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WFDC9 |
0.99444707911102 |
|
24549 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WFDC10A |
0.99444707911102 |
|
24550 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WFDC11 |
0.99444707911102 |
|
24551 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WFDC10B |
0.99444707911102 |
|
24552 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WFDC13 |
0.99444707911102 |
|
24553 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3617 |
0.99444707911102 |
|
24554 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPINT4 |
0.99444707911102 |
|
24555 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WFDC3 |
0.99444707911102 |
|
24556 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNU6ATAC38P |
0.99444707911102 |
|
24557 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DNTTIP1 |
0.99444707911102 |
|
24558 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2C |
0.99444707911102 |
|
24559 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TNNC2 |
0.99444707911102 |
|
24560 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX21 |
0.99444707911102 |
|
24561 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ACOT8 |
0.99444707911102 |
|
24562 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSWIM3 |
0.99444707911102 |
|
24563 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZSWIM1 |
0.99444707911102 |
|
24564 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NEURL2 |
0.99444707911102 |
|
24565 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA25 |
0.99444707911102 |
|
24566 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CTSA |
0.99444707911102 |
|
24567 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PLTP |
0.99444707911102 |
|
24568 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCIF1 |
0.99444707911102 |
|
24569 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF335 |
0.99444707911102 |
|
24570 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMP9 |
0.99444707911102 |
|
24571 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC12A5 |
0.99444707911102 |
|
24572 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCOA5 |
0.99444707911102 |
|
24573 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CD40 |
0.99444707911102 |
|
24574 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDH22 |
0.99444707911102 |
|
24575 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC35C2 |
0.99444707911102 |
|
24576 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ELMO2 |
0.99444707911102 |
|
24577 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF334 |
0.99444707911102 |
|
24578 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OCSTAMP |
0.99444707911102 |
|
24579 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC13A3 |
0.99444707911102 |
|
24580 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TP53RK |
0.99444707911102 |
|
24581 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC2A10 |
0.99444707911102 |
|
24582 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP33 |
0.99444707911102 |
|
24583 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
EYA2 |
0.99444707911102 |
|
24584 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3616 |
0.99444707911102 |
|
24585 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZMYND8 |
0.99444707911102 |
|
24586 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL243P |
0.99444707911102 |
|
24587 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NCOA3 |
0.99444707911102 |
|
24588 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SULF2 |
0.99444707911102 |
|
24589 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP486 |
0.99444707911102 |
|
24590 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD36|ENSG00000252227.1 |
0.99444707911102 |
|
24591 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00494 |
0.99444707911102 |
|
24592 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PREX1 |
0.99444707911102 |
|
24593 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARFGEF2 |
0.99444707911102 |
|
24594 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ARAP2 |
0.995206714719985 |
|
24595 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DTHD1 |
0.995206714719985 |
|
24596 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KIAA1239 |
0.995206714719985 |
|
24597 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4801 |
0.995206714719985 |
|
24598 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C4orf19 |
0.995206714719985 |
|
24599 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RELL1 |
0.995206714719985 |
|
24600 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PGM2 |
0.995206714719985 |
|
24601 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TBC1D1 |
0.995206714719985 |
|
24602 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTTG2 |
0.995206714719985 |
|
24603 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLF3 |
0.995206714719985 |
|
24604 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLR10 |
0.995206714719985 |
|
24605 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLR1 |
0.995206714719985 |
|
24606 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TLR6 |
0.995206714719985 |
|
24607 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM114A1 |
0.995206714719985 |
|
24608 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR574 |
0.995206714719985 |
|
24609 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM156 |
0.995206714719985 |
|
24610 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLHL5 |
0.995206714719985 |
|
24611 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WDR19 |
0.995206714719985 |
|
24612 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RFC1 |
0.995206714719985 |
|
24613 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KLB |
0.995206714719985 |
|
24614 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5591 |
0.995206714719985 |
|
24615 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RPL9 |
0.995206714719985 |
|
24616 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIAS |
0.995206714719985 |
|
24617 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UGDH |
0.995206714719985 |
|
24618 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SMIM14 |
0.995206714719985 |
|
24619 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2K |
0.995206714719985 |
|
24620 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL558P |
0.995206714719985 |
|
24621 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PDS5A |
0.995206714719985 |
|
24622 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP159 |
0.995206714719985 |
|
24623 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
N4BP2 |
0.995206714719985 |
|
24624 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA51|ENSG00000201863.1 |
0.995206714719985 |
|
24625 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RHOH |
0.995206714719985 |
|
24626 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHRNA9 |
0.995206714719985 |
|
24627 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RBM47 |
0.995206714719985 |
|
24628 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4802 |
0.995206714719985 |
|
24629 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NSUN7 |
0.995206714719985 |
|
24630 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
APBB2 |
0.995206714719985 |
|
24631 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238351.1 |
0.995206714719985 |
|
24632 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP160 |
0.995206714719985 |
|
24633 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UCHL1 |
0.995206714719985 |
|
24634 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LIMCH1 |
0.995206714719985 |
|
24635 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PHOX2B |
0.995206714719985 |
|
24636 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00682 |
0.995206714719985 |
|
24637 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM33 |
0.995206714719985 |
|
24638 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCAF4L1 |
0.995206714719985 |
|
24639 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC30A9 |
0.995206714719985 |
|
24640 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BEND4 |
0.995206714719985 |
|
24641 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SHISA3 |
0.995206714719985 |
|
24642 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP8A1 |
0.995206714719985 |
|
24643 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL193P |
0.995206714719985 |
|
24644 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCTD8 |
0.995206714719985 |
|
24645 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
YIPF7 |
0.995206714719985 |
|
24646 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GUF1 |
0.995206714719985 |
|
24647 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GNPDA2 |
0.995206714719985 |
|
24648 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP158 |
0.99612943734253 |
|
24649 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DDX27 |
0.99740736482268 |
|
24650 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNFX1 |
0.99740736482268 |
|
24651 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD12B |
0.99740736482268 |
|
24652 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD12C |
0.99740736482268 |
|
24653 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORD12 |
0.99740736482268 |
|
24654 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFAS1 |
0.99740736482268 |
|
24655 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNB1 |
0.99740736482268 |
|
24656 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTGIS |
0.99740736482268 |
|
24657 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
B4GALT5 |
0.99740736482268 |
|
24658 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL197P |
0.99740736482268 |
|
24659 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC9A8 |
0.99740736482268 |
|
24660 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SPATA2 |
0.99740736482268 |
|
24661 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNF114 |
0.99740736482268 |
|
24662 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239157.1 |
0.99740736482268 |
|
24663 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNAI1 |
0.99740736482268 |
|
24664 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00651 |
0.99740736482268 |
|
24665 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM189 |
0.99740736482268 |
|
24666 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
UBE2V1 |
0.99740736482268 |
|
24667 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CEBPB |
0.99740736482268 |
|
24668 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL636P |
0.99740736482268 |
|
24669 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PTPN1 |
0.99740736482268 |
|
24670 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL672P |
0.99740736482268 |
|
24671 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FAM65C |
0.99740736482268 |
|
24672 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR645 |
0.99740736482268 |
|
24673 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PARD6B |
0.99740736482268 |
|
24674 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
BCAS4 |
0.99740736482268 |
|
24675 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADNP |
0.99740736482268 |
|
24676 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DPM1 |
0.99740736482268 |
|
24677 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MOCS3 |
0.99740736482268 |
|
24678 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
KCNG1 |
0.99740736482268 |
|
24679 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NFATC2 |
0.99740736482268 |
|
24680 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR3194 |
0.99740736482268 |
|
24681 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP9A |
0.99740736482268 |
|
24682 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SALL4 |
0.99740736482268 |
|
24683 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL603P |
0.99740736482268 |
|
24684 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFP64 |
0.99740736482268 |
|
24685 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TSHZ2 |
0.99740736482268 |
|
24686 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF217 |
0.99740736482268 |
|
24687 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ADRA1D |
0.998891966465287 |
|
24688 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRNP |
0.998891966465287 |
|
24689 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRND |
0.998891966465287 |
|
24690 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PRNT |
0.998891966465287 |
|
24691 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RASSF2 |
0.998891966465287 |
|
24692 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC23A2 |
0.998891966465287 |
|
24693 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA31|ENSG00000252096.1 |
0.998891966465287 |
|
24694 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000252058.1 |
0.998891966465287 |
|
24695 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL514P |
0.998891966465287 |
|
24696 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP474 |
0.998891966465287 |
|
24697 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM230 |
0.998891966465287 |
|
24698 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PCNA |
0.998891966465287 |
|
24699 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA26|ENSG00000212517.1 |
0.998891966465287 |
|
24700 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CDS2 |
0.998891966465287 |
|
24701 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PROKR2 |
0.998891966465287 |
|
24702 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
GPCPD1 |
0.998891966465287 |
|
24703 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00654 |
0.998891966465287 |
|
24704 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00658 |
0.998891966465287 |
|
24705 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HNF4G |
0.999327731488349 |
|
24706 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238595.1 |
0.999327731488349 |
|
24707 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFHX4 |
0.999327731488349 |
|
24708 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PEX2 |
0.999327731488349 |
|
24709 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PKIA |
0.999327731488349 |
|
24710 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZC2HC1A |
0.999327731488349 |
|
24711 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IL7 |
0.999327731488349 |
|
24712 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
STMN2 |
0.999327731488349 |
|
24713 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
HEY1 |
0.999327731488349 |
|
24714 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MRPS28 |
0.999327731488349 |
|
24715 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TPD52 |
0.999327731488349 |
|
24716 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL41P |
0.999327731488349 |
|
24717 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR5708 |
0.999327731488349 |
|
24718 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNORA20|ENSG00000206649.1 |
0.999327731488349 |
|
24719 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZBTB10 |
0.999327731488349 |
|
24720 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL107P |
0.999327731488349 |
|
24721 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZNF704 |
0.999327731488349 |
|
24722 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL308P |
0.999327731488349 |
|
24723 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PAG1 |
0.999327731488349 |
|
24724 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FABP5 |
0.999327731488349 |
|
24725 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PMP2 |
0.999327731488349 |
|
24726 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FABP9 |
0.999327731488349 |
|
24727 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FABP4 |
0.999327731488349 |
|
24728 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
FABP12 |
0.999327731488349 |
|
24729 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IMPA1P |
0.999327731488349 |
|
24730 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
IMPA1 |
0.999327731488349 |
|
24731 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC10A5 |
0.999327731488349 |
|
24732 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ZFAND1 |
0.999327731488349 |
|
24733 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CHMP4C |
0.999327731488349 |
|
24734 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SNX16 |
0.999327731488349 |
|
24735 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RALYL |
0.999327731488349 |
|
24736 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000238566.1 |
0.999327731488349 |
|
24737 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRCC1 |
0.999327731488349 |
|
24738 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
E2F5 |
0.999327731488349 |
|
24739 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
C8orf59 |
0.999327731488349 |
|
24740 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CA13 |
0.999327731488349 |
|
24741 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CA1 |
0.999327731488349 |
|
24742 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CA3 |
0.999327731488349 |
|
24743 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CA2 |
0.999327731488349 |
|
24744 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REXO1L10P|ENSG00000255940.1 |
0.999327731488349 |
|
24745 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REXO1L10P|ENSG00000270416.1 |
0.999327731488349 |
|
24746 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REXO1L11P |
0.999327731488349 |
|
24747 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
REXO1L1 |
0.999327731488349 |
|
24748 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
ATP6V0D2 |
0.999327731488349 |
|
24749 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
PSKH2 |
0.999327731488349 |
|
24750 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC7A13 |
0.999327731488349 |
|
24751 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
WWP1 |
0.999327731488349 |
|
24752 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RMDN1 |
0.999327731488349 |
|
24753 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CPNE3 |
0.999327731488349 |
|
24754 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNGB3 |
0.999327731488349 |
|
24755 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CNBD1 |
0.999327731488349 |
|
24756 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DCAF4L2 |
0.999327731488349 |
|
24757 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MMP16 |
0.999327731488349 |
|
24758 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP272 |
0.999327731488349 |
|
24759 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RIPK2 |
0.999327731488349 |
|
24760 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OSGIN2 |
0.999327731488349 |
|
24761 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NBN |
0.999327731488349 |
|
24762 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
DECR1 |
0.999327731488349 |
|
24763 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
CALB1 |
0.999327731488349 |
|
24764 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LINC00534 |
0.999327731488349 |
|
24765 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RNA5SP273 |
0.999327731488349 |
|
24766 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM64 |
0.999327731488349 |
|
24767 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
NECAB1 |
0.999327731488349 |
|
24768 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
TMEM55A |
0.999327731488349 |
|
24769 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
OTUD6B |
0.999327731488349 |
|
24770 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
LRRC69 |
0.999327731488349 |
|
24771 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SL777P |
0.999327731488349 |
|
24772 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
MIR4661 |
0.999327731488349 |
|
24773 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
SLC26A7 |
0.999327731488349 |
|
24774 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
snoU13|ENSG00000239134.1 |
0.999327731488349 |
|
24775 |
Head and Neck squamous cell carcinoma (HNSC) |
Cetuximab |
RN7SKP231 |
0.999327731488349 |
|